Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.7505565624929764,2.025958729532585,0.0,0.14197399637752023,0.08,4/31,2.47%,GPC4;UGDH;HSPG2;GPC1
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.7654507719560629,1.9449777031666926,0.0,0.35493499094380054,0.31,6/25,4.40%,UGDH;DSEL;BGN;BCAN;VCAN;CHST7
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.8364055964354962,1.9247784068704594,0.0,0.3016947423022305,0.37,4/11,4.20%,DSEL;BGN;BCAN;VCAN
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.7468772726837489,1.9071802042361705,0.0,0.32831486662301546,0.44,6/25,4.40%,UGDH;BGN;BCAN;B3GAT2;VCAN;CHST7
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),0.871428155116899,1.9022096547346845,0.0,0.27329994302672644,0.44,4/11,7.98%,BANF1;H1-10;NOC2L;H1-4
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.8191822083044958,1.892068116381485,0.0,0.25437007684305707,0.46,4/13,4.20%,DSEL;BGN;BCAN;VCAN
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.7762486802568809,1.8886955547156201,0.0,0.24338399379003467,0.48,5/32,5.67%,USP51;RFWD3;SMYD2;UBE2N;FXR2
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.6910153691274358,1.8665077626983675,0.0,0.28838468014183793,0.6,22/74,10.81%,NOX4;STOX1;SIRT2;HSPA1A;GPX1;LRRC8D;PRR5L;GSTP1;TMEM161A;PYCR1;PRDX1;SLC25A24;ZFAND1;PRDX6;PPIA;CAT;PARP1;PRDX5;MT3;TXNRD1;ATF4;PRDX3
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.8722387148424757,1.8635351510013909,0.0,0.27211682639024704,0.63,1/10,0.01%,CPA1
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.7356396352516151,1.8431481130367668,0.0,0.3247655167135775,0.71,5/25,10.54%,UBB;CCDC88C;IKBKB;MAPK11;UBC
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),0.8897279190686327,1.8330642522154903,0.0,0.33234821879283144,0.73,2/10,7.70%,VPS37B;CHMP2A
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),0.8049529867261567,1.8226975766622506,0.03571428571428571,0.3608505741261972,0.77,5/19,5.35%,MMP2;LAMA3;COL12A1;COL8A1;ITGB5
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),0.8654227069584066,1.8191614169397858,0.0,0.31944149184942056,0.78,2/14,1.73%,CUBN;CD320
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),0.8654227069584066,1.8191614169397858,0.0,0.31944149184942056,0.78,2/14,1.73%,CUBN;CD320
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.858220239788098,1.8174613097673866,0.0,0.3087934421211065,0.78,2/11,4.11%,CXCL12;TMEM161A
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.725944607264328,1.8173423049043307,0.0,0.28949385198853733,0.78,16/53,7.02%,EIF5A;PPP1R14B;DHCR7;TUBG1;SLC25A1;TUBA1C;NR2F6;TRIM28;FKBP4;PYCR1;KDELR1;TRAF4;CCT3;RPL8;SSRP1;NOC2L
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),0.9558619336913945,1.807970115632068,0.0,0.2975190365264211,0.79,3/7,1.48%,MMP2;CCND1;OPN3
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.8428841220348153,1.7983902173993094,0.0,0.3066243949542277,0.82,3/10,4.20%,BGN;BCAN;VCAN
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.8364999563518576,1.7970605483985433,0.0,0.29328838725356154,0.82,4/10,4.20%,DSEL;BGN;BCAN;VCAN
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.7546761284935655,1.7853444040671578,0.0,0.318554154372061,0.85,10/25,12.13%,DHCR7;ARV1;ACAA2;MSMO1;TM7SF2;SQLE;ACLY;LBR;HMGCS1;HMGCR
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),0.8176071657659743,1.7707909801146398,0.04,0.3540899076320296,0.86,4/15,8.43%,GPNMB;FGL1;THY1;DUSP3
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),0.833121397959581,1.769452629815758,0.037037037037037035,0.3420282640003896,0.86,3/12,7.70%,SNF8;SMPD3;CHMP2A
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.8703081124323881,1.7669296909281567,0.0,0.3379598392030101,0.87,1/9,2.64%,TSR1
prerank,GO_Biological_Process_2021__heart process (GO:0003015),0.9719038914460572,1.766619447303133,0.02857142857142857,0.3246176271340176,0.87,2/7,1.24%,NOX4;GPX1
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.8727284479411307,1.764716477465418,0.0,0.3187316218675329,0.87,3/9,3.27%,SIRT2;BTC;TGFA
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),0.8542061017255748,1.764011970562309,0.0,0.31125068436610204,0.87,3/16,2.98%,EIF5A;UBB;PLA2R1
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.7699014654902332,1.755143607487383,0.0,0.32601436205208345,0.89,10/23,12.13%,DHCR7;ARV1;ACAA2;MSMO1;TM7SF2;SQLE;ACLY;LBR;HMGCS1;HMGCR
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.6223610630125679,1.754336652087268,0.0,0.3156386169464512,0.89,11/75,5.67%,SOX4;PIWIL2;PLD1;AURKAIP1;BAD;NR1H2;EIF3D;MSN;NPM1;EEF2;FXR2
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),0.8106369148477496,1.7514147757473884,0.0,0.31332192304004464,0.9,4/14,3.59%,THNSL2;HSD17B10;AADAT;HPD
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.5404994021793194,1.7436256568951976,0.0,0.33068109989597416,0.95,11/69,5.75%,GPC4;UGDH;DSEL;BGN;HSPG2;GPC1;BCAN;B4GALT3;VCAN;CHST7;B4GALT6
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.6748404245337547,1.7426320106507611,0.0,0.3257387255597137,0.95,10/37,12.84%,GPC4;UGDH;HSPG2;GPC1;B3GAT2;HS3ST1;SGSH;SDC2;GUSB;EXT2
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.7817639126469628,1.7375197979506072,0.0,0.3366336554732608,0.95,10/22,12.13%,DHCR7;ARV1;ACAA2;MSMO1;TM7SF2;SQLE;ACLY;LBR;HMGCS1;HMGCR
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.7493092250882318,1.732924974140842,0.0,0.3431038245790072,0.95,5/19,4.40%,UGDH;BGN;BCAN;VCAN;CHST7
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.7691984652809941,1.7320529236789757,0.047619047619047616,0.3361443149526582,0.96,6/22,8.71%,MMP2;LAMA3;COL12A1;COL8A1;ITGB5;CDC73
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.7165901092315273,1.7217594389897295,0.0,0.37166764051686546,0.96,3/19,6.18%,SOX11;CRB2;RBPJ
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.8728261809680323,1.7206558481620862,0.03225806451612903,0.364794296247795,0.96,2/8,6.60%,UNC119B;ZDHHC3
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.6498294198258345,1.7012024647371256,0.0,0.42784055665117576,0.98,6/28,7.18%,NOX4;AADAT;THAP4;PYCR1;SRR;OAT
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.742890668017271,1.6949476254083056,0.0,0.44413575840467673,0.99,3/15,4.64%,SOX4;BAD;NLGN2
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),0.7328793242159047,1.6932111738799478,0.0,0.43911829007790715,0.99,5/24,12.59%,POLR2J;POLR2L;POLR2K;GTF2F1;POLR2E
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.6586624377035992,1.692460412935345,0.0,0.43124601399671764,0.99,15/42,13.22%,DHCR7;STARD3;ARV1;ACAA2;FDX1;MSMO1;TM7SF2;SQLE;ACLY;MT3;LBR;SNX17;HMGCS1;HMGCR;SOAT1
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),0.9481417882765606,1.6921033473250213,0.0,0.4224592087331089,0.99,1/5,2.41%,CUL7
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.846406362732018,1.6867839874789796,0.0,0.43690807218558303,1.0,3/10,1.54%,SOX4;SOX11;ASCL1
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.9576628211732345,1.684770214057976,0.0,0.43665258188202444,1.0,1/8,0.09%,NOX4
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),0.9111894235450915,1.6839444615870944,0.0,0.43076201173633977,1.0,3/7,1.15%,SOX11;GPNMB;FGL1
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.7357230064230114,1.680003039484394,0.0,0.43657003886087464,1.0,8/20,13.07%,UBB;TAB3;MAP2K6;UBE2N;RIPK2;UBC;INAVA;OTULIN
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.824177103843618,1.6713642035566956,0.03333333333333333,0.4776190421613316,1.0,2/17,3.97%,USP51;ATXN7L3
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",0.6078006225037951,1.6651648102486378,0.0,0.49728657773721846,1.0,11/47,13.09%,TAF1A;ACTB;H1-10;POLR2L;POLR1F;WBP2;H1-4;POLR2K;POLR1A;POLR2E;BAZ1B
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.6056952671814829,1.6645061458786514,0.0,0.49062368019002434,1.0,23/94,10.81%,NOX4;SIRT2;HSPA1A;GPX1;PRR5L;GSTP1;PLA2R1;PDGFRA;TMEM161A;PYCR1;PRDX1;SLC25A24;ZFAND1;PRDX6;PPIA;CAT;PARP1;JUN;PRDX5;MT3;TXNRD1;ATF4;PRDX3
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.9395884954623177,1.6581337508833334,0.0,0.5179153439281987,1.0,1/5,1.55%,EYS
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.8697099029228305,1.6494844980063936,0.04,0.5473097560353405,1.0,1/12,0.01%,CPA1
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.7767770831547016,1.6493051472999456,0.0,0.5372741431541451,1.0,4/28,1.66%,EIF5A;UBB;BAD;STYXL1
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),0.7656704549975821,1.6488471091643562,0.0,0.5293309336094564,1.0,4/28,4.36%,SIRT2;UBB;PHB2;UBE2D1
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.8786694871995183,1.6427312959711462,0.037037037037037035,0.5471356369831794,1.0,3/7,6.73%,SOX11;PDGFRA;EPHB3
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),0.8687624576518745,1.6426994697052986,0.03125,0.5272397956383363,1.0,1/5,5.04%,KMT5B
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),0.8687624576518745,1.6426994697052986,0.03125,0.5272397956383363,1.0,1/5,5.04%,KMT5B
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),0.8582879996756511,1.6416041346553627,0.0,0.5232122054001918,1.0,2/7,5.43%,PHB2;PPIF
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.5943774538380813,1.641509710434306,0.0,0.5140330439019427,1.0,14/64,10.83%,SOX4;PIWIL2;PLD1;EIF3D;CHRNA7;NPM1;EEF2;FXR2;LRRTM3;SP1;SMPD3;EIF4A3;NAT10;POLDIP3
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.743549655536788,1.6400197680169357,0.0,0.5091481249400726,1.0,7/17,13.06%,SOX11;MOB3B;WTIP;LIMD1;WWC2;SHANK2;WWC1
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.747488689704445,1.6327369509922633,0.08,0.5372151642590066,1.0,3/11,1.96%,ACTB;ACTG1;LAMA3
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.8757452291101382,1.6324808962185038,0.0,0.5300362531427422,1.0,2/7,1.51%,UGDH;LRRC8D
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),0.7520581732153508,1.632210938958909,0.07407407407407407,0.5225108555205458,1.0,2/14,0.49%,SOX4;SOX11
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),0.839047474179417,1.6243374601436458,0.06451612903225806,0.5538703286098823,1.0,4/12,2.85%,DHCR7;STARD3;TSPO;FDX1
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.8428101147714067,1.6229464568818546,0.0,0.5538112636472317,1.0,2/10,0.49%,SOX4;SOX11
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.7470316234099985,1.6226260314885945,0.0,0.5490400641161914,1.0,4/17,14.39%,UBB;RNF139;UBC;UGGT1
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.782982312570698,1.6226032405950874,0.03333333333333333,0.54086632081513,1.0,5/11,13.63%,LSM4;EDC3;LIMD1;RC3H1;PATL1
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.7095170072374865,1.619812341103624,0.058823529411764705,0.5387595310296197,1.0,2/17,2.08%,GPC4;SLITRK2
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.7095170072374865,1.619812341103624,0.058823529411764705,0.5387595310296197,1.0,2/17,2.08%,GPC4;SLITRK2
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),0.7069397261491643,1.6197548781839424,0.0,0.5318805231937247,1.0,3/22,2.47%,GPC4;ACTB;GPC1
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),0.9555913644047882,1.6132665148705336,0.0,0.5591512103708859,1.0,2/5,3.65%,SOX11;PDGFRA
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.7159375067491235,1.6128544379691074,0.03571428571428571,0.5534450608787975,1.0,5/15,15.97%,SIRT2;CALM3;SMAD7;CALM1;CADM4
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.6855593912380806,1.6121255889686261,0.0,0.5486495106490438,1.0,4/30,3.78%,NR0B1;CALR;RNF6;ESR1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.8228658134699562,1.6111806870037388,0.0,0.5471914443716924,1.0,2/10,4.03%,DSEL;B3GAT2
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),0.9557618929415214,1.6109854175707443,0.0,0.5404249896356634,1.0,2/5,3.29%,UBE2D4;RNF6
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),0.6467681061691478,1.6106802866088044,0.0,0.534321053934316,1.0,19/73,9.56%,AURKAIP1;MRPL10;CHCHD1;MRPL15;MRPL11;MRPS33;MRPL28;MRPL44;MRPS12;MRPS26;MRPL47;MRPL36;MRPL40;MRPS16;TUFM;MRPS18A;MRPL13;MRPL52;MRPL4
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.7966261916913938,1.6103925373175791,0.04,0.5286165131789669,1.0,1/12,0.20%,SYNDIG1
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.753258896395162,1.6103627252735637,0.0,0.5221280524673277,1.0,6/18,10.54%,UBB;TAB3;MAP2K6;UBE2N;RIPK2;UBC
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.789228217405568,1.6030438090406995,0.0625,0.5538368722324368,1.0,3/9,12.51%,CFL1;TENM4;PLCB1
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.7283591378413841,1.6020401722972695,0.05,0.5517418929735362,1.0,2/10,4.06%,CFL1;KIF25
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.5920847953733434,1.5995727184585111,0.0,0.5586856471374886,1.0,19/56,14.03%,SOX11;EMILIN3;TUBB2B;RND2;DNMT3B;SALL2;TOX3;CXCL12;GAL3ST3;SEMA5B;MYCN;MEX3A;KCNQ2;SALL3;LINGO1;TRIM71;DPYSL5;NLGN4X;GRID2
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.9652870072771013,1.5972352172849535,0.03125,0.5616846231685644,1.0,1/7,0.29%,FERMT1
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.632200021719836,1.5959968946791352,0.0,0.56154221098084,1.0,7/32,4.89%,SOX11;SOX8;KLHL12;PEF1;SEMA5A;SOX10;SEMA5B
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),0.6381247284297421,1.593327741402839,0.0,0.5687616806099437,1.0,18/74,9.56%,AURKAIP1;MRPL10;CHCHD1;MRPL15;MRPL11;MRPS33;MRPL28;MRPL44;MRPS12;MRPS26;MRPL47;MRPL36;MRPL40;MRPS16;MRPS18A;MRPL13;MRPL52;MRPL4
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.8808710242109636,1.5917108217237865,0.03125,0.5704617806253373,1.0,2/7,6.92%,YAP1;WBP2
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),0.9489289486370235,1.5915863372308168,0.025,0.5643043814350542,1.0,1/5,1.51%,LRRC8D
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.581357450329011,1.590318954168012,0.0,0.5645554208894334,1.0,11/57,11.43%,DAPL1;MLST8;TFEB;RRAGA;ATP6V0E1;ATP6V1G1;LAMTOR2;ATP6V1B2;ATP6V0D1;ATF4;MIOS
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),-0.916911361177206,-1.5899990160683084,0.0,1.0,0.81,2/10,1.60%,HEY2;HES1
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.6547850350563228,1.589755642822443,0.06666666666666667,0.5621179740296004,1.0,6/36,7.60%,STOX1;WDR18;UBE2N;SUB1;KPNA2;SMARCAD1
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.6815784849807117,1.5861677570580934,0.03225806451612903,0.5821749793986246,1.0,5/26,10.32%,COPZ1;COG3;GOSR1;COG6;RAB6A
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),0.6904499304620467,1.5839688183247473,0.06666666666666667,0.588466081576142,1.0,6/35,12.59%,POLR2J;POLR2L;LARP7;POLR2K;GTF2F1;POLR2E
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.8237198747053474,1.5819993586772263,0.06666666666666667,0.5864314794815905,1.0,2/6,6.35%,SIRT2;BCAR1
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.8237198747053474,1.5819993586772263,0.06666666666666667,0.5864314794815905,1.0,2/6,6.35%,SIRT2;BCAR1
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),0.8537240479801166,1.5801358248988673,0.05555555555555555,0.5899331580247235,1.0,2/7,2.63%,FBLN5;DHFR
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),0.8685291153948855,1.5799137602254125,0.03333333333333333,0.5839066399928718,1.0,2/7,0.51%,EIF5A;UBB
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.6993865707887912,1.5770789470198574,0.05,0.5942298719349435,1.0,4/21,3.99%,ZNF488;SOX4;SOX11;SOX10
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.5498530043964212,1.57541729023004,0.0,0.5950824954547125,1.0,9/153,4.57%,CPA1;MMP2;MMP16;MALT1;NCSTN;CUL7;CTSV;CTSC;CTSA
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),0.7403888888575465,1.5749238859092012,0.037037037037037035,0.5919942033162653,1.0,5/16,7.42%,CUBN;CD320;SLC5A6;ABCG2;SLC2A10
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.6615458712751838,1.570121780192179,0.0,0.6117082734547062,1.0,15/48,13.87%,MMP2;OPN3;COPS9;TMEM161A;NPM1;RUVBL2;SMPD1;NOC2L;PARP1;ZBTB1;SDE2;ATF4;N4BP1;ERCC4;SIRT1
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.7641462652966542,1.569970706721172,0.043478260869565216,0.6063167834988428,1.0,3/14,7.65%,GPC4;SLITRK2;PTPRF
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.8079679657864351,1.5690316824145776,0.034482758620689655,0.6062869131019614,1.0,2/7,13.87%,DHFR;CALM1
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),0.8624383459266076,1.5667856282665769,0.0,0.6096635879797301,1.0,2/8,5.74%,WDR18;METTL4
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.8877504870284988,1.5628630510479329,0.02564102564102564,0.6234433115927857,1.0,1/5,1.20%,LPCAT1
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),0.9158279237883515,1.5627423175240256,0.0,0.6112189329341036,1.0,2/5,3.64%,SNF8;VPS28
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),0.9158279237883515,1.5627423175240256,0.0,0.6112189329341036,1.0,2/5,3.64%,SNF8;VPS28
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.8424478224868867,1.56256156015559,0.03333333333333333,0.6064908583117369,1.0,3/11,9.10%,GPX1;PPIF;PSMD10
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.8552797410939785,1.5620080383286477,0.10344827586206896,0.6042426937173067,1.0,3/8,8.25%,SIRT2;BOK;FZD3
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.7413992482538676,1.5618334861306389,0.05555555555555555,0.5993330847079603,1.0,4/18,16.10%,PCBP4;TMBIM6;SAP18;SRSF9
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.8881045721129102,1.5616912178296645,0.034482758620689655,0.5936789990031682,1.0,1/7,2.47%,UNC119B
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.6793853227983272,1.5614320973702571,0.0,0.5899550293397656,1.0,2/25,1.24%,CPA1;GPX1
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,0.5078983454235094,1.5600703933804538,0.0,0.590243744199135,1.0,44/174,16.06%,NDUFB1;IDH1;MRPL15;ACAA2;MRPL11;HSD17B10;PHB2;FDX1;NDUFA5;ACADVL;NDUFS3;NDUFS6;ECH1;ATP5MC1;MRPS12;SLC25A20;ATP6V0E1;OAT;ATP5F1A;GRPEL1;DLD;ATP6V1G1;ALDH6A1;UQCRC1;NDUFB7;MTX2;UQCR10;TIMM13;PRDX3;SUCLA2;NDUFS8;SLC25A4;PDP1;ISCA1;COX6B1;GPX4;ATP5F1D;NDUFA6;CYB5R3;ATP5PD;ISCU;NDUFB3;IDH3G;TIMM50
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.7830137252190601,1.5582716478543077,0.037037037037037035,0.5924809321305,1.0,2/10,4.80%,VEZF1;LGALS3BP
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.8972443193212674,1.5580564132906953,0.0,0.5890307508799162,1.0,1/6,3.36%,EIF3D
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.8697693516379951,1.5574825978301332,0.0,0.5878810638289885,1.0,2/5,4.27%,TGFBR2;LYN
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.8216495103566068,1.5574614104085818,0.06060606060606061,0.5826321257590868,1.0,4/9,8.95%,SIRT2;HSPA1A;BAG3;JUN
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.6419247667371529,1.551951071266906,0.0,0.6038606372473068,1.0,19/80,9.56%,AURKAIP1;TRMT112;MRPL10;CHCHD1;MRPL15;MRPL11;MRPS33;MRPL28;MRPL44;MRPS12;MRPS26;MRPL47;MRPL36;MRPL40;MRPS16;MRPS18A;MRPL13;MRPL52;MRPL4
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.7986094100655887,-1.5508067831182675,0.0,1.0,0.99,5/21,10.54%,HEY2;HES1;TTN;CAV3;VEGFA
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),0.7775584814842915,1.5504970036073955,0.043478260869565216,0.6058802564707333,1.0,3/11,12.23%,LRRC8D;SLC25A24;SLC25A4
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.7878426052719764,1.5501243887280438,0.08333333333333333,0.6018462889916618,1.0,5/10,18.51%,LRRC8D;SLC1A2;SLC25A30;SLC25A11;SLC25A14
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.8132869525501946,-1.5490798057245667,0.0,1.0,0.99,7/20,10.62%,MAP3K19;DUOX1;CP;FMO6P;FMO3;TMC4;FUT2
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.7291759945839177,1.54788227052988,0.06060606060606061,0.6087441073126648,1.0,4/9,18.07%,NLGN2;NLGN3;NLGN4X;NLGN1
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.8782906149814398,1.5460572446211696,0.07142857142857142,0.6130971082883939,1.0,2/5,4.27%,CXCL12;LYN
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.7225267668279804,1.545511642089703,0.0625,0.6110596899172295,1.0,2/27,1.48%,CRB2;CFL1
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.7605839694085685,1.544822366733219,0.0,0.6086091168242227,1.0,5/13,12.98%,GPX1;NT5E;PNP;NT5C1A;DERA
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),0.8217337219379061,1.5439516011777326,0.0,0.6072346136730188,1.0,4/9,10.41%,SPCS2;SEC11C;HM13;SEC11A
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),0.8130684397849535,1.5420590979763191,0.037037037037037035,0.60822950720824,1.0,2/11,3.33%,IDH1;AADAT
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),0.784239090275784,1.5391428129827989,0.0,0.621136234151651,1.0,4/10,12.44%,GPX1;NT5E;PNP;NT5C1A
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.7025032008919856,1.5387234075888034,0.05555555555555555,0.6185391488520622,1.0,7/21,14.91%,HSPA1A;ERN1;BAG3;TMBIM6;HSPA8;TM7SF3;HSPA5
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.765670853083525,1.5374393206895949,0.0,0.6201344015159225,1.0,1/9,0.31%,DGKB
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.7854681298662378,-1.5368749048300938,0.011627906976744186,1.0,1.0,2/37,1.05%,IL5;PIP4K2C
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.8674314184199443,1.536684099016698,0.0625,0.6188646502096106,1.0,3/8,8.43%,GPNMB;FGL1;DUSP3
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.8911416304933997,-1.5360602691921899,0.0,1.0,1.0,2/9,4.01%,SOX9;SRF
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.6158719617925738,1.53570871590019,0.1111111111111111,0.6187418314349665,1.0,11/45,11.01%,DAPL1;SIRT2;TAB3;LZTS1;KIF25;CTSA;RRAGA;LEPR;MT3;EIF4E;ZKSCAN3
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),-0.8205247712765684,-1.5310223529141525,0.012195121951219513,1.0,1.0,3/22,6.59%,ABLIM1;VCL;P2RY12
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.8847238024217134,-1.5302846059122668,0.0,1.0,1.0,2/15,1.83%,CD44;NR4A3
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),0.9019195519593023,1.5268142050080464,0.0,0.658865544212606,1.0,1/6,0.23%,NR0B1
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.5938545282081418,1.525868624973728,0.0,0.65829349101608,1.0,10/74,5.83%,SOX4;EIF5A;PIWIL2;PLD1;CNBP;EIF3D;NPM1;EEF2;FXR2;CDC123
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.6281477660186789,1.5253709349651743,0.058823529411764705,0.6553915879287852,1.0,7/31,11.61%,PMEPA1;YAP1;ESR1;DDX54;WBP2;NR3C1;TRIP4
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.659736668711452,1.5250285494220908,0.05555555555555555,0.6536264371688143,1.0,4/22,8.70%,SOX4;BAD;NLGN2;TRPM4
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.6150795735475335,1.5243586298707932,0.0,0.6525655921283537,1.0,15/37,22.12%,HSPA1A;ERN1;BAG3;TMBIM6;HSPA8;HSPA4;TM7SF3;HSPA5;DNAJA1;HSPB1;HERPUD1;STT3B;HSPH1;OPTN;PTPN1
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.7286473730396399,1.5211249868939105,0.0,0.6636208770070452,1.0,9/26,16.14%,CRB2;MSN;LIN7C;RAP2A;CAMSAP3;PARD3B;RHOA;LIN7B;CDC42
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5897388679712205,1.520694881252139,0.0,0.6606327594596829,1.0,16/52,13.87%,UBB;HSPA1A;PMEPA1;TGFBR2;PPM1A;SLC2A10;BAMBI;SPRY1;VEPH1;SMURF2;UBC;SMAD3;TGFBR1;PEG10;SMAD7;SIRT1
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),0.5964202135352542,1.5203409872540246,0.0,0.6579541175405975,1.0,19/88,9.56%,AURKAIP1;MRPL10;CHCHD1;MRPL15;MRPL11;MRPS33;MRPL28;MRPL44;MRPS12;MRPS26;MRPL47;MRPL36;MRPL40;MRPS16;TUFM;MRPS18A;MRPL13;MRPL52;MRPL4
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.7611870602614195,1.5199292292473972,0.07692307692307693,0.6557095314176582,1.0,5/13,9.89%,TMEM9;PPT1;ATP6V0A4;ATP6V0E1;ATP6V0D1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),0.8702399063449995,1.5198078823040164,0.02631578947368421,0.6512796102207753,1.0,3/6,9.27%,NR1H2;MID1IP1;ABCD2
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),-0.8264980322344035,-1.5181128294311237,0.012195121951219513,1.0,1.0,4/16,7.54%,HEY2;SOX9;EFNA1;ROBO2
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.5769089941614107,1.5173653626472645,0.0,0.6610340360533629,1.0,11/58,11.43%,DAPL1;MLST8;TFEB;RRAGA;ATP6V0E1;ATP6V1G1;LAMTOR2;ATP6V1B2;ATP6V0D1;ATF4;MIOS
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),0.8555110354715938,1.5166858368512235,0.030303030303030304,0.6599733237404292,1.0,2/5,7.14%,PRR5L;SYAP1
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),0.7106878044870756,1.5152124868222763,0.08333333333333333,0.6642902006764728,1.0,5/13,3.99%,SOX4;SOX11;ASCL1;SOX8;SOX10
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.7240160733557928,1.5138493520867409,0.16,0.6670242579808138,1.0,4/13,3.48%,SOX11;SOX8;KLHL12;PEF1
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),-0.8107062277706192,-1.5132889620415308,0.0125,1.0,1.0,4/19,7.54%,HEY2;SOX9;EFNA1;ROBO2
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.9083003667221912,1.5132835025304128,0.05128205128205128,0.6646849954518478,1.0,3/6,2.85%,STARD3;TSPO;FDX1
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.9031016348651155,-1.5096943721750828,0.0,1.0,1.0,2/9,2.02%,HEY2;EMP2
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.8199067484090893,1.509330620559565,0.0625,0.6851245142091248,1.0,5/10,11.16%,SOX11;TGFBR2;PDGFRA;EIF4A3;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.8938788515495839,1.5075534569473443,0.10344827586206896,0.6910063040472313,1.0,2/5,7.59%,SIRT2;BOK
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),0.8500040432200869,1.5064580590855798,0.06666666666666667,0.6901513712796121,1.0,1/6,0.87%,TRMT112
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),0.8929709288481997,1.5058153320668313,0.0,0.6882067083024105,1.0,2/6,6.11%,POP5;POP4
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),0.8612543649931702,1.5043293810478597,0.09090909090909091,0.6863283753454102,1.0,2/7,5.57%,CRB2;LIN7C
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),0.8612543649931702,1.5043293810478597,0.09090909090909091,0.6863283753454102,1.0,2/7,5.57%,CRB2;LIN7C
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.7962699799324626,1.5033479738425746,0.09090909090909091,0.6858878879049117,1.0,1/9,0.85%,SMDT1
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.8111261760611214,1.5025759476586056,0.06666666666666667,0.6842622560309175,1.0,3/12,3.41%,MOSPD2;CALR;CXCL12
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.6406314545008615,1.501979818183216,0.07142857142857142,0.683368169230464,1.0,2/19,5.33%,NOX4;CDO1
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.7123913765572962,1.5013858817986425,0.1,0.6810755869269285,1.0,5/10,16.14%,MSN;RAP2A;CAMSAP3;RHOA;CDC42
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.8820930070742149,1.5013770502421637,0.03125,0.6765948264866198,1.0,1/6,0.65%,RFWD3
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),-0.7964344758988839,-1.498528310009774,0.01282051282051282,1.0,1.0,3/25,6.59%,ABLIM1;VCL;P2RY12
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.6462688779169776,1.4965865934197635,0.06666666666666667,0.6957189789806915,1.0,6/25,8.97%,HSPA1A;ERN1;BAG3;TMBIM6;DNAJB12;HSPA8
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.7357619700262881,1.4937669207913218,0.0,0.7030709025156258,1.0,3/16,5.77%,FERMT1;MSN;RAP2A
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.7351369164271275,1.4933714680283123,0.09090909090909091,0.7004813789013458,1.0,5/14,22.30%,PCBP4;SAP18;SRSF9;BARD1;SRSF7
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.7376636069024056,-1.4933522754299773,0.012195121951219513,1.0,1.0,9/28,12.75%,SYT1;UNC13C;CPLX1;STX1B;STX19;RIMS1;RAB3A;SYT2;SNAP25
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),0.7965828652466241,1.4909637669346987,0.041666666666666664,0.7091874145973246,1.0,4/10,12.44%,GPX1;NT5E;PNP;NT5C1A
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),0.8360913876053807,1.4904183281331607,0.09090909090909091,0.7084005058104452,1.0,1/8,0.29%,FERMT1
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.7979200867166176,1.4878805884094055,0.09375,0.7126603513132599,1.0,2/9,9.32%,CHMP2A;VTA1
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.7979200867166176,1.4878805884094055,0.09375,0.7126603513132599,1.0,2/9,9.32%,CHMP2A;VTA1
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.5336765268447531,1.487355002296866,0.0,0.7120883255809999,1.0,11/89,5.18%,SOX4;UGDH;SOX11;OLIG2;ASCL1;MYT1L;OLIG1;PPT1;EPHA5;POU3F2;WNT3
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.6660780015087505,1.4858191848950366,0.07142857142857142,0.7169245904032542,1.0,3/20,2.47%,GPC4;HSPG2;GPC1
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.6801800959991263,1.4848654753006651,0.09523809523809523,0.7176478782940856,1.0,5/21,5.69%,TUBG1;RAN;KIF25;WRAP73;CHAMP1
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),-0.8334360853715815,-1.4828658677027056,0.0,1.0,1.0,3/14,1.83%,SOX9;FABP3;NR4A3
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.612937371174163,1.4813280267698474,0.037037037037037035,0.7330605196394505,1.0,3/26,2.95%,PANX1;MALT1;GSTP1
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.7548659864825611,1.4811106193613057,0.045454545454545456,0.7298891810719312,1.0,3/13,16.10%,PCBP4;SAP18;SRSF9
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.6445314841909819,1.479352729481938,0.1111111111111111,0.73428520702222,1.0,8/23,18.27%,SOX4;MAP2;CEND1;GRID2;FAIM2;MDGA2;TOX;LRP6
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),0.8813927682068067,1.477486588029374,0.05555555555555555,0.7392697175832472,1.0,2/6,9.08%,PRDX1;MT3
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.8003294005694621,1.4768306687550605,0.06666666666666667,0.7388811353389956,1.0,2/11,5.75%,MAP2;B4GALT6
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),-0.8994879654793108,-1.4763197827806973,0.02857142857142857,1.0,1.0,3/10,4.65%,GLRA2;GRIN2A;GLRA1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.5841153580860335,1.4761489274701163,0.0,0.738180272831928,1.0,4/29,6.31%,USP51;PPP4C;PML;MGMT
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),0.8531496178110519,1.475441680346689,0.06060606060606061,0.7381177666698148,1.0,3/8,6.11%,HSD17B10;POP5;POP4
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.7099785993631337,1.47533960229251,0.043478260869565216,0.7345066459648767,1.0,4/14,19.98%,TNFAIP1;KCTD13;KCTD10;KANK1
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.8243179799840746,-1.475172222621003,0.01282051282051282,1.0,1.0,4/16,7.28%,IHO1;SYCE2;RNF212B;STAG3
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),0.7866815051300824,1.4750588858206257,0.03125,0.731871800039673,1.0,5/8,18.98%,LSM1;DCPS;EDC3;PATL1;DCP1A
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.9018350046760343,-1.475021325569458,0.015384615384615385,1.0,1.0,1/6,6.70%,RNF213
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.8218349927481613,1.4746428464533583,0.13793103448275862,0.7305057371750314,1.0,1/9,0.64%,CRB2
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),0.784481312309445,1.4722956663974827,0.10344827586206896,0.7414653510236389,1.0,3/9,9.86%,NT5E;MSN;CERCAM
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.7174865790336985,1.4720509556399224,0.0967741935483871,0.7384279696646885,1.0,4/10,18.07%,NLGN2;NLGN3;NLGN4X;NLGN1
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),-0.7824474728177591,-1.4716591033071478,0.023529411764705882,1.0,1.0,8/24,14.52%,HTR2C;GRIN2A;ITPR1;PTPRC;GRIN2D;RYR3;HTR2B;SLC24A2
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),0.5405967748935655,1.471343943278498,0.0,0.7393802911346429,1.0,8/65,6.26%,GPC4;UBB;TCF7L1;CCDC88C;PORCN;KLHL12;WNT3;FRZB
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.8742329754354246,-1.4706907334230415,0.014925373134328358,1.0,1.0,4/9,6.91%,HEY2;TTN;MYLK;ZFPM1
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),0.7458009419586159,1.4701266455712159,0.03571428571428571,0.7417334640291467,1.0,5/8,22.87%,NOC2L;RBBP4;TP53;SUV39H2;MTA2
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.7832058825574971,1.469145735708961,0.1111111111111111,0.7415534443560308,1.0,4/8,16.27%,ZDHHC21;FUT9;RHOA;ETS1
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),-0.9298057440463643,-1.4689215161016478,0.0,1.0,1.0,2/8,0.68%,HEY2;SOX9
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),0.810623257182542,1.4681330693483121,0.058823529411764705,0.7433694641789261,1.0,2/8,7.98%,H1-10;H1-4
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),-0.9627965503286936,-1.4673835995119884,0.0,1.0,1.0,1/5,0.56%,ENPP2
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),0.8607855361249321,1.4662584735645887,0.058823529411764705,0.7502215297407091,1.0,3/7,12.48%,CBLL1;PPIA;GRB2
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.8360333259484596,1.4653808809815656,0.06666666666666667,0.7484029795232127,1.0,4/8,8.87%,ABHD10;PPT1;ABHD17B;LYPLAL1
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.8360333259484596,1.4653808809815656,0.06666666666666667,0.7484029795232127,1.0,4/8,8.87%,ABHD10;PPT1;ABHD17B;LYPLAL1
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.5606854956419801,1.464393664392,0.0,0.7500439424010202,1.0,21/87,13.01%,SOX4;UBB;MALT1;HSPA1A;VPS28;UBE2D1;UBE2N;UBXN1;PRICKLE1;BAG2;COMMD1;PSMD10;PTTG1IP;RIPK2;TGFBR1;INAVA;N4BP1;RCHY1;CHP1;SMAD7;PRR7
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),0.8326406068433924,1.4642739165197345,0.06060606060606061,0.7467211558107278,1.0,1/5,8.99%,RPRD1B
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.9051120077116107,1.4640492458234846,0.038461538461538464,0.7432415870143824,1.0,1/5,1.00%,HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),0.8544285080150253,1.46253661130663,0.029411764705882353,0.7467064782450118,1.0,1/7,0.50%,SIRT2
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.676157427538753,1.4625075130559848,0.07692307692307693,0.7427873399186793,1.0,5/16,16.07%,ESR1;PIH1D1;RUVBL2;PPHLN1;LRWD1
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.832501813488445,1.462095355726863,0.07692307692307693,0.740808165590189,1.0,4/12,4.15%,BANF1;RBM15B;NUTF2;NPM1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.9194906902588372,-1.4618192843836422,0.015625,1.0,1.0,1/6,6.70%,RNF213
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),0.6847235407096743,1.4617868046000146,0.11538461538461539,0.7385668534958233,1.0,3/13,7.70%,VPS37B;KPNA2;CHMP2A
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.7182801641783867,1.4597273746773936,0.08333333333333333,0.7452695828362289,1.0,3/14,11.65%,HSPA1A;TMBIM6;CREB3L1
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.742097852695602,1.4582632393568302,0.08571428571428572,0.7500336782312417,1.0,3/8,7.24%,PIH1D1;RUVBL2;NUFIP1
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.7324040075095865,1.4576626297402986,0.10714285714285714,0.7479650987166478,1.0,3/10,16.75%,SMAD3;TGFBR1;GDF6
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.8101253316576039,1.4575949215908772,0.1,0.7445316020969566,1.0,7/10,15.91%,NEU1;ACER2;NEU3;GBA3;ACER3;GM2A;NEU4
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),0.8229151572399847,1.4566728368126185,0.09302325581395349,0.745087624771403,1.0,1/7,0.62%,PIWIL2
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),0.7334893354050864,1.4560408965409342,0.15,0.7445401781679363,1.0,4/12,9.96%,GPNMB;FGL1;DUSP3;TNFRSF21
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.7074829101728819,1.4558220689756982,0.09090909090909091,0.7418141310725432,1.0,3/14,2.39%,ODC1;TMEM9;SNF8
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),0.5332225764516945,1.4548134756584843,0.1111111111111111,0.7440958560143247,1.0,14/62,12.59%,POLR2J;ADRM1;POLR2L;ELOC;GTF2H2;SSRP1;TCEA1;EAF2;CDC73;POLR2K;EAF1;ERCC3;GTF2F1;POLR2E
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.6127826843331864,1.4536732991448358,0.058823529411764705,0.7464445012589673,1.0,7/23,14.91%,HSPA1A;ST13;DNAJB12;HSPA8;BAG1;UGGT1;HSPA5
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.7008304713305097,-1.4526169200459116,0.03571428571428571,1.0,1.0,5/28,12.64%,GCA;MX1;RIMS1;DNM1;DNM2
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.6806879243090586,1.4520540289034392,0.045454545454545456,0.7516375843572504,1.0,5/18,7.70%,VPS37B;TRIM35;TRIM28;PML;CHMP2A
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.7267522618537035,1.4518868441557367,0.047619047619047616,0.7491090261125438,1.0,3/17,5.97%,AEN;HIPK1;PML
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),0.8878941554868742,1.450830383613224,0.05405405405405406,0.7513086420802898,1.0,2/5,9.08%,PRDX1;MT3
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),0.8583541152855919,1.4504355025065645,0.0,0.750307849015029,1.0,2/6,2.57%,LAMA3;CD151
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),0.9712086905674054,1.4488448259792823,0.0,0.7538854349724634,1.0,1/5,1.92%,IL15
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),-0.7731490644966503,-1.4472568631722544,0.012987012987012988,1.0,1.0,2/18,8.83%,TTN;NCAPD3
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.7304677831382784,1.4472145593351677,0.07692307692307693,0.7583894203047955,1.0,5/12,15.86%,PRR5L;ZC3HAV1;RC3H1;KHSRP;NUDT21
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.9449974946682074,-1.446479774474309,0.013333333333333334,1.0,1.0,1/5,2.06%,DUOX1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.6772421008144887,1.4460102183655779,0.043478260869565216,0.759978451197314,1.0,6/18,10.54%,UBB;TAB3;MAP2K6;UBE2N;RIPK2;UBC
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.7179096441001979,-1.4453876838923903,0.02631578947368421,1.0,1.0,7/27,12.86%,HEY2;SOX9;HES1;TTN;ZFPM1;VEGFA;HTR2B
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.91327818287253,-1.4436678573790849,0.0,1.0,1.0,2/6,3.09%,DNAH7;CCDC39
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.7804191742139522,1.4435755826031438,0.047619047619047616,0.7682178316183623,1.0,3/10,12.23%,LRRC8D;SLC25A24;SLC25A4
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),-0.8667267398407996,-1.4422969879243026,0.0684931506849315,1.0,1.0,1/7,1.10%,ARIH2
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.8774143315480254,-1.4421470616813776,0.0,1.0,1.0,2/9,0.56%,CD44;ENPP2
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.7049650058417749,1.4418792618583145,0.13043478260869565,0.7735342921564041,1.0,2/12,4.27%,SLC39A10;LYN
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.764319274922422,1.4408031303667268,0.12121212121212122,0.7755415285211642,1.0,4/11,2.85%,STARD3;TSPO;HSD17B10;FDX1
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.7419393263707238,1.4407596780409215,0.10344827586206896,0.7720689262140509,1.0,5/11,18.79%,LDHD;ACOT8;NUDT19;ACBD5;ACOX1
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),0.7803602809729542,1.4400718892866502,0.1111111111111111,0.7716864109323588,1.0,1/9,1.48%,OPN3
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.6460110564177043,1.4393386347321857,0.09523809523809523,0.772659671952183,1.0,2/17,3.27%,BTC;TGFA
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.571211630961801,1.437950663268137,0.06666666666666667,0.7757264031930504,1.0,13/65,9.88%,HSPA1A;ERN1;C9ORF78;HNRNPLL;RBM22;LARP7;METTL4;TMBIM6;KHDRBS2;AFF2;RBM23;CLK2;JMJD6
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.8343929644031896,-1.4378656769867324,0.0,1.0,1.0,1/10,1.83%,NR4A3
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.6542851605107479,1.4361557623123127,0.047619047619047616,0.78127553549021,1.0,12/25,20.02%,OSTC;UBE2J1;DDOST;ALG8;STT3A;MAGT1;FUT8;UGGT1;DPM2;HIF1AN;STT3B;DPM3
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.6242626129340956,1.436098638994161,0.13636363636363635,0.7778575294486672,1.0,4/24,5.95%,HSPA1A;NR1H2;UBXN1;TMBIM6
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),0.6612271140172997,1.4357641079531214,0.2,0.77579832716805,1.0,3/25,4.44%,UBB;DYNLL2;UBE2N
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),0.6946114887047322,1.4356759193387165,0.10526315789473684,0.7688614919565012,1.0,4/17,12.59%,POLR2J;POLR2L;POLR2K;POLR2E
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),0.6946114887047322,1.4356759193387165,0.10526315789473684,0.7688614919565012,1.0,4/17,12.59%,POLR2J;POLR2L;POLR2K;POLR2E
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),0.8382174694797864,1.4354168073726534,0.034482758620689655,0.7665450852802401,1.0,1/5,0.50%,SIRT2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),-0.7674333802723594,-1.4341898880703485,0.04477611940298507,1.0,1.0,4/11,13.20%,CD160;HLA-F;PVR;RASGRP1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.7674333802723594,-1.4341898880703485,0.04477611940298507,1.0,1.0,4/11,13.20%,CD160;HLA-F;PVR;RASGRP1
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.8205214539662951,1.4341424843377015,0.08823529411764706,0.7695413920623271,1.0,1/7,2.15%,NR1H2
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),0.820928004451224,1.433435152041559,0.0625,0.7660142440914386,1.0,1/6,1.48%,OPN3
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),0.820928004451224,1.433435152041559,0.0625,0.7660142440914386,1.0,1/6,1.48%,OPN3
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),-0.9212854605501983,-1.4333865053582617,0.016129032258064516,1.0,1.0,1/5,6.70%,RNF213
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),0.7665611419542516,1.4330109010104033,0.17857142857142858,0.7641541569731235,1.0,3/10,12.58%,STOX1;MCTP1;AIFM2
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",0.5295974779176386,1.432044123655192,0.125,0.7643892755415812,1.0,14/63,12.59%,POLR2J;ADRM1;POLR2L;ELOC;GTF2H2;SSRP1;TCEA1;EAF2;CDC73;POLR2K;EAF1;ERCC3;GTF2F1;POLR2E
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),0.6156880087894728,1.4318447531400116,0.09090909090909091,0.761439011961947,1.0,5/31,4.68%,GPC4;HSPG2;RBP1;GPC1;BCO1
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.7771771049448143,-1.430945716092187,0.025974025974025976,1.0,1.0,2/21,1.60%,HEY2;HES1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.651361099335035,1.4305203799848134,0.045454545454545456,0.7640609492549135,1.0,11/24,20.02%,OSTC;UBE2J1;DDOST;ALG8;STT3A;MAGT1;FUT8;UGGT1;DPM2;STT3B;DPM3
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),0.7588870665837182,1.4302536406902722,0.18181818181818182,0.7622426116624197,1.0,5/10,10.06%,SOX11;GPNMB;LYN;TNFRSF21;RC3H1
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.7493107606014038,1.4292625796934535,0.08,0.7637384340529655,1.0,5/8,20.96%,NLGN2;NLGN3;NLGN4X;NLGN1;NRXN1
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.5798616286640468,1.4275882753311364,0.0,0.7691300530627995,1.0,7/26,14.02%,SIRT2;HNRNPA0;SRR;PELI1;PRDX3;INAVA;OTUD5
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.6863654532107721,1.427219540367196,0.0,0.7677025911576107,1.0,7/31,11.73%,STOX1;UBB;BAD;PYCR1;ARL6IP5;PRDX3;SLC25A33
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.7346349016536785,1.42656518145976,0.12903225806451613,0.7686124978560293,1.0,5/10,16.14%,MSN;RAP2A;CAMSAP3;RHOA;CDC42
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.7427105933265823,1.4263512368560858,0.2,0.7659651424128496,1.0,2/9,7.60%,SIRT2;SMARCAD1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.66349823793087,-1.4256671904009506,0.011235955056179775,1.0,1.0,22/60,21.29%,NLRC5;MX1;PTPRC;IRF1;TRIM52;PLSCR1;STAT2;AGBL4;OAS1;IFIH1;TRIM5;IFIT1;AGBL5;IFIT3;RSAD2;IFI6;TRIM56;MAP3K14;STAT1;ATG7;IRF2;BNIP3L
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),-0.7226026822558619,-1.4254092996512442,0.038461538461538464,1.0,1.0,5/23,13.36%,HEY2;TTN;ZFPM1;GJA1;ADAMTS9
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.6665478412953273,-1.4253817315318291,0.0,1.0,1.0,13/53,15.88%,SLC28A2;NAAA;SYT1;SLC6A15;CPLX1;SLC29A2;GLUL;RIMS1;RAB3A;SNAP25;PPFIA4;PPFIA1;SYN3
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),0.7729039346199189,1.4252799055327163,0.10344827586206896,0.7680270788885658,1.0,2/9,9.52%,DHFR;RTN4RL2
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.6138913174255499,1.4249308809883867,0.0,0.7660935203237419,1.0,6/28,11.53%,UBB;TAB3;TLR1;CNPY3;UBC;INAVA
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.6733850947232309,1.4241195367013986,0.14285714285714285,0.7676802089533402,1.0,4/17,12.07%,UGDH;UAP1;GNPNAT1;SLC35D1
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.9414946051942166,1.424108330523853,0.029411764705882353,0.7644753651097242,1.0,1/5,1.74%,SLC30A10
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.8531918691176834,1.4228310236875956,0.046511627906976744,0.7668861346881477,1.0,2/5,12.48%,CBLL1;GRB2
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),-0.8694908528395853,-1.4222712512887055,0.0,1.0,1.0,1/7,1.60%,HES1
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),0.8076627479087699,1.4218389024136697,0.12903225806451613,0.7679981064637786,1.0,2/6,12.23%,SLC25A24;SLC25A4
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),-0.7876191488140657,-1.4211984508052116,0.014925373134328358,1.0,1.0,1/10,0.27%,PON1
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),0.7275481419101496,1.4210461952217903,0.0625,0.7687262905124591,1.0,4/14,8.53%,SLC25A1;PPT1;SCD5;ACLY
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),0.8546197251799823,1.4208127125738335,0.11538461538461539,0.7637785181690234,1.0,2/6,7.37%,ABCG2;BLVRB
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),0.8546197251799823,1.4208127125738335,0.11538461538461539,0.7637785181690234,1.0,2/6,7.37%,ABCG2;BLVRB
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),-0.8666299765800088,-1.4199347606008996,0.058823529411764705,1.0,1.0,3/7,9.69%,OCIAD2;LRRC19;LPCAT3
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.7066160612138715,1.418538641801616,0.125,0.7708004886662868,1.0,3/12,6.48%,GPNMB;IL15;LEPR
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.6269427923257209,1.4183097182262268,0.1,0.7684121640038504,1.0,5/22,8.87%,SIRT2;ABHD10;PPT1;ABHD17B;LYPLAL1
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),0.8131828911285048,1.4162029615392762,0.11428571428571428,0.7733769451432482,1.0,2/5,6.49%,LEPR;GREM1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.6159226058581242,1.4160319551432856,0.09090909090909091,0.7707055472078039,1.0,5/32,5.55%,HSPA1A;HIPK1;GSTP1;IKBKB;CLIP3
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.7799084146118194,1.4148875294239083,0.13043478260869565,0.7740201175458864,1.0,4/9,14.97%,ATP5MC1;ATP5F1A;ATP5F1D;ATP5PD
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.7013560699237852,1.4148557787343161,0.041666666666666664,0.7710781588972973,1.0,2/12,6.01%,ESR1;RUVBL2
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),0.6050350708815666,1.4135341629965554,0.05263157894736842,0.7734985717275263,1.0,6/26,7.98%,USP51;PPP4C;H1-10;KPNA2;SMARCAD1;H1-4
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),0.8687399400091458,1.412090351593304,0.03333333333333333,0.7771208222769528,1.0,2/6,7.70%,FNBP1L;CHMP2A
prerank,GO_Biological_Process_2021__caveola assembly (GO:0070836),-0.9008805207655642,-1.4105405386873218,0.047619047619047616,1.0,1.0,2/5,8.23%,EMP2;CAV3
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),0.7428195503164482,1.409998884677146,0.07407407407407407,0.7819303721860702,1.0,1/10,6.37%,THY1
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.6455879249702541,-1.4099826058929243,0.011363636363636364,1.0,1.0,8/74,5.01%,TMSB4X;GTPBP2;TTN;TUBA4A;F8;A2M;VCL;TIMP3
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.754620841836707,1.4096785660251943,0.16129032258064516,0.7801442592110122,1.0,1/8,0.14%,MYRFL
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.6086730118335382,1.409374771845571,0.08,0.7786563831325096,1.0,3/21,4.96%,NR0B1;CALR;CNOT9
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.8341834783647397,1.408397471759459,0.15384615384615385,0.7807155717134353,1.0,1/5,3.08%,CAP1
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),0.8659853754876292,1.4073126548250432,0.06060606060606061,0.7825471466999031,1.0,1/8,0.23%,NR0B1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.7327673475873742,-1.4070598592378636,0.038461538461538464,1.0,1.0,4/22,11.88%,STMN2;ANKRD53;CAV3;PAK1
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),0.826372895203685,1.4057598152880555,0.14285714285714285,0.786819326762176,1.0,3/7,11.73%,GSTP1;MID1IP1;SLC25A33
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),-0.9520157782696239,-1.4048084423178648,0.0,1.0,1.0,1/5,0.63%,CYP2E1
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.6069990913379203,1.404093602098297,0.13636363636363635,0.7904989148697164,1.0,6/19,14.91%,HSPA1A;ST13;DNAJB12;HSPA8;BAG1;HSPA5
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),-0.8740795385423368,-1.4034224347206086,0.047619047619047616,1.0,1.0,2/5,8.23%,TTN;CAV3
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),0.6159526226139203,1.40330935935447,0.1,0.7915746249009387,1.0,6/24,11.17%,HSPA1A;GPX1;ACAA2;PPIF;PSMD10;MUL1
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.8513204571728827,1.403139150930171,0.07894736842105263,0.7897996780903749,1.0,1/5,1.17%,DSEL
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.7255366849813294,1.4018881582622928,0.1724137931034483,0.7924579681072091,1.0,4/10,15.31%,KDELR1;GPAA1;HSPA5;INSIG1
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),-0.8379481575589114,-1.4016559593886473,0.056338028169014086,1.0,1.0,1/10,1.05%,PIP4K2C
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.85822508616446,-1.4016066390816109,0.027777777777777776,1.0,1.0,1/10,0.76%,IHO1
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.8382073902768019,-1.4012632429598564,0.056338028169014086,1.0,1.0,1/10,0.19%,CD44
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.5263377548256215,1.4011007870034564,0.0,0.7933072190997774,1.0,13/52,15.66%,NDUFB1;NDUFA5;NDUFB11;NDUFS3;NDUFS6;UQCRC1;NDUFB7;UQCR10;NDUFS8;COX6B1;NDUFB10;NDUFA6;NDUFB3
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),0.7983658646602225,1.4001858626534118,0.11764705882352941,0.7949036351233649,1.0,4/6,18.98%,LSM1;DCPS;PATL1;DCP1A
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.478118382782552,1.3983728551316554,0.0,0.8016752824297957,1.0,17/116,7.61%,UGDH;ODC1;IDH1;G0S2;ACADS;OSTC;ACAA2;HSD17B10;PCBD1;AADAT;ACADVL;S100A10;ECH1;ALAD;MGLL;PRDX6;DLD
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.5267819798664867,1.397991245013737,0.125,0.8003036098483778,1.0,4/57,1.07%,SOX4;SOX11;HSPA1A;GPNMB
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.6186985122998383,1.3978194802174437,0.037037037037037035,0.7980618441411942,1.0,3/21,4.61%,TRMT112;SMYD2;PRMT6
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.849531652753398,1.3976546921399555,0.19444444444444445,0.7959046042171346,1.0,2/5,9.01%,CMPK1;DHODH
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),-0.671984942046541,-1.3972717177694387,0.022988505747126436,1.0,1.0,9/55,8.97%,DEPP1;PIP4K2C;ITPR1;TPCN2;DRAM1;USP13;WDR91;CISD2;DAPK1
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.9387706066465982,-1.3972052751585244,0.015384615384615385,1.0,1.0,1/6,1.82%,ALOX12
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),0.7638398135341842,1.39705896207458,0.12903225806451613,0.7957131605685164,1.0,2/11,7.82%,TIPARP;PARP1
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.843428073062952,1.3966766994466557,0.034482758620689655,0.7941168155870919,1.0,2/6,6.41%,SIRT2;RCC2
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.8173176174822553,-1.3961019371761594,0.0,1.0,1.0,2/14,0.68%,HEY2;SOX9
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),0.8261124083908946,1.3954658283610661,0.21428571428571427,0.7979365585879425,1.0,1/5,0.83%,IDH1
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),0.7959385822251254,1.3950291770137355,0.02857142857142857,0.7970085161811071,1.0,2/7,9.88%,PLOD1;JMJD6
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.7423009162189809,1.3941377701628028,0.20833333333333334,0.7950411851047845,1.0,4/15,4.36%,UBB;IRF3;IKBKB;UBE2D1
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.7423009162189809,1.3941377701628028,0.20833333333333334,0.7950411851047845,1.0,4/15,4.36%,UBB;IRF3;IKBKB;UBE2D1
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),-0.6897724961781058,-1.3941153952849166,0.039473684210526314,1.0,1.0,5/36,8.41%,HTR2C;G6PC2;ITPR1;KCNJ11;CACNA1C
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),-0.8736984435299031,-1.3938943715430108,0.05555555555555555,1.0,1.0,1/7,1.85%,MYLK
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.7254296065082276,-1.3931386706446927,0.058823529411764705,1.0,1.0,5/21,15.34%,HES1;OCIAD2;PTPRC;CRLF3;CYP1B1
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),0.7600910996467634,1.3927692830699938,0.0967741935483871,0.7978149851992318,1.0,3/8,14.37%,PPP1R3D;PPP1R3B;PPP1R3F
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.7878767409654958,1.392381226811362,0.04,0.796639144802829,1.0,1/9,0.31%,DGKB
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),-0.9038010009665853,-1.3918328770096866,0.0,1.0,1.0,2/7,3.39%,AHR;IRF1
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.5751936542533156,1.3914579744275917,0.11764705882352941,0.7985384842208043,1.0,5/45,3.28%,SIRT2;BAD;ACAA2;ZFP36L1;HP1BP3
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.7704107343242685,-1.390820245181881,0.0410958904109589,1.0,1.0,1/14,0.47%,CMTR1
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),-0.85109212923786,-1.3900434650373297,0.04411764705882353,1.0,1.0,3/6,10.54%,HEY2;HES1;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.6918979002111892,1.389870684789976,0.10344827586206896,0.8017890436448417,1.0,7/15,23.88%,NR1H2;MCTP1;PRKD1;RUBCN;EPHA3;NR1H3;SYT11
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.8563844449540988,1.3893848431918996,0.04,0.8014535726165307,1.0,1/5,1.51%,LRRC8D
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),-0.813503476690077,-1.3893816874023521,0.05714285714285714,1.0,1.0,1/8,0.27%,PON1
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.702007455736994,-1.3882111889891966,0.046511627906976744,1.0,1.0,13/41,18.87%,ENPP2;SOX9;EMP2;RHOJ;RAB11A;DOCK5;GLUL;VIL1;MACF1;PTPRR;PFN2;TGFB2;HDAC6
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.5146153602272422,1.3880560127633788,0.0,0.8057669630771442,1.0,23/113,5.99%,SYNDIG1;GPR17;CHRNA4;OLIG2;ASCL1;OLIG1;CNP;PDGFRA;CA10;TCEAL6;SOX10;VCAN;MAP2;ADGRA1;PCDH15;TCEAL7;GPR37L1;CDO1;CLIP3;ZNF536;BRINP1;TMEM178A;LRRTM3
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.757693224862015,1.387923095978023,0.16129032258064516,0.8036191153651485,1.0,6/8,21.10%,PDE4B;CALM3;SRI;CALM1;CACNA2D1;NOS1AP
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.5792173793526765,1.3877615701605261,0.041666666666666664,0.8012945725151829,1.0,6/35,3.81%,DHCR7;STARD3;ARV1;FDX1;MSMO1;TM7SF2
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),-0.8385975550401129,-1.387343647452019,0.08450704225352113,1.0,1.0,1/9,1.05%,PIP4K2C
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.7390339944910691,1.3867723468702637,0.0967741935483871,0.802306288881598,1.0,4/12,6.49%,MOSPD2;CXCL12;LYN;GREM1
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),0.5276750074719062,1.3850602836204824,0.0,0.8066183907093789,1.0,13/51,15.66%,NDUFB1;NDUFA5;NDUFB11;NDUFS3;NDUFS6;UQCRC1;NDUFB7;UQCR10;NDUFS8;COX6B1;NDUFB10;NDUFA6;NDUFB3
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),0.6620537625526044,1.3846011838964862,0.08695652173913043,0.8058291919391929,1.0,2/12,4.27%,MSN;LYN
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),-0.8865352361204394,-1.3845240205696914,0.109375,1.0,1.0,2/5,1.08%,HTR2C;FABP3
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.7976587096639043,-1.3840042213956818,0.06060606060606061,1.0,1.0,3/15,9.39%,SLC22A4;SLC6A6;SFXN3
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.877396875379687,-1.383369614685136,0.078125,1.0,1.0,2/6,8.23%,EMP2;CAV3
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),-0.788983172601039,-1.3832587547457604,0.07575757575757576,1.0,1.0,1/10,0.68%,SOX9
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),0.7746358265124211,1.3826924953775814,0.13513513513513514,0.8121190477840446,1.0,2/7,4.42%,TBRG4;TRMT10A
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),0.6445614247339941,1.382486614739478,0.13333333333333333,0.8097426468925323,1.0,3/10,5.97%,TRIM35;TRIM28;PML
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.7650790703180882,-1.3821323561827015,0.08,1.0,1.0,4/18,10.81%,FAR2;ELOVL2;ACSBG1;ACSL1
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),-0.8104719094383285,-1.3820883162279485,0.08823529411764706,1.0,1.0,1/11,1.60%,HES1
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),-0.847955758224074,-1.3816971585232043,0.014492753623188406,1.0,1.0,2/10,2.73%,SOX9;MAFF
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.6528410383144174,1.3813775532708712,0.06666666666666667,0.8123997893422147,1.0,6/38,5.96%,TRMT112;HSPA1A;ERN1;HNRNPLL;RBM22;MYCN
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),0.7685222507885907,1.3812528217399795,0.20689655172413793,0.810039135141635,1.0,2/6,9.17%,KDELR1;GPAA1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.8359951381032622,1.3811831568323663,0.06451612903225806,0.8076327776387882,1.0,2/5,11.49%,TGFBR2;PNP
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.8938231480506708,-1.3810605357883174,0.0136986301369863,1.0,1.0,1/5,0.84%,IL5
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.7414411326606737,1.380105000537918,0.1724137931034483,0.8100832704145657,1.0,5/7,20.94%,PCBP2;TSPAN6;MUL1;TRAF3IP1;ILRUN
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),0.7127146822945377,1.3800780336489302,0.125,0.8073225159864564,1.0,4/10,13.33%,SLC30A10;GSTP1;ABCD2;ASXL3
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.7774220043246303,1.3799566035724957,0.10714285714285714,0.8048890367548477,1.0,2/8,9.52%,DHFR;RTN4RL2
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),-0.930769418446497,-1.3792506096687018,0.015151515151515152,1.0,1.0,1/5,2.51%,ART4
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.7291870607545639,1.3790963511242138,0.15789473684210525,0.8052357329145428,1.0,1/16,0.64%,CRB2
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.662205006069395,1.3789699943501021,0.13333333333333333,0.8028874277901142,1.0,3/15,2.15%,ARV1;TSPO;NR1H2
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.8171539636674642,1.3776894565778666,0.09375,0.8055560644977082,1.0,2/6,7.77%,GPX1;CAT
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.6572739711422162,-1.3776379010715605,0.058823529411764705,1.0,1.0,12/33,15.84%,CD44;NAAA;MX1;PTPRC;IGSF6;SPI1;PLSCR1;AOAH;OAS1;IFIT1;MYO1F;IFIT3
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.717791670965673,-1.3770771847162275,0.07407407407407407,1.0,1.0,6/24,13.36%,EPN1;FGF1;RHOJ;GLUL;VEGFA;ADAMTS9
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.718992700796794,-1.3758324778267768,0.024390243902439025,1.0,1.0,5/22,14.75%,PON1;SLC2A3;PON3;ST3GAL1;TBXAS1
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.7778983184427242,-1.3749519514334636,0.02631578947368421,1.0,1.0,4/14,9.21%,PHKG1;PYGL;PYGB;AOAH
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.6725175849864704,1.3740396978020881,0.14814814814814814,0.8206656134784484,1.0,3/11,10.06%,GPNMB;TNFRSF21;RC3H1
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.5150708654506886,1.3729757072909958,0.07142857142857142,0.822589097612245,1.0,10/32,11.02%,AURKAIP1;ZFP36L1;TRIM35;BTG1;BTG3;BRINP1;FZD3;GAS1;HECA;SMAD3
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.6366059234525325,1.3711814625164946,0.23809523809523808,0.8275176515048573,1.0,7/13,14.71%,ENPP6;MGLL;PRDX6;GPCPD1;GDE1;ABHD2;PNPLA6
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,-0.6460834257547052,-1.37086705647515,0.011764705882352941,1.0,1.0,14/63,16.42%,HEY2;FABP3;SGCA;TTN;LAMA2;CKMT2;CAV3;CTNNA3;EDNRA;TPM1;BDNF;SORBS1;CRYAB;MYOM2
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.7361295723677014,1.3699999624353159,0.19047619047619047,0.8297658186589562,1.0,4/11,9.08%,SIRT2;ZFP36L1;THEM4;MT3
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.8236025922987142,-1.3689361310523869,0.0847457627118644,1.0,1.0,1/8,0.49%,TMSB4X
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.9301155195765436,-1.3688132577899896,0.047619047619047616,1.0,1.0,1/5,2.81%,MCCC1
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.714573158547205,-1.3684197582225421,0.15492957746478872,1.0,1.0,5/12,19.12%,CD160;HLA-F;PVR;RASGRP1;ARRB2
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.695485909074119,1.3675508384710986,0.09090909090909091,0.8383540503998586,1.0,3/18,3.60%,UBB;TAB3;TLR1
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.7900112851284747,-1.3655215668423595,0.08,1.0,1.0,5/14,12.86%,HTR2C;ITPR1;PTPRC;RYR3;HTR2B
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),-0.7926811511045607,-1.3652877739074427,0.13043478260869565,1.0,1.0,1/8,1.60%,HES1
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.5210049631368654,1.364697968882572,0.0625,0.8465259287375122,1.0,3/26,4.03%,UGDH;GAL3ST3;B3GAT2
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),0.7453214984462209,1.3643178322009604,0.17857142857142858,0.8449954004197291,1.0,2/10,5.39%,NOL11;PIH1D1
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.4936582458841926,1.3635870166138597,0.058823529411764705,0.8453150737494327,1.0,5/45,4.34%,GPR17;TNFAIP1;RIT2;GPR174;STARD13
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.5727407992947979,1.3634120530784566,0.21052631578947367,0.8430297593233502,1.0,14/35,20.35%,TSPO;DNAJC15;MFF;AIP;GRPEL1;TIMM13;TIMM22;FIS1;DNAJC19;TIMM21;TIMM50;TIMM23;RALA;PINK1
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),-0.9334128316559713,-1.362495602286461,0.028985507246376812,1.0,1.0,1/5,1.50%,CRYM
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),-0.9334128316559713,-1.362495602286461,0.028985507246376812,1.0,1.0,1/5,1.50%,CRYM
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,0.736525303051575,1.3624511579732126,0.11764705882352941,0.8447688621665738,1.0,3/15,7.89%,GPR174;S100B;ASPM
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),-0.7929493741666443,-1.3618631133936956,0.14754098360655737,1.0,1.0,1/8,5.76%,SREBF1
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),-0.7929493741666443,-1.3618631133936956,0.14754098360655737,1.0,1.0,1/8,5.76%,SREBF1
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),0.7271956078242785,1.3616449007180238,0.18181818181818182,0.8458500429875935,1.0,3/15,7.70%,SNF8;SMPD3;CHMP2A
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.508955467167136,1.3610346345572357,0.1,0.8461626756047997,1.0,20/79,13.87%,UBB;HSPA1A;PMEPA1;TGFBR2;UBE2D1;PPM1A;GREM1;BMPER;SLC2A10;BAMBI;SPRY1;VEPH1;SMURF2;UBC;SMAD9;SMAD3;TGFBR1;PEG10;SMAD7;SIRT1
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.6028576455585248,1.3608625624319834,0.041666666666666664,0.8439046429413786,1.0,7/25,11.67%,LAMA3;CD151;TRIP6;THY1;RCC2;PEAK1;THSD1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.7727017810327931,-1.3605910916240247,0.056338028169014086,1.0,1.0,4/11,15.34%,HES1;OCIAD2;CRLF3;CYP1B1
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),-0.7878637708700715,-1.3600504767953607,0.11290322580645161,1.0,1.0,1/10,0.68%,SOX9
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.8075693886821316,-1.3599087648913826,0.07894736842105263,1.0,1.0,5/13,12.86%,HTR2C;ITPR1;PTPRC;RYR3;HTR2B
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.7675474354941423,-1.3598717271007519,0.04838709677419355,1.0,1.0,4/13,15.34%,HES1;OCIAD2;CRLF3;CYP1B1
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.7817098707775126,1.3597752910004413,0.10714285714285714,0.8456180694075826,1.0,5/7,16.14%,MSN;RAP2A;CAMSAP3;RHOA;CDC42
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.5148647421213032,1.3595870199493258,0.0,0.8441305217625845,1.0,11/52,12.91%,SOX11;CRB2;UBE2D1;RBPJ;GREM1;BMPER;BAMBI;SMURF2;SMAD9;TWSG1;SMAD7
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),0.8764532165767449,1.3593318839838595,0.12121212121212122,0.8425948579799408,1.0,3/6,3.58%,ASCL1;MYT1L;POU3F2
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.6551997943320276,-1.3590432515306932,0.08139534883720931,1.0,1.0,8/48,10.54%,CD44;ENPP2;IL5;EFNA1;PTPRC;AGT;EFNA5;VEGFA
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),0.7896616178925482,1.3582453527829397,0.17142857142857143,0.8442958477758945,1.0,3/6,14.37%,PPP1R3D;PPP1R3B;PPP1R3F
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),0.7356376044054653,1.3579505515563568,0.09090909090909091,0.8431716184540349,1.0,2/11,10.16%,TRIR;EXOSC8
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.8111820252011935,1.357939352731925,0.21052631578947367,0.840451710007409,1.0,3/6,12.91%,DACH1;MAD2L2;SMAD7
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),-0.7041441912050239,-1.3578152917695396,0.10526315789473684,1.0,1.0,5/18,13.36%,HEY2;HES1;LRP2;VEGFA;ADAMTS9
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.7025034698810682,1.357427381690272,0.12903225806451613,0.840031833068117,1.0,2/10,9.74%,ARV1;STARD4
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.6704460923883347,1.3568055139661395,0.12903225806451613,0.8405247373680355,1.0,1/13,0.54%,MYH3
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),-0.8593221124888689,-1.356629476641021,0.07042253521126761,1.0,1.0,1/6,0.55%,HEY2
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),-0.9232632269207641,-1.3556565368433566,0.030303030303030304,1.0,1.0,2/5,4.32%,F8;A2M
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.7173335962444465,1.3549364917835969,0.1875,0.8475915622394367,1.0,4/6,23.66%,MARCHF7;DDX3X;SPSB4;BIRC2
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),0.83576066510078,1.3543901216704977,0.10526315789473684,0.8461921471991373,1.0,5/6,15.91%,NEU1;NEU3;GBA3;GM2A;NEU4
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-0.8669225610189444,-1.3531424762559812,0.11594202898550725,1.0,1.0,4/6,8.55%,NR4A3;FGF9;DOCK7;DOCK5
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),0.5982790486917255,1.352618838834607,0.15789473684210525,0.8508862171784476,1.0,3/17,4.17%,SIRT2;NFKBIL1;PCBP2
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.7665670104425969,-1.3515066688412136,0.05194805194805195,1.0,1.0,3/14,9.01%,HEY2;SOX9;ASPN
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),-0.8333520588096994,-1.351188491114497,0.10526315789473684,1.0,1.0,1/7,0.49%,TMSB4X
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),-0.7825270821195011,-1.3504480878540672,0.02564102564102564,1.0,1.0,3/14,10.95%,KCNMB4;SCN8A;SCN9A
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.8106785442303547,-1.349818005168002,0.08333333333333333,1.0,1.0,2/12,5.75%,DUOX1;KCNJ11
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.7331132459834473,1.3496087413110942,0.125,0.8605488712392177,1.0,2/9,4.05%,ACADS;ACADVL
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.7683136168946549,-1.3494792837631062,0.0547945205479452,1.0,1.0,3/13,8.24%,PHKG1;PYGL;PYGB
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.770441418533406,1.3494289778143678,0.20689655172413793,0.858841907897294,1.0,3/5,17.85%,NLGN2;INAVA;MYADM
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.6190597789769308,1.3493300483437816,0.08333333333333333,0.8563643767346886,1.0,1/13,2.95%,DSCC1
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.7714589393579544,1.3490668209495555,0.07894736842105263,0.855181924888417,1.0,1/8,0.54%,MYH3
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.4784287193606381,1.3489563617350306,0.0,0.8527313157424808,1.0,17/58,12.54%,DHCR7;ACTG1;TM7SF2;ANTXR2;FABP5;ECH1;NFIL3;SQLE;LDLR;PLAUR;SEMA3B;STARD4;HMGCS1;GUSB;HMGCR;GNAI1;ERRFI1
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.6837397431822573,1.348797744318771,0.25,0.8509041192548339,1.0,1/12,0.74%,BICD2
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.7193365535285701,1.3484212853835398,0.07407407407407407,0.850576353297465,1.0,2/9,5.70%,ODC1;SRM
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.6547130331952348,1.3477749813674915,0.16666666666666666,0.8509099388152693,1.0,2/14,5.39%,NOL11;PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.5735581002891869,1.347599801914668,0.15384615384615385,0.8493243780207671,1.0,16/62,12.91%,UBB;MALT1;PEF1;UBE2D1;UBE2N;PRICKLE1;BMI1;RPS2;COMMD1;PSMD10;PTTG1IP;RIPK2;INAVA;RCHY1;MARCHF7;SMAD7
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",0.8027168069520122,1.3475643490939557,0.16666666666666666,0.8467656776254638,1.0,1/6,0.51%,UBB
prerank,PanglaoDB_Augmented_2021__Clara Cells,-0.7481298799488965,-1.347485989794359,0.11392405063291139,1.0,1.0,5/18,3.06%,SCEL;CYP2E1;AHR;DUOX1;STEAP4
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.7240920086058478,-1.3461362675623016,0.08108108108108109,1.0,1.0,5/20,12.53%,FGF1;CCDC39;FGF9;VEGFA;LOXL3
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.512539204161227,1.3450201181570598,0.10526315789473684,0.8557635057724762,1.0,8/37,10.16%,BAD;STYXL1;NDUFS3;PPIF;NOC2L;BOK;PLAUR;SGMS1
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),-0.8131433015868001,-1.3449841423743076,0.1076923076923077,1.0,1.0,4/11,11.17%,KCNJ11;P2RY12;RYR3;TAF1
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.897775392105737,-1.3449511035718327,0.045454545454545456,1.0,1.0,2/5,2.02%,MYLK;EMP2
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.9020447563930603,-1.3445630791278198,0.07462686567164178,1.0,1.0,1/5,0.19%,CD44
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),-0.8676914447925611,-1.3443356846107248,0.06944444444444445,1.0,1.0,2/7,3.16%,HES1;PTPRC
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),-0.8172460754451027,-1.3442976052075875,0.029850746268656716,1.0,1.0,5/11,13.08%,PTPRC;P2RY12;SHTN1;ITGA2;ITGB1BP1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.729089570543654,1.343573420132512,0.14285714285714285,0.8585736325276644,1.0,1/8,2.15%,NR1H2
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.7155738556239064,1.343308956658095,0.0967741935483871,0.8575251023579717,1.0,3/9,4.10%,ACTB;ACTG1;CGNL1
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.7907176489636825,-1.3432574870713698,0.08333333333333333,1.0,1.0,2/9,9.85%,ANGPTL4;APOE
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),0.725213519195781,1.3432275578147221,0.13793103448275862,0.8551883505202148,1.0,4/10,9.17%,LTV1;RAN;NPM1;LSG1
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.5228636969503355,1.34140553025749,0.0,0.8605022409229928,1.0,11/97,4.22%,STOX1;SIRT2;UBB;BAD;ACAA2;PSMD8;PSMB4;ZFP36L1;HP1BP3;ELOC;PSMB6
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.5189029651079545,1.3409952268409082,0.06666666666666667,0.8598326963392341,1.0,6/38,4.89%,AMOTL2;SOX8;AMOT;SEMA5A;SOX10;SEMA5B
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),-0.8337969889370727,-1.3398366031457447,0.0967741935483871,1.0,1.0,1/5,0.55%,HEY2
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),-0.8337969889370727,-1.3398366031457447,0.0967741935483871,1.0,1.0,1/5,0.55%,HEY2
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",-0.9096296706980411,-1.339739715540105,0.05333333333333334,1.0,1.0,3/5,5.37%,PLET1;ARHGAP24;COL5A1
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.551762870232189,1.339471952317189,0.0,0.8639245969327868,1.0,15/60,12.59%,POLR2J;POLR2L;NT5E;RAN;LSM1;PCBP2;KPNA2;HNRNPC;HNRNPA0;DDX54;PCBP1;EXD2;POLR2K;GTF2F1;POLR2E
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.8389447591825687,-1.339310436292556,0.06756756756756757,1.0,1.0,1/7,0.19%,CD44
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.8389447591825687,-1.339310436292556,0.06756756756756757,1.0,1.0,1/7,0.19%,CD44
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.61646795800243,1.3391804450936189,0.09090909090909091,0.8623428060753208,1.0,4/14,13.87%,SIRT2;SMARCAD1;HDAC9;SIRT1
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.6833814670319137,-1.3385268134539812,0.03529411764705882,1.0,1.0,8/37,11.44%,CD44;IRF1;A2M;IFNGR2;IL3RA;STAT2;IL7;OSMR
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.7548081697097873,1.337949303725247,0.16129032258064516,0.864968071493133,1.0,2/7,9.27%,SLC30A10;ABCD2
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.8014458849643064,1.3376016066836922,0.125,0.8640812891469151,1.0,2/7,5.57%,SOX11;LIN7C
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.8180495168726318,-1.337038983483133,0.13043478260869565,1.0,1.0,2/7,11.17%,TMSB4X;TAF1
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.8585843012247787,1.3363023131223601,0.11428571428571428,0.8676892903608266,1.0,3/5,12.91%,MALT1;RC3H1;SMAD7
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.7385791967978659,-1.3362244418123161,0.07042253521126761,1.0,1.0,7/17,18.38%,STAT2;STAT4;STAT6;STAT5A;STAT3;STAT5B;STAT1
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.768311607572497,1.3354759493476478,0.07407407407407407,0.8684848472767297,1.0,2/12,3.65%,SOX11;PDGFRA
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.8030960751089827,-1.3354636508887854,0.07042253521126761,1.0,1.0,1/11,0.49%,TMSB4X
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.5893302863584129,1.335100064451375,0.1,0.8677005414700071,1.0,10/30,15.66%,NDUFB1;NDUFA5;NDUFB11;NDUFS3;NDUFS6;NDUFB7;NDUFS8;NDUFB10;NDUFA6;NDUFB3
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.5779338336711265,1.334983792863051,0.08,0.8654550546139985,1.0,2/18,2.59%,TRIR;ERN1
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),-0.8605250689505947,-1.3347547101715556,0.04225352112676056,1.0,1.0,2/6,13.33%,SOX9;SULF1
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),0.8265054385680342,1.3345349764969021,0.26666666666666666,0.8646842735257353,1.0,2/5,13.56%,CLK2;MST1
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.8987111924013607,-1.334502213180125,0.04838709677419355,1.0,1.0,2/6,7.68%,COL5A1;INTU
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.7847457507386877,-1.334115257053893,0.0821917808219178,1.0,1.0,1/11,1.06%,STMN2
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),-0.7990231483291619,-1.3340494714852134,0.0547945205479452,1.0,1.0,3/10,9.13%,ALOX12;HRNR;FLG
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),-0.7990231483291619,-1.3340494714852134,0.0547945205479452,1.0,1.0,3/10,9.13%,ALOX12;HRNR;FLG
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.5019160722429181,1.3334432630089639,0.09090909090909091,0.8659997432998301,1.0,16/74,12.91%,SOX11;UBB;HSPA1A;PMEPA1;TGFBR2;PPM1A;SLC2A10;BAMBI;SPRY1;VEPH1;SMURF2;UBC;SMAD3;TGFBR1;PEG10;SMAD7
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7286768378002155,1.3332589358130573,0.11538461538461539,0.8643497286770302,1.0,2/5,4.27%,TLR1;LYN
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.6504977750360038,1.3325982374439878,0.1111111111111111,0.8645202279416856,1.0,5/15,10.66%,FBLN5;LTBP3;GPM6B;NTNG2;NTN4
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.7532932608227887,1.3321767086496368,0.13793103448275862,0.8640706632729238,1.0,3/7,14.92%,CEND1;GRID2;FAIM2
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),-0.8295435283710566,-1.3316430785960935,0.0273972602739726,1.0,1.0,2/10,3.39%,VSIR;IRF1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.8564428030472918,-1.3315297743452166,0.04054054054054054,1.0,1.0,2/6,12.04%,ENPP2;VIL1
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.49713803755428376,1.329929591259781,0.14285714285714285,0.8708252843025506,1.0,9/51,10.54%,UBB;TAB3;ZFP36L1;IKBKB;UBE2N;GPS1;MAPK11;RIPK2;UBC
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.7335080708995326,1.3294576357695713,0.24242424242424243,0.8701036396489353,1.0,1/10,1.37%,PMEPA1
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),-0.8590457800801647,-1.3294358945377407,0.057971014492753624,1.0,1.0,1/7,1.82%,ALOX12
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),0.8140591149817795,1.329296579027474,0.07692307692307693,0.8683121435509864,1.0,1/5,1.24%,GPX1
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),0.8253512371496282,1.329208098684911,0.16129032258064516,0.8661739685604098,1.0,2/6,3.01%,TMEM9;PPT1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),-0.8377637283381275,-1.3291918047391655,0.07575757575757576,1.0,1.0,2/6,14.55%,CDKN2A;PDCD4
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.6598782210963033,1.328945065371819,0.13636363636363635,0.8647599507149386,1.0,3/19,3.88%,TRMT112;SMYD2;CSKMT
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.6566013862077336,1.3287470544765392,0.23076923076923078,0.8629990779804979,1.0,2/15,3.27%,BTC;TGFA
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.8686098080317419,-1.328612865324395,0.06153846153846154,1.0,1.0,3/7,7.29%,PMS2;POLQ;MSH6
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),0.68133133548603,1.328135327007629,0.125,0.8627650549095458,1.0,3/11,13.95%,ACTB;STX7;ZDHHC2
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.8251980232973992,-1.3275288372690077,0.06329113924050633,1.0,1.0,1/9,0.19%,CD44
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.8042941659500363,1.3270357562121884,0.125,0.8647507052085323,1.0,1/5,3.45%,NUTF2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),-0.8574972092522948,-1.3258577615057918,0.05194805194805195,1.0,1.0,1/8,2.79%,GALNTL6
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),-0.8701636248238667,-1.3257604050331755,0.06060606060606061,1.0,1.0,3/6,12.64%,MX1;DNM1;DNM2
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),-0.8437438479166326,-1.325705948573716,0.10606060606060606,1.0,1.0,1/9,5.36%,SPI1
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),-0.8899383187601733,-1.3253164206050452,0.08333333333333333,1.0,1.0,2/5,0.69%,HTR2C;HTR1F
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.6866199127240278,-1.3250293173324579,0.06493506493506493,1.0,1.0,5/30,13.33%,CD44;SOX9;SLC39A14;RUNX2;SULF1
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.7549549771028757,1.3245540476456599,0.2571428571428571,0.8715514168557685,1.0,3/6,7.24%,PIH1D1;RUVBL2;NUFIP1
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.6011326142051787,1.3241989457739538,0.09523809523809523,0.8703928407861956,1.0,1/18,0.31%,DGKB
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.7844960788193451,1.3238259131233099,0.19444444444444445,0.8706405355320043,1.0,3/5,12.91%,PMEPA1;GREM1;SMAD7
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),-0.7569228418651819,-1.323734314369562,0.08333333333333333,1.0,1.0,1/12,0.68%,SOX9
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.7553331801156156,-1.3236101604903527,0.05555555555555555,1.0,1.0,5/14,13.03%,GADD45B;GADD45A;SPI1;VEGFA;RELL1
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.4889045316847996,1.3235271989313557,0.0,0.8701889328532278,1.0,22/122,10.55%,CPA1;TCF7L1;PODN;CYBRD1;ACHE;PCBD1;CXCL12;PDGFRA;RAB27B;STARD13;CALCRL;IGFBP7;LDB2;RBFOX1;ENPP3;SSPN;EDNRB;HS3ST1;EPB41L3;LIMA1;RNF128;ST6GALNAC3
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.6855676599636477,1.3225241446899718,0.16129032258064516,0.871380316001944,1.0,5/11,9.56%,ATG16L1;SLC26A3;WNT3;FBP1;RIPK2
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.7966856034679409,1.3215834134876525,0.15625,0.8731103345660837,1.0,5/6,19.81%,B4GALT3;UGT8;B3GALT2;GAL3ST1;UGCG
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.695330539683958,-1.3212948669270719,0.10256410256410256,1.0,1.0,5/17,13.20%,CD160;SPI1;HLA-F;PVR;RASGRP1
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),0.7931614018869914,1.3211706754268862,0.18181818181818182,0.8723590230063021,1.0,3/6,15.04%,GPR37L1;PRCP;RNLS
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.7931583164457422,-1.3209704309713224,0.0547945205479452,1.0,1.0,2/13,8.58%,CHAC2;ADAMTS13
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),-0.7743579029492205,-1.320871227371586,0.140625,1.0,1.0,2/10,2.01%,TMSB4X;FGF1
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),-0.7926406413536702,-1.3207439727496428,0.058823529411764705,1.0,1.0,3/10,12.75%,SLC29A2;GLUL;SNAP25
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.4375069961440091,1.3187307243113486,0.0,0.8802387775406254,1.0,8/80,6.33%,IPO13;CALR;PHB2;NUTF2;RAN;PRICKLE1;PML;PPP1R10
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),-0.8476648745085472,-1.318103957466319,0.08450704225352113,1.0,1.0,3/7,12.64%,MX1;DNM1;DNM2
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.4981520954304155,1.3180215362419538,0.0,0.8806517212974021,1.0,5/37,10.06%,PRR5L;ZFP36L1;TOB1;ZC3HAV1;RC3H1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.6004142822912846,1.317498301807368,0.1111111111111111,0.8810133594269391,1.0,6/28,10.16%,LSM4;LSM1;LSM7;DCPS;EDC3;EXOSC8
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),-0.7685378679677664,-1.3171240076237685,0.12,1.0,1.0,1/13,0.42%,RFC4
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),-0.8930541456787797,-1.317014978402574,0.03125,1.0,1.0,1/6,0.49%,TMSB4X
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.5742674794382175,1.3161871144592923,0.1111111111111111,0.88347523709992,1.0,3/13,16.70%,SP1;JUN;ZNF639
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),0.7484987413921977,1.3151878633990879,0.11363636363636363,0.8847534726177402,1.0,5/7,18.71%,KIF25;CEP85;RANBP1;NSFL1C;MAP9
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.8214213292134533,-1.3146131846502438,0.13846153846153847,1.0,1.0,5/7,15.16%,PTPRC;IGSF6;SPI1;AOAH;MYO1F
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),-0.7413527582385522,-1.3145846826858099,0.08571428571428572,1.0,1.0,1/13,0.49%,TMSB4X
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.844805007125792,-1.314503523602698,0.08333333333333333,1.0,1.0,2/7,6.91%,HEY2;ZFPM1
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),-0.7759794126341978,-1.3144683716027752,0.05333333333333334,1.0,1.0,3/15,6.96%,GLRA2;GLRA1;OPRM1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.5125735694713829,1.3143399139535683,0.125,0.8862191890318702,1.0,14/57,11.57%,HSPA1A;GPX1;ACAA2;GSTP1;NDUFS3;PIH1D1;PPIF;TMBIM6;NOC2L;PSMD10;PLAUR;PSME3;TGFBR1;QARS1
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.7725793962894933,1.3141050207459402,0.13333333333333333,0.8848160812489716,1.0,2/9,3.88%,SMYD2;CSKMT
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.7176535725111147,-1.3134862357482942,0.1643835616438356,1.0,1.0,5/13,13.65%,SYT1;RIMS1;RNF157;SYT2;SYT4
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),-0.8647871862783746,-1.313482741953707,0.06944444444444445,1.0,1.0,1/5,5.39%,BRCA1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5650428533247897,1.3133126650282556,0.09090909090909091,0.885693364322432,1.0,4/19,11.65%,HSPA1A;TMBIM6;BOK;CREB3L1
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.7409598464180465,1.3128597389569625,0.19230769230769232,0.8856496071580022,1.0,1/7,3.01%,PPT1
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),0.7929243061689785,1.312662836759156,0.03225806451612903,0.8838746969600497,1.0,5/8,10.81%,GPX1;PRDX1;CAT;PRDX5;PRDX3
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.7014464162646796,-1.3126400527181648,0.08,1.0,1.0,3/19,6.36%,NLRC5;SPI1;PLSCR1
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.6675003190911015,-1.3126254178568626,0.09090909090909091,1.0,1.0,2/26,0.68%,CD44;SOX9
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.8165386456845282,-1.3123882093636239,0.056338028169014086,1.0,1.0,2/9,7.28%,SYCE2;STAG3
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.8165386456845282,-1.3123882093636239,0.056338028169014086,1.0,1.0,2/9,7.28%,SYCE2;STAG3
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.5110026185051856,1.3123016126491756,0.0,0.8826849511268596,1.0,7/33,6.18%,NOVA1;IL15;NR1H2;PLCL2;MAP2K6;PLCL1;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.5142944534592336,1.3120145055772816,0.125,0.8816929586355973,1.0,6/34,6.73%,SYNDIG1;SOX11;SLITRK2;CLSTN2;NLGN2;EPHB3
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.8253183574081909,-1.3109604321687445,0.13432835820895522,1.0,1.0,5/9,10.88%,NR4A3;FGF9;DOCK7;DOCK5;TPM1
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.7869282104235535,1.3107680624362286,0.14814814814814814,0.884475098400277,1.0,1/8,1.00%,HSPA1A
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.6759017388925768,1.3101551864667227,0.11764705882352941,0.8844351939214891,1.0,2/9,6.73%,SEMA5A;EPHB3
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.7950307232900713,1.3099620363478486,0.19444444444444445,0.8828296131697071,1.0,3/6,9.37%,PSPH;SRR;PSAT1
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),0.5110430771666921,1.309716413182727,0.2,0.8816111928389413,1.0,21/87,9.56%,AURKAIP1;MRPL10;CHCHD1;MRPL15;MRPL11;MRPS33;MRPL28;MRPL44;EEF2;EEF1A1;MRPS12;MRPS26;MRPL47;MRPL36;MRPL40;MRPS16;TUFM;MRPS18A;MRPL13;MRPL52;MRPL4
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),-0.8684241098969767,-1.309353228067275,0.12698412698412698,1.0,1.0,1/5,3.09%,CCDC39
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),-0.85197447808843,-1.3088805034509343,0.06060606060606061,1.0,1.0,1/5,0.55%,HEY2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.8040299840490766,1.3086624244281742,0.12195121951219512,0.8832311815866144,1.0,2/5,9.85%,ZFP36L1;EDC3
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.8008476588240281,-1.3084261513691309,0.14285714285714285,1.0,1.0,4/8,8.55%,NR4A3;FGF9;DOCK7;DOCK5
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.7334795600820172,-1.3080145181200011,0.07142857142857142,1.0,1.0,4/18,5.37%,CD44;PLET1;ARHGAP24;COL5A1
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.7425274840161151,1.3079382222548974,0.25,0.8840893985299095,1.0,5/11,15.93%,SOX8;GREM1;MN1;RHOA;BMP2
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.5399044884469061,1.3077124778746492,0.15,0.8825017228532566,1.0,6/22,15.40%,UBB;RNF139;UBC;MAN1A2;UGGT1;EDEM1
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),-0.8313005779409499,-1.3075051246388367,0.1044776119402985,1.0,1.0,2/5,6.96%,DPAGT1;DHDDS
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),-0.8313005779409499,-1.3075051246388367,0.1044776119402985,1.0,1.0,2/5,6.96%,DPAGT1;DHDDS
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.6065269447258861,1.3067750870372852,0.043478260869565216,0.8845279655578354,1.0,1/16,1.00%,HSPA1A
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.7185043622703249,-1.306561970942191,0.08433734939759036,1.0,1.0,9/15,20.25%,HTR2C;HTR1F;AGT;OPRM1;HTR2B;TSHR;CHRM2;CHRM5;CHRM3
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),-0.8594908299525569,-1.3062026109273144,0.09090909090909091,1.0,1.0,2/5,12.03%,GJA1;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.5414386689093718,1.3061202821247204,0.16,0.8848155708449008,1.0,4/29,5.81%,SOX11;ASCL1;NGF;BRINP1
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),-0.7461748869209128,-1.3058247348170782,0.1111111111111111,1.0,1.0,3/11,9.82%,MYLK;TPCN2;EDNRA
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.8474507317161447,-1.304989293066431,0.09090909090909091,1.0,1.0,3/6,10.25%,AHR;PTPRC;HLA-F
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),-0.8423939255613797,-1.3047571567173133,0.2033898305084746,1.0,1.0,1/5,5.01%,TIMP3
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.7176293473177239,-1.3035797631957873,0.17567567567567569,1.0,1.0,5/14,13.65%,SYT1;RIMS1;RNF157;SYT2;SYT4
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.601928428689481,-1.303116405159005,0.1348314606741573,1.0,1.0,22/67,20.09%,NLRC5;MX1;PTPRC;IRF1;TRIM52;PLSCR1;STAT2;AGBL4;OAS1;IFIH1;TRIM5;IFIT1;AKAP1;AGBL5;IFIT3;RSAD2;IFI6;TRIM56;MAP3K14;STAT1;ATG7;IRF2
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),0.5624673850985658,1.3031153421633233,0.13333333333333333,0.8953025539279251,1.0,12/32,18.46%,LSM4;GEMIN8;AAR2;CD2BP2;SNRPF;SNRPB;STRAP;SNRPD2;PRPF19;SNRPE;PRMT5;COIL
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.7793418957175309,1.3030899178662312,0.20930232558139536,0.8930517448838584,1.0,3/6,17.74%,NLGN2;NLGN3;MTG2
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.7299099324700007,1.3015660324260083,0.13793103448275862,0.8968827264632119,1.0,3/7,14.81%,LIG4;SIRT1;ERCC8
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.7853558982896636,-1.3011273241349275,0.1267605633802817,1.0,1.0,1/10,1.01%,DCAKD
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.7853558982896636,-1.3011273241349275,0.1267605633802817,1.0,1.0,1/10,1.01%,DCAKD
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),-0.7853558982896636,-1.3011273241349275,0.1267605633802817,1.0,1.0,1/10,1.01%,DCAKD
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.6525686098460658,-1.301064362580918,0.07317073170731707,1.0,1.0,10/36,17.40%,GLRA2;AHR;GLRA1;BRCA1;AKR1C2;GRAMD1C;KLF9;ADCY1;ADCY5;CTNNA1
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.7361899549367723,-1.30079701185019,0.13157894736842105,1.0,1.0,5/14,19.93%,PARP9;LIFR;IFIH1;IRAK2;MAP2K5
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),0.780803584144112,1.3004776033103949,0.17857142857142858,0.8995383676731946,1.0,5/7,19.67%,B4GALT3;GBA3;UGT8;B3GALT2;GAL3ST1
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),-0.7235738812238401,-1.3004711211324969,0.14473684210526316,1.0,1.0,3/12,10.54%,HEY2;TTN;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),-0.8392176917713704,-1.299793199689953,0.1509433962264151,1.0,1.0,1/5,2.01%,FGF1
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.5598366576618408,1.299790777937944,0.14285714285714285,0.900059822489435,1.0,5/24,6.73%,SYNDIG1;SLITRK2;CLSTN2;NLGN2;EPHB3
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),0.7201331642873785,1.2997739356016544,0.19444444444444445,0.8977740373263722,1.0,2/7,3.01%,NR1H2;PPT1
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.7946105182839158,-1.299712489167201,0.15151515151515152,1.0,1.0,1/7,5.10%,AGT
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.7692578303641612,1.2990023403698019,0.13333333333333333,0.898022212874993,1.0,3/7,12.44%,NT5E;PNP;NT5C1A
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),0.7728874391082098,1.2984908099657941,0.22857142857142856,0.8977659796707368,1.0,2/5,12.67%,CXCL12;BRK1
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.7644032460582972,-1.2983345462126525,0.0958904109589041,1.0,1.0,6/16,10.83%,SOX9;PTPRC;SPI1;KLF6;AOAH;CAMK2B
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.7316554879316268,-1.298063188516018,0.07352941176470588,1.0,1.0,3/15,10.44%,NLRC5;STAT2;OAS1
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.7226864326636329,-1.2973267956585992,0.11538461538461539,1.0,1.0,9/16,21.24%,MYLK;IGSF6;SPI1;DOCK8;AOAH;TBXAS1;MYO1F;PILRA;ARG2
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),0.7608198358626663,1.2973203823199946,0.2571428571428571,0.8997008941391632,1.0,2/8,3.41%,MOSPD2;CXCL12
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.7315724258926783,-1.297253050619182,0.1323529411764706,1.0,1.0,3/8,15.82%,CAV3;KCNQ1;SNTA1
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.54723326025833,1.296864145880755,0.13043478260869565,0.89930515718235,1.0,2/29,0.74%,UBB;BICD2
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),-0.7457222286016699,-1.2966546688170424,0.125,1.0,1.0,4/13,16.68%,SLC22A4;PDZK1;SEC14L1;SLC25A19
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.5487846336368049,1.2961238049421662,0.05,0.9004546400682939,1.0,5/30,9.12%,AURKAIP1;BAD;RNF139;CSTB;PLAUR
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.6271230845154913,1.2958703916208265,0.037037037037037035,0.8993799145522374,1.0,2/20,0.98%,PANX1;MALT1
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),0.7800078054114375,1.2956303143360781,0.2,0.8979042442654619,1.0,1/5,3.77%,SLC39A10
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),0.6960863066466341,1.2954674980239056,0.1875,0.8963459796677197,1.0,2/11,8.49%,GREM1;MDFI
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.6052246869363257,1.295056735133253,0.13333333333333333,0.8959188170139655,1.0,3/16,3.51%,SOX11;BAD;PDE3A
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),0.7655475755447976,1.2950194920315374,0.1935483870967742,0.893880470879425,1.0,1/5,7.28%,NDP
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.5819155434812724,1.294931360077021,0.21052631578947367,0.8921653084705757,1.0,10/43,13.01%,SOX4;HSPA1A;COPS9;VPS28;UBXN1;BAG2;N4BP1;CHP1;SMAD7;PRR7
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.5244687996366143,1.2943560382104187,0.18181818181818182,0.89148433089691,1.0,9/47,11.01%,DAPL1;SIRT2;TAB3;KIF25;RRAGA;LEPR;MT3;EIF4E;ZKSCAN3
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.5646434308421701,1.293878622371501,0.10526315789473684,0.8916518500564373,1.0,4/24,3.46%,NUP42;CALR;NUTF2;RAN
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),-0.7521431478112399,-1.2935850226584333,0.11594202898550725,1.0,1.0,2/11,8.23%,TTN;CAV3
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.65048425766099,1.293116485004997,0.3,0.8918628984940349,1.0,2/12,10.79%,NR1H2;SCARB1
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.7133353308872393,-1.2930149769789556,0.0875,1.0,1.0,7/21,16.46%,CD44;PTPRC;AOAH;TCF7;TRAF3IP3;MYO1F;GPR171
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.6549799932287794,-1.292822966309043,0.11904761904761904,1.0,1.0,9/28,16.46%,AHR;HSD11B1;PTPRC;ITGA2;CD27;AOAH;TRAF3IP3;MYO1F;GPR171
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.7023378185449944,1.2927748295344959,0.17391304347826086,0.8909222322555672,1.0,2/9,11.17%,ZDHHC6;MUL1
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.5782642771453346,1.2927444196712696,0.2,0.8887501539403722,1.0,6/23,7.92%,GPX1;ADCY6;CXCL12;MEOX2;MYOF;GUCY1B1
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.6416269826015921,-1.2927023928357622,0.1375,1.0,1.0,3/30,5.76%,ARIH2;SAE1;SREBF1
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.7792006527292545,-1.29221877478151,0.06060606060606061,1.0,1.0,2/9,6.91%,HEY2;ZFPM1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),-0.7968048900158662,-1.291921446482627,0.16129032258064516,1.0,1.0,2/6,5.45%,HEY2;FGF9
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.7492213239311916,-1.2917496007627414,0.136986301369863,1.0,1.0,2/12,1.85%,HEY2;MYLK
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),-0.7371975041116308,-1.2913018301503112,0.11594202898550725,1.0,1.0,2/12,7.54%,HEY2;ROBO2
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),-0.6128973212939478,-1.2908361432444497,0.034482758620689655,1.0,1.0,16/50,22.65%,SLC6A6;SLC6A15;SLC6A11;SCN8A;SCN9A;SLC4A4;HCN3;SLC24A2;SLC6A17;SLC6A9;ANO6;ASIC4;ATP1B1;HCN1;HCN2;SLC4A8
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.509204546331395,1.290823461127023,0.13793103448275862,0.894119113662894,1.0,6/23,13.89%,CCND1;PHB2;CDC73;LSM11;PLCB1;EZH2
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.7011110347008545,-1.2906812203555258,0.12658227848101267,1.0,1.0,4/19,15.96%,DND1;THRAP3;TENT5A;MEIOC
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),0.6575593560749243,1.2895742036885787,0.2,0.8977043904613252,1.0,5/10,15.52%,ATP7B;MT1E;MT3;ATP5F1D;MT2A
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),-0.8004876014323015,-1.2886727146781745,0.11428571428571428,1.0,1.0,1/8,0.68%,SOX9
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),0.5890620783792747,1.28836767719716,0.25925925925925924,0.9003955794954585,1.0,6/25,9.12%,BAD;GPX1;MFF;PPIF;PSMD10;PLAUR
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.6132640660547504,1.2883551979113559,0.12,0.8982215675990342,1.0,2/22,0.98%,PANX1;MALT1
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.7139972797982489,-1.2877783423245923,0.12857142857142856,1.0,1.0,1/16,0.29%,TUFT1
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.7480970583331226,1.2874735042506826,0.1724137931034483,0.9001569966884297,1.0,5/7,19.46%,COPRS;PRMT6;PRMT5;PRDM4;PRMT1
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),-0.8162207048342227,-1.287083978170357,0.11594202898550725,1.0,1.0,1/7,0.55%,HEY2
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.8837085220418259,-1.2867756491970437,0.057971014492753624,1.0,1.0,1/5,9.78%,ATG14
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.6686312940437131,-1.28665912341728,0.1566265060240964,1.0,1.0,3/25,15.58%,ENPP2;VIL1;AVIL
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),0.7546611274004608,1.2863773645155763,0.18181818181818182,0.9025179077319752,1.0,3/8,14.94%,HSD17B10;TRMT5;TRMT10C
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.5641813437145445,1.286205979874833,0.19047619047619047,0.9011790741945959,1.0,3/19,4.90%,CTSV;ZFP36L1;SGPP1
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),-0.8588962049007093,-1.286171958029248,0.07936507936507936,1.0,1.0,2/6,4.66%,ABHD12B;CHAC2
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.7450958492359901,-1.2861647701397427,0.12162162162162163,1.0,1.0,2/12,1.95%,FAM161A;CAMK1
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.649540626785662,-1.2857677175900368,0.10256410256410256,1.0,1.0,12/38,23.21%,MAP3K19;DNAH7;TMCO5A;MROH9;FMO6P;FUT2;CFAP52;CHST9;DNAH5;ATP1B1;DNAH9;CFAP43
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),0.7486737429145528,1.285694345149852,0.2903225806451613,0.9014915922422602,1.0,2/6,3.59%,AADAT;HPD
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),0.7088784492689321,1.2855564126685814,0.1875,0.8978046136215576,1.0,2/5,21.08%,DUSP3;MAP4K4
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),0.7088784492689321,1.2855564126685814,0.1875,0.8978046136215576,1.0,2/5,21.08%,DUSP3;MAP4K4
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.5208991743205916,1.2853488420064658,0.0,0.8964042186535862,1.0,8/37,6.18%,NOVA1;IL15;NR1H2;GSTP1;PLCL2;MAP2K6;PLCL1;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),-0.7930838433450761,-1.2853129427539474,0.08823529411764706,1.0,1.0,1/9,1.18%,VSIR
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,0.5069399696593748,1.2852885440489166,0.08333333333333333,0.8944533237962974,1.0,22/94,11.04%,BANF1;LSM4;YIF1A;CALR;ERN1;BAG3;LSM1;NPM1;PREB;EEF2;POP4;PSAT1;IMP3;EIF4A3;ATP6V0D1;EIF4E;NFYA;MTREX;ATF4;SEC11A;PDIA6;NHP2
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.6028233713027449,1.2851370116086223,0.11764705882352941,0.8928111736053816,1.0,6/26,10.16%,LSM4;LSM1;LSM7;DCPS;EDC3;EXOSC8
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),0.7182388643543846,1.284831609759954,0.2692307692307692,0.8916035229237297,1.0,2/9,1.22%,RFWD3;CCND1
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),-0.692744608933078,-1.2847840730101567,0.13157894736842105,1.0,1.0,2/19,0.86%,MSL3;JADE2
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),0.6215430494083138,1.2841257119374143,0.22580645161290322,0.8926146882560279,1.0,2/8,8.01%,POLR2L;GTF3C6
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.463449541073013,1.2835199484789017,0.25,0.8926869760268362,1.0,9/71,7.68%,GPC4;LRRN1;FREM1;AMOT;LGR5;TOX3;FRZB;EPHB3;BMI1
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.5984017333856949,1.2834959902631882,0.13333333333333333,0.8905988131951424,1.0,5/19,8.11%,LRRC8D;TSPO;SLC26A3;ABCG2;ABCC11
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.7124114851680683,-1.2834075730438919,0.17105263157894737,1.0,1.0,2/12,9.85%,ANGPTL4;APOE
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.7483253811826662,-1.283159725389814,0.17567567567567569,1.0,1.0,3/10,14.80%,SRF;APOE;LRPAP1
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),-0.8122079541925622,-1.2831018194560857,0.15625,1.0,1.0,2/7,10.54%,TTN;VEGFA
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.5535781685366041,1.2825652655817514,0.16666666666666666,0.8893608597306774,1.0,8/20,6.60%,ZDHHC6;ZDHHC1;GOLGA7;CLIP3;ZDHHC4;ZDHHC21;ZDHHC11B;ZDHHC3
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.5535781685366041,1.2825652655817514,0.16666666666666666,0.8893608597306774,1.0,8/20,6.60%,ZDHHC6;ZDHHC1;GOLGA7;CLIP3;ZDHHC4;ZDHHC21;ZDHHC11B;ZDHHC3
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),-0.7872627349292319,-1.2823675936468673,0.15625,1.0,1.0,3/8,11.17%,P2RY12;RYR3;TAF1
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.7160742159488953,-1.2818611457738294,0.12048192771084337,1.0,1.0,2/14,2.06%,MYLK;DUOX1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.7016792633221232,1.2816104309742502,0.27586206896551724,0.8890156569857132,1.0,1/6,10.16%,EXOSC8
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.7016792633221232,1.2816104309742502,0.27586206896551724,0.8890156569857132,1.0,1/6,10.16%,EXOSC8
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.8328365625512418,-1.2814421549704647,0.07246376811594203,1.0,1.0,1/7,0.17%,EPN1
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.7312580462001891,-1.28110984921665,0.0958904109589041,1.0,1.0,3/13,8.24%,PHKG1;PYGL;PYGB
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.5929716825711765,1.2798793138598816,0.19047619047619047,0.8941180750638523,1.0,5/12,19.56%,UBE2J1;YOD1;EDEM1;UBAC2;DERL2
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),-0.8254236027889084,-1.2794549162996531,0.11688311688311688,1.0,1.0,3/6,14.45%,PON1;EPHX2;PON3
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.7177614733215452,-1.2790843502503007,0.13333333333333333,1.0,1.0,4/16,4.67%,NLRC5;PARP9;IFNGR2;PARP14
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),-0.7723271429536183,-1.2790291415754067,0.18181818181818182,1.0,1.0,2/8,4.02%,TMSB4X;OTUD7B
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.6812659039115868,-1.278867699782775,0.18666666666666668,1.0,1.0,6/17,14.17%,FGF1;SREBF1;SEC14L2;LPCAT3;APOE;MBTPS1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.5973721889923433,1.2785374460716068,0.10526315789473684,0.8974844423947183,1.0,6/22,12.40%,UBB;GPS1;PARP1;UBC;COPS2;COPS7B
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.6472756931203286,1.2779942621064637,0.2,0.8980855087754052,1.0,5/13,12.23%,BAD;PPIF;THEM4;MUL1;SLC25A4
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.722325553572466,-1.2770421932808302,0.13333333333333333,1.0,1.0,2/15,8.19%,TMEM43;EMD
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),0.7427717939032632,1.2768817271323643,0.24,0.8998890426130174,1.0,4/7,21.04%,JUN;ZNF639;TARDBP;PSMC3
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.7061947826229071,-1.2768364237961443,0.10666666666666667,1.0,1.0,2/12,5.39%,SOX9;BRCA1
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.7962213025719482,-1.2766828558613794,0.1267605633802817,1.0,1.0,3/6,11.40%,HSD11B1;YWHAH;SPP1
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.7016658813374682,1.2764147478959695,0.22727272727272727,0.8995694659492701,1.0,3/10,13.58%,MRPL44;SMAD3;DGCR8
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.7153145653643144,-1.2761700981541688,0.16,1.0,1.0,9/19,14.45%,PAH;SLC3A1;FMO3;SPATA6L;PDZK1;FMO5;TSHR;CYP3A5;PON3
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),0.7884077662564855,1.2759978537325765,0.21875,0.8994582177262302,1.0,1/6,2.47%,GPC1
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),-0.7930624429845358,-1.2759764208009423,0.22727272727272727,1.0,1.0,1/8,1.05%,PIP4K2C
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.7862318256408343,-1.275969555747488,0.10606060606060606,1.0,1.0,4/9,12.42%,SYT1;UNC13C;RIMS1;SYT2
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.4678445883005734,1.2751381850868437,0.0,0.9009983473597802,1.0,9/80,6.62%,U2AF1;AURKAIP1;HSPA1A;PCBP3;ERN1;TBRG4;PCBP2;NUDT16L1;HNRNPA0
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",0.7167914342636148,1.2750356374955818,0.28,0.8991960942263013,1.0,3/9,3.54%,CHRNA4;ACHE;CHRNA7
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),0.6869869510551375,1.2749832444829599,0.12,0.897402184857329,1.0,3/8,9.45%,MOXD1;SNCAIP;COMT
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.6003685361283637,1.274840097413058,0.2222222222222222,0.8957395181381942,1.0,2/16,4.05%,NR0B1;ACADVL
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),-0.7674336331610384,-1.2744016954920954,0.12903225806451613,1.0,1.0,2/10,11.86%,HEY2;GJA1
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),-0.717217555287851,-1.2732978385361808,0.14864864864864866,1.0,1.0,1/18,0.55%,HEY2
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.5671149829735013,1.2731155644072463,0.1875,0.9012813520037221,1.0,4/21,10.36%,TRIR;NUDT16L1;EXOSC8;MTREX
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.5455131754557383,1.2727257574806408,0.2,0.9008821229909201,1.0,13/47,14.00%,BAD;STARD3;TSPO;MFF;SLC25A24;PPIF;AIP;MTX2;TIMM13;TIMM22;SLC25A4;FIS1;DNAJC19
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),0.7686482859058194,1.272695171002909,0.22857142857142856,0.898856583143572,1.0,3/5,12.28%,RBP1;BCO1;ALDH1A2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.7362042869528562,1.2717982228459712,0.2222222222222222,0.9000891463705258,1.0,2/5,15.92%,GNAI1;EPB41
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),-0.8325956538685892,-1.271743231939138,0.09230769230769231,1.0,1.0,2/6,12.02%,DUSP22;BDNF
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),0.7357118319710024,1.2714955804335635,0.22857142857142856,0.8988445021800537,1.0,3/6,12.08%,ABHD10;GBA3;GUSB
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.6641071127745035,-1.271448699756335,0.17567567567567569,1.0,1.0,7/16,29.36%,TRIM5;TRIM25;HS3ST5;GSN;MID2;CIITA;NECTIN2
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),-0.7922010147938754,-1.2712503651876033,0.15942028985507245,1.0,1.0,4/5,20.38%,CAMK1;CAMK2B;SHANK3;FRMPD4
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.6139336832243272,1.2708534496014057,0.16666666666666666,0.8990204172664215,1.0,5/19,12.25%,UBB;GTF2H2;PARP1;UBC;ERCC3
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.6092150121027263,1.270150010986123,0.19047619047619047,0.8989938651302694,1.0,2/12,3.52%,YAP1;SEMA5A
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.7653801415554997,-1.2700773722268388,0.06578947368421052,1.0,1.0,1/13,0.19%,CD44
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.6774485011343414,-1.2697675101498072,0.10843373493975904,1.0,1.0,5/25,15.96%,DND1;THRAP3;PARN;TENT5A;MEIOC
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.7661620967477767,-1.2696147140752854,0.16666666666666666,1.0,1.0,1/8,1.60%,HES1
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),0.5968350624466491,1.2693344217074296,0.26666666666666666,0.9005771159105797,1.0,3/17,7.25%,TSPO;ALAD;ABCG2
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.5847357335130597,1.2683893043155103,0.1,0.9023941087626602,1.0,2/25,1.12%,TUBG1;MAP7D3
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.470172116227184,1.26829223005723,0.09090909090909091,0.9004772828933124,1.0,16/58,8.25%,MMP2;PRRX1;FIBIN;BGN;FBLN2;PODN;CYBRD1;CXCL12;PDGFRA;VSTM4;IGFBP7;LDB2;THY1;ZNF521;MSRB3;SSC5D
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.550936356844011,1.2678935553023143,0.25,0.9002078677968779,1.0,10/42,16.12%,ACADS;ACAA2;HSD17B10;ACADVL;ABCD2;ACOT8;ECHDC1;CRAT;HADH;CROT
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),0.7845850701173341,1.267256097596369,0.3783783783783784,0.9006575096039091,1.0,1/5,2.15%,NR1H2
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),0.7245180308589908,1.2669583137821774,0.16666666666666666,0.8998716166136828,1.0,3/10,8.09%,STARD3;ARV1;LDLR
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.7278828164193204,-1.2668373001919635,0.11267605633802817,1.0,1.0,5/17,12.53%,FGF1;CCDC39;FGF9;VEGFA;LOXL3
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),-0.7419815134225367,-1.2668000050303254,0.1111111111111111,1.0,1.0,4/16,10.95%,YWHAH;CACNA1C;SCN8A;SCN9A
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.6961214563935034,-1.2667607886590728,0.11688311688311688,1.0,1.0,5/16,12.03%,AGT;KCNMB4;CAV3;TPM1;KCNQ1
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),-0.7801350858429842,-1.2665966639753514,0.18032786885245902,1.0,1.0,3/7,19.39%,KIF1C;SYT4;KIF1A
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),-0.7454687733383677,-1.2661885192173,0.15151515151515152,1.0,1.0,2/10,7.54%,HEY2;ROBO2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.6911176835549071,1.265405133981304,0.22857142857142856,0.9038534679895484,1.0,4/8,26.55%,LANCL1;PINK1;P4HB;FYN
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",-0.7720182094115213,-1.265241899243497,0.16923076923076924,1.0,1.0,1/7,4.17%,NDST3
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.5600751672032716,1.2650547011387967,0.09523809523809523,0.9029451097737712,1.0,4/23,7.87%,IDH1;STARD3;FDX1;SQLE
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.6846056439103096,1.2646598998071183,0.17857142857142858,0.9029498739544681,1.0,3/9,20.27%,ARL6IP5;SLC1A2;SLC1A3
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),-0.7481943728685231,-1.2645777724393392,0.125,1.0,1.0,2/11,1.96%,HES1;OPALIN
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.7167063278110778,-1.2640609006139405,0.1506849315068493,1.0,1.0,6/15,15.96%,BRME1;TDRD9;BCL2L11;SGO2;BTBD18;MEIOC
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),-0.7958551411033561,-1.2639797323661426,0.1095890410958904,1.0,1.0,3/8,18.12%,STX1B;RAB11A;GRIPAP1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),0.73981781877661,1.2638806249596999,0.21875,0.9036250497217003,1.0,1/5,3.41%,CXCL12
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.5765384806199986,1.2637786373733821,0.10526315789473684,0.9019362447253716,1.0,3/18,3.60%,HSPA1A;AFAP1L2;TLR1
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),0.7871262480653047,1.2637750253884052,0.21621621621621623,0.8999408105556252,1.0,1/5,1.74%,ADCY6
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.691579322872535,1.2636621856673314,0.24242424242424243,0.8983459467254183,1.0,4/6,17.57%,BMP2;SALL1;GDNF;PAX8
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),-0.6238378682600895,-1.2635590059897936,0.11904761904761904,1.0,1.0,5/45,7.24%,GABRA4;GLRA2;GLRA1;GABRG3;GABRG2
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),0.6065925695390363,1.2635018475629942,0.2413793103448276,0.8968753779971983,1.0,1/15,0.87%,TRMT112
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,-0.8285722980071631,-1.2634699966007765,0.13157894736842105,1.0,1.0,2/7,2.02%,SCEL;EMP2
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.6778330034172461,1.2631459580548874,0.25,0.8965813886621037,1.0,1/9,2.15%,NR1H2
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),-0.5494607110697617,-1.2631239334732158,0.07216494845360824,1.0,1.0,33/178,13.01%,GABRA4;HTR2C;HTR1F;GLRA2;GRIN2A;NAAA;CAMK1;AKAP5;PCDHB5;GRM1;GLRA1;SYT1;GABRG3;UNC13C;SNCB;GRIN2D;CPLX1;SST;GABRG2;NRGN;KCNMB4;GRIK5;CACNA1B;RIMS1;APOE;APBA2;RAB3A;SHISA6;GRM3;SNAP25;SLC1A4;HTR2B;HAP1
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),-0.6630534257941966,-1.2630624368043655,0.1038961038961039,1.0,1.0,5/33,7.24%,GABRA4;GLRA2;GLRA1;GABRG3;GABRG2
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.6348891689147212,1.2628569147275719,0.17391304347826086,0.8955881591665283,1.0,5/9,19.56%,UBE2J1;YOD1;INSIG1;UBAC2;DERL2
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.7538976664744697,-1.262709566973385,0.12987012987012986,1.0,1.0,4/11,9.49%,HHIP;GLRA1;OPRM1;UBASH3B
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),-0.7958774517724065,-1.2616211808669728,0.13095238095238096,1.0,1.0,1/9,0.27%,PON1
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.7727893584498683,-1.261422655468868,0.14666666666666667,1.0,1.0,2/11,1.95%,FAM161A;CAMK1
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.7638179573807928,1.2610740673370482,0.21212121212121213,0.9000747505574844,1.0,2/7,6.45%,ADRA1A;ZDHHC21
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.5302064436830988,1.2605807490564052,0.08333333333333333,0.8999694431944009,1.0,13/36,15.91%,NEU1;CTSA;B4GALT6;SMPD1;SMPD3;NEU3;GBA3;ST6GALNAC3;ESYT2;UGT8;GM2A;GLTP;NEU4
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),-0.8061646790244503,-1.2603345953886953,0.1791044776119403,1.0,1.0,2/5,14.81%,SLC6A15;SLC6A17
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),0.6889743600013877,1.260212148570554,0.2692307692307692,0.8995166192056121,1.0,2/8,9.62%,SLC2A10;ACOT8
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.5075952045090998,1.2599761379067465,0.16666666666666666,0.898795704784535,1.0,12/51,11.65%,HSPA1A;CXCL12;TMEM161A;NDUFS3;PPIF;TMBIM6;PPIA;NOC2L;PLAUR;PTTG1IP;ARMC10;CREB3L1
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.7692824235211422,-1.2599585110810358,0.15714285714285714,1.0,1.0,1/9,0.68%,SOX9
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.5318345494470454,1.2597951251554818,0.1,0.8975774673368386,1.0,4/32,4.44%,DGKB;PLD1;LPCAT1;AGPAT5
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.6430242877831358,1.2591449672474742,0.29411764705882354,0.8979778445122539,1.0,3/10,7.11%,ERN1;SEMA5A;BMPER
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.5601433121688213,-1.2581529885039127,0.06666666666666667,1.0,1.0,18/113,13.69%,TMSB4X;GTPBP2;TTN;TUBA4A;F8;A2M;SYT1;VCL;TIMP3;CPLX1;STEAP2;RIMS1;RAB3A;VEGFA;SYT2;SNAP25;SYT4;SYNGR2
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.8005324151331086,1.257668598308549,0.16666666666666666,0.901404555294315,1.0,2/6,6.41%,SIRT2;RCC2
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),-0.7875761228312965,-1.2576345720142825,0.1746031746031746,1.0,1.0,2/8,4.62%,MREG;USP13
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),0.5655872433097378,1.257246302761783,0.18181818181818182,0.9008005287401283,1.0,3/17,10.40%,SHROOM2;AP1M1;BLOC1S4
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),0.661650871932153,1.2572372719916163,0.3333333333333333,0.8988633233019775,1.0,3/8,10.06%,LYN;TNFRSF21;RC3H1
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.6195347189867828,1.257116017372245,0.34615384615384615,0.8974675961997429,1.0,6/10,20.96%,NLGN2;NLGN3;NLGN4X;NLGN1;WNT5A;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.6975218831227359,-1.2569221316945196,0.15,1.0,1.0,2/14,5.10%,NR4A3;AGT
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.6055570526694475,-1.2566273177082554,0.0975609756097561,1.0,1.0,26/67,20.71%,CMTR1;MX1;PARP9;IRF1;PROCR;PSMB8;PARP14;PLSCR1;STAT2;TMEM140;B2M;IL7;OAS1;HLA-C;TENT5A;IFIH1;TRIM5;LPAR6;HERC6;IFIT3;RSAD2;IFI35;PSMA3;C1S;IRF2;TRIM25
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.7977015632138195,1.2564400482388467,0.22857142857142856,0.8964762949682039,1.0,4/5,19.67%,B4GALT3;UGT8;B3GALT2;GAL3ST1
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.7977015632138195,1.2564400482388467,0.22857142857142856,0.8964762949682039,1.0,4/5,19.67%,B4GALT3;UGT8;B3GALT2;GAL3ST1
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.5808991857887642,-1.2556524877909887,0.09876543209876543,1.0,1.0,17/62,16.74%,SGCA;TTN;MYLK;TMOD3;TPCN2;GLRA1;VCL;CKMT2;EMD;CAV3;EDNRA;TPM1;SORBS1;SNTA1;CRYAB;MYOM2;OXTR
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.5439678967193602,1.255494158232096,0.125,0.8977811935109394,1.0,14/44,15.50%,EXTL1;CUL7;YIF1A;ERN1;ACADVL;PREB;TLN1;VAPB;ATP6V0D1;PDIA6;PDIA5;HSPA5;EDEM1;SSR1
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.6365960050930966,-1.2552840912514838,0.1511627906976744,1.0,1.0,1/26,0.68%,SOX9
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.6916386702613744,-1.2546733374909476,0.10256410256410256,1.0,1.0,6/21,16.46%,IL5;AHR;PTPRC;STAT6;TRAF3IP3;GPR171
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.6199072009224383,1.2546623979377776,0.18518518518518517,0.8986274307948413,1.0,4/11,22.36%,IKBKB;FHOD3;LLGL1;RHOQ
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.6051757902572685,1.2546187107922546,0.17391304347826086,0.8968702324241279,1.0,3/20,10.40%,NOL11;PIH1D1;ATF4
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.7207556320371032,-1.2545372809476765,0.14864864864864866,1.0,1.0,6/15,13.61%,SLC28A2;SLC3A1;VIL1;PBLD;FMO5;CYP3A5
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),-0.725937156864608,-1.254339405159173,0.21621621621621623,1.0,1.0,1/13,1.08%,FABP3
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.7929420956789837,-1.2541931564826294,0.1095890410958904,1.0,1.0,1/8,2.58%,SLC2A3
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.40248739297725333,1.2541829475834176,0.25,0.8963988473613504,1.0,27/114,13.00%,AMOTL2;PIWIL2;FNBP1L;MAGI1;NACC1;DNMT3B;YAP1;PAWR;PIWIL4;TRIM28;PML;THY1;PCGF2;ABCG2;PTPRF;PTPN14;MDFI;TSPAN6;CDK8;WWC2;SMAD9;LRIG3;SMAD3;LAPTM4B;LYPD6;SH3D19;RAI14
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.7394949557103918,1.2539846661321092,0.13793103448275862,0.8952916230339291,1.0,2/6,14.81%,LIG4;ERCC8
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.6354255368898463,-1.2538286072554288,0.15584415584415584,1.0,1.0,5/32,13.20%,VSIR;ZFPM1;RARA;BTN3A1;RASGRP1
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),0.7656549545693145,1.253230201476775,0.18518518518518517,0.8957990077343219,1.0,2/6,8.27%,SOX4;SOX6
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),-0.5578687521727461,-1.2522778131476773,0.1348314606741573,1.0,1.0,15/66,17.93%,RASGRF1;ARHGAP24;USP6;RAP1GAP2;DOCK7;TBC1D4;TSC1;RASGRP1;TBC1D10B;NTRK3;TBC1D8;TBC1D2B;TIAM1;BCR;TBC1D13
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),-0.8177320288350436,-1.251925019149378,0.06349206349206349,1.0,1.0,1/5,9.85%,APOE
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),-0.8177320288350436,-1.251925019149378,0.06349206349206349,1.0,1.0,1/5,9.85%,APOE
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),-0.8177320288350436,-1.251925019149378,0.06349206349206349,1.0,1.0,1/5,9.85%,APOE
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.6397101391457382,-1.251551699245598,0.2077922077922078,1.0,1.0,5/26,13.08%,PLET1;CDKN2A;DUSP22;RASA1;ITGB1BP1
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.7495789012494394,-1.251350773757173,0.136986301369863,1.0,1.0,4/8,22.24%,APOE;DNM2;OLFM1;SIN3A
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),0.623826294948704,1.2512906775406971,0.2926829268292683,0.9013480691072829,1.0,1/8,2.92%,ZFP36L1
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.6879701821614365,-1.251085339990871,0.12658227848101267,1.0,1.0,5/20,15.67%,SLC6A6;SLC6A15;SLC1A4;SLC6A17;SLC6A9
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),-0.7788606597251411,-1.250919777116536,0.19696969696969696,1.0,1.0,1/6,14.55%,PDCD4
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.5608236886166009,1.2509043366890025,0.19230769230769232,0.901244068916438,1.0,5/29,14.17%,FLRT3;SEMA5A;SEMA5B;NLGN3;NRP1
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.824662662428068,-1.2507246826002625,0.171875,1.0,1.0,1/5,1.02%,NLRC5
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.6672581682256241,1.249899447615799,0.23076923076923078,0.9028891362918399,1.0,1/9,0.65%,RFWD3
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.6350801641722001,1.249853638378204,0.17391304347826086,0.9012601365230919,1.0,5/13,23.23%,TRIM28;PPHLN1;MORC2;ATF7IP;ZNF304
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.8278486314142027,-1.2497919668461015,0.17647058823529413,1.0,1.0,2/6,13.61%,CYP2E1;CYP3A5
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),-0.6642013544547377,-1.2497502105521865,0.14473684210526316,1.0,1.0,1/18,4.04%,RAB17
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),-0.777906707011671,-1.2496130427832643,0.1267605633802817,1.0,1.0,1/7,2.01%,FGF1
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.6668635729332092,-1.2492905908871432,0.21518987341772153,1.0,1.0,8/20,20.04%,PTPRC;IRF1;IGSF6;FPR3;APOL6;IFIH1;IL6R;TYMP
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.8817629035057328,-1.2491342999733468,0.16129032258064516,1.0,1.0,1/5,1.18%,VSIR
prerank,GO_Biological_Process_2021__protein localization to membrane raft (GO:1903044),-0.8418636316978316,-1.248568982801316,0.12280701754385964,1.0,1.0,1/5,6.51%,RFTN1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),0.7015024473961606,1.248013468895558,0.2564102564102564,0.906825557238044,1.0,1/6,0.91%,BAD
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.8267538581287543,-1.2479373910705955,0.2112676056338028,1.0,1.0,2/6,7.48%,CLDN18;CLDN12
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.6288383897826517,1.2476483488441519,0.17857142857142858,0.9066000950971805,1.0,3/13,18.85%,LARP7;NELFA;RNF168
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),-0.826581154606104,-1.2475589311320192,0.07462686567164178,1.0,1.0,1/6,3.51%,AKAP5
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.648735483852459,-1.2470049876137217,0.19444444444444445,1.0,1.0,8/17,26.35%,ABHD12B;PLSCR1;LPCAT3;MBOAT2;ABHD12;SERINC1;OSBPL10;PLAAT3
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),0.623321121499429,1.2469717370184683,0.20588235294117646,0.9074455407757562,1.0,2/7,8.01%,POLR2L;GTF3C6
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),-0.8525258287794706,-1.2468599081827507,0.18461538461538463,1.0,1.0,2/5,8.27%,SLC3A1;SLC7A6
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.7513209646255836,-1.2467789418784792,0.22857142857142856,1.0,1.0,6/10,18.81%,IGSF6;SPI1;AOAH;TBXAS1;MYO1F;PILRA
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.7394497662471845,-1.2467617941355398,0.208955223880597,1.0,1.0,3/14,10.81%,ELOVL2;ACSBG1;ACSL1
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.7188326670637293,1.2466792693865107,0.23333333333333334,0.9071092709421592,1.0,2/6,18.76%,PTPRF;FRS2
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.7437051649495992,-1.2462642490812024,0.18571428571428572,1.0,1.0,1/11,0.55%,HEY2
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.6617246874583749,1.246229708032558,0.28,0.9068478790356047,1.0,4/10,18.52%,HIRA;RBBP4;UBN1;H3-3A
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.5586562542656976,1.2460807882241016,0.18518518518518517,0.9054142284478581,1.0,9/20,21.17%,DACH1;HNRNPC;NAT10;ERCC4;PIF1;CTC1;POT1;XRN1;TP53
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),0.48336900029000757,1.2457601817823267,0.07692307692307693,0.9027472063901891,1.0,14/50,15.84%,NDUFB1;NDUFAF8;NDUFA5;DMAC2;NDUFB11;NDUFS3;NDUFS6;NDUFB7;TIMMDC1;NDUFS8;NDUFB10;NDUFA6;NDUFB3;TIMM21
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),0.48336900029000757,1.2457601817823267,0.07692307692307693,0.9027472063901891,1.0,14/50,15.84%,NDUFB1;NDUFAF8;NDUFA5;DMAC2;NDUFB11;NDUFS3;NDUFS6;NDUFB7;TIMMDC1;NDUFS8;NDUFB10;NDUFA6;NDUFB3;TIMM21
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),0.5615654838144943,1.2453004717880674,0.3333333333333333,0.9031164148419105,1.0,4/19,10.94%,TSPO;ALAD;ABCG2;SUCLA2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.7662839793965619,-1.2448519427304447,0.13157894736842105,1.0,1.0,1/11,0.19%,CD44
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.8205602095301938,-1.2448388909094124,0.14754098360655737,1.0,1.0,1/6,3.18%,TPCN2
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),-0.8165106951871658,-1.24442832499194,0.20634920634920634,1.0,1.0,5/5,18.38%,STAT5A;STAT3;STAT5B;JAK1;STAT1
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),-0.8165106951871658,-1.24442832499194,0.20634920634920634,1.0,1.0,5/5,18.38%,STAT5A;STAT3;STAT5B;JAK1;STAT1
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),0.7498412274890467,1.2443993446859491,0.2702702702702703,0.9043569011055771,1.0,5/7,22.04%,RAD17;ZNF830;SETMAR;NAE1;STK33
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.5189364309401349,1.2440477475965248,0.17647058823529413,0.9037414258162086,1.0,5/23,14.03%,CRB2;NECTIN1;DCHS1;TENM4;GRID2
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.6703233735197277,1.2438633286653353,0.27586206896551724,0.902621412683816,1.0,1/7,6.07%,RO60
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.6163520585049704,-1.2435868625768094,0.125,1.0,1.0,20/44,24.09%,CD44;IRF1;IFNGR2;DAPK1;B2M;HLA-F;OAS1;CAMK2B;HLA-C;CAMK2A;TRIM5;DAPK3;JAK1;STAT1;IRF2;TRIM25;AQP4;HLA-B;HLA-A;CAMK2D
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.6722665436271456,-1.2433372266282283,0.22666666666666666,1.0,1.0,4/22,10.30%,CCDC39;ENKUR;MMP21;DNAH11
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.6288610452492532,1.2430567374846422,0.1724137931034483,0.9039637600310032,1.0,3/12,18.85%,LARP7;NELFA;RNF168
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.6274752400617783,-1.2427617404711078,0.10975609756097561,1.0,1.0,7/34,11.68%,NR4A3;PDHX;ENO4;LDHA;GPI;SLC16A3;GAPDHS
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.8184413691990337,-1.2427536598004394,0.07936507936507936,1.0,1.0,1/7,1.82%,ALOX12
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.5025193219449045,1.2421306857334335,0.16666666666666666,0.9055531450857839,1.0,6/45,5.97%,SOX4;RFWD3;CCND1;PCBP4;CNOT9;PML
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),-0.6424168313315202,-1.2420308451046063,0.19767441860465115,1.0,1.0,8/28,14.03%,SLC22A4;SLC6A6;SLC39A14;SLC29A2;GLUL;LRP2;SNAP25;NEURL1B
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.45810995879878097,1.2417770532547843,0.058823529411764705,0.9054082040789524,1.0,10/46,7.89%,MMP2;FBLN5;FIBIN;BGN;COL12A1;CXCL12;PDGFRA;IGFBP7;BMPER;MSRB3
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.5130777637636448,1.241644478886878,0.18181818181818182,0.9041861120510645,1.0,21/56,21.68%,ACADS;ACAA2;HSD17B10;ACADVL;ABCD2;ACOT8;PCCB;ECHDC1;NUDT19;ABHD2;PEX13;ACBD5;HADH;CROT;ACOX1;ABHD3;PEX2;ECHS1;GLYATL2;DECR1;ACAT2
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.6686762434237927,-1.2416270094138675,0.13513513513513514,1.0,1.0,8/23,12.42%,SOX9;EFNA1;OVOL2;RAB17;TMC4;SPP1;SLC44A3;GPRC5C
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.675525970368561,-1.24137586460152,0.21951219512195122,1.0,1.0,4/14,16.16%,PTPRC;RFTN1;VAV3;BLNK
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.7780915517194646,-1.2406712902761572,0.19696969696969696,1.0,1.0,2/7,9.87%,DONSON;ZRANB3
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.7446440337181411,-1.2405941855494662,0.17391304347826086,1.0,1.0,3/10,10.54%,SRPX2;RHOJ;VEGFA
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.7601179552161036,1.2405200475205695,0.21621621621621623,0.9059088233502982,1.0,3/6,16.07%,PIH1D1;RUVBL2;LRWD1
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),-0.8583660565704342,-1.2403090094409803,0.19047619047619047,1.0,1.0,1/5,1.18%,VSIR
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),-0.6423342877173013,-1.239986748880308,0.20253164556962025,1.0,1.0,8/23,21.13%,GADD45B;GADD45A;SPI1;VEGFA;RELL1;RASGRP1;PER1;DAB2IP
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.6038690290223714,1.2399711852714188,0.11538461538461539,0.9061933987533908,1.0,9/20,20.03%,HNRNPC;PARP1;NAT10;ERCC4;PIF1;CTC1;SLX4;POT1;XRN1
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.5554718827943691,1.2398864720138891,0.18518518518518517,0.9046557339598779,1.0,5/16,17.03%,SMYD2;CSKMT;KMT2D;SETMAR;SETD3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),0.7316280001906941,1.2396924592431018,0.2682926829268293,0.9034449689163887,1.0,4/5,26.03%,HAVCR2;LRFN5;NR1H3;CD200
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),0.6999284770431133,1.2395746195687627,0.21951219512195122,0.9021679273819025,1.0,3/6,20.35%,ISCU;VCP;PINK1
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),-0.7811900709777302,-1.2395577474671897,0.22535211267605634,1.0,1.0,1/5,7.54%,ROBO2
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),0.7781844976643375,1.2395339084296937,0.2857142857142857,0.9004345785253276,1.0,4/5,18.01%,XYLB;RPIA;RPE;DCXR
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.531958239847285,1.2394886240625558,0.15,0.8986727265712794,1.0,4/31,4.44%,DGKB;PLD1;LPCAT1;AGPAT5
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),0.7141469563258731,1.2394488539127961,0.2222222222222222,0.8970593023106513,1.0,6/9,20.88%,OXSM;ABHD2;CRAT;CROT;ABHD3;GLYATL2
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),0.5990607593618555,1.2392350763686897,0.19047619047619047,0.8960873658042392,1.0,5/11,15.86%,ERN1;CPSF1;CPSF4;CSTF2T;NUDT21
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.6319136445419293,1.2392063751327307,0.32142857142857145,0.8925736470278802,1.0,3/7,13.87%,CALM3;SRI;CALM1
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.6319136445419293,1.2392063751327307,0.32142857142857145,0.8925736470278802,1.0,3/7,13.87%,CALM3;SRI;CALM1
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.6185313503564589,1.2388458844762955,0.28125,0.8925983714940439,1.0,2/11,6.73%,SEMA5A;EPHB3
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.45133405144370464,1.2387813975525999,0.2,0.8909778362409763,1.0,6/54,2.43%,MMP2;PRRX1;AMOTL2;TCF7L1;YAP1;COL12A1
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.5537854542770607,1.2380984786887044,0.3181818181818182,0.8912501465510078,1.0,8/32,9.88%,ZFP36L1;C9ORF78;LARP7;KHDRBS2;PTCD2;CPSF4;RBM23;JMJD6
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.5248255988215043,1.2380851894869256,0.2777777777777778,0.8895688957701501,1.0,14/41,16.06%,TSPO;DNAJC15;MFF;AIP;GRPEL1;IMMP2L;TIMM13;HSPA4;TIMM22;IMMP1L;FIS1;DNAJC19;TIMM21;TIMM50
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),0.6336494559820678,1.2379700510438119,0.16666666666666666,0.8879986307740044,1.0,6/11,26.28%,POLD3;PNP;AMPD2;AMPD3;GMPR2;POLL
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.803177477080897,-1.237814685743322,0.16176470588235295,1.0,1.0,4/6,19.02%,MX1;DNM1;DNM2;DNM1L
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.803177477080897,-1.237814685743322,0.16176470588235295,1.0,1.0,4/6,19.02%,MX1;DNM1;DNM2;DNM1L
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.4928347577851735,1.2376169785924105,0.2,0.8876153129688507,1.0,9/28,6.60%,PORCN;ZDHHC6;ZDHHC1;GOLGA7;CLIP3;ZDHHC4;ZDHHC21;ZDHHC11B;ZDHHC3
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.5583817746809094,1.2370226805373257,0.09523809523809523,0.8877187551818042,1.0,11/28,17.33%,MALT1;RBM15B;NUTF2;NPM1;GEMIN8;LSG1;SNRPF;AAAS;SNRPB;SNRPD2;SNRPE
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.7965641005593888,-1.2367633558730882,0.21212121212121213,1.0,1.0,1/7,8.31%,RAB11A
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.519419669805358,1.2365161292959683,0.2,0.8880293584334659,1.0,5/26,7.00%,HSPA1A;ERN1;HNRNPLL;RBM22;PRDX6
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.656864756226275,1.2353998844804817,0.32142857142857145,0.8901341441169379,1.0,1/8,0.43%,STOX1
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.7196838988982264,1.2353295453504871,0.3142857142857143,0.8885780268424118,1.0,4/7,22.12%,BOK;HSPA5;PPP1R15B;PTPN1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.7310453041894693,-1.2352089728361069,0.16666666666666666,1.0,1.0,1/9,1.83%,NR4A3
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),-0.8090705186306971,-1.2351289253510085,0.171875,1.0,1.0,1/6,4.00%,PHF19
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),-0.7577264028611254,-1.235048892522708,0.208955223880597,1.0,1.0,3/13,9.85%,RASGRF1;CALB1;APOE
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.6003308607125788,1.2348736337757913,0.22727272727272727,0.8884380509748309,1.0,8/18,13.87%,GPNMB;RAP2A;GREM1;RAP2C;PDGFD;CALM3;PDGFC;CALM1
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),-0.6802878792588192,-1.2346146637109183,0.17721518987341772,1.0,1.0,3/19,5.29%,HOOK1;EMP2;WDR91
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),-0.8468517708123006,-1.234143001926561,0.15873015873015872,1.0,1.0,1/5,1.28%,LETM2
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),-0.7869355554987543,-1.2336758024920416,0.23809523809523808,1.0,1.0,1/5,7.54%,ROBO2
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.7024331249910095,-1.2331726379392018,0.2328767123287671,1.0,1.0,6/14,17.57%,PTPRC;AOAH;TRAF3IP3;MYO1F;GPR171;IL6R
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.6984698470193462,1.2324316438720884,0.15789473684210525,0.8947176536702284,1.0,4/10,12.13%,DHFR;SPTLC1;ACER2;ACER3
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.6534402892386705,-1.2324166356595843,0.14666666666666667,1.0,1.0,3/24,10.44%,NLRC5;STAT2;OAS1
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.6003198631079986,1.2316600244251708,0.19230769230769232,0.8956626899849206,1.0,5/11,17.69%,ATP7B;COX19;COMMD1;MT2A;SLC31A1
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,-0.5546993853614092,-1.2314770057855964,0.13953488372093023,1.0,1.0,17/76,16.22%,ENPP2;GRIN2A;OPALIN;A2M;P2RY12;TNS1;GLUL;MMD2;GALNT15;SHISA6;SPP1;BAALC;RASSF4;SPARCL1;TMEM132C;PLP1;PLXDC2
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.6759388461296223,-1.2314246885628228,0.21739130434782608,1.0,1.0,3/12,10.81%,ALOX12;ELOVL2;ACSL1
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),-0.6884124613360842,-1.2310787131610936,0.16666666666666666,1.0,1.0,3/20,10.93%,PMS2;MSH6;RPA3
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.6903709945849082,1.2308208682140775,0.32,0.8967750551533828,1.0,4/8,19.21%,QRICH1;ATF4;HSPA5;HERPUD1
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.7703712005667877,1.230808109308048,0.27586206896551724,0.8950846161041401,1.0,1/6,4.52%,ARFIP1
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.7642659938347902,-1.2306871741725434,0.18421052631578946,1.0,1.0,4/9,9.49%,HHIP;GLRA1;OPRM1;UBASH3B
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.6984261457920149,-1.2306783253270321,0.14285714285714285,1.0,1.0,2/12,5.10%,NR4A3;AGT
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),0.8087743021187623,1.2304337438444015,0.18181818181818182,0.8944225520347712,1.0,3/6,4.15%,LTV1;RAN;NPM1
prerank,PanglaoDB_Augmented_2021__Germ Cells,-0.5857803959139992,-1.2304112382337749,0.1724137931034483,1.0,1.0,14/53,11.68%,HOOK1;TAF7L;TMCO5A;BRCA1;TSSK3;MAEL;GGNBP1;SPATA12;ACYP1;BCL2L14;SPATA20;ZMYND19;PARN;GAPDHS
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.7893233644117628,-1.2302883507921232,0.15,1.0,1.0,1/5,6.59%,P2RY12
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),0.7906885656138487,1.2299744664584513,0.1875,0.8943749814902836,1.0,2/5,10.81%,RAB6A;PRDX3
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.6508445402286734,-1.2298620224167103,0.10843373493975904,1.0,1.0,6/28,8.11%,SCEL;CLDN18;STEAP4;CRLF1;FPR3;CEBPD
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.4474291588794013,1.2297857930773488,0.0,0.8934792778720088,1.0,18/147,9.09%,COPZ1;YIF1A;TMED2;TGFA;KLHL12;DYNLL2;PEF1;CTSC;YIF1B;PREB;KDELR1;SEC24D;TMED5;COG3;GOSR1;COG6;RAB1B;VAPB
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.5868826121770064,-1.229184442550573,0.13253012048192772,1.0,1.0,11/65,5.10%,CD44;ENPP2;IL5;HES1;NEDD9;EFNA1;PARP9;PTPRC;CRLF1;PARP14;AGT
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.5892489999563739,1.2290971397808639,0.21052631578947367,0.8945513278433781,1.0,5/15,7.10%,RBM22;RAP2A;FBP1;PDE4B;ACER2
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.7163201893924184,-1.2289837984773115,0.20270270270270271,1.0,1.0,1/11,6.36%,PLSCR1
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),0.7118009843857936,1.228882346420965,0.3225806451612903,0.8934220772042523,1.0,5/10,18.02%,ARPC5;JMY;ARPC2;ARPC5L;WHAMM
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",-0.7734187849440624,-1.2287735191699913,0.1891891891891892,1.0,1.0,3/8,7.24%,GABRA4;GABRG3;GABRG2
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),0.7784066209136049,1.2284378379889334,0.20588235294117646,0.8894885985167365,1.0,2/5,18.01%,XYLB;DCXR
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),0.7784066209136049,1.2284378379889334,0.20588235294117646,0.8894885985167365,1.0,2/5,18.01%,XYLB;DCXR
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),0.7784066209136049,1.2284378379889334,0.20588235294117646,0.8894885985167365,1.0,2/5,18.01%,XYLB;DCXR
prerank,GO_Biological_Process_2021__artery development (GO:0060840),-0.668152206913566,-1.2282500944438313,0.125,1.0,1.0,3/16,10.54%,HES1;ROBO2;VEGFA
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.6421251381092474,1.22822330602235,0.20588235294117646,0.8884445524730312,1.0,3/10,12.31%,CMPK1;ENPP3;SMPDL3A
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.6585310452443413,-1.2278213791991783,0.17105263157894737,1.0,1.0,4/20,4.60%,CDH7;CDH12;PCDHB5;CDH9
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.7938677695470246,-1.227782600991236,0.17142857142857143,1.0,1.0,1/7,2.81%,MCCC1
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.6311177706780218,1.2276172043650337,0.25,0.8888107924162492,1.0,7/14,22.74%,NLGN2;NLGN3;NLGN4X;NRXN3;NLGN1;NRXN1;NCAM2
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),0.5249461256292491,1.2275455166114755,0.13333333333333333,0.8873040559855895,1.0,4/28,12.23%,BAD;PPIF;MTX2;SLC25A4
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.7201624515892753,-1.2274505143242542,0.2,1.0,1.0,1/10,0.19%,CD44
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.45553878013776167,1.2273937432707938,0.2222222222222222,0.88647015501321,1.0,8/68,5.59%,PANX1;CHRNA4;TSPO;CHRNA7;KCNN2;SLC26A3;MCOLN1;SLC15A2
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),-0.8046194517062552,-1.2268276861269332,0.2028985507246377,1.0,1.0,3/6,12.75%,UNC13C;STX1B;SNAP25
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.5905290013058633,1.2267840061971134,0.17391304347826086,0.8869046298095699,1.0,4/17,11.37%,HSPA1A;MKKS;PSMG1;HSPA4
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",-0.8023678142014635,-1.226773756437641,0.12698412698412698,1.0,1.0,2/7,7.46%,P2RY12;SHTN1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.4477627161205701,1.2266319892542383,0.25,0.885709030303673,1.0,10/61,8.14%,RND2;RHOBTB1;MLST8;EPHA5;PDGFRA;RHOC;TWF1;RAPGEF3;ARHGAP18;GPM6B
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5963577000707976,1.2265406735304638,0.16666666666666666,0.8845179003286393,1.0,3/13,9.32%,SNF8;VPS28;VTA1
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.5370485946341281,1.226447089291918,0.2727272727272727,0.883132557224253,1.0,4/20,4.85%,BAG3;RAN;TRIM28;RBM22
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.7292395305642627,1.226435845177763,0.25,0.8798495365654266,1.0,2/7,13.86%,ATF4;GABPA
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.7292395305642627,1.226435845177763,0.25,0.8798495365654266,1.0,2/7,13.86%,ATF4;GABPA
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.7680394933468155,1.2260942165838966,0.2,0.87933662366754,1.0,1/5,4.46%,MAP2
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.4804162318839729,1.2258894703392742,0.09090909090909091,0.8784969669369198,1.0,13/69,10.54%,STOX1;UBB;HSPA1A;PSMD8;PSMB4;BAG3;ELOC;PSMB6;PSMD10;PSME3;LIMD1;ATF4;UBC
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),0.8345500470702272,1.225522634983029,0.20512820512820512,0.8782180755589121,1.0,4/5,15.91%,NEU1;NEU3;GM2A;NEU4
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),-0.8318598809662126,-1.225368453167243,0.1774193548387097,1.0,1.0,1/5,1.74%,TTN
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.7295133633401656,-1.225131159417099,0.15942028985507245,1.0,1.0,1/12,0.51%,FHDC1
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),-0.7142153688132132,-1.2250204663127107,0.16,1.0,1.0,4/15,15.67%,SLC22A4;SLC6A6;SLC1A4;SLC6A9
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),-0.605523921674488,-1.2249781550205323,0.07228915662650602,1.0,1.0,22/50,27.39%,SLC6A6;SLC6A15;SLC6A11;SCN8A;SCN9A;SLC4A4;HCN3;SLC9B2;SLC24A2;SLC6A17;SLC6A9;ANO6;ASIC4;ATP1B1;SLC5A9;HCN1;HCN2;SLC4A8;SLC6A8;NALCN;SLC6A1;NEDD4L
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.5035130815689659,1.2249698752655855,0.1,0.8784968456662517,1.0,10/26,17.30%,SOX8;SEMA5A;SOX10;SEMA5B;SEMA3B;SEMA4F;NRP1;SEMA6C;ANXA6;GDNF
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.6185399213447065,1.2247961635390292,0.15384615384615385,0.8772384983354098,1.0,5/12,13.06%,WTIP;LIMD1;WWC2;SHANK2;WWC1
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),0.7399079386684395,1.2246152009245392,0.2903225806451613,0.8761805134897607,1.0,1/6,1.91%,CAND2
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.4777672034328944,1.224329756127025,0.15384615384615385,0.8752240996869239,1.0,11/23,22.12%,ARFIP1;SNX12;HSPA8;CHP1;DNAJA1;NDFIP2;P3H1;LLGL1;RHBDF2;STXBP5;PTPN1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),-0.7924960769783023,-1.2242984075380783,0.208955223880597,1.0,1.0,1/5,14.55%,PDCD4
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),0.6756835641732539,1.223881318817831,0.21428571428571427,0.8753762981775124,1.0,4/7,14.17%,SIRT2;BCAR1;MST1;NRP1
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),-0.7593592105419384,-1.2236910232431675,0.14864864864864866,1.0,1.0,2/8,9.85%,ENPP4;APOE
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.6556962807655831,-1.2232958618996714,0.16091954022988506,1.0,1.0,4/27,6.47%,SOX9;SRF;SPI1;FOS
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),0.6920321087332534,1.2228415764501204,0.22857142857142856,0.8775718985410292,1.0,2/7,14.35%,TXN2;ADO
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),-0.7115335717738607,-1.2227818259915684,0.208955223880597,1.0,1.0,6/11,19.53%,AZIN2;NR4A3;ACSL1;AZIN1;CA2;ANO6
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),0.7478932347688944,1.2227708448256265,0.2962962962962963,0.8761971820233091,1.0,1/9,0.51%,UBB
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.5476950680675914,1.222704572603779,0.2,0.8747628223980134,1.0,7/25,10.15%,TMEM9;ATP6V0A4;ATP6V0E1;ATP6V1G1;ATP6V1B2;ATP6V0D1;CLCN3
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),-0.7990768448304075,-1.2225529890725013,0.18333333333333332,1.0,1.0,1/5,6.36%,PLSCR1
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),0.4044077079237296,1.222267629922425,0.16666666666666666,0.874592084502883,1.0,33/175,14.90%,UTP11;WDR18;NOL11;SBDS;POP5;MPHOSPH6;MRPL44;PIH1D1;POP4;RPL8;AARS1;RPL15;DDX54;EBNA1BP2;RPS19;RPL29;WDR46;RPS2;INTS9;IMP3;EXOSC8;MTREX;RPF1;SMAD3;C1D;DDX49;INTS7;RPL23A;MRTO4;DGCR8;RPL27;WDR36;RPL7A
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),0.730199029928673,1.221789179761572,0.375,0.8743253415753547,1.0,2/6,15.93%,TGFBR1;BMP2
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),-0.7833076253650904,-1.2216439685682972,0.20833333333333334,1.0,1.0,1/6,3.19%,GUK1
prerank,PanglaoDB_Augmented_2021__T Cells,-0.5896151345571901,-1.2215704911463863,0.21518987341772153,1.0,1.0,7/31,16.46%,CD160;MAFF;PTPRC;TCF7;TRAF3IP3;IFIT3;GPR171
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),0.5835505448408843,1.2213732172912188,0.1,0.8744775139195087,1.0,7/10,29.84%,MFHAS1;WNT5A;LRFN5;NR1H3;GPR137B;CD200;KARS1
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.7177706052360374,-1.220876959228407,0.24285714285714285,1.0,1.0,4/11,18.38%,PARP9;IFNGR2;JAK1;STAT1
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.6153959938537998,1.2204875300686497,0.23529411764705882,0.8756560725942624,1.0,2/8,12.67%,WASF3;BRK1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.5839382005024347,-1.2202928512379125,0.09411764705882353,1.0,1.0,10/63,13.08%,ENPP2;SOX9;FGF1;AGT;RAB11A;DOCK5;GPI;VEGFA;VIL1;ITGB1BP1
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),-0.77910417667273,-1.2198930420599505,0.21666666666666667,1.0,1.0,2/5,9.53%,DSC2;CTNNA3
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),-0.677786750045065,-1.2197124496763263,0.1951219512195122,1.0,1.0,5/16,19.31%,ARHGAP24;P2RY12;PLEKHM1;PFN2;RDX
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.7184707386921013,-1.2194272001445299,0.15625,1.0,1.0,1/9,3.16%,PTPRC
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.35051610724546556,1.2193861707226061,0.0,0.8775671549553624,1.0,43/225,14.81%,U2AF1;LSM4;POLR2J;NOVA1;RBM15B;POLR2L;SMU1;CPSF1;SF3B6;PCBP2;SF3B5;RBM22;SNRNP40;RBM41;HNRNPC;HNRNPA0;PCBP1;CPSF4;LSM7;HSPA8;POLR2K;UBL5;EIF4A3;PUF60;PPWD1;MTREX;RBM8A;CD2BP2;SNRPB2;CSTF2T;GTF2F1;POLR2E;SRSF3;SF3A2;PHF5A;SNRPF;MAGOH;DNAJC8;ZMAT2;SNRPB;SNIP1;HNRNPH1;RAVER2
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.6695364216891697,1.2184004790709737,0.26666666666666666,0.8785120667738718,1.0,3/8,17.87%,WWC2;WWC1;LATS1
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),0.7426561297694806,1.2181127415155155,0.26666666666666666,0.8782087536715584,1.0,1/5,4.46%,MAP2
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.7049836075491114,1.2178925942210848,0.18181818181818182,0.8773967487082925,1.0,5/7,29.21%,RIOX2;KDM5C;KDM1B;KDM5A;KDM1A
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),-0.7548300219425305,-1.217566095406007,0.14473684210526316,1.0,1.0,2/11,7.59%,VSIR;RARA
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),-0.7768169999541558,-1.2170089580136625,0.18309859154929578,1.0,1.0,1/8,0.49%,TMSB4X
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.7334947772552356,-1.216642731094923,0.19480519480519481,1.0,1.0,1/9,2.51%,ART4
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.6344127062219252,-1.2163621927084325,0.13333333333333333,1.0,1.0,17/31,24.09%,CD44;IRF1;IFNGR2;B2M;HLA-F;OAS1;CAMK2B;HLA-C;CAMK2A;TRIM5;JAK1;STAT1;IRF2;TRIM25;HLA-B;HLA-A;CAMK2D
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.7309838557133536,-1.2162445320325543,0.19480519480519481,1.0,1.0,2/13,7.84%,CD44;CEMIP
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),-0.5528904320113232,-1.2161914625719599,0.10752688172043011,1.0,1.0,25/136,13.01%,GABRA4;HTR2C;HTR1F;GLRA2;GRIN2A;CAMK1;AKAP5;PCDHB5;GRM1;GLRA1;SYT1;GABRG3;UNC13C;SNCB;CPLX1;SST;GABRG2;NRGN;KCNMB4;CACNA1B;APBA2;GRM3;SNAP25;HTR2B;HAP1
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),0.5164282672762786,1.2160852581783033,0.23529411764705882,0.8820261741796075,1.0,8/27,12.59%,TAF1A;POLR2L;POLR1F;GTF2H2;POLR2K;POLR1A;ERCC3;POLR2E
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),0.7445565293239117,1.2160035865909982,0.25,0.8806705410358701,1.0,1/5,1.54%,ASCL1
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),-0.6424612547455845,-1.2156957834103093,0.2328767123287671,1.0,1.0,1/22,1.03%,SYNJ2
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),-0.6280723312809814,-1.215575090321078,0.14634146341463414,1.0,1.0,8/31,20.90%,ITPR1;AGT;KCNJ11;RYR3;AHCYL1;ATP2B3;ATP1B1;RYR2
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.7336522439907273,-1.2154807899069648,0.18571428571428572,1.0,1.0,6/11,18.38%,MX1;CRLF1;OAS1;STAT3;JAK1;STAT1
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),0.43981330476177305,1.2154785791609952,0.125,0.8809993525212192,1.0,29/141,14.90%,UTP11;WDR18;TRIR;NOL11;SBDS;POP5;MPHOSPH6;PIH1D1;POP4;RPL8;RPL15;DDX54;EBNA1BP2;RPS19;RPL29;WDR46;RPS2;IMP3;EXOSC8;MTREX;RPF1;C1D;DDX49;RPL23A;MRTO4;NIFK;RPL27;WDR36;RPL7A
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),-0.8358649112281566,-1.2154058937762418,0.16901408450704225,1.0,1.0,3/5,11.27%,GRIN2A;GRIN2D;SHISA6
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.6663726179599654,1.2153409466943725,0.23809523809523808,0.8796820167705174,1.0,5/11,23.23%,TRIM28;PPHLN1;MORC2;ATF7IP;ZNF304
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),-0.7491904348976022,-1.215306584717091,0.2153846153846154,1.0,1.0,1/8,7.59%,RARA
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.6923198838784764,-1.2150374337558285,0.21052631578947367,1.0,1.0,5/15,24.69%,KIF1C;HAP1;NEFL;KIF1A;MAP1A
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),0.7349830672764487,1.214999314560741,0.2413793103448276,0.8795377493556651,1.0,2/5,19.33%,COLGALT1;EFEMP2
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.7140497811142225,1.214742140184214,0.2222222222222222,0.8788581245563147,1.0,4/8,19.71%,PIH1D1;RUVBL2;LRWD1;POT1
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),0.6895115520966065,1.2147161150689891,0.20689655172413793,0.8773627972062049,1.0,1/10,0.87%,TRMT112
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),0.5335383170247922,1.21419137652824,0.26666666666666666,0.8775375023883096,1.0,5/37,4.68%,GPC4;HSPG2;RBP1;GPC1;BCO1
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.6582001253167802,-1.2139578191211402,0.20253164556962025,1.0,1.0,4/21,12.52%,PHKG1;PYGL;PYGB;NR1D1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.5887967150812271,1.2138011961736705,0.22580645161290322,0.8773980434258277,1.0,2/18,2.81%,SMDT1;PHB2
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.6349312872583875,1.2137074881850047,0.3142857142857143,0.8762261967788092,1.0,3/10,13.87%,SLC30A10;ZKSCAN3;SIRT1
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),-0.8024844231219463,-1.2135958388919152,0.203125,1.0,1.0,3/5,17.60%,ATP8B1;PDZK1;CA2
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.5926689542121204,1.213574517657629,0.16,0.8750897206297505,1.0,3/15,12.67%,ARFIP1;WASF3;BRK1
prerank,MSigDB_Hallmark_2020__Myc Targets V1,0.4320393359631932,1.2126959599334253,0.0,0.8763276309796102,1.0,33/176,11.39%,U2AF1;ODC1;EIF4H;CCT5;PSMD8;PHB2;CNBP;EIF3D;RAN;ILF2;TRIM28;NPM1;YWHAQ;MCM4;SRM;KPNA2;RUVBL2;EIF1AX;CCT3;HNRNPC;PPIA;PCBP1;LSM7;RANBP1;CANX;RPS2;TUFM;EIF4E;ERH;PRDX3;SNRPB2;NHP2;VBP1
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),-0.7844915548317988,-1.2125408230744434,0.22413793103448276,1.0,1.0,1/5,6.36%,PLSCR1
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),-0.7844915548317988,-1.2125408230744434,0.22413793103448276,1.0,1.0,1/5,6.36%,PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),-0.7844915548317988,-1.2125408230744434,0.22413793103448276,1.0,1.0,1/5,6.36%,PLSCR1
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),-0.6917374725190588,-1.2122736599768462,0.17567567567567569,1.0,1.0,1/13,1.01%,DCAKD
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.571873775798897,1.21198801391902,0.2222222222222222,0.8768451008728292,1.0,2/29,0.50%,STOX1;SIRT2
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),0.6223321912444744,1.2119525129720894,0.2222222222222222,0.8753716304669127,1.0,5/15,19.48%,POLR2L;POLR2K;ATF4;WDR43;MAF1
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.6415573240027295,-1.2115304132060756,0.12,1.0,1.0,4/27,10.44%,NLRC5;A2M;STAT2;OAS1
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.8738124302720454,-1.211403091860148,0.13432835820895522,1.0,1.0,2/5,3.39%,VSIR;IRF1
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.6368321781460787,1.2113092818909277,0.1724137931034483,0.8759510139262517,1.0,3/11,8.86%,PML;PPP1R10;LIG4
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),-0.7409115280937355,-1.211262133259823,0.19402985074626866,1.0,1.0,2/12,1.94%,RASGRF1;ARHGAP24
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.5360630500292347,1.211018700771115,0.17391304347826086,0.875134651318327,1.0,2/26,2.40%,TRMT112;SMYD2
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),-0.6649522417590261,-1.2110063304165455,0.24675324675324675,1.0,1.0,3/10,22.54%,ROBO2;ADAMTS9;PDGFRB
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),0.7203223141957387,1.21086985657518,0.2972972972972973,0.8740428740401779,1.0,3/5,6.43%,ACAA2;STPG1;THEM4
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",-0.8009180766233817,-1.2108502213013739,0.23880597014925373,1.0,1.0,2/5,18.12%,RAB11A;GRIPAP1
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.3965239586585588,1.2108498492564947,0.14285714285714285,0.8725845273011417,1.0,17/96,7.89%,NOX4;MMP2;PRRX1;FBLN5;FIBIN;BGN;FBLN2;PODN;COL12A1;TNS2;CXCL12;PDGFRA;SEC24D;LDB2;THY1;PDGFD;MSRB3
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),0.7967957134438761,1.2107971922895526,0.28,0.8713469165695854,1.0,2/5,11.04%,METTL4;NHP2
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.705371744811428,-1.2102039503686417,0.29333333333333333,1.0,1.0,4/9,28.02%,TRIM5;GSN;MID2;CIITA
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.42305747178061925,1.2102018126844936,0.0,0.8713746298465176,1.0,45/258,12.59%,NR0B1;TAF1A;GMEB2;PRRX1;POLR2J;ADRM1;POLR2L;YAP1;NR1H2;NR2F6;NR2E1;CPSF1;ELOC;ESR1;TAF9B;MED23;MAML2;GTF2A2;RBPJ;GTF2H2;SSRP1;SP1;TCEA1;CPSF4;EAF2;PARP1;NR3C1;ESRRG;CDC73;RPRD1B;INTS9;POLR2K;ZBTB1;NFYA;ATF4;LSM11;EAF1;COPS2;TRIM24;ESRRA;CSTF2T;ERCC3;INTS7;GTF2F1;POLR2E
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),-0.6043384060606355,-1.2101831033036328,0.17073170731707318,1.0,1.0,5/45,7.24%,GABRA4;GLRA2;GLRA1;GABRG3;GABRG2
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),-0.8140431711106616,-1.209294181680831,0.2727272727272727,1.0,1.0,2/6,13.89%,CCDC39;SRP54
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),0.73457106306739,1.2090893180817872,0.32432432432432434,0.873336581522964,1.0,1/6,0.87%,TRMT112
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.7599420095180497,-1.2085384656256153,0.1506849315068493,1.0,1.0,2/8,7.59%,ZFPM1;RARA
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.6211176999021516,-1.2084329316902875,0.18518518518518517,1.0,1.0,7/24,24.80%,NR4A3;TRIB1;OGN;IL6R;STAT1;PDGFRB;IGFBP5
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.44081598509153075,1.2084285760931248,0.06666666666666667,0.8739431258014322,1.0,7/59,6.33%,IPO13;PHB2;NUTF2;RAN;KPNA2;PRICKLE1;PPP1R10
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.6804679820745205,-1.2082431716814086,0.2,1.0,1.0,4/16,7.85%,GRIN2A;VSIR;NLRC4;C1RL
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),-0.7844256048717042,-1.208070134601474,0.2,1.0,1.0,1/7,2.65%,TESPA1
prerank,PanglaoDB_Augmented_2021__Eosinophils,-0.7480676399555155,-1.208030282400988,0.17391304347826086,1.0,1.0,7/11,15.16%,IL5;PTPRC;SPI1;AOAH;NR1D1;TRAF3IP3;MYO1F
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),-0.717446088387406,-1.2077568622916122,0.15714285714285714,1.0,1.0,1/12,0.68%,SOX9
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.6733406725005167,1.2072696380690098,0.23684210526315788,0.8769036125395154,1.0,6/8,27.71%,AGPS;FAR1;PLA2G4C;DHRS7B;LPCAT2;GNPAT
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",0.6907099852124389,1.2070929073076542,0.25,0.8759441252405652,1.0,4/7,21.96%,SEC61B;HSPA5;SEC61G;SEC61A2
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),-0.7959720871488912,-1.2070478498349364,0.23880597014925373,1.0,1.0,3/6,16.74%,SLC22A4;VEGFA;OXTR
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.5858114756292062,-1.2069652872925236,0.1780821917808219,1.0,1.0,9/36,14.77%,SYT1;SHTN1;LIMK1;RIMS1;RNF157;BDNF;SYT2;SYT4;MACF1
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.6637747731692785,-1.2067171082598893,0.16666666666666666,1.0,1.0,4/11,12.32%,DNAH7;CCDC39;EFHC1;DNAH17
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.7678803549958363,1.2066448887737546,0.35714285714285715,0.8762381357183036,1.0,2/6,18.05%,ATP2C1;PKDCC
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.6346796306202703,1.2063170352135035,0.3181818181818182,0.8754961641967965,1.0,4/11,3.48%,SOX11;SOX8;KLHL12;PEF1
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.7389698715944644,-1.206254391973644,0.2676056338028169,1.0,1.0,2/7,7.49%,APIP;NLRC4
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),0.7229384463710711,1.2062464696675115,0.36666666666666664,0.8744224627061524,1.0,2/5,8.30%,EYS;GNA11
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.7475835878559148,1.2060229287759667,0.19230769230769232,0.8736861315539705,1.0,1/5,8.19%,ATP8A2
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.7762445545272323,1.2058148446045966,0.2903225806451613,0.8728917443663109,1.0,3/7,10.08%,PCGF2;BMI1;RNF2
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.7831629535428279,-1.205186417410405,0.26865671641791045,1.0,1.0,1/5,3.09%,CCDC39
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),0.37202079010696615,1.2051613999185466,0.0,0.8731582174998215,1.0,24/150,11.33%,SOX4;PIWIL2;PLD1;EIF4H;EIF1;CALR;DHFR;EIF3D;NPM1;CAPRIN1;EEF2;CNOT9;EIF5;EIF4E2;RNF139;FXR2;TOB1;MRPL13;GRM5;EIF4A3;EIF4E;NAT10;POLDIP3;TRIM71
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.6658810730603324,1.2048062498257541,0.34615384615384615,0.8727597902314523,1.0,2/8,8.91%,RAP2C;RAB1B
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),-0.6916698955018028,-1.2046291673955938,0.20987654320987653,1.0,1.0,3/13,10.87%,SCEL;BRCA1;CELF4
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.6793560076351194,-1.2044526123131991,0.19480519480519481,1.0,1.0,7/15,26.71%,TTN;TPM1;KCNQ1;ATP1B1;RYR2;CAMK2D;GSN
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.4235716185966657,1.2044280813161166,0.2,0.8691403026969005,1.0,7/72,4.27%,MALT1;PSMD8;TAB3;PSMB4;IKBKB;PSMB6;LYN
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.4235716185966657,1.2044280813161166,0.2,0.8691403026969005,1.0,7/72,4.27%,MALT1;PSMD8;TAB3;PSMB4;IKBKB;PSMB6;LYN
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.4235716185966657,1.2044280813161166,0.2,0.8691403026969005,1.0,7/72,4.27%,MALT1;PSMD8;TAB3;PSMB4;IKBKB;PSMB6;LYN
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.5911997108490398,-1.2033607862513154,0.1794871794871795,1.0,1.0,18/33,23.05%,MX1;IRF1;PSMB8;STAT2;HLA-F;OAS1;HLA-C;IFIT1;IFIT3;RSAD2;IFI6;JAK1;IFI35;STAT1;IRF2;HLA-B;ADAR;HLA-A
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.5911997108490398,-1.2033607862513154,0.1794871794871795,1.0,1.0,18/33,23.05%,MX1;IRF1;PSMB8;STAT2;HLA-F;OAS1;HLA-C;IFIT1;IFIT3;RSAD2;IFI6;JAK1;IFI35;STAT1;IRF2;HLA-B;ADAR;HLA-A
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),-0.7686846915309411,-1.2031624662443758,0.1774193548387097,1.0,1.0,1/5,5.01%,TIMP3
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.40466161195991346,1.2029940422834136,0.2222222222222222,0.8720788700630153,1.0,12/70,14.07%,BAD;MALT1;NGF;ACER2;BOK;ARL6IP5;SMAD3;MUL1;PRR7;FIS1;SIRT1;CRADD
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),0.5763118866255084,1.2029895229798246,0.13333333333333333,0.870608248022437,1.0,6/23,13.51%,UBB;GTF2H2;PARP1;UBC;ERCC3;ERCC4
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),-0.7920418106851699,-1.202943403629133,0.19402985074626866,1.0,1.0,1/5,0.68%,SOX9
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.6785671917334657,-1.2023501665059972,0.25333333333333335,1.0,1.0,1/15,0.19%,CD44
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.671999456224083,1.2020163949932716,0.1111111111111111,0.8723393826243341,1.0,6/12,23.23%,TRIM28;PPHLN1;MORC2;ATF7IP;TET1;ZNF304
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),-0.8357506231594285,-1.2017780162033127,0.208955223880597,1.0,1.0,1/5,4.00%,PHF19
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.7353025691519972,1.2016032993819183,0.25806451612903225,0.871827713049352,1.0,4/5,22.61%,NLGN2;NLGN1;NRXN1;LRRC4
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.6830996143308901,-1.201164115268933,0.24675324675324675,1.0,1.0,2/14,2.02%,NLRC5;EMP2
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.5121621855413387,1.2011141679156427,0.23076923076923078,0.8707797897585218,1.0,8/43,12.04%,BANF1;SIRT2;RAN;UBE2I;CHMP2A;PPP2R1A;LBR;SUMO1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.5121621855413387,1.2011141679156427,0.23076923076923078,0.8707797897585218,1.0,8/43,12.04%,BANF1;SIRT2;RAN;UBE2I;CHMP2A;PPP2R1A;LBR;SUMO1
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.6020649970493709,1.2009081669191912,0.21052631578947367,0.8700062035542188,1.0,4/14,8.50%,STYXL1;IKBKB;TIPRL;PPP1R11
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.466212041829551,1.2007257770337971,0.2,0.8692944548649458,1.0,6/32,9.12%,ODC1;TMEM9;SNF8;CHRNA7;LDLR;PLAUR
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.6223673585205244,-1.2002792382020409,0.15584415584415584,1.0,1.0,5/29,9.39%,SLC38A4;SLC22A4;SLC6A6;SLC7A6;SFXN3
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),-0.74561025186484,-1.1999658140806473,0.2318840579710145,1.0,1.0,1/7,7.54%,ROBO2
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,-0.5656464887684873,-1.1997511293658232,0.16666666666666666,1.0,1.0,10/56,7.60%,ENPP2;GRIN2A;MYLK;FGF1;FAM13C;A2M;AGT;TREH;SST;RHOJ
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.5664752687226735,-1.1993061962032998,0.20454545454545456,1.0,1.0,4/40,9.85%,TMSB4X;LRRC19;IRF1;APOE
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),0.7806952152207629,1.1986843451336016,0.28125,0.8743823501900526,1.0,2/6,15.53%,GAL3ST3;B3GALT2
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.6348573102187286,-1.1979957605111968,0.24358974358974358,1.0,1.0,1/16,0.79%,MSL3
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.6551154300790375,-1.197755546391668,0.25,1.0,1.0,4/18,19.95%,STMN2;BDNF;NTRK3;RAB35
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.36406170879654365,1.1976284202501397,0.0,0.8764413865393466,1.0,46/348,9.39%,NOX4;SOX4;SOX11;SIRT2;PIWIL2;PLXNA3;FABP7;HSPA1A;GPNMB;PODN;NR1H2;SMYD2;TNS2;PPT1;CGRRF1;SEMA5A;PIWIL4;BTG1;NPM1;LYN;NDUFS3;EI24;P3H2;BTG3;RNF139;IGFBP7;CBLL1;ADRA1A;NGF;ROR2;BRINP1;TMBIM6;PML;IP6K2;CDKN2C;FRZB;FBP1;CHMP2A;PTPN14;ATP8A2;ZNF268;CDC73;TOB1;MT3;SPEG;H2AC6
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),0.6804734507278949,1.1971359899969674,0.3157894736842105,0.8761646898538784,1.0,1/6,7.14%,SYAP1
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.5557325947830861,-1.196988611073359,0.16853932584269662,1.0,1.0,8/47,20.13%,ANKRD53;CAV3;CDC42EP3;VASP;PAK1;PFN2;BAIAP2;DCTN1
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),0.6704559916789623,1.1965314276425498,0.28125,0.8767718337650714,1.0,2/6,4.15%,RAN;NPM1
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.598153246574304,1.1957532761483225,0.28,0.8781409001934907,1.0,1/11,5.75%,B4GALT6
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.5823603214648942,-1.1956682251664248,0.17721518987341772,1.0,1.0,6/36,15.19%,STMN2;ANKRD53;PRUNE1;CAV3;PAK1;TBCD
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.5395786621641613,1.1954968982890595,0.30434782608695654,0.8774814313299875,1.0,4/19,4.85%,BAG3;RAN;TRIM28;RBM22
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),-0.7977373251749444,-1.1946873106018223,0.22058823529411764,1.0,1.0,1/5,1.60%,HES1
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),-0.7977373251749444,-1.1946873106018223,0.22058823529411764,1.0,1.0,1/5,1.60%,HES1
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.6292693025912284,-1.1944468334644203,0.2318840579710145,1.0,1.0,4/22,12.03%,DSC2;CACNA1C;CTNNA3;KCNQ1
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),-0.7936289903858917,-1.1941591951489872,0.17647058823529413,1.0,1.0,3/5,20.19%,PAH;BCAT2;GAD2
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.726960145716998,-1.1941518690268533,0.20270270270270271,1.0,1.0,5/11,21.52%,IHO1;RNF212B;SGO2;CENPC;ZCWPW1
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),-0.6539235017841217,-1.1941241756178833,0.2,1.0,1.0,4/23,13.33%,SOX9;SLC39A14;RUNX2;SULF1
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),-0.7997535649765328,-1.1938537021053783,0.22058823529411764,1.0,1.0,2/6,16.22%,GPAM;TAMM41
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.7170427743896344,1.1938484263787077,0.25,0.8816268896339203,1.0,2/8,6.40%,FNBP1L;MICALL1
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.7698287831599483,-1.193776415995597,0.23809523809523808,1.0,1.0,2/5,6.51%,EMP2;RFTN1
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.4846342180546902,1.193693053728807,0.17647058823529413,0.8805837720128771,1.0,4/29,9.93%,SOX11;YAP1;CTNNBIP1;LRP3
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),-0.764028735092928,-1.193633374398846,0.19117647058823528,1.0,1.0,1/8,3.39%,CDK7
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.7323413894859132,-1.1934756776048407,0.22727272727272727,1.0,1.0,1/8,12.24%,CDC7
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.7837401637409871,-1.1930318148049666,0.30303030303030304,1.0,1.0,3/5,19.12%,PTPRC;HLA-F;ARRB2
prerank,GO_Biological_Process_2021__liver development (GO:0001889),-0.719921184334896,-1.1930315069865112,0.2571428571428571,1.0,1.0,1/12,3.09%,CCDC39
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.6075447448627648,-1.193027555405315,0.24358974358974358,1.0,1.0,2/24,5.48%,ARIH2;SAE1
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),-0.693383173338789,-1.1923825563536523,0.25,1.0,1.0,3/12,8.31%,MREG;RAB17;RAB11A
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),-0.693383173338789,-1.1923825563536523,0.25,1.0,1.0,3/12,8.31%,MREG;RAB17;RAB11A
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.67372601846057,1.1910875307800972,0.32432432432432434,0.8875709872219645,1.0,3/7,14.17%,ASCL1;FZD3;NRP1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.5490043980460284,1.191085548250799,0.25806451612903225,0.8861135635976262,1.0,8/15,24.79%,HNRNPC;NAT10;PIF1;CTC1;POT1;XRN1;TERF1;TERF2
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.6857864003201388,-1.191055869669879,0.225,1.0,1.0,4/15,14.32%,CYP2E1;ALOX12;ACSBG1;EPHX2
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),0.7136949965978292,1.1907172677477786,0.27450980392156865,0.8854755233086486,1.0,2/5,9.86%,ACHE;LIMD1
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),-0.6749454315888574,-1.1906133553776503,0.23880597014925373,1.0,1.0,2/12,15.46%,ATAD5;BCAR3
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.6623610782599012,-1.1904508420175621,0.24675324675324675,1.0,1.0,1/18,0.35%,HTR2C
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.4934799956540903,1.1904464512096162,0.2,0.8849847986142929,1.0,8/26,15.07%,PLXNA3;SEMA5A;SEMA5B;SEMA3B;PLXNA2;SEMA4F;NRP1;SEMA6C
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.7475957017938727,1.1903030130973464,0.34210526315789475,0.8840317102869856,1.0,3/5,25.13%,REL;PTPRS;YY1
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",-0.7376613618127206,-1.1898688470908327,0.25,1.0,1.0,1/6,5.18%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",-0.7376613618127206,-1.1898688470908327,0.25,1.0,1.0,1/6,5.18%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",-0.7376613618127206,-1.1898688470908327,0.25,1.0,1.0,1/6,5.18%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",-0.7376613618127206,-1.1898688470908327,0.25,1.0,1.0,1/6,5.18%,ELOVL2
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.6279878524183816,-1.1894089650943096,0.1728395061728395,1.0,1.0,6/30,16.07%,B3GNT5;PIGH;PIGL;PIGC;MPPE1;ST6GALNAC5
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.6603812174864546,-1.1892984009559506,0.25,1.0,1.0,3/14,10.54%,EMP2;SRF;VEGFA
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),-0.6578842699631549,-1.1889320508272239,0.24,1.0,1.0,2/20,10.16%,CMTR1;PUS7
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.7040988836956525,1.1882584664022433,0.34615384615384615,0.8887850099489948,1.0,2/7,14.99%,RHOC;RHOA
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.8085487331516553,-1.1878916431529143,0.1791044776119403,1.0,1.0,2/5,14.80%,APOE;LRPAP1
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),-0.7263300866403697,-1.1877883800935822,0.19480519480519481,1.0,1.0,3/10,14.34%,AKAP5;GRM3;ADGRV1
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),0.7068967504197031,1.1874413821859333,0.24,0.8899387924397084,1.0,3/6,11.49%,SLC16A9;ABCG2;PNP
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),0.727860178771291,1.1871131409053235,0.3,0.8892997195858573,1.0,2/7,6.89%,GREM1;MN1
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.6638811177835902,-1.1871107845438418,0.26582278481012656,1.0,1.0,2/18,3.43%,EFNA1;OVOL2
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.5822784242142555,-1.1870986349833024,0.26744186046511625,1.0,1.0,11/39,19.30%,RFC4;POLQ;RFC1;RFC2;RPA3;NEIL2;PNKP;NTHL1;WRN;LIG3;PARG
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),-0.6590904558682427,-1.186765534505899,0.2972972972972973,1.0,1.0,2/9,12.52%,PTPRC;NR1D1
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.469317335568999,1.1865919415146642,0.25,0.8893253437860535,1.0,10/64,9.56%,SOX4;SOX11;UBB;HSPA1A;CHRNA7;SLC25A24;ACER2;CHMP2A;MT3;RIPK2
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),-0.663518310417367,-1.186515811862668,0.2916666666666667,1.0,1.0,2/12,10.54%,TTN;VEGFA
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),-0.6007726145261908,-1.1864917939723973,0.24675324675324675,1.0,1.0,2/20,4.95%,EMP2;VCL
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),-0.7888134970298213,-1.1864505573980757,0.22058823529411764,1.0,1.0,2/6,11.63%,SLC22A4;SLC25A45
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.5171201232811261,1.1858889940194333,0.2608695652173913,0.8900699590563945,1.0,11/26,21.62%,CCDC88C;RNF139;CDC73;MUL1;SIRT1;RAD23A;SERF2;PEX2;PRNP;MDM2;BTRC
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.6055349133903294,-1.185742828773679,0.2345679012345679,1.0,1.0,7/29,12.64%,SYNJ2;MX1;SYT1;SNCB;DNM1;SYT2;DNM2
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.6993470558248155,-1.1852802442144381,0.27631578947368424,1.0,1.0,2/10,12.05%,GRM1;GRM3
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),-0.7003650214223875,-1.1851715444803337,0.2753623188405797,1.0,1.0,2/7,12.52%,PTPRC;NR1D1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.5694033886090958,1.1849101761777656,0.24,0.891817239381122,1.0,1/17,1.00%,HSPA1A
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.5871753431407664,1.18476130921618,0.2682926829268293,0.8908638912436764,1.0,2/9,10.06%,RNF139;GAS1
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),0.4669836055449733,1.1844619915946117,0.18518518518518517,0.8902857276875024,1.0,5/37,5.11%,UBB;NCSTN;HSPG2;TSPAN14;SNCAIP
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.5864376264754191,-1.1842081542992988,0.24444444444444444,1.0,1.0,8/44,14.32%,CYP2E1;ALOX12;ELOVL2;LIPI;ACSBG1;LIPH;ACSM6;EPHX2
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.7329855931467871,1.1838553711413207,0.3548387096774194,0.8910811556053659,1.0,2/6,17.74%,METTL4;MTG2
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.610430766565952,1.1838153293984686,0.2702702702702703,0.8896770809975553,1.0,5/10,25.84%,UQCRC1;UQCR10;UQCRH;UQCRFS1;UQCRC2
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.6090076217710931,-1.1836942719975454,0.3076923076923077,1.0,1.0,3/23,4.01%,HES1;CCDC39;SRF
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.6426615663588494,1.1835994353037862,0.3142857142857143,0.8889326908019454,1.0,5/8,27.57%,SPRY1;ZEB1;SPRED1;DLL1;CAV1
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),-0.7834648571799102,-1.1833279796714553,0.2923076923076923,1.0,1.0,1/6,1.60%,HES1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),0.6826703041455305,1.1832426962390514,0.2702702702702703,0.8884750895099622,1.0,1/5,5.39%,PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),-0.6675321941274157,-1.1827376690241045,0.30666666666666664,1.0,1.0,4/13,11.86%,SOX9;AGT;VEGFA;GJA1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.4265254099849303,1.1826681778595753,0.07142857142857142,0.889069560115307,1.0,14/72,11.73%,NDUFB1;NDUFAF8;NDUFA5;DMAC2;NDUFB11;NDUFS3;COX19;NDUFS6;SDHAF3;IMMP2L;NDUFB7;TIMMDC1;NDUFS8;SLC25A33
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.43931357860972353,1.1826401983725126,0.21428571428571427,0.8877343695218985,1.0,10/73,2.65%,MMP2;PRRX1;AMOTL2;BGN;HSPG2;YAP1;ACHE;COL12A1;GPC1;TNS2
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),0.7706634777132475,1.1824265795803321,0.38461538461538464,0.8868563055216988,1.0,3/5,19.10%,RAD17;ZNF830;NAE1
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.7294786191099003,-1.1819776702821223,0.2916666666666667,1.0,1.0,2/7,8.45%,RFC4;RFC2
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.7294786191099003,-1.1819776702821223,0.2916666666666667,1.0,1.0,2/7,8.45%,RFC4;RFC2
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.6885874443336485,-1.1818585835484856,0.2625,1.0,1.0,7/15,24.00%,DUOX1;P2RY12;AKT2;TGFB1;PDGFRB;CCDC25;STX4
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.6101373755533984,1.1817623694032426,0.3333333333333333,0.8874787731361511,1.0,3/9,15.59%,PHB2;DNAJC19;ABCA3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),-0.7848525254156877,-1.1816891253210509,0.2835820895522388,1.0,1.0,1/5,1.18%,VSIR
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5787966361495915,1.1807661790725865,0.21212121212121213,0.889425330247406,1.0,3/9,6.49%,GSTP1;LYN;GREM1
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.4622501796719232,1.1806797302064647,0.2727272727272727,0.8882670690024494,1.0,15/67,16.32%,COPZ1;BICD2;TMED2;KDELR1;SURF4;COG3;RAB1B;RAB6A;TMED3;ARCN1;ARF5;KIF15;LMAN2;SCYL1;ERGIC3
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.5464155213727971,-1.1805929037583285,0.1956521739130435,1.0,1.0,12/84,13.61%,NAAA;ALOX12;PDHX;MCCC1;CKMT2;AOAH;BTD;LDHA;SLC16A3;PTGR1;GPAM;CYP3A5
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.6633874492576478,1.1801678651127918,0.3235294117647059,0.8884062198044985,1.0,2/6,15.92%,GNAI1;EPB41
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),-0.6330347594621457,-1.1800199148764452,0.13580246913580246,1.0,1.0,11/27,25.21%,GRIN2A;OPRM1;DAPK1;CAMK2B;NEFL;CAMK2A;SLC6A9;DLG4;GRIN1;MAPK8IP2;RELN
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.4487961151237453,1.179527639996117,0.0625,0.8888257332550727,1.0,8/56,7.91%,SIRT2;BTC;TGFA;SVIL;MAP10;PKP4;RCC2;RANBP1
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),-0.7928529374998512,-1.1794331133520604,0.23529411764705882,1.0,1.0,1/5,12.80%,SLC1A4
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),0.5206634083184877,1.179326840293346,0.3333333333333333,0.8882065914763463,1.0,4/21,13.84%,PML;PPP1R10;ERCC4;PIF1
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),-0.7501601022397971,-1.1790110683794963,0.3235294117647059,1.0,1.0,1/6,1.83%,NR4A3
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.6659200372842058,-1.178731506957525,0.31343283582089554,1.0,1.0,4/9,27.88%,PTPRN;LTBP4;CDK16;RAB1A
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),-0.7503027981785158,-1.1786424003619551,0.2638888888888889,1.0,1.0,5/9,17.75%,IL7;STAT5A;STAT3;STAT5B;JAK1
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),-0.7503027981785158,-1.1786424003619551,0.2638888888888889,1.0,1.0,5/9,17.75%,IL7;STAT5A;STAT3;STAT5B;JAK1
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.530679331467225,1.1784572624881717,0.26666666666666666,0.890164640930899,1.0,6/24,12.04%,HSBP1;HSPA1A;BAG3;ZFAND1;CLPB;SUMO1
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.5693173860974554,-1.178050812921678,0.2441860465116279,1.0,1.0,9/42,21.57%,CD44;VASP;BCL11A;STAT5A;MPP1;WRN;LMO2;FAM117A;IGBP1
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.7305942311424969,-1.1780387911464387,0.21739130434782608,1.0,1.0,4/11,20.90%,DUOX1;KCNJ11;STAT1;RYR2
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),-0.7646813632177201,-1.1775015105014168,0.3064516129032258,1.0,1.0,1/5,10.81%,ACSL1
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),0.7725136214303001,1.1770015890335657,0.3225806451612903,0.8923601423256873,1.0,1/5,5.10%,MCM4
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),0.7725136214303001,1.1770015890335657,0.3225806451612903,0.8923601423256873,1.0,1/5,5.10%,MCM4
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.5529735757061687,1.1769898597391537,0.2631578947368421,0.891098562428372,1.0,3/22,2.56%,AMOTL2;YAP1;AMOT
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.6905250066443729,-1.1769460666645368,0.2077922077922078,1.0,1.0,4/14,12.06%,OVOL2;TMC4;FUT2;LIPH
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),-0.7490416963777021,-1.175759820490972,0.30434782608695654,1.0,1.0,2/7,20.44%,SLC4A4;ATP1B1
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),-0.7693134235528469,-1.1756563950003656,0.30434782608695654,1.0,1.0,2/5,12.55%,SOX9;PBLD
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.5938902894078981,-1.1755816778254038,0.25675675675675674,1.0,1.0,4/26,19.53%,MYLK;AHCYL1;CAMK2A;ANO6
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),-0.7691511472292405,-1.1755719509260725,0.21739130434782608,1.0,1.0,1/6,5.36%,SPI1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.6469048068107733,-1.175526484864158,0.3116883116883117,1.0,1.0,3/21,9.85%,PON1;LPCAT3;APOE
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.6566266648018841,-1.1752516232815802,0.24615384615384617,1.0,1.0,3/11,15.82%,CAV3;KCNQ1;SNTA1
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),-0.7202522124701353,-1.17524933629325,0.2564102564102564,1.0,1.0,1/7,9.85%,APOE
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.7259719153728915,-1.1750509222861838,0.29333333333333333,1.0,1.0,1/9,2.02%,EMP2
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.6206521943682562,-1.1749681047598084,0.2191780821917808,1.0,1.0,4/25,11.68%,TMSB4X;PRXL2C;SLC4A4;GAPDHS
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5686435504623868,1.1747518387978693,0.21739130434782608,0.8971566036763635,1.0,4/15,9.27%,SIRT2;SLC30A10;MT3;ABCD2
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.5354403442096388,1.174481866954845,0.38095238095238093,0.8966968742255469,1.0,3/12,16.04%,ZFYVE27;LNPK;REEP1
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),0.6529061113641955,1.1744641601831574,0.2727272727272727,0.8952957853595694,1.0,4/9,11.78%,ACTB;SHROOM2;MAL;INSC
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.5910388402261662,-1.1744234825747952,0.23943661971830985,1.0,1.0,13/33,26.55%,NAAA;SYT1;CPLX1;RIMS1;RAB3A;SNAP25;SYN3;GAD2;DVL1;UNC13A;SYN2;PCLO;BRSK1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),-0.7267673820983365,-1.1742043293247786,0.29411764705882354,1.0,1.0,1/7,0.68%,SOX9
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.7020289938686696,-1.1740995125282803,0.23880597014925373,1.0,1.0,1/11,3.33%,NECAB1
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.5356485141031303,-1.1737662934268525,0.1744186046511628,1.0,1.0,19/89,14.68%,ENPP2;STMN2;ARX;PCSK2;OLFM3;CALY;KCNC1;SST;CACNA1B;SULT4A1;ACTL6B;VEGFA;CELF4;PTPRN;SNAP25;LRRTM1;SYT4;UNC5D;KCNB2
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.7079060702942633,1.1735003069624295,0.3333333333333333,0.8966399857024901,1.0,5/6,27.52%,DDX1;DDX3X;DCP1A;YBX1;SSB
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.5914791012002572,-1.1734458785908755,0.26666666666666666,1.0,1.0,6/30,15.19%,PLET1;CDKN2A;EFNA5;RASA1;ITGB1BP1;TBCD
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),0.5079689302363711,1.173370847969148,0.3333333333333333,0.8957962084520873,1.0,6/25,12.43%,BAG3;RAN;TRIM28;RBM22;SMAD3;CHP1
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),-0.7562778969678323,-1.17332466177845,0.26865671641791045,1.0,1.0,1/6,0.68%,SOX9
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),-0.7650927136818881,-1.172481307126527,0.2876712328767123,1.0,1.0,1/5,4.87%,CNTNAP1
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.6510167021431872,1.1724621120335144,0.2857142857142857,0.8969974498968522,1.0,1/7,0.50%,SIRT2
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.5911423171487002,-1.17214920444607,0.2535211267605634,1.0,1.0,13/32,26.55%,NAAA;SYT1;CPLX1;RIMS1;RAB3A;SNAP25;SYN3;GAD2;DVL1;UNC13A;SYN2;PCLO;BRSK1
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),0.5022975983819675,1.1718136665626098,0.06666666666666667,0.8976162624233242,1.0,7/49,4.70%,UBB;COLEC12;TAB3;IKBKB;TLR1;UBE2D1;CNPY3
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),-0.7764510715445517,-1.1716215883633083,0.22950819672131148,1.0,1.0,3/6,17.60%,AHCYL1;CAMK2A;CA2
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.5280656792106736,1.1710769706167028,0.21052631578947367,0.8981230987897315,1.0,1/17,0.32%,UGDH
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.5760072148652038,-1.1710669364545214,0.24050632911392406,1.0,1.0,5/33,10.44%,NLRC5;PTPRC;PARP14;STAT2;OAS1
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.7332449117833377,-1.1710554808554587,0.26666666666666666,1.0,1.0,2/11,7.84%,CD44;CEMIP
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.43639829517754103,1.1710485688287349,0.2,0.8967602871035977,1.0,15/78,11.34%,NOVA1;RBM15B;PCBP4;SMU1;C9ORF78;LARP7;FXR2;KHDRBS2;PRDX6;RBM23;RBFOX1;PUF60;JMJD6;RBM8A;SAP18
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),-0.7692176528664589,-1.1709518178948028,0.31746031746031744,1.0,1.0,2/5,6.91%,HEY2;ZFPM1
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.8071857761329106,-1.1706497367564233,0.23880597014925373,1.0,1.0,2/5,16.34%,IL7;RAB3D
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.6655333322580257,1.1703790276253996,0.38461538461538464,0.8974863140402747,1.0,1/12,4.02%,NDUFA5
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.5729265347466238,-1.1699897617003676,0.21348314606741572,1.0,1.0,10/60,15.67%,SLC28A2;SLC2A3;SLC6A6;SLC29A2;LRP2;SLC4A4;SLC13A3;SLC1A4;SLC6A17;SLC6A9
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),-0.7640447951570477,-1.1699232426301875,0.2542372881355932,1.0,1.0,2/5,10.30%,CCDC39;DNAH11
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),-0.7640447951570477,-1.1699232426301875,0.2542372881355932,1.0,1.0,2/5,10.30%,CCDC39;DNAH11
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),0.6273372274810197,1.1699026078359547,0.32,0.8976075870511623,1.0,4/13,12.44%,NT5E;DHODH;ERH;NT5C1A
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),-0.7247104934617437,-1.169744342319439,0.25,1.0,1.0,1/9,11.75%,GPAM
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),-0.6278909696115281,-1.169456751649406,0.23943661971830985,1.0,1.0,3/15,8.23%,LHFPL5;TTN;CAV3
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.5730583034667878,-1.1687737007025154,0.23529411764705882,1.0,1.0,10/31,20.25%,HTR1F;AKAP5;P2RY12;OPRM1;AKAP12;ADCY1;CHRM2;ADCY5;CHRM5;CHRM3
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),-0.6748348063794266,-1.1686673165530213,0.27631578947368424,1.0,1.0,3/15,16.28%,RAB11A;DNM2;CCDC186
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.6466198944681575,-1.1685720643855477,0.27710843373493976,1.0,1.0,2/15,3.16%,TESPA1;PTPRC
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.7846871691453459,1.1681501184280756,0.34210526315789475,0.9012286156799519,1.0,3/5,18.30%,WNT3;LRP6;WNT5A
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.6412262487078795,1.1679207743993751,0.30303030303030304,0.9006338881740885,1.0,2/6,21.16%,PPTC7;H6PD
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.7107282709483335,-1.1679092839993213,0.2602739726027397,1.0,1.0,3/10,18.38%,IRF1;OAS1;STAT1
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.5755595700105708,-1.1678494535617003,0.23529411764705882,1.0,1.0,15/40,28.18%,FGF1;TPD52L1;DVL2;VEGFA;PAK1;HTR2B;RASGRP1;DAB2IP;TGFB1;PDGFRB;IL34;DVL3;MAP3K10;DIRAS2;SASH1
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),-0.7422540169728944,-1.167542693819368,0.34328358208955223,1.0,1.0,2/6,16.85%,ITGA2;ITGA8
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.730322830584557,-1.1675004907313966,0.25757575757575757,1.0,1.0,2/7,13.65%,SYT1;SYT4
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.7144046052505604,1.167413907561742,0.3333333333333333,0.9002590738039993,1.0,4/6,25.30%,SNX12;GAS1;PRNP;LRRK2
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.5852836930277651,1.1672891095588334,0.23529411764705882,0.8991232788225892,1.0,4/18,8.91%,MSN;RAP2C;RAPGEF3;RAB1B
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.6011184533207706,-1.1671176758981596,0.21428571428571427,1.0,1.0,10/32,18.03%,SLC6A6;SLC6A15;SLC7A6;SLC6A11;SLC16A3;SLC13A3;SLC1A4;SLC6A17;SLC6A9;SLC16A4
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.5942218439318913,-1.1671159600407668,0.2564102564102564,1.0,1.0,9/25,24.00%,TMSB4X;P2RY12;VEGFA;NTRK3;IL6R;PRKD2;TGFB1;PDGFRB;STX4
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.4458878728345535,1.1670152362489872,0.0,0.8988062802828001,1.0,27/136,13.79%,NR0B1;TAF1A;POLR2J;POLR2L;YAP1;NR1H2;POLR1F;NR2F6;NR2E1;ESR1;TAF9B;MED23;MAML2;GTF2A2;RBPJ;GTF2H2;NR3C1;ESRRG;POLR2K;ESRRA;POLR1A;ERCC3;GTF2F1;POLR2E;NR4A1;HDAC9;CRCP
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.6251080706361932,-1.1666023899045088,0.3157894736842105,1.0,1.0,5/23,13.79%,CPLX1;STX1B;KCNMB4;RIMS1;CAMK2A
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),-0.7811069157816439,-1.166339553915853,0.2923076923076923,1.0,1.0,2/5,12.07%,PRUNE1;PRUNE2
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.5360886093052302,1.1660239007401623,0.17391304347826086,0.9001455290204704,1.0,4/26,3.98%,RND2;RHOBTB1;IKBKB;RHOC
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.5786943162662422,-1.165982524188829,0.3023255813953488,1.0,1.0,5/36,9.13%,SCEL;ALOX12;COL5A1;HRNR;FLG
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,-0.5803104635643055,-1.165688828944778,0.20238095238095238,1.0,1.0,10/51,15.72%,SYCP2L;KCNJ11;CKMT2;HIF3A;CTNNA3;KBTBD12;CECR2;WIPF3;ACACB;SORBS1
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.6248876870623606,-1.1656671372785716,0.2375,1.0,1.0,8/19,24.56%,GRIN2A;GJA1;IGF1R;PSEN1;EPHA4;GRIN1;CACNB1;ITGA4
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.7986358189010714,-1.1654687524156324,0.24,1.0,1.0,1/5,5.76%,SREBF1
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.5278221753714574,1.1654287865282256,0.20833333333333334,0.9004240117584216,1.0,5/17,21.71%,PML;SUN2;SUPT7L;ARL2BP;BARD1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.49064511137889827,1.165348755670032,0.1111111111111111,0.8993219438982288,1.0,12/63,10.54%,STOX1;SIRT2;UBB;PSMD8;PSMB4;ELOC;PSMB6;RBPJ;PSMD10;PSME3;LIMD1;UBC
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.5605272428915776,-1.1652912140300002,0.25,1.0,1.0,7/43,11.68%,G6PC2;SLC39A14;KCNJ11;BRAT1;GPI;OAS1;GAPDHS
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.44421737281403884,1.1651921346422174,0.11764705882352941,0.8985473724311662,1.0,5/39,7.02%,SOX4;BAD;ACHE;NLGN2;PPIA
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.7178866205529312,-1.1651321864696518,0.2923076923076923,1.0,1.0,5/6,25.37%,P2RY12;TGFB2;RAC3;ADAM9;PIEZO1
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),0.6283173522756081,1.1648179708742414,0.36666666666666664,0.8983954823965044,1.0,4/9,8.87%,ABHD10;PPT1;ABHD17B;LYPLAL1
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.5835103074243583,-1.1647563460095411,0.275,1.0,1.0,8/25,14.84%,PTPRC;GPR18;SP140;CD27;HVCN1;IL7;TRAF3IP3;GNG7
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),0.6945588675043561,1.1646456586295506,0.375,0.8977593166231774,1.0,1/5,7.89%,MSRB3
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.6214467942364073,1.164476643334496,0.3157894736842105,0.8969637445381287,1.0,4/8,19.56%,UBE2J1;YOD1;UBAC2;DERL2
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.3919110342223218,1.1642972439624366,0.16666666666666666,0.8961705796303419,1.0,10/60,3.84%,MMP2;PRRX1;FIBIN;BGN;FBLN2;PODN;COL12A1;CXCL12;PDGFRA;DYNLT1
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.5252720601743434,-1.1640310018801752,0.2765957446808511,1.0,1.0,15/101,17.18%,HEY2;CAMK1;EMP2;SLC6A6;SRF;YWHAH;CEBPD;TCFL5;RUNX2;ALK;BDNF;NR1D1;SUZ12;TIAM1;MBOAT2
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),0.4231710452934704,1.1637236980426604,0.1111111111111111,0.8965325454783627,1.0,4/77,0.69%,UBB;RFWD3;HDAC11;TCF7L1
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.5026342510357276,1.1634597336216017,0.25925925925925924,0.896304537839605,1.0,4/25,8.47%,CFL1;ARC;LZTS3;ABHD17B
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.516505890845896,-1.1634057538949236,0.16129032258064516,1.0,1.0,31/108,20.71%,CMTR1;NLRC5;MX1;GPR18;IRF1;PSMB8;PARP14;PLSCR1;STAT2;RNF213;APOL6;STAT4;B2M;IL7;PFKP;IFIH1;TAPBP;P2RY14;IFIT1;HERC6;IFIT3;RSAD2;STAT3;IFI35;STAT1;PSMA3;HLA-DMA;RIPK1;C1S;IRF2;TRIM25
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.58916915610984,1.1633704949225203,0.2692307692307692,0.8938490666670418,1.0,2/10,6.78%,RAP2A;RAP2C
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.58916915610984,1.1633704949225203,0.2692307692307692,0.8938490666670418,1.0,2/10,6.78%,RAP2A;RAP2C
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),-0.6238858907194113,-1.1618589790667735,0.3,1.0,1.0,7/20,21.35%,CAMK1;APOE;CAMK2B;FOXO6;SHANK3;KIF1A;PSEN1
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),-0.7586492657235901,-1.161854914969539,0.2807017543859649,1.0,1.0,2/5,16.81%,STAT4;STAT3
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),0.6933050989271063,1.1614895539072088,0.36363636363636365,0.897596484229874,1.0,2/7,13.73%,MRPL44;HENMT1
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.5957740874067142,-1.160682980043601,0.31645569620253167,1.0,1.0,8/27,15.16%,PTPRC;GPR18;SP140;STAG3;DOCK8;P2RY14;TRAF3IP3;MYO1F
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.4189217094083614,1.1605139090024665,0.125,0.8991509058436877,1.0,6/72,3.07%,TAF1A;ACTB;GPX1;POLR2L;DNMT3B;POLR1F
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.4725260886392891,1.15991099907096,0.2222222222222222,0.8995051589352693,1.0,16/74,13.75%,UBB;PSMD8;TAB3;PSMB4;IKBKB;PSMB6;UBE2N;PELI1;PSMD10;RIPK2;TOLLIP;PSME3;UBC;PLCB1;PSMB2;PSMD12
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),-0.6113096503885891,-1.1597955711665997,0.35064935064935066,1.0,1.0,6/25,18.92%,HOOK1;TPCN2;MBTPS1;CLVS1;HOOK3;HOOK2
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.5376885651656538,1.159711977329946,0.2692307692307692,0.898664625426243,1.0,2/14,9.48%,NR1H2;ABHD5
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,-0.534718545466998,-1.159690120441793,0.18681318681318682,1.0,1.0,15/100,14.12%,NEFM;GNRHR;STMN2;FAM13C;PCSK2;OLFM3;SST;ROBO2;CACNA1C;GMPPA;CELF4;PTPRN;SULF1;SYT4;UNC5D
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),-0.6660142537480296,-1.1594608432063276,0.27710843373493976,1.0,1.0,1/17,1.06%,STMN2
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),-0.5999193160084132,-1.159400307449604,0.23170731707317074,1.0,1.0,3/24,1.45%,HTR2C;SOX9;AHR
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),-0.7741669401080618,-1.1589378103361263,0.38095238095238093,1.0,1.0,2/5,15.67%,SLC6A17;SLC6A9
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.6300697454772011,-1.158808212823837,0.22666666666666666,1.0,1.0,7/19,24.09%,NR4A3;AGT;CAV3;MLIP;SMAD4;PDE9A;CAMK2D
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.44900156103393696,1.1580293961614625,0.17647058823529413,0.902223556830428,1.0,8/46,10.16%,LSM4;LSM1;CNOT9;LSM7;DCPS;EDC3;RC3H1;EXOSC8
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.5961269997140014,1.157934682256557,0.32,0.9010376506314006,1.0,8/11,35.14%,RNF128;LAMTOR5;LMBRD1;LAMTOR4;ATP13A2;SZT2;SH3GLB1;CD81
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.41252010900097463,1.157578084542089,0.16666666666666666,0.9007531749338651,1.0,18/116,11.02%,SOX4;PIWIL2;PLD1;OPN3;NR1H2;EIF3D;NPM1;MID1IP1;EEF2;FXR2;SP1;LDLR;EIF4A3;STARD4;NAT10;SCARB1;POLDIP3;SMAD3
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),-0.7118488443272442,-1.1574779633875185,0.30158730158730157,1.0,1.0,2/6,12.52%,PTPRC;NR1D1
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.6160459799307824,-1.1572367998364828,0.2753623188405797,1.0,1.0,3/20,3.88%,SCEL;MAFF;MLANA
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.6102976169090644,-1.1565260508709396,0.25882352941176473,1.0,1.0,9/36,9.21%,NAAA;AHR;NR4A3;PTPRC;PARP14;IGSF6;SPI1;GPR34;AOAH
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.6178924184120753,1.1562974516188378,0.2608695652173913,0.9033174628358716,1.0,2/11,2.25%,YAP1;EVI5L
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.5989407831896557,-1.1561215048519728,0.325,1.0,1.0,6/27,18.92%,HOOK1;TPCN2;MBTPS1;CLVS1;HOOK3;HOOK2
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.5622347013793058,-1.1559844784784359,0.2247191011235955,1.0,1.0,11/45,20.90%,PTPRC;TPCN2;P2RY12;CACNA1C;ACKR4;HTR2B;PPP3CC;PTPRJ;CHRM3;ATP1B1;RYR2
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),-0.5187030758674631,-1.155864767224646,0.21839080459770116,1.0,1.0,24/79,31.52%,SYNJ2;PIP4K2C;PLEKHA4;INPP5E;INPP4B;PIP4P1;INPP4A;PIP5K1B;PDGFRB;IMPA1;PIK3CB;TPTE2;PITPNM2;PLAAT3;SACM1L;MTMR4;PLCG1;MTMR7;PLEKHA2;PIK3CD;PIP4K2A;PIP5K1A;PLA2G12A;PGAP1
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.6393640262333189,-1.1541574411328401,0.28378378378378377,1.0,1.0,4/19,13.20%,RASGRF1;MMD2;RASGEF1A;RASGRP1
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.4918872185980295,1.1540801590039682,0.2,0.9089811392701693,1.0,4/27,9.20%,ASCL1;BTBD3;BTBD6;DCHS1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.5236579035283815,1.153893813983657,0.17391304347826086,0.908212913123159,1.0,3/21,3.64%,VPS37B;SNF8;VPS28
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.6499609932416421,1.153725920120195,0.2647058823529412,0.9059492826453285,1.0,2/8,6.75%,SIRT2;PDE4B
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.6499609932416421,1.153725920120195,0.2647058823529412,0.9059492826453285,1.0,2/8,6.75%,SIRT2;PDE4B
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.5778501236356921,1.1535453391811044,0.2962962962962963,0.9039342166267557,1.0,1/13,1.00%,HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.5778501236356921,1.1535453391811044,0.2962962962962963,0.9039342166267557,1.0,1/13,1.00%,HSPA1A
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),-0.7603082355719459,-1.1533451787633338,0.36923076923076925,1.0,1.0,1/5,10.46%,PLEKHM1
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.5187520964182121,1.153208697429053,0.35,0.9039620059794427,1.0,2/22,2.43%,EIF5A;IRF3
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),0.5990118585473179,1.1531724741510878,0.22727272727272727,0.9027909611795949,1.0,5/11,15.79%,IDH1;ACLY;SIRT4;IREB2;IDH3G
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),-0.7443075276990594,-1.153167949141564,0.3225806451612903,1.0,1.0,4/5,25.07%,PROCR;APOE;HS3ST5;KNG1
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),-0.6629281155405945,-1.1531670507538059,0.3150684931506849,1.0,1.0,5/11,22.65%,RAB3A;RAB15;SYT4;RAB3D;SLC4A8
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.4809999160193314,1.1530544168800736,0.2857142857142857,0.9018315235439366,1.0,10/23,24.24%,FNBP1L;ARAP1;NRP1;CDC42;NLGN1;RALA;WASL;RHOQ;NEURL1;AGRN
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),-0.729544276647359,-1.1529226004177642,0.2702702702702703,1.0,1.0,3/8,14.34%,AKAP5;GRM3;ADGRV1
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),-0.729544276647359,-1.1529226004177642,0.2702702702702703,1.0,1.0,3/8,14.34%,AKAP5;GRM3;ADGRV1
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.4572833331112132,1.152786803798476,0.23076923076923078,0.8998691733116839,1.0,3/51,2.06%,NUP42;POLR2J;POLR2L
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.4572833331112132,1.152786803798476,0.23076923076923078,0.8998691733116839,1.0,3/51,2.06%,NUP42;POLR2J;POLR2L
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),0.5957015010000363,1.152711966592501,0.2727272727272727,0.8987627569949916,1.0,5/15,18.84%,HSD17B10;ACOT8;OSBPL7;OSBP;CYP7B1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),-0.6523936299404901,-1.1526315259510622,0.3382352941176471,1.0,1.0,2/10,10.54%,TMSB4X;VEGFA
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),0.596722945958708,1.1525839145244543,0.3333333333333333,0.8977889158683421,1.0,5/8,20.84%,ATP7B;COX19;MT2A;SLC31A1;PRNP
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),-0.6292373546702217,-1.1524432144112504,0.27710843373493976,1.0,1.0,7/22,20.25%,KCNJ13;KCNJ11;AHCYL1;KCNQ1;WWP2;ANO6;CHRM3
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),-0.7079213365539875,-1.152276831248527,0.375,1.0,1.0,1/8,7.65%,MTHFD1
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.6770482999236358,-1.1518701789730292,0.35064935064935066,1.0,1.0,3/10,19.03%,DONSON;ZRANB3;LIG3
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),-0.6976628119509413,-1.151587529926888,0.2948717948717949,1.0,1.0,1/7,0.68%,SOX9
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),-0.6781306154765221,-1.1514177866844633,0.3150684931506849,1.0,1.0,2/9,20.44%,KCNQ1;ATP1B1
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.7394212593825389,-1.151015577173015,0.3108108108108108,1.0,1.0,2/7,1.82%,PON1;ALOX12
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.655435972228319,1.1509618277577764,0.3142857142857143,0.9014160486887859,1.0,1/6,3.29%,STIM1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),0.7101263665222204,1.1508462159741504,0.37142857142857144,0.9004153872729104,1.0,3/7,21.09%,BAG2;MAD2L2;RPS7
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.6747578848547072,1.1507168165231132,0.3157894736842105,0.8995979313282423,1.0,3/6,14.17%,ASCL1;FZD3;NRP1
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.6862994273374099,-1.1506770425228976,0.3194444444444444,1.0,1.0,2/10,13.66%,KCNJ11;BMP8A
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),-0.6219485136155658,-1.1504631610383425,0.3055555555555556,1.0,1.0,1/15,4.17%,NDST3
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.4413532329698276,1.1504497748680904,0.375,0.8991429237974147,1.0,12/82,6.37%,MMP2;PRRX1;AMOTL2;FIBIN;BGN;MAGI1;TNS2;CXCL12;PDGFRA;TCEAL7;FRZB;THY1
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.38489745726552366,1.149925036244396,0.0,0.8992799354484208,1.0,26/259,6.33%,COPZ1;SYNDIG1;IPO13;NUP42;ARL4A;EVI5L;SNF8;CALR;TMED2;PHB2;BAG3;NUTF2;RAN;VPS28;NPM1;ARFIP1;CTSA;PREB;VPS26B;TMED5;RAB5B;CLIP3;SURF4;PRICKLE1;AP4E1;PPP1R10
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),-0.7574334980418526,-1.1495617309040251,0.2571428571428571,1.0,1.0,1/5,11.47%,XRCC3
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),-0.7574334980418526,-1.1495617309040251,0.2571428571428571,1.0,1.0,1/5,11.47%,XRCC3
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),0.6816331778297584,1.1492095999662792,0.29411764705882354,0.9000063997241139,1.0,3/5,30.46%,RPS6KA3;DDIT3;RELA
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.6051053356371863,-1.1489373008255166,0.28378378378378377,1.0,1.0,3/16,9.33%,GLRA2;GLRA1;HVCN1
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.4084573902180767,1.1487788970814834,0.2222222222222222,0.9000393356212709,1.0,8/57,9.48%,IPO13;PHB2;NUTF2;RAN;PRICKLE1;PPP1R10;GEMIN8;PTTG1IP
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),-0.7875738450283098,-1.1484322561057423,0.2535211267605634,1.0,1.0,2/5,19.44%,PDPN;DDR2
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),-0.6975768807072844,-1.1483193975899302,0.3472222222222222,1.0,1.0,1/7,8.67%,GLUL
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.6741003229930934,1.1483111725244866,0.325,0.9000721766022977,1.0,3/5,18.30%,DNAJC19;CHD7;WNT5A
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.5782264242775035,1.1481146248982934,0.26666666666666666,0.8993644112252948,1.0,3/14,11.73%,SLC30A10;ABCD2;SLC25A33
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.6492613242219867,1.1471821818843422,0.34285714285714286,0.9009025215536179,1.0,2/8,13.89%,CALR;EZH2
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),-0.6216995523116978,-1.1467760668577476,0.35526315789473684,1.0,1.0,2/22,5.75%,KCNJ13;KCNJ11
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.5446494250888811,1.1466225942575345,0.38461538461538464,0.9009594443720503,1.0,9/29,17.62%,AEN;HIPK1;PML;BOK;JMY;SIRT1;MYBBP1A;FHIT;PHLDA3
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),-0.5443614845566223,-1.146590642624169,0.22727272727272727,1.0,1.0,12/48,20.90%,ITPR1;AGT;KCNJ11;CAV3;RYR3;AHCYL1;TPM1;KCNQ1;ATP2B3;TGFB2;ATP1B1;RYR2
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.727835580730004,-1.1463510530238847,0.2987012987012987,1.0,1.0,8/10,26.21%,RNF213;CSNK1D;TIAM1;DAAM2;ZNRF3;SFRP4;GPC3;WNT5B
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.6543659368622338,-1.1462729868122925,0.21621621621621623,1.0,1.0,2/15,5.36%,TMSB4X;SPI1
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.7248342062340414,-1.1461999353094139,0.2857142857142857,1.0,1.0,2/6,16.04%,TMOD3;PGM5
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.621300003938585,1.1460581470315738,0.4166666666666667,0.9013213057992643,1.0,4/8,13.87%,SIRT2;SIRT4;HDAC9;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.5716266103812057,1.145961544173247,0.28,0.9003619158683833,1.0,4/13,7.18%,STOX1;CCND1;RCC2;RAD51B
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),0.7137273465550368,1.1459563810886906,0.34210526315789475,0.8990756845599999,1.0,3/5,20.35%,ATF4;LANCL1;PINK1
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),-0.6970469751787562,-1.1458366260584691,0.2962962962962963,1.0,1.0,5/11,26.80%,SOX9;FOXO1;PPP5C;GLDC;PDK3
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),0.6179939026280976,1.1452772771374988,0.38095238095238093,0.8997677969424832,1.0,3/13,7.59%,BAD;MFF;BOK
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.5845380780845194,-1.1450034685947854,0.22784810126582278,1.0,1.0,7/27,18.40%,AGT;VEGFA;SULF1;IFT27;ITGA8;STAT1;TGFB2
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,-0.5085857320098932,-1.1448730353076078,0.18888888888888888,1.0,1.0,27/113,16.74%,STMN2;GRIN2A;CALB1;GRM1;SPINK8;OLFM3;CALY;SNCB;GRIN2D;STX1B;KCNC1;GABRG2;NRGN;MMD2;CACNA1B;ACTL6B;PSD2;CELF4;GRM3;SNAP25;LRRTM1;SYT4;CAMK2A;KCNB2;ATP2B3;SRRM4;OXTR
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),-0.6500959654335,-1.144847345499617,0.20270270270270271,1.0,1.0,4/14,26.71%,SHTN1;KIF20B;BCAS3;GSN
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.5640108147907745,-1.1444031365186096,0.2441860465116279,1.0,1.0,8/33,15.62%,MAP3K19;FAM161A;CCDC39;ANKUB1;ECT2L;CFAP52;CFAP70;CFAP77
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.5248488264288305,-1.1437277240861983,0.21348314606741572,1.0,1.0,6/62,8.01%,TMSB4X;LRRC19;IRF1;NMT1;P2RY12;GRK4
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.6615373546644099,-1.1426124951953303,0.3561643835616438,1.0,1.0,3/10,23.87%,HAP1;NEFL;SYBU
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),-0.6740876914460665,-1.1425171587337242,0.2894736842105263,1.0,1.0,6/13,24.10%,GRIN2A;GRIN2D;ARRB2;GRIN1;MPP2;MAPK8IP2
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.5054251468368063,1.1425086470200294,0.2727272727272727,0.9056909533869372,1.0,7/46,10.26%,BANF1;SIRT2;RAN;UBE2I;CHMP2A;PPP2R1A;LBR
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.5917743514445225,-1.1424958359488981,0.32,1.0,1.0,5/20,21.70%,MAN1A1;CD27;GNG7;PDK1;RASGRP3
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),0.6263204885599771,1.1422738796558074,0.3,0.9050842269066913,1.0,3/10,12.98%,NT5E;NT5C1A;DERA
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),-0.7659046466025996,-1.1422578823246163,0.3230769230769231,1.0,1.0,1/5,12.02%,BDNF
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.7141313602664845,-1.1417388548349288,0.352112676056338,1.0,1.0,3/6,15.34%,AGBL4;AGBL3;AGBL5
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.48811443377431774,1.141528734301215,0.3181818181818182,0.906067356498084,1.0,3/29,3.75%,AURKAIP1;BAD;CTSC
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),-0.746739257517969,-1.1415199457714131,0.3225806451612903,1.0,1.0,4/6,20.90%,TTN;HTR2B;HDAC4;RYR2
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),-0.6121403438182351,-1.1412512208343455,0.2916666666666667,1.0,1.0,4/25,8.02%,SOX9;IRF1;GADD45A;TMEM150C
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),0.6103806756714889,1.1410522481114451,0.25,0.9060659619880252,1.0,2/10,6.37%,CRB2;THY1
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),0.5214500432122721,1.1407216360472459,0.2962962962962963,0.9057880639992144,1.0,2/17,7.03%,TRMT112;MRM3
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),0.6735435607574516,1.1406801401371212,0.36363636363636365,0.9046072987010384,1.0,2/5,24.84%,LAGE3;OSGEP
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,-0.546009257396788,-1.1405154695289799,0.27058823529411763,1.0,1.0,13/42,18.04%,PON1;ARX;PAH;A2M;AGT;ELOVL2;ACSL1;ACSS3;PON3;THSD4;SORBS1;MATN2;ABCA8
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.6451579777687234,-1.140216160729187,0.3466666666666667,1.0,1.0,4/10,16.46%,PTPRC;CD27;TRAF3IP3;GPR171
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),-0.7561478844913097,-1.1401803225059086,0.27586206896551724,1.0,1.0,2/5,23.49%,ITPK1;IMPA1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.6992886025060838,-1.1398960244385257,0.3333333333333333,1.0,1.0,2/7,24.09%,CAV3;CAMK2D
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),-0.7390748112181268,-1.1395997969809732,0.3287671232876712,1.0,1.0,1/5,6.19%,STX1B
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.6649469561446327,-1.1393932873311452,0.30303030303030304,1.0,1.0,1/12,1.60%,HES1
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),0.6471288257960237,1.1391050592415175,0.36585365853658536,0.907791358193551,1.0,2/5,22.21%,SPRY1;SPRED1
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),-0.655039221958886,-1.1388146233378416,0.34615384615384615,1.0,1.0,1/10,2.65%,TESPA1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.6618724912106575,1.1386628362785929,0.37142857142857144,0.9076373558965551,1.0,1/6,19.22%,FBXW7
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.46054475201475864,1.1386584510296647,0.3076923076923077,0.9063589934234614,1.0,3/38,4.27%,IL15;PDGFRA;LYN
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.5587031879549526,-1.1378721393671276,0.29333333333333333,1.0,1.0,8/42,12.89%,HES1;EFNA1;OVOL2;RAB17;TMC4;SLC44A3;GPRC5C;KIAA1217
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.6837703649618344,-1.137861813584789,0.3333333333333333,1.0,1.0,5/8,27.89%,CD160;PDCD4;ANO6;ITGA4;PLCG1
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.6829258694933062,-1.1373413951290632,0.30434782608695654,1.0,1.0,1/11,4.26%,CDKN2A
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),0.6316303942229919,1.1367614045634262,0.40540540540540543,0.9100263596919849,1.0,4/6,13.73%,MFF;PEX11A;ACOT8;FIS1
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),0.7170955086449728,1.136581729876335,0.34375,0.9065009842234839,1.0,1/6,2.77%,TMED2
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),0.7170955086449728,1.136581729876335,0.34375,0.9065009842234839,1.0,1/6,2.77%,TMED2
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),0.7170955086449728,1.136581729876335,0.34375,0.9065009842234839,1.0,1/6,2.77%,TMED2
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),-0.7013697504807227,-1.1365331479784067,0.3384615384615385,1.0,1.0,2/7,12.52%,PTPRC;NR1D1
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.6404341503921239,-1.1364940813174143,0.2911392405063291,1.0,1.0,3/15,10.94%,G6PC2;GPI;RBKS
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.7153338848694634,-1.136351003512645,0.3472222222222222,1.0,1.0,3/6,19.57%,ITPK1;DNM1L;RIPK1
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),0.46924413003288745,1.1360304967726527,0.21052631578947367,0.9067223884033552,1.0,8/24,16.89%,STARD3;LDLR;STARD4;LIMA1;SCARB1;SOAT1;OSBP;LCAT
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),-0.6000397139820652,-1.135969664505263,0.3375,1.0,1.0,3/29,12.05%,GRIN2A;GRM1;GRM3
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.556382312064004,-1.1358074325215068,0.26136363636363635,1.0,1.0,10/61,15.67%,SLC28A2;SLC2A3;SLC6A6;SLC29A2;LRP2;SLC4A4;SLC13A3;SLC1A4;SLC6A17;SLC6A9
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",0.6190790159347641,1.1353222312654732,0.3448275862068966,0.9075380372491102,1.0,3/5,6.60%,NLGN2;ADRA1A;ZDHHC3
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),-0.7623532592842873,-1.1353025163905275,0.32857142857142857,1.0,1.0,2/5,7.60%,SHTN1;RHOJ
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.5931344745848618,-1.1352398830268406,0.3466666666666667,1.0,1.0,4/17,22.75%,SREBF1;HDAC6;DNM1L;USP36
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.6865127655463243,-1.1352200395171488,0.2857142857142857,1.0,1.0,3/10,12.75%,STX1B;STX19;SNAP25
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.6035201519675061,-1.134931658606024,0.2564102564102564,1.0,1.0,2/20,2.65%,CD160;TESPA1
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),-0.7370662849099825,-1.1346432363265164,0.37142857142857144,1.0,1.0,2/5,14.32%,HSD11B1;EPHX2
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.44381559794220243,1.1345876071087626,0.25,0.9085246706822275,1.0,20/112,12.59%,POLR2J;PCBP3;NOVA1;POLR2L;TBRG4;LSM1;PCBP2;MRPL44;SNRNP40;HNRNPC;HNRNPA0;DDX54;NUFIP1;PCBP1;PPP1R8;POLR2K;MTREX;RNASEH2C;GTF2F1;POLR2E
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.6889335392147617,1.1344666748107184,0.36666666666666664,0.9075312021228081,1.0,2/5,26.10%,BCL11B;GPLD1
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.581613096716506,1.1337295515955872,0.3181818181818182,0.908144862433606,1.0,6/9,18.30%,NLGN2;LRRTM3;NLGN3;NLGN4X;NLGN1;WNT5A
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.4701128625897622,1.1335864165493041,0.3,0.9073518671266102,1.0,4/29,3.39%,ASCL1;HIPK1;SALL2;SHROOM2
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.7174399391138806,-1.133414268953591,0.3548387096774194,1.0,1.0,1/7,12.24%,CDC7
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.6112979454919003,-1.133347466453013,0.30864197530864196,1.0,1.0,4/17,11.68%,ENO4;LDHA;GPI;GAPDHS
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.7086071427906766,-1.1332116880946972,0.2361111111111111,1.0,1.0,3/9,12.58%,PARP9;NUDT12;NAXE
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),-0.7684505235016923,-1.1329175045636366,0.2923076923076923,1.0,1.0,1/5,0.59%,HOOK1
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),-0.5985550120572561,-1.132880327152543,0.32926829268292684,1.0,1.0,6/25,7.24%,GABRA4;GRIN2A;GLRA1;GABRG3;GRIN2D;GABRG2
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",-0.7329006705109211,-1.1328242017936638,0.3,1.0,1.0,2/6,18.12%,RAB11A;GRIPAP1
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),0.6149583237018325,1.132538331385278,0.2,0.9089486370022654,1.0,1/10,0.51%,PODXL2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.6681071951236262,-1.1321618121919717,0.32926829268292684,1.0,1.0,3/9,22.26%,PDPN;DDR2;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.6172013586574572,-1.1320779407659067,0.35526315789473684,1.0,1.0,3/16,11.81%,PTPRC;DUSP22;SH3BP5
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.6456890707110938,1.1320778305271328,0.28125,0.9091890844889361,1.0,4/7,31.01%,BMP2;LRP6;EDA;HDAC2
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.7597591731920214,-1.1320024894103184,0.2894736842105263,1.0,1.0,2/7,15.64%,PLEKHA4;CSNK1D
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.4488125032856337,1.1316547597501596,0.23809523809523808,0.9092570449191704,1.0,6/33,10.54%,UBB;TAB3;UBE2N;GPS1;RIPK2;UBC
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),-0.7311499777264442,-1.1313787566848617,0.390625,1.0,1.0,2/6,13.20%,PTPRC;RASGRP1
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),-0.7084468626921889,-1.1310627385692846,0.3783783783783784,1.0,1.0,1/7,0.68%,SOX9
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.6036464003469886,1.1309167348859956,0.375,0.9103788372688365,1.0,4/8,23.01%,PNP;AMPD2;AMPD3;GMPR2
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.45864042235473035,1.1308722807611895,0.15,0.9092455336970668,1.0,4/27,3.27%,AURKAIP1;BTC;CUL7;TGFA
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.6562424994215209,-1.130619407496926,0.30985915492957744,1.0,1.0,3/12,10.88%,TTN;ZFPM1;TPM1
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.6048418443040715,1.1305520212634301,0.4090909090909091,0.9086775770216182,1.0,4/11,19.21%,QRICH1;ATF4;HSPA5;HERPUD1
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),-0.692527130544905,-1.1300057164809134,0.36486486486486486,1.0,1.0,2/9,20.43%,GABRG2;GABRA2
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.6160287042240278,-1.1299135675953913,0.32,1.0,1.0,12/21,35.76%,BRCA1;DONSON;FZR1;ATM;BRSK1;NOP53;BABAM2;TAOK1;ABRAXAS1;BRCC3;TAOK3;MRNIP
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),0.6752971387497958,1.1298052055934527,0.35294117647058826,0.9101372903953686,1.0,3/5,28.23%,LAPTM4B;FURIN;CDH3
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.6161699745957855,1.1294701310822584,0.37037037037037035,0.9097159335192821,1.0,2/12,5.15%,PLOD1;P3H2
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),-0.7497846793040558,-1.1293866593704016,0.3333333333333333,1.0,1.0,1/5,8.77%,DVL2
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.7467412959158682,-1.129178831593645,0.3783783783783784,1.0,1.0,1/6,3.17%,APIP
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.6231117668161037,1.1291554704815185,0.41379310344827586,0.9093931084839926,1.0,5/10,26.05%,CNTN6;PALLD;DSCAML1;DSCAM;ROBO3
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.750770151225954,-1.1290295651694127,0.3492063492063492,1.0,1.0,1/6,12.24%,CDC7
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.6172661203299366,-1.1289694094824831,0.32142857142857145,1.0,1.0,1/20,0.19%,CD44
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.7127511678549978,-1.1287531737812588,0.3333333333333333,1.0,1.0,2/8,4.67%,PARP9;PARP14
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.5141958148577768,1.1285617223230677,0.2631578947368421,0.9098734182228508,1.0,14/33,19.25%,DHCR7;HSD17B10;MSMO1;TM7SF2;SQLE;ACOT8;LBR;HMGCR;INSIG1;OSBPL7;OSBP;SC5D;CYP7B1;FDFT1
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.5857105367067232,-1.1285233141102076,0.2911392405063291,1.0,1.0,7/27,17.57%,HES1;PARP9;CRLF1;PARP14;VEGFA;STAT3;IL6R
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),0.47302242352054685,1.1275624497433043,0.29411764705882354,0.9115905591620223,1.0,7/41,13.84%,UBB;MCM4;GTF2H2;PARP1;UBC;ERCC3;PIF1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.4007056278714833,1.1275266453821018,0.09090909090909091,0.9105391704150491,1.0,8/46,6.16%,YAP1;CCT5;BAG3;RAN;TRIM28;RBM22;LARP7;CCT3
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.7396486046987714,-1.1274451613666798,0.453125,1.0,1.0,3/5,23.35%,P4HA3;P4HTM;EGLN3
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),-0.5476036855590424,-1.1274247608683952,0.25555555555555554,1.0,1.0,4/50,7.39%,HEY2;SOX9;SPI1;KIAA0319
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.5501925014243386,1.1274077213835405,0.25,0.9095390726320434,1.0,2/8,13.87%,FPGS;CALM1
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.5696585465210542,-1.1272185977347238,0.24691358024691357,1.0,1.0,4/36,13.61%,ENPP2;ADAMTS13;PDXDC1;CYP3A5
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.7186560314037043,-1.1270683070562961,0.3194444444444444,1.0,1.0,1/7,16.65%,IFI6
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.6199339286959988,1.1268423523945466,0.30434782608695654,0.9099198534863072,1.0,5/10,21.17%,ESR1;ATF7IP;PSMC3;HMGB1;TP53
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),0.5009945902281588,1.126452698920795,0.21428571428571427,0.9097442577401713,1.0,2/14,4.21%,GPR17;GPR174
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.6061203854734236,-1.1263636206498602,0.3375,1.0,1.0,6/22,17.33%,KCNJ11;OPRM1;APOE;BMP8A;RSAD2;RAB11FIP5
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.5843536825801453,-1.1262197463207229,0.3116883116883117,1.0,1.0,8/33,14.81%,SLC38A4;SLC6A6;SLC6A15;SLC3A1;SLC7A6;SLC25A45;SLC1A4;SLC6A17
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.6746505875124443,-1.125951071813588,0.26865671641791045,1.0,1.0,2/12,11.84%,NAAA;DEGS2
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.6096839990359781,-1.1259398487825176,0.3625,1.0,1.0,1/18,0.19%,CD44
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),0.6768171624388688,1.1258067213643996,0.3939393939393939,0.9101237250797385,1.0,3/5,18.58%,ATP6V1G1;ATP6V0D1;ATP6AP1
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),-0.7080209981433343,-1.1255123776425315,0.3181818181818182,1.0,1.0,1/6,7.65%,MTHFD1
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.5854745883048111,-1.1254788274811238,0.2911392405063291,1.0,1.0,8/30,19.30%,RFC4;RFC1;RFC2;RPA3;PNKP;NTHL1;LIG3;PARG
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.6867475720333016,-1.1253893326424484,0.29411764705882354,1.0,1.0,2/12,11.03%,CDKN2A;CAMK2N1
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.5952217739601281,-1.124862308425989,0.4069767441860465,1.0,1.0,5/23,15.34%,CYP2E1;ALOX12;EPHX2;TBXAS1;CYP1B1
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),-0.6966284969008708,-1.1245046148153337,0.3150684931506849,1.0,1.0,4/7,23.51%,CDKN2A;B2M;ARG2;CGAS
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.7076603865983804,-1.1244759704644487,0.3181818181818182,1.0,1.0,3/8,10.54%,SOX9;AGT;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.7076603865983804,-1.1244759704644487,0.3181818181818182,1.0,1.0,3/8,10.54%,SOX9;AGT;VEGFA
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),0.6323955606525529,1.124228820868312,0.42105263157894735,0.9137529241074898,1.0,2/8,4.03%,GAL3ST3;B3GAT2
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.5557022423671544,1.1236779835639383,0.38095238095238093,0.9142461667135742,1.0,2/16,10.13%,BAD;TSPAN33
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),-0.723511300646647,-1.1234814924850134,0.3380281690140845,1.0,1.0,1/7,3.74%,VAMP1
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),-0.5561714077816045,-1.1234718807852002,0.2682926829268293,1.0,1.0,4/26,17.40%,CAMK1;SRF;RBM4;CTNNA1
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),-0.7238533496675623,-1.1233225205898723,0.36923076923076925,1.0,1.0,1/5,0.68%,SOX9
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.7545694627725503,-1.1231791827119946,0.36923076923076925,1.0,1.0,1/5,5.36%,SPI1
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.6898464070401849,-1.1227662967968066,0.3442622950819672,1.0,1.0,4/9,21.08%,CAV3;FOXO1;MLIP;SMAD4
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),-0.7224532671645145,-1.1226742663771463,0.3424657534246575,1.0,1.0,3/7,19.53%,ENPP4;USF1;ANO6
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),-0.6609958412131494,-1.122568400821744,0.3116883116883117,1.0,1.0,4/8,23.51%,CDKN2A;B2M;ARG2;CGAS
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),-0.6881436548174176,-1.122432378771515,0.3382352941176471,1.0,1.0,1/9,3.42%,TSPYL2
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.4633280095453307,1.1222883073116618,0.3333333333333333,0.9171635435808951,1.0,4/29,6.66%,SOX4;LRRC8D;ERN1;ZNF236
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),0.6941378639759902,1.1222529222818298,0.32432432432432434,0.9149036159948802,1.0,3/5,29.60%,KHSRP;CAV1;ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),0.6941378639759902,1.1222529222818298,0.32432432432432434,0.9149036159948802,1.0,3/5,29.60%,KHSRP;CAV1;ATP2B4
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.5825935562995292,-1.1221486268603695,0.358974358974359,1.0,1.0,5/24,19.05%,PTPRC;KLF6;BLNK;HDAC4;PTPRJ
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.5439243912818471,-1.1221375229970756,0.35714285714285715,1.0,1.0,17/51,26.38%,GRIN2A;OPRM1;DAPK1;CAMK2B;SHISA6;NEFL;CAMK2A;BEGAIN;SHISA9;CACNG8;CACNG2;CACNG7;DLG4;GRIN1;MAPK8IP2;RELN;CNIH2
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.662614557122713,-1.1221359390173573,0.3333333333333333,1.0,1.0,1/12,1.15%,NAAA
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.6200084877395591,-1.122127822432216,0.3188405797101449,1.0,1.0,1/16,4.38%,GADD45A
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.7144866767270164,-1.1218520184162413,0.37142857142857144,1.0,1.0,1/7,4.67%,PARP14
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.7474230182838815,-1.1218343744905865,0.3150684931506849,1.0,1.0,3/6,20.13%,RAB3A;CBLN2;DCTN1
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.6144997831894118,-1.121767105830929,0.3448275862068966,1.0,1.0,1/20,1.06%,STMN2
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.5077880744289085,1.1217180869481784,0.3103448275862069,0.9152491441001629,1.0,4/17,5.38%,ADCY6;LGR5;CAP1;RXFP1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.7091209054122793,-1.1211638691567478,0.35714285714285715,1.0,1.0,1/7,5.76%,SREBF1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.7565090802695994,-1.1209121593978866,0.3,1.0,1.0,5/6,23.05%,B2M;HLA-F;HLA-C;HLA-B;HLA-A
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.4718374563798774,1.1209068217033602,0.26666666666666666,0.9159759063057743,1.0,8/29,12.59%,TAF1A;POLR2L;POLR1F;GTF2H2;POLR2K;POLR1A;ERCC3;POLR2E
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.45829211868443515,1.1207825874119182,0.21428571428571427,0.915007140632002,1.0,7/39,11.17%,BAD;ZDHHC6;MFF;PPIF;BOK;PLAUR;MUL1
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),-0.7267079785998252,-1.1201547594792356,0.34328358208955223,1.0,1.0,1/5,3.16%,PTPRC
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.5975024462872409,1.1200219745712614,0.37142857142857144,0.9161134148803142,1.0,3/8,18.58%,ATP6V1G1;ATP6V0D1;ATP6AP1
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),-0.7454085144003286,-1.1199535396504365,0.3561643835616438,1.0,1.0,2/5,11.82%,MAP3K12;NEK11
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.6340546841109591,-1.1199207086166785,0.37333333333333335,1.0,1.0,6/16,23.51%,POLQ;SHLD2;FANCB;RIF1;HELB;CGAS
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.6349293268931214,-1.119818505717204,0.3625,1.0,1.0,7/15,28.00%,PARP9;NUDT12;NAXE;NMNAT3;NNMT;PARP10;NMNAT2
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),0.6937253350538857,1.1193004038266565,0.3333333333333333,0.9170026203693485,1.0,2/6,16.12%,BHMT;CROT
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),-0.6978951541336463,-1.1192770033556616,0.3684210526315789,1.0,1.0,2/8,17.70%,WDR91;RBL2
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.665434426914721,-1.1191779495603262,0.35135135135135137,1.0,1.0,6/12,15.16%,PTPRC;CD27;AOAH;TSHR;TRAF3IP3;MYO1F
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),-0.6498551631725238,-1.1191306154795868,0.38095238095238093,1.0,1.0,1/10,0.68%,SOX9
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),-0.6442917191195441,-1.1191182193807965,0.36231884057971014,1.0,1.0,1/9,9.85%,APOE
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.5098544184025127,1.1189366042551487,0.4090909090909091,0.9167966064605932,1.0,2/19,11.22%,PPT1;TRIM24
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.7261673591889751,-1.1188843460857938,0.38235294117647056,1.0,1.0,4/6,23.05%,HLA-F;ARRB2;HLA-B;HLA-A
prerank,PanglaoDB_Augmented_2021__Microglia,-0.5738533641394419,-1.118575914958145,0.25316455696202533,1.0,1.0,10/29,17.57%,PTPRC;IGSF6;SPI1;FOS;P2RY12;GPR34;AOAH;TBXAS1;MYO1F;IL6R
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.4965655394786825,-1.118561664722905,0.3076923076923077,1.0,1.0,9/63,8.57%,CD44;MAFF;PTPRC;PROCR;FPR3;SPI1;MGST1;IL3RA;TNS1
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),-0.5047908085513221,-1.1183254472360413,0.2696629213483146,1.0,1.0,9/96,13.30%,SYNJ2;PIP4K2C;PLEKHA4;PIGH;INPP5E;PIGL;ITPKC;PIGC;MPPE1
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.43510793500191225,1.1183188992570086,0.3333333333333333,0.9170182042091467,1.0,5/40,5.67%,PLA2R1;TRIM28;TMEM161A;UBE2N;FXR2
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),-0.7262947694703898,-1.1182928522219326,0.31746031746031744,1.0,1.0,1/6,10.54%,VEGFA
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),-0.6709587662639298,-1.1178680090306647,0.34328358208955223,1.0,1.0,2/9,18.62%,XRCC3;WRN
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),-0.6709587662639298,-1.1178680090306647,0.34328358208955223,1.0,1.0,2/9,18.62%,XRCC3;WRN
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),-0.6709587662639298,-1.1178680090306647,0.34328358208955223,1.0,1.0,2/9,18.62%,XRCC3;WRN
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.4931496101838383,1.1177505992813854,0.391304347826087,0.9171918223921575,1.0,9/32,12.13%,DHCR7;HSD17B10;MSMO1;TM7SF2;SQLE;PSAT1;ACOT8;LBR;HMGCR
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.6037159103692495,1.1174803776338391,0.4074074074074074,0.9165367959478112,1.0,3/7,28.70%,FIS1;MCU;BCAP31
prerank,PanglaoDB_Augmented_2021__Beta Cells,-0.49970487332858116,-1.1172214602826014,0.3023255813953488,1.0,1.0,22/106,14.68%,STMN2;G6PC2;PCSK2;NKX6-2;EDARADD;KCNC1;SST;ROBO2;EFNA5;CACNA1B;SULT4A1;ACTL6B;RIMS1;CAMK2B;CELF4;SHISA6;SNAP25;LRRTM1;JPH3;SYT4;UNC5D;KCNB2
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),-0.5967983295368101,-1.117068364919617,0.34210526315789475,1.0,1.0,7/19,29.25%,UNC13C;DCTN1;DVL1;CACNB1;UNC13A;PDZRN3;CACNB4
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),-0.5355207327712886,-1.1169993408232048,0.25609756097560976,1.0,1.0,11/39,20.54%,CDH7;CDH12;CDH9;VCL;CDH19;PVR;TBCD;PAK2;CTNNA1;CDHR3;CDH8
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.6525119764381802,-1.1168298968854626,0.36486486486486486,1.0,1.0,2/12,13.66%,KCNJ11;BMP8A
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.5061338424315638,1.1168103955880948,0.23529411764705882,0.9175613024871392,1.0,5/17,11.72%,STYXL1;TIPRL;PPP1R8;PPP1R11;YWHAB
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.6525904636179471,1.1164460351616976,0.28205128205128205,0.9170727226114421,1.0,4/7,31.17%,ZDHHC5;PUM2;USP15;ANKRD17
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.7686847033433223,-1.1162324216205526,0.373134328358209,1.0,1.0,4/5,23.05%,HLA-F;HLA-C;HLA-B;HLA-A
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.7686847033433223,-1.1162324216205526,0.373134328358209,1.0,1.0,4/5,23.05%,HLA-F;HLA-C;HLA-B;HLA-A
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),0.5593924204676468,1.1157445926134861,0.38235294117647056,0.9182587727192801,1.0,2/9,6.33%,FBP1;SDHAF3
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),-0.5458077754274897,-1.1156228555989869,0.3333333333333333,1.0,1.0,3/42,5.75%,KCNJ13;SLC39A14;KCNJ11
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.6379303483989383,-1.1155369640435535,0.390625,1.0,1.0,2/11,10.81%,ELOVL2;ACSL1
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.6590721603532717,-1.1152676743889411,0.37142857142857144,1.0,1.0,6/10,29.86%,TDRD9;BTBD18;MEIOC;MYBL1;HSF2BP;SYCP3
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.766492288355247,-1.1142219038933527,0.3898305084745763,1.0,1.0,1/5,12.68%,FANCB
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.541783693625145,-1.114123806913086,0.32098765432098764,1.0,1.0,15/52,20.14%,MAP3K19;TMCO5A;CP;FPR3;ALDH1L1;FMO3;APOL6;HVCN1;ANKUB1;FMO5;RASSF4;L3MBTL4;ST3GAL6;FAM20A;CCPG1
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.6416775423798267,-1.1140781376000333,0.3466666666666667,1.0,1.0,5/11,20.25%,SRF;KCNB2;DAPK3;CHRM2;CHRM3
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),0.6599142276144752,1.1140743210733075,0.32432432432432434,0.9219130411324751,1.0,3/5,22.12%,SULT1C4;ALDH2;ACSS2
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),-0.722234359783366,-1.1139976015987438,0.3709677419354839,1.0,1.0,2/5,27.41%,PER1;CLOCK
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.525794598220741,1.1136070450761046,0.3333333333333333,0.9220552907120837,1.0,3/17,6.66%,SOX4;ERN1;ZNF236
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),0.7069607986448119,1.1135975091084984,0.45714285714285713,0.9208591153930826,1.0,1/5,10.06%,RC3H1
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),-0.6543901854565946,-1.1134047660242534,0.3287671232876712,1.0,1.0,4/13,13.00%,GRIN2A;GRIN2D;CACNA1C;JPH3
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.6160041045132512,-1.1126299247157228,0.3150684931506849,1.0,1.0,7/21,17.57%,HES1;PARP9;CRLF1;PARP14;VEGFA;STAT3;IL6R
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.5551879391885355,1.1124713928092997,0.3448275862068966,0.9222683318183035,1.0,1/12,1.20%,LPCAT1
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.6422018874938068,-1.1124068860679726,0.33766233766233766,1.0,1.0,4/15,13.69%,STX1B;STX19;SNAP25;SYNGR2
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.5836860002642299,-1.1123788593129498,0.31645569620253167,1.0,1.0,4/17,20.13%,TMEM43;EMD;CHMP4B;DCTN1
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.6343489129683823,-1.1119819144340182,0.38461538461538464,1.0,1.0,1/15,0.42%,RFC4
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),0.6884480895193957,1.1114086264448182,0.35714285714285715,0.9239079559778534,1.0,3/6,27.09%,UNC80;SLC7A8;COX11
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.38814667779750056,1.1112901209911261,0.0,0.9229712669641359,1.0,46/174,19.26%,SIRT2;TNFAIP1;PSMD8;GID8;PSMB4;KBTBD6;PCBP2;PSMB6;FBXO45;UBXN1;RNF139;PML;KBTBD7;DNAJB12;KLHL42;PELI1;PSMD10;AREL1;PSME3;SMURF2;UBE2G1;TRIM71;HECTD3;FBXW5;PSMB2;DDI2;PSMD12;SIRT1;RAD23A;KCTD13;ERCC8;FBXO44;KCTD10;CDC34;PSMC1;RBCK1;NSFL1C;PSMD4;PRPF19;TBL1XR1;VCP;PSMA7;RNF126;UBE2A;FBXW7;SPSB3
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.5182716629727291,1.1112707101823032,0.2777777777777778,0.9218035330590442,1.0,5/20,3.99%,SOX4;SOX11;SOX8;GPC1;SOX10
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.6737207299499625,-1.1111840628032075,0.37142857142857144,1.0,1.0,2/10,8.01%,NMT1;GRK4
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.47819105825563574,1.1109059457329382,0.3157894736842105,0.9217815628801317,1.0,5/24,17.03%,CSKMT;KMT5B;VCPKMT;KMT2D;SETD3
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),0.5021700979694215,1.1105474621945508,0.2692307692307692,0.9215267533900459,1.0,4/15,14.97%,ATP5MC1;ATP5F1A;ATP5F1D;ATP5PD
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),-0.7624450062129686,-1.1103159367667426,0.3559322033898305,1.0,1.0,3/5,14.81%,SLC6A15;SLC1A4;SLC6A17
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),-0.6924978615749975,-1.1100445340599514,0.3939393939393939,1.0,1.0,2/7,20.44%,KCNQ1;ATP1B1
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.616935233698521,1.1099371778797549,0.2903225806451613,0.9219006095051426,1.0,5/9,18.50%,MICALL1;WASHC2A;TOLLIP;NRP1;VPS35
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.5571994952441435,1.1098675424859363,0.3333333333333333,0.9208797631528816,1.0,2/18,1.22%,STOX1;CCND1
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),-0.7169952696109476,-1.1097729974137236,0.4090909090909091,1.0,1.0,2/6,11.87%,VEGFA;THOC5
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),0.644592850535281,1.1094607475582052,0.3235294117647059,0.9208359170276614,1.0,1/5,3.17%,BAG3
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.5196328022378296,-1.1093933844350015,0.3253012048192771,1.0,1.0,9/54,9.44%,DNAH7;TMEM213;ALDH1L1;AGBL4;FMO6P;TMEM150C;CFAP221;EFHC1;WDR93
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.5439890399081719,-1.1090106859747164,0.3333333333333333,1.0,1.0,2/31,0.68%,HEY2;SOX9
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.6003630558352501,1.1089697658731752,0.3870967741935484,0.9210933704277205,1.0,2/10,5.53%,KIF25;SYNE2
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.5429834988463045,-1.1086903601529763,0.2808988764044944,1.0,1.0,7/54,15.14%,TRIM52;BRCA1;RNF213;DDB2;DTX3L;RNF157;WWP2
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),-0.6322057766051843,-1.1085035348303411,0.35526315789473684,1.0,1.0,2/11,17.33%,PTPRN;RAB11FIP5
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.7350363359286083,-1.108348082770445,0.30303030303030304,1.0,1.0,2/7,17.09%,SLIRP;NRDE2
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),-0.7269371015877182,-1.1079140809809418,0.4098360655737705,1.0,1.0,3/6,21.08%,CAV3;MLIP;SMAD4
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.6526235474755578,1.1076860609821362,0.4,0.9235945263040212,1.0,1/7,0.91%,BAD
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.6881035086352203,-1.1076521704602063,0.3380281690140845,1.0,1.0,2/9,12.93%,XRCC3;LCMT1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.5406715883149865,1.107581884078317,0.2916666666666667,0.9202265833385145,1.0,2/10,10.80%,UAP1;GNPNAT1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),0.5406715883149865,1.107581884078317,0.2916666666666667,0.9202265833385145,1.0,2/10,10.80%,UAP1;GNPNAT1
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),0.5406715883149865,1.107581884078317,0.2916666666666667,0.9202265833385145,1.0,2/10,10.80%,UAP1;GNPNAT1
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.6852265649645134,-1.107519517826157,0.4225352112676056,1.0,1.0,4/8,22.71%,DVL2;TGFB2;CD59;CD55
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.697339262705088,-1.10746635307193,0.30303030303030304,1.0,1.0,1/5,8.67%,GLUL
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.4855234547444895,1.10724649864344,0.26666666666666666,0.919953747279564,1.0,6/41,6.73%,SYNDIG1;GPC4;SLITRK2;CLSTN2;NLGN2;EPHB3
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),0.5657264532130414,1.1069170212854158,0.4,0.9197505821024261,1.0,7/10,26.24%,GPS1;COPS2;COPS7B;COPS3;COPS4;TOR1A;COPS8
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.5954915158912797,-1.10661689716573,0.38461538461538464,1.0,1.0,8/18,28.45%,PRXL2C;SLC4A4;GAPDHS;PSEN1;PFKFB2;PRKAA1;PRKAA2;PFKFB3
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),-0.7299654929019286,-1.106598585529429,0.3484848484848485,1.0,1.0,1/7,2.58%,SLC2A3
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.6559982454960963,-1.106152462084093,0.38095238095238093,1.0,1.0,1/9,1.87%,NUAK1
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.5341951036905117,1.1059903414293049,0.25925925925925924,0.9210402307039708,1.0,1/11,1.61%,NCSTN
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.37115381343589793,1.1058109956650737,0.0,0.9203776144363758,1.0,10/77,5.75%,UGDH;DSEL;BGN;GSTP1;BCAN;B4GALT3;VCAN;CHST7;CDO1;B4GALT6
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),-0.6793365655105036,-1.1054798016546699,0.3939393939393939,1.0,1.0,2/6,10.23%,MTHFD1;SHMT1
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),0.6727517960637451,1.1054439885483764,0.4375,0.920220486843069,1.0,3/5,31.05%,PGM2;GALK1;GALE
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.6711144039709711,-1.1052109127789052,0.3939393939393939,1.0,1.0,6/9,29.32%,KLF9;RDX;LMO2;MED1;GAS2L1;BRD8
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.6711144039709711,-1.1052109127789052,0.3939393939393939,1.0,1.0,6/9,29.32%,KLF9;RDX;LMO2;MED1;GAS2L1;BRD8
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),-0.6366361296087326,-1.1051486451216384,0.27848101265822783,1.0,1.0,2/10,14.99%,NR4A3;AKT2
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),0.7191009877538735,1.1045998865481381,0.3333333333333333,0.9212987184388535,1.0,3/5,23.66%,SLC15A2;ZDHHC5;BIRC2
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),-0.7151780498517035,-1.1045162853941966,0.34782608695652173,1.0,1.0,1/6,3.33%,NECAB1
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.6840390917945769,-1.1043457377324328,0.37142857142857144,1.0,1.0,3/9,13.55%,IL7;TRIM44;IFIH1
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),0.45205125281920816,1.1042860093839644,0.25,0.9207296882192078,1.0,4/37,6.99%,LTV1;NOL11;NPM1;RPS19
prerank,PanglaoDB_Augmented_2021__B Cells,-0.5728916681060146,-1.104045935552983,0.3373493975903614,1.0,1.0,9/35,16.16%,PTPRC;EBF1;SP140;CD27;HVCN1;BCL11A;TRAF3IP3;IFIT3;BLNK
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),0.3626870622685186,1.1039951795438747,0.0,0.9202305529983805,1.0,41/303,10.83%,NOX4;U2AF1;NUP42;POLR2J;MRPL10;NOVA1;MRPL11;RBM15B;POLR2L;MRPS33;MRPL28;CPSF1;MRPL44;TSPAN14;SNRNP40;RPL8;EEF1A1;MRPS12;RPL15;DDX54;RPS19;RPS15A;NUFIP1;CPSF4;PTMA;NXF1;RPL29;MRPL36;TSPAN17;RPS2;MRPS16;MRPS18A;MRPL13;MRPL52;POLR2K;AGFG1;EIF4A3;EIF4E;TSPAN33;RBM8A;POLDIP3
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.5736001670400429,1.1039093147751138,0.27586206896551724,0.9192315073544514,1.0,1/9,3.55%,MSN
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.6111504106384369,-1.103744630956091,0.39473684210526316,1.0,1.0,3/20,14.89%,OTUD7B;USP50;USP8
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),-0.6712623229058896,-1.1037318858935279,0.3561643835616438,1.0,1.0,1/12,0.68%,SOX9
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.6309377209914823,1.1035530675019487,0.32142857142857145,0.9189175906562959,1.0,2/9,5.11%,HSPA1A;SNCAIP
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),0.5167218977329753,1.1032303465629842,0.2857142857142857,0.9187862627286576,1.0,4/18,5.73%,SOX8;GPC1;SOX10;NGF
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),-0.6258517065482063,-1.103225034741662,0.36486486486486486,1.0,1.0,2/18,9.85%,PON1;APOE
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.5612927728610531,-1.1029555684109866,0.38095238095238093,1.0,1.0,6/35,9.68%,GNA12;ARHGDIG;SHTN1;RHOJ;LIMK1;CDC42EP3
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),-0.5759012783486834,-1.1027517191223182,0.37142857142857144,1.0,1.0,3/15,15.14%,LFNG;ARRB1;WWP2
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.5812631771828045,-1.1027269945577538,0.4177215189873418,1.0,1.0,3/25,12.58%,PON1;APOE;NAXE
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.6608121280163388,-1.102720758048332,0.3783783783783784,1.0,1.0,4/13,16.46%,IL5;PTPRC;TRAF3IP3;GPR171
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.6301116601867228,1.1025954046121553,0.42105263157894735,0.9195176446969892,1.0,2/6,10.40%,MT3;ATF4
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.5562154356078188,-1.1025107910881344,0.35,1.0,1.0,6/31,13.95%,MX1;GRK4;CAV3;DNM1;DNM2;ARRB1
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),-0.676773159157473,-1.10221769604898,0.34782608695652173,1.0,1.0,2/8,9.85%,AGT;APOE
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),0.6151375439867905,1.101669460983472,0.2857142857142857,0.9206097996267747,1.0,1/9,0.51%,PODXL2
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),-0.5592953202024974,-1.1013976614642857,0.36046511627906974,1.0,1.0,3/24,9.13%,SCEL;OVOL2;FLG
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),0.5862645242505886,1.1012587785598826,0.34285714285714286,0.9207031774010296,1.0,1/8,0.51%,UBB
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),-0.6980866434056662,-1.1010716612571063,0.4057971014492754,1.0,1.0,3/6,25.53%,RAB3A;CAST;PCLO
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.6619056040430183,-1.100896957944942,0.35714285714285715,1.0,1.0,2/9,11.17%,TAF7L;TAF1
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.5915263270584733,-1.1007590796189795,0.32,1.0,1.0,6/21,22.24%,APOE;DNM2;STAT5A;OLFM1;STAT5B;SIN3A
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),-0.6376621730728317,-1.1002765340297866,0.3582089552238806,1.0,1.0,4/10,20.90%,CAV3;KCNQ1;SNTA1;RYR2
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.4120366455116965,1.09983011247407,0.2857142857142857,0.923328337587688,1.0,10/61,9.09%,TMED2;TGFA;KLHL12;PEF1;CTSC;PREB;SEC24D;RAB1B;SEC23B;VAPB
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.4546399992742166,1.099687735051364,0.29411764705882354,0.9225374551509381,1.0,2/23,2.10%,SIRT2;YAP1
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.6349550364811853,1.0996013210424975,0.3783783783783784,0.9216358332188103,1.0,3/9,13.87%,SLC30A10;ZKSCAN3;SIRT1
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.5719208828332838,-1.0994118923824487,0.3875,1.0,1.0,6/25,20.12%,GLRA2;GLRA1;VEGFA;RPTOR;CAPN2;NSMF
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),-0.6743437650812174,-1.0993625768519275,0.3835616438356164,1.0,1.0,1/7,4.02%,OTUD7B
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.6589080609546643,1.0992162339684957,0.46875,0.921614828642272,1.0,1/5,2.95%,GSTP1
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),0.6648953517828131,1.0992044573054072,0.4222222222222222,0.9192816265444435,1.0,4/5,27.71%,AGPS;FAR1;DHRS7B;GNPAT
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),0.6648953517828131,1.0992044573054072,0.4222222222222222,0.9192816265444435,1.0,4/5,27.71%,AGPS;FAR1;DHRS7B;GNPAT
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),-0.5920855707151419,-1.098935720213758,0.3125,1.0,1.0,4/25,14.89%,OTUD7B;USP13;USP50;USP8
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.5676845090182684,-1.0985646439557986,0.4,1.0,1.0,4/13,18.40%,HEY2;PDCD4;OLFM1;TGFB2
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.7456779157476874,1.0983017230448469,0.4642857142857143,0.9207444433212788,1.0,2/5,13.87%,PLA2R1;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.5081107593652356,-1.0982223322028846,0.3218390804597701,1.0,1.0,13/53,19.14%,CD44;CAMK1;MTCP1;DOCK7;VEGFA;PAK1;BDNF;NTRK3;BCAR3;PFN2;PRKD2;HDAC6;RPTOR
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),0.658220280163262,1.0981809547886454,0.4074074074074074,0.9200748524711738,1.0,1/5,8.21%,ARL6IP5
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.4858204612575091,1.098174441008429,0.3157894736842105,0.9189369860109922,1.0,2/18,3.78%,PDGFRA;ESR1
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.6457891463120875,-1.098054512819997,0.4411764705882353,1.0,1.0,2/11,0.55%,TMSB4X;HEY2
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),-0.7454070878139989,-1.0976098692071226,0.4027777777777778,1.0,1.0,4/7,22.71%,A2M;C4BPA;CD59;CD55
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.6158580701421676,-1.0976091579392198,0.36231884057971014,1.0,1.0,7/14,20.09%,EFNA1;P2RY12;ITGB1BP1;CYP1B1;TGFB2;RAC3;ADAM9
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.5901709826810974,1.097499864809011,0.35294117647058826,0.9199029862892947,1.0,4/9,16.79%,RPS19;ENPP3;RC3H1;HAVCR2
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.6158244347075581,-1.0974929015506845,0.3670886075949367,1.0,1.0,4/17,17.04%,TMSB4X;VIL1;TMSB15B;PFN2
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.4681878366534833,-1.097418103014659,0.2653061224489796,1.0,1.0,50/221,22.29%,CD44;ENPP2;SOX9;IL5;CARD14;CAMK1;FGF1;SPDYA;EFNA1;PTPRC;AGT;FGF9;MTCP1;BRAT1;CEMIP;EFNA5;DOCK7;DVL2;MMD2;ATG14;VEGFA;PDE8A;PAK1;BDNF;RASGRP1;BMP8A;ARRB1;AKT2;NTRK3;BCAR3;CSNK1D;PFN2;PAK2;IL6R;PRKD2;TOM1L1;TGFB2;HDAC6;PTPRJ;RPTOR;DDR2;RIPK1;FAM20A;SMAD4;TERF2IP;DDRGK1;CACUL1;RB1CC1;TGFB1;TNIK
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),0.6774507822249906,1.0971081619832628,0.41935483870967744,0.9201075758944384,1.0,1/6,0.29%,FERMT1
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),0.6990215242161119,1.09699960980483,0.4444444444444444,0.9192414957037588,1.0,1/5,3.55%,MSN
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.38919845584378854,1.0968985388676107,0.5,0.9182217202979612,1.0,36/224,9.39%,NOX4;SOX4;SOX11;SIRT2;FABP7;HSPA1A;GPNMB;PODN;SMYD2;TNS2;GSTP1;CGRRF1;BTG1;NPM1;LYN;P3H2;BTG3;RNF139;IGFBP7;ADRA1A;NGF;ROR2;PML;CDKN2C;FRZB;GREM1;MN1;PTPN14;ATP8A2;ZNF268;MTSS1;CDC73;TOB1;SPEG;CTNNBIP1;H2AC6
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.6587941195710032,1.09683853364681,0.3,0.917160022651208,1.0,2/5,21.26%,KIFAP3;KIF13A
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),0.5913648534063431,1.0965456702577085,0.4,0.9167006849957782,1.0,6/11,19.83%,PPIF;ZFAND1;VCP;DDX3X;GSTO2;MKNK2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.5914298249245338,-1.0964684284586719,0.328125,1.0,1.0,4/20,9.53%,DSC2;CAV3;CACNA1C;CTNNA3
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.4022474144221964,1.0964652463845233,0.3076923076923077,0.9156879097611375,1.0,4/44,4.05%,ACADS;ACAA2;HSD17B10;ACADVL
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.4986740876884366,1.0964246061100196,0.2916666666666667,0.9146776633036118,1.0,5/21,10.69%,BTC;TGFA;ARC;GREM1;NLGN3
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.4455006415410835,1.0963235595002303,0.3076923076923077,0.9137805767471473,1.0,5/60,1.76%,MYRFL;MMP16;TMEM208;NCSTN;SPCS2
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),-0.6862164632277427,-1.0959402728098662,0.3684210526315789,1.0,1.0,2/8,24.30%,ST3GAL1;ST6GAL1
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),-0.7453687545241923,-1.095575417943756,0.45161290322580644,1.0,1.0,1/5,10.16%,PUS7
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.5972507902823757,-1.0952267253554122,0.3375,1.0,1.0,2/21,2.06%,MYLK;DUOX1
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.5328047412376541,1.09500539306442,0.28,0.9162892107428375,1.0,1/8,0.32%,UGDH
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),0.4141788580146695,1.0949800533051404,0.25,0.9152378398317006,1.0,36/154,17.90%,UTP11;WDR18;NOL11;SBDS;POP5;MPHOSPH6;PIH1D1;POP4;RPL8;RPL15;DDX54;EBNA1BP2;RPS19;RPL29;WDR46;RPS2;IMP3;EXOSC8;MTREX;NAT10;RPF1;NHP2;C1D;DDX49;RPL23A;MRTO4;RPL27;WDR36;RPL7A;UTP14A;WDR3;TFB1M;HELQ;WDR43;RPL18;WDR74
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.3952575957598264,1.0949668827318395,0.4,0.9141008984157607,1.0,17/112,9.51%,NR0B1;POLR2J;POLR2L;YAP1;NR1H2;NR2F6;NR2E1;ESR1;TAF9B;MED23;MAML2;GTF2A2;RBPJ;GTF2H2;NR3C1;ESRRG;POLR2K
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),-0.7254708765858604,-1.0949482958209118,0.3611111111111111,1.0,1.0,1/5,0.49%,TMSB4X
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),-0.6647082973432181,-1.094774521358988,0.36619718309859156,1.0,1.0,4/6,31.55%,APOE;EPHA4;FAM107A;APP
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.6845983106942966,-1.0946702849155545,0.3382352941176471,1.0,1.0,4/10,20.90%,CACNA1C;GJA1;ATP1B1;RYR2
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.6136005115767038,1.0946553525690328,0.4,0.9137154003837367,1.0,1/7,3.52%,SEMA5A
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),-0.6195180860773823,-1.0939808647125904,0.35526315789473684,1.0,1.0,1/13,4.62%,USP13
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),-0.5938943529314648,-1.0939063111024394,0.375,1.0,1.0,3/15,16.41%,CHAC2;PLSCR1;GCLC
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),-0.7326589089985153,-1.0929873263167602,0.32857142857142857,1.0,1.0,3/5,19.44%,ITGA2;UBASH3B;DDR2
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.6433119044224961,-1.0928187977854342,0.43478260869565216,1.0,1.0,4/11,13.79%,CPLX1;KCNMB4;RIMS1;CAMK2A
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.6145517217697936,1.0926587107079233,0.41379310344827586,0.9176850788156627,1.0,2/5,16.27%,PML;ETS1
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.431371125731273,1.092447262327753,0.3,0.9171862801251341,1.0,7/28,13.89%,CRB2;TGFBR2;BAMBI;SMAD3;TGFBR1;GLIPR2;EZH2
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.6601202645262398,-1.0922842130747148,0.34210526315789475,1.0,1.0,2/13,12.13%,NR4A3;RTN2
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.5982588710090515,-1.0922827128336952,0.3974358974358974,1.0,1.0,1/24,0.19%,CD44
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.5391104764418769,-1.0922208152129331,0.36046511627906974,1.0,1.0,12/57,12.80%,SLC38A4;SLC6A6;SLC6A15;SLC3A1;SLC7A6;NCOA1;ACSL1;SLC51A;ATP8B1;SLC13A3;SLC25A45;SLC1A4
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.5988406467422989,-1.0920823406354319,0.425,1.0,1.0,4/21,13.30%,PIGH;PIGL;PIGC;MPPE1
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),-0.6301917739004717,-1.0918313643542015,0.38461538461538464,1.0,1.0,4/16,14.52%,GRIN2A;GRIN2D;PLK2;SLC24A2
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.7378415642159432,-1.0916503205348393,0.35384615384615387,1.0,1.0,2/5,13.61%,MGST1;CYP3A5
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.7378415642159432,-1.0916503205348393,0.35384615384615387,1.0,1.0,2/5,13.61%,MGST1;CYP3A5
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.7378415642159432,-1.0916503205348393,0.35384615384615387,1.0,1.0,2/5,13.61%,MGST1;CYP3A5
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),-0.6760929275545693,-1.0914316187436672,0.4057971014492754,1.0,1.0,1/7,6.59%,P2RY12
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),-0.6590100638782237,-1.0912260049846776,0.4025974025974026,1.0,1.0,3/8,12.86%,HTR2C;APOE;HTR2B
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.5734653942377967,-1.0909312249262548,0.38961038961038963,1.0,1.0,4/21,12.41%,CCDC39;SRF;MMP21;AHI1
prerank,PanglaoDB_Augmented_2021__Platelets,-0.5073922179054492,-1.0907832016321717,0.27058823529411763,1.0,1.0,11/52,15.16%,ALOX12;SLC2A3;SPI1;P2RY12;ITGA2;NRGN;AOAH;VEGFA;PREX1;TBXAS1;MYO1F
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.6811992370487351,-1.0904740824891728,0.3918918918918919,1.0,1.0,2/7,11.40%,APOE;SPP1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.38017763354058604,1.0901353101875217,0.3333333333333333,0.9211877589032157,1.0,12/51,16.14%,ACTB;ACTG1;ARPC5;LYN;GRB2;BRK1;MYO10;ARPC2;ELMO1;CYFIP2;WIPF1;CDC42
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.38017763354058604,1.0901353101875217,0.3333333333333333,0.9211877589032157,1.0,12/51,16.14%,ACTB;ACTG1;ARPC5;LYN;GRB2;BRK1;MYO10;ARPC2;ELMO1;CYFIP2;WIPF1;CDC42
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.6027847461416262,-1.090091788254449,0.358974358974359,1.0,1.0,7/17,29.57%,TRIB1;TPM1;PDCD4;OGN;IGFBP5;MEF2C;NDRG4
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.39295357853480317,1.0900289905668752,0.29411764705882354,0.9202926004397335,1.0,3/37,4.87%,STOX1;PRMT6;MFF
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.5345950614998242,1.0898759858498437,0.38095238095238093,0.9195526360202871,1.0,3/24,3.41%,MOSPD2;CALR;CXCL12
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.5987534321345866,-1.0896410900266984,0.41333333333333333,1.0,1.0,3/13,20.09%,TIMP3;APOE;ADAM9
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.5244524011188197,-1.0892028068425146,0.367816091954023,1.0,1.0,6/54,10.93%,RFC4;IHO1;RFC1;RFC2;DDB2;RPA3
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.6770480233909486,-1.0891843073730914,0.4342105263157895,1.0,1.0,3/9,20.13%,VRK1;NEK6;DCTN1
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.4812173821824641,1.0890912295966586,0.3684210526315789,0.9207572480320081,1.0,4/22,14.17%,SEMA5A;SEMA5B;NLGN3;NRP1
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),0.5027214439448052,1.0890824557189425,0.42105263157894735,0.91964789852527,1.0,7/24,16.06%,BAD;MFF;THEM4;BOK;AIFM2;FIS1;TIMM50
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.41696853967142117,1.089043104583188,0.4117647058823529,0.918519496195791,1.0,1/30,0.49%,SOX11
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.579996087048871,1.0889559395678334,0.35714285714285715,0.9153894910080548,1.0,1/8,3.72%,RAB27B
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.579996087048871,1.0889559395678334,0.35714285714285715,0.9153894910080548,1.0,1/8,3.72%,RAB27B
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.579996087048871,1.0889559395678334,0.35714285714285715,0.9153894910080548,1.0,1/8,3.72%,RAB27B
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),0.50264011527614,1.088612562048351,0.3684210526315789,0.9151602202393451,1.0,4/10,15.86%,CPSF1;CPSF4;CSTF2T;NUDT21
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),0.527115485413219,1.0885488849366718,0.32142857142857145,0.9141307407002589,1.0,4/11,13.73%,PPIF;FBP1;PARP1;FIS1
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.5800804938677561,-1.0882789378511022,0.36486486486486486,1.0,1.0,2/16,3.97%,ENPP2;ABHD12B
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.35603664327946477,1.0874194389713003,0.0,0.9158922351571117,1.0,32/270,6.92%,TAF1A;SOX4;STOX1;SOX11;PIWIL2;PLD1;HSPA1A;ACTB;ACTG1;IL15;POLR2L;DNMT3B;YAP1;SNF8;ERN1;PLA2R1;POLR1F;EIF3D;MSN;NPM1;HNRNPLL;RBM22;EEF2;WNT3;MED23;FXR2;NGF;MYCN;RBPJ;SP1;LIMS1;WBP2
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.5449789071508633,1.0872205714297143,0.38461538461538464,0.9152961642982009,1.0,1/10,1.41%,ACTG1
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),-0.6842680195556243,-1.0872015939571766,0.45,1.0,1.0,1/6,1.45%,AHR
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.6555414834089515,-1.0871190420080672,0.391304347826087,1.0,1.0,2/9,6.51%,VSIR;RFTN1
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),-0.5921564481568001,-1.0871080868503278,0.3972602739726027,1.0,1.0,4/19,20.90%,HES1;PAK1;PRKD2;RYR2
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),-0.6842961414182723,-1.0871027535278142,0.4507042253521127,1.0,1.0,2/7,17.58%,VRK1;NEK6
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.6790227027879915,-1.0868810964298197,0.4166666666666667,1.0,1.0,3/7,15.34%,ENPP2;PDXDC1;CYP1B1
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.3396129309501128,1.0868680183020425,0.0,0.9150896847315956,1.0,56/244,17.52%,U2AF1;LSM4;POLR2J;NOVA1;RBM15B;POLR2L;SMU1;CPSF1;SF3B6;PCBP2;SF3B5;RBM22;SNRNP40;RBM41;HNRNPC;HNRNPA0;PCBP1;CPSF4;LSM7;GEMIN8;DCPS;HSPA8;POLR2K;UBL5;EIF4A3;PUF60;PPWD1;MTREX;RBM8A;CD2BP2;SNRPB2;CSTF2T;GTF2F1;POLR2E;SRSF3;SF3A2;PHF5A;SNRPF;MAGOH;DNAJC8;ZMAT2;SNRPB;SNIP1;HNRNPH1;RAVER2;SNRPA;NUDT21;STRAP;SRSF9;SNRPD2;PRPF19;DDX1;DHX15;SNRPE;PRMT5;PAPOLA
prerank,PanglaoDB_Augmented_2021__Parietal Cells,-0.4955782196222665,-1.0868571690776287,0.34831460674157305,1.0,1.0,12/88,17.31%,ABLIM1;HOOK1;CP;SLC22A23;RAPGEF5;KIAA1671;MYRIP;KCNQ1;CHDH;SPARCL1;SORBS1;ADCY5
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),-0.5610276526641811,-1.0867908996324074,0.37349397590361444,1.0,1.0,5/24,12.42%,SYNJ2;SYT1;SNCB;RAB3A;SYT2
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),0.39505425223184387,1.0866501671906588,0.2,0.9145821838852239,1.0,17/145,10.54%,SIRT2;UBB;SSNA1;TUBG1;PSMD8;KCNH5;PSMB4;ZFP36L1;PSMB6;UBE2D1;HAUS8;PRKAR2B;TUBA1A;PSMD10;PSME3;PPP2R1A;UBC
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.4871695989320063,1.0863829380043726,0.28,0.9141619581902238,1.0,3/29,4.34%,FERMT1;PLEKHG5;STARD13
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.6045631618213841,1.0860007908545941,0.4,0.9140865126939463,1.0,3/8,21.17%,MAD2L2;ING4;TP53
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",0.5224602996537125,1.0857896656636532,0.38095238095238093,0.9133889331639616,1.0,2/15,8.52%,RBM22;DCPS
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),-0.6584882918971141,-1.0857413387042638,0.39344262295081966,1.0,1.0,1/10,1.03%,SYNJ2
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.4653622112527577,1.085717932061737,0.391304347826087,0.9124572726122873,1.0,5/20,13.87%,FBP1;SDHAF3;CLK2;MST1;SIRT1
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.5578161308658605,-1.0856522457359932,0.43373493975903615,1.0,1.0,6/24,15.51%,PTPRC;RANBP3L;GJA1;SH3PXD2B;SULF1;PLS3
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.5641963975373138,-1.0850663531219364,0.3698630136986301,1.0,1.0,9/28,16.16%,PTPRC;SPI1;IL3RA;DOCK8;AOAH;BCL11A;TRAF3IP3;MYO1F;BLNK
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.6188443780141419,-1.0850033714026939,0.379746835443038,1.0,1.0,4/15,20.13%,ANKRD53;BORA;TACC3;DCTN1
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.5931332057266946,-1.0848059615593306,0.3411764705882353,1.0,1.0,5/19,12.30%,NLRC5;PARP9;PARP14;IL7;TRIM44
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),-0.6993011411572789,-1.0846572079634884,0.3880597014925373,1.0,1.0,3/7,14.81%,SLC6A6;SLC1A4;SLC6A17
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),-0.698941815005738,-1.0844543788568046,0.4915254237288136,1.0,1.0,3/5,24.00%,YME1L1;BNIP3L;AFG1L
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.6784979699501072,-1.0840699590246687,0.38235294117647056,1.0,1.0,3/7,17.20%,TPST1;SULT4A1;BPNT1
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.6595330045133965,-1.0837318273568501,0.42857142857142855,1.0,1.0,5/7,30.83%,RIPK1;TGFB1;IL34;PRKCA;CSF1
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),-0.5161867877897415,-1.0837076250236533,0.38636363636363635,1.0,1.0,10/56,13.36%,FGF1;EMP2;AGT;RHOJ;GLUL;APOE;GPI;VEGFA;ITGB1BP1;ADAMTS9
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.6017397149578627,-1.0836975591046085,0.32098765432098764,1.0,1.0,3/18,11.81%,PTPRC;PARP14;SH3BP5
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.5425571857201799,1.0833090058455037,0.3333333333333333,0.9179714925609839,1.0,3/9,6.81%,RAP2A;RAP2C;RAPGEF3
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.5942704615915112,1.0831531224675919,0.3333333333333333,0.9173358985820407,1.0,3/10,2.92%,SOX11;YAP1;ZFP36L1
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.6487263618335828,-1.0829173052438414,0.42105263157894735,1.0,1.0,1/13,0.19%,CD44
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.4655689188848572,1.08291099956092,0.4,0.9167659019997273,1.0,13/37,13.51%,OPN3;COPS9;TMEM161A;NPM1;RUVBL2;SMPD1;NOC2L;PARP1;ZBTB1;SDE2;ATF4;N4BP1;ERCC4
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.6621955239606319,1.0825936267977263,0.42857142857142855,0.9162612662849697,1.0,4/5,30.91%,SH3GL2;TMEM108;AUTS2;LLPH
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),0.6879740030620656,1.082149249735997,0.43333333333333335,0.9163756761984209,1.0,4/9,20.35%,PPIF;SLC25A33;VCP;PINK1
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.5504077477051219,-1.0818454492450242,0.35365853658536583,1.0,1.0,5/20,12.42%,EFNA1;PAH;RAB17;SLC44A3;GPRC5C
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),-0.6016328755085839,-1.0813602863821816,0.4266666666666667,1.0,1.0,8/17,28.45%,PRXL2C;SLC4A4;GAPDHS;PSEN1;PFKFB2;PRKAA1;PRKAA2;PFKFB3
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),-0.6016328755085839,-1.0813602863821816,0.4266666666666667,1.0,1.0,8/17,28.45%,PRXL2C;SLC4A4;GAPDHS;PSEN1;PFKFB2;PRKAA1;PRKAA2;PFKFB3
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.608284396809096,1.0812483816222735,0.38235294117647056,0.9172558584906154,1.0,1/12,0.51%,UBB
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),-0.6764299910712809,-1.0810526626257377,0.36619718309859156,1.0,1.0,4/7,25.62%,DVL2;DVL1;DLG4;DVL3
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.4181848764775765,1.08077572941019,0.5555555555555556,0.9174538176090441,1.0,16/80,13.00%,AMOTL2;EMILIN3;TUBB2B;MAGI1;YAP1;IGDCC4;AADAT;BCAR1;GPR161;PCGF2;MEX3A;MEIS3;LAPTM4B;C1QL1;LYPD6;RAI14
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.5079744199275021,-1.0807060382259213,0.32222222222222224,1.0,1.0,12/74,13.47%,SOX9;GLRA2;AHR;GLRA1;BRCA1;P2RY12;GABRG2;RYR3;TAF1;KCNQ1;HCN3;TSHR
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.67952926834798,-1.0806657620863331,0.3880597014925373,1.0,1.0,3/10,18.43%,VEGFA;PRKD2;CTBP1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.5563456682758182,-1.080628013941004,0.38271604938271603,1.0,1.0,5/33,14.31%,TMSB4X;SRPX2;RHOJ;VEGFA;STAT5A
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),0.5006241604327033,1.0799024551704943,0.3,0.9188188524533802,1.0,3/17,5.47%,EIF4H;EIF3D;EIF5
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.47620582431542285,1.0794932678716216,0.24,0.9184844009972817,1.0,7/19,11.59%,BTC;AFAP1L2;TGFA;CNOT9;NEU3;PLAUR;ARAP1
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),0.5546248486560672,1.0794380760007585,0.44,0.9174518900756161,1.0,2/14,2.15%,LPCAT1;NR1H2
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.6244925597607875,-1.07843434415842,0.44594594594594594,1.0,1.0,1/9,1.14%,CD160
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.4019242553433774,1.0784126975179529,0.3,0.918896655338533,1.0,26/94,18.50%,MLST8;ERN1;LZTS1;CAPNS1;RRAGA;VPS26B;ATP6V0E1;TBC1D25;ATP6V1G1;GPSM1;LAMTOR2;ATP6V1B2;ATP6V0D1;SIRT1;LAMTOR1;EXOC7;GAPDH;UBQLN2;SNX5;SCOC;ATP6V1H;SESN3;CAPN1;ATG101;EPM2A;VPS35
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.4831143366394752,-1.0783546919900977,0.3595505617977528,1.0,1.0,7/85,7.59%,TMSB4X;NLRC5;VSIR;PTPRC;OTUD7B;ZFPM1;RARA
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.5553120276800961,-1.0783485746271266,0.35064935064935066,1.0,1.0,3/20,10.03%,NUBP1;CIAO2A;MMS19
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.6957880470566387,-1.0780629488343803,0.36231884057971014,1.0,1.0,2/9,10.25%,B2M;HLA-F
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),-0.6524640041666021,-1.077939304915544,0.4782608695652174,1.0,1.0,2/8,20.44%,KCNQ1;ATP1B1
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.5911062927935805,1.0777303042776782,0.3684210526315789,0.9194295161240034,1.0,2/7,10.15%,ATP6V0A4;CLCN3
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.5414969280663962,-1.0777008806106938,0.36585365853658536,1.0,1.0,1/29,0.17%,EPN1
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.4696313681587545,1.0773741328677136,0.36363636363636365,0.9192436430139025,1.0,3/19,6.01%,ESR1;LOC400499;RUVBL2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.625315375451198,1.0772230389882336,0.4090909090909091,0.9185102120154325,1.0,2/8,16.27%,RHOA;ETS1
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),0.4014039468445825,1.077074376348314,0.14285714285714285,0.9178416767591199,1.0,31/170,13.12%,UTP11;WDR18;LTV1;ZNF658;NOL11;SBDS;RAN;POP5;NPM1;MPHOSPH6;PIH1D1;POP4;RPL8;RPL15;DDX54;EBNA1BP2;RPS19;NOC2L;RPL29;MRPL36;WDR46;RPS2;LSG1;IMP3;EXOSC8;MTREX;RPF1;C1D;DDX49;RPL23A;MRTO4
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.7370663783723558,-1.0770153258778528,0.3950617283950617,1.0,1.0,1/5,2.19%,PDHX
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.5431090162955777,1.0768827608668075,0.34285714285714286,0.9171536987551359,1.0,1/9,0.64%,CRB2
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.6082297029403578,-1.0765396952704485,0.3972602739726027,1.0,1.0,3/16,10.00%,SOX9;HES1;B2M
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.5471402237796299,1.0764174399893414,0.42857142857142855,0.9172864298497889,1.0,4/12,11.17%,HSPA1A;ACAA2;BOK;MUL1
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.5306020602734697,1.0762548798389984,0.4,0.9166007345915699,1.0,2/10,2.65%,SOX11;LTBP3
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),-0.5698091479231495,-1.0761378424673207,0.39759036144578314,1.0,1.0,2/18,1.45%,SOX9;AHR
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),-0.7011260967263122,-1.076099506430147,0.48333333333333334,1.0,1.0,2/5,10.75%,GLRA1;SPINK13
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),-0.6336431147499797,-1.0757552495998293,0.39436619718309857,1.0,1.0,5/11,20.29%,TPM1;KCNB2;DAPK3;CHRM2;ENO1
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.3977670673109255,1.075693492361421,0.3333333333333333,0.9168595199946734,1.0,16/72,12.25%,CCND1;GPX1;COPS9;TMEM161A;NPM1;RUVBL2;SMPD1;GTF2H2;NOC2L;CAT;PARP1;ZBTB1;SDE2;ATF4;N4BP1;ERCC3
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.5247515851354211,-1.075644528488625,0.3614457831325301,1.0,1.0,9/49,15.74%,PLET1;EMP2;CDKN2A;VCL;EFNA5;TSC1;RASA1;MACF1;DAPK3
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),-0.6900697021514517,-1.0753589348067873,0.4696969696969697,1.0,1.0,3/6,20.87%,ATP10A;DNM2;PLEKHM2
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.32601440984696894,1.075320349032019,0.16666666666666666,0.9166154285582264,1.0,31/177,13.89%,SOX11;CRB2;BAD;G0S2;CFL1;IL15;SOX8;ACHE;TGFBR2;PLA2R1;KMT5B;ADRA1A;FABP5;LEPR;RPS19;BAMBI;SOX6;ESRRG;TRPM4;SMURF2;SMAD3;TGFBR1;ZNF516;MAD2L2;PLCB1;GNAS;PDGFC;MST1;GLIPR2;SIRT1;EZH2
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.4588857386030519,1.0746900948815894,0.2608695652173913,0.9172289400832726,1.0,2/19,2.47%,UGDH;GPC1
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.6361010565568834,-1.0746723352823415,0.3561643835616438,1.0,1.0,4/14,11.96%,F8;A2M;APOE;CPB2
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),0.6310861337961091,1.0746287689904725,0.45454545454545453,0.9162751183858605,1.0,4/7,26.58%,NOMO3;LEMD3;SKI;IGSF1
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.7077614591943727,1.0742994600165647,0.39285714285714285,0.9164079460654743,1.0,3/5,22.34%,PFAS;AMPD2;AMPD3
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.6663458451581781,-1.074038969767456,0.4225352112676056,1.0,1.0,1/8,17.68%,ZC3H12B
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),-0.735220141734398,-1.073899359864723,0.421875,1.0,1.0,2/5,21.37%,PLSCR1;PPP5C
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.5973711818587422,1.0737895935752801,0.4230769230769231,0.9167487571255017,1.0,1/6,4.27%,LYN
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),-0.6806849049547312,-1.0731838324664675,0.45588235294117646,1.0,1.0,1/7,0.68%,SOX9
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),-0.6881999941183173,-1.073183166588597,0.4264705882352941,1.0,1.0,1/6,7.80%,LFNG
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4394180768516783,1.0729167868375822,0.21428571428571427,0.9178169475665745,1.0,12/60,12.91%,UBB;MALT1;UBE2D1;PRICKLE1;COMMD1;PSMD10;PTTG1IP;RIPK2;MUL1;INAVA;RCHY1;SMAD7
prerank,PanglaoDB_Augmented_2021__Pinealocytes,-0.5285291642001201,-1.072896631526209,0.3522727272727273,1.0,1.0,17/47,21.34%,CDH7;SLC6A6;GABRG3;UNC13C;OPRM1;CATSPERG;MGAT4C;SV2B;SLC24A2;RBFOX3;SRRM4;MCF2L2;SV2C;KCNG4;PDE6B;SLC7A14;HCN1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.6602139789879369,-1.0728473891535475,0.5087719298245614,1.0,1.0,3/10,9.53%,DSC2;CACNA1C;CTNNA3
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.5324015383170105,-1.0727931435467981,0.39080459770114945,1.0,1.0,15/37,24.09%,NAAA;NR4A3;PTPRC;IGSF6;SPI1;AOAH;HLA-C;MYO1F;PDCD1LG2;PDPN;HLA-DMA;HLA-B;ETV6;HLA-A;CAMK2D
prerank,PanglaoDB_Augmented_2021__Interneurons,-0.46039318537693974,-1.0727366132820348,0.3163265306122449,1.0,1.0,41/235,14.90%,GABRA4;NEFM;ZIC4;STMN2;CALB1;ARX;PCSK2;GRM1;SYT1;OLFM3;SNCB;PDE4A;GRIN2D;CPLX1;KCNC1;SST;OPRM1;GABRG2;NRGN;MMD2;CACNA1B;SULT4A1;ACTL6B;SCN8A;PSD2;HPCAL4;CELF4;SRGAP3;SHISA6;GRM3;SNAP25;ADGRL2;LRRTM1;HAP1;RAB15;SYT4;SV2B;CAMK2A;NRIP3;ATP2B3;SHISA9
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),0.6622814974662812,1.0724908496294996,0.375,0.9165625339237629,1.0,1/5,0.51%,UBB
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),0.6622814974662812,1.0724908496294996,0.375,0.9165625339237629,1.0,1/5,0.51%,UBB
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.5788139149339986,-1.072277688893604,0.48717948717948717,1.0,1.0,3/20,9.60%,B3GNT5;GCNT1;ALG6
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),-0.7088550662440949,-1.0722506169891126,0.5079365079365079,1.0,1.0,2/5,16.87%,FOXO1;MLIP
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),-0.7206187461171183,-1.072238400302138,0.39622641509433965,1.0,1.0,3/5,19.52%,VEGFA;NTRK3;ANGPT2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.42429692600799784,1.0722101664148365,0.2857142857142857,0.9161344810055843,1.0,4/37,5.97%,SOX4;PCBP4;CNOT9;PML
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.6286458366194114,1.0720598554744973,0.3888888888888889,0.9155210551118066,1.0,1/5,3.23%,CNBP
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.5991926713468911,-1.0717921796237262,0.4027777777777778,1.0,1.0,6/16,10.25%,AHR;PTPRC;IGSF6;SPI1;AOAH;HLA-F
prerank,MSigDB_Hallmark_2020__Myogenesis,-0.4824749817663785,-1.0717183257981673,0.36666666666666664,1.0,1.0,23/112,18.66%,ABLIM1;FABP3;SGCA;MYLK;GADD45B;TPD52L1;LAMA2;CKMT2;PTP4A3;CAV3;IFRD1;ACSL1;CAMK2B;MEF2D;SYNGR2;PPFIA4;AKT2;SORBS1;CRYAB;MYOM2;KCNH1;MYL6B;BHLHE40
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.614567580757329,-1.071668387062111,0.4383561643835616,1.0,1.0,4/11,16.46%,PTPRC;AOAH;TRAF3IP3;GPR171
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.5623617238835639,-1.0713376244039707,0.36363636363636365,1.0,1.0,11/23,27.52%,CARD14;RPS6KB2;TMC4;SLC14A1;SYNGR2;PRKD2;TRIM25;TMEM79;PIEZO1;DTX2;TMCO4
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.45582937953375824,1.0712765612416943,0.36363636363636365,0.9159639358365538,1.0,4/41,7.82%,GPC4;GPC1;MAP2;PARP1
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.6263916708331715,-1.0711873204845672,0.41333333333333333,1.0,1.0,4/13,12.58%,EMP2;RFTN1;CAV3;NAXE
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.6077377589414336,-1.0711342535656374,0.3815789473684211,1.0,1.0,2/15,15.80%,SHTN1;KIF20B
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.6043601654221605,-1.071055139830077,0.38961038961038963,1.0,1.0,1/11,6.59%,P2RY12
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.4022154537052948,1.0709849690202733,0.2857142857142857,0.9157859920585476,1.0,5/51,7.10%,SOX4;PCBP4;CNOT9;PML;ACER2
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.5063728123858691,1.0708728029008103,0.28,0.914948117934083,1.0,4/14,14.97%,ATP5MC1;ATP5F1A;ATP5F1D;ATP5PD
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),-0.681261281606492,-1.0706764932056165,0.4126984126984127,1.0,1.0,1/7,10.81%,ACSL1
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.6507470063962173,-1.070568382379707,0.3918918918918919,1.0,1.0,2/9,14.64%,MSH6;IFIT1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.3136924889415732,1.0696600623418269,0.0,0.9173688526095082,1.0,72/292,19.26%,SIRT2;RNF144A;ADRM1;VPS37B;TNFAIP1;PSMD8;GID8;PSMB4;UBE2D4;RNF6;ELOC;KBTBD6;VPS28;PCBP2;PSMB6;UBE2D1;FBXO45;UBA1;UBXN1;KLHL8;UBE2I;PML;KBTBD7;KLHL42;PPP1R11;PELI1;PSMD10;AREL1;TOLLIP;PSME3;RC3H1;RNF128;SMURF2;UBE2G1;TRIM71;RCHY1;HECTD3;FBXW5;PSMB2;PSMD12;SIRT1;RAD23A;FBXL7;KCTD13;FEM1A;ERCC8;ANAPC11;KCTD10;CDC34;UBQLN2;ANAPC7;WDR81;PSMC1;RBCK1;NSFL1C;RNF166;PSMD4;NDFIP2;TBL1XR1;RLIM;VCP;UBE2D2;FBXL14;PSMA7;RNF126;CDC26;RNF168;RNF146;UBE2A;HERPUD1;FBXW7;SPSB3
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.48473566367654464,1.0696150951907473,0.4230769230769231,0.9164281468608698,1.0,5/18,11.67%,TRIP6;THY1;RCC2;PEAK1;THSD1
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),-0.7104939854192381,-1.0695000804570591,0.48214285714285715,1.0,1.0,1/6,12.03%,KCNQ1
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.6542053473253362,-1.0694012956188754,0.44,1.0,1.0,4/10,14.00%,SPI1;RARA;SRP54;CDK4
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.5805608315239381,-1.0693917554729115,0.4666666666666667,1.0,1.0,6/20,16.46%,PTPRC;SP140;AOAH;HLA-F;TRAF3IP3;GPR171
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.5697070502782363,1.0692881601487159,0.37037037037037035,0.9162710539677242,1.0,4/11,18.27%,LDLR;STARD4;OSBP;LRP6
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),0.5819793165545344,1.069242867120431,0.47368421052631576,0.9153954170371189,1.0,5/19,18.84%,HSD17B10;ACOT8;OSBPL7;OSBP;CYP7B1
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.5236544325303666,-1.0689537673446639,0.3409090909090909,1.0,1.0,8/49,14.34%,LHFPL5;CRYM;CEMIP;LRP2;KCNQ1;NDUFB9;SLC26A5;ADGRV1
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.5188047880606885,-1.0689117904408916,0.3780487804878049,1.0,1.0,12/49,21.13%,TMSB4X;NLRC5;CDKN2A;SPI1;ARRB1;CYP1B1;IRAK2;TRAF3;ARRB2;MAP2K5;NLRP12;DAB2IP
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),-0.6851229665942855,-1.0685444734866338,0.44776119402985076,1.0,1.0,4/8,23.06%,EFNA1;DAB2IP;EPHA4;RGP1
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.6041555336765241,-1.0684986748670013,0.4444444444444444,1.0,1.0,3/14,10.44%,IRF1;PLSCR1;OAS1
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.5386565207187545,-1.0682973665882851,0.3855421686746988,1.0,1.0,9/34,20.90%,TPCN2;AGT;P2RY12;ACKR4;APOE;HTR2B;INPP5A;CHRM3;RYR2
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.7645457139479341,-1.0681034951377844,0.39473684210526316,1.0,1.0,1/5,7.93%,LMBR1L
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),-0.6848582803771246,-1.0680852374020144,0.4603174603174603,1.0,1.0,2/6,19.53%,PDZK1;ANO6
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),-0.49672262751063306,-1.0679236626039672,0.41304347826086957,1.0,1.0,9/62,18.57%,MSL3;JADE2;SPI1;ACTL6B;POLE3;MORF4L2;ING5;MRGBP;PER1
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),-0.7136679277072563,-1.067666233385686,0.4393939393939394,1.0,1.0,2/5,15.30%,AGT;NTRK3
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.5715188655772376,-1.0673588982049549,0.36,1.0,1.0,2/15,12.48%,BCL2L2;MOAP1
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.6075558929095817,-1.0673266557274905,0.33766233766233766,1.0,1.0,3/12,17.75%,FGF1;VEGFA;JAK1
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.5447284417227091,1.067213940996865,0.5,0.919425241858698,1.0,1/11,1.61%,NCSTN
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.5036649334619578,-1.0671980373314105,0.43529411764705883,1.0,1.0,3/35,11.17%,GNA12;CAV3;TAF1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.616399701630883,1.06662628138803,0.42857142857142855,0.9199619869196937,1.0,3/7,12.71%,PLXNA3;PLXNA2;PLXNC1
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),-0.512153103408167,-1.06661502683988,0.42045454545454547,1.0,1.0,7/44,18.57%,MSL3;JADE2;ACTL6B;MORF4L2;ING5;KANSL1;PER1
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),-0.6810215454258678,-1.06561912847083,0.4342105263157895,1.0,1.0,3/5,13.01%,SEPTIN9;CEP135;HAP1
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),-0.6852859219018701,-1.0656157158476216,0.46153846153846156,1.0,1.0,2/5,10.54%,SRF;VEGFA
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.5593488883674904,1.0654458331003767,0.3888888888888889,0.9222373712210458,1.0,2/9,3.52%,GPNMB;SEMA5A
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),0.5161904860296944,1.0654207741901427,0.39285714285714285,0.9212566680263081,1.0,2/13,3.67%,PIWIL2;PIWIL4
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.38172693381276035,1.0653175637169094,0.3076923076923077,0.9205845524605661,1.0,11/74,4.53%,AMOTL2;FIBIN;BGN;HSPG2;LAMA3;YAP1;COL12A1;TNS2;PLA2R1;CXCL12;COBLL1
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),-0.6916101234363163,-1.0652530225353751,0.45454545454545453,1.0,1.0,2/9,9.85%,ALOX12;APOE
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.6072520661168739,-1.065250635596931,0.42857142857142855,1.0,1.0,6/15,29.38%,PPFIA1;MRAP;TGFB1;AP2M1;CLTC;LZTFL1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.4525201487007482,1.0650913584080623,0.2857142857142857,0.9199139819880789,1.0,2/34,1.26%,USP51;PPP4C
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.5793379852744255,1.0647013015982048,0.30303030303030304,0.919713579575902,1.0,2/6,21.26%,KIFAP3;KIF13A
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.6141592915125482,-1.0646793228948577,0.39436619718309857,1.0,1.0,1/11,1.14%,CD160
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.47042001464330213,1.0645871058910723,0.35714285714285715,0.9188216763841607,1.0,8/31,12.59%,TAF1A;POLR2L;POLR1F;GTF2H2;POLR2K;POLR1A;ERCC3;POLR2E
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.5121134212917268,-1.0643048241186766,0.3411764705882353,1.0,1.0,11/60,11.96%,PON1;CYP2E1;AHR;HSD11B1;PAH;CP;SLBP;PLSCR1;GLUL;TMEM97;CPB2
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.3974109426914568,1.064122894348443,0.3333333333333333,0.9190092251195495,1.0,10/36,9.96%,SIRT2;GPC1;SOX10;BCAS1;B4GALT6;ABCD2;PLLP;EPB41L3;MAL;TNFRSF21
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),0.5995572823350952,1.063840969811559,0.36363636363636365,0.9187699353675679,1.0,1/9,2.91%,COPS9
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.5282733331536932,-1.0631927534620467,0.37037037037037035,1.0,1.0,7/46,15.34%,CYP2E1;ALOX12;ELOVL2;ACSBG1;ACSL1;EPHX2;CYP1B1
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.4147862454546357,1.0630640017211832,0.3333333333333333,0.9199914965263309,1.0,6/36,7.84%,PARD6G;EPHA5;LYN;MAP2;PARP1;GOSR1
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.653053478056081,-1.062664837824438,0.4117647058823529,1.0,1.0,3/6,28.90%,DAB2IP;NOP53;STAMBP
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.38838519524371584,1.0626195018925308,0.36363636363636365,0.9201162910208637,1.0,17/102,11.08%,AMOTL2;DHCR7;ADCY6;MAGI1;YAP1;GPC1;NR2F6;EPDR1;AADAT;ITGB5;BCAR1;BOK;PTPRF;GNA11;S100A16;LRIG3;SLC7A2
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),0.4439282570300746,1.0625395633546584,0.36363636363636365,0.9193504280820266,1.0,5/24,6.35%,CXCL12;SEMA5A;PDGFRA;PLEKHG5;BCAR1
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.6810344944426571,-1.062229396648162,0.4925373134328358,1.0,1.0,4/9,23.05%,PTPRC;HLA-F;HLA-B;HLA-A
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),-0.676795628247077,-1.0620770821392684,0.45454545454545453,1.0,1.0,1/7,2.83%,EFNA1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.6397876363746293,-1.0620121644901968,0.4225352112676056,1.0,1.0,2/10,10.00%,CD27;IL7
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.5185783140631495,-1.0616707272450747,0.4125,1.0,1.0,2/46,0.59%,KATNAL2;HOOK1
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.6613880295351147,-1.061353767152583,0.47058823529411764,1.0,1.0,1/8,1.95%,CAMK1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),-0.6827295881708213,-1.0611719054330246,0.423728813559322,1.0,1.0,1/5,8.23%,CAV3
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),0.4186885403874344,1.060879688906806,0.3125,0.9229926780442886,1.0,5/33,12.59%,POLR2J;POLR2L;PTMA;POLR2K;POLR2E
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,-0.48599678493162113,-1.0603509448332513,0.4105263157894737,1.0,1.0,20/118,15.90%,NEFM;STMN2;PCSK2;GRM1;OLFM3;KCNC1;GABRG2;MMD2;CACNA1B;ACTL6B;CELF4;VWC2L;SNAP25;LRTM1;SYT4;SV2B;SLC24A2;ATP2B3;NTRK3;SRRM4
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.5495220853243212,-1.0603490809492417,0.379746835443038,1.0,1.0,7/24,16.34%,SYT1;RIMS1;RAB3A;SYT2;RAB15;SYT4;RAB3D
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.5390367130973264,1.0601537672096937,0.4090909090909091,0.9230124773015231,1.0,2/11,9.06%,ZFP36L1;TOB1
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.5390367130973264,1.0601537672096937,0.4090909090909091,0.9230124773015231,1.0,2/11,9.06%,ZFP36L1;TOB1
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.5553191085070613,-1.0598739841651348,0.3333333333333333,1.0,1.0,3/19,10.03%,NUBP1;CIAO2A;MMS19
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.5301059337484589,-1.059782647374156,0.45348837209302323,1.0,1.0,10/39,27.64%,MX1;GRK4;DNM1;DNM2;ARFGEF2;ARRB2;TGFB1;AP2M1;CLTC;SNX25
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.5163158772184746,1.0597337285628934,0.42857142857142855,0.9232539977257215,1.0,2/7,11.16%,TGFBR2;TGFBR1
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.548912360273913,1.0594982633579313,0.32142857142857145,0.9229315816100446,1.0,2/12,13.55%,NDUFA5;PDIA5
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.47857671689284037,-1.0592954032634714,0.3838383838383838,1.0,1.0,21/118,18.66%,CD44;AHR;SLC2A3;MAFF;GADD45B;SLC29A2;IL3RA;PLSCR1;KLF6;SCN9A;SPP1;ETV4;SYNGR2;PTRH2;IGF2R;IKZF4;GALM;TIAM1;CA2;CTSZ;BHLHE40
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.3808141877169266,1.0590302466877943,0.36363636363636365,0.9230319588949595,1.0,11/65,6.37%,MMP2;PRRX1;FIBIN;BGN;PODN;COL12A1;TNS2;CXCL12;PDGFRA;LDB2;THY1
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.570674914606506,1.0587618553051676,0.34782608695652173,0.9226101458599684,1.0,2/9,17.05%,LDLR;CDH13
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.454869466982816,1.0587242851528669,0.35,0.921627806993055,1.0,4/41,3.50%,UBB;TAB3;IKBKB;NFKBIL1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),-0.6297634001923994,-1.0586993213264617,0.4594594594594595,1.0,1.0,2/11,10.97%,PTP4A3;CEP135
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.354479569328545,1.0586490778062276,0.25,0.9208279573176297,1.0,24/82,13.69%,TUBB2B;MAGI1;NKX2-2;YAP1;SOWAHA;ONECUT1;FLRT3;TOX3;EFNA2;BCAR1;PCGF2;PTPRF;CXXC4;PRR36;LRIG3;SLC7A2;CAMSAP3;LINGO1;C1QL1;LYPD6;RPL23A;WWC1;DUSP15;C2CD4C
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.4532680809453954,1.0581557526679286,0.4,0.9211503372633921,1.0,9/31,13.87%,GPNMB;RAP2A;RAP2C;PDGFD;CALM3;CHP1;ERRFI1;PDGFC;CALM1
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),-0.6685624691823406,-1.0580603649134688,0.5303030303030303,1.0,1.0,3/7,24.72%,AGO1;ADAR;AGO4
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.48308376907774875,-1.057997677010143,0.38095238095238093,1.0,1.0,13/69,19.14%,CD44;CAMK1;MTCP1;DOCK7;VEGFA;PAK1;BDNF;NTRK3;BCAR3;PFN2;PRKD2;HDAC6;RPTOR
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.6132599832250062,1.0579581404011085,0.34375,0.9204927222905692,1.0,2/7,6.20%,CTSA;EEF1A1
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),0.5970751658814953,1.057435223737154,0.4,0.9209744548477075,1.0,2/10,5.70%,ODC1;SRM
prerank,PanglaoDB_Augmented_2021__Fibroblasts,0.37689686253255783,1.0571940910463176,0.3333333333333333,0.9206973784746125,1.0,21/119,6.49%,NOX4;MMP2;PRRX1;FBLN5;FIBIN;BGN;FBLN2;PODN;CYBRD1;COL12A1;COL8A1;NR2F6;NT5E;CXCL12;PDGFRA;IGFBP7;NGF;COL4A4;FRZB;THY1;GREM1
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),-0.662637384622617,-1.0570822825508577,0.45901639344262296,1.0,1.0,1/6,9.13%,FLG
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.49471893970038133,1.056763876109081,0.3333333333333333,0.9210582932780117,1.0,2/12,12.82%,NR3C1;ABHD2
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.5056369285112159,-1.0562155236260193,0.4157303370786517,1.0,1.0,14/77,19.97%,RFC4;BRCA1;DONSON;RFC1;RFC2;RPA3;CDC7;POLE3;ORC2;PNKP;ING5;WRN;ATM;HELB
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.6755462375596502,-1.0558677343425227,0.4605263157894737,1.0,1.0,2/8,10.63%,STK17A;BCL2L11
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),0.6502444495536704,1.0558008194783466,0.4594594594594595,0.9225524400260107,1.0,3/6,15.34%,LIN7C;AP4M1;LIN7B
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.6356746479812281,-1.0556142435882312,0.4358974358974359,1.0,1.0,3/11,14.90%,RAB3A;SHISA6;SHISA9
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.47293641309694706,-1.0555627775260223,0.3488372093023256,1.0,1.0,15/72,22.91%,G6PC2;TTN;ITPR1;KCNJ11;CACNA1C;APOE;SNAP25;RSAD2;TGFB2;GOLPH3L;DNM1L;ADAM9;SLC8B1;TGFB1;CACNA1E
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),-0.6890131608568443,-1.0555379363094928,0.5070422535211268,1.0,1.0,1/6,7.24%,GABRG2
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),-0.6890131608568443,-1.0555379363094928,0.5070422535211268,1.0,1.0,1/6,7.24%,GABRG2
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.6370132941163152,-1.0555208473813151,0.4788732394366197,1.0,1.0,1/11,1.23%,LHFPL5
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),0.6484758433243851,1.0553418611194003,0.4878048780487805,0.9228111032740974,1.0,1/5,2.92%,ZFP36L1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.5394953447827042,1.0552246356650716,0.4,0.9221560441444804,1.0,4/10,16.17%,GPC1;SPRY1;CREB3L1;SPRY4
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.5385577736568359,-1.055187821108544,0.4166666666666667,1.0,1.0,8/33,23.31%,SOX9;NR1D1;IRAK2;HDAC4;DAB2IP;IGBP1;ADAMTS7;USP10
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.5275693352398735,1.0551788354053604,0.4782608695652174,0.9214033049819286,1.0,5/13,18.36%,BAG3;CLIP3;CAMSAP3;CDC42;DYNC1I1
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.47830353599056963,1.0551353168570061,0.391304347826087,0.9204541796395257,1.0,3/14,11.61%,ESR1;DDX54;TRIP4
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.6278594576850504,-1.0549835538503982,0.44285714285714284,1.0,1.0,4/9,32.81%,ETV4;SFRP4;MED1;MACROH2A1
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),-0.5508232931723953,-1.054915824500611,0.48148148148148145,1.0,1.0,6/26,22.26%,MTHFD1;DVL2;LRP2;VASP;TGFB2;TGFB1
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),-0.5508232931723953,-1.054915824500611,0.48148148148148145,1.0,1.0,6/26,22.26%,MTHFD1;DVL2;LRP2;VASP;TGFB2;TGFB1
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.5186096083348282,-1.0547681345577409,0.4146341463414634,1.0,1.0,10/33,11.95%,PON1;CYP2E1;HSD11B1;PAH;LRP2;AOAH;APOE;SLC4A4;SLC13A3;PDZK1
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.40555873484253535,1.0546159607615775,0.2727272727272727,0.9205755367120981,1.0,9/64,11.17%,STOX1;MSN;PRMT6;PREB;MFF;SURF4;TBC1D25;CAMSAP3;MUL1
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),-0.5597340892547725,-1.0545038529113624,0.4520547945205479,1.0,1.0,3/20,5.36%,SRF;CDKN2A;SPI1
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),0.5660362468524286,1.054324677607571,0.3181818181818182,0.9200839851542607,1.0,2/13,2.35%,CUBN;RBP1
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.6169969159444059,-1.0540286861289052,0.4266666666666667,1.0,1.0,3/12,13.12%,PIGH;PIGL;PIGC
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.5299072406228176,-1.0536569826348436,0.40476190476190477,1.0,1.0,11/31,24.04%,PTPRC;OAS1;RASGRP1;IFIH1;ARFGEF2;STAT3;C1QTNF4;PTPRJ;RIPK1;PSEN1;TIRAP
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.4001728832145285,1.0536418303421267,0.4166666666666667,0.9189901150091511,1.0,7/54,5.45%,TMED2;TGFA;KLHL12;PEF1;CTSC;PREB;SEC24D
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.4001728832145285,1.0536418303421267,0.4166666666666667,0.9189901150091511,1.0,7/54,5.45%,TMED2;TGFA;KLHL12;PEF1;CTSC;PREB;SEC24D
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.4001728832145285,1.0536418303421267,0.4166666666666667,0.9189901150091511,1.0,7/54,5.45%,TMED2;TGFA;KLHL12;PEF1;CTSC;PREB;SEC24D
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.6111944292211267,-1.0534341266817895,0.4266666666666667,1.0,1.0,2/10,5.39%,CAMK1;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.5947364005996251,-1.0532380345245904,0.42857142857142855,1.0,1.0,2/14,10.54%,LRP2;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.5343578543122652,-1.0530935838433109,0.4166666666666667,1.0,1.0,11/30,24.04%,PTPRC;OAS1;RASGRP1;IFIH1;ARFGEF2;STAT3;C1QTNF4;PTPRJ;RIPK1;PSEN1;TIRAP
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),0.5885867588065409,1.0530901445953087,0.4642857142857143,0.9183304164911942,1.0,3/8,12.13%,SPTLC1;ACER2;ACER3
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),0.5885867588065409,1.0530901445953087,0.4642857142857143,0.9183304164911942,1.0,3/8,12.13%,SPTLC1;ACER2;ACER3
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.5392901172138087,1.053035788863432,0.4642857142857143,0.9174912465016296,1.0,3/15,8.35%,TMED2;RCC2;GPSM1
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.5231050901244874,-1.0528070511437584,0.4186046511627907,1.0,1.0,11/42,21.28%,TMSB4X;LRRC19;SPI1;PTP4A3;CD27;TRIM44;PDCD4;IFI35;C1QTNF4;NLRP12;TERF2IP
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.5922797146211678,-1.052502813137492,0.45714285714285713,1.0,1.0,3/12,17.20%,TPST1;SULT4A1;BPNT1
prerank,PanglaoDB_Augmented_2021__Alpha Cells,-0.48066021036355006,-1.0523983872417977,0.3953488372093023,1.0,1.0,13/82,14.68%,DEPP1;STMN2;FAM13C;ARX;PCSK2;RGS4;AGT;SST;ACTL6B;CAMK2N1;SNAP25;SYT4;KCNB2
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),-0.6428980907089962,-1.051876334408281,0.4520547945205479,1.0,1.0,1/8,3.80%,SLC39A14
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.4021135368681967,1.0518062487603608,0.14285714285714285,0.9196149909005785,1.0,8/41,9.76%,IDH1;DHFR;AADAT;SDHAF3;ALDH1L2;ACLY;ACOT8;MTHFD2L
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.45456912404880184,1.051729074673172,0.2916666666666667,0.9187958435546307,1.0,6/22,11.60%,GPX1;CHRNA7;MAP2;HSPA8;CAMSAP3;MAP1S
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),0.5976599795469771,1.051487213236547,0.4482758620689655,0.918369831032978,1.0,2/9,12.44%,NT5E;NT5C1A
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),-0.688538465701669,-1.0511046859895483,0.5,1.0,1.0,2/6,22.40%,APOBEC2;ADAR
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),-0.6608273749027577,-1.0510354599807108,0.4864864864864865,1.0,1.0,1/7,11.34%,ACSS3
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.502996770332733,1.0510005865584402,0.34615384615384615,0.9187656417558466,1.0,3/16,9.56%,STOX1;CALM3;RIPK2
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.6454251311780584,-1.0507560548475685,0.4714285714285714,1.0,1.0,2/8,27.57%,TAMM41;HADHA
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.5971294993706253,-1.050481015831823,0.42857142857142855,1.0,1.0,1/20,1.06%,STMN2
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.40289427744482226,1.050123034954559,0.3888888888888889,0.9202343673342155,1.0,3/25,8.71%,TCF7L1;TLE4;CDC73
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),-0.5619936223361556,-1.0496778494076269,0.4567901234567901,1.0,1.0,4/19,12.42%,SYNJ2;SYT1;SNCB;SYT2
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),0.6880083241613981,1.049623445063667,0.4444444444444444,0.9205687534346791,1.0,1/5,2.95%,GSTP1
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),-0.6900192767844472,-1.0494285495255153,0.48,1.0,1.0,4/6,25.77%,ZFPM1;CDKN2B;UBA5;MED1
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.42804032167757183,1.0493646511032573,0.42857142857142855,0.9201816263568255,1.0,18/51,16.62%,TUBB2B;DLL3;IGDCC4;AADAT;POU3F2;EFNA2;BCAR1;PCGF2;MEX3A;MEIS3;LINGO1;C1QL1;LYPD6;C2CD4C;CSPG5;CBARP;FHOD3;FAM171A2
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),-0.5787247296599575,-1.049324356216469,0.4533333333333333,1.0,1.0,6/18,25.25%,SLC9B1;SLC4A4;CA2;SLC4A8;SLC9A8;SLC4A3
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.5323555840107838,-1.0492145801856314,0.45,1.0,1.0,3/37,6.36%,PARP9;IRF1;PLSCR1
prerank,PanglaoDB_Augmented_2021__Reticulocytes,0.3962036091000357,1.0490428961873068,0.3333333333333333,0.9199315623282989,1.0,12/85,11.36%,RFWD3;TSR1;EIF3D;TBRG4;CEP85;SSRP1;RCC2;NEU3;GANAB;LSG1;NAT10;STIP1
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.5738637569740848,-1.0490138063763206,0.47761194029850745,1.0,1.0,4/18,12.47%,G6PC2;PCSK2;SST;FOXO1
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),-0.6437108775723697,-1.0490119307225696,0.4852941176470588,1.0,1.0,1/9,2.58%,SLC2A3
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),-0.663319663437133,-1.0489932070472507,0.4482758620689655,1.0,1.0,1/9,1.03%,SYNJ2
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.663319663437133,-1.0489932070472507,0.4482758620689655,1.0,1.0,1/9,1.03%,SYNJ2
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),0.5586328711772977,1.0489093303440664,0.37037037037037035,0.9190211594645613,1.0,2/8,14.69%,MCM4;GINS1
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.3939691493906809,1.0488703996816457,0.36363636363636365,0.9182680813296039,1.0,11/57,12.07%,IPO13;PHB2;NUTF2;RAN;LAMP5;PRICKLE1;PPP1R10;TSPAN17;PTTG1IP;LAMP1;FAM53C
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),0.645407350070403,1.0479670136983097,0.47619047619047616,0.9195143708008001,1.0,1/5,20.35%,PINK1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.45894608920093855,1.047881680147213,0.3125,0.9187430243201947,1.0,4/37,2.17%,STOX1;ACTB;CCND1;CNPPD1
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),-0.6516521508224326,-1.0475431761029137,0.4246575342465753,1.0,1.0,1/9,0.68%,SOX9
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),-0.6252822032927293,-1.0473606013005394,0.42105263157894735,1.0,1.0,6/15,28.18%,DVL2;PAK1;DAB2IP;DVL3;MAP3K10;SASH1
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),-0.5993086121795472,-1.0471607901927726,0.4189189189189189,1.0,1.0,3/13,8.31%,MREG;RAB17;RAB11A
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),-0.5993086121795472,-1.0471607901927726,0.4189189189189189,1.0,1.0,3/13,8.31%,MREG;RAB17;RAB11A
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.6354720650788206,-1.046956574108442,0.4647887323943662,1.0,1.0,7/13,20.04%,IGSF6;SPI1;AOAH;MYO1F;CHIT1;PILRA;TYMP
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.3670818715664615,1.046878890989936,0.25,0.9201796082009206,1.0,14/77,6.37%,MMP2;PRRX1;FIBIN;BGN;PODN;RBP1;COL12A1;TNS2;CXCL12;PDGFRA;IGFBP7;LDB2;FRZB;THY1
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),0.622051901412394,1.046842877929256,0.3870967741935484,0.9192158978424168,1.0,1/6,3.13%,PLIN2
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),-0.6578886969018043,-1.0467576715030185,0.4647887323943662,1.0,1.0,2/9,10.46%,P2RY12;PLEKHM1
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.5101034838588189,1.046542606455151,0.36,0.9188143019100126,1.0,2/11,10.83%,NXF1;POLDIP3
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.6079537555927244,-1.0464321138023598,0.4647887323943662,1.0,1.0,5/8,35.24%,RIPK1;IL34;PRKCA;CSF1;PTPN2
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.3500810986240317,1.046173678934595,0.36363636363636365,0.9187222181348038,1.0,13/100,12.30%,VPS37B;SNF8;MTERF3;DYNLL2;VPS28;ATG16L1;EI24;MAP1LC3A;CHMP2A;VTA1;TMEM74;YOD1;MTMR14
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),0.5914274500376433,1.0460846697465052,0.4523809523809524,0.9179944573047558,1.0,1/6,3.55%,MSN
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.6486458929506569,-1.045799529568857,0.47761194029850745,1.0,1.0,1/9,1.93%,ITPR1
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),0.5632748945570456,1.0457344321057902,0.4,0.9176532371608291,1.0,1/11,5.49%,LARP7
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),-0.4420962436423084,-1.0453104676771652,0.3711340206185567,1.0,1.0,65/354,22.66%,NUAK1;CAMK1;STK17A;MAK;CDK7;RPS6KB2;TSSK3;EEF2K;RARA;NEK3;GRK4;LIMK1;DAPK1;MAP3K12;TLK1;CDK19;ALK;TRIB1;CAMK2B;TAF1;PLK2;NEK11;PAK1;CDC7;VRK1;CAMK1D;CAMK2A;CDK4;AKT2;FAM20C;STRADB;CSNK1D;DAPK3;VRK2;MASTL;TYRO3;CIT;PAK2;MAP2K1;BCR;PDK1;NEK6;JAK1;COQ8B;PRKD2;TGFB2;CTBP1;CDC42BPB;PDK2;ATM;DDR2;RIPK1;FAM20A;MKNK1;IGF1R;CSNK1G2;PRKAR1B;DAB2IP;CDKL1;DCLK1;TGFB1;TNIK;EPHA4;PDGFRB;MAPK12
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),-0.602199999433793,-1.044741853984,0.5064935064935064,1.0,1.0,4/11,30.83%,CAMK1D;MPP1;IL34;CSF1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.4865567689192073,1.044497766069992,0.43478260869565216,0.9194854353691457,1.0,2/18,6.01%,SOX4;RUVBL2
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.4018291942538542,1.0444116249655317,0.25,0.9187400049673539,1.0,9/54,11.02%,SIRT2;YAP1;ZFP36L1;FRZB;SYAP1;PTPRQ;TRPM4;LRP3;SMAD3
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.6146620747158695,-1.0444077723379364,0.36619718309859156,1.0,1.0,3/10,9.33%,GLRA2;GLRA1;HVCN1
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.5701007789961209,-1.0443293150519368,0.3888888888888889,1.0,1.0,7/19,18.38%,STAT2;STAT4;STAT6;STAT5A;STAT3;STAT5B;STAT1
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.5792334509170679,1.0437083342323263,0.3,0.9193775549203742,1.0,3/14,7.42%,SOX11;PDGFRA;SLC2A10
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),-0.5087211502618812,-1.0436068225573258,0.4819277108433735,1.0,1.0,8/41,22.26%,SOX9;RUNX2;BMP8A;PDCD4;TGFB2;SMAD4;ADAMTS7;TGFB1
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.47313672173966276,1.0433921137403475,0.32,0.9189213253657316,1.0,2/23,3.57%,FGF12;KCNN2
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.6729112482153876,-1.0432643696779365,0.4927536231884058,1.0,1.0,1/5,12.16%,USP50
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),0.6012547704514554,1.0427304523899505,0.40540540540540543,0.9195955927715997,1.0,4/7,20.84%,MT1E;MT3;MT2A;PRNP
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.5746010935677646,-1.0425755573662365,0.5,1.0,1.0,3/16,13.36%,FBXO6;AOAH;ADAMTS9
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.39058632064194926,1.042509631590849,0.375,0.9191401115157266,1.0,16/117,10.21%,STOX1;SSNA1;TUBG1;CCND1;PSMD8;KCNH5;PSMB4;PSMB6;HAUS8;RCC2;RAD51B;PRKAR2B;TUBA1A;PSMD10;PSME3;PPP2R1A
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),0.6411767881128132,1.0422619945452822,0.4482758620689655,0.9187811261804646,1.0,1/7,3.78%,ESR1
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.49831202081619924,-1.0422392115199024,0.4367816091954023,1.0,1.0,6/47,11.21%,SCEL;MYLK;SRPX2;TMEM14A;ITGA2;SLC16A3
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.5926112610422356,1.0421376057316323,0.375,0.9180794273815693,1.0,2/8,8.43%,SPOCK3;DUSP3
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.3953885821543432,1.0419491135884829,0.3125,0.917627042376134,1.0,7/31,12.86%,SIRT2;NGF;MDFI;JUN;PLAUR;SUMO1;SUMO3
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.6541675422420564,-1.0418586571956792,0.4722222222222222,1.0,1.0,2/7,12.53%,EMP2;LOXL3
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.5812549526647675,-1.0417693615780024,0.44594594594594594,1.0,1.0,6/16,16.41%,AGT;KCNMB4;EDNRA;HTR2B;ITGB1BP1;GCLC
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),-0.6860128709782257,-1.0416947276061614,0.42857142857142855,1.0,1.0,1/5,8.29%,MAN1A1
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),-0.6860128709782257,-1.0416947276061614,0.42857142857142855,1.0,1.0,1/5,8.29%,MAN1A1
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),-0.6860128709782257,-1.0416947276061614,0.42857142857142855,1.0,1.0,1/5,8.29%,MAN1A1
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.6086383433731789,1.0415489764474228,0.5,0.9177087923034586,1.0,1/7,3.55%,MSN
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.5513375053367862,-1.040906611517857,0.5324675324675324,1.0,1.0,4/20,10.93%,RFC4;RFC1;RFC2;RPA3
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.4364192748051483,1.0406370235726605,0.5263157894736842,0.9192930392451168,1.0,7/34,12.69%,BTBD3;CHRNA7;MAP2;ARC;EPHB3;SDC2;TMEM106B
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.431087926690382,1.0406308297545142,0.36363636363636365,0.9183087854557752,1.0,8/44,6.73%,SYNDIG1;SLITRK2;CLSTN2;NLGN2;S100A10;THY1;LIMS1;EPHB3
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),-0.6008276781619429,-1.0401639593022367,0.4931506849315068,1.0,1.0,5/13,35.42%,GPAM;PNPLA2;DGAT2L6;MOGAT1;PLA2G15
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.595973525311637,-1.040135418647687,0.4868421052631579,1.0,1.0,5/15,25.87%,PPFIA1;MRAP;TGFB1;AP2M1;CLTC
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.4603484498270965,-1.0399078102731074,0.42391304347826086,1.0,1.0,23/123,16.43%,ABLIM1;CD44;HES1;MREG;OVOL2;TPD52L1;RAB17;ELOVL2;FOS;ITPK1;RARA;SEC14L2;FKBP5;SH3BP5;GJA1;PDZK1;SLC1A4;RASGRP1;AKAP1;THSD4;TIAM1;ADCY1;OLFM1
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),-0.7066353661770621,-1.0398313488293922,0.5454545454545454,1.0,1.0,2/5,21.13%,BCL2L11;DAB2IP
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.5576038861422453,-1.0398075760761774,0.45569620253164556,1.0,1.0,6/24,16.46%,PTPRC;ARHGAP15;CD27;TCF7;TRAF3IP3;GPR171
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.5107554629750545,-1.0397534426591113,0.4523809523809524,1.0,1.0,9/48,14.00%,SPDYA;CDK7;CDKN2A;MAX;PLK2;CRLF3;CDC7;CAMK2A;CDK4
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),0.48213097528988796,1.039447940305497,0.47368421052631576,0.9204584163539897,1.0,2/25,1.50%,BANF1;H1-10
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.5305440387537678,-1.0391558714338658,0.43037974683544306,1.0,1.0,1/32,0.17%,EPN1
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.40573954531999823,1.0384698517813908,0.4583333333333333,0.9219777673410356,1.0,3/28,6.10%,LPCAT1;AGPAT5;IP6K2
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),-0.6555512040668448,-1.038468510257506,0.5,1.0,1.0,1/6,9.85%,APOE
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.5175301133321174,-1.0384280640315828,0.3625,1.0,1.0,12/35,25.54%,STAT2;STAT4;STAT6;TSC1;EIF2B4;STAT5A;STAT3;STAT5B;STAT1;IGFBP5;XBP1;TGFBR3
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.5130685265631639,-1.0383813597854061,0.4268292682926829,1.0,1.0,5/34,12.86%,HEY2;SOX9;RANBP3L;LOXL3;HTR2B
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),0.6312251473260239,1.0381089443473728,0.3548387096774194,0.9218082182088992,1.0,1/7,1.61%,NCSTN
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.6298414419101086,-1.0380444078346667,0.4583333333333333,1.0,1.0,3/8,17.80%,MX1;IFIT1;TRIM56
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.4544963400184948,1.0379883019883256,0.3157894736842105,0.9212417153004018,1.0,3/15,5.53%,FNBP1L;MYO1D;SYNE2
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.5815511563100481,1.0377702171543783,0.47619047619047616,0.9208087163883337,1.0,4/10,12.20%,CFL1;TWF1;MICAL1;CFL2
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),0.5802168900766898,1.0376847327543057,0.43333333333333335,0.919999048334649,1.0,2/5,9.30%,ZFP36L1;CTNNBIP1
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),-0.5161348881132412,-1.037667387452966,0.4235294117647059,1.0,1.0,8/23,25.21%,CALB1;AKAP5;APOE;ADCY1;SHANK3;EPHA4;FAM107A;RELN
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.4991824117528189,-1.0374710345013312,0.43820224719101125,1.0,1.0,14/43,25.77%,SOX9;APOE;B2M;KLF9;SULF1;STAT1;TGFB2;CDKN2B;CNMD;DAB2IP;TGFB1;SCG2;TGFBR3;MED1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.5875903270448846,-1.0373459799409999,0.42857142857142855,1.0,1.0,3/13,12.78%,LIMK1;DTX3L;BAG5
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.6236021821395688,-1.0372155242425372,0.484375,1.0,1.0,5/10,29.57%,TRIB1;TPM1;IGFBP5;MEF2C;NDRG4
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.45321456308398766,1.037152453835416,0.3076923076923077,0.9203792469733981,1.0,5/41,7.18%,STOX1;CCND1;PHB2;RCC2;RAD51B
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.5176357526049831,-1.0369840652001685,0.4431818181818182,1.0,1.0,4/49,4.26%,HEY2;SOX9;SRF;CDKN2A
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),-0.6416304125677393,-1.0368149771257251,0.4603174603174603,1.0,1.0,2/6,9.85%,AGT;APOE
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.5357240343891944,1.0365687814747453,0.4838709677419355,0.9207021200856941,1.0,3/14,10.15%,ATP6V0A4;SLC12A8;CLCN3
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.678460052184342,-1.036495174756502,0.5070422535211268,1.0,1.0,2/7,10.63%,STK17A;BCL2L11
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.4778594756201121,-1.0360382421116434,0.43478260869565216,1.0,1.0,9/62,12.04%,STMN2;ANKRD53;CAV3;LIMK1;CDC42EP3;APOE;VASP;PAK1;VIL1
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),-0.6166376675119662,-1.036022981994109,0.4657534246575342,1.0,1.0,2/9,8.41%,AKAP5;CACNA1C
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),-0.6083925599283434,-1.0359052940116167,0.5068493150684932,1.0,1.0,4/12,14.17%,SREBF1;SEC14L2;LPCAT3;MBTPS1
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.39008064071426507,1.0358015214435283,0.3076923076923077,0.9213818781345456,1.0,8/79,8.14%,BICD2;RND2;RHOBTB1;MLST8;EPHA5;RHOC;ARHGAP18;GPM6B
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.46762126860766184,1.035801260997834,0.47368421052631576,0.920405838009403,1.0,7/19,13.36%,STYXL1;PPP1R35;TIPRL;GPATCH2;PPP1R11;CHP1;PPP1R26
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),-0.5451409628721428,-1.0357700161935086,0.45569620253164556,1.0,1.0,1/31,1.05%,PIP4K2C
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),0.4152294153438068,1.0352727076852277,0.35294117647058826,0.9205586413266751,1.0,11/33,19.12%,MRPS12;MRPL47;MRPS16;MRPS18A;SLC25A33;RARS2;TEFM;MRPS2;MRPS7;TFB2M;GATC
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.4256292763153997,1.0349649582119904,0.45454545454545453,0.9202984064867877,1.0,6/44,2.43%,FERMT1;AMOTL2;HSPG2;LAMA3;YAP1;COL12A1
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.7041151993071831,-1.0347575923942023,0.3968253968253968,1.0,1.0,3/7,23.09%,ENTPD3;ENTPD7;ENTPD1
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.5455963910565872,-1.0344817216866333,0.47435897435897434,1.0,1.0,8/24,7.56%,HTR2C;GPR18;GRM1;AGT;FPR3;P2RY12;OPRM1;GNA14
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.4719246915154809,1.0343954259896286,0.3181818181818182,0.9206946201197951,1.0,5/19,9.89%,ATP6V0A4;ATP6V0E1;ATP6V1G1;ATP6V1B2;ATP6V0D1
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),-0.6353964277949193,-1.0342715218236926,0.44776119402985076,1.0,1.0,2/10,8.41%,AKAP5;CACNA1C
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),-0.5700903701582177,-1.0332475458689,0.43902439024390244,1.0,1.0,2/19,5.75%,KCNJ13;KCNJ11
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.5179239225639448,-1.0322907185267192,0.4146341463414634,1.0,1.0,9/32,25.66%,ANKRD53;EML3;RAB11A;CHMP4B;CENPC;NUF2;ZW10;RMDN1;CHMP6
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5462888286586308,-1.0322182451841522,0.4153846153846154,1.0,1.0,4/20,20.44%,GLRX;PDZK1;SLC6A9;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),0.6485618194964357,1.0317767138950682,0.5,0.9263878144432972,1.0,4/5,34.15%,PSMC3;CCNK;EIF2AK4;VAPA
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.4404550242797219,1.031576230953433,0.38095238095238093,0.9258417527205808,1.0,9/23,16.68%,MCF2;RNF6;MAP2;THY1;MT3;LINGO1;RHOA;DCC;GDI1
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.44285131741906525,1.0311945884384355,0.4,0.9258759450603993,1.0,9/66,6.73%,MMP2;ACTB;ACTG1;NCSTN;ARPC5;EPHA5;LYN;EFNA2;EPHB3
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),0.6082194390658308,1.0307947424283237,0.3958333333333333,0.9259847100747807,1.0,1/7,3.54%,CHRNA7
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),-0.5847719434682076,-1.0306659109290286,0.5,1.0,1.0,2/24,4.65%,GLRA2;GLRA1
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),-0.6462025215812041,-1.030493886494995,0.4696969696969697,1.0,1.0,1/7,1.83%,NR4A3
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.6281704876220002,-1.0304384297942848,0.5,1.0,1.0,4/9,14.17%,SREBF1;SEC14L2;LPCAT3;MBTPS1
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),-0.6563846561829347,-1.030317687269654,0.5142857142857142,1.0,1.0,4/8,21.60%,CACNG8;CACNG2;CACNG7;DLG4
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),-0.6563846561829347,-1.030317687269654,0.5142857142857142,1.0,1.0,4/8,21.60%,CACNG8;CACNG2;CACNG7;DLG4
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),-0.6976459665924479,-1.030199181799008,0.4915254237288136,1.0,1.0,3/5,24.50%,RHCE;RHCG;SLC12A4
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.6508398769306222,-1.0299870727821003,0.47297297297297297,1.0,1.0,2/7,18.21%,SLC39A14;MRAP
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),-0.6227960735493073,-1.0296194950387894,0.44776119402985076,1.0,1.0,1/8,8.23%,CAV3
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),-0.7174811787431735,-1.0294721134125782,0.5076923076923077,1.0,1.0,2/5,24.30%,ST3GAL1;ST6GAL1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.48213261614694036,1.0293954520090278,0.38095238095238093,0.9286284965265453,1.0,1/18,0.85%,SMDT1
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.4156422123309438,1.0291880089585537,0.375,0.9281382415335763,1.0,4/25,9.46%,SIRT2;ANKRD13D;MT3;EDNRB
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.6188117691487591,1.028877800653547,0.48,0.9279838586599314,1.0,2/5,7.02%,LYN;NOC2L
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.4915948516468196,-1.0287171148811467,0.4883720930232558,1.0,1.0,12/60,17.31%,HTR1F;GNA12;AKAP5;CALCB;P2RY12;GNA14;AKAP12;ADGRL2;TSHR;ADCY1;CHRM2;ADCY5
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),-0.5239115946459847,-1.0286059001498675,0.4375,1.0,1.0,1/25,1.28%,LETM2
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.4523200393637662,-1.028140013575823,0.46236559139784944,1.0,1.0,18/124,17.93%,RASGRF1;ARHGAP24;USP6;ZC3H15;RAP1GAP2;DOCK7;DOCK8;TBC1D4;TSC1;RASGRP1;TBC1D10B;NTRK3;BCAR3;TBC1D8;TBC1D2B;TIAM1;BCR;TBC1D13
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.5495377391678092,-1.0277860440467266,0.47368421052631576,1.0,1.0,7/25,21.13%,SHTN1;CAMK2B;CAMK2A;IGSF10;KIF20B;NSMF;DAB2IP
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.35837237731637545,1.0274456146541455,0.3333333333333333,0.9311933191724525,1.0,9/76,6.20%,SIRT2;ODC1;TIPARP;TMEM9;SNF8;RAB26;VPS28;CTSA;EEF1A1
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.40243841271348985,1.0273266666453584,0.375,0.9304791572210803,1.0,8/102,4.36%,USP51;NUP42;HSBP1;HSPA1A;MLST8;BAG3;NPM1;FKBP4
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.6799657975256892,-1.027313372028944,0.47368421052631576,1.0,1.0,1/5,10.54%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.5732640688929331,-1.0272675470060215,0.4533333333333333,1.0,1.0,1/20,1.05%,PIP4K2C
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.5399615587722886,-1.0269357827059244,0.4605263157894737,1.0,1.0,9/24,22.26%,ALOX12;SPI1;AOAH;VEGFA;TBXAS1;MYO1F;PILRA;PDE6B;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),-0.6816076886692372,-1.0268858919894353,0.47619047619047616,1.0,1.0,2/6,16.37%,RARA;RSAD2
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),-0.5603039478634765,-1.026718711280293,0.4520547945205479,1.0,1.0,4/16,18.08%,DNAH7;CCDC39;DNAH17;DNAH5
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.5456420616798089,1.0266991276859094,0.39285714285714285,0.9310089456809565,1.0,2/6,4.27%,PDGFRA;LYN
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),-0.6363124229420003,-1.0266186256160363,0.49230769230769234,1.0,1.0,2/6,12.80%,SFXN3;SLC1A4
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),0.6266023171642923,1.0264194577968226,0.5,0.930555814200414,1.0,2/5,1.78%,HSPA1A;ACAA2
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.5226036908473602,1.025891440364603,0.37037037037037035,0.9308993631093296,1.0,2/9,9.86%,WTIP;LIMD1
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),0.4580961614781436,1.0253713857415616,0.35714285714285715,0.9310573343169017,1.0,8/39,2.99%,CUBN;STARD3;ARV1;TSPO;HSD17B10;DHRS4;FDX1;MSMO1
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),0.556652545051149,1.0253562238966716,0.375,0.9301254260596463,1.0,4/7,23.05%,GREM1;PLCB1;WASL;SLIT2
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.5650520631468483,-1.025346335240584,0.4634146341463415,1.0,1.0,8/21,27.64%,AP2A2;TGFB1;ZNRF3;CLTA;AP2M1;AP2A1;CLTC;SNX25
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),-0.6102218829977235,-1.0252305756252797,0.5324675324675324,1.0,1.0,3/11,10.81%,FABP3;APOE;ACSL1
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),0.5586141935438194,1.0252062776637731,0.5,0.9295090672398302,1.0,7/10,35.49%,INSIG1;SAR1B;GCC2;SAR1A;TMEM30A;CD81;TM9SF4
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.4875617537092124,1.0251807912846513,0.38461538461538464,0.9285807021638744,1.0,5/15,21.50%,PML;HSPA5;SUPT7L;PINK1;ARL2BP
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),-0.6638078702099695,-1.0251627499475031,0.5,1.0,1.0,1/5,9.85%,APOE
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.5543225422149909,1.0248926272060728,0.37037037037037035,0.9283906428058021,1.0,1/10,0.74%,BICD2
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.5647784289285195,-1.024890729762179,0.45454545454545453,1.0,1.0,3/19,13.20%,ZFPM1;BTN3A1;RASGRP1
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.6191425769155156,-1.0248380806244703,0.5,1.0,1.0,2/10,5.39%,LRIF1;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.6279201762388313,-1.0242697592817744,0.5161290322580645,1.0,1.0,2/8,21.10%,ARRB1;NLRP12
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),-0.6769234334593957,-1.023931305237622,0.4666666666666667,1.0,1.0,3/6,23.81%,DENND3;DENND4B;MADD
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),-0.6420696061943387,-1.0238931586799294,0.5483870967741935,1.0,1.0,1/6,6.58%,MYRF
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.5205392863446215,-1.023793336828842,0.5135135135135135,1.0,1.0,4/27,7.93%,CD44;PTPRC;LFNG;LMBR1L
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.5091932508189856,-1.023547347793524,0.4,1.0,1.0,8/51,14.34%,LHFPL5;CRYM;CEMIP;LRP2;KCNQ1;NDUFB9;SLC26A5;ADGRV1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.5519493522116568,-1.0232828357939938,0.36923076923076925,1.0,1.0,4/20,9.53%,DSC2;CAV3;CACNA1C;CTNNA3
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),-0.5855540163574898,-1.0230730482813255,0.47368421052631576,1.0,1.0,1/12,13.99%,PTRH2
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),0.6160240963869476,1.0229352456901322,0.42857142857142855,0.9320629643012279,1.0,4/5,36.00%,SKI;DDIT3;WLS;RIPPLY2
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),-0.6096682279439821,-1.022868855921703,0.463768115942029,1.0,1.0,3/10,24.53%,VEGFA;STAT3;RORB
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),0.5977230430915746,1.022625769935966,0.42424242424242425,0.9319064363672477,1.0,1/7,4.27%,LYN
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.5349930849063359,-1.022609761534125,0.48,1.0,1.0,3/26,5.39%,CAMK1;SPI1;BRCA1
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.676134543191046,-1.022365183104615,0.546875,1.0,1.0,3/6,24.72%,AGO1;ADAR;AGO4
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.6464159258276307,-1.021957156727359,0.47297297297297297,1.0,1.0,1/6,7.59%,RARA
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),0.619419387555441,1.021887397188266,0.3888888888888889,0.9328146700978022,1.0,3/6,31.17%,PUM2;USP15;ANKRD17
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),-0.6576135203307283,-1.0217319841854204,0.5230769230769231,1.0,1.0,2/6,8.41%,AKAP5;CACNA1C
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.4190106177378912,1.0212844597917992,0.35,0.9332993586764492,1.0,5/40,8.71%,SIRT2;GSTP1;NFKBIL1;PDE4B;CDC73
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),-0.7112464756699919,-1.0212668560061542,0.5223880597014925,1.0,1.0,2/5,11.95%,SLC22A4;PDZK1
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.5614321302399046,-1.0209119263723359,0.38666666666666666,1.0,1.0,1/13,1.15%,NAAA
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),0.5744485835677727,1.0205582166727352,0.5135135135135135,0.934460683329491,1.0,1/6,5.02%,CMPK1
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),-0.5642174986926543,-1.0204454392587685,0.5131578947368421,1.0,1.0,1/20,0.49%,TMSB4X
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.5042277227971387,1.02023015670237,0.39473684210526316,0.9342291465238808,1.0,1/8,3.41%,CXCL12
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.46276911516404773,-1.020161201532815,0.4725274725274725,1.0,1.0,14/90,21.10%,TMSB4X;LRRC19;AGT;AOAH;LPCAT3;APOE;NR1D1;PDCD4;TYRO3;IFI35;RIPK1;NINJ1;BRD4;NLRP12
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.5248897790059004,1.0198391812593375,0.38461538461538464,0.9342539614868306,1.0,1/10,2.17%,SPOCK3
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),0.5824628135355313,1.0195194339901783,0.42857142857142855,0.9341509195806899,1.0,1/6,5.02%,CMPK1
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),-0.5750773280850994,-1.019479790744241,0.47297297297297297,1.0,1.0,3/11,17.39%,SOX9;HTR2B;MAP2K1
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.4808723425644948,-1.0192799155071066,0.47058823529411764,1.0,1.0,19/61,20.51%,CD44;EMP2;VCL;THBS3;ITGA2;ADAMTS13;TSC1;ITGB1BP1;ADAMTS9;ECM2;PPFIA1;SORBS1;TIAM1;ITGA8;BCR;MKLN1;ADAM9;ITGBL1;SGCE
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),-0.6638800231518972,-1.0192473174770038,0.42857142857142855,1.0,1.0,2/5,27.70%,PAPSS2;SLC26A2
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),-0.6638800231518972,-1.0192473174770038,0.42857142857142855,1.0,1.0,2/5,27.70%,PAPSS2;SLC26A2
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),-0.693204444998253,-1.0192216917503,0.46153846153846156,1.0,1.0,1/5,11.19%,PARN
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),0.6176837065632054,1.019180023090276,0.46511627906976744,0.9337562621463447,1.0,2/5,22.73%,MKKS;PPARA
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),-0.5879459632702297,-1.0191317246282376,0.4794520547945205,1.0,1.0,2/17,4.65%,GRIN2A;GLRA1
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),-0.6241202565348336,-1.0190683349841132,0.5373134328358209,1.0,1.0,4/10,26.71%,ATP1B1;CAMK2D;PLN;GSN
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.41637893867190806,1.0187953817057653,0.4,0.9337268247385012,1.0,5/52,7.70%,TUBG1;RAN;KIF25;WRAP73;CHMP2A
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.5089720013832242,1.018720640054269,0.3870967741935484,0.9329147705555668,1.0,1/9,4.40%,CHST7
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),0.5319242384366283,1.0185691663811745,0.42857142857142855,0.9325044096087023,1.0,4/9,21.36%,SGPP1;GLTP;CERT1;ABCA12
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),-0.5855254866237323,-1.0185214803584413,0.4647887323943662,1.0,1.0,3/13,25.31%,SAE1;HDAC4;PIAS3
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),-0.6168525270701042,-1.018502358994811,0.5223880597014925,1.0,1.0,4/11,26.71%,ATP1B1;CAMK2D;PLN;GSN
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.3718225200404044,1.018356747329441,0.4,0.9319677369679413,1.0,7/85,5.67%,SOX4;PIWIL2;PLD1;EIF3D;NPM1;EEF2;FXR2
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.3860598846315863,1.0182047242851193,0.4,0.9313777239351968,1.0,9/54,13.99%,POLR2J;POLR2L;KPNA2;PPIA;VAPB;POLR2K;GTF2F1;POLR2E;RAD23A
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),-0.7115960388868774,-1.0181039472421585,0.5147058823529411,1.0,1.0,4/5,25.42%,USF1;PDK2;CDKN2B;XBP1
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),-0.6650172228984546,-1.017947910761968,0.453125,1.0,1.0,1/5,9.69%,LPCAT3
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),0.46167814133754537,1.0178106492395944,0.4117647058823529,0.9314415035579827,1.0,5/25,8.21%,TIPARP;DHFR;ESR1;LOC400499;ARL6IP5
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),0.417865128195534,1.0177048385693501,0.4375,0.9308894494625545,1.0,8/51,10.54%,UBB;PSMD8;PSMB4;PSMB6;MCM4;PSMD10;PSME3;UBC
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.5387792503245266,1.0174969194581711,0.4482758620689655,0.9303927922650184,1.0,2/8,12.54%,PDGFRA;ERRFI1
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.31612993183033866,1.0172305722384924,0.5,0.9300055788675621,1.0,57/334,12.05%,ZNF488;SOX4;SOX11;ZNF676;TCF7L1;POU6F2;SLC2A4RG;ONECUT1;CALR;DSCC1;ZNF117;CNBP;HP1BP3;RNF6;TFEB;ESR1;BTG1;ZNF519;WTIP;SOX21;MED23;ZNF536;POFUT1;PML;SP1;GPBP1L1;NFIL3;ZNF678;ZNF22;RYBP;ZNF114;NR3C1;SPIN2B;ZNF268;SOX6;ESRRG;ZFPL1;GRM5;ACTR8;ZNF195;LIMD1;EIF4E;FOXN2;SP3;PPP2R1A;KAT6B;WWC2;NFYA;ATF4;HES6;TGFBR1;ZNF516;ESRRA;RABL3;TRIP4;ZBTB11;ZNF257
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),-0.466576124064583,-1.0171239910412053,0.43956043956043955,1.0,1.0,13/91,19.95%,RASGRF1;STMN2;FAM161A;DOCK7;RAB11A;APOE;TPM1;MICALL2;PLP1;MNS1;MAP4;STMN3;RAB35
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),-0.5318476642974431,-1.0169996917522497,0.4578313253012048,1.0,1.0,1/24,0.79%,MSL3
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),-0.6039109542921062,-1.0167540509612845,0.4857142857142857,1.0,1.0,1/7,6.96%,DHDDS
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),-0.678216040835251,-1.0167053338868481,0.4861111111111111,1.0,1.0,2/6,17.33%,PTPRN;RAB11FIP5
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.6403942811074219,-1.01653484141449,0.47692307692307695,1.0,1.0,4/8,13.20%,LMBR1L;BTN3A1;DOCK8;RASGRP1
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),-0.6399499559948282,-1.0159833956583706,0.4927536231884058,1.0,1.0,1/7,2.76%,NEDD9
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.47813066738067944,-1.0159231170728764,0.4642857142857143,1.0,1.0,5/44,11.42%,PON1;ENPP2;PCTP;LPCAT3;SLC44A3
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.5355033371107973,-1.0157841477806742,0.4642857142857143,1.0,1.0,1/21,3.25%,LRRC19
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.6197371527500724,1.01578129335268,0.4722222222222222,0.932760490442645,1.0,2/6,11.77%,NPM1;DUSP26
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),-0.6120170737902272,-1.0154941928095649,0.5151515151515151,1.0,1.0,3/10,13.20%,PTPRC;LMBR1L;RASGRP1
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.6525114125894027,1.0154387329840968,0.5,0.9326782582148223,1.0,4/7,15.13%,VEZF1;BTG1;ZEB1;TMEM100
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),-0.6975785749945174,-1.0152458920074168,0.45714285714285713,1.0,1.0,2/5,10.90%,APOE;DTX3L
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.4235080378612802,1.0151874613109169,0.3125,0.9322899038775107,1.0,13/26,18.48%,ST6GAL2;GAL3ST3;NEU1;NEU3;ST6GALNAC3;FUT9;GAL3ST4;FUT8;B3GALT2;MPDU1;NEU4;MANBA;MAN2B1
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.6313715079766906,-1.015174433727272,0.46774193548387094,1.0,1.0,1/8,12.86%,HTR2B
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.5211972938200505,-1.0151011555998168,0.5,1.0,1.0,6/31,21.57%,CD44;VEGFA;CAST;IFI6;MAP2K5;IGBP1
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),-0.6855482149119931,-1.0146576780911258,0.5522388059701493,1.0,1.0,1/5,15.26%,RNF169
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.46768550306259876,-1.014539556404915,0.4942528735632184,1.0,1.0,11/61,24.15%,USP6;PIGH;LCMT1;ST3GAL1;AKT2;WWP2;FBXO22;ST3GAL6;CHRM3;DUSP12;RABGGTB
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),-0.49624270322485314,-1.0145063089684472,0.41333333333333333,1.0,1.0,6/31,21.76%,MYLK;CAV3;CAMK2B;CAMK2A;PLPP4;SLC8B1
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),-0.4465642645760968,-1.013790536361869,0.5111111111111111,1.0,1.0,41/149,23.80%,SLC6A6;TRPC5;SLC39A14;SLC6A15;KCNJ11;KCNC1;KCNN3;KCNH7;CACNA1C;SLC6A11;RHCE;HVCN1;SCN8A;RYR3;SCN9A;SLC4A4;KCNQ1;HCN3;SLC24A2;KCNB2;SLC6A17;SLC6A9;SLC39A11;KCNH1;KCNG4;RHCG;KCNK10;ANO6;ASIC4;ATP1B1;HCN1;HCN2;TRPC4AP;DMAC2L;SLC24A5;SLC4A8;KCNQ5;KCNC4;SLC9A8;SLC41A1;TRPM3
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.6069843340652061,-1.013541498661305,0.4810126582278481,1.0,1.0,1/11,4.67%,PARP14
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.487326860555609,-1.0130950601569462,0.5,1.0,1.0,4/40,5.48%,ARIH2;YWHAH;NMT1;SAE1
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.5164431706293073,1.0129061295588155,0.56,0.9356510700984068,1.0,4/10,19.93%,SLC25A30;SLC25A11;SLC25A14;SLC37A4
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.5164431706293073,1.0129061295588155,0.56,0.9356510700984068,1.0,4/10,19.93%,SLC25A30;SLC25A11;SLC25A14;SLC37A4
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.5454925758863046,1.0128991271190295,0.35714285714285715,0.9347399794394957,1.0,3/8,13.87%,CALM3;SRI;CALM1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.6192875877286212,-1.0126316174509538,0.5606060606060606,1.0,1.0,3/8,32.81%,ETV4;MED1;MACROH2A1
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),-0.673930295646413,-1.0125281543562585,0.5,1.0,1.0,1/5,25.77%,MED1
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.6149714159165438,-1.0124800239634164,0.5352112676056338,1.0,1.0,1/11,1.82%,ALOX12
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.3456192684235339,1.0120980450037438,0.42857142857142855,0.9358045860824137,1.0,22/120,13.97%,THNSL2;DUSP7;PLPPR2;SGPP1;PPM1A;FBP1;PSPH;PPM1H;PTPRF;PTPN14;DUSP3;HDHD2;PPP2R1A;DUSP26;PPP1R12A;PPP1CC;PDP1;PTPRO;PPM1E;DUSP15;PLPPR1;PPP6C
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.4490116488084069,1.012001252320702,0.4782608695652174,0.9351640710886961,1.0,4/20,6.18%,SOX4;SOX11;TGFBR2;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),-0.5957460946721755,-1.011951238565405,0.5522388059701493,1.0,1.0,1/10,8.23%,CAV3
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.39357381502410815,1.0115204185854265,0.375,0.9352948893548343,1.0,18/78,15.59%,CUBN;CD320;PPT1;SCAMP4;CALCRL;SCAMP3;ABCG2;CHMP2A;ABCC11;ARL6IP5;ABCD2;MYH9;GM2A;TOM1;ARRDC4;HSP90B1;ABCA6;ABCA3
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),-0.6526927262587753,-1.0114304219814219,0.5342465753424658,1.0,1.0,1/8,8.23%,AKR1C2
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.4892951818236001,-1.0113024047528922,0.4777777777777778,1.0,1.0,12/47,20.69%,SLC39A14;RGS4;NMT1;GRK4;RNF157;TULP3;CAMK2A;GNG7;RGS5;MRAP;GNG4;PDE6B
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.5095396086238317,-1.0108560971289038,0.4810126582278481,1.0,1.0,4/29,11.68%,G6PC2;SLC39A14;GPI;GAPDHS
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),-0.4929751796555614,-1.0107544760047955,0.46835443037974683,1.0,1.0,15/48,26.96%,GADD45B;TPD52L1;GADD45A;DUSP22;CD27;TNFRSF19;RASGRP1;TRAF3;RIPK1;DAB2IP;ZNF622;TIRAP;WNT7A;MAP3K10;SEMA3A
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.3298343626465106,1.0107459137482766,0.6,0.9361768183512642,1.0,13/90,6.37%,MMP2;PRRX1;FIBIN;BGN;PODN;COL12A1;CHAD;CXCL12;SEMA5A;PDGFRA;IGFBP7;FRZB;THY1
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.5020648224137022,1.0107335278184861,0.38461538461538464,0.9352519139516628,1.0,2/11,9.48%,PLIN2;ABHD5
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),-0.5223529302028111,-1.0102706855978927,0.5555555555555556,1.0,1.0,7/29,22.26%,MTHFD1;DVL2;LRP2;VASP;TGFB2;DVL1;TGFB1
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.4350551281616516,1.0100276583009933,0.5714285714285714,0.935971426822827,1.0,6/18,22.39%,DNAJB12;AUP1;UGGT1;VCP;RNF126;STUB1
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.5414524164251333,-1.010009871795771,0.5063291139240507,1.0,1.0,6/25,12.06%,FABP3;CAV3;LIPI;APOE;GPAM;LIPH
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.487999436276663,-1.0094998048304338,0.4943820224719101,1.0,1.0,9/46,19.16%,RFC4;CCT6A;RFC2;CCT8;PARN;PNKP;PRKD2;PARM1;ATM
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.44501575403348737,1.0094925493659943,0.38095238095238093,0.9364219544990662,1.0,10/43,13.01%,SOX4;HSPA1A;VPS28;UBXN1;BAG2;N4BP1;CHP1;MARCHF7;SMAD7;PRR7
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.560941102350997,-1.009136218563342,0.48,1.0,1.0,1/21,1.05%,PIP4K2C
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.6183723582334162,1.0090826895156249,0.5641025641025641,0.9366221251983845,1.0,2/5,18.30%,LRP6;WNT5A
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.5839586783841494,-1.0088313623824325,0.5,1.0,1.0,3/12,13.08%,EMP2;LOXL3;ITGB1BP1
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),-0.6142971875658649,-1.0087605570893081,0.4852941176470588,1.0,1.0,3/9,12.03%,CACNA1C;GJA1;KCNQ1
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),0.5630816801046854,1.0085500015074775,0.4772727272727273,0.9368040942016689,1.0,3/8,19.10%,RAD17;ZNF830;NAE1
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.37666914098759297,1.008502512475487,0.5,0.9360076712579574,1.0,6/37,9.41%,ACTB;HNRNPC;VPS72;SMARCAD1;ZNHIT1;ACTR8
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.3515434344390215,1.0082884108402292,0.2727272727272727,0.9355326040076761,1.0,8/64,8.49%,MMP2;AMOTL2;TCF7L1;YAP1;P3H2;GPR161;PTPN14;MDFI
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.5730753697513247,-1.0081191538652978,0.48717948717948717,1.0,1.0,4/14,17.95%,NCOA1;SLC51A;ATP8B1;ABCC3
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),-0.6443841273435786,-1.0080315773819288,0.5230769230769231,1.0,1.0,1/6,2.83%,EFNA1
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.48868222788804955,1.0079387243618503,0.5238095238095238,0.9355199023801223,1.0,6/15,18.30%,NLGN2;LRRTM3;NLGN3;NLGN4X;NLGN1;WNT5A
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),-0.5795090977251429,-1.007783737363643,0.5138888888888888,1.0,1.0,1/15,0.68%,SOX9
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.5170347714265905,-1.0076191743323037,0.4878048780487805,1.0,1.0,7/26,23.51%,POLQ;SHLD2;FANCB;RNF169;RIF1;HELB;CGAS
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.550203482327083,1.0075798162463334,0.3870967741935484,0.9355072261304457,1.0,1/6,3.54%,CHRNA7
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.3922473870485892,1.007499615170147,0.2857142857142857,0.9346975654724616,1.0,14/77,9.94%,AMOTL2;ADCY6;MAGI1;YAP1;COL12A1;GPC1;NLGN2;BCAR1;PCGF2;BOK;PTPRF;GNA11;MCAM;MEIS3
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),-0.5656869898675747,-1.0074374159325914,0.48717948717948717,1.0,1.0,2/17,10.23%,MTHFD1;SHMT1
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.6455582038674805,-1.0072568793759344,0.5070422535211268,1.0,1.0,4/8,30.14%,OAS1;TIRAP;SCIMP;RAB11FIP2
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.5261117053157982,-1.0065047281179018,0.5,1.0,1.0,3/19,12.41%,CCDC39;SRF;AHI1
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),-0.44866278023179434,-1.0063434672212497,0.4948453608247423,1.0,1.0,21/133,15.64%,SOX9;CARD14;FAM161A;CAMK1;FGF1;EFNA1;FGF9;BRAT1;EFNA5;DVL2;ATG14;ALG10B;VEGFA;PDE8A;PAK1;PTPA;RASGRP1;ARRB1;AKT2;NTRK3;CSNK1D
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,-0.45484968344999627,-1.0063263761292291,0.48863636363636365,1.0,1.0,23/125,16.11%,NEFM;STMN2;FAM13C;VAMP1;OLFM3;CALCB;KCNC1;MMD2;CACNA1B;SULT4A1;ACTL6B;SYNM;SCN9A;SHISA6;PRUNE2;SNAP25;LRRTM1;SYT4;ATP2B3;CREBRF;AVIL;CRMP1;PLP1
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,-0.4467740136732711,-1.0058962026746243,0.5,1.0,1.0,21/134,16.20%,NEFM;STMN2;IGF2BP3;FAM13C;OLFM3;FSTL5;KCNC1;EFNA5;ARHGAP26;CACNA1B;SULT4A1;ACTL6B;MFSD6;SHISA6;SNAP25;LRRTM1;JPH3;SYT4;ATP2B3;CRMP1;GPR22
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),-0.7024669347565395,-1.005536961258812,0.5522388059701493,1.0,1.0,1/5,1.60%,HES1
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.4987490938841894,-1.0053194523069093,0.5,1.0,1.0,9/38,28.17%,NR4A3;ZFPM1;RBM15;AGO1;KMT2A;SIN3A;AGO4;ZNF16;MEF2C
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.48960825879636405,-1.00508830801238,0.4659090909090909,1.0,1.0,11/56,17.67%,MMP19;SLC39A14;FPR3;ITGA2;CEBPD;TNS1;SPP1;RASSF4;FAM20C;CA2;CTSZ
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",0.41662428289166936,1.005026944436947,0.4166666666666667,0.9400469159448245,1.0,18/57,17.52%,TAF1A;POLR2L;POLR1F;CPSF1;GTF2H2;CPSF4;POLR2K;LSM11;POLR1A;CSTF2T;ERCC3;POLR2E;SNRPF;SNRPB;NUDT21;SNRPE;PRMT5;PAPOLA
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.47681886316616046,-1.0049161914928522,0.5164835164835165,1.0,1.0,10/77,12.27%,PON1;NAAA;ALOX12;AOAH;LIPI;ACSBG1;ACSL1;GPAM;LIPH;ACSM6
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.5443254183922932,-1.0047314154838694,0.48863636363636365,1.0,1.0,3/18,25.74%,PNKP;ATM;MAP2K7
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),-0.6321498698250585,-1.0045088450941653,0.5,1.0,1.0,4/8,30.41%,ST3GAL1;ST6GAL1;NAGK;GNPDA2
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),-0.6900584672528576,-1.0044598552954234,0.5357142857142857,1.0,1.0,1/5,5.75%,KCNJ11
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),-0.5610411403526422,-1.0044435929440456,0.5584415584415584,1.0,1.0,4/22,15.72%,NR4A3;AKT2;CLTCL1;SORBS1
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.49675330083970576,-1.0041314251800986,0.4878048780487805,1.0,1.0,5/28,15.34%,HEY2;HES1;VEGFA;RASA1;CYP1B1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.6444203869736087,-1.0041146581310585,0.5753424657534246,1.0,1.0,5/9,33.79%,UCK1;TK2;TYMP;PUDP;UCKL1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.6444203869736087,-1.0041146581310585,0.5753424657534246,1.0,1.0,5/9,33.79%,UCK1;TK2;TYMP;PUDP;UCKL1
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),-0.6762803066254905,-1.0040033436891322,0.5652173913043478,1.0,1.0,3/5,30.62%,PANK2;C3;GNB3
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.6203235808624249,-1.0038608121169557,0.5373134328358209,1.0,1.0,4/9,18.38%,STAT4;STAT3;JAK1;STAT1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.5612983905829294,-1.003430612975423,0.5277777777777778,1.0,1.0,4/14,24.09%,CAV3;UBASH3B;CACNB1;CAMK2D
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.3621300419701901,1.0031086099521505,0.4,0.9442896955278741,1.0,9/70,11.16%,PTPN20;TIPARP;TGFBR2;PTPN14;ARL6IP5;DCPS;CPNE3;SMAD3;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.6105176789423867,-1.0029929293027537,0.6197183098591549,1.0,1.0,4/13,27.39%,CAV3;CAMK2D;PLN;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.597815263310574,-1.0028092713096541,0.5135135135135135,1.0,1.0,7/14,23.51%,PARP9;DTX3L;TRIM44;TOMM70;STAT1;SIN3A;CGAS
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),-0.5447019767636176,-1.0027101199028137,0.4935064935064935,1.0,1.0,3/21,8.86%,SCEL;OVOL2;SVEP1
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.6396791817225385,-1.0026689378346698,0.547945205479452,1.0,1.0,1/6,9.85%,APOE
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.6211562339164862,-1.0026150014519384,0.47761194029850745,1.0,1.0,1/9,7.68%,INTU
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),0.647566344530069,1.0025333942212553,0.4666666666666667,0.944656829628336,1.0,1/5,0.72%,PLD1
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.5052410106602923,-1.002440124514474,0.5060240963855421,1.0,1.0,12/49,19.20%,KCNJ13;SYT1;YWHAH;KCNJ11;B2M;PDZK1;SYT2;SYT4;WWP2;CA2;PER1;NKAIN2
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.4774253367058376,-1.0023085520421233,0.4666666666666667,1.0,1.0,16/63,23.59%,NLRC5;TTN;EMP2;TSPYL2;ALK;EPHA7;NTRK3;TYRO3;RBL2;DDR2;IGF1R;ROR1;EPHA4;PDGFRB;ECT2;ZNF622
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),-0.4399564477533788,-1.0022551998975984,0.4791666666666667,1.0,1.0,22/210,15.91%,ABLIM1;FHDC1;FAM161A;MYLK;EMP2;MAK;RAB17;VCL;P2RY12;SHTN1;INTU;RAB11A;CFAP221;INPP5E;CCDC57;RPGR;AHI1;RILPL1;CFAP52;CFAP70;AVIL;B9D1
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,0.4164924869260931,1.0021890092569072,0.36363636363636365,0.9444410840038892,1.0,6/33,3.31%,FERMT1;AMOTL2;CCND1;YAP1;CTSV;ATP6V0A4
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),-0.6249598643139458,-1.0021088602740833,0.5074626865671642,1.0,1.0,4/7,29.21%,NBR1;ATM;USP30;MAP1LC3B
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),0.5522467127052273,1.001669872966804,0.2727272727272727,0.9447015982890977,1.0,6/13,18.11%,DNAJC15;GRPEL1;DNAJC19;TIMM21;TIMM50;TIMM23
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),-0.672691019499755,-1.0015504719879917,0.5522388059701493,1.0,1.0,1/5,11.19%,PARN
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.36196314161717197,1.0010504525405242,0.45454545454545453,0.9454369550437544,1.0,11/55,9.89%,SLC30A10;SLC22A17;CYBRD1;ATP7B;SLC39A10;COX19;ABCG2;ATP6V1G1;MT1E;MT3;ATP6V0D1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),0.5439366779085705,1.0009445128546528,0.41379310344827586,0.9449044855537064,1.0,2/9,7.09%,GSTP1;TMEFF2
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.4096304365469895,1.0006239206618486,0.47058823529411764,0.9448650595550461,1.0,3/29,2.25%,STYXL1;YAP1;EVI5L
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.6267013906639523,-1.0004578722776505,0.5588235294117647,1.0,1.0,2/6,28.60%,DDX11;WAPL
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),-0.4767363657553135,-1.0001953930745018,0.4835164835164835,1.0,1.0,18/56,26.01%,CALB1;TRPC5;FPR3;CALCB;CAV3;CACNA1C;ACKR4;EDNRA;ATP2B3;ADCY5;RYR2;DLG4;SLC8B1;CD55;KNG1;TACR1;ATP2B2;PLN
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.24891546762880057,1.0,1.0,0.9435909944335656,1.0,177/1410,11.35%,ZNF761;MYRFL;NR0B1;ZNF488;SOX4;GMEB2;PRRX1;SOX11;SIRT2;ZNF676;TCF7L1;POU6F2;ZXDB;OLIG2;ZNF699;E2F5;ZNF658;ZBTB34;ASCL1;SLC2A4RG;MYT1L;OLIG1;AFAP1L2;RBM15B;CAND2;NACC1;NKX2-2;POLR2L;YAP1;NR1H2;ZNF701;ZNF557;SOX8;SFR1;ZNF239;SNF8;IRF3;DACH1;ONECUT1;CALR;VEZF1;DHFR;MTERF3;ZNF584;KDM3B;PHB2;ETV3;ZNF117;ZNF320;SALL2;ZBTB33;IKBKB;ZNF688;NR2F6;TOX3;CNBP;NR2E1;TGFA;HP1BP3;RNF6;ZNF32;ELOC;POU3F2;ILF2;TFEB;ESR1;MEOX2;ATXN7L3;SOX10;TRIM28;BTG1;NPM1;ZNF384;YWHAQ;ZNF519;WTIP;SUB1;PRMT6;TCEAL7;ZNF34;SOX21;JUND;ZNF12;MED23;ZNF525;ZNF77;ZNF536;PRICKLE1;METTL4;ZNF527;UBE2I;POFUT1;PPM1A;HIC2;MYCN;PML;RUVBL2;DPF1;RBPJ;GTF2H2;ZNF491;SP1;LIMS1;ZNF444;QRICH1;ZNF236;ZNF300;GPBP1L1;NFIL3;WBP2;ZNF678;ZNF22;NDP;RYBP;ZNF426;ZBTB43;ZNF114;ZNF521;RBM23;MED24;NR3C1;ZNF358;SPIN2B;ZNF268;BAMBI;SOX6;ZSCAN12;ESRRG;ZFPL1;ZBTB21;JUN;HSPA8;TCF12;ZNF79;MT3;ACTR8;ZNF195;POLR2K;ZNF510;ZNF446;PHC3;LIMD1;JMJD6;HSF4;MEIS3;FOXN2;SIM2;ZBTB1;SP3;PPP2R1A;KAT6B;SALL3;WWC2;SMURF2;NFYA;ATF4;RGMB;ZNF667;SMAD9;CDK15;NFATC1;LBH;ZNF225;ZNF853;ZBTB10;HES6;ZKSCAN3;SMAD3;CSRNP3;TGFBR1;ZNF516;ESRRA;ZSCAN25;JMY;KCTD1;SAP18;MYNN
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.2560204015433717,1.0,1.0,0.9435909944335656,1.0,61/463,11.02%,NR0B1;SOX11;SIRT2;UBB;HSBP1;HSPA1A;CCND1;ASCL1;MYT1L;DNMT3B;YAP1;NR1H2;ZNF557;SOX8;ZNF239;SMYD2;DACH1;CALR;BAG3;ZNF688;NR2F6;CNBP;NR2E1;ESR1;SOX10;TAF9B;UBE2D1;LARP7;ZNF77;ZNF536;UBE2I;PPM1A;RBPJ;LDB2;FBP1;ZNF491;NFIL3;NOC2L;PCGF2;VPS72;BMI1;PARP1;NR3C1;ZNF268;MDFI;CDC73;ZBTB21;JUN;ZNF79;PSMD10;EDNRB;HSF4;ZBTB1;RNF2;WWC2;SMURF2;ATF4;UBC;ATN1;ZKSCAN3;SMAD3
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.31699563974704603,1.0,1.0,0.9435909944335656,1.0,49/265,14.50%,U2AF1;LSM4;AURKAIP1;POLR2J;NOVA1;RBM15B;POLR2L;SMU1;ERN1;CPSF1;TBRG4;SF3B6;PCBP2;SF3B5;RBM22;SNRNP40;RBM41;HNRNPC;GTF2H2;HNRNPA0;PCBP1;CPSF4;LSM7;HSPA8;RPRD1B;POLR2K;UBL5;EIF4A3;PUF60;PPWD1;MTREX;RBM8A;POLDIP3;CD2BP2;SNRPB2;CSTF2T;ERCC3;GTF2F1;POLR2E;SRSF3;SF3A2;PHF5A;SNRPF;MAGOH;DNAJC8;ZMAT2;SNRPB;SNIP1;HNRNPH1
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),-0.7062883121626808,-0.9996658802005323,0.5714285714285714,1.0,1.0,1/5,6.23%,CKMT2
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3958103981927754,0.9996187412618075,0.47058823529411764,0.9436755313954034,1.0,6/37,7.08%,ADCY6;LGR5;CALCRL;RXFP1;ADRA1A;GPR161
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),-0.5445964727034671,-0.999609455571611,0.4883720930232558,1.0,1.0,5/17,20.29%,PRELP;ST3GAL1;OGN;ST3GAL6;ACAN
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),-0.5220764246049293,-0.999553842396289,0.48717948717948717,1.0,1.0,2/31,4.65%,GLRA2;GLRA1
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),-0.5987682531608078,-0.9995024241090844,0.5131578947368421,1.0,1.0,2/10,5.39%,SPI1;BRCA1
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.31348571219433313,0.9993448422169084,0.5,0.9433402742064468,1.0,65/430,9.39%,NOX4;SOX4;STOX1;SOX11;SIRT2;FABP7;HSPA1A;GPNMB;TSPO;BTC;IL15;NACC1;PODN;YAP1;SMYD2;GID8;CALR;TNS2;TGFBR2;COPS9;ZFP36L1;CNBP;TGFA;HP1BP3;CGRRF1;TBRG4;CHRNA7;POU3F2;PDGFRA;CAPNS1;BTG1;NPM1;LYN;P3H2;JUND;BTG3;RNF139;IGFBP7;ADRA1A;NGF;ROR2;CDC123;PML;CDKN2C;FRZB;CLEC11A;GREM1;S100B;LIMS1;ACER2;RPS15A;PDGFD;BOK;PTPN14;SQLE;ATP8A2;ZNF268;BAMBI;TRPM4;CDC73;JUN;RPRD1B;TOB1;SPEG;H2AC6
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.5589475683390391,-0.9993043896004226,0.5116279069767442,1.0,1.0,6/20,22.26%,SRF;SPI1;FOS;STAT3;TGFB2;TGFB1
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.6532060578246027,-0.9991615372831252,0.5217391304347826,1.0,1.0,3/7,29.62%,WRN;DDX11;DHX36
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),0.5625548405535031,0.998968285407358,0.45454545454545453,0.9433375551629376,1.0,2/5,13.87%,CALM3;CALM1
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),-0.5266081381382427,-0.9989632348747287,0.47560975609756095,1.0,1.0,8/30,18.92%,HOOK1;PLEKHF1;DNM1;USP50;USP8;ARFGEF2;HOOK3;HOOK2
prerank,MSigDB_Hallmark_2020__Protein Secretion,0.36127262329666043,0.9989170896765869,0.3157894736842105,0.9425321369639872,1.0,20/89,17.84%,TMED2;PPT1;CTSC;ARFIP1;SEC24D;SCAMP3;TMX1;SSPN;SNX2;CLCN3;SGMS1;ARCN1;STX7;GNAS;ERGIC3;RAB14;ATP6V1H;VAMP4;YIPF6;OCRL
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.5562563759319797,-0.9988905007955341,0.5119047619047619,1.0,1.0,2/16,5.96%,GSTM5;MGST1
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.5562563759319797,-0.9988905007955341,0.5119047619047619,1.0,1.0,2/16,5.96%,GSTM5;MGST1
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.5800469235905824,0.9987017558920581,0.5454545454545454,0.942251289809058,1.0,4/10,26.58%,SMAD7;LEMD3;SKI;IGSF1
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),-0.5557468233153833,-0.9986796212485988,0.5,1.0,1.0,2/13,15.72%,APOE;SORBS1
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),-0.6307444653963162,-0.9983336058961013,0.5492957746478874,1.0,1.0,1/5,6.19%,STX1B
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),-0.5885851894666987,-0.9981890250619389,0.5147058823529411,1.0,1.0,2/12,3.80%,TRPC5;SLC39A14
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),-0.5388407596523588,-0.9981779241221672,0.5,1.0,1.0,6/21,21.35%,CAMK1;APOE;CAMK2B;FOXO6;SHANK3;PSEN1
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,-0.4546170671834815,-0.9979479983079641,0.4835164835164835,1.0,1.0,25/96,24.28%,NEFM;STMN2;ROBO2;CACNA1B;SULT4A1;ACTL6B;SHISA6;SNAP25;LRRTM1;NEFL;UNC5D;NTRK3;CRMP1;SRRM4;PLP1;KIF1A;CACNG7;DCLK1;PNMA2;TMEM132B;KCNIP1;TRPM3;GDAP1L1;UNC13A;INA
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.5589617547201045,0.9979248264947242,0.36363636363636365,0.9431552715682786,1.0,1/8,2.98%,PLA2R1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),0.6140424691268018,0.9978935300294819,0.42105263157894735,0.9423176034076587,1.0,1/5,6.08%,NUDT16L1
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.43503947602400994,0.9977947774509569,0.4444444444444444,0.9416380117232837,1.0,5/24,16.42%,BICD2;IFT20;RAB6A;ARL5A;RAB33B
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),0.6568182836197172,0.9977804207362835,0.4864864864864865,0.9407687379824992,1.0,3/5,29.19%,FUT9;PPARA;AKT1
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.6785133341663434,-0.9977437498487267,0.53125,1.0,1.0,1/5,2.89%,SLC6A6
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),-0.6482169054099536,-0.9974165246590325,0.5454545454545454,1.0,1.0,1/5,8.23%,CAV3
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.5289337213407863,-0.9974089752175049,0.5428571428571428,1.0,1.0,5/18,19.31%,RAP1GAP2;CAV3;VAV3;RPTOR;RDX
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.4766138162945659,-0.9973290830264654,0.4642857142857143,1.0,1.0,13/34,28.17%,GRM1;SYT1;GRM3;CACNG8;SHANK3;CACNG2;CACNG7;DGKZ;UNC13A;MAPK8IP2;RELN;TPRG1L;MEF2C
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.5969035239864664,0.9969762205625395,0.36666666666666664,0.9419655461025135,1.0,2/5,23.68%,SIRT1;MTHFR
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.5485348056503105,0.9969022613884286,0.5,0.9412189659749445,1.0,5/13,18.02%,ARPC5;JMY;ARPC2;ARPC5L;WHAMM
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.6480540271454154,-0.9967144823434314,0.484375,1.0,1.0,3/6,19.53%,PLSCR1;IL6R;ANO6
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.5170016819773007,-0.9966060303231739,0.4810126582278481,1.0,1.0,11/31,22.83%,PARP9;SHLD2;MMS19;DTX3L;FANCB;PNKP;RIF1;SLF1;ZCWPW1;SPIRE1;DDX11
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.5336067985217887,-0.9965989597808442,0.4714285714285714,1.0,1.0,3/18,13.01%,APOE;RTN2;HAP1
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),-0.6546526697276647,-0.9964610498151393,0.5151515151515151,1.0,1.0,1/7,10.00%,B2M
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.5225771444619298,-0.9960940381535033,0.5256410256410257,1.0,1.0,6/26,11.42%,SCEL;NEDD9;OVOL2;BTN3A1;RUNX2;SLC44A3
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.48607187468697893,-0.9958127015402358,0.5176470588235295,1.0,1.0,9/42,16.34%,SYT1;CPLX1;KCNMB4;RIMS1;RAB3A;HAP1;RAB15;CAMK2A;RAB3D
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.6652037854094437,-0.995730204403384,0.5694444444444444,1.0,1.0,3/6,27.92%,PLK2;ZW10;CHFR
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),-0.5679321681329179,-0.9955161922320327,0.5,1.0,1.0,2/12,10.54%,SRF;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.4467295555887363,0.9953354404531078,0.35714285714285715,0.944230959322493,1.0,2/18,3.13%,SOX11;CLSTN2
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),-0.6275432986156199,-0.9950918949167739,0.5588235294117647,1.0,1.0,1/7,7.80%,LFNG
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),-0.4613740064407359,-0.9948781108428968,0.4523809523809524,1.0,1.0,13/45,20.54%,CDH7;CDH12;CDH9;CNTNAP1;VCL;CLDN12;CDH19;GJA1;TBCD;PAK2;CTNNA1;CDHR3;CDH8
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),-0.6743558667637037,-0.9945868314998985,0.5068493150684932,1.0,1.0,1/7,1.24%,DND1
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.43429531552866435,0.9943621173137472,0.5,0.9457322400021072,1.0,13/36,16.20%,SIRT2;ACTB;CNP;YWHAQ;NDUFS3;CALM3;RAD1;COX6B1;CALM1;HSPA5;RHOA;CDC42;S100A1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.38759080080484165,0.9943347269861149,0.5,0.9448459315883703,1.0,6/49,11.17%,BAD;NGF;ACER2;BOK;SMAD3;MUL1
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),0.5369347337081092,0.9942433626889483,0.5161290322580645,0.944099454510436,1.0,1/8,0.91%,BAD
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.5520929863352076,-0.9941754393988615,0.5454545454545454,1.0,1.0,4/24,13.30%,PIGH;PIGL;PIGC;MPPE1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.6132439882371946,-0.993992751239693,0.5342465753424658,1.0,1.0,5/13,18.58%,PARP9;SHLD2;DTX3L;PNKP;RIF1
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),0.576713908454217,0.9937751171877821,0.4772727272727273,0.9442340048193458,1.0,2/5,21.16%,BMP2;H6PD
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.6793119660704502,-0.99365883666434,0.5373134328358209,1.0,1.0,1/6,1.82%,ALOX12
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),-0.48372920210225967,-0.9933172595630894,0.4358974358974359,1.0,1.0,8/41,16.75%,STMN2;YWHAH;STX1B;APOE;MAG;BAG5;CRMP1;GAK
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.5040367781423096,-0.9929712713676643,0.48,1.0,1.0,5/28,12.47%,HEY2;HES1;PRUNE1;DOCK7;FOXO1
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.48279237144888465,0.9928507152593974,0.4642857142857143,0.945660532910218,1.0,3/15,9.27%,MID1IP1;SLC25A20;ABCD2
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.5263447797619594,-0.9924322109802065,0.5542168674698795,1.0,1.0,5/25,12.86%,NOSTRIN;CAV3;APOE;DNM2;HTR2B
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.515444759352123,-0.9923545330723156,0.5402298850574713,1.0,1.0,6/28,12.03%,YWHAH;GNA14;KCNMB4;SCN8A;SCN9A;KCNQ1
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.44694464232943004,0.99228907880908,0.3684210526315789,0.9462408497654027,1.0,7/32,14.47%,CHRNA4;CHRNA7;C12ORF57;GRM5;DGCR2;MAGT1;CUX2
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.5089496809876063,-0.992121609056661,0.5454545454545454,1.0,1.0,9/25,18.08%,DNAH7;CCDC39;DNAH11;DNHD1;DNAH17;CFAP251;CFAP70;CABYR;DNAH5
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),-0.5665319085471303,-0.9920350749154417,0.5068493150684932,1.0,1.0,3/13,18.08%,MMP21;DNAH11;DNAH5
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.4524325140564009,0.991831949482361,0.5238095238095238,0.9466308808853843,1.0,3/22,3.75%,UBB;GPX1;CTSC
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),-0.6411388472914213,-0.9916620878938046,0.5454545454545454,1.0,1.0,2/7,20.90%,UBASH3B;RYR2
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),-0.6001502172392,-0.9916249369742,0.49230769230769234,1.0,1.0,2/7,14.52%,PLK2;SLC24A2
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.6508579969324242,-0.9913698586645046,0.5733333333333334,1.0,1.0,4/6,18.16%,SEPTIN9;CEP135;HAP1;MAP4
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.49435819197007047,0.9913138876174827,0.42857142857142855,0.9470716963097238,1.0,6/13,16.17%,GPC1;FGFBP3;SPRY1;CREB3L1;DSTYK;SPRY4
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.5342393355991182,-0.9912065733903876,0.5205479452054794,1.0,1.0,3/16,13.01%,APOE;RTN2;HAP1
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),-0.6593501017564259,-0.9910728425799632,0.5522388059701493,1.0,1.0,1/7,10.46%,PLEKHM1
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),-0.5989641311313008,-0.9909365492874392,0.5066666666666667,1.0,1.0,2/9,11.98%,BRCA1;CENATAC
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.3525530681603303,0.9908701858168946,0.42857142857142855,0.9474086798886746,1.0,10/98,2.65%,MMP2;PRRX1;AMOTL2;GPNMB;CCND1;HSPG2;YAP1;COL12A1;GPC1;TNS2
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),0.5523553813528979,0.9907442129403148,0.4074074074074074,0.9468019483060279,1.0,2/7,2.81%,IRF3;PHB2
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.4033231595634432,0.9906967772700521,0.2727272727272727,0.9459736971471766,1.0,8/55,8.86%,SOX11;PLXNA3;SOX8;CUL7;CAPRIN1;NGF;FZD3;LIG4
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.4467260312289783,0.9905061660988451,0.5416666666666666,0.9454722008038644,1.0,3/18,10.75%,NCSTN;HM13;MYH9
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),0.5817780817746931,0.9904924445154368,0.4444444444444444,0.9445784383267386,1.0,1/6,8.21%,ARL6IP5
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),-0.47840035552597626,-0.9904787240878616,0.5058823529411764,1.0,1.0,8/31,16.43%,KIAA0319;SHTN1;LIMK1;APOE;MAG;DNM2;MACF1;OLFM1
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),-0.6946276313715488,-0.9903376012913383,0.5081967213114754,1.0,1.0,1/5,8.39%,TMEM25
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.5357070150336571,-0.9903134330980927,0.527027027027027,1.0,1.0,4/17,13.65%,SYT1;RIMS1;SYT2;SYT4
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),-0.6425933527154254,-0.9902060480224735,0.5072463768115942,1.0,1.0,4/5,35.42%,GPAM;PNPLA2;MOGAT1;PLA2G15
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.5040964578310716,0.9896996239094512,0.4666666666666667,0.9455311017168415,1.0,4/15,9.12%,BAD;MFF;PPIF;PLAUR
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",-0.4984478286420686,-0.9895306698189622,0.49295774647887325,1.0,1.0,3/27,7.10%,PHF19;SPI1;AEBP2
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.39212798674201077,0.9893695798199259,0.3333333333333333,0.9454580821265488,1.0,7/93,6.01%,USP51;SIRT2;HDAC11;ATXN7L3;UBE2N;PRMT6;RUVBL2
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,-0.510482454340913,-0.9882343635222289,0.5517241379310345,1.0,1.0,9/37,21.10%,EFNA1;OVOL2;DSC2;TMC4;SLC44A3;KCNQ1;RAB3D;CHRM3;SLC5A9
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),-0.6041053367775369,-0.9879761416657906,0.5555555555555556,1.0,1.0,1/6,8.23%,CAV3
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),-0.6706807695254187,-0.9877004172369335,0.5151515151515151,1.0,1.0,1/5,1.87%,NUAK1
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),-0.45106722845584296,-0.9876198451922816,0.5,1.0,1.0,24/116,22.54%,MAK;EEF2K;DAPK1;MAP3K12;ALK;CAMK2B;TAF1;PAK1;VRK1;CAMK2A;DAPK3;VRK2;TYRO3;PAK2;NEK6;PRKD2;ATM;DDR2;RIPK1;MKNK1;IGF1R;TNIK;EPHA4;PDGFRB
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.5021574000831831,-0.9875041605569278,0.5454545454545454,1.0,1.0,4/31,5.57%,CD44;MMP19;A2M;SCUBE3
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.5021574000831831,-0.9875041605569278,0.5454545454545454,1.0,1.0,4/31,5.57%,CD44;MMP19;A2M;SCUBE3
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.6622128040209886,-0.9874132129678174,0.5714285714285714,1.0,1.0,1/6,9.78%,ATG14
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.39650827135905164,0.9873343742455022,0.5,0.9500562973250269,1.0,24/110,9.50%,SYNDIG1;EXTL1;BCHE;OLIG1;SLC22A17;TNS2;CD82;CNP;BAG3;TCEAL6;SOX10;BCAS1;TCEAL7;GPR37L1;CLIP3;TMEM178A;THY1;S100B;CMTM5;RBFOX1;RGS11;MT3;EDNRB;SEMA3B
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.6134388485829327,-0.9871278998747935,0.5538461538461539,1.0,1.0,2/9,16.99%,STAT5A;STAT5B
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.5715494766052505,-0.9866630568567359,0.5833333333333334,1.0,1.0,8/18,31.93%,ITGB1BP1;PPFIA1;MRAP;TGFB1;AP2M1;CLTC;LZTFL1;DMTN
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,-0.45518840272976707,-0.986633260969838,0.5465116279069767,1.0,1.0,16/95,16.32%,STMN2;OLFM3;CALY;SNCB;KCNC1;GABRG2;CACNA1B;SULT4A1;ACTL6B;CELF4;SNAP25;LRRTM1;JPH3;SYT4;KCNB2;ADCY1
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),-0.6360859602109323,-0.9865488421580109,0.5,1.0,1.0,1/7,0.55%,HEY2
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.49609327109603935,-0.986472095221037,0.5833333333333334,1.0,1.0,10/48,21.13%,EPN1;CD160;NAXE;SULF1;ADAMTS9;STAT1;TGFB2;CNMD;AGO1;DAB2IP
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),-0.6358495474728254,-0.986305180959554,0.6119402985074627,1.0,1.0,5/10,33.79%,UCK1;TK2;TYMP;PUDP;UCKL1
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.5601000395505328,-0.9862564324060732,0.5540540540540541,1.0,1.0,7/17,23.51%,PARP9;DTX3L;TRIM44;TOMM70;STAT1;SIN3A;CGAS
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),0.5861048382141912,0.9862122245744556,0.48484848484848486,0.9517503437582275,1.0,1/5,1.18%,CUBN
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),-0.6214928549297343,-0.9854995471654845,0.5352112676056338,1.0,1.0,1/6,10.58%,AHCYL1
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),-0.5931230896384745,-0.9845866642717075,0.5394736842105263,1.0,1.0,1/8,4.10%,PYGL
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.43957946141603765,-0.9844247866269698,0.4838709677419355,1.0,1.0,19/108,12.26%,CD44;HES1;NR4A3;SLC2A3;MAFF;EFNA1;DRAM1;IRF1;GADD45B;TNC;GADD45A;IFNGR2;FOS;KLF6;CEBPD;VEGFA;TRIB1;PLK2;KLF9
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.46323813453455287,-0.984378323587101,0.4943820224719101,1.0,1.0,8/68,11.17%,PON1;HES1;PARP9;RARA;APOE;B2M;DTX3L;TAF1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),0.5981521380023186,0.9843443880187495,0.5263157894736842,0.9551936971046536,1.0,2/6,12.41%,GREM1;C5
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.561107689914407,0.9842424726531489,0.475,0.9545507414491463,1.0,3/7,17.55%,RPS19;GAPDH;FAM3A
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.3878030224659494,0.9838500902638635,0.7142857142857143,0.9545713352134011,1.0,13/156,7.24%,U2AF1;PIWIL2;LSM4;AURKAIP1;NOVA1;SMU1;LSM1;MRPL44;SNRNP40;HNRNPC;HNRNPA0;DDX54;NUFIP1
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.4472754931176484,-0.9837259093430257,0.4878048780487805,1.0,1.0,10/78,13.58%,SLC28A2;AHR;IRF1;IFNGR2;KLF6;SLC4A4;OSMR;PVR;RASGRP1;TAPBP
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),-0.49831380906459743,-0.9837047390749493,0.5057471264367817,1.0,1.0,7/38,19.52%,TMSB4X;GADD45A;APOE;VEGFA;STAT5A;PRKD2;ANGPT2
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),0.4610209809189325,0.9836689678302639,0.48,0.9540829006086844,1.0,2/14,5.95%,ESR1;TMBIM6
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),-0.6685421914899209,-0.9836068749900465,0.5555555555555556,1.0,1.0,1/6,7.54%,ROBO2
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.3441794020879459,0.9834752686520798,1.0,0.9537818500672235,1.0,46/270,13.90%,COPZ1;SYNDIG1;ARL4A;EVI5L;UNC119B;TMED2;PPT1;ATP6V0A4;RAB26;NPM1;SCAMP4;ARFIP1;CTSA;TVP23B;MCOLN1;PREB;CALCRL;VPS26B;GOLGA7;TMED5;RAB5B;SCAMP3;ATP6V0E1;TBC1D25;STX6;CHMP2A;CANX;ARL6IP5;ATP6V1G1;RAB1B;ATP6V1B2;ATP6V0D1;RAB6A;MYH9;AP4M1;SNX17;RABL3;TMED3;ARCN1;STX7;RAB28;TOM1;STX2;VLDLR;SNX27;ARF5
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),0.43103797652333803,0.9833494361215225,0.5,0.953193497387194,1.0,4/21,7.98%,H1-10;DACH1;SUB1;H1-4
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),-0.5135048108329414,-0.9833154515581113,0.5432098765432098,1.0,1.0,10/34,24.02%,RAB17;RTN4IP1;KIAA0319;ALK;CAMK1D;BCL11A;NSMF;DAB2IP;TNIK;PACSIN1
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.5387911917224051,-0.9831863766710162,0.5263157894736842,1.0,1.0,1/16,1.06%,STMN2
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.35381233770203524,0.983106465797483,0.3076923076923077,0.9528938686801508,1.0,13/80,8.54%,AMOTL2;CCND1;ADCY6;MAGI1;YAP1;COL12A1;AADAT;BCAR1;PCGF2;ABCG2;PTPRF;GNA11;TSPAN6
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.5116124930559605,-0.9831052096068579,0.4567901234567901,1.0,1.0,6/22,29.88%,PLSCR1;IFI35;SCIMP;POLR3D;SASH1;PRKCA
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),-0.6066836038464357,-0.9830403466344725,0.5428571428571428,1.0,1.0,1/10,12.64%,DNM2
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.5986066714669713,-0.9828110945763168,0.5753424657534246,1.0,1.0,2/11,11.17%,TAF7L;TAF1
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.6678047778058548,-0.982779703449912,0.5362318840579711,1.0,1.0,1/5,10.34%,ALG10B
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.4594265133827829,-0.9825212226787599,0.5,1.0,1.0,16/46,24.56%,SCEL;OVOL2;CDKN2A;BRCA1;ITGA2;TMC4;LIPH;FMO5;KIF20B;EMILIN2;CDKL1;FZD6;ECT2;NRP2;ST6GAL1;ITGA4
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.48020328975610516,-0.9824488255041988,0.5384615384615384,1.0,1.0,11/36,22.71%,KIAA0040;IRF1;HLA-F;VASP;HLA-C;IFIH1;PRKD2;IFI35;TYMP;JUNB;CD55
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.49461974872209197,-0.9824144465492368,0.5679012345679012,1.0,1.0,3/28,8.23%,OTUD7B;SPI1;CAV3
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),-0.5983587951895288,-0.9824039351104552,0.5555555555555556,1.0,1.0,1/9,1.74%,TTN
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,-0.4383351155452051,-0.9822497502674978,0.5319148936170213,1.0,1.0,39/135,23.31%,STMN2;CALB1;PDE5A;OLFM3;CALY;SNCB;CPLX1;KCNC1;GABRG2;MMD2;CACNA1B;SULT4A1;ACTL6B;PSD2;CELF4;SHISA6;GRM3;SYT2;SNAP25;LRRTM1;SYT4;CAMK2A;SLC24A2;NRIP3;ATP2B3;SRRM4;PLP1;HDAC6;GNG4;KIF1A;GAD2;CACNG2;HCN1;DLG4;CELF3;PDE9A;GRIN1;SLC22A15;TCEAL2
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.5152051627386218,-0.9821756107227869,0.5294117647058824,1.0,1.0,4/28,14.77%,CD44;EFNA5;VIL1;MACF1
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),0.3777446897036946,0.9821248286544423,0.4,0.9543018789842318,1.0,8/40,4.48%,GPC4;BGN;HSPG2;GPC1;BCAN;STAB2;VCAN;GALNS
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),-0.6605484780492867,-0.9820689341750646,0.5857142857142857,1.0,1.0,1/5,12.70%,VRK1
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),-0.6408069238195143,-0.9819827941188443,0.6515151515151515,1.0,1.0,1/6,0.86%,JADE2
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.4578926917218337,-0.9816970595645645,0.5280898876404494,1.0,1.0,13/70,19.14%,SYT1;SHTN1;BRAT1;LIMK1;RIMS1;RNF157;BDNF;SYT2;SYT4;MACF1;NCBP1;TGFB2;RPTOR
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.5100090313250567,-0.9816545695639164,0.5375,1.0,1.0,4/27,15.96%,DND1;THRAP3;TENT5A;MEIOC
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.5534506596495136,0.9816296600604908,0.5517241379310345,0.9545083334001502,1.0,1/8,0.50%,SIRT2
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),0.5718919566044067,0.981577330559332,0.45161290322580644,0.9537697014249332,1.0,1/7,1.61%,NCSTN
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.5677018357474782,-0.9814465292386824,0.5285714285714286,1.0,1.0,5/12,26.96%,SHTN1;KIF20B;NSMF;DAB2IP;SEMA3A
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.5249615876353919,-0.9813723825387272,0.5116279069767442,1.0,1.0,4/18,10.54%,AHR;PTPRC;IL7;VAV3
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",-0.5640171120832875,-0.9812953597733391,0.5733333333333334,1.0,1.0,6/16,24.05%,UNC13C;GRIK5;SLC1A4;CDH8;SLC17A7;UNC13A
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),-0.6665795968356111,-0.9812806069290653,0.5692307692307692,1.0,1.0,2/5,21.38%,PTPRR;TENM3
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.4480192001265369,-0.9811787841753085,0.5465116279069767,1.0,1.0,10/83,13.08%,TTN;SPDYA;PTPRC;TSPYL2;CAV3;MMD2;UBASH3B;TRIB1;CAMK2N1;ITGB1BP1
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),-0.6257393760316847,-0.9808873412137029,0.5873015873015873,1.0,1.0,2/5,19.31%,CAV3;RDX
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),-0.5981849588111153,-0.9808779544170367,0.6029411764705882,1.0,1.0,1/8,3.16%,PTPRC
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.5801663594506519,0.9808444681383289,0.5428571428571428,0.9546841166667868,1.0,2/5,11.16%,TGFBR2;TGFBR1
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),-0.6281156113208439,-0.9805314692556812,0.5970149253731343,1.0,1.0,2/6,18.47%,APOE;SHANK3
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.6090789990196849,-0.9800630957296244,0.5079365079365079,1.0,1.0,5/8,31.45%,LPCAT3;MBOAT2;OSBPL10;PLAAT3;PLA2G12A
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),0.622947472124349,0.9800250127796654,0.5714285714285714,0.9558830346712761,1.0,1/8,2.59%,ERN1
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.39513586050766736,0.9798680669977246,0.45454545454545453,0.9553807019266898,1.0,6/72,4.36%,NUP42;HSBP1;HSPA1A;MLST8;BAG3;FKBP4
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5301422342494073,0.9798576731379566,0.5185185185185185,0.9545095966209772,1.0,4/10,14.17%,PLXNA3;PLXNA2;PLXNC1;NRP1
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.5343494889935682,0.9796561213931216,0.48148148148148145,0.9540934624111831,1.0,5/12,9.02%,THNSL2;CDO1;PSPH;SRR;SEPHS2
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.5027021241843516,-0.9795390120437721,0.5125,1.0,1.0,8/32,20.90%,PLSCR1;MSH6;TPM1;DNAJC10;PFN2;DNAJC9;ATP1B1;RYR2
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.5731184793320834,-0.9794025406724005,0.5466666666666666,1.0,1.0,1/14,1.18%,VSIR
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.4869351856118045,-0.9793779714966967,0.5,1.0,1.0,4/32,11.68%,G6PC2;SLC39A14;GPI;GAPDHS
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.3302245917168109,0.9793656228486906,0.5,0.9538794012287858,1.0,11/71,8.79%,PODN;SPOCK3;DACH1;RAP2A;THY1;RAP2C;TMEFF2;SRGAP2C;SRGAP2B;DUSP3;SRGAP1
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),0.5311715690575186,0.9793169701519362,0.42857142857142855,0.9531294874844003,1.0,3/9,11.03%,EIF4H;EIF5;DENR
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.5114180554179485,0.979267634567909,0.46153846153846156,0.9523809886716081,1.0,1/11,3.23%,CNBP
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.5098869842058372,-0.9788985290618376,0.5862068965517241,1.0,1.0,7/29,22.26%,PARP9;OTUD7B;GLUL;DTX3L;CTNNA1;SIN3A;TGFB1
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",-0.6546515594585147,-0.9786366341475186,0.576271186440678,1.0,1.0,1/5,1.18%,VSIR
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),0.5205938256513962,0.9785715607420825,0.46875,0.9532061858579316,1.0,2/10,6.62%,HNRNPC;HNRNPA0
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.6071587698098555,0.9785084848876897,0.5384615384615384,0.9525091564876003,1.0,1/6,2.81%,PHB2
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),-0.5606399130589389,-0.9784205918337011,0.5466666666666666,1.0,1.0,1/15,0.86%,JADE2
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),-0.5606399130589389,-0.9784205918337011,0.5466666666666666,1.0,1.0,1/15,0.86%,JADE2
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.5846496692985887,-0.9780449187247093,0.5285714285714286,1.0,1.0,2/12,5.39%,LRIF1;BRCA1
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.5643823284902341,-0.9778819748638612,0.5512820512820513,1.0,1.0,2/17,12.64%,NOSTRIN;DNM2
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),-0.5613556228525592,-0.977828973011527,0.5138888888888888,1.0,1.0,5/14,25.87%,CALY;CLTA;FCHO1;EPS15;CLTC
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.567525645017732,0.9774927766737614,0.5,0.9543844634192522,1.0,5/9,15.26%,FLRT2;NTNG2;NTN4;NID1;LAMB4
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.4363317543937075,0.9770780968987957,0.36,0.9545216006452921,1.0,7/15,20.46%,MFF;MUL1;FIS1;VPS35;RALA;PINK1;MCU
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),-0.5927020420592988,-0.9768497128998435,0.5733333333333334,1.0,1.0,2/9,27.39%,ATP1B1;NEDD4L
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),0.6277273805416796,0.9768159635580518,0.47058823529411764,0.9542085627424812,1.0,4/6,34.65%,VCP;UBXN6;CHMP2B;VPS4B
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.5760069300837146,-0.9765839248345531,0.5352112676056338,1.0,1.0,3/11,25.62%,DVL2;DVL1;DVL3
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.3805853463160676,0.9761833591142646,0.375,0.9545287354950164,1.0,10/65,12.59%,POLR2J;POLR2L;GTF2A2;SP1;RPRD1B;INTS9;POLR2K;INTS7;GTF2F1;POLR2E
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.44169353490695407,0.9761519282141413,0.47058823529411764,0.9537173062656262,1.0,3/31,6.66%,SOX4;ERN1;ZNF236
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),-0.6261115470238772,-0.9759303152291823,0.5932203389830508,1.0,1.0,1/6,7.65%,MTHFD1
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),-0.5920604334175121,-0.9756917002132443,0.5342465753424658,1.0,1.0,3/9,25.31%,SAE1;HDAC4;PIAS3
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.4756864360813905,0.9754963159411552,0.46875,0.954552460429149,1.0,2/13,7.92%,ADCY6;GUCY1B1
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.40880749149096146,0.9753597036961255,0.55,0.9539417422643905,1.0,6/35,8.05%,PLCL2;PDGFRA;PIK3C2G;NGF;PLCL1;PLCB4
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),-0.4598668773411001,-0.9752936533332731,0.5348837209302325,1.0,1.0,21/67,27.25%,GADD45B;TPD52L1;GADD45A;SPI1;DUSP22;CD27;TNFRSF19;VEGFA;RELL1;RASGRP1;TGFB2;TRAF3;RIPK1;DAB2IP;ZNF622;TIRAP;WNT7A;SCIMP;MAP3K10;SEMA3A;MID1
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),-0.6269589286518346,-0.9752544233202446,0.5735294117647058,1.0,1.0,1/8,0.68%,SOX9
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.3148536978439931,0.9749829391024287,0.5,0.9542941389688528,1.0,22/202,8.21%,SOX4;UTP11;UBB;BAD;NCSTN;FGD3;PAWR;MCF2;TRIM35;PLEKHG5;CLIP3;NGF;SMPD1;IP6K2;FRZB;STPG1;QRICH1;PHLDA1;RYBP;BOK;ZNF268;ARL6IP5
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",-0.659664605030038,-0.9749089332770642,0.5666666666666667,1.0,1.0,3/5,31.77%,ANO6;C3;APPL2
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),-0.6216322549486137,-0.9748099803920353,0.5492957746478874,1.0,1.0,1/7,13.20%,RASGRP1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),-0.6098659765398974,-0.9744772383909402,0.5569620253164557,1.0,1.0,3/7,31.93%,DDR2;TGFB1;DMTN
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),-0.6012517062786402,-0.9743412576627808,0.5942028985507246,1.0,1.0,2/5,24.08%,NRDE2;NCBP2
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),-0.6012517062786402,-0.9743412576627808,0.5942028985507246,1.0,1.0,2/5,24.08%,NRDE2;NCBP2
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.3762641967026958,0.9741914897847642,0.375,0.955126415172344,1.0,10/66,12.59%,POLR2J;POLR2L;GTF2A2;SP1;RPRD1B;INTS9;POLR2K;INTS7;GTF2F1;POLR2E
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),0.4970710466039439,0.9738410893673801,0.4444444444444444,0.9550466244192097,1.0,3/15,9.52%,DHFR;FLRT3;RTN4RL2
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.5727729494041909,0.9736911147836663,0.4666666666666667,0.9544211830103893,1.0,4/8,29.19%,WASL;CD200;APOD;AKT1
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,-0.4397379881622272,-0.9736765768536748,0.5416666666666666,1.0,1.0,23/127,15.77%,NEFM;STMN2;LHFPL5;GALNTL6;OLFM3;CALY;SNCB;KCNC1;MMD2;CACNA1B;SULT4A1;KLHDC8A;ACTL6B;PSD2;RTN2;SNAP25;LRRTM1;JPH3;NEFL;SYT4;ATP2B3;NARF;CRMP1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.43321970659411824,0.9736341233627901,0.4,0.9536647144939714,1.0,6/46,11.40%,HSPA1A;GPX1;GSTP1;PSME3;TGFBR1;PEA15
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.42693081109776804,0.973632096381459,0.5217391304347826,0.9527775845270001,1.0,7/26,18.85%,LARP7;EAF2;CDC73;EAF1;NELFA;WDR43;RNF168
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.4952087377217454,-0.9735364616896153,0.5357142857142857,1.0,1.0,11/32,25.42%,GRIN2A;TRIM41;GJA1;IGF1R;PSEN1;EPHA4;GRIN1;DDX11;CACNB1;ITGA4;XBP1
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),-0.643930691384532,-0.9734510669468077,0.6,1.0,1.0,1/5,13.08%,ITGB1BP1
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.4422322056577946,0.9733803933789111,0.4,0.9525188474436045,1.0,4/14,17.45%,TRIM71;TAFA1;TOX;PTPRZ1
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",0.6431381235246241,0.9732445710161954,0.5151515151515151,0.9519310318859499,1.0,1/5,1.61%,NCSTN
prerank,GO_Biological_Process_2021__lung development (GO:0030324),-0.5407348114251654,-0.972928411052864,0.5540540540540541,1.0,1.0,5/18,12.53%,FGF1;CCDC39;FGF9;VEGFA;LOXL3
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.5809416648803897,0.9726627745168712,0.5151515151515151,0.9528753344535306,1.0,2/6,14.17%,CHRNA7;NRP1
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.5129675380373797,-0.9726483327640975,0.5194805194805194,1.0,1.0,7/22,27.83%,PREX1;VIL1;MICALL2;SPIRE1;FAM107A;GSN;PSTPIP1
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.42421098525170153,0.9725101376724526,0.3333333333333333,0.9524198573022548,1.0,2/24,3.13%,SOX11;CLSTN2
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.5129702128170988,-0.9724918646732175,0.5569620253164557,1.0,1.0,6/20,19.39%,HOOK1;KIF1C;HOOK3;CCDC186;HOOK2;KIF1A
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),-0.5751008267274559,-0.9724788906359326,0.5277777777777778,1.0,1.0,4/8,34.11%,BAIAP2;GAS2L1;FLNA;BAIAP2L2
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.5740677955227358,-0.9723153572714319,0.5625,1.0,1.0,5/11,29.73%,TRIM5;TRIM25;HS3ST5;NECTIN2;FUCA2
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.5866581080450185,-0.9721073093455689,0.5522388059701493,1.0,1.0,1/11,1.06%,STMN2
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),-0.4503025620940599,-0.9721047446104067,0.5714285714285714,1.0,1.0,18/65,25.21%,GRIN2A;OPRM1;DAPK1;CAMK2B;SHISA6;JPH3;NEFL;CAMK2A;SHISA9;CACNG8;CACNG2;CACNG7;DLG4;GRIN1;CACNB1;CAMK2D;MAPK8IP2;RELN
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.5810850866635904,-0.9719606571870927,0.6081081081081081,1.0,1.0,5/11,12.06%,CLDN18;ATP8B1;SLC44A3;PTGR1;LIPH
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.46189542946951717,-0.9715014637118009,0.5833333333333334,1.0,1.0,18/55,26.76%,MAP3K19;DNAH7;ENKUR;NME9;CFAP221;EFHC1;CFAP52;CFAP70;CFAP77;DNAH6;GFAP;DNAH9;AQP4;CFAP43;DRC3;VWA3B;RGS22;PCP4L1
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.483006063035154,0.9713583906244202,0.5714285714285714,0.9545286430062238,1.0,5/15,15.07%,SEMA5A;SEMA5B;SEMA3B;SEMA4F;SEMA6C
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),-0.6355611699116117,-0.9711958484219456,0.5757575757575758,1.0,1.0,1/7,2.83%,EFNA1
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,-0.44943171351857636,-0.9706895931609645,0.5824175824175825,1.0,1.0,18/99,15.90%,STMN2;GRIN2A;GRM1;OLFM3;KCNC1;GABRG2;MMD2;CACNA1B;ACTL6B;PSD2;CELF4;GRM3;SNAP25;CAMK2A;ATP2B3;MEIS2;NTRK3;SRRM4
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.5620968254340453,-0.9705887842692413,0.5588235294117647,1.0,1.0,2/10,11.56%,NR4A3;PDE8A
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),-0.582420740535545,-0.970581879253816,0.5211267605633803,1.0,1.0,1/10,5.18%,ELOVL2
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),-0.582420740535545,-0.970581879253816,0.5211267605633803,1.0,1.0,1/10,5.18%,ELOVL2
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.3989496015494991,0.970305230308158,0.4444444444444444,0.9563380216211477,1.0,11/74,3.65%,MMP2;PRRX1;FIBIN;BGN;HSPG2;FBLN2;PODN;COL12A1;TNS2;CXCL12;PDGFRA
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),0.554115643139377,0.9702952135204131,0.5416666666666666,0.9554541602333279,1.0,2/7,9.01%,CMPK1;DHODH
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.6098584354535022,-0.9702890450818028,0.6111111111111112,1.0,1.0,2/8,9.81%,MCCC1;BTD
prerank,MSigDB_Hallmark_2020__Apical Junction,0.36339729932450104,0.969746564096922,0.5714285714285714,0.956177823479303,1.0,28/129,12.55%,MMP2;TUBG1;ACTB;ACTG1;LAMA3;PARD6G;CAP1;SHROOM2;MSN;VCAN;NLGN2;TSPAN4;NECTIN1;THY1;ADAM23;MAPK11;SPEG;TNFRSF11B;CERCAM;CDK8;NEGR1;LIMA1;NLGN3;MYH9;COL9A1;ZYX;GNAI1;GTF2F1
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),-0.6450203525435584,-0.9696349090359744,0.5882352941176471,1.0,1.0,1/5,2.83%,EFNA1
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),-0.599202784865705,-0.9695006561081062,0.5303030303030303,1.0,1.0,1/7,6.62%,ITPK1
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,-0.42930594512592857,-0.9694250338063659,0.5595238095238095,1.0,1.0,15/95,14.71%,STMN2;GADD45B;OLFM3;SNCB;KCNC1;SST;GABRG2;MMD2;SULT4A1;ACTL6B;PSD2;CAMK2B;SNAP25;CAMK2A;ATP2B3
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),-0.5109512369323947,-0.9693768823893146,0.5512820512820513,1.0,1.0,2/28,4.65%,GLRA2;GLRA1
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),-0.48502629633088357,-0.9692484484495635,0.5609756097560976,1.0,1.0,9/46,20.89%,CAMK1;MMD2;BORA;TRIM5;STX10;USP8;TRIM25;PLEKHM2;DVL1
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.6401299158552411,0.9687650883776449,0.5588235294117647,0.9577351001020449,1.0,1/6,0.50%,SIRT2
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.45138789475930496,0.9684626820409287,0.5909090909090909,0.9575230094396788,1.0,7/19,29.60%,SMAD3;KHSRP;NOS1AP;DDAH1;CAV1;AKT1;ATP2B4
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.5654740558089135,-0.9680109812413061,0.5789473684210527,1.0,1.0,2/11,12.86%,NEK11;EME2
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.3584799288060526,0.9679690984554753,0.5,0.9578832580180826,1.0,17/65,14.32%,U2AF1;NUP42;MALT1;CALR;NUTF2;RAN;NXF1;LSG1;EIF4A3;EIF4E;RBM8A;POLDIP3;WASHC4;CHP1;SRSF3;MAGOH;XPO7
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.6056790210199707,-0.9677839811067508,0.6119402985074627,1.0,1.0,4/12,27.30%,SEC14L1;UFD1;NPLOC4;NOP53
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),-0.5783355831944411,-0.9677062385414191,0.5797101449275363,1.0,1.0,2/12,10.66%,SLC2A3;SLC2A12
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.41549278793287986,0.967660682109877,0.6153846153846154,0.9575734631479204,1.0,7/47,8.14%,RND2;RHOBTB1;MLST8;EPHA5;RHOC;ARHGAP18;GPM6B
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),-0.5333018567414591,-0.9675089798787434,0.5324675324675324,1.0,1.0,1/18,1.83%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),-0.6028859600670107,-0.9673824763643784,0.6031746031746031,1.0,1.0,1/7,10.58%,AHCYL1
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.5448313085334053,-0.9673681026896278,0.5797101449275363,1.0,1.0,1/15,3.45%,RPS6KB2
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.5742907109754178,-0.9673674194929447,0.5571428571428572,1.0,1.0,2/11,9.03%,ENPP2;PDXDC1
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),0.4304944065550018,0.9673592027520362,0.48,0.9573947285591164,1.0,3/19,8.71%,ATXN7L3;UBE2N;CDC73
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.5552824545282086,0.966969794421291,0.5517241379310345,0.9573303968316603,1.0,2/8,15.93%,GREM1;BMP2
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.3108173129207887,0.9666666095287247,1.0,0.9570708060848362,1.0,33/218,14.02%,USP51;UBB;ACTB;ADRM1;USP12;PSMD8;PSMB4;ESR1;PSMB6;TAF9B;UBE2D1;JOSD2;GPS1;PSMD10;ACTR8;OTULINL;INO80D;PSME3;RNF128;SMURF2;UBC;COPS2;SMAD3;TGFBR1;POLB;YOD1;USP31;COPS7B;SMAD7;PSMB2;PSMD12;RAD23A;OTUD5
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),-0.5924967629758647,-0.9666090238776854,0.5294117647058824,1.0,1.0,2/8,33.41%,PLEKHM2;TUBB4B
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.5963804612426031,-0.9664003619730208,0.5652173913043478,1.0,1.0,2/10,20.44%,GLRX;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.4513331185797401,0.9663687777227324,0.5416666666666666,0.9569906226950354,1.0,2/13,8.71%,ZFP36L1;CDC73
prerank,MSigDB_Hallmark_2020__DNA Repair,0.3149323991687427,0.9661350546164034,0.4,0.9566993153333173,1.0,27/115,14.81%,POLR2J;ADRM1;VPS37B;ADCY6;TMED2;VPS28;GTF2A2;SSRP1;PDE4B;MPC2;MRPL40;POLR2K;POLD3;RFC5;POLB;PNP;ERCC3;GTF2F1;POLR2E;REV3L;GPX4;ERCC4;DGCR8;NUDT9;AAAS;PRIM1;ERCC8
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),-0.48915952206014646,-0.965926850539711,0.5802469135802469,1.0,1.0,8/37,23.76%,STK17A;CYP1B1;ACACB;CNDP1;PDK2;MKLN1;PANK2;ABCA2
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),-0.6379937849033461,-0.9659116775447705,0.5,1.0,1.0,1/5,10.23%,SHMT1
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.4407121998472379,0.9655764261929319,0.47368421052631576,0.9570580103472726,1.0,2/21,3.65%,SOX11;PDGFRA
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),-0.6667012529228116,-0.9651663455660868,0.5882352941176471,1.0,1.0,1/5,10.78%,THRAP3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.49863117041216165,0.9651515831260032,0.5263157894736842,0.9571889431275089,1.0,5/15,7.18%,STOX1;CCND1;NPM1;RCC2;RAD51B
prerank,PanglaoDB_Augmented_2021__Neurons,-0.4177181348355889,-0.9651366742831999,0.5957446808510638,1.0,1.0,38/237,16.00%,NWD2;RASGRF1;NEFM;STMN2;CALB1;PCSK2;NMT1;OLFM3;CALY;SNCB;CPLX1;ARHGDIG;KCNC1;GABRG2;NRGN;MMD2;CACNA1B;SULT4A1;ACTL6B;SCN8A;PSD2;VSNL1;CELF4;CAMK2N1;GRM3;PRUNE2;SNAP25;LRRTM1;HAP1;SYT4;ATP2B3;SLC6A17;RBFOX3;ZIC1;BEX2;IFIT3;SRRM4;NRSN2
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),-0.5061481847877745,-0.9650597841596045,0.5128205128205128,1.0,1.0,8/21,21.08%,SPI1;STAT3;IL6R;JAK1;STAT1;ST18;ST3GAL6;SMAD4
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.35230258743003073,0.9649319154124111,0.4166666666666667,0.9568658385991774,1.0,9/66,4.32%,MMP2;PRRX1;FIBIN;BGN;PODN;COL12A1;CXCL12;PDGFRA;VSTM4
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.5720499434606099,-0.9647414251145179,0.56,1.0,1.0,3/8,18.43%,BRCA1;KLF15;CTBP1
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.5535374602445691,0.9645901845874957,0.5161290322580645,0.9569481309209703,1.0,2/6,12.67%,CXCL12;BRK1
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.4409468015118212,0.9636567880022481,0.4090909090909091,0.9585347834280367,1.0,2/19,7.70%,HSPA1A;CHMP2A
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.46077655185784255,-0.9636231846663557,0.6265060240963856,1.0,1.0,13/54,13.46%,FABP3;SGCA;TTN;LAMA2;CKMT2;CAV3;DOCK5;ARHGAP26;EDNRA;TPM1;MEF2D;SULF1;NBR1
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),-0.5557657768883939,-0.9635867254850401,0.5,1.0,1.0,1/13,7.54%,ROBO2
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),-0.5778447200744685,-0.9631149222232522,0.527027027027027,1.0,1.0,3/8,24.42%,DOCK7;HOOK3;WNT7A
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),-0.43905653485722196,-0.9630503244560317,0.5730337078651685,1.0,1.0,21/75,26.96%,GADD45B;TPD52L1;GADD45A;DUSP22;CD27;TNFRSF19;RASGRP1;PER1;TRAF3;RIPK1;IGF1R;DAB2IP;MEN1;ZNF622;NCOR1;TIRAP;MAPK8IP2;WNT7A;TGFBR3;MAP3K10;SEMA3A
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),0.4363748678445505,0.9623519038658169,0.47058823529411764,0.9604741273604439,1.0,7/25,17.97%,POLR2L;RO60;GTF3C6;POLR2K;CRCP;SNAPC5;ICE2
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),-0.5412327911981305,-0.962275252507459,0.5822784810126582,1.0,1.0,3/21,19.39%,KIF1C;HAP1;KIF1A
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),-0.6274868824344785,-0.9621039797920694,0.56,1.0,1.0,4/6,32.84%,SHMT1;CTPS1;PAICS;CTPS2
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),-0.4422195517988504,-0.9620935745938488,0.6041666666666666,1.0,1.0,14/123,13.24%,ENPP2;SOX9;CAMK1;SLC6A6;SRF;DVL2;SHLD2;APOE;VEGFA;ALK;CAMK2B;GJA1;VIL1;FOXO6
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),-0.6331374427427242,-0.9619661384814183,0.625,1.0,1.0,3/5,32.27%,UBASH3B;PRXL2A;FOXP1
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.4795654568318872,0.9619135912330353,0.44,0.9607789850397745,1.0,4/9,20.05%,MFF;FIS1;VPS35;ERBB4
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),-0.6360979867083765,-0.9618540778840363,0.5714285714285714,1.0,1.0,1/7,7.65%,MTHFD1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.5603556834863654,-0.9617375699443493,0.5694444444444444,1.0,1.0,4/15,19.02%,MX1;DNM1;DNM2;DNM1L
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),-0.455384158422724,-0.9613265520579473,0.6091954022988506,1.0,1.0,18/66,23.07%,KCNJ13;KCNJ11;KCNC1;KCNN3;KCNH7;KCNMB4;KCNQ1;HCN3;SLC24A2;KCNB2;KCNH1;KCNG4;KCNK10;HCN1;HCN2;KCNQ5;KCNC4;SLC9A8
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.5194210154167154,-0.9612720248087144,0.5342465753424658,1.0,1.0,4/20,10.93%,RFC4;RFC1;RFC2;RPA3
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),-0.43118485891693625,-0.9609853019741219,0.5894736842105263,1.0,1.0,10/117,8.97%,PON1;HEY2;SOX9;EFNA1;OVOL2;PROCR;SRF;SPI1;DOCK7;PCTP
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),-0.5780697591730444,-0.9609599587799893,0.5238095238095238,1.0,1.0,1/7,6.58%,MYRF
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),-0.4877304494742388,-0.9608419977394562,0.6049382716049383,1.0,1.0,2/32,9.78%,NUAK1;ATG14
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),-0.6357249304917889,-0.960770312485094,0.6338028169014085,1.0,1.0,2/5,18.87%,CLEC16A;HDAC6
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.6112178939741113,-0.9607033972777336,0.5507246376811594,1.0,1.0,4/8,23.05%,HLA-F;PVR;HLA-B;HLA-A
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.6047235558930025,0.9603559355058545,0.6153846153846154,0.9634064992822295,1.0,2/7,12.54%,SQLE;AUP1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.5938262365816739,-0.9603281254576148,0.5522388059701493,1.0,1.0,2/11,14.55%,TPM1;PDCD4
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),0.45135014853388566,0.9596679143377548,0.5172413793103449,0.9644496025491082,1.0,5/19,16.35%,TRMT112;NAT10;NHP2;METTL5;TFB1M
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),-0.5724571960491842,-0.9596641826017416,0.5671641791044776,1.0,1.0,3/8,22.10%,HOOK3;DCTN1;CCDC120
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.33925125030320213,0.9596271428908884,0.5555555555555556,0.9636227338069052,1.0,8/64,10.21%,SSNA1;TUBG1;KCNH5;NPM1;HAUS8;PRKAR2B;TUBA1A;PPP2R1A
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.4668954856939123,-0.9595421436777508,0.524390243902439,1.0,1.0,13/48,21.35%,VSIR;PTPRC;RARA;OAS1;RASGRP1;IFIH1;ARFGEF2;STAT3;C1QTNF4;PTPRJ;RIPK1;ARG2;PSEN1
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),-0.5615973669356928,-0.9594178554647544,0.5733333333333334,1.0,1.0,1/11,11.47%,XRCC3
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.6442107073488477,-0.9592871974738322,0.6197183098591549,1.0,1.0,2/7,23.05%,B2M;HLA-A
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.5339669645585386,0.9591567805882272,0.5454545454545454,0.9638270941748608,1.0,4/8,13.87%,LEPR;MT3;MKKS;SIRT1
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.594535910191583,-0.9590943505103808,0.5737704918032787,1.0,1.0,2/8,14.07%,VEGFA;EIF2B4
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.5152450213217463,-0.9590742223587475,0.5844155844155844,1.0,1.0,7/25,21.54%,AHR;DUOX1;KCNQ1;HCN3;STAT1;HCN1;HCN2
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),-0.6285040663008298,-0.9589058841508392,0.609375,1.0,1.0,2/6,30.64%,AKT2;IRS2
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.5037084378841261,-0.9588365048841127,0.5641025641025641,1.0,1.0,12/28,33.03%,BRCA1;DONSON;FZR1;ATM;BRSK1;NOP53;BABAM2;CHFR;TAOK1;INTS3;ABRAXAS1;BRCC3
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.48182894867182613,0.9585338242728144,0.5555555555555556,0.964465108090858,1.0,3/11,17.87%,MDFI;YWHAB;LATS1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.5105836341923283,-0.9584912905195346,0.6025641025641025,1.0,1.0,3/22,11.03%,EFNA1;TIMP3;CAMK2N1
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),0.3846779463385436,0.958120032981863,0.5882352941176471,0.9645077321778253,1.0,4/25,5.95%,CRB2;SPOCK3;UBXN1;CSTB
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.5549909469749152,-0.9579259239867762,0.6153846153846154,1.0,1.0,4/11,16.99%,STAT6;STAT5A;STAT3;STAT5B
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.4963940910958884,-0.9578834266503743,0.5764705882352941,1.0,1.0,9/29,21.28%,LRRC19;PTP4A3;CD27;TRIM44;PDCD4;IFI35;C1QTNF4;NLRP12;TERF2IP
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),0.5594502708362341,0.9574990254044049,0.5517241379310345,0.9653044358132051,1.0,2/6,13.87%,NPM1;SIRT1
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),0.40814487820279766,0.9572296138825712,0.5,0.9642507366786408,1.0,7/21,12.40%,ACOT9;THEM4;ACLY;ACOT8;ACSM5;OXSM;ACOT13
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),0.40814487820279766,0.9572296138825712,0.5,0.9642507366786408,1.0,7/21,12.40%,ACOT9;THEM4;ACLY;ACOT8;ACSM5;OXSM;ACOT13
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.47617269581545385,-0.9571058296514662,0.5679012345679012,1.0,1.0,1/35,0.19%,CD44
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.5331564101253401,-0.9570813260980683,0.49295774647887325,1.0,1.0,5/13,30.27%,KCNH1;ADAM12;SORT1;MEF2C;ERVW-1
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.4069418328613894,0.9570752824030433,0.5,0.9638453309078472,1.0,2/24,2.31%,LPCAT1;ACHE
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.39972546763517564,0.9568992105272023,0.4,0.9634086794725917,1.0,19/69,15.50%,VPS37B;ZDHHC6;ZDHHC1;YIF1B;GOLGA7;MICALL1;ZDHHC4;ZDHHC21;ZDHHC11B;ZDHHC3;ABCD2;SRP14;SSR2;TRAM1;FIS1;ZDHHC2;PEX13;ACBD5;SSR1
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.5035769161850568,-0.956653946777696,0.5641025641025641,1.0,1.0,5/22,21.62%,DAPK1;CALCOCO2;DAPK3;STAT1;AQP4
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),-0.6353650211788204,-0.9566061345869783,0.6451612903225806,1.0,1.0,1/6,12.47%,FOXO1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.4459044382114568,0.9564215172159783,0.4838709677419355,0.963627734638871,1.0,2/14,7.70%,HSPA1A;CHMP2A
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.3973083234218643,0.9563258191650477,0.5555555555555556,0.9629367153136732,1.0,4/22,9.86%,WTIP;EIF4E2;MYCN;LIMD1
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.4999479656747879,0.9559144804833183,0.4482758620689655,0.9631079659922479,1.0,2/8,10.55%,B4GALT6;ST6GALNAC3
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),0.4506667409095111,0.9557588137519256,0.5714285714285714,0.9626098217136063,1.0,1/10,0.91%,BAD
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.5843814528414588,-0.9556597862213657,0.5616438356164384,1.0,1.0,2/7,19.02%,CHMP4B;DNM1L
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),-0.6062708053252375,-0.9556257022422928,0.5,1.0,1.0,2/7,18.62%,XRCC3;WRN
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.555758016722255,-0.9555064777227144,0.5733333333333334,1.0,1.0,7/11,28.93%,PARP9;DTX3L;MED25;DDX11;HMBOX1;WAPL;KDM4D
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),-0.4961252981289511,-0.9551114157149326,0.5694444444444444,1.0,1.0,2/26,4.38%,RRH;GADD45A
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.4642119244556452,0.9550592188808906,0.5,0.9632744657807064,1.0,3/26,3.27%,NOX4;BTC;TGFA
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),-0.6033050204100504,-0.9547511330700348,0.578125,1.0,1.0,2/7,16.41%,CHAC2;GCLC
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),-0.6033050204100504,-0.9547511330700348,0.578125,1.0,1.0,2/7,16.41%,CHAC2;GCLC
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.5463852630727566,-0.9546946943604362,0.6190476190476191,1.0,1.0,5/14,25.45%,VEGFA;AHI1;ARRB1;ARRB2;SFRP4
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.3807241291280422,0.9546590809911514,0.5,0.9633654429375619,1.0,16/61,14.99%,UBB;TGFBR2;ITGB5;BAMBI;JUN;UBC;SMAD9;SMAD3;TGFBR1;TWSG1;ZYX;SMAD7;DUSP15;FNTA;SIRT1;RHOA
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),-0.5571496790900307,-0.9545907791656638,0.6296296296296297,1.0,1.0,2/15,7.93%,PTPRC;LMBR1L
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.46830631269686007,-0.9544811826196021,0.5476190476190477,1.0,1.0,2/35,6.47%,SLC6A6;FOS
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),0.550794798006464,0.9544049101577373,0.5151515151515151,0.9615280889607122,1.0,2/7,7.98%,H1-10;H1-4
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),0.550794798006464,0.9544049101577373,0.5151515151515151,0.9615280889607122,1.0,2/7,7.98%,H1-10;H1-4
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),0.550794798006464,0.9544049101577373,0.5151515151515151,0.9615280889607122,1.0,2/7,7.98%,H1-10;H1-4
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.5775844024355552,-0.9543514171185488,0.6216216216216216,1.0,1.0,2/10,11.89%,PTPRC;PTPA
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),-0.607543155843566,-0.9542915905249119,0.609375,1.0,1.0,2/6,13.95%,BRCA1;ARRB1
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),-0.6703767477027469,-0.9541542177626431,0.6567164179104478,1.0,1.0,2/5,24.72%,AGO1;AGO4
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.604753013913819,-0.9541145595389392,0.5949367088607594,1.0,1.0,1/8,1.20%,PRELP
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.39788825559978797,0.9540463445170605,0.5,0.9615727645278811,1.0,9/31,16.57%,SMPD1;SPTLC1;ACER2;SGMS1;PPP2R1A;ST6GALNAC3;ACER3;CERS2;SAMD8
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.5418482576120366,0.9537696625051568,0.5925925925925926,0.9612215809605145,1.0,4/8,11.16%,TGFBR2;PDGFRA;EIF4A3;TGFBR1
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),0.4860696926939513,0.9535434338789585,0.43478260869565216,0.9609817428601402,1.0,2/13,3.11%,SIRT2;IKBKB
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.5015027788818295,0.9533906796928844,0.5789473684210527,0.9604578782097669,1.0,1/9,1.74%,ADCY6
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),0.3435791729003849,0.9528281009908336,0.5,0.9608980700110656,1.0,15/93,10.54%,UBB;PSMD8;TAB3;PSMB4;IKBKB;PSMB6;UBE2N;PELI1;MAPK11;PSMD10;RIPK2;TOLLIP;PSME3;RC3H1;UBC
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),-0.6157939355201361,-0.9526578636317367,0.5932203389830508,1.0,1.0,2/5,25.77%,KLF9;MED1
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.5202351434952074,-0.9524140341895507,0.5652173913043478,1.0,1.0,2/16,9.53%,DSC2;CTNNA3
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),0.6053426918464757,0.952319914306885,0.5,0.96108508103338,1.0,3/5,25.15%,GLTP;CERT1;TTPA
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.400427633995177,0.9517101342635874,0.5,0.9617603471302221,1.0,9/26,13.96%,PIWIL2;RAN;PIWIL4;TRIM71;NIFK;DGCR8;DTD1;HENMT1;KHSRP
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),-0.464439161123846,-0.9516747125437711,0.5851063829787234,1.0,1.0,8/48,22.24%,NR4A3;SPI1;ZFPM1;RBM15;MEIS2;AGO1;KMT2A;SIN3A
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.5159249763655793,-0.9512867248281368,0.5657894736842105,1.0,1.0,5/22,19.53%,PLSCR1;ATP10A;ATP8B1;ATP8B2;ANO6
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.5408961082319151,0.9509286649481007,0.6,0.9627650996585609,1.0,3/8,22.92%,STXBP6;RAB33B;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.4365469600617423,0.9503102032146905,0.42857142857142855,0.9632803497569182,1.0,3/23,6.08%,USP51;KMT5B;NUDT16L1
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),0.5021581445233916,0.9502555924462011,0.48148148148148145,0.9626472001943884,1.0,3/10,10.73%,ADRM1;PSMD10;PSMG1
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),-0.6446089667347561,-0.9500110520384403,0.6507936507936508,1.0,1.0,5/6,35.45%,MAP1A;BRSK1;SLC6A1;ADCY3;SHANK1
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),-0.47306008031857427,-0.9497507260723015,0.5061728395061729,1.0,1.0,1/21,0.68%,SOX9
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),-0.5327416621840457,-0.9497091289391645,0.5733333333333334,1.0,1.0,3/18,13.01%,SEPTIN9;CEP135;HAP1
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.5386180609551293,-0.9495513865623616,0.589041095890411,1.0,1.0,3/9,27.39%,CAV3;CAMK2D;NEDD4L
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),-0.4565836595355938,-0.9493435016293665,0.5955056179775281,1.0,1.0,8/58,16.27%,HTR2C;LETM2;TPCN2;CALCB;HTR2B;SLC24A2;ATP2B3;ATP13A5
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.5545414793841271,-0.9490539067861192,0.5542168674698795,1.0,1.0,2/12,11.45%,BRCA1;PLK2
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),0.5223022629149127,0.9488715825550057,0.5128205128205128,0.965266124486189,1.0,2/10,6.41%,CHAMP1;RCC2
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.4542309989839817,0.9488137837648523,0.48148148148148145,0.9645538827721646,1.0,3/15,17.48%,KPNA2;KPNA4;NUP35
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),0.5072716629941988,0.9487733331481143,0.4782608695652174,0.9629452091020312,1.0,6/11,32.89%,SMAD3;NOS1AP;DDAH1;AKT1;P2RX4;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.5072716629941988,0.9487733331481143,0.4782608695652174,0.9629452091020312,1.0,6/11,32.89%,SMAD3;NOS1AP;DDAH1;AKT1;P2RX4;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),-0.6318074900967929,-0.948495727214809,0.6285714285714286,1.0,1.0,2/6,12.04%,STMN2;VIL1
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.5631009098717749,-0.9484768332345354,0.6,1.0,1.0,1/10,3.16%,PTPRC
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.3666710100622227,0.9483774804792361,0.5,0.9632071791273826,1.0,3/37,2.81%,CHRNA4;MALT1;PHB2
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),-0.6204211952702609,-0.9483595261541399,0.6285714285714286,1.0,1.0,2/8,20.26%,CALCOCO2;IGF1R
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.38210106896804347,0.9483472517456911,0.5,0.9623898102462961,1.0,6/53,11.58%,SOX11;CRB2;RBPJ;SLC2A10;TGFBR1;TWSG1
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.5334260538328781,-0.948250956791231,0.5903614457831325,1.0,1.0,3/19,2.96%,MYLK;DUOX1;ENPP4
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.47078260847400233,-0.9482230251929755,0.575,1.0,1.0,1/27,1.05%,PIP4K2C
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.4880768850219047,0.9479149161704602,0.45,0.9627299186576871,1.0,3/19,4.56%,NR1H2;ACADVL;MID1IP1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),-0.44857623355928944,-0.9478804596112975,0.6292134831460674,1.0,1.0,7/59,14.31%,TMSB4X;FGF1;AGT;GPI;VEGFA;ITGB1BP1;STAT5A
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.47703483750467635,-0.9476425317215068,0.651685393258427,1.0,1.0,5/33,10.93%,RFC4;RFC1;RFC2;DDB2;RPA3
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),-0.6069553184352695,-0.9473562886025462,0.6086956521739131,1.0,1.0,1/7,20.44%,ATP1B1
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),-0.6189438748550394,-0.9473239262280725,0.6376811594202898,1.0,1.0,1/6,0.68%,SOX9
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),-0.5923801516297519,-0.9471899880138033,0.6428571428571429,1.0,1.0,4/7,30.54%,CAMK2B;DAB2IP;RELN;ADGRL1
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.5461607760120749,-0.9470579531454764,0.6,1.0,1.0,2/11,9.83%,MYRF;RIMS1
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.5910612306180231,-0.9469443236209685,0.6338028169014085,1.0,1.0,3/11,19.89%,AGBL4;LCMT1;ATG7
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),-0.40861091979769637,-0.9469188142306729,0.6210526315789474,1.0,1.0,56/297,22.29%,NUAK1;CAMK1;STK17A;MAK;CDK7;TSSK3;RARA;NEK3;GRK4;LIMK1;DAPK1;MAP3K12;TLK1;CDK19;ALK;TRIB1;CAMK2B;TAF1;PLK2;NEK11;PAK1;VRK1;HTR2B;CAMK2A;CDK4;EPHA7;PNKP;FAM20C;STRADB;CSNK1D;DAPK3;VRK2;STAT3;PAK2;MAP2K1;BCR;PDK1;NEK6;JAK1;COQ8B;PRKD2;TGFB2;CTBP1;CDC42BPB;PDK2;ATM;AGK;FAM20A;MKNK1;PANK2;CSNK1G2;PRKAR1B;CDKL1;DCLK1;TGFB1;TNIK
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.517341534847769,-0.9457836848629965,0.5833333333333334,1.0,1.0,1/19,1.15%,NAAA
prerank,MSigDB_Hallmark_2020__Apical Surface,-0.48129157032650516,-0.9457128189913759,0.5866666666666667,1.0,1.0,6/31,11.11%,CD160;SRPX;BRCA1;CRYBG1;EFNA5;ATP8B1
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),0.533901010767264,0.9453555682054752,0.5294117647058824,0.9684699348320553,1.0,5/8,16.57%,SMPD1;SMPD3;SGMS1;SMPDL3A;SAMD8
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.5764225130853144,-0.945234348321617,0.6086956521739131,1.0,1.0,3/8,18.43%,SPI1;ARRB1;CTBP1
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.4101270255644166,0.9449600920011909,0.5652173913043478,0.9687729133308777,1.0,2/13,5.03%,FNBP1L;MYO1D
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),-0.6219818712824279,-0.9449066096270499,0.6307692307692307,1.0,1.0,1/7,13.08%,ITGB1BP1
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.5621918605962388,-0.9447074012895452,0.5857142857142857,1.0,1.0,6/8,28.93%,PARP9;DTX3L;MED25;DDX11;HMBOX1;KDM4D
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.28462669594468953,0.9443695718907873,1.0,0.9699478953570444,1.0,59/305,12.83%,UTP11;MARCKS;POU6F2;FABP7;MARCKSL1;ASCL1;FGF12;MYT1L;YAP1;SOX8;ACHE;UNC119B;FLRT3;GSTP1;PPT1;BTBD3;SDCBP2;BCAN;NR2E1;SEMA5A;POU3F2;BTBD6;SOX10;DOC2A;SDK1;VCAN;NLGN2;SCD5;NGF;SMPD1;DPF1;LDB2;S100B;NDP;ZNF358;GPM6B;ADAM23;RBFOX1;SOX6;DCX;DPYSL4;LIG4;DCHS1;EDNRB;KCNQ2;MAL;SHANK2;NLGN3;ATN1;TGFBR1;TRIM71;MAP1S;TAGLN3;HMGCR;GLIS2;ALDH1A2;DPYSL5;UGT8;CNTN6
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.5246125261067741,-0.9441042204345139,0.6301369863013698,1.0,1.0,2/14,15.94%,MTHFD1;ASPA
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),-0.6422636795072985,-0.9440097269388298,0.6190476190476191,1.0,1.0,2/5,29.11%,ADGRV1;WHRN
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.4801262687719217,-0.943997330971445,0.6136363636363636,1.0,1.0,5/31,10.93%,RFC4;RFC1;RFC2;DDB2;RPA3
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),0.5194381697470529,0.9437205719162217,0.6451612903225806,0.9704981230446672,1.0,2/6,11.53%,CAMSAP3;INAVA
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.46659632858132244,0.9437103102033052,0.5666666666666667,0.9696631086945381,1.0,4/16,8.53%,SLC25A1;PPT1;SCD5;ACLY
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.4930449342323114,-0.9436114107047787,0.5925925925925926,1.0,1.0,5/26,10.54%,PTPRC;CD27;SHLD2;IL7;VAV3
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.480363645470603,-0.9432590485367142,0.6506024096385542,1.0,1.0,10/29,36.21%,HAP1;NEFL;KIF1A;DCTN1;SYBU;BLOC1S2;AP3B2;DTNBP1;AP3D1;PAFAH1B1
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),-0.509982844309133,-0.9431782784661249,0.5977011494252874,1.0,1.0,8/25,21.60%,APOE;RAB3A;CAMK2B;SHISA6;CAMK2A;SHISA9;NSMF;DLG4
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.43980676374266436,-0.9431436358291457,0.6063829787234043,1.0,1.0,21/81,19.05%,IL5;PLAG1;MX1;NRIP2;SNCB;CALCB;ARHGDIG;STAG3;LFNG;KLHDC8A;MFSD6;EFHD1;GPRC5C;CAMK1D;NUDT11;RSAD2;ZC2HC1C;TGFB2;ENTPD7;PDK2;PTPRJ
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.39826780316729915,0.9430552557278409,0.5185185185185185,0.970414642928046,1.0,3/25,6.73%,CHRNA7;ARC;EPHB3
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.3572053848627326,0.9429664563975327,0.2,0.9697985332170046,1.0,19/102,6.37%,MMP2;PRRX1;AMOTL2;FIBIN;BGN;HSPG2;PODN;YAP1;COL12A1;TNS2;PAWR;PLA2R1;CXCL12;PDE3A;PDGFRA;CSTB;PML;LDB2;THY1
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),-0.6231534083110195,-0.9426830306097584,0.6388888888888888,1.0,1.0,1/5,3.58%,PAH
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.46680914865692746,-0.9426213007002627,0.5903614457831325,1.0,1.0,12/36,27.41%,RRH;UVSSA;MSH6;ZRANB3;DDB2;USF1;FECH;MEN1;UBE4B;MAP2K7;BRSK1;CLOCK
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),-0.5405390273895406,-0.942547753660772,0.5769230769230769,1.0,1.0,4/15,10.97%,PTP4A3;CCT6A;CCT8;CEP135
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),0.5743971275067344,0.9424360941145711,0.6388888888888888,0.9703779933788266,1.0,1/5,3.36%,EIF3D
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),0.48750466825826555,0.9421859259176492,0.5,0.9702589708769396,1.0,1/10,1.86%,ANKRD13D
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.37036359516240364,0.9421684046155179,0.42857142857142855,0.9694587800198405,1.0,7/88,6.29%,U2AF1;LSM4;NOVA1;SMU1;LSM1;SNRNP40;HNRNPC
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.43517164912776174,-0.9419690739373253,0.6736842105263158,1.0,1.0,19/118,15.30%,CD44;HTR2C;PTPRC;APIP;TIMP3;OPRM1;PRXL2C;MAP3K12;APOE;CAMK2N1;PDE8A;TRAF7;HTR2B;ITGB1BP1;RASGRP1;ARRB1;EPHA7;PTPRR;NTRK3
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),-0.6232090108570316,-0.9418152175162596,0.6774193548387096,1.0,1.0,2/5,16.34%,POLE3;EZH1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.442133174168865,0.9416747890921723,0.5652173913043478,0.9698977699347464,1.0,4/14,10.24%,MSN;CTSC;PTTG1IP;RNF128
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.5207336386423523,-0.9415514735978859,0.5866666666666667,1.0,1.0,7/15,21.08%,SPI1;STAT3;IL6R;JAK1;STAT1;ST18;SMAD4
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.36251398714795874,0.9413073027729251,0.5714285714285714,0.9697640179393073,1.0,9/65,11.60%,ACTB;SLITRK2;DHFR;SEMA5A;S100B;EPHB3;RTN4RL2;NTNG2;MAP1S
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),0.45081835773997014,0.9412530607048922,0.45714285714285713,0.9689972378956141,1.0,1/11,2.15%,NR1H2
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.5463077386014494,0.941155507421517,0.5675675675675675,0.9684015428998399,1.0,5/12,16.59%,SLC30A10;STIM1;SRI;EPB41;CACNA2D1
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.41101545161244935,0.9410821259483438,0.8,0.9676681160570338,1.0,23/99,14.00%,VPS37B;TSPO;SPCS2;ZDHHC6;ZDHHC1;YIF1B;MFF;GOLGA7;AP4E1;MICALL1;ZDHHC4;ZDHHC21;ZDHHC11B;ZDHHC3;AIP;SRP14;TIMM13;AP4M1;TIMM22;KATNB1;FIS1;ZDHHC2;DNAJC19
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),-0.45187895007908824,-0.9410156932553022,0.6052631578947368,1.0,1.0,10/48,16.75%,STMN2;EFNA1;STX1B;KIAA0319;APOE;MAG;BAG5;BCL11A;CRMP1;GAK
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.5586467525996407,0.94096724562178,0.5,0.9670592038410191,1.0,1/5,10.92%,LNPK
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.46027642412118186,-0.9407405635884211,0.5813953488372093,1.0,1.0,13/48,20.12%,NR4A3;ROBO2;RARA;AKR1C2;ARID5A;NCOA1;KLF9;SRA1;STAT3;STAT5B;RDX;LMO2;NSMF
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.399695406357533,0.9405555324019441,0.5882352941176471,0.9671285872056705,1.0,6/46,7.59%,BAD;G0S2;HIPK1;BAG3;NGF;BOK
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),0.550502981656071,0.9405453857625895,0.5925925925925926,0.9662905208389411,1.0,1/9,1.00%,HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),-0.641023054718445,-0.9404375640955858,0.6181818181818182,1.0,1.0,1/5,4.26%,CDKN2A
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.485969264237482,0.9402118138362464,0.5,0.9664372753412627,1.0,1/12,3.46%,RAN
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.47441512547339004,-0.9401198598087137,0.5915492957746479,1.0,1.0,5/38,10.93%,RFC4;BRCA1;RFC1;RFC2;RPA3
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.46145750905016425,0.9401132000476065,0.5161290322580645,0.9658008311100968,1.0,3/12,13.87%,PPIA;POLD3;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),0.5297358499098925,0.9399798460925872,0.6071428571428571,0.9653802273129178,1.0,2/9,10.58%,TMEM178A;TCTA
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.4444407267280385,-0.9399694345896479,0.6559139784946236,1.0,1.0,3/86,3.35%,RASGRF1;ITPR1;TTC23L
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5279229275185663,0.9399572105953261,0.5714285714285714,0.9645772163213647,1.0,3/8,13.01%,PIH1D1;PLAUR;PRR7
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.6282335386207067,-0.939934866349701,0.6461538461538462,1.0,1.0,1/5,19.16%,ATM
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),-0.4796226221190365,-0.9394953974527055,0.6172839506172839,1.0,1.0,3/23,9.85%,FABP3;SREBF1;APOE
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),0.3331343045271091,0.9393812608897388,0.6363636363636364,0.9651383698955431,1.0,13/95,7.80%,PPP1R14B;MALT1;COLEC12;PHB2;IKBKB;TRIM35;TRIM28;ZDHHC1;LYN;PML;SMPD1;S100B;TNK2
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),-0.6009530968261667,-0.9392031546789206,0.6351351351351351,1.0,1.0,2/10,12.34%,SHMT1;TMLHE
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.5848637701647226,-0.9391422444382862,0.6363636363636364,1.0,1.0,5/12,25.35%,AKAP5;AKAP12;ADGRV1;PRKAR1B;PRKAR2A
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.5009371496445003,-0.9391027425390538,0.5294117647058824,1.0,1.0,4/19,22.79%,MYLK;CAMK2A;PDGFRB;GRIN1
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.4802234374198704,0.9391026322451834,0.4642857142857143,0.9649030120183405,1.0,1/13,3.46%,RAN
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.5349252286571778,-0.9389914912326418,0.5975609756097561,1.0,1.0,2/13,25.74%,PNKP;MAP2K7
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),-0.5776866911603655,-0.9389529891700678,0.6233766233766234,1.0,1.0,1/8,11.34%,ACSS3
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.4005928537221116,0.9383069588131717,0.5333333333333333,0.9660743480895408,1.0,5/32,11.43%,MLST8;RRAGA;PIH1D1;LAMTOR2;MIOS
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.4668230688594739,-0.9382956630871491,0.6296296296296297,1.0,1.0,7/39,10.00%,HEY2;HES1;PRUNE1;OPRM1;DOCK7;LRP2;B2M
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.516112814435429,-0.9382210618773833,0.5789473684210527,1.0,1.0,6/15,27.89%,CD160;PDCD4;ANO6;ITGA4;SCG2;PLCG1
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.43645541153298106,-0.9380995775694441,0.6144578313253012,1.0,1.0,9/67,13.20%,CAMK1;FGF1;SPDYA;TPD52L1;MTCP1;CEMIP;VEGFA;HTR2B;RASGRP1
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),-0.4981903942347926,-0.9379991868674311,0.5555555555555556,1.0,1.0,4/20,22.66%,CAMK1;RBM4;CTNNA1;MAPK12
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.4556698788856604,-0.9379858220727895,0.611764705882353,1.0,1.0,8/44,9.82%,HTR2C;GPR18;GRM1;FPR3;CAV3;CACNA1C;ACKR4;EDNRA
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),-0.5686106447132382,-0.9377748425670996,0.625,1.0,1.0,2/8,9.19%,STEAP4;STEAP2
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.601388213267136,-0.9375251511734145,0.5882352941176471,1.0,1.0,3/7,4.21%,HTR2C;GPR18;GRM1
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.40961992989680485,-0.9372050793103341,0.6391752577319587,1.0,1.0,17/170,15.91%,ABLIM1;FHDC1;FAM161A;MAK;RAB17;INTU;RAB11A;CFAP221;INPP5E;CCDC57;RPGR;AHI1;RILPL1;CFAP52;CFAP70;AVIL;B9D1
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.34493477632626823,0.9368367864871555,0.5,0.9689389255786375,1.0,16/104,10.54%,UBB;HSPA1A;PRR5L;PCBP4;PSMD8;PSMB4;ZFP36L1;PSMB6;FXR2;HSPA8;PSMD10;PSME3;ZC3HAV1;RC3H1;EXOSC8;UBC
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),0.43911050377814165,0.9367246073174685,0.6296296296296297,0.9684262366834634,1.0,3/16,5.75%,ZNF488;SOX10;B4GALT6
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.6185913632474251,-0.9364257227528043,0.6428571428571429,1.0,1.0,3/6,31.37%,VEGFA;GDF11;MEST
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.4944326197052442,-0.9363566356710871,0.5875,1.0,1.0,8/33,18.92%,HOOK1;PLEKHF1;DNM1;USP50;USP8;ARFGEF2;HOOK3;HOOK2
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.4417008685975102,0.9362184583886213,0.48148148148148145,0.9689969194340287,1.0,1/19,0.20%,SYNDIG1
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),0.5204915257174499,0.9362168453049499,0.5405405405405406,0.9681803956830527,1.0,2/7,4.42%,HSD17B10;TRMT10A
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),-0.5966132664550989,-0.9358397720643186,0.639344262295082,1.0,1.0,1/6,1.83%,NR4A3
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),-0.528935634136802,-0.9350091769728307,0.620253164556962,1.0,1.0,2/14,13.36%,FBXO6;ADAMTS9
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.5215596359727628,0.9347713978364052,0.5277777777777778,0.9707441561919211,1.0,2/8,13.59%,METAP1D;NAA30
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),-0.5711938131790627,-0.9347197657370834,0.5882352941176471,1.0,1.0,2/8,7.49%,GRIN2A;NLRC4
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),0.5658998193708795,0.9347189722313484,0.5526315789473685,0.97001877752066,1.0,2/5,21.08%,TRPM4;HMGB1
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),-0.5425166312734496,-0.9346537472230209,0.5857142857142857,1.0,1.0,6/12,35.71%,EPAS1;MAPK12;HINFP;PLEKHM3;NRG1;JAG1
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.4429932551131334,-0.9345886045819667,0.5978260869565217,1.0,1.0,15/58,21.60%,GRIN2A;AKAP5;SYT1;GRIN2D;STX1B;RIMS1;PLK2;HAP1;SLC24A2;CACNG8;ADCY1;SHANK3;CACNG2;CACNG7;DLG4
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.3277896461439674,0.9344217298513786,0.6666666666666666,0.9697200767129811,1.0,11/70,10.78%,TCF7L1;GSKIP;ESR1;FRZB;MDFI;CDC73;CTNNBIP1;AMER2;PPP2R1A;CXXC4;NFATC1
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.36702110264830706,0.9344126252204458,0.4090909090909091,0.968920909409629,1.0,8/23,19.56%,PREB;SURF4;SEC61B;AUP1;HSP90B1;VCP;HERPUD1;DERL2
prerank,GO_Biological_Process_2021__somite development (GO:0061053),0.5448085813983459,0.9343995253700789,0.53125,0.9681079400422251,1.0,2/7,3.79%,SOX11;MEOX2
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.5142183034634348,0.9342939053717492,0.5625,0.966713297433196,1.0,1/7,1.74%,ADCY6
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.5142183034634348,0.9342939053717492,0.5625,0.966713297433196,1.0,1/7,1.74%,ADCY6
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.4512275126406938,0.9341381243508357,0.6176470588235294,0.9663581703560685,1.0,3/10,18.02%,WASF3;BRK1;WHAMM
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.41554920130037226,0.9341160619668626,0.5172413793103449,0.9656257362222758,1.0,2/12,9.30%,ZFP36L1;CTNNBIP1
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),-0.580176058247444,-0.9340973886521305,0.6428571428571429,1.0,1.0,2/10,15.72%,AKT2;SORBS1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.5647033011433955,0.9337651188985641,0.5555555555555556,0.9657856621663992,1.0,3/6,13.87%,CALM3;SRI;CALM1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),-0.6150780132860473,-0.9333532660759856,0.578125,1.0,1.0,3/6,22.26%,HLA-F;TGFB2;TGFB1
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.5924295489054232,-0.9329801300205206,0.6363636363636364,1.0,1.0,5/8,32.27%,OAS1;MAP2K5;TIRAP;OAS3;FOXP1
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),0.48191472289054305,0.9329509623981036,0.4,0.9670318518141872,1.0,1/11,2.83%,RFK
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.4232452083918532,0.9328946903177997,0.5833333333333334,0.96640625783993,1.0,4/17,13.96%,RAN;TRIM71;DGCR8;KHSRP
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.581197562890398,-0.9328599212428904,0.6363636363636364,1.0,1.0,7/10,41.46%,STAT3;CD55;CD46;JAG1;GNL1;BACH2;MSH2
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.5810827828157683,-0.9326589993087465,0.5571428571428572,1.0,1.0,3/5,36.07%,STAT3;IL17RA;APPL1
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),-0.5743883902558486,-0.9326552124112439,0.6410256410256411,1.0,1.0,3/9,24.02%,ALK;DAB2IP;PACSIN1
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.4267117338535276,-0.9326240904198012,0.6451612903225806,1.0,1.0,17/138,13.95%,CD44;SOX9;ANGPTL4;PYGL;NDST3;TPST1;DSC2;COL5A1;PYGB;GMPPA;LDHA;VEGFA;SLC16A3;GLRX;GAPDHS;PFKP;PPFIA4
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.4635777170968389,-0.9322474952493338,0.5975609756097561,1.0,1.0,7/35,15.08%,RASGRF1;GPR18;MMD2;RASGEF1A;RASGRP1;ARRB1;LPAR6
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.3274071118324351,0.9318343779233894,0.6,0.9682976064482954,1.0,21/82,12.88%,ARV1;KDSR;PPT1;NEU1;CTSA;SGPP1;SMPD1;SPTLC1;ACER2;SMPD3;NEU3;VAPB;GBA3;SGMS1;PPP2R1A;ST6GALNAC3;ESYT2;ELOVL4;ACER3;UGT8;GM2A
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.5146531448106535,-0.9317934574942818,0.6133333333333333,1.0,1.0,5/17,20.59%,ANGPTL4;CEBPD;ABCC3;RBM47;RAB20
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),0.4286184907262146,0.9316677263058806,0.5652173913043478,0.9678676809875477,1.0,4/15,9.08%,SLC30A10;SLC39A10;MT1E;MT3
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.31522360465823396,0.9313496202831874,0.6666666666666666,0.9677693558157491,1.0,32/208,14.02%,USP51;UBB;ACTB;ADRM1;USP12;PSMD8;PSMB4;ESR1;ATXN7L3;PSMB6;TAF9B;UBE2D1;JOSD2;PSMD10;ACTR8;OTULINL;INO80D;PSME3;RNF128;SMURF2;UBC;SMAD3;TGFBR1;POLB;YOD1;USP31;SMAD7;OTULIN;PSMB2;PSMD12;RAD23A;OTUD5
prerank,MSigDB_Hallmark_2020__Coagulation,0.32670082128071376,0.9305440555837492,0.7,0.9688282671938887,1.0,4/66,3.48%,MMP2;SIRT2;CTSV;PEF1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),-0.5147955192735512,-0.9304593634815832,0.6216216216216216,1.0,1.0,2/23,6.94%,STMN2;PRUNE1
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),-0.60452479057182,-0.9303388725060481,0.5555555555555556,1.0,1.0,1/6,5.39%,BRCA1
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.6340617106913493,-0.9303269257950652,0.6129032258064516,1.0,1.0,2/5,24.83%,DDRGK1;UBA5
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.6340617106913493,-0.9303269257950652,0.6129032258064516,1.0,1.0,2/5,24.83%,DDRGK1;UBA5
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.6340617106913493,-0.9303269257950652,0.6129032258064516,1.0,1.0,2/5,24.83%,DDRGK1;UBA5
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),-0.4325465602888466,-0.9302178705242952,0.6444444444444445,1.0,1.0,15/86,17.42%,IQSEC2;GRM1;SYT1;CPLX1;STX1B;KCNMB4;GRIK5;CACNA1B;RIMS1;BDNF;GRM3;CAMK2A;BEGAIN;SYN3;BCR
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),-0.512765736989169,-0.9302114807014796,0.5972222222222222,1.0,1.0,5/20,26.71%,P2RY12;RHOJ;RAC3;RHOU;GSN
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.518864280773257,0.9300501168078428,0.5476190476190477,0.9691797208296644,1.0,2/6,22.21%,SPRY1;SPRED1
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5856090565394343,0.9297852281958446,0.52,0.9683519885947733,1.0,4/6,29.60%,CHP1;PRNP;DYRK2;ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.5856090565394343,0.9297852281958446,0.52,0.9683519885947733,1.0,4/6,29.60%,CHP1;PRNP;DYRK2;ATP2B4
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.5027895074574015,0.929665284122629,0.5769230769230769,0.9677295040002745,1.0,2/7,9.30%,ZFP36L1;CTNNBIP1
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.5677612399240964,-0.9296516743840263,0.6575342465753424,1.0,1.0,2/10,4.67%,PARP9;PARP14
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.4369327205883372,0.9296201515123259,0.3684210526315789,0.9670033243993325,1.0,6/25,9.89%,ATP6V0A4;MCOLN1;ATP6V0E1;ATP6V1G1;ATP6V1B2;ATP6V0D1
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.5367618001148309,0.9296136784717483,0.5757575757575758,0.9662036137212766,1.0,5/10,15.91%,NEU1;NEU3;ST6GALNAC3;GM2A;NEU4
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.5394174708347983,0.929547803480747,0.5925925925925926,0.96558450945393,1.0,3/8,15.31%,TGFBR2;TGFBR1;INSIG1
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),0.5675670541747226,0.9294425893041994,0.59375,0.9650261496834073,1.0,2/5,11.56%,PHB2;CLPB
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.30110822463042475,0.9292518374306383,0.8333333333333334,0.9647073400912844,1.0,39/167,19.21%,UBB;RNF144A;ADRM1;UBE2D4;RNF6;ELOC;UBE2D1;FBXO45;UBA1;KLHL8;UBE2I;PPP1R11;AREL1;TOLLIP;RC3H1;RNF128;SMURF2;UBC;UBE2G1;RCHY1;FBXL7;FEM1A;ANAPC11;KCTD10;CDC34;UBQLN2;ANAPC7;WDR81;RNF166;NDFIP2;RLIM;UBE2D2;FBXL14;RNF126;CDC26;RNF168;RNF146;UBE2A;HERPUD1
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.6436598851104256,-0.9291268723082119,0.6756756756756757,1.0,1.0,1/5,10.27%,RAB3A
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),-0.5868502514377896,-0.9288666568052051,0.6461538461538462,1.0,1.0,2/7,26.32%,ALK;PRKAA1
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),-0.6158673947314676,-0.9288304748014306,0.6212121212121212,1.0,1.0,3/6,22.78%,EDNRA;HTR2B;ACTA2
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),-0.6054657033183878,-0.9287955224300328,0.6338028169014085,1.0,1.0,2/6,32.47%,CPEB1;CPEB3
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.45863116388278563,0.9284590664385381,0.5,0.9657301300612368,1.0,8/15,16.33%,PPP1R35;PPP1R8;GPATCH2;YWHAB;CHP1;PPP1R26;ZCCHC9;MFHAS1
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),-0.5763485903041986,-0.9283359845734241,0.6231884057971014,1.0,1.0,1/7,2.73%,MAFF
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.6111100048730708,-0.9279739123690911,0.6060606060606061,1.0,1.0,1/7,7.29%,MSH6
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),-0.5346779207466966,-0.9279484523414209,0.5972222222222222,1.0,1.0,2/11,19.02%,HAP1;DNM1L
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),-0.607433609326308,-0.9278812350628208,0.6031746031746031,1.0,1.0,2/7,32.09%,RAB20;SYT7
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),-0.5214876391039772,-0.9278343049097876,0.6282051282051282,1.0,1.0,2/16,9.13%,SCEL;FLG
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.33528245851399086,0.9275246627068214,0.5,0.9667363157279277,1.0,12/48,18.51%,LRRC8D;SLC25A1;SLC5A6;ARL6IP5;SLC7A2;SLC25A4;SLC35B4;SLC1A2;SLC25A30;SLC7A1;SLC25A11;SLC25A14
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.4644511590664352,0.9275142613164259,0.47058823529411764,0.9659408508778182,1.0,4/15,11.53%,LYN;KLHDC10;ARL6IP5;INAVA
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),-0.5073192965454881,-0.9275025340091048,0.5857142857142857,1.0,1.0,4/17,24.37%,RBSN;ARMH3;MAP2K1;STX5
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),-0.595550623703168,-0.9274569116409109,0.6197183098591549,1.0,1.0,1/6,6.59%,P2RY12
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.6013635701753887,0.9273650699197881,0.631578947368421,0.9655777534201448,1.0,2/5,10.40%,ZBTB1;ATF4
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.5535160357572376,-0.92716493016468,0.6329113924050633,1.0,1.0,5/13,25.62%,DVL2;MACF1;DVL1;DLG4;DVL3
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.48333419172263115,-0.9270020565218088,0.6790123456790124,1.0,1.0,5/27,8.30%,HEY2;HES1;NKX6-2;PRUNE1;DOCK7
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.5133082057333881,-0.926668695426316,0.5975609756097561,1.0,1.0,5/17,22.57%,GNA12;ITGB1BP1;DDR2;TGFB1;RFFL
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.5882745680321493,-0.9266244266304882,0.5967741935483871,1.0,1.0,3/6,28.47%,CENPC;NUF2;CENPH
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.6356464841982346,-0.9263933761366067,0.609375,1.0,1.0,4/5,34.60%,TGFB1;MEF2C;USP19;FLOT1
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.3555265832837296,0.9263686671415026,0.6,0.9672052757400771,1.0,10/101,6.37%,SYNDIG1;AMOTL2;FIBIN;BGN;MAGI1;GPC1;TCEAL7;FRZB;BCAR1;THY1
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.45467527879490666,0.9262093219859587,0.5,0.9659895294462543,1.0,3/10,6.16%,CCT5;LARP7;CCT3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.45467527879490666,0.9262093219859587,0.5,0.9659895294462543,1.0,3/10,6.16%,CCT5;LARP7;CCT3
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.49368706520986905,-0.9261708988841537,0.581081081081081,1.0,1.0,4/25,16.12%,KCNJ11;BRAT1;OAS1;GALM
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),-0.5793063741178305,-0.9260635977141662,0.6363636363636364,1.0,1.0,1/8,7.54%,ROBO2
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.400452255472454,0.9259672851672527,0.5,0.9657312992323974,1.0,4/22,7.95%,YAP1;CATSPERD;WBP2;NR3C1
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),0.4864809941456497,0.9257379145008175,0.6451612903225806,0.9654734997611829,1.0,2/9,7.98%,H1-10;H1-4
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.4066166014919082,-0.9256881773929811,0.7446808510638298,1.0,1.0,54/221,24.00%,SOX9;IL5;DUOX1;IRF1;CRLF1;IFNGR2;BRCA1;IL3RA;FOS;STAT2;OPRM1;CEBPD;LIFR;DAPK1;DOCK8;STAT4;STAT6;IL7;SHMT1;OAS1;VEGFA;BCL2L11;OSMR;FOXO1;NR1D1;TCF7;STAT5A;IFIT1;DAPK3;STAT3;STAT5B;IRAK2;IL6R;JAK1;STAT1;GRB10;PTPRJ;RIPK1;ST3GAL6;NLRP12;DAB2IP;JUNB;AQP4;ADAMTS7;RUFY4;TGFB1;TXLNA;RHOU;BCL6;USP10;IL34;PIK3CB;ZFP36L2;STX4
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.46745821477486726,-0.9254745886457649,0.6103896103896104,1.0,1.0,6/29,30.32%,FOS;EPHA7;TGFB2;BACE1;DDIT4;EFNB2
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),0.49147108785763405,0.9254280516031812,0.47619047619047616,0.9654231753671375,1.0,2/9,12.44%,NT5E;NT5C1A
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.27456595003750633,0.9253525779093142,1.0,0.9647375390815507,1.0,41/328,9.10%,SOX4;STOX1;SOX11;SIRT2;CCND1;BTC;IL15;NACC1;GID8;CALR;TGFBR2;COLEC12;COPS9;ZFP36L1;CNBP;TGFA;CXCL12;TBRG4;CHRNA7;POU3F2;PDGFRA;CAPNS1;NPM1;TAF9B;LYN;FXR2;CDC123;CLEC11A;GREM1;S100B;RPS19;ACER2;RPS15A;PDGFD;ZNF268;BAMBI;ACLY;TRPM4;RPRD1B;MT3;PSMD10
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),-0.5344125492338744,-0.9251486509139794,0.6410256410256411,1.0,1.0,2/16,13.01%,BRAT1;HAP1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),0.6058637798423596,0.9251203359558159,0.6578947368421053,0.9644812097921702,1.0,1/5,2.69%,TGFBR2
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),0.5551935949831598,0.9249878826709511,0.5,0.9639450171754264,1.0,3/5,22.55%,SF3A2;SF1;SLU7
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.3621591135294458,0.9249552822062846,0.48148148148148145,0.9632180975164234,1.0,7/32,8.35%,TMED2;MAP2;CSTB;RCC2;PPP1R35;GPATCH2;GPSM1
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3061267844137737,0.9249161307647583,1.0,0.9625365671420345,1.0,57/270,16.56%,SIRT2;UBB;TNFAIP1;UBE2J1;PSMD8;GID8;PSMB4;KBTBD6;PCBP2;PSMB6;UBE2D1;DMAC2;FBXO45;UBXN1;PML;KBTBD7;DNAJB12;RHBDD2;KLHL42;PELI1;PSMD10;AREL1;PSME3;SMURF2;SEC61B;UBC;UBE2G1;TRIM71;YOD1;HECTD3;AUP1;FBXW5;TMUB2;PSMB2;PSMD12;SIRT1;RAD23A;FBXL7;FOXRED2;KCTD13;FEM1A;HSP90B1;ERCC8;HSPA5;FBXO44;UBXN4;ANAPC11;KCTD10;EDEM1;CDC34;UBQLN2;ANAPC7;PSMC1;RBCK1;NSFL1C;UBE2J2;PSMD4
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.5348825772879973,-0.9248556029192307,0.6338028169014085,1.0,1.0,4/12,21.86%,NBR1;ATM;USP30;RB1CC1
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.46552725645126947,-0.9248512872945432,0.7111111111111111,1.0,1.0,7/37,21.13%,FBXO6;SIDT2;ADAMTS9;DENND3;NCBP1;RIPK1;DAB2IP
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.3830173170984124,0.9246985013905856,0.5,0.9622829130509101,1.0,14/66,6.37%,MMP2;PRRX1;FBLN5;FIBIN;BGN;FBLN2;PODN;CYBRD1;CXCL12;TLR1;PDGFRA;IGFBP7;LDB2;THY1
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),-0.5989544844721757,-0.924594178878029,0.6818181818181818,1.0,1.0,1/5,10.54%,VEGFA
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.36588539358248295,0.9244394084159466,0.3333333333333333,0.9620884920222305,1.0,14/69,15.20%,IPO13;PHB2;NUTF2;RAN;PRICKLE1;PPP1R10;ABCD2;PTTG1IP;HSPA4;FAM53C;FIS1;PEX13;ACBD5;NUP214
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.6635469797929872,-0.9244355162940597,0.6438356164383562,1.0,1.0,2/5,12.02%,B2M;BDNF
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.5946517738666108,-0.9241013719512612,0.6376811594202898,1.0,1.0,2/6,21.02%,NEFL;GFAP
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.31677289293793265,0.9240204760103311,1.0,0.9620706850967162,1.0,24/221,8.21%,SOX4;UTP11;SIRT2;UBB;BAD;NCSTN;FGD3;PAWR;MCF2;TRIM35;PLEKHG5;BTG1;CLIP3;NGF;SMPD1;IP6K2;FRZB;STPG1;QRICH1;PHLDA1;RYBP;BOK;ZNF268;ARL6IP5
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),0.5421564811007987,0.9231829995907368,0.6666666666666666,0.9624311613938924,1.0,1/7,7.52%,SMPD3
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),0.5421564811007987,0.9231829995907368,0.6666666666666666,0.9624311613938924,1.0,1/7,7.52%,SMPD3
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.5161386711992343,-0.9231438172393703,0.5970149253731343,1.0,1.0,4/14,16.09%,CAV3;B2M;RFLNA;HOOK3
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.32790072937693043,0.9229506869240862,1.0,0.9621346777631825,1.0,54/302,12.05%,ZNF488;SOX4;SOX11;ZNF676;TCF7L1;POU6F2;SLC2A4RG;ONECUT1;CALR;ZNF117;CNBP;HP1BP3;RNF6;TFEB;ESR1;BTG1;ZNF519;WTIP;SOX21;MED23;ZNF536;POFUT1;PML;SP1;GPBP1L1;NFIL3;ZNF678;ZNF22;RYBP;ZNF114;NR3C1;SPIN2B;ZNF268;SOX6;ESRRG;ZFPL1;ACTR8;ZNF195;LIMD1;FOXN2;SP3;PPP2R1A;KAT6B;WWC2;NFYA;ATF4;COPS2;HES6;TGFBR1;ZNF516;ESRRA;TRIP4;ZBTB11;ZNF257
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.5333629677719485,-0.9223189868292699,0.5394736842105263,1.0,1.0,2/11,9.13%,SCEL;FLG
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.5020719428533277,0.9216247622668337,0.47619047619047616,0.9642986288611769,1.0,4/11,3.48%,SOX11;SOX8;KLHL12;PEF1
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.39047499673218466,0.9210931618560824,0.5333333333333333,0.9647179871328634,1.0,4/21,7.14%,PRR5L;MLST8;TIPRL;SYAP1
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.5051195531743188,-0.9210905548444098,0.6375,1.0,1.0,4/17,17.95%,NCOA1;SLC51A;ATP8B1;ABCC3
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.5283389418456105,-0.9208510567847025,0.6,1.0,1.0,3/13,10.54%,PTPRC;IL7;VAV3
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),-0.5394942962071305,-0.9204369099894426,0.620253164556962,1.0,1.0,4/12,12.86%,P2RY12;EDNRA;BDNF;HTR2B
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.4136294871600796,-0.9200502694590574,0.6808510638297872,1.0,1.0,24/139,17.23%,AHR;MX1;IRF1;TRPC5;GADD45A;PLSCR1;BCL2L14;BRAT1;EFNA5;DAPK1;TNFRSF19;AHCYL1;BCL2L11;PRUNE2;FOXO1;TRAF7;C19ORF12;PDCD4;AKAP1;YARS1;TCHP;DAPK3;IFI6;CIT
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.49325973139304347,0.9199638371746208,0.5454545454545454,0.96674467961678,1.0,2/12,10.79%,PLIN2;SCARB1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.5546886681997423,-0.9199577211334179,0.6623376623376623,1.0,1.0,1/11,1.24%,DND1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.4915913360017612,-0.9197941183402919,0.5925925925925926,1.0,1.0,5/24,21.28%,RFC1;GAR1;TELO2;ZBTB48;TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),-0.48603579774768085,-0.9196894970801183,0.5774647887323944,1.0,1.0,4/18,14.77%,SHTN1;LIMK1;VEGFA;MACF1
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.5794533657777167,0.918984943011997,0.6060606060606061,0.9681253553393434,1.0,2/5,6.92%,YAP1;WBP2
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),-0.5151478756667148,-0.9188448297702606,0.6410256410256411,1.0,1.0,4/20,18.10%,HES1;CCDC57;MEIS2;EIF4EBP1
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),-0.5846826634705005,-0.9186784770421681,0.6470588235294118,1.0,1.0,3/6,37.49%,STAT3;GHR;JAK2
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),-0.5966071108586385,-0.9186720874144764,0.5972222222222222,1.0,1.0,2/6,26.07%,PUS7;TRUB2
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),-0.5079863216124831,-0.9186515285987293,0.5753424657534246,1.0,1.0,3/16,18.84%,SLC13A3;GJA1;PDPN
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.5606247303165801,-0.9184981558805562,0.625,1.0,1.0,4/8,16.99%,STAT6;STAT5A;STAT3;STAT5B
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.42472947816614715,0.9183719382972618,0.5925925925925926,0.9687740418934819,1.0,2/15,2.57%,CHRNA4;SYT9
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),-0.5761160357311976,-0.9181073683872797,0.6612903225806451,1.0,1.0,2/7,10.54%,LRP2;VEGFA
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.5167315592019466,0.9180494962816756,0.5853658536585366,0.9688237850585135,1.0,1/6,3.37%,MAP2K6
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.5114536570932311,-0.9179761688443788,0.6,1.0,1.0,2/13,16.00%,VEGFA;DENND6A
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),-0.4245891305635277,-0.9178249007326645,0.6744186046511628,1.0,1.0,18/73,23.07%,KCNJ13;KCNJ11;KCNC1;KCNN3;KCNH7;KCNQ1;HCN3;SLC24A2;KCNB2;KCNH1;KCNG4;KCNK10;ATP1B1;HCN1;HCN2;KCNQ5;KCNC4;SLC9A8
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),-0.5897438587889381,-0.9177350741287462,0.6176470588235294,1.0,1.0,2/7,26.64%,IRAK2;IRAK4
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.44829964532985056,-0.9177124860110274,0.625,1.0,1.0,10/52,18.73%,FHDC1;TTN;TMOD3;TPM1;ARRB1;SORBS1;PGM5;MYOM2;CIT;CDC42BPB
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.4118829827893063,-0.9174468208759077,0.6777777777777778,1.0,1.0,12/108,13.08%,CD44;SOX9;STMN2;OVOL2;DUSP22;EMD;LRP2;RUNX2;VEGFA;PDE8A;VIL1;ITGB1BP1
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.40841252805248607,0.9173071960566411,0.625,0.9697913818648778,1.0,4/15,11.04%,CCT5;RUVBL2;CCT3;NHP2
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.4970066172656012,-0.9171560667718525,0.5512820512820513,1.0,1.0,7/20,22.79%,VSIR;EFNA1;USP50;STAT3;APH1B;EPHA4;GRIN1
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.5783713903687635,-0.9171148057095007,0.6363636363636364,1.0,1.0,2/7,21.28%,RIF1;TERF2IP
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),0.37946064122543677,0.9170277557478718,0.5625,0.9698110919491908,1.0,11/45,16.56%,ODC1;PSMD8;PSMB4;PSMB6;PSMD10;PSME3;PSMB2;PSMD12;BHMT;PSMC1;PSMD4
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.462105970279005,-0.9168188417766391,0.6075949367088608,1.0,1.0,8/40,24.99%,CRNKL1;SRSF5;CELF4;NCBP1;LUC7L3;TXNL4A;CELF3;ZRSR2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.42119862343394254,-0.9167705055701973,0.651685393258427,1.0,1.0,3/65,5.10%,SOX9;PIP4K2C;AGT
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),0.588253994266588,0.9163512644018562,0.6774193548387096,0.9703980838467595,1.0,1/6,1.00%,HSPA1A
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),0.5344164202883287,0.9159552789295934,0.5,0.9705190069733987,1.0,1/5,12.23%,SLC25A4
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.5196211370786238,-0.915630929730688,0.625,1.0,1.0,5/15,22.26%,OVOL2;KIAA0319;PBLD;SMAD4;TGFB1
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.32167137321873174,0.9149532685456534,1.0,0.9718886851039696,1.0,26/179,12.59%,TAF1A;GMEB2;POLR2J;POLR2L;ELOC;TAF9B;RO60;GTF2A2;GTF2H2;SSRP1;TCEA1;PTMA;EAF2;PARP1;GTF3C6;CDC73;POLR2K;NFYA;ATF4;EAF1;COPS2;TRIM24;SLC25A33;ERCC3;GTF2F1;POLR2E
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.46777481204974736,0.9148378269669655,0.5416666666666666,0.9697982923983631,1.0,1/10,1.54%,MOSPD2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.46777481204974736,0.9148378269669655,0.5416666666666666,0.9697982923983631,1.0,1/10,1.54%,MOSPD2
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.46777481204974736,0.9148378269669655,0.5416666666666666,0.9697982923983631,1.0,1/10,1.54%,MOSPD2
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.6320916287936887,-0.9145117065884125,0.6774193548387096,1.0,1.0,4/5,32.61%,CYP1B1;RDH10;RDH12;RDH11
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.49390754247518864,-0.9144776958271049,0.6081081081081081,1.0,1.0,6/21,29.62%,ZRANB3;WRN;RECQL;DDX11;MTERF1;DHX36
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.42367126746007144,0.914471043022782,0.4,0.9698757856124195,1.0,3/20,6.75%,SIRT2;ADCY6;PDE4B
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.5769396557865539,-0.914129302414905,0.7058823529411765,1.0,1.0,2/8,20.09%,APOE;ADAM9
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),0.4107420543874503,0.9134796242628103,0.5454545454545454,0.9714573594837533,1.0,3/18,9.12%,SIRT2;NGF;PLAUR
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-0.6124622883716494,-0.9131980442251595,0.6153846153846154,1.0,1.0,1/6,7.29%,MSH6
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),-0.44234242819373865,-0.9131073970699461,0.6043956043956044,1.0,1.0,5/45,13.36%,FBXO6;GCNT1;MAN1A1;ADAMTS13;ADAMTS9
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.4680257178927447,-0.9130831805360012,0.6538461538461539,1.0,1.0,8/28,24.83%,KLC1;MCTS1;VRK1;DDRGK1;RB1CC1;EIF2D;STX5;UBA5
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),0.3386943104156771,0.9129320397213648,0.5238095238095238,0.9719958314697938,1.0,4/56,3.75%,UBB;MALT1;CTSV;CTSC
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),-0.6173082774822434,-0.9127713732743051,0.7241379310344828,1.0,1.0,1/6,18.35%,IFI35
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.4379467709009907,-0.9127626935966762,0.6588235294117647,1.0,1.0,10/59,14.00%,SPDYA;CDK7;CDKN2A;MAX;BACH1;PLK2;CRLF3;CDC7;CAMK2A;CDK4
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),-0.5825327609034907,-0.912370034237894,0.6617647058823529,1.0,1.0,2/9,15.72%,AKT2;SORBS1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),-0.5051491975305331,-0.9123185336517908,0.684931506849315,1.0,1.0,3/22,13.46%,SOX9;RANBP3L;NBR1
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),-0.43566198608981554,-0.912175769219041,0.6703296703296703,1.0,1.0,13/51,22.79%,HTR2C;TPCN2;CALCB;HTR2B;SLC24A2;ATP2B3;ATP13A5;FAM20A;ATP1B1;RYR2;SLC8B1;SLC24A5;GRIN1
prerank,PanglaoDB_Augmented_2021__Pericytes,0.32793211566368996,0.912133338816264,0.7777777777777778,0.9727933470261171,1.0,13/80,6.37%,MMP2;PRRX1;FIBIN;BGN;FBLN2;PODN;TNS2;NT5E;CXCL12;PDGFRA;LDB2;FRZB;THY1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.4382908436669182,0.9121200034126131,0.5517241379310345,0.9720168863777601,1.0,6/17,5.57%,ACTB;ACTG1;LAMA3;SOX8;SOX10;LIN7C
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.48557847269867127,0.9118681506605795,0.6176470588235294,0.9716597666377422,1.0,3/8,17.57%,CHRNA7;MTPN;PAX8
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),-0.5761343169325953,-0.9118613716552588,0.6617647058823529,1.0,1.0,1/8,0.76%,IHO1
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.33098929943757993,0.9118591518183361,0.6,0.9708710817622246,1.0,8/92,4.44%,UBB;MALT1;HSPA1A;TAB3;IKBKB;TRAF5;NPM1;UBE2N
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.3431312788083427,0.9117886964766566,0.5882352941176471,0.9702995733773466,1.0,2/41,0.65%,SIRT2;HDAC11
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.5085184163706271,0.9115084242422843,0.5882352941176471,0.970146054257978,1.0,2/9,10.40%,ZBTB1;ATF4
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),0.5157001294008209,0.9110685127709186,0.5769230769230769,0.9703232900194386,1.0,4/7,21.16%,SRI;GRK2;RNLS;PDE4D
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.551511489323079,0.9107137863254108,0.5384615384615384,0.9703279404523479,1.0,1/5,1.18%,ACTB
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),-0.5964899670814449,-0.9106383507857714,0.6461538461538462,1.0,1.0,3/7,28.46%,SHMT1;GDA;PAICS
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),0.5039352214003794,0.9104746212740158,0.5428571428571428,0.9701030376972049,1.0,1/7,4.63%,PYCR1
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),-0.4044063060121697,-0.9103424309780495,0.6629213483146067,1.0,1.0,34/130,29.88%,CAMK1;RPS6KB2;MAP3K12;TLK1;TAF1;PLK2;CDC7;VRK1;CAMK1D;CAMK2A;AKT2;CSNK1D;VRK2;MASTL;PAK2;NEK6;PRKD2;ATM;RIPK1;MKNK1;CSNK1G2;MAPK12;CAMK2D;MAP3K10;BRSK1;PDK3;PNCK;TOP1;STK32B;PRKCZ;VRK3;MAST4;SGK2;PRKCA
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.37372207590796636,0.9099300556445751,0.5333333333333333,0.9704518989060342,1.0,1/27,0.31%,DGKB
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.535273015840482,-0.9095768641013889,0.6153846153846154,1.0,1.0,2/14,7.59%,ZFPM1;RARA
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.46349694937182945,0.9095496208642634,0.6666666666666666,0.9705137280621102,1.0,2/14,8.91%,SEC24D;SEC23B
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.5354789396580664,0.909248189381862,0.6551724137931034,0.9705897693885371,1.0,2/7,6.18%,STARD13;RBPJ
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.5089355158413953,0.9089303150385488,0.4594594594594595,0.9705798859930171,1.0,4/6,16.14%,IL15;PARP1;SIRT1;CDC42
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.5715470691526047,0.9081633649767954,0.5294117647058824,0.9713987717122541,1.0,2/5,28.10%,B3GALT2;B4GAT1
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),-0.42231472725570773,-0.9079498920450889,0.6741573033707865,1.0,1.0,12/84,15.74%,TMSB4X;ENPP2;FGF1;DUOX1;FGF9;NRG4;SST;PLXNA4;TMSB15B;MACF1;AKT2;DAPK3
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.5602047349114162,-0.9077412946369577,0.6493506493506493,1.0,1.0,4/12,23.03%,BCL2L11;DAB2IP;DDRGK1;BFAR
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5260198232680332,-0.9077030172831146,0.6621621621621622,1.0,1.0,7/12,27.89%,CD160;PDCD4;ANO6;ITGA4;SFRP4;GSN;PLCG1
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.519659821383393,-0.9074073475512099,0.6571428571428571,1.0,1.0,4/14,28.00%,MTHFD1;NMNAT3;RRM1;NMNAT2
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.6028984305562026,0.9071814021019908,0.6470588235294118,0.9728017113011583,1.0,1/5,0.31%,SOX4
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.39499514177327655,-0.9071640149293105,0.7252747252747253,1.0,1.0,24/186,16.75%,EPN1;GCA;SYNJ2;AZIN2;MX1;SYT1;TMEM43;KIAA0319;EMD;CAV3;DVL2;LRP2;LPCAT3;RIMS1;DNM1;SYT2;DNM2;SYNGR2;ARRB1;IGF2R;CHMP4B;CLTCL1;CHRM2;GAK
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.5557829911511749,-0.9069599605613747,0.6721311475409836,1.0,1.0,1/7,10.54%,VEGFA
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.5195185386774372,-0.906932161894109,0.6666666666666666,1.0,1.0,5/15,27.52%,THRAP3;CELF4;NCBP1;CELF3;RBM3
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),-0.5576131106826236,-0.9066962310557408,0.6455696202531646,1.0,1.0,5/11,35.74%,COQ6;COQ8B;COQ3;UBIAD1;PDSS1
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),-0.5576131106826236,-0.9066962310557408,0.6455696202531646,1.0,1.0,5/11,35.74%,COQ6;COQ8B;COQ3;UBIAD1;PDSS1
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.4617552224352238,-0.9066357428124792,0.5795454545454546,1.0,1.0,8/26,21.16%,ENO4;LDHA;MAN2B2;GPI;GAPDHS;ENO1;MAN2C1;ENOSF1
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.43657498550061247,-0.9066334877361967,0.717391304347826,1.0,1.0,12/75,15.30%,CD44;HTR2C;PTPRC;OPRM1;PRXL2C;MAP3K12;APOE;PDE8A;HTR2B;RASGRP1;ARRB1;NTRK3
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.6086067464948363,-0.9064136911437792,0.6229508196721312,1.0,1.0,2/5,27.01%,PRKAA1;PRKAA2
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.5023384741667788,-0.9060914838215566,0.6623376623376623,1.0,1.0,1/15,0.55%,HEY2
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.5955685067479454,-0.9060038623690962,0.676056338028169,1.0,1.0,3/7,24.09%,VEGFA;PRKD2;CAMK2D
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),0.44575912064012585,0.9060019187632407,0.5333333333333333,0.9748015621455319,1.0,2/14,4.66%,NOX4;PRDX1
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.4894857330475611,0.90596444224334,0.59375,0.9740898610897814,1.0,1/7,2.33%,HIPK1
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.4825384984935397,-0.9059249236482642,0.6883116883116883,1.0,1.0,6/25,24.42%,PTPRC;LMBR1L;HTR2B;TGFB2;FBXL17;WNT7A
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),-0.6090269180240226,-0.9055142121592219,0.6551724137931034,1.0,1.0,2/6,26.32%,ALK;PRKAA1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),-0.49778277843610774,-0.9052172808878806,0.6875,1.0,1.0,8/22,28.17%,GADD45A;APOE;ADAMTS9;ANGPT2;DAB2IP;TGFB1;ADGRB1;MEF2C
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),0.5391965665859647,0.9051453027482415,0.6428571428571429,0.9750030018081004,1.0,2/8,3.67%,PIWIL2;PIWIL4
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.4463873124512805,-0.9047569867149258,0.6235294117647059,1.0,1.0,11/40,30.25%,HHIP;INTU;TULP3;ZIC1;TUBD1;FBXL17;GPC3;EVC;WDR11;TXNDC15;IFT122
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.5778583983553855,-0.9045777514442915,0.6857142857142857,1.0,1.0,1/7,3.16%,PTPRC
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,-0.4095778121069021,-0.9045492623833238,0.6701030927835051,1.0,1.0,23/91,22.91%,PCSK2;UNC13C;ACTL6B;CELF4;MOBP;KCNQ1;SV2B;SLC24A2;GNG7;RBFOX3;RPH3A;SRRM4;ASPA;MCF2L2;CNDP1;CCK;ST18;GAD2;CACNG2;SLC7A14;HCN1;CELF3;CACNA1E
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),-0.6149321603417474,-0.9044778862678539,0.6285714285714286,1.0,1.0,3/5,37.00%,ATG7;ULK1;ULK2
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.4331573362072825,0.9043791104413957,0.6111111111111112,0.9758577517648918,1.0,2/17,1.92%,GPNMB;IL15
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.6198837886117656,-0.9043695591594325,0.6521739130434783,1.0,1.0,1/5,5.10%,AGT
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),0.4396116574813862,0.904253571361104,0.5416666666666666,0.975388657805175,1.0,1/8,2.81%,PHB2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.49598557976475055,-0.9042455604980922,0.6428571428571429,1.0,1.0,6/23,22.54%,WDR91;P2RY12;ATG14;DAB2IP;TGFB1;PDGFRB
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),-0.4782927877278944,-0.90409676180775,0.6428571428571429,1.0,1.0,5/25,18.76%,RTN2;AKT2;CLTCL1;SORBS1;GRB10
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.48525632756893616,0.9039661768967963,0.6060606060606061,0.9755455007293617,1.0,1/10,1.74%,ADCY6
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.48702414854193055,-0.9039549190762731,0.676056338028169,1.0,1.0,1/14,1.18%,VSIR
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.40898809991827684,0.903731620578306,0.5384615384615384,0.9752903681153751,1.0,11/24,22.33%,UBE2N;BMI1;RPS2;ARRDC4;DCUN1D5;FBXW7;PINK1;PIN1;BTRC;DCUN1D1;GORASP1
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.41175839932931235,0.9036762235128479,0.5833333333333334,0.9746951781681314,1.0,3/19,12.51%,CCND1;LSM11;PLCB1
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.5264260968991454,-0.9032892558620871,0.6626506024096386,1.0,1.0,2/13,8.19%,CAMK1;EMD
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.4514857491004098,-0.9029934787051908,0.6904761904761905,1.0,1.0,5/43,10.58%,TTN;SNCB;PLSCR1;HVCN1;AHCYL1
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),0.5493989512000188,0.9029926079849989,0.6129032258064516,0.9754758868518556,1.0,3/6,22.68%,TMEM100;HIF1AN;RIN2
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.3973279808204799,0.9029836402413545,0.6428571428571429,0.9747398647942257,1.0,5/23,16.14%,TWF1;BRK1;CAPZB;ARPC2;CDC42
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),0.3740134620943924,0.9028849157847489,0.6842105263157895,0.9743022109858832,1.0,14/62,16.56%,UBB;PSMD8;PSMB4;PSMB6;UBE2D1;PSMD10;PSME3;UBC;PSMB2;PSMD12;ANAPC11;ANAPC7;PSMC1;PSMD4
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),0.38970957978660964,0.90211611573671,0.5555555555555556,0.9751379299001411,1.0,3/37,4.15%,NUP42;RAN;NPM1
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),0.42846261735883096,0.9021030083625609,0.65,0.9743756757756563,1.0,4/16,9.08%,SLC30A10;SLC39A10;MT1E;MT3
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),0.43642042776892226,0.9020256315804607,0.59375,0.9737558178355158,1.0,2/12,2.31%,NCSTN;ACHE
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.4241010401802676,0.9019618570223392,0.5217391304347826,0.9731933738175288,1.0,1/12,3.11%,IKBKB
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.4035737608994125,0.9018699173250434,0.6,0.9726741110042102,1.0,3/25,7.84%,PRR5L;ZFAND1;PTPN14
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.4982750904126067,-0.9018255868478638,0.6625,1.0,1.0,4/21,10.93%,RFC4;RFC1;RFC2;RPA3
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),-0.40092856868467464,-0.9015960082588211,0.7241379310344828,1.0,1.0,36/139,29.88%,CAMK1;RPS6KB2;MAP3K12;TLK1;TAF1;PLK2;CDC7;VRK1;CAMK1D;CAMK2A;AKT2;CSNK1D;VRK2;MASTL;PAK2;NEK6;PRKD2;NTMT1;ATM;MKNK1;CSNK1G2;MAPK12;CAMK2D;GALNT2;MAP3K10;BRSK1;PDK3;PNCK;TOP1;STK32B;PRKCZ;VRK3;PARP2;MAST4;SGK2;PRKCA
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.452294114954253,-0.9015212124102797,0.627906976744186,1.0,1.0,2/30,3.39%,CMTR1;CDK7
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.452294114954253,-0.9015212124102797,0.627906976744186,1.0,1.0,2/30,3.39%,CMTR1;CDK7
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),-0.6366777080336001,-0.9011949100129003,0.7083333333333334,1.0,1.0,2/5,20.90%,RYR3;RYR2
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),-0.6366777080336001,-0.9011949100129003,0.7083333333333334,1.0,1.0,2/5,20.90%,RYR3;RYR2
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),-0.6366777080336001,-0.9011949100129003,0.7083333333333334,1.0,1.0,2/5,20.90%,RYR3;RYR2
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.414104503197646,-0.9010209104900785,0.7659574468085106,1.0,1.0,23/127,19.12%,CD44;HTR2C;FGF1;PTPRC;TPD52L1;OPRM1;PRXL2C;MAP3K12;APOE;VEGFA;PDE8A;TRAF7;HTR2B;RASGRP1;ARRB1;TRIM5;NTRK3;BCAR3;MAP2K1;PRKD2;TGFB2;PTPRJ;ARRB2
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.37199976776426075,0.9009829186795949,0.5172413793103449,0.9738599237629841,1.0,5/29,13.96%,OPN3;ACADVL;CLK2;MST1;KHSRP
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.5147573605577404,0.9009698915365121,0.6785714285714286,0.9731439262010696,1.0,1/9,2.73%,KDM3B
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.4053783039420081,0.9009626569155221,0.42105263157894735,0.9723868761403297,1.0,4/29,7.70%,SNF8;RAB27B;SMPD3;CHMP2A
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),-0.5467675152070564,-0.90085968378845,0.6708860759493671,1.0,1.0,1/8,13.89%,SRP54
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.566078213699302,0.9008562372762476,0.7027027027027027,0.9718979989549009,1.0,1/5,9.17%,GPAA1
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),-0.5091424564919678,-0.9007593894727818,0.6376811594202898,1.0,1.0,5/15,25.42%,BDNF;FBXO22;HDAC4;PIEZO1;XBP1
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.4020224509098469,0.9004650758471623,0.5185185185185185,0.9717328187583616,1.0,3/15,13.93%,MSN;SNX12;DNAJC13
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),0.36976332170777193,0.90038876205523,0.65,0.971189115338596,1.0,7/45,7.02%,BANF1;TRIM35;TRIM28;LARP7;BTBD17;PML;PPIA
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.44462971973185494,0.9001647772265724,0.5217391304347826,0.9709406482121405,1.0,8/12,32.76%,CHP1;BARD1;CABP1;APOD;RANGAP1;TPR;UFM1;RAB23
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.5426651226462172,-0.9001076679502401,0.704225352112676,1.0,1.0,4/15,22.26%,BRCA1;SULF1;CYP1B1;TGFB1
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.34311305890001303,0.8999177674511771,0.47058823529411764,0.9707486009218664,1.0,10/49,12.42%,CD151;STON2;RIT2;RAB5B;CLIP3;CBLL1;SMPD1;SNX12;SNX17;MCTP1
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.3975249793563347,0.8997498372304276,0.6111111111111112,0.9703609145155985,1.0,5/23,7.02%,ACTB;ACTG1;PDGFRA;TLN1;PPIA
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),0.5311087891470307,0.8993530009130425,0.5925925925925926,0.9706031564800446,1.0,2/7,2.31%,MOXD1;ACHE
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),0.2840345942881631,0.8992231526923918,0.6666666666666666,0.9701323522154864,1.0,44/275,9.72%,PLD1;IDH1;YPEL5;HSPA1A;C6ORF120;LPCAT1;MOSPD2;NCSTN;ARPC5;GSTP1;CAP1;ILF2;CTSC;DYNLT1;NEU1;GHDC;GALNS;OSTF1;CTSA;TSPAN14;EEF2;GOLGA7;RAB5B;SURF4;AP1M1;FABP5;CSTB;EEF1A1;ALAD;RAP2C;PRDX6;PPIA;IRAG2;CAT;DDOST;ACLY;HSPA8;PLAUR;SRP14;LAMTOR2;CPNE3;TOLLIP;CD58;PRCP
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),-0.5640824455252205,-0.8991313698571058,0.6470588235294118,1.0,1.0,3/8,25.42%,BDNF;HDAC4;XBP1
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),-0.6158889760936386,-0.8989096222833949,0.6619718309859155,1.0,1.0,1/5,9.17%,TRIM41
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,-0.39994078750438,-0.8987953076166645,0.686046511627907,1.0,1.0,15/108,15.77%,STMN2;FAM13C;RGS4;LIFR;CACNA1B;SULT4A1;ACTL6B;AKAP12;SHISA6;ARNT2;SNAP25;LRRTM1;SYT4;UNC5D;CRMP1
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),0.28269309208800353,0.8987602140635326,0.75,0.9701928761108983,1.0,44/277,9.72%,PLD1;IDH1;YPEL5;HSPA1A;C6ORF120;LPCAT1;MOSPD2;NCSTN;ARPC5;GSTP1;CAP1;ILF2;CTSC;DYNLT1;NEU1;GHDC;GALNS;OSTF1;CTSA;TSPAN14;EEF2;GOLGA7;RAB5B;SURF4;AP1M1;FABP5;CSTB;EEF1A1;ALAD;RAP2C;PRDX6;PPIA;IRAG2;CAT;DDOST;ACLY;HSPA8;PLAUR;SRP14;LAMTOR2;CPNE3;TOLLIP;CD58;PRCP
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.4170906347118769,0.898717680043473,0.5263157894736842,0.9695417606394098,1.0,5/25,9.32%,VPS37B;SNF8;VPS28;CHMP2A;VTA1
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.3838820892630881,0.8985793263376466,0.5882352941176471,0.96911472232715,1.0,6/32,6.06%,CD151;PPT1;VPS28;CLIP3;CBLL1;SMPD1
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),-0.5072558776927141,-0.8985151768349487,0.6493506493506493,1.0,1.0,2/14,11.19%,IHO1;PARN
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),0.5559912169756285,0.8984766654139128,0.6666666666666666,0.9684515453448135,1.0,3/5,23.53%,ABCD2;ACOX1;ABCD3
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),0.5529165933252598,0.8982619231911233,0.5588235294117647,0.9682626552946878,1.0,1/6,4.27%,LYN
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.34708281334950214,0.8979335590613851,0.6470588235294118,0.9681018775323323,1.0,7/46,10.81%,GPX1;GSTP1;PDGFRA;CAT;JUN;PRDX5;PRDX3
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.28235990201357564,0.8978684095103863,1.0,0.9675105377649353,1.0,57/311,15.72%,UBB;NUP42;RFWD3;RNF144A;TNFAIP1;CAND2;CUL7;UBE2D4;TRIM35;RNF6;ELOC;TRIM28;UBE2D1;UBE2N;FBXO45;RRAGA;UBA1;KLHL13;KLHL8;RNF139;CBLL1;UBE2I;DTX4;TSPAN17;COMMD1;UBE2Q2;TRPM4;CDC73;KLHL2;AREL1;SMURF2;SDE2;RNF25;UBC;UBE2G1;MUL1;TRIM24;MKRN2;RCHY1;SUMO1;CUL9;FBXW5;SUMO3;OTULIN;TRIM4;SIRT1;FBXL7;AAAS;KCTD13;PEX13;ARRDC4;ANAPC11;NUP214;KCTD10;CDC34;VHL;ANAPC7
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),-0.39478084314824546,-0.8977722509987625,0.7741935483870968,1.0,1.0,22/172,15.64%,SOX9;CARD14;TTN;FGF1;EFNA1;TSPYL2;FGF9;STAT2;BRAT1;EFNA5;DVL2;ATG14;VEGFA;PDE8A;PAK1;RASGRP1;ARRB1;EPHA7;DNAJC10;AKT2;NTRK3;CSNK1D
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.49790239151882393,-0.8977220047604632,0.6375,1.0,1.0,3/20,10.00%,SLC39A14;CP;B2M
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.45809257104966855,0.8976368757061638,0.6086956521739131,0.9658529794577334,1.0,5/10,28.94%,ANAPC11;ANAPC7;ANAPC4;CDC16;CUL3
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.45809257104966855,0.8976368757061638,0.6086956521739131,0.9658529794577334,1.0,5/10,28.94%,ANAPC11;ANAPC7;ANAPC4;CDC16;CUL3
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.45809257104966855,0.8976368757061638,0.6086956521739131,0.9658529794577334,1.0,5/10,28.94%,ANAPC11;ANAPC7;ANAPC4;CDC16;CUL3
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.2862468041850025,0.8975158571660505,1.0,0.9654314876620074,1.0,28/103,14.47%,POU6F2;TUBB2B;RND2;ASCL1;DLL3;POU3F2;GAL3ST3;SEMA5B;BTBD17;EFNA2;DCX;GRM5;KCNQ2;SALL3;PRR36;LINGO1;CSRNP3;TAGLN3;DPYSL5;NOL4;PPM1E;VLDLR;PAK5;C2CD4C;SIRT1;EZH2;GRID2;CUX2
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.4655419674238407,-0.8973626538263854,0.6395348837209303,1.0,1.0,2/40,2.59%,ABLIM1;CRYBG3
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.5645962605729923,-0.8973483414764389,0.6818181818181818,1.0,1.0,1/7,7.29%,MSH6
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),0.3836857903394997,0.8973342216625473,0.631578947368421,0.9651490836034602,1.0,6/33,10.65%,NOL11;TSR1;RPS19;WDR46;NGDN;NAT10
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),0.2841278352963891,0.8972689974207047,0.6666666666666666,0.964535146278338,1.0,44/274,9.72%,PLD1;IDH1;YPEL5;HSPA1A;C6ORF120;LPCAT1;MOSPD2;NCSTN;ARPC5;GSTP1;CAP1;ILF2;CTSC;DYNLT1;NEU1;GHDC;GALNS;OSTF1;CTSA;TSPAN14;EEF2;GOLGA7;RAB5B;SURF4;AP1M1;FABP5;CSTB;EEF1A1;ALAD;RAP2C;PRDX6;PPIA;IRAG2;CAT;DDOST;ACLY;HSPA8;PLAUR;SRP14;LAMTOR2;CPNE3;TOLLIP;CD58;PRCP
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.5208206831607065,-0.8971047874467623,0.6111111111111112,1.0,1.0,4/9,31.45%,LPCAT3;MBOAT2;PLAAT3;PLA2G12A
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.49492622688466514,-0.8969045556815959,0.6708860759493671,1.0,1.0,4/21,21.28%,RFC1;GAR1;TELO2;TERF2IP
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.3154318194183241,0.8968887463632356,0.5,0.9644335591151291,1.0,3/53,1.51%,SOX4;BAD;LRRC8D
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),0.34572769465507747,0.896721067171748,0.5714285714285714,0.9639316197631713,1.0,15/87,13.87%,MALT1;PSMD8;TAB3;PSMB4;IKBKB;PSMB6;LYN;JUN;PSMD10;PSME3;NFATC1;GRB2;PSMB2;PSMD12;CALM1
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.39049875926416233,0.8967075651445989,0.6363636363636364,0.9632234616207751,1.0,23/101,14.92%,SYNDIG1;OLIG2;NOVA1;MAP2;ADGRA1;TCEAL7;SEMA5B;ZNF536;BRINP1;TMEM178A;PCDH17;RGS7BP;PDGFD;GPM6B;SPRY1;DOK5;CSRNP3;ASXL3;LRRC3B;FBXL7;LRRC4C;SHC3;FAIM2
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),0.44195921789375836,0.8966522084012593,0.52,0.9625853501481696,1.0,3/15,6.92%,YAP1;CATSPERD;WBP2
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.35292448393539855,0.8965319015918307,0.6086956521739131,0.9621135719189736,1.0,5/36,7.59%,BAD;G0S2;STYXL1;PML;BOK
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),-0.5823486402954757,-0.8964906168627611,0.6216216216216216,1.0,1.0,4/7,37.00%,ATG7;RB1CC1;ULK1;ULK2
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),-0.5823486402954757,-0.8964906168627611,0.6216216216216216,1.0,1.0,4/7,37.00%,ATG7;RB1CC1;ULK1;ULK2
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.4936232762966273,-0.8962786443235226,0.6493506493506493,1.0,1.0,4/16,12.06%,FABP3;ABHD12B;LIPI;LIPH
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.3287547506565062,0.8960968217720257,0.4444444444444444,0.962193239413863,1.0,17/90,12.05%,HDAC11;ADCY6;GPC1;NR2F6;ENPP5;MYO1D;SMPD1;BCAR1;PTGFRN;PTPRF;GNA11;SEC23B;RNF128;HID1;LAMA5;CAMSAP3;TMEM117
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.4016654898845479,-0.8958772998307716,0.6956521739130435,1.0,1.0,9/98,7.59%,CD44;NEDD9;IRF1;GADD45B;GADD45A;TIMP3;BCL2L2;BRCA1;RARA
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),-0.5959311192623646,-0.8956981955177894,0.6933333333333334,1.0,1.0,3/6,30.61%,NMNAT3;NMNAT2;QPRT
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.5240062371129975,-0.8955671860497904,0.6216216216216216,1.0,1.0,3/12,14.75%,AKR1C2;PTGR1;TBXAS1
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.5685668367504991,-0.8955310607513152,0.7428571428571429,1.0,1.0,3/9,28.77%,DDRGK1;TGFB1;GTF2B
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.5449989622787789,-0.8955135280996034,0.6901408450704225,1.0,1.0,4/14,22.26%,BRCA1;SULF1;CYP1B1;TGFB1
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),-0.5481603319074139,-0.8954270630781319,0.640625,1.0,1.0,5/11,41.85%,XBP1;TGFBR3;PRKCSH;PROX1;PHF2
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.39637700256758857,0.8952534621033597,0.6,0.9629570507592631,1.0,2/33,3.46%,NUP42;RAN
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),0.39637700256758857,0.8952534621033597,0.6,0.9629570507592631,1.0,2/33,3.46%,NUP42;RAN
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.3516966218394,0.894672676885939,0.7058823529411765,0.9635166360194982,1.0,6/35,11.70%,HSPA1A;ERN1;NUDT16L1;PPP1R8;MTREX;RNASEH2C
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.5020587950190145,-0.8946626309453993,0.6338028169014085,1.0,1.0,7/18,36.12%,CAV3;WWP2;ATP1B1;NEDD4L;CACNA1D;DLG1;STK39
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.37104341551667364,0.8945866041445905,0.6666666666666666,0.9630047861403666,1.0,5/41,8.25%,TCF7L1;PORCN;WNT3;FRZB;FZD3
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),0.5138509897009671,0.8945737067857776,0.625,0.9622742930672652,1.0,1/6,3.01%,PPT1
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),0.38155408548855535,0.8945392159661942,0.6470588235294118,0.9616271524910203,1.0,6/42,9.80%,ODC1;PSMD8;PSMB4;PSMB6;PSMD10;PSME3
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),0.49819290799163685,0.894373266017118,0.6285714285714286,0.9612685736598708,1.0,2/8,5.05%,PYCR1;GPR37L1
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),-0.5654912311128029,-0.8939940951805302,0.6571428571428571,1.0,1.0,3/6,32.27%,ADAM9;CSF1;FOXP1
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.41038546092259737,-0.8939507114457862,0.7222222222222222,1.0,1.0,10/105,11.62%,RASGRF1;ARHGAP24;A2M;ARHGAP15;ARHGDIG;RHOJ;ARHGAP26;VAV3;SRGAP3;PREX1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.5372593829343905,-0.8939222717181966,0.6515151515151515,1.0,1.0,1/9,9.88%,FZR1
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),-0.43920211172491064,-0.8938977523004124,0.6666666666666666,1.0,1.0,5/32,13.08%,SRF;RNF213;VEGFA;NAXE;ITGB1BP1
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),-0.6215016229549697,-0.8937111438729644,0.6551724137931034,1.0,1.0,1/5,15.82%,SNTA1
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.44275721747561936,-0.8936332511974726,0.7126436781609196,1.0,1.0,3/57,5.45%,CD44;FGF1;FGF9
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),-0.474136338514322,-0.8935972560932293,0.6097560975609756,1.0,1.0,5/21,22.15%,PHF19;BRCA1;RIF1;SMAD4;KMT2A
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.45150915350229914,-0.8932074563078272,0.6282051282051282,1.0,1.0,5/25,18.38%,EMP2;PTP4A3;VEGFA;CYP1B1;STAT1
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.4658234790220307,-0.8928314802542306,0.6666666666666666,1.0,1.0,7/27,20.87%,NR4A3;RAB3A;PLEKHM1;HDAC6;PIP4P1;BORCS5;PLEKHM2
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),0.548542177372263,0.8927736241235208,0.625,0.9642491806785107,1.0,2/5,19.41%,ENPP3;PRPS1
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),-0.5085961134550441,-0.8926752436453238,0.6521739130434783,1.0,1.0,5/15,20.64%,CRYM;ASPA;SLC25A21;GCDH;AASS
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.3045772519480602,0.8925238854897969,0.8571428571428571,0.9640121857267137,1.0,23/129,13.87%,AFAP1L2;PSMD8;CUL7;PSMB4;TRIM35;BTG1;PSMB6;UBE2D1;BTG3;BRINP1;ZNF268;DUSP3;PSMD10;PSME3;EIF4E;GAS1;HECA;SMAD3;ERCC3;CUL9;PSMB2;PSMD12;SIRT1
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.484277969131405,-0.8924586763248086,0.7160493827160493,1.0,1.0,9/19,32.76%,IRF1;TRIM5;TRAF3;CD55;TIRAP;APPL2;HERC5;FOXP1;ERAP1
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),-0.38462747791637975,-0.8924015367881897,0.75,1.0,1.0,24/111,24.15%,SOX9;AGT;ANP32E;BCL2L14;NLRC4;DAPK1;ALK;BCL2L11;MOAP1;FANK1;LCMT1;TOMM70;BEX2;DAPK3;SRA1;STAT1;WRN;ATM;RIPK1;BNIP3L;USP36;BCL6;MADD;RABGGTB
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.4566051518310028,0.8921692884877171,0.6578947368421053,0.9639804834870889,1.0,1/8,1.79%,RHOBTB1
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.5304799979575561,-0.8919909172482032,0.7361111111111112,1.0,1.0,4/11,14.66%,MX1;OAS1;IFIT1;AKAP1
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.37510875689739964,0.8917691271199667,0.5882352941176471,0.9641399488614176,1.0,10/32,16.33%,SMPD1;PPIA;TIPRL;PPP1R8;PPP1R16A;CALM3;YWHAB;CALM1;HSP90B1;MFHAS1
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),0.33896976301919124,0.8912604325113477,0.7142857142857143,0.9645583452969668,1.0,10/68,10.28%,VANGL1;PSMD8;PSMB4;PSMB6;PRICKLE1;ROR2;FZD3;PSMD10;PSME3;SMURF2
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.4125061086638293,-0.8910927654164187,0.6463414634146342,1.0,1.0,9/58,13.20%,FGF1;TPD52L1;AGT;CAV3;APOE;VEGFA;TRIB1;HTR2B;RASGRP1
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.4099500882748628,0.8910048618276816,0.6296296296296297,0.9643082106106398,1.0,4/16,14.48%,MRPL44;TRIM71;HENMT1;SNIP1
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.5473033861605825,0.8909973518635184,0.6153846153846154,0.963595382743014,1.0,2/5,15.13%,MGLL;TMEM100
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),-0.538890500228406,-0.8909644540966828,0.684931506849315,1.0,1.0,4/8,30.54%,CAMK2B;DAB2IP;RELN;ADGRL1
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.42450252648950615,0.8906975341642719,0.6842105263157895,0.9635369027542229,1.0,4/16,20.02%,CRPPA;TMTC3;DPM2;DPM3
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),-0.59980326793048,-0.890666296954631,0.71875,1.0,1.0,1/5,15.67%,SLC6A9
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.43388944345695146,-0.890483335002977,0.6666666666666666,1.0,1.0,5/55,8.57%,SPDYA;CDK7;CDKN2A;GADD45A;CCNI2
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.44636459797844935,-0.8904035895937654,0.7108433734939759,1.0,1.0,13/40,27.67%,NR4A3;STEAP4;PSMB8;FOXO1;AKT2;TMEM120B;CTBP1;CBY1;OSBPL11;MED1;WNT5B;BBS7;METRNL
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.5663673019359644,0.8903446461655277,0.6875,0.9635873047243249,1.0,1/6,4.60%,PCDH15
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.43416549584197456,0.8898490779413449,0.6,0.9636919840253978,1.0,5/20,13.89%,PHB2;MN1;CDC73;PSME3;EZH2
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.35226136272548103,0.8898256173506369,0.6470588235294118,0.963022543905819,1.0,2/40,0.65%,SIRT2;HDAC11
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),-0.5977581488763535,-0.8892441227315578,0.6984126984126984,1.0,1.0,1/6,5.36%,SPI1
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),-0.609551951683026,-0.8891033407085523,0.7384615384615385,1.0,1.0,2/5,11.40%,PLEKHM1;SPP1
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),-0.4566388141319242,-0.8890626455287796,0.5949367088607594,1.0,1.0,5/26,25.74%,PARN;PNKP;PARM1;HMBOX1;MAP2K7
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),-0.40511005469828804,-0.8887573045848149,0.7021276595744681,1.0,1.0,36/153,23.61%,SOX9;CARD14;FGF1;EFNA1;FGF9;BRAT1;PRXL2C;EFNA5;DVL2;ATG14;VEGFA;ALK;SLC4A4;PDE8A;GAPDHS;PAK1;RASGRP1;ARRB1;EPHA7;AKT2;NTRK3;CSNK1D;TYRO3;DDR2;RIPK1;FAM20A;IGF1R;PSEN1;ROR1;RB1CC1;TGFB1;TNIK;EPHA4;PDGFRB;ZNF622;IL34
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.3911654294625398,-0.8886399936787194,0.75,1.0,1.0,31/165,20.26%,ENPP2;SOX9;VSIR;PLET1;MYLK;FGF1;NEDD9;PTPRC;SHTN1;CEMIP;RAB11A;DOCK5;VEGFA;PAK1;VIL1;SEMA4B;TMSB15B;AKT2;NTRK3;KIF20B;TIAM1;STAT3;TGFB2;PDPN;HDAC6;ATM;RDX;DDR2;ADAM9;NSMF;IGF1R
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.364863188201082,0.8886036639004757,0.55,0.9650948333648118,1.0,1/22,1.00%,HSPA1A
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.4928992703330608,0.8885925121038599,0.6818181818181818,0.9643982294039842,1.0,4/15,12.60%,NT5E;DPYSL4;NT5C1A;DPYSL5
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.44126288617341125,-0.8883724797000115,0.5844155844155844,1.0,1.0,4/35,10.93%,RFC4;RFC1;RFC2;RPA3
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),0.4815521673474946,0.888253765320935,0.5925925925925926,0.9644071400877182,1.0,4/8,16.13%,SEMA5A;LIMA1;CFL2;MTPN
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),-0.6178554921224264,-0.8882400799570065,0.6440677966101694,1.0,1.0,4/5,27.01%,APOE;XBP1;PRKAA1;PRKAA2
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),-0.4497648851640589,-0.8878174490425309,0.6666666666666666,1.0,1.0,5/34,18.57%,JADE2;SPI1;POLE3;ING5;PER1
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.4946531226171509,-0.8877420615801724,0.6296296296296297,1.0,1.0,2/17,16.09%,CSNK1D;HOOK3
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.42169636584437875,-0.8877037929648983,0.7209302325581395,1.0,1.0,19/60,24.56%,CD160;AHR;IRF1;PLSCR1;B2M;HLA-F;PVR;HLA-C;RSAD2;TGFB2;PILRA;NPDC1;TRAF3;HLA-B;BCL6;HLA-A;SPPL2B;TIRAP;ITGA4
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),0.3876072813369373,0.8876559181605405,0.4666666666666667,0.964795067679121,1.0,4/53,4.44%,UBB;PHB2;DYNLL2;UBE2N
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.5161755823535538,-0.8875808295901277,0.6623376623376623,1.0,1.0,2/10,20.44%,GLRX;ATP1B1
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.4319188598859474,-0.8875713570321309,0.7160493827160493,1.0,1.0,10/47,19.57%,PTPRC;IFNGR2;LIFR;IL7;TRIM44;VRK2;IRAK2;JAK1;STAT1;RIPK1
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,-0.40574327876126476,-0.8873733182334844,0.7209302325581395,1.0,1.0,20/110,14.71%,STMN2;OLFM3;SNCB;ARHGDIG;KCNC1;SST;GABRG2;NRGN;MMD2;SULT4A1;ACTL6B;PSD2;CELF4;SHISA6;GRM3;SNAP25;LRRTM1;SYT4;CAMK2A;ATP2B3
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.3806303428250208,-0.8873065763989746,0.8421052631578947,1.0,1.0,57/298,19.57%,CD44;TMSB4X;IL5;CARD14;DUOX1;MX1;IRF1;CRLF1;PSMB8;IFNGR2;SPI1;IL3RA;EDARADD;FOS;STAT2;OPRM1;CEBPD;CD27;LIFR;STAT4;STAT6;B2M;IL7;HLA-F;OAS1;VEGFA;BCL2L11;CAMK2B;OSMR;PSMA4;FOXO1;HLA-C;CAMK2A;TRIM5;STAT5A;PDCD4;PITPNA;IFIT1;SNRPA1;IFIT3;RSAD2;IFI6;STAT3;STAT5B;IRAK2;PAK2;IL6R;JAK1;MAP3K14;IFI35;STAT1;PSMA3;GRB10;TRAF3;PTPRJ;ST18;RIPK1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),-0.5222595596573061,-0.8870835832640801,0.6621621621621622,1.0,1.0,1/11,1.83%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.6082237468770493,-0.8870727707981974,0.684931506849315,1.0,1.0,1/6,16.00%,DENND6A
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.4060185530256913,-0.8869756469989349,0.7222222222222222,1.0,1.0,7/67,14.91%,TTN;ANKRD53;EML3;RAB11A;NCAPD3;SGO2;CHMP4B
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3918097284523805,0.8868980325979292,0.625,0.9656828838970962,1.0,8/27,16.75%,PMEPA1;GREM1;BMPER;TGFBR1;TWSG1;SMAD7;BMP2;GDF6
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),-0.5528776252113122,-0.8868339386724452,0.7397260273972602,1.0,1.0,1/10,1.28%,ANGPTL4
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.5556936928851087,-0.8863678258481354,0.684931506849315,1.0,1.0,1/9,1.37%,CARD14
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.42334133853530015,-0.8863315264244237,0.6666666666666666,1.0,1.0,14/63,26.15%,AGT;PLSCR1;P2RY12;PDCD4;USF1;IFI35;RIPK1;NINJ1;NLRP12;TGFB1;PDGFRB;STX4;SCIMP;POLR3D
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.5066322424311083,-0.8860150121626323,0.7066666666666667,1.0,1.0,5/17,20.90%,TTN;TPM1;KCNQ1;ATP1B1;RYR2
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.4508497305833807,0.8859546295613872,0.7142857142857143,0.9673668026214299,1.0,2/16,3.65%,SOX11;PDGFRA
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.32092724874664424,0.8857590621017931,0.625,0.9669682500613525,1.0,22/86,16.75%,UBB;TGFBR2;ITGB5;BAMBI;JUN;SMURF2;RGMB;UBC;SMAD9;SMAD3;TGFBR1;TWSG1;ZYX;SMAD7;DUSP15;FNTA;SIRT1;RHOA;TMEM100;BMP2;EID2;GDF6
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.4165204626541839,0.8856973774783018,0.5,0.9663543736323512,1.0,5/26,9.32%,VPS37B;SNF8;VPS28;CHMP2A;VTA1
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.4494617425783515,0.8854310812078838,0.5416666666666666,0.9662269035381196,1.0,4/11,10.06%,RNF139;BAG2;SNX12;GAS1
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),-0.47284497592750196,-0.8854155737846013,0.7012987012987013,1.0,1.0,1/30,1.05%,PIP4K2C
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),-0.5946864056378648,-0.8853545945160541,0.7162162162162162,1.0,1.0,2/7,24.23%,EEFSEC;SEPSECS
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),-0.5946864056378648,-0.8853545945160541,0.7162162162162162,1.0,1.0,2/7,24.23%,EEFSEC;SEPSECS
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.4587643652197902,-0.8852703808371677,0.7066666666666667,1.0,1.0,3/22,10.00%,NUAK1;CDKN2A;B2M
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),-0.5921724143939033,-0.8851568261512031,0.6610169491525424,1.0,1.0,1/5,20.09%,ADAM9
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.37505777193215656,0.8847162039404355,0.6111111111111112,0.9670024609001143,1.0,9/46,11.34%,NOVA1;RBM15B;SMU1;FXR2;KHDRBS2;RBFOX1;PUF60;RBM8A;SAP18
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),-0.5135609835202326,-0.8847103519642954,0.6617647058823529,1.0,1.0,1/11,7.02%,TRNT1
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),-0.5778881545743754,-0.8845330902878816,0.7049180327868853,1.0,1.0,3/6,21.08%,ZFPM1;OLFM1;SMAD4
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.5000921640553951,-0.8844880056304825,0.6842105263157895,1.0,1.0,4/19,17.32%,ATP10A;ATP8B1;ATP8B2;RFT1
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.48659229212909827,0.8842494967773629,0.6428571428571429,0.9673594292251693,1.0,4/12,19.39%,EFNA2;OSTM1;GLO1;SNX10
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.39059968205760337,0.8841372419170173,0.6,0.9668278460667028,1.0,12/63,11.17%,SIRT2;ADCY6;VIPR2;PCBP2;LYN;CALCRL;RXFP1;PRKAR2B;ENPP3;RC3H1;MYH9;MUL1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),0.5183998012201065,0.8839846277825689,0.6071428571428571,0.9664180689023587,1.0,1/5,5.95%,TMBIM6
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),0.49728605499751194,0.8839608800347615,0.5862068965517241,0.965713356888878,1.0,1/9,0.32%,UGDH
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.43905897587787573,-0.8837480159392965,0.75,1.0,1.0,18/53,21.76%,AHR;CEBPD;OAS1;DTX3L;HLA-C;IFIH1;TAPBP;SYNGR2;CTSZ;ABCC3;BHLHE40;TYMP;IRF2;NFIC;RBM47;RAB20;JUNB;SLC8B1
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),0.4570578606720076,0.8837142767257388,0.42857142857142855,0.9656540710495971,1.0,2/8,4.12%,CCDC88C;RILPL2
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),-0.3886812814815638,-0.8834777950839526,0.7419354838709677,1.0,1.0,15/81,19.16%,NUAK1;EFNA1;ARHGDIG;EFNA5;VEGFA;FUT2;PLXNA4;TPM1;RASA1;ITGB1BP1;EPHA7;PRKD2;PTPRJ;ZFHX3;ATM
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.5466196795269058,-0.8832091759979044,0.7101449275362319,1.0,1.0,4/9,26.32%,ALK;CCDC3;NCOR1;PRKAA1
prerank,PanglaoDB_Augmented_2021__Delta Cells,-0.4035521704583433,-0.8831599316306123,0.6470588235294118,1.0,1.0,15/92,15.72%,STMN2;FAM13C;PCSK2;AGT;SST;GABRG2;ACTL6B;SHISA6;SNAP25;LRRTM1;SYT4;UNC5D;KCNB2;SPARCL1;SORBS1
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),-0.5665324211347943,-0.8830612796149987,0.6470588235294118,1.0,1.0,4/7,39.59%,RAB29;VAMP3;SNCA;INPP5F
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.3720261803020419,0.8830265049786324,0.6666666666666666,0.9662655758747439,1.0,4/20,8.43%,S100A10;THY1;LIMS1;DUSP3
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.40885513476101,0.8829197873322533,0.6363636363636364,0.965857461383247,1.0,2/18,2.57%,CHRNA4;SYT9
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),0.46794346666421316,0.882882641007343,0.6551724137931034,0.96522226876849,1.0,2/9,16.57%,SMPD3;SAMD8
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.4957702185515603,0.8826138084575771,0.6764705882352942,0.9650163117274432,1.0,2/9,6.97%,MID1IP1;SLC25A20
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.46688593190745703,0.8825379003043953,0.6129032258064516,0.9643827103220951,1.0,5/11,20.94%,PCBP2;ELMOD2;TRAF3IP1;ZMPSTE24;ILRUN
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),-0.45868665826484245,-0.8824397222337531,0.6363636363636364,1.0,1.0,10/28,34.11%,CDC42EP3;VASP;PFN2;BAIAP2;SPIRE1;GSN;LMOD1;CARMIL1;CRACD;BAIAP2L2
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.45487133372572097,-0.8824225175688916,0.7325581395348837,1.0,1.0,2/38,2.59%,ABLIM1;CRYBG3
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),-0.45847909995033104,-0.8823827752494275,0.6666666666666666,1.0,1.0,6/19,20.90%,CAV3;CACNA1C;GJA1;KCNQ1;SNTA1;RYR2
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.5458856440670481,-0.882320859574988,0.6212121212121212,1.0,1.0,1/6,8.67%,GLUL
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.4491718358944967,-0.8822924426602291,0.6428571428571429,1.0,1.0,6/29,17.31%,AHR;AKR1C2;SPP1;KLF9;ADCY1;ADCY5
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),0.5476858854423633,0.8817887377501188,0.6451612903225806,0.9654605932125682,1.0,4/6,23.11%,SRM;SAT1;SAT2;SMS
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),-0.6019546781130524,-0.8815674370455935,0.703125,1.0,1.0,1/5,7.59%,RARA
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),-0.4170803649637388,-0.8811814131973122,0.6282051282051282,1.0,1.0,3/38,5.83%,GADD45A;FBXO6;DONSON
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.5519179317214304,-0.8810989156328629,0.71875,1.0,1.0,2/8,11.84%,NAAA;DEGS2
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),0.5075313426403781,0.8807680389507402,0.5769230769230769,0.9670576389823189,1.0,2/7,3.29%,UBE2D4;RNF6
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.48035249002856356,-0.8805053057651833,0.6790123456790124,1.0,1.0,4/19,18.87%,PARP9;CAMK2A;IFIT1;HDAC6
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),0.5658275149576913,0.8803508049838397,0.6578947368421053,0.9664311800747013,1.0,1/5,0.75%,AURKAIP1
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),0.5658275149576913,0.8803508049838397,0.6578947368421053,0.9664311800747013,1.0,1/5,0.75%,AURKAIP1
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),-0.5633336396796607,-0.8802879086645393,0.6714285714285714,1.0,1.0,1/8,0.68%,SOX9
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.3263597658360358,0.880248277127348,0.75,0.9658655117672627,1.0,5/58,5.83%,EIF4H;EIF1;NPM1;EIF5;CDC123
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.5254957219773274,0.8801458500199187,0.6,0.9654338260795438,1.0,1/7,5.30%,PIK3C2G
prerank,PanglaoDB_Augmented_2021__Basophils,-0.4323325195652958,-0.8800630006942569,0.7073170731707317,1.0,1.0,10/39,16.67%,CD44;FAR2;SPI1;IL3RA;AOAH;TULP3;TBXAS1;MYO1F;ST6GALNAC5;CABLES1
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.5077520061714011,-0.8799772858259223,0.7105263157894737,1.0,1.0,7/16,31.01%,GPI;GAPDHS;PFKP;ENO1;HK1;PFKL;FOXK2
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.49448467799390516,-0.8799742765359494,0.7361111111111112,1.0,1.0,3/17,10.25%,CD160;B2M;HLA-F
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.5382320998958097,-0.8798646263053442,0.6379310344827587,1.0,1.0,1/7,20.44%,ATP1B1
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),-0.4556927585032512,-0.8798559896445755,0.7051282051282052,1.0,1.0,1/32,1.24%,DND1
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.48008064204539336,0.8796960569730016,0.6296296296296297,0.965787688813609,1.0,5/10,16.75%,TGFBR2;TGFBR1;SMAD7;BMP2;GDF6
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.5647328712186598,-0.8792460379649202,0.6716417910447762,1.0,1.0,2/9,12.68%,MMS19;FANCB
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.5012979261735938,-0.8792412320412417,0.6805555555555556,1.0,1.0,3/13,22.66%,PSMB8;PSMA3;MAPK12
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),0.49495820177578237,0.8791761531322663,0.65625,0.9662207820883595,1.0,3/6,18.70%,THY1;CERS2;PTPRS
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.4062818743442673,-0.8789258888909794,0.7311827956989247,1.0,1.0,18/85,13.33%,CD44;CALB1;SLC6A6;SRPX2;TNC;PAMR1;TIMP3;COL5A1;LAMA2;ITGA2;SVEP1;RUNX2;EDNRA;SPP1;OSMR;GJA1;FOXO1;SULF1
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.4180314538755721,-0.8787163790043662,0.6931818181818182,1.0,1.0,13/55,23.50%,CRYM;MCCC1;GLUL;SHMT1;ASPA;SLC25A21;GCDH;BCAT2;AASS;AUH;ACMSD;ACADSB;GLDC
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.5196914911922298,-0.8784124442147065,0.676056338028169,1.0,1.0,4/11,20.64%,CRYM;SLC25A21;GCDH;AASS
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.5196914911922298,-0.8784124442147065,0.676056338028169,1.0,1.0,4/11,20.64%,CRYM;SLC25A21;GCDH;AASS
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),-0.5648266546217873,-0.8782648463497086,0.6716417910447762,1.0,1.0,2/7,17.56%,SULF1;TMEM63C
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.32791237981558796,0.8778557942997397,0.5555555555555556,0.9681941124596104,1.0,13/86,10.83%,U2AF1;NUP42;RBM15B;ZFP36L1;CPSF1;ARC;CPSF4;NXF1;AGFG1;EIF4A3;EIF4E;RBM8A;POLDIP3
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.49011707415405753,0.8778505844360952,0.5945945945945946,0.9674699582992069,1.0,1/8,2.59%,ERN1
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),-0.4365404665476227,-0.877783470501624,0.6705882352941176,1.0,1.0,5/25,19.93%,EMD;LRP2;STAT5B;HDAC6;MAP2K5
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),-0.4884192115507284,-0.8774287876658768,0.6438356164383562,1.0,1.0,4/15,14.34%,AKAP5;CACNA1C;GRM3;ADGRV1
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.38968190067686576,0.8772489301689002,0.7222222222222222,0.9682854687544945,1.0,6/24,9.50%,RNF6;SEMA5A;MAP2;SEMA5B;MT3;SEMA3B
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),-0.5076211853540725,-0.8770788814615674,0.64,1.0,1.0,4/14,18.04%,SLC22A4;GJA1;ABCC3;ABCA8
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.47201397289246216,-0.8770325998198579,0.6867469879518072,1.0,1.0,2/20,8.19%,CAMK1;EMD
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.4874995198209318,-0.8767904184713596,0.6714285714285714,1.0,1.0,2/12,24.08%,NRDE2;NCBP2
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.3256973237973308,0.8767883575134968,0.6,0.9685696117693053,1.0,9/73,3.65%,AMOTL2;DHCR7;FIBIN;BGN;YAP1;COL12A1;TNS2;CXCL12;PDGFRA
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.4610455804338017,0.8765946639693603,0.625,0.9682043823857269,1.0,3/9,6.60%,NLGN2;ADRA1A;ZDHHC3
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.37194050573511317,0.8763632815874498,0.7647058823529411,0.9679588034157891,1.0,5/26,14.48%,RAN;WTIP;LIMD1;TRIM71;SNIP1
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),-0.4673272684958225,-0.8762450815120971,0.6538461538461539,1.0,1.0,3/27,4.02%,TMSB4X;PTPRC;OTUD7B
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.4879187325885158,-0.8762268173968807,0.6410256410256411,1.0,1.0,11/16,20.71%,PLET1;KLHDC4;IGSF6;SPI1;AOAH;NR1D1;MYO1F;MPP1;PILRA;TYMP;TRIM25
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.422529899969464,-0.8754917333411985,0.7613636363636364,1.0,1.0,26/90,23.80%,KCNJ13;PANX2;SLC22A4;SLC6A6;KCNC1;KCNMB4;SLC7A6;LRP2;SCN8A;SCN9A;SLC4A4;SLC9B2;KCNB2;SLC6A17;SLC6A9;KCNH1;TMEM63C;RHCG;ANO6;ATP1B1;SLC5A9;SLC8B1;GRIN1;KCNC4;SLC41A1;TRPM3
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.4848297134342303,-0.8751279009354636,0.5833333333333334,1.0,1.0,2/16,7.59%,VSIR;RARA
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.4848297134342303,-0.8751279009354636,0.5833333333333334,1.0,1.0,2/16,7.59%,VSIR;RARA
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),-0.5571388015403512,-0.8750501734122673,0.7183098591549296,1.0,1.0,3/5,37.75%,PODXL;JAG1;IQGAP1
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),-0.5571388015403512,-0.8750501734122673,0.7183098591549296,1.0,1.0,3/5,37.75%,PODXL;JAG1;IQGAP1
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.32841469025056486,0.8747943479081143,0.6666666666666666,0.970913823960277,1.0,10/52,12.13%,KDSR;SGPP1;B4GALT6;SMPD1;SPTLC1;ACER2;VAPB;SGMS1;ELOVL4;ACER3
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),0.5414073991411094,0.8746814988475579,0.6551724137931034,0.9703758795594583,1.0,3/5,16.02%,CALM3;CALM1;CBARP
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.565749163468011,-0.8744410709830793,0.6461538461538462,1.0,1.0,1/7,7.29%,MSH6
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),-0.48799348192757785,-0.8744047314556088,0.68,1.0,1.0,5/20,21.13%,APOE;ADAMTS9;PTPRR;PFN2;DAB2IP
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.49904573226180415,-0.8743366900488835,0.6962025316455697,1.0,1.0,1/16,0.10%,SLC28A2
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.4300959027602201,-0.8743034160362524,0.6103896103896104,1.0,1.0,4/30,13.01%,EFNA1;APOE;RTN2;HAP1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.486731089047652,-0.8742522999135259,0.696969696969697,1.0,1.0,4/17,14.99%,CEMIP;PDZK1;ITGB1BP1;AKT2
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.38041258801131944,-0.8740745184147821,0.7731958762886598,1.0,1.0,29/164,22.64%,TUBA4A;SPDYA;CDK7;TPD52L1;CDKN2A;MAX;CCNI2;BORA;CEP135;CCDC57;PLK2;CRLF3;CDC7;DNM2;LCMT1;TACC3;CAMK2A;CDK4;CHMP4B;CSNK1D;MASTL;HAUS5;EIF4EBP1;CDKN2B;DCTN1;CACUL1;FBXL17;CEP72;PPP2R2D
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.5619842453972294,-0.8739777667826388,0.7323943661971831,1.0,1.0,5/9,25.87%,AP2A2;CLTA;AP2M1;AP2A1;CLTC
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.5619842453972294,-0.8739777667826388,0.7323943661971831,1.0,1.0,5/9,25.87%,AP2A2;CLTA;AP2M1;AP2A1;CLTC
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),-0.3928368596045352,-0.8738337612298543,0.7634408602150538,1.0,1.0,29/166,19.43%,FGF1;EMP2;PTPRC;SLC39A14;TPD52L1;STX1B;RSPO4;RIMS1;IL7;BDNF;TRIM44;TRAF7;LOXL3;HAP1;ITGB1BP1;SULF1;MACF1;NTRK3;SORBS1;MYORG;STAT3;ING5;PRKD2;TGFB2;SHANK3;MAML3;GRB10;TUBD1;ASXL2
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.295968612468564,0.8730756803344406,0.5,0.973047411370521,1.0,20/61,21.31%,SIRT2;NFKBIL1;PCBP2;DUSP3;ENPP3;MUL1;OTULIN;TRAFD1;GRID2;FEM1A;CERS2;MFHAS1;TRAF3IP1;VPS35;PTPRS;CRK;CASK;LRFN5;ILRUN;NR1H3
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),-0.587283814082696,-0.8730740050027891,0.7727272727272727,1.0,1.0,1/5,3.97%,ABHD12B
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.45226248437518685,-0.8725845940783193,0.6527777777777778,1.0,1.0,4/20,14.99%,CEMIP;PDZK1;ITGB1BP1;AKT2
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),-0.5217735247048177,-0.8722359097081357,0.7,1.0,1.0,2/10,27.39%,ATP1B1;NEDD4L
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.3160847620856686,0.872201804941083,0.8,0.9742767582267394,1.0,9/115,5.18%,SOX11;OLIG2;TUBB2B;ASCL1;MYT1L;OLIG1;YAP1;POU3F2;WNT3
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),-0.5849765572504231,-0.8720022939604896,0.696969696969697,1.0,1.0,1/5,32.52%,CARMIL1
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),0.3602911023707001,0.8717925304895963,0.5789473684210527,0.9743440154441277,1.0,15/39,22.66%,MTERF3;SBDS;NPM1;RPS19;RPSA;RPL23A;MRPS2;RPS5;BRIX1;MRPS7;DDX3X;RRP7A;MRPS11;ERAL1;BOP1
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),-0.3967589017747684,-0.871648139169046,0.7241379310344828,1.0,1.0,24/99,26.35%,HOOK1;EMP2;WDR91;RBSN;STX10;CLTCL1;TBC1D10B;HOOK3;RAB6B;TMEM87B;GAK;VPS52;HOOK2;DCTN1;ANKFY1;VPS51;RGP1;STX5;AKTIP;AP2A1;EPS15;CLTC;EEA1;RAB29
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.3560361906392376,0.8716237547286139,0.6666666666666666,0.974042272289017,1.0,6/70,4.82%,PANX1;CHRNA4;STIM1;CHRNA7;MCOLN1;CALCRL
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),-0.4272196481879371,-0.8710738011062268,0.7012987012987013,1.0,1.0,4/36,17.00%,TSPYL2;ATAD5;BCAR3;ESCO1
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.42788318317192925,-0.8708397763754125,0.6447368421052632,1.0,1.0,6/37,14.32%,FABP3;CAV3;APOE;TMEM97;NR1D1;EPHX2
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.42788318317192925,-0.8708397763754125,0.6447368421052632,1.0,1.0,6/37,14.32%,FABP3;CAV3;APOE;TMEM97;NR1D1;EPHX2
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.5300438034831055,-0.8707815583075134,0.6212121212121212,1.0,1.0,5/10,31.55%,CAMK2B;SHANK3;DLG4;SYP;APP
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.471002816873509,-0.8704824352921913,0.6794871794871795,1.0,1.0,3/17,12.69%,HEY2;VEGFA;RASA1
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),0.5170652268500302,0.870161881745281,0.5882352941176471,0.9762555385180485,1.0,1/6,1.74%,ADCY6
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.5295651197438666,0.869948124883389,0.5925925925925926,0.976031758639824,1.0,3/8,22.14%,DCUN1D5;NAE1;DCUN1D1
prerank,PanglaoDB_Augmented_2021__Astrocytes,-0.3797227252182931,-0.8691489903689306,0.7362637362637363,1.0,1.0,26/129,17.31%,SOX9;STMN2;GRIN2A;OPALIN;FGF1;AGT;ALDH1L1;SLC6A11;MMD2;ACSBG1;APOE;SYNM;PSD2;SHISA6;SLC4A4;GJA1;SNAP25;BAALC;CAMK2A;SPARCL1;SORBS1;CRYAB;TMEM132C;PLP1;DAAM2;ADCY5
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.4662169673345091,-0.8691039546034071,0.6388888888888888,1.0,1.0,4/18,13.08%,SRPX2;RHOJ;VEGFA;ITGB1BP1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),-0.5133711418911744,-0.8687913968254323,0.6521739130434783,1.0,1.0,4/10,29.57%,TRIB1;PDGFRB;IGFBP5;NDRG4
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),0.39032268870543163,0.8683245216141128,0.5862068965517241,0.9788712678017859,1.0,4/23,6.28%,SIRT2;SVIL;MAP10;PKP4
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),-0.5474286313197254,-0.8682855579231059,0.6901408450704225,1.0,1.0,3/7,16.11%,CNTNAP1;MYRF;PLP1
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.33177213418102275,0.8680965615831497,0.6363636363636364,0.9788560592212874,1.0,4/60,4.45%,NUP42;POLR2J;POLR2L;WTIP
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.5360441770947463,-0.8676876580862716,0.7027027027027027,1.0,1.0,2/9,10.42%,PTPRC;GPI
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.5078021319184568,-0.8676601441789707,0.7123287671232876,1.0,1.0,7/15,31.01%,GPI;GAPDHS;PFKP;ENO1;HK1;PFKL;FOXK2
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.5078021319184568,-0.8676601441789707,0.7123287671232876,1.0,1.0,7/15,31.01%,GPI;GAPDHS;PFKP;ENO1;HK1;PFKL;FOXK2
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),-0.5506379433659304,-0.8673904437878106,0.6530612244897959,1.0,1.0,2/6,25.13%,TLK1;PARP10
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.3025981368179049,0.8673143999029376,0.75,0.9795628193110968,1.0,8/69,10.02%,UGDH;LRRC8D;ARC;ALAD;BOK;CHMP2A;JMJD6;ZBTB1
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),-0.48280596576192275,-0.8670889360275741,0.6666666666666666,1.0,1.0,3/16,6.91%,HEY2;EFNA1;ZFPM1
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.3690007662296681,0.8670103007964087,0.7272727272727273,0.9796389382342804,1.0,8/47,8.05%,SIRT2;ZFP36L1;PLCL2;PDGFRA;PIK3C2G;NGF;PLCL1;PLCB4
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.43954887985608254,-0.8668083697622779,0.6538461538461539,1.0,1.0,10/32,26.15%,IRF1;OAS1;IFIH1;TOMM70;TRIM56;TRAF3;POLR3A;TIRAP;ISG15;POLR3D
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.5086200781346693,-0.8667652553404078,0.7123287671232876,1.0,1.0,1/12,3.09%,CCDC39
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),-0.4604053186611863,-0.8666930432956818,0.7341772151898734,1.0,1.0,4/23,10.95%,YWHAH;CACNA1B;SCN8A;SCN9A
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),0.523801636314924,0.8666857496310915,0.625,0.979400378998691,1.0,5/8,24.48%,TRPM4;INAVA;WNT5A;TNFRSF14;SPHK2
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),0.4394191084132524,0.8666400401885213,0.5333333333333333,0.9788216438444625,1.0,4/10,9.37%,PSPH;SRR;SEPHS2;PSAT1
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),-0.5682920451016299,-0.8665213039426389,0.7164179104477612,1.0,1.0,1/6,15.59%,ARFGEF2
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),-0.5478221453479839,-0.8661426727104892,0.7205882352941176,1.0,1.0,1/7,3.97%,ABHD12B
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.5313602170017457,-0.8659980398160178,0.7162162162162162,1.0,1.0,4/10,25.54%,TPM1;ADAMTS9;TGFB1;TGFBR3
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.376778450248633,-0.8658004188129432,0.7959183673469388,1.0,1.0,23/235,15.91%,ABLIM1;FHDC1;FAM161A;TUBA4A;CCDC39;MAK;RAB17;INTU;RAB11A;CFAP221;INPP5E;CEP135;CCDC57;NPHP4;RPGR;AHI1;RILPL1;CFAP52;CFAP70;AVIL;CSNK1D;IFT27;B9D1
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),-0.5482018127766914,-0.8657977696419714,0.6666666666666666,1.0,1.0,3/7,35.12%,PGM5;ENG;POGLUT1
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.4390429605576299,0.8656345506202489,0.7647058823529411,0.980442474615187,1.0,3/23,6.66%,SOX4;ERN1;ZNF236
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.34831599461072366,0.8654441211952185,0.5263157894736842,0.9801646168480459,1.0,1/25,1.00%,HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.44450685866496276,0.865316641709244,0.5238095238095238,0.9798740999984207,1.0,4/12,10.79%,NR1H2;LDLR;ABHD5;SCARB1
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.3050632480951397,0.8652483552865757,0.8,0.9793750717734787,1.0,4/52,4.27%,ACTB;ACTG1;ARPC5;LYN
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),0.5623263087909416,0.8652380718532088,0.631578947368421,0.9786810412053324,1.0,1/5,0.98%,MALT1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.5230967131823239,-0.8651916453068402,0.6712328767123288,1.0,1.0,1/9,20.26%,IGF1R
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),-0.49423157068182233,-0.8649730797655567,0.6986301369863014,1.0,1.0,4/15,17.20%,TPST1;SULT4A1;PPA1;BPNT1
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.417411741904318,0.8647864218404882,0.7619047619047619,0.9789138345012468,1.0,4/17,12.91%,SOX11;SMURF2;SMAD3;SMAD7
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),-0.39625105505425884,-0.8646169956548024,0.7802197802197802,1.0,1.0,11/85,16.27%,HTR2C;CALB1;TPCN2;TRPC5;CALCB;CAV3;C19ORF12;HTR2B;SLC24A2;ATP2B3;ATP13A5
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),-0.498638847653488,-0.8642106071874308,0.6842105263157895,1.0,1.0,2/13,18.10%,RBM4;EIF4EBP1
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),-0.588248473031538,-0.8638599570260853,0.6440677966101694,1.0,1.0,3/5,32.54%,KDM7A;UTY;KDM6B
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),-0.5202989431370061,-0.8636770758563745,0.676056338028169,1.0,1.0,4/9,28.42%,KIAA0319;SMAD4;TGFB1;RBPMS
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.34404184005060123,0.863645409180422,0.7647058823529411,0.980527457360605,1.0,7/37,12.91%,UBE2D1;GREM1;BMPER;BAMBI;SMURF2;SMAD9;SMAD7
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),-0.40304756519150126,-0.8631657948062608,0.7032967032967034,1.0,1.0,18/64,26.41%,GRIN2A;TRPC5;GRIN2D;CACNA1C;RYR3;SLC24A2;ATP2B3;ANO6;YME1L1;SLC8B1;TRPC4AP;SLC24A5;GRIN1;TRPM3;AFG3L2;SPG7;PMPCB;NALCN
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),-0.4484823408212617,-0.8631024749047018,0.6625,1.0,1.0,1/21,3.09%,CCDC39
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.3283731381929467,0.8630388238473873,0.8333333333333334,0.9817481016930852,1.0,25/106,17.15%,MALT1;TAB3;IKBKB;TRAF5;RHOC;PLEKHG5;UBE2N;PPM1A;S100B;TMEM9B;TSPAN6;PELI1;ATP2C1;RIPK2;MUL1;INAVA;LITAF;RHOA;GAPDH;REL;RBCK1;DDX21;PRKD1;NDFIP2;DDX1
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),0.4842592568688419,0.8628390433718703,0.6363636363636364,0.9814967343045264,1.0,2/6,5.39%,DNMT3B;PIH1D1
prerank,PanglaoDB_Augmented_2021__Spermatocytes,-0.5689033334782653,-0.8626305702782291,0.7945205479452054,1.0,1.0,3/8,20.74%,TMCO5A;TTC6;SYCP2
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),0.5423218526035851,0.8626126963492321,0.5405405405405406,0.9811807288112359,1.0,1/5,0.09%,NOX4
prerank,GO_Biological_Process_2021__gland development (GO:0048732),-0.442729193695606,-0.8622017619635566,0.7105263157894737,1.0,1.0,2/30,1.60%,SOX9;HES1
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.5256872459765172,-0.8619983243851335,0.7123287671232876,1.0,1.0,4/10,32.19%,PLK2;ZW10;CHFR;INTS3
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),-0.5454614180041378,-0.8616648367009192,0.6666666666666666,1.0,1.0,1/8,12.03%,KCNQ1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),-0.5784273054418184,-0.8616271169152793,0.78125,1.0,1.0,2/7,19.15%,MSH6;XRCC4
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.5365342292892563,-0.8614988578416056,0.7428571428571429,1.0,1.0,3/10,20.90%,PTPRC;PTPRJ;RYR2
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),0.3688459437796663,0.8613342912492524,0.6666666666666666,0.9831777199726937,1.0,2/38,0.65%,UBB;RFWD3
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.533332025529319,-0.8610692561971155,0.68,1.0,1.0,4/11,20.25%,OPRM1;CHRM2;CHRM5;CHRM3
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),-0.5488326106651651,-0.861063942641385,0.7101449275362319,1.0,1.0,4/6,41.53%,MDH1;ME2;FH;ME3
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.41615860558503553,-0.8609597189515601,0.7073170731707317,1.0,1.0,8/32,21.77%,BRCA1;MAX;CDC7;SUZ12;CDKN2B;DAB2IP;TFDP1;UXT
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.4932085952270172,0.8604987552238246,0.6285714285714286,0.9844577651155574,1.0,2/6,8.70%,GREM1;TRPM4
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),-0.5825503448780927,-0.8604247259034974,0.7777777777777778,1.0,1.0,3/5,23.05%,NLRC4;HLA-B;HLA-A
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.479905055280892,-0.8597744511349038,0.75,1.0,1.0,4/18,11.86%,VCL;LAMA2;CLDN12;GJA1
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),-0.4513204866816944,-0.859694913930004,0.7407407407407407,1.0,1.0,4/19,15.34%,TTLL6;AGBL4;TTLL4;AGBL5
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.36671291864502686,0.8596063289809825,0.6,0.9860343125605407,1.0,11/50,15.34%,CPSF1;POP5;TRMT10A;AARS1;CPSF4;TYW5;TSEN34;ANKRD16;DTWD1;TRMT10C;RTRAF
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.34266086197111445,0.8592211951865311,0.7222222222222222,0.986182594450315,1.0,2/25,2.17%,CRB2;SPOCK3
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),0.47825183744224004,0.8591475577831804,0.7096774193548387,0.9855534299630013,1.0,4/7,28.70%,UBQLN2;HERPUD1;CAV1;BCAP31
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.5836278164309204,-0.8590139656093965,0.7692307692307693,1.0,1.0,1/5,26.55%,BRSK1
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.33079978829533985,0.8584600928329217,0.8571428571428571,0.9861419553271902,1.0,7/44,9.98%,UBB;GPX1;ALAD;BAG2;COMMD1;PSME3;TMTC3
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),-0.545725536088198,-0.8582312936016923,0.6811594202898551,1.0,1.0,2/8,17.56%,SULF1;TMEM63C
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),-0.484880966278542,-0.8581195671410934,0.7083333333333334,1.0,1.0,3/10,19.61%,FUT2;ST6GALNAC5;ST3GAL6
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),-0.484880966278542,-0.8581195671410934,0.7083333333333334,1.0,1.0,3/10,19.61%,FUT2;ST6GALNAC5;ST3GAL6
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),-0.4387508581678521,-0.8580960668726997,0.7631578947368421,1.0,1.0,3/21,15.30%,FGF1;ITGB1BP1;NTRK3
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.3392963338215793,0.8578686797511953,0.5833333333333334,0.986703752885386,1.0,10/69,10.28%,VANGL1;PSMD8;PSMB4;PSMB6;PRICKLE1;ROR2;FZD3;PSMD10;PSME3;SMURF2
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),-0.37965859383744877,-0.857813202977321,0.7640449438202247,1.0,1.0,21/105,24.02%,EMP2;RAB40A;PLEKHF1;CAV3;RAB11A;RAB3A;RAB40B;PDZK1;ITGB1BP1;RAB15;KCNB2;RAB3D;GAK;MRAP;RDX;ATP1B1;RAB8B;TNIK;RAB40C;MAP7;PACSIN1
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.5660925878551275,-0.8577867544331136,0.7246376811594203,1.0,1.0,2/5,27.87%,ADGRV1;CAPN7
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.5259956208943513,-0.8577830376965823,0.7121212121212122,1.0,1.0,2/9,13.08%,EFNA5;ITGB1BP1
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.5259956208943513,-0.8577830376965823,0.7121212121212122,1.0,1.0,2/9,13.08%,EFNA5;ITGB1BP1
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),-0.4297986002523526,-0.8575633305596485,0.7349397590361446,1.0,1.0,10/40,25.66%,SYT1;CPLX1;RAB3A;HAP1;RAB15;RAB3D;RAB8B;CADPS2;STX4;CHMP6
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.5372593071135591,-0.8569502598626261,0.7534246575342466,1.0,1.0,2/7,31.93%,MED1;DMTN
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.48639447162517574,-0.856828201856737,0.7142857142857143,1.0,1.0,4/14,25.86%,DUSP22;ITGB1BP1;FAM107A;BCAS3
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.48639447162517574,-0.856828201856737,0.7142857142857143,1.0,1.0,4/14,25.86%,DUSP22;ITGB1BP1;FAM107A;BCAS3
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),-0.48258033736562195,-0.8567564437550921,0.6527777777777778,1.0,1.0,4/13,20.25%,AGT;KCNMB4;OXTR;CHRM3
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.46087738493792446,-0.8565728891227202,0.6962025316455697,1.0,1.0,3/22,11.34%,ALOX12;FAR2;ACSS3
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.4847465659183321,-0.8565601793382003,0.7468354430379747,1.0,1.0,3/21,20.40%,THOC5;BTBD18;BRD4
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.47185831432715075,0.8557015056539974,0.6756756756756757,0.9906641458811598,1.0,6/8,18.86%,MEOX2;STARD13;RHOA;HDAC5;NOTCH1;PDCD10
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.580269700502748,-0.855679458962458,0.7391304347826086,1.0,1.0,3/6,36.38%,PNKP;WARS1;XRCC1
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.5430295625202248,-0.8553861923662799,0.7058823529411765,1.0,1.0,3/8,24.30%,PARN;ST3GAL1;ST6GAL1
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),-0.5744725733620415,-0.8552867485472505,0.725,1.0,1.0,2/5,30.41%,NAGK;GNPDA2
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),-0.5744725733620415,-0.8552867485472505,0.725,1.0,1.0,2/5,30.41%,NAGK;GNPDA2
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),-0.4892286539312107,-0.8550453579039352,0.7142857142857143,1.0,1.0,3/17,15.72%,AKT2;CLTCL1;SORBS1
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.46828899353936093,-0.8550069287601687,0.6923076923076923,1.0,1.0,3/15,23.67%,EPHA7;TGFB2;BACE1
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.42300375491085396,0.8548850770962217,0.6666666666666666,0.991790143726405,1.0,1/21,3.57%,KCNN2
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.5235401450717974,-0.8544793602763383,0.6666666666666666,1.0,1.0,3/8,19.57%,ITPK1;DNM1L;RIPK1
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),-0.40164423071280586,-0.8542242086053395,0.813953488372093,1.0,1.0,10/67,15.58%,STMN2;CAMK1;APOE;ALK;CAMK2B;BDNF;CAMK1D;NTRK3;PTK7;AVIL
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.4729474390838988,-0.8540224027554321,0.7625,1.0,1.0,1/19,3.12%,ENO4
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.2939386085194455,0.8539933998540632,1.0,0.9929661306643764,1.0,16/181,4.20%,SOX4;SOX11;MARCKS;POU6F2;MARCKSL1;HSPG2;NKX2-2;SOX8;TGFBR2;GSTP1;PPT1;BCAN;SHROOM2;CA10;SOX10;VCAN
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.47578639839358294,-0.8536904144683044,0.7195121951219512,1.0,1.0,5/22,22.37%,ZER1;HDAC6;YME1L1;UFD1;FBXL17
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),0.4031360686278435,0.8535226025525716,0.6538461538461539,0.9930699285134722,1.0,4/15,13.00%,COLEC12;NPM1;MUL1;RALB
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),0.39004606655757346,0.8533788499043387,0.5555555555555556,0.9926322804100043,1.0,2/35,3.46%,NUP42;RAN
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.4506399241288259,-0.8533072217332487,0.7307692307692307,1.0,1.0,7/27,12.42%,EFNA1;RAB17;SLC3A1;ATP8B1;SPP1;SLC44A3;GPRC5C
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.4550367315883095,-0.8531365307416818,0.7027027027027027,1.0,1.0,6/19,29.25%,CAV3;JPH3;CACNB1;CAMK2D;PLN;CACNB4
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.5076015423825119,-0.8530607821430997,0.6619718309859155,1.0,1.0,6/12,37.00%,DDRGK1;RB1CC1;UBA5;RETREG1;ULK1;ULK2
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),-0.5790474847377175,-0.8523218191286802,0.6666666666666666,1.0,1.0,1/5,3.16%,PTPRC
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),-0.5252207746932608,-0.8522098725801721,0.75,1.0,1.0,3/8,27.01%,KLF15;PRKAA1;PRKAA2
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,-0.4519314045971197,-0.8522067030841556,0.6962025316455697,1.0,1.0,2/21,3.45%,GUK1;RPS6KB2
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.4043628068206809,-0.8521896092924871,0.7674418604651163,1.0,1.0,12/72,15.74%,IGF2BP2;IGF2BP3;DAPK1;APOE;PUS7;SHMT1;RTN2;TSC1;HAP1;ZNF540;RBM4;DAPK3
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.4760124122466578,-0.8520551012971526,0.7142857142857143,1.0,1.0,4/21,12.04%,SOX9;DUSP22;PDE8A;VIL1
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.35288155213694516,0.851495809075267,0.7368421052631579,0.9962777926132608,1.0,4/58,3.54%,UBB;GPNMB;SIGMAR1;CHRNA7
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.48500303773822107,-0.8513859887732559,0.72,1.0,1.0,1/16,4.26%,CDKN2A
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.5180143203707165,-0.8513725543229873,0.6865671641791045,1.0,1.0,1/7,10.54%,VEGFA
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.37568394421286705,0.8513191633019638,0.625,0.9959542766185905,1.0,10/57,6.60%,VPS37B;ZDHHC6;ZDHHC1;YIF1B;GOLGA7;MICALL1;ZDHHC4;ZDHHC21;ZDHHC11B;ZDHHC3
prerank,MSigDB_Hallmark_2020__Adipogenesis,0.3039382495546638,0.8511379870674252,1.0,0.9956569494145604,1.0,32/163,11.23%,DHCR7;IDH1;ACADS;MRPL15;ADCY6;ACAA2;ARL4A;SLC25A1;CD151;PLIN2;DNAJC15;NDUFA5;SLC5A6;PREB;NDUFS3;CMPK1;ECH1;CDKN2C;MGLL;GRPEL1;DLD;CAT;ACLY;UQCRC1;SSPN;TOB1;NDUFB7;UQCR10;UBC;SCARB1;PRDX3;ESRRA
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.5140826439773496,0.8510218042707796,0.6129032258064516,0.9952957995506262,1.0,2/6,10.50%,ACADS;PCCB
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),0.4402358874795893,0.850758322791358,0.6153846153846154,0.994973696393182,1.0,3/12,13.62%,POP5;AARS1;DTD1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.31227508915874735,0.8507342449069736,0.9411764705882353,0.9942670970100685,1.0,9/45,10.08%,AURKAIP1;KIF25;PPP1R10;PCGF2;RYBP;BMI1;CHMP2A;PHC3;RNF2
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.4751179745591982,-0.8503984492413719,0.72,1.0,1.0,7/18,14.32%,SREBF1;SEC14L2;LPCAT3;APOE;FMO5;MBTPS1;EPHX2
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,-0.3672607477108048,-0.8502309284334872,0.8526315789473684,1.0,1.0,20/163,19.27%,TUBA4A;NEDD9;VCL;RAPGEF5;SEPTIN9;RFC1;TLK1;KLC1;BCL2L11;PREX1;TSC1;RASA1;TBCD;CSNK1D;KIF20B;HOOK3;TIAM1;BCR;HDAC6;TUBD1
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.37888145992641614,0.8501144684569172,0.68,0.9948181527240583,1.0,4/20,14.03%,NT5E;PNP;NT5C1A;NUDT4
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.47683975485904995,-0.8495740332448412,0.7297297297297297,1.0,1.0,1/13,0.56%,ENPP2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.43686677491682574,-0.8495355681882093,0.7469879518072289,1.0,1.0,7/27,27.39%,CAV3;BDNF;RAB11FIP5;ABCA2;STX4;MAP1A;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.44484734902811773,-0.8493669444047559,0.6962025316455697,1.0,1.0,8/24,26.15%,IRF1;OAS1;IFIH1;TOMM70;TRIM56;POLR3A;ISG15;POLR3D
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",-0.47549380357308724,-0.8491139061758293,0.7012987012987013,1.0,1.0,3/18,5.69%,GRIN2A;GLRA1;GRIN2D
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.3404131143685595,0.8484454788731944,0.5555555555555556,0.9975082734654507,1.0,11/99,7.68%,CRB2;GPNMB;CFL1;LZTS1;WTIP;ARC;RAP2A;VASH1;EPHB3;BMPER;LZTS3
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.3676541374691519,0.8484053255894014,0.7222222222222222,0.9968525919894555,1.0,5/25,14.48%,MRPL44;SMAD3;TRIM71;DGCR8;SNIP1
prerank,GO_Biological_Process_2021__brain development (GO:0007420),-0.3890081313076326,-0.8483725024964225,0.851063829787234,1.0,1.0,17/101,19.09%,SYNJ2;GRIN2A;B3GNT5;GRIN2D;ROBO2;ARNT2;ADGRL2;HAP1;EPHA7;SLC6A17;ZIC1;MEIS2;SMARCA1;SHANK3;MDGA1;DHX37;ZFHX3
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.45664249579604677,-0.8482655765004089,0.7333333333333333,1.0,1.0,3/19,18.57%,PDCD4;STAT3;PER1
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),0.41635082558983855,0.8479340806411997,0.6111111111111112,0.997131895430473,1.0,5/18,18.51%,UQCRC1;UQCR10;NDUFS8;ATP5F1D;SLC25A14
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.5578684894291994,0.8478217029053213,0.6785714285714286,0.9958750132870603,1.0,1/6,0.50%,SIRT2
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.5578684894291994,0.8478217029053213,0.6785714285714286,0.9958750132870603,1.0,1/6,0.50%,SIRT2
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.4681970371618801,0.8477685144717677,0.7037037037037037,0.995260696008708,1.0,3/8,23.13%,SNAPC5;ICE2;SNAPC1
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.44498020018273665,-0.8476132471528356,0.6623376623376623,1.0,1.0,6/27,23.80%,KCNJ11;SFXN3;SLC6A9;SLC25A19;ATP1B1;TRPM3
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.443305301288924,0.8475524070332622,0.6666666666666666,0.9950810430863308,1.0,3/10,12.82%,ESR1;NR3C1;ABHD2
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),-0.38342975527562984,-0.8475485992920073,0.8461538461538461,1.0,1.0,24/131,22.73%,RASGRF1;STMN2;CNTNAP1;SHTN1;DOCK7;RAB11A;APOE;PAK1;BDNF;DNM2;ADGRV1;MICALL2;KIF20B;PLP1;MAP4;SHANK3;STMN3;RAB35;DAB2IP;DLG4;DCLK1;TNIK;EPHA4;LAMB1
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),0.5002162339663647,0.8472175264538516,0.5714285714285714,0.9950291393028305,1.0,1/5,5.55%,CLIP3
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.4647045760433859,-0.8471655007952367,0.7671232876712328,1.0,1.0,3/24,11.57%,YWHAH;CAV3;GLRX
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),-0.5565590391130735,-0.8468657702626907,0.7352941176470589,1.0,1.0,1/6,15.67%,SLC6A9
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),-0.49849060149981683,-0.8467331944730632,0.6962025316455697,1.0,1.0,1/11,4.62%,USP13
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),-0.509222843907275,-0.8465977534437439,0.7285714285714285,1.0,1.0,4/7,16.81%,NR4A3;LRP2;NR1D1;STAT3
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),-0.5535942156469655,-0.8462875234931634,0.7121212121212122,1.0,1.0,1/6,13.61%,CYP3A5
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.4665626373658734,-0.846228642473256,0.76,1.0,1.0,2/20,11.17%,EFNA1;TAF1
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.4003110501968673,-0.8462250218532822,0.8387096774193549,1.0,1.0,7/67,10.93%,RFC4;CDK7;PPIE;UVSSA;RFC1;RFC2;RPA3
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.45216221388553196,0.8460207889679141,0.6071428571428571,0.9968628225549016,1.0,4/15,8.76%,ERN1;CPSF1;CPSF4;TSEN34
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.4085972892658389,-0.8459758108165849,0.6818181818181818,1.0,1.0,7/36,25.74%,PARN;PNKP;PARM1;ATM;MEN1;HMBOX1;MAP2K7
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.43033437751666453,0.8459616976877798,0.627906976744186,0.9964023291319383,1.0,2/9,4.95%,SHROOM2;C12ORF57
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.43558173996032024,-0.8457902114329197,0.6623376623376623,1.0,1.0,8/28,26.15%,PTPRC;PLSCR1;RSAD2;IFI35;TGFB2;STX4;XBP1;POLR3D
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),-0.38427390945411255,-0.8457635976522825,0.7380952380952381,1.0,1.0,8/62,15.72%,SLC39A14;TBC1D4;TSC1;FOXO1;RAB15;AKT2;USF1;SORBS1
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.33104470159967564,0.8457135349589007,0.8235294117647058,0.9962605380211795,1.0,7/47,12.51%,GPNMB;CCND1;CDKN2C;CDC73;PSME3;LSM11;PLCB1
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.3217800496984345,0.8456469505995236,0.6875,0.9956740100537373,1.0,5/38,7.82%,TRIM28;TMEM161A;UBE2N;MGMT;PARP1
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),-0.572589570582958,-0.8456410854583588,0.7846153846153846,1.0,1.0,2/6,18.02%,VEGFA;PRKD2
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),-0.37022159612075073,-0.8453622998770628,0.8125,1.0,1.0,24/149,22.15%,HOOK1;PLEKHF1;CAV3;SPTBN5;ATP8B1;DNM1;USP50;GOLGA8B;BAG5;SYNGR2;TANGO2;USP8;ATP8B2;ARFGEF2;CSNK1D;HOOK3;GAK;GOLPH3L;HOOK2;DNM1L;GOLGA8M;PLEKHM2;VPS51;FAM174B
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.423448644785641,-0.8452068214304553,0.7375,1.0,1.0,6/41,14.77%,FGF1;SRF;RAB3A;TPM1;PAK1;MACF1
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.5125396640737582,0.8451329942238486,0.5652173913043478,0.9961045994948207,1.0,3/6,9.17%,RAN;NPM1;LSG1
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),-0.4616761913377132,-0.8445982163169505,0.7764705882352941,1.0,1.0,5/19,23.53%,P2RY12;ATG14;TGFB1;PDGFRB;DGKZ
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.38907139419825754,0.844297982490524,0.7391304347826086,0.9971565977691874,1.0,3/18,3.99%,ZNF488;SOX8;SOX10
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),-0.39085467481821035,-0.844240234042097,0.6785714285714286,1.0,1.0,12/51,24.55%,SEPTIN9;EFHC1;TTC19;CECR2;RASA1;USP8;CHMP4B;CIT;RAB35;SPIRE1;ECT2;MITD1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.4206680183968663,-0.8441375493273805,0.6931818181818182,1.0,1.0,4/38,5.39%,STK17A;GADD45A;AGT;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.36041794852873754,0.8437854125101698,0.7894736842105263,0.9975220853415547,1.0,4/33,8.70%,ZFP36L1;FRZB;SYAP1;TRPM4
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),-0.4956427882994021,-0.843348318166514,0.7435897435897436,1.0,1.0,2/15,16.09%,CSNK1D;HOOK3
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.30725302048717507,0.8429652942472927,0.8333333333333334,0.9986603020190892,1.0,20/137,12.91%,SOX4;HSPA1A;CCT5;CALR;PHB2;BAG3;TAF9B;GOLGA7;CCT3;COG3;BAG2;MT3;GBA3;LAMP1;MUL1;RABL3;SUMO1;CHP1;MARCHF7;SMAD7
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),-0.5276931662697655,-0.8429017496421359,0.7638888888888888,1.0,1.0,6/8,45.30%,METRNL;FNDC5;VSTM2A;SOX13;BMP7;HNRNPU
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),-0.5748487795229291,-0.8425896038348724,0.7258064516129032,1.0,1.0,1/5,5.39%,BRCA1
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.3954402828566221,-0.8425613089836382,0.7241379310344828,1.0,1.0,8/55,20.56%,PON1;VEGFA;DNM2;LCMT1;CRYAB;HDAC6;RDX;SVIP
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),0.45885210924855646,0.8425440718339179,0.5333333333333333,0.9988848553127885,1.0,2/5,21.18%,KDM1B;MECP2
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.4302184289470529,-0.8424209714944568,0.7307692307692307,1.0,1.0,5/27,14.91%,ANKRD53;EML3;BORA;TACC3;CHMP4B
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.39480564440227717,-0.8423610153576259,0.8085106382978723,1.0,1.0,10/92,10.93%,RFC4;CDK7;PPIE;FANCC;UVSSA;RFC1;RFC2;MMS19;DDB2;RPA3
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.40745305523701003,0.8422187051307851,0.7407407407407407,0.9987040269430804,1.0,2/12,3.77%,SLC30A10;SLC39A10
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.39206094829942983,-0.8419837083634554,0.7906976744186046,1.0,1.0,13/61,23.81%,RASGRF1;MMD2;RASGEF1A;RASGRP1;DENND3;BCR;TGFB2;RDX;SYNGAP1;DAB2IP;DENND4B;ARHGAP17;MADD
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),0.47851325243091763,0.8417838042322581,0.6666666666666666,0.9980903402743725,1.0,1/5,8.71%,CDC73
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),0.47851325243091763,0.8417838042322581,0.6666666666666666,0.9980903402743725,1.0,1/5,8.71%,CDC73
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),-0.4994573224208436,-0.8413974668790576,0.6805555555555556,1.0,1.0,2/8,27.39%,KCNQ1;NEDD4L
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.44073147065643214,0.8412697431660032,0.6521739130434783,0.9984157090449027,1.0,3/16,6.24%,CGNL1;NLGN2;NECTIN1
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.4403700594118708,0.84116685121818,0.6486486486486487,0.9978191976913323,1.0,1/8,2.45%,MLST8
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.3837081037787297,0.84112915054964,0.55,0.9971983078897254,1.0,4/15,16.02%,CALM3;SRI;CALM1;CBARP
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),-0.5580257552289523,-0.8407502273414511,0.7466666666666667,1.0,1.0,2/9,20.90%,RYR3;RYR2
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.4282719932705036,0.8407461933697424,0.5909090909090909,0.9972589282125157,1.0,2/8,12.70%,MKKS;GNAS
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.30789270721022854,0.8406747995382615,0.7777777777777778,0.9967526748871377,1.0,15/107,10.28%,SOX4;TMEM9;PSMD8;GID8;LGR5;GSKIP;PSMB4;SEMA5A;PSMB6;PPM1A;BAMBI;TRPM4;PSMD10;PSME3;SMURF2
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),-0.5720920937967344,-0.8405877221860811,0.7931034482758621,1.0,1.0,1/5,19.02%,DNM1L
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.4055577039617104,-0.8402401228043584,0.7325581395348837,1.0,1.0,7/47,17.71%,LIMK1;CDC42EP3;VASP;VIL1;NTRK3;PFN2;BAIAP2
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),-0.5416335176248898,-0.8398908834776867,0.7536231884057971,1.0,1.0,2/8,16.97%,MACF1;ERMN
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.3609700143474587,0.8395553431514018,0.6875,0.9980344009534987,1.0,8/23,22.35%,UBE2D4;ANAPC11;ANAPC7;UBE2E3;CDC26;UBE2A;UBE2E2;ANAPC1
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.5537019252010491,-0.8394820128551155,0.7580645161290323,1.0,1.0,1/5,21.28%,TERF2IP
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.4271042779201049,-0.839337357965826,0.7530864197530864,1.0,1.0,6/21,22.37%,RBM4;PER1;BHLHE40;PDE6B;RBM4B;FBXL17
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),-0.5718607775544919,-0.8392172141405683,0.7285714285714285,1.0,1.0,1/5,26.80%,PDK3
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.4737309686084937,0.8392010878354902,0.65625,0.998169764396949,1.0,3/5,22.73%,ABHD5;OSBPL8;PPARA
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.3612732855592815,0.8391445633088058,0.9285714285714286,0.9975885304954439,1.0,5/31,11.10%,BICD2;MAP10;KLHL42;MEMO1;CAMSAP3
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),-0.5436821824416176,-0.8388925811439997,0.7611940298507462,1.0,1.0,2/5,40.43%,MEF2C;INPPL1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.4654133518680996,0.8388263816206336,0.7586206896551724,0.9975356235215999,1.0,2/12,13.59%,NAA11;NAA30
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.37842683013032363,0.8386503249309716,0.7272727272727273,0.997131370597704,1.0,1/23,0.54%,MYH3
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.43385190235052623,0.8385740788088224,0.5454545454545454,0.9965771865863743,1.0,4/17,12.82%,DUSP7;PPM1A;PDP1;PPM1E
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),-0.4262929605212071,-0.8378934264079212,0.7721518987341772,1.0,1.0,4/26,7.54%,HEY2;HES1;ZFPM1;ROBO2
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.4260790514350945,-0.837331997512789,0.7,1.0,1.0,4/26,12.03%,KCNN3;KCNMB4;PDZK1;KCNQ1
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.4222254679783785,-0.8373133731748186,0.7469879518072289,1.0,1.0,8/47,12.52%,SOX9;NR4A3;FGF1;FGF9;B2M;VEGFA;FUT2;NR1D1
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.4156139242789221,-0.8372482109911555,0.7948717948717948,1.0,1.0,7/36,21.28%,RPA3;XRCC3;ZBTB48;RIF1;WRN;ATM;TERF2IP
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.3432157766537972,0.8371523170719007,0.8333333333333334,0.9986807845468152,1.0,9/54,3.65%,MMP2;FIBIN;BGN;PODN;COL12A1;TNS2;CXCL12;SEMA5A;PDGFRA
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),0.3377766045393256,0.8371361964652138,0.5555555555555556,0.998026095918475,1.0,7/54,8.18%,LTV1;ZNF658;NPM1;EBNA1BP2;RPS19;NOC2L;MRPL36
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.4211372024135161,-0.837126135468505,0.6794871794871795,1.0,1.0,9/34,28.41%,DCAKD;ADCY1;ADCY5;ADSS2;PANK2;PANK4;PAPSS2;SLC26A2;ADCY3
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.4634706557136719,-0.8370927604487718,0.6794871794871795,1.0,1.0,4/15,11.58%,DPAGT1;DHDDS;ALG6;ALG14
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.37662907719406785,0.8370119605493163,0.6363636363636364,0.9975475454219522,1.0,4/30,10.20%,RAB26;RILPL2;GOLGA7;GORASP2
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.39930512039722793,0.836810053592384,0.6818181818181818,0.9973698258557507,1.0,3/17,10.79%,PRELID3B;LDLR;SCARB1
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.41403672107244516,-0.836334725531981,0.6710526315789473,1.0,1.0,4/36,10.93%,RFC4;RFC1;RFC2;RPA3
prerank,MSigDB_Hallmark_2020__Complement,-0.36980149079349095,-0.8360718751264206,0.8152173913043478,1.0,1.0,26/116,25.53%,GCA;MAFF;IRF1;F8;CP;PLSCR1;RBSN;GNB4;HPCAL4;RASGRP1;USP8;L3MBTL4;CA2;C1S;IRF2;ADAM9;USP14;PSEN1;CD59;ATOX1;CD55;ZFPM2;STX4;DGKG;LIPA;PCLO
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),-0.45989033468609025,-0.8357514917053254,0.7368421052631579,1.0,1.0,3/13,18.47%,AKAP5;ADCY1;SHANK3
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),-0.5418347280187734,-0.835501669299433,0.7571428571428571,1.0,1.0,1/8,11.75%,TTC19
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),-0.5418347280187734,-0.835501669299433,0.7571428571428571,1.0,1.0,1/8,11.75%,TTC19
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.36140418019221104,0.8351882599214128,0.6428571428571429,1.0,1.0,5/32,13.87%,GPX1;PPIF;CAT;PRDX3;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.43750087070764987,-0.835157340296511,0.7105263157894737,1.0,1.0,1/22,1.06%,STMN2
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),0.5531579566491591,0.8350012130649421,0.6538461538461539,1.0,1.0,1/5,7.59%,BOK
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.5095202964805087,-0.8347143433924346,0.7058823529411765,1.0,1.0,2/10,17.58%,TACC3;NEK6
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.3655413542747647,0.8342023537559443,0.5909090909090909,1.0,1.0,3/21,4.60%,CHRNA4;CHRNA7;PCDH15
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),-0.5284232784912263,-0.8341832421045523,0.7049180327868853,1.0,1.0,1/5,18.62%,WRN
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),-0.4748963567284985,-0.8338626434701316,0.7027027027027027,1.0,1.0,3/11,16.11%,CNTNAP1;MYRF;PLP1
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.43487838247232447,0.8336339302110759,0.5789473684210527,1.0,1.0,3/9,10.79%,NR1H2;LDLR;SCARB1
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.4403724723982398,0.8334637901582361,0.8,1.0,1.0,1/18,0.89%,TUBG1
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.45045345866445446,-0.8331447127609308,0.7195121951219512,1.0,1.0,2/24,9.30%,LAS1L;WDR12
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),-0.5038325224845668,-0.8331078717354131,0.7142857142857143,1.0,1.0,1/14,0.51%,FHDC1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),-0.5038325224845668,-0.8331078717354131,0.7142857142857143,1.0,1.0,1/14,0.51%,FHDC1
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,-0.35542830833206657,-0.8330758488370265,0.8804347826086957,1.0,1.0,26/145,17.31%,SEC14L5;ENPP2;OPALIN;NKX6-2;SNCB;NFE2L3;MYRF;KIF6;ZDHHC9;MMD2;PSD2;MAG;SHISA6;PEX5L;PDE8A;MOBP;GRM3;CAMK2A;SPARCL1;SORBS1;ASPA;PLP1;SLC25A19;ERMN;TYRO3;ADCY5
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),0.5442267572594162,0.832599462189952,0.7777777777777778,1.0,1.0,1/5,10.16%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),0.5442267572594162,0.832599462189952,0.7777777777777778,1.0,1.0,1/5,10.16%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),0.5442267572594162,0.832599462189952,0.7777777777777778,1.0,1.0,1/5,10.16%,EXOSC8
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),0.5442267572594162,0.832599462189952,0.7777777777777778,1.0,1.0,1/5,10.16%,EXOSC8
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.4254399164256314,0.832170341024441,0.7272727272727273,1.0,1.0,5/12,28.37%,ARID2;SMARCB1;ARID1A;SET;HMGA1
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.5680165702294289,-0.8320739690953891,0.7910447761194029,1.0,1.0,1/5,1.15%,NAAA
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.32287933770936994,0.8319764506520433,0.7,1.0,1.0,7/57,9.14%,PANX1;CHRNA4;CHRNA7;CALCRL;NIPA2;MT3;ATP2C1
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.3224210955921105,0.831946864604417,0.8636363636363636,0.9994483200615263,1.0,9/33,13.95%,PORCN;ZDHHC6;ZDHHC1;ZDHHC21;ZDHHC3;NAT10;NAT9;ZDHHC16;ZDHHC2
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),-0.35736855816882696,-0.8317347696179562,0.8351648351648352,1.0,1.0,12/134,12.06%,SYNJ2;PIP4K2C;PLEKHA4;PLSCR1;DDHD2;PCTP;LIPI;INPP5E;LPCAT3;SLC44A3;GPAM;LIPH
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.4340635568922765,-0.8317132432911865,0.7692307692307693,1.0,1.0,3/25,4.67%,ART4;PARP9;PARP14
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.29492530710566034,0.831662014643224,0.9,0.9993824233484294,1.0,22/117,17.26%,DAPL1;MLST8;TFEB;RRAGA;MAP1LC3A;ATP6V0E1;ATP6V1G1;HSPA8;LAMTOR2;ATP6V1B2;ATP6V0D1;ATF4;MIOS;RALB;SIRT1;HSPA5;LAMTOR1;PRKD1;FADS1;MYBBP1A;ATP6V1H;SESN3
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.4163296509928093,-0.8315622837537675,0.7777777777777778,1.0,1.0,4/37,5.10%,VSIR;PSMB8;TIMP3;AGT
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.30301952040748065,0.8315369219604462,0.9,0.9989327042748742,1.0,10/117,7.02%,SIRT2;PMEPA1;PRR5L;GSKIP;GSTP1;LYN;CEP85;THY1;GREM1;PPIA
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.5202832363129846,-0.8314372248437627,0.7213114754098361,1.0,1.0,1/5,9.85%,APOE
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.44227638168351174,0.831422340895428,0.68,0.9984588610305051,1.0,4/10,18.79%,ACOT8;CRAT;CROT;ACOX1
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.3949633382574085,-0.8312245734792802,0.788235294117647,1.0,1.0,7/38,15.20%,BRCA1;VEGFA;ZNF568;ARNT2;KIAA1217;SULF1;PTPRR
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.4215973734480054,-0.8311773112402011,0.6823529411764706,1.0,1.0,3/35,4.92%,NUBP1;SLC39A14;CP
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.519929026272546,-0.8310350858267544,0.7464788732394366,1.0,1.0,3/10,23.09%,ENTPD3;ENTPD7;ENTPD1
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),-0.4098438248687905,-0.8310200591802931,0.7777777777777778,1.0,1.0,4/31,16.75%,EMP2;RFTN1;CHMP4B;GAK
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),-0.5475187715315648,-0.8309852919586951,0.7538461538461538,1.0,1.0,2/5,22.26%,STAT1;TGFB1
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),-0.5475187715315648,-0.8309852919586951,0.7538461538461538,1.0,1.0,2/5,22.26%,STAT1;TGFB1
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),0.37189842835890013,0.8308899420108681,0.7272727272727273,0.9988513732947017,1.0,6/29,9.97%,TRMT112;HSD17B10;TRMT10A;METTL2A;TRMT1L;TRMT5
prerank,PanglaoDB_Augmented_2021__Goblet Cells,-0.5069802389334022,-0.830826533483369,0.7794117647058824,1.0,1.0,2/12,8.93%,OVOL2;TMC4
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),-0.459180178147731,-0.8308185208630039,0.7066666666666667,1.0,1.0,2/16,9.56%,FOS;BAZ2A
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),-0.459180178147731,-0.8308185208630039,0.7066666666666667,1.0,1.0,2/16,9.56%,FOS;BAZ2A
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.40987154499250056,0.8307226524662884,0.6428571428571429,0.9984771143218134,1.0,3/19,6.28%,SVIL;MAP10;PKP4
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),-0.4471742363614646,-0.830601080680317,0.7183098591549296,1.0,1.0,3/24,12.78%,LIMK1;DTX3L;BAG5
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),-0.4680208590593986,-0.8305150625002911,0.6973684210526315,1.0,1.0,3/15,10.23%,ALDH1L1;MTHFD1;SHMT1
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),-0.5472578781313436,-0.8303516442910067,0.765625,1.0,1.0,1/5,14.09%,DPH6
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-0.5472578781313436,-0.8303516442910067,0.765625,1.0,1.0,1/5,14.09%,DPH6
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.44087459758513975,0.8301407545735668,0.6666666666666666,0.9986714698215181,1.0,2/7,21.17%,ING4;TP53
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.4429987856553699,0.8300593804317703,0.6551724137931034,0.9981991263041523,1.0,6/15,25.85%,EXOSC8;INTS7;INTS6L;INTS8;INTS1;INTS14
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.5065430948153606,-0.8300130744334078,0.7428571428571429,1.0,1.0,1/10,14.91%,CHMP4B
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.26499111981994783,0.8298928128401003,1.0,0.997887764323373,1.0,73/405,16.56%,UBB;RFWD3;RNF144A;TNFAIP1;CAND2;UBE2J1;PSMD8;CUL7;PSMB4;UBE2D4;TRIM35;RNF6;KLHL12;ELOC;PSMB6;UBE2D1;UBE2N;FBXO45;RRAGA;UBA1;KLHL13;KLHL8;RNF139;CBLL1;DTX4;KLHL42;RNF141;TSPAN17;PELI1;COMMD1;UBE2Q2;CDC73;PSMD10;KLHL2;AREL1;PSME3;RC3H1;SMURF2;SDE2;RNF25;UBC;UBE2G1;MUL1;TRIM24;TRIM71;MKRN2;RCHY1;CUL9;FBXW5;MARCHF7;OTULIN;PSMB2;TRIM4;PSMD12;SIRT1;FBXL7;KCTD13;PEX13;ARRDC4;ERCC8;FBXO28;FBXO44;ANAPC11;KCTD10;CDC34;VHL;ANAPC7;PSMC1;RBCK1;RNF166;UBE2E3;UBE2J2;PSMD4
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.3793377209614814,-0.8297763530606986,0.8222222222222222,1.0,1.0,26/99,22.31%,CAMK1;EMP2;SPDYA;NEDD9;EFNA1;PTPRC;AGT;MTCP1;MMD2;BORA;VEGFA;PAK1;STRADB;PAK2;TELO2;MAP2K1;IL6R;TOM1L1;TGFB2;RPTOR;DDR2;DAB2IP;DLG4;CACUL1;TNIK;EPHA4
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.40754144304825246,-0.8295145907746856,0.7674418604651163,1.0,1.0,2/50,6.48%,SOX9;ANP32E
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),-0.5431126211519559,-0.8292695009932729,0.7611940298507462,1.0,1.0,1/5,14.99%,AKT2
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.3716102094514289,-0.8288362494035479,0.851063829787234,1.0,1.0,20/90,21.59%,TMSB4X;NLRC5;HES1;CDKN2A;SPI1;TRIB1;TAF1;ARRB1;WWP2;CYP1B1;IRAK2;BHLHE40;HDAC4;TRAF3;ARRB2;MAP2K5;NLRP12;PEX14;DAB2IP;MEN1
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),0.26948312051060314,0.8286095743338276,1.0,0.9997582060882982,1.0,67/461,11.34%,SOX4;UTP11;UBB;BAD;MALT1;HSPA1A;OPN3;CFL1;ASCL1;NCSTN;SIGMAR1;FGD3;SOX8;IRF3;CALR;PHB2;PAWR;MCF2;GSTP1;PPT1;IKBKB;TRIM35;BAG3;TOX3;PLEKHG5;NPM1;TAF9B;PPIF;CLIP3;API5;NGF;TMBIM6;SMPD1;IP6K2;FRZB;MGMT;BCAR1;STPG1;GREM1;QRICH1;PHLDA1;SPTLC1;PPIA;ACER2;RYBP;PTMA;BOK;CAT;ZNF268;ARL6IP5;JUN;PRDX5;MT3;PSMD10;PLAUR;AREL1;RIPK2;GAS1;ATF4;HS1BP3;UBC;PRDX3;ZNF830;CSRNP3;TRIM24;JMY;SAP18
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.47012042444916174,-0.8285879977179473,0.7875,1.0,1.0,7/18,31.55%,IL7;OAS1;IL6R;TIRAP;OAS3;MAVS;APP
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.4182608374435257,0.8284854435622224,0.7407407407407407,0.9994338787325227,1.0,3/11,13.56%,FBP1;CLK2;MST1
prerank,PanglaoDB_Augmented_2021__Podocytes,0.2969924037802239,0.8279035872011345,0.8,0.9999961079801514,1.0,22/141,11.00%,AMOTL2;CRB2;ADCY6;MAGI1;LAMA3;YAP1;COL12A1;DACH1;TNS2;STARD13;MYO1D;ITGB5;COL4A4;BCAR1;PTPRF;LRRC49;SRGAP1;TOB1;S100A16;THSD7A;NTN4;LRIG3
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.49519688650370597,-0.8277529415909174,0.71875,1.0,1.0,3/9,17.31%,AHR;ADCY1;ADCY5
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.49519688650370597,-0.8277529415909174,0.71875,1.0,1.0,3/9,17.31%,AHR;ADCY1;ADCY5
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.3302897329201717,0.8274742059017075,0.6111111111111112,1.0,1.0,3/43,3.75%,MALT1;CTSV;CTSC
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.39631627373942707,0.8271438478262165,0.8235294117647058,1.0,1.0,5/23,12.91%,SOX11;SMURF2;SMAD3;TWSG1;SMAD7
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.43686058851543186,-0.8270852731062268,0.7466666666666667,1.0,1.0,1/22,0.55%,HEY2
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.4356002128547578,-0.8270211430558422,0.7638888888888888,1.0,1.0,5/21,16.42%,TTN;TMOD3;TPM1;PGM5;MYOM2
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.5407764731730978,0.8270095470394315,0.717948717948718,0.9997867776045338,1.0,2/5,16.61%,CHMP2A;CEP120
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.3830586962633685,-0.8269184133192259,0.8023255813953488,1.0,1.0,14/75,18.40%,CARD14;FGF1;EMP2;BORA;VEGFA;PAK1;ITGB1BP1;STRADB;NTRK3;ADCY1;ADCY5;PAK2;TOM1L1;TGFB2
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),-0.5160300163309256,-0.8266955556638335,0.8208955223880597,1.0,1.0,3/8,18.84%,MGST1;SLC1A4;PDPN
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.38648042669839267,-0.8266022334653043,0.7578947368421053,1.0,1.0,21/73,25.07%,IGF2BP2;IGF2BP3;DAPK1;APOE;PUS7;SHMT1;CAMK2N1;TSC1;ZNF540;RBM4;DAPK3;HDAC6;DAB2IP;SAMD4A;GIGYF2;RGP1;MALSU1;ENC1;IGFBP5;SAMD4B;KNG1
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),-0.58270326156798,-0.8265081901235325,0.8153846153846154,1.0,1.0,2/5,20.29%,CTSZ;ENO1
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.3502061478522276,0.8263470635059185,0.8888888888888888,1.0,1.0,4/32,8.53%,DYNLL2;DYNLRB1;IFT20;WDR35
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.3332795050634276,0.8262568104681689,0.7368421052631579,0.9999011728288242,1.0,1/42,0.59%,NUP42
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),-0.3789900326396782,-0.8261757086882279,0.7386363636363636,1.0,1.0,12/75,17.39%,USP6;PTPRC;RAB17;SYT1;CPLX1;RAB11A;RAB3A;HAP1;RAB15;MBTPS1;RAB3D;MAP2K1
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.37577854128999766,0.8261341196917525,0.7619047619047619,0.9995292904499554,1.0,5/20,13.73%,MFF;PEX11A;ABCD2;ACOT8;FIS1
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.3969385877650333,-0.8259981840770099,0.7582417582417582,1.0,1.0,2/42,1.60%,HEY2;HES1
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.3816118771354894,-0.8259206513827366,0.8617021276595744,1.0,1.0,19/124,13.95%,ANGPTL4;PHKG1;SLC2A3;MAFF;EFNA1;SLC6A6;SRPX;CP;COL5A1;FOS;KLF6;LDHA;GPI;VEGFA;AKAP12;GLRX;GAPDHS;PFKP;PPFIA4
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.43281348080996385,-0.8258218439477345,0.7857142857142857,1.0,1.0,6/20,19.31%,LIMK1;VIL1;TSC1;PFN2;SHANK3;RDX
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.47118034560096067,-0.8254865023619937,0.6933333333333334,1.0,1.0,6/12,38.60%,RMND1;RPUSD3;TRUB2;RCC1L;FASTKD3;MRPS27
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),-0.4695758434493985,-0.825226400427957,0.684931506849315,1.0,1.0,4/14,26.71%,RHOJ;RAC3;RHOU;GSN
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),-0.5049630598286423,-0.8251472057899919,0.6944444444444444,1.0,1.0,1/8,7.48%,SIDT2
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.4117993479872166,-0.825066341763559,0.7619047619047619,1.0,1.0,7/28,25.74%,CCT6A;CCT8;PARN;PNKP;ATM;HMBOX1;MAP2K7
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),-0.47699973624281583,-0.8249552177945818,0.7183098591549296,1.0,1.0,2/10,23.62%,LPCAT3;MOSPD3
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.3934618629055549,0.8248478398083822,0.6785714285714286,1.0,1.0,3/12,13.06%,MAML2;RBPJ;WWC1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.4805003925422789,-0.8244106955503328,0.7307692307692307,1.0,1.0,3/14,22.24%,OTUD7B;CTNNA1;SIN3A
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.3857040967912499,-0.824171426036251,0.8111111111111111,1.0,1.0,11/66,18.04%,FABP3;PCTP;APOE;NCOA1;ACSL1;SLC51A;ATP8B1;PITPNA;PITPNC1;ABCC3;ABCA8
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.4802885094256331,-0.8241524869837001,0.7088607594936709,1.0,1.0,3/11,34.92%,STX4;MAP1A;RIC3
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.40289511094886304,-0.8240139704655249,0.7764705882352941,1.0,1.0,8/42,23.63%,SOX9;AGT;NTRK3;TGFB2;IGF1R;ROR1;PDGFRB;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.41652832089011943,-0.8233650656013103,0.7674418604651163,1.0,1.0,3/28,12.45%,EMP2;VEGFA;TSC1
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),-0.37695159287556745,-0.8232381247176878,0.8461538461538461,1.0,1.0,18/84,25.82%,SOX9;HES1;SKAP2;FANCC;RIMS1;VIL1;TAPBP;NDUFAF1;DNM1L;PEX14;DLG4;KMT2A;ZW10;AFG3L2;DARS1;WDR19;SPG7;FANCA
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),-0.3990091662113218,-0.823215148598435,0.7692307692307693,1.0,1.0,12/57,24.04%,ARIH2;PTPRC;ZFPM1;RUNX2;ZNF160;KITLG;TGFB2;KMT2A;TGFB1;ETV6;ZFP36L2;TIRAP
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),-0.5087981961031411,-0.8231948632543625,0.7538461538461538,1.0,1.0,2/6,30.26%,ST3GAL6;PTPRT
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),-0.5151044276626766,-0.8230966323675655,0.7142857142857143,1.0,1.0,3/7,12.06%,FABP3;LIPI;LIPH
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),0.32067038534265035,0.823007918840494,0.7058823529411765,1.0,1.0,8/65,6.87%,NOX4;HSPG2;AFAP1L2;IKBKB;TLR1;CDO1;HNRNPA0;MGLL
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),-0.413551962909132,-0.8227371073770072,0.75,1.0,1.0,2/37,6.91%,HEY2;ZFPM1
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),-0.5462485589159422,-0.822396901951693,0.7313432835820896,1.0,1.0,2/5,22.78%,EDNRA;ACTA2
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.43828563787108865,0.8219696089498231,0.65625,1.0,1.0,9/9,56.20%,WDR45B;WDR45;STX17;ATG13;MFN2;TRAPPC8;WIPI2;PACS2;WIPI1
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),0.47687062234569155,0.8215124559591245,0.6388888888888888,1.0,1.0,3/5,23.32%,VCP;TEX264;SPRTN
prerank,GO_Biological_Process_2021__heart development (GO:0007507),-0.3789294000903146,-0.8215018642169808,0.8045977011494253,1.0,1.0,13/85,15.30%,SOX9;SRF;ZFPM1;MMP21;MTHFD1;CACNA1C;DVL2;VEGFA;MEF2D;HTR2B;SH3PXD2B;TCF25;NTRK3
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.36651467685228156,0.821446565039021,0.6470588235294118,1.0,1.0,4/29,5.77%,CUL7;LZTS1;CAPRIN1;RAP2A
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.46549872856035773,-0.82136705055907,0.7027027027027027,1.0,1.0,2/16,22.65%,RIMS1;SLC4A8
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.37323528581003335,-0.8212947737053925,0.8876404494382022,1.0,1.0,12/82,17.35%,GLRA2;GLRA1;SYT1;FOS;HVCN1;B2M;RYR3;SYT2;SYT4;ADGRV1;ADCY1;KCNH1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),-0.5311548248429419,-0.8212144247361015,0.7571428571428571,1.0,1.0,1/5,5.39%,BRCA1
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.3853460407685484,0.8210349020149481,0.64,1.0,1.0,1/14,3.26%,NT5E
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.38240942109801246,-0.8207205059361669,0.7710843373493976,1.0,1.0,13/62,21.57%,PTPRC;TIMP3;AGT;CAV3;APOE;CAMK2N1;FOXO1;ITGB1BP1;PTPRR;PTPRJ;SMAD4;DAB2IP;IGBP1
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),-0.45714667751886096,-0.8203990046975375,0.7285714285714285,1.0,1.0,6/15,24.08%,ROBO2;LRP2;TGFB2;SMAD4;ZFPM2;NRP2
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),-0.49001202708166225,-0.820140698651569,0.7123287671232876,1.0,1.0,2/8,15.83%,NEIL2;NTHL1
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),-0.5448971726400907,-0.820096532046504,0.7571428571428571,1.0,1.0,1/6,23.64%,AP2M1
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.31315672118633153,0.8200545213519066,0.7333333333333333,1.0,1.0,10/82,8.14%,SYNDIG1;FREM1;SOX10;ZNF536;FRZB;THY1;PCDH17;S100B;RGS7BP;GPM6B
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),-0.46724363912874745,-0.8199577738370308,0.7297297297297297,1.0,1.0,3/12,16.09%,ROBO2;B2M;HOOK3
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.4736346854495789,-0.8198975573967021,0.7051282051282052,1.0,1.0,3/15,10.00%,VSIR;TESPA1;IL7
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.43175336409378867,0.8197883397772538,0.6363636363636364,1.0,1.0,5/11,28.37%,ARID2;SMARCB1;ARID1A;SET;HMGA1
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.43175336409378867,0.8197883397772538,0.6363636363636364,1.0,1.0,5/11,28.37%,ARID2;SMARCB1;ARID1A;SET;HMGA1
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),-0.4400506105492653,-0.819742262793341,0.7088607594936709,1.0,1.0,3/19,13.08%,DUSP22;ROBO2;ITGB1BP1
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.30532529738727926,0.8197193804541352,0.9090909090909091,1.0,1.0,22/105,11.15%,FABP7;TUBB2B;RND2;ASCL1;DLL3;TOX3;POU3F2;MAP2;ADGRA1;SOX21;SEMA5B;ZNF536;BTBD17;S100B;GPM6B;DCX;STOX2;KCNQ2;MEIS3;SALL3;LINGO1;CSRNP3
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.5187533755993832,-0.8196505890117844,0.7,1.0,1.0,2/6,18.76%,PRKD2;GRB10
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.30795514018690195,0.8196480688942177,0.6666666666666666,1.0,1.0,7/61,9.10%,SIRT2;RNF144A;HSPA1A;PRICKLE1;ZYG11B;BAG2;PSMD10
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),-0.4985864532055987,-0.8195660966374323,0.8059701492537313,1.0,1.0,2/9,33.41%,PLEKHM2;TUBB4B
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.31111472164310655,0.8192198159637829,0.9375,1.0,1.0,5/46,6.33%,TRIM28;TMEM161A;UBE2N;PML;PPP1R10
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.35152371811780936,-0.8186782869653872,0.8260869565217391,1.0,1.0,25/131,22.31%,STMN2;CAMK1;RAB17;STX1B;RTN4IP1;APOE;CAMK2B;MAG;PAK1;BDNF;BAG5;CAMK1D;NTRK3;PTK7;AVIL;CRMP1;GAK;PAK2;SHANK3;KIF1A;DAB2IP;PSEN1;TENM3;ROR1;EPHA4
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.35891727148063135,0.8182306103900638,0.7916666666666666,1.0,1.0,4/31,12.86%,KLHL12;ATXN7L3;CDC73;MARCHF7
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.5031620783904324,0.8181989794476983,0.75,1.0,1.0,1/8,2.95%,GSTP1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.3738694891516419,0.8181973082326438,0.6923076923076923,1.0,1.0,5/23,13.87%,PYCR1;GPR37L1;PPIA;ATF4;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),-0.5004803421305443,-0.8180340494162561,0.6865671641791045,1.0,1.0,5/9,31.75%,ATM;CASTOR2;RNF152;SESN2;STK11
prerank,PanglaoDB_Augmented_2021__Immature Neurons,-0.3643928375173425,-0.8175374040773562,0.8222222222222222,1.0,1.0,17/114,15.90%,STMN2;OLFM3;KCNC1;ROBO2;MMD2;CACNA1B;SULT4A1;ACTL6B;CELF4;GRM3;SNAP25;SYT4;EPHA7;ATP2B3;RBFOX3;NTRK3;SRRM4
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),0.45910022240882215,0.8174440465160884,0.78125,1.0,1.0,2/7,11.16%,TGFBR2;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),-0.39273888953669195,-0.8170181952309294,0.7974683544303798,1.0,1.0,10/45,21.13%,VSIR;C4BPA;FZR1;PLK2;FOXO1;WWP1;WWP2;ATG7;OAZ2;DAB2IP
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.39569022662179415,-0.8169162921143281,0.7613636363636364,1.0,1.0,4/53,10.62%,B3GNT5;GCNT1;ALG10B;FUT2
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),0.4072774812575596,0.8165037217445595,0.6296296296296297,1.0,1.0,3/16,6.92%,YAP1;CATSPERD;WBP2
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.3751658201163671,0.816441624038206,0.5882352941176471,1.0,1.0,2/23,5.43%,SIGMAR1;PPIF
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),0.36669603957703095,0.816386521444652,0.7714285714285715,1.0,1.0,5/14,18.92%,IRF3;RIPK2;HAVCR2;PTPRS;DDX3X
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.3699351848944505,-0.8162381882437976,0.813953488372093,1.0,1.0,12/93,8.62%,NOSTRIN;MYLK;SRPX;PROCR;F8;A2M;TIMP3;PTPRB;ELK3;RHOJ;TNS1;LIFR
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.30960398061131267,0.8161545358142405,0.6923076923076923,1.0,1.0,16/81,13.00%,PLD1;CCDC88C;RIT2;TRIM28;ARHGAP18;RUNDC3A;TNK2;MAPK11;JUN;NUCB1;ARL3;RIT1;CHP1;GRB2;NRAS;RALB
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),-0.4790077966516617,-0.8158644643245766,0.775,1.0,1.0,5/11,30.61%,GLUL;ASPA;GOT1;DDO;QPRT
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),0.4895056086610927,0.815731334496903,0.6666666666666666,1.0,1.0,1/6,5.10%,MCM4
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),0.45849650323538327,0.8155146550116997,0.7058823529411765,1.0,1.0,2/11,13.99%,C12ORF57;NFIB
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),-0.42987972100704475,-0.8150583564857813,0.7721518987341772,1.0,1.0,4/22,15.65%,FABP3;APOE;ACSL1;ACACB
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.3567727320356003,-0.814988550960242,0.9368421052631579,1.0,1.0,38/213,22.79%,RASGRF1;SOX9;IL5;FGF1;PSMB8;FGF9;NRG4;IL3RA;ZDHHC9;SPTBN5;RASGEF1A;CAMK2B;WDR83;PAK1;PSMA4;RASA3;RASA1;HTR2B;NEFL;RASGRP1;CAMK2A;KITLG;MAP2K1;JAK1;PSMA3;SHANK3;SYNGAP1;DAB2IP;PPP5C;BRAP;MEN1;DLG4;RASGRP3;TGFB1;TNIK;PDGFRB;MAPK12;GRIN1
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.4142242162960314,0.8146931771622343,0.7241379310344828,1.0,1.0,1/9,4.61%,PRMT6
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.4418275189096288,0.814514832001628,0.71875,1.0,1.0,3/8,21.08%,TOP1MT;ERCC3;HMGB1
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),0.37598383591909335,0.8142679797379522,0.6666666666666666,1.0,1.0,8/23,20.23%,DNAJC15;GRPEL1;DNAJC19;TIMM21;TIMM50;PEX5;TIMM23;PEX2
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.4460282507340584,-0.8142307180072118,0.775,1.0,1.0,3/20,12.64%,MX1;DNM1;DNM2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),-0.5053844693011691,-0.8141601291824284,0.7534246575342466,1.0,1.0,1/11,5.10%,AGT
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.47148354037068896,-0.8140980168146845,0.7125,1.0,1.0,2/12,15.83%,NEIL2;NTHL1
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),-0.3855950811227309,-0.814056810413516,0.7951807228915663,1.0,1.0,10/54,20.26%,SLC39A14;ATP6V1E2;FOXO1;AKT2;BCAR3;SORBS1;BAIAP2;GRB10;PDK2;IGF1R
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),-0.40008270647679334,-0.8138754753279248,0.7435897435897436,1.0,1.0,7/35,16.30%,SHTN1;ROBO2;LIMK1;PLXNA4;BDNF;MACF1;TIAM1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.5226452898042961,-0.8137345919401776,0.7575757575757576,1.0,1.0,2/5,23.63%,DAB2IP;PIK3CB
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),-0.5359700624479088,-0.8136517303784769,0.8235294117647058,1.0,1.0,1/6,7.65%,MTHFD1
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),0.4659759358288771,0.8133183120768788,0.7142857142857143,1.0,1.0,5/5,53.42%,LRRK2;BCAP31;GBF1;MIA3;SEC16A
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.3849758084168037,0.8130353496692861,0.7391304347826086,1.0,1.0,6/17,11.59%,AFAP1L2;CNOT9;RBPJ;NEU3;PLAUR;ARAP1
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),-0.44293535929759276,-0.8130069987322538,0.7738095238095238,1.0,1.0,5/21,20.29%,PRELP;ST3GAL1;OGN;ST3GAL6;ACAN
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.4334151391307748,-0.8128074835117808,0.8148148148148148,1.0,1.0,3/29,11.43%,SLC38A4;SLC7A6;SLC13A3
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),-0.4613091242569955,-0.8124549453615881,0.7,1.0,1.0,3/15,10.23%,ALDH1L1;MTHFD1;SHMT1
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.34577979272186754,-0.8124197261526294,0.91,1.0,1.0,24/324,11.88%,RFC4;TMSB4X;GNA12;PIP4K2C;NUAK1;ARHGAP24;FGF1;AKAP5;A2M;ARHGAP15;BRCA1;ARHGDIG;RHOJ;RFC2;ARHGAP26;VEGFA;VAV3;AKAP12;RPA3;SRGAP3;TAF1;PEX5L;PREX1;PAK1
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),-0.3540888196786143,-0.8121100264329895,0.8241758241758241,1.0,1.0,30/175,21.54%,SOX9;GLRA2;AHR;NR4A3;GLRA1;FOS;P2RY12;DAPK1;TRIM41;RYR3;SHMT1;TPM1;TAF1;KCNQ1;HCN3;FOXO1;NR1D1;TSHR;PDCD4;PTK7;PDCD1LG2;PDK2;RPTOR;ATM;CAPN2;ADAM9;NSMF;DAB2IP;HCN1;HCN2
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.364943336152811,-0.8119260775363161,0.8850574712643678,1.0,1.0,22/109,23.15%,ARIH2;CAMK1;AKAP5;YWHAH;NMT1;SAE1;CEMIP;EMD;PDZK1;ITGB1BP1;MICALL2;AKT2;ZIC1;KIF20B;PPP3CC;OAZ2;TFDP1;PSEN1;TGFB1;USP36;RHOU;ECT2
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),0.4404867512254397,0.8119058106248458,0.65,1.0,1.0,2/6,18.52%,ERCC3;USH2A
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.4138018889521026,0.8118055138888645,0.5555555555555556,1.0,1.0,2/15,7.74%,ADCY6;PRKAR2B
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),-0.4766127084514997,-0.8117583637261918,0.6428571428571429,1.0,1.0,1/10,5.39%,BRCA1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.4722801008830725,-0.8117309670573641,0.7808219178082192,1.0,1.0,1/15,2.09%,SPDYA
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.36532954506352505,0.8116580268253963,0.625,1.0,1.0,5/11,18.90%,TBCCD1;ARCN1;CDC42;PDCD10;YWHAZ
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.4801861351946395,-0.8109023028929648,0.7391304347826086,1.0,1.0,1/7,9.85%,APOE
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.3439494972599789,0.8103515419962638,0.7692307692307693,1.0,1.0,9/51,13.87%,ODC1;PSMD8;PSMB4;PSMB6;PSMD10;PSME3;PSMB2;PSMD12;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.5201029310297679,-0.8099514945505047,0.7397260273972602,1.0,1.0,3/8,36.12%,CAMK2D;NEDD4L;STK39
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.4247436718871054,-0.8099432876998239,0.7906976744186046,1.0,1.0,6/29,17.40%,CLDN18;VCL;MICALL2;TBCD;PAK2;CTNNA1
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),-0.507329142040134,-0.8098203502211702,0.8571428571428571,1.0,1.0,3/8,26.80%,PDK1;PDK2;PDK3
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),-0.507329142040134,-0.8098203502211702,0.8571428571428571,1.0,1.0,3/8,26.80%,PDK1;PDK2;PDK3
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.4054470131578487,0.8096573402959956,0.5862068965517241,1.0,1.0,1/12,4.63%,PYCR1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),-0.4154934555814186,-0.8091745104116089,0.7368421052631579,1.0,1.0,3/24,11.88%,ANKRD53;CAV3;PAK1
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.4585658091238714,-0.8090278271188511,0.6533333333333333,1.0,1.0,3/12,21.62%,CCDC39;CABYR;AQP4
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,-0.38656601649335876,-0.8089228523862686,0.872093023255814,1.0,1.0,11/65,13.65%,STMN2;SYT1;CALY;CPLX1;GRIK5;ACTL6B;DUSP8;IQSEC3;HCN3;LRRTM1;SYT4
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),0.43266195979265626,0.8087430920691149,0.625,1.0,1.0,1/9,12.23%,SLC25A4
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.38559287122518987,0.8086446104053375,0.7142857142857143,1.0,1.0,1/13,4.04%,LSM1
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.4452341820278032,-0.8078861871467635,0.7575757575757576,1.0,1.0,2/11,23.26%,ATM;ZW10
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),-0.4452341820278032,-0.8078861871467635,0.7575757575757576,1.0,1.0,2/11,23.26%,ATM;ZW10
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),-0.4452341820278032,-0.8078861871467635,0.7575757575757576,1.0,1.0,2/11,23.26%,ATM;ZW10
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),-0.4452341820278032,-0.8078861871467635,0.7575757575757576,1.0,1.0,2/11,23.26%,ATM;ZW10
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,-0.35857892779444284,-0.8077937683288431,0.8586956521739131,1.0,1.0,19/144,15.77%,NEFM;STMN2;SYT1;OLFM3;SNCB;KCNC1;RNF138;KCNH7;CACNA1B;SULT4A1;ACTL6B;SRGAP3;TRIM44;SNAP25;NEFL;SYT4;EPHA7;INSYN2A;CRMP1
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.44847476430888866,-0.8077339557465484,0.7397260273972602,1.0,1.0,1/14,1.83%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),0.3850975259643401,0.8075544336371634,0.8,1.0,1.0,2/12,9.56%,IRF3;RIPK2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.47490537192400506,0.8073386286198565,0.7916666666666666,1.0,1.0,3/8,12.51%,MAPK11;RIPK2;PLCB1
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.4200392935667279,-0.8073207947761816,0.759493670886076,1.0,1.0,7/34,21.13%,PTPRC;TIMP3;CAMK2N1;ITGB1BP1;PTPRR;SMAD4;DAB2IP
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.49818275309120874,-0.8071961672019023,0.7323943661971831,1.0,1.0,2/8,11.43%,AKR1C2;PTGR1
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.41397406135446124,-0.8069875579012434,0.7380952380952381,1.0,1.0,1/36,1.83%,NR4A3
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.48404875220925186,-0.8069604400396462,0.6857142857142857,1.0,1.0,3/8,13.33%,SPINK13;GJA1;SULF1
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.4711071482995436,0.8068723306327281,0.7073170731707317,1.0,1.0,2/5,10.85%,DCX;ARL3
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.3782477959590374,0.8067206641505485,0.7428571428571429,1.0,1.0,1/11,2.92%,ZFP36L1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.37857124656960517,-0.8065455036756891,0.8260869565217391,1.0,1.0,8/63,14.31%,SOX9;NR4A3;FGF1;FGF9;VEGFA;PTPRN;HTR2B;STAT5A
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.31236434355382425,0.8064264057093565,0.9,1.0,1.0,12/84,10.83%,U2AF1;NUP42;RBM15B;CPSF1;RAN;CPSF4;NXF1;AGFG1;EIF4A3;EIF4E;RBM8A;POLDIP3
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.45897925139871554,-0.8060644263796104,0.796875,1.0,1.0,3/10,25.86%,NTRK3;BAIAP2;BCAS3
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.39450314344920484,0.8058038913999573,0.7083333333333334,1.0,1.0,2/15,6.81%,MSN;RAPGEF3
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.3388923551578529,0.8056693675796707,0.7058823529411765,1.0,1.0,4/38,5.97%,TRIM28;TMEM161A;UBE2N;PML
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),-0.43012428660081287,-0.8056063666868863,0.8354430379746836,1.0,1.0,4/22,7.54%,HEY2;HES1;ZFPM1;ROBO2
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),-0.3845340148479201,-0.805204971763429,0.7948717948717948,1.0,1.0,7/31,20.11%,ITPK1;PLCH1;ITPKC;NUDT11;INPP4B;INPP5A;INPP4A
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),-0.5408980949048107,-0.805172583795455,0.7761194029850746,1.0,1.0,1/5,18.47%,SHANK3
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),-0.5408980949048107,-0.805172583795455,0.7761194029850746,1.0,1.0,1/5,18.47%,SHANK3
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),0.5008921606291964,0.8049050425855054,0.6944444444444444,1.0,1.0,3/5,11.57%,GSTP1;PPIA;QARS1
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),-0.4129911846299548,-0.8046615357855775,0.7804878048780488,1.0,1.0,10/27,30.25%,FSIP2;NPHP4;TULP3;CSNK1D;TCTN1;WDR19;TUB;RAB29;ODAD4;IFT122
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.42933703579104043,-0.8046436822076047,0.7922077922077922,1.0,1.0,4/25,14.85%,RPA3;CDC7;POLE3;ORC2
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),-0.4801834026948543,-0.8044899007540466,0.8414634146341463,1.0,1.0,2/11,12.57%,TTLL6;TTLL4
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),-0.5379781835459718,-0.8043064594878394,0.796875,1.0,1.0,1/5,23.18%,RNF20
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.4822972212152433,0.8042558213518083,0.7777777777777778,1.0,1.0,3/7,12.60%,ALDH6A1;DPYSL4;DPYSL5
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.44547859550722246,-0.8041506392839363,0.7142857142857143,1.0,1.0,1/11,10.88%,TPM1
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),0.31610776177176303,0.8038581370487726,0.7692307692307693,1.0,1.0,7/56,9.80%,YAP1;PSMD8;PSMB4;PSMB6;TCF12;PSMD10;PSME3
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),-0.398076791617756,-0.8038272996707037,0.7948717948717948,1.0,1.0,7/31,21.77%,BRCA1;MAX;CDC7;SUZ12;DAB2IP;TFDP1;UXT
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),-0.49650603889016603,-0.803814837911239,0.7662337662337663,1.0,1.0,3/8,35.84%,IL34;CSF1;CXCL17
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",-0.5198872647123912,-0.8036155583065069,0.7333333333333333,1.0,1.0,2/5,30.20%,HS3ST5;HS6ST1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),0.46413456959590815,0.803613712933963,0.5925925925925926,1.0,1.0,1/7,11.17%,MUL1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),0.4955905803755039,0.8035883957627471,0.7037037037037037,1.0,1.0,1/8,2.95%,GSTP1
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),-0.5227874466771048,-0.803582787976389,0.7205882352941176,1.0,1.0,3/7,29.62%,AGO1;AGO4;DHX36
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.4130567860042755,0.8034236165254802,0.7619047619047619,1.0,1.0,3/11,8.71%,ZFP36L1;ZC3H3;CDC73
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.3429876470025956,0.8033327356463491,0.6538461538461539,1.0,1.0,5/16,17.55%,BRK1;RHOG;ELMO1;CDH13;DBNL
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.3590562773143713,-0.8031359849535448,0.8854166666666666,1.0,1.0,26/125,22.73%,VSIR;PLET1;MYLK;FGF1;DUOX1;NEDD9;CEMIP;VEGFA;PAK1;VIL1;SEMA4B;TMSB15B;AKT2;NTRK3;TIAM1;STAT3;PDPN;ATM;RDX;ADAM9;IGF1R;DDRGK1;TGFB1;PDGFRB;CCDC25;LAMB1
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),0.47280629849183586,0.8031097937456119,0.68,1.0,1.0,3/9,15.16%,GSTP1;MAPK8IP1;DNAJA1
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.3217471189074417,0.8027793671367206,0.8571428571428571,1.0,1.0,8/94,5.21%,GPC4;SLITRK2;ACHE;FLRT3;CHRNA7;SDK1;NLGN2;RAB39B
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.47304580716517813,-0.8019894078270992,0.8108108108108109,1.0,1.0,2/9,10.54%,VCL;VEGFA
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.429870303516513,0.8016705721799839,0.6666666666666666,1.0,1.0,7/7,57.03%,KAT2A;KAT7;HAT1;EP300;BAG6;MAPT;KAT2B
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.4921607622201449,-0.8013486614692015,0.7083333333333334,1.0,1.0,1/8,14.75%,TBXAS1
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.45912205339564865,0.8011569196215864,0.6363636363636364,1.0,1.0,1/8,0.31%,SOX4
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),-0.5446809521170937,-0.8011191623629138,0.7833333333333333,1.0,1.0,2/5,35.92%,MAPK8IP2;NCK2
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),-0.47927854579346596,-0.8008135060970598,0.7857142857142857,1.0,1.0,3/8,32.48%,VRK1;STX5;STK25
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),0.3298987715986512,0.8007687700504207,0.8571428571428571,1.0,1.0,17/95,13.87%,VANGL1;PSMD8;CCDC88C;PSMB4;PSMB6;PRICKLE1;ROR2;FRZB;FZD3;PSMD10;PSME3;SMURF2;NFATC1;PLCB1;PSMB2;PSMD12;CALM1
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),-0.41425720862225207,-0.8006179551367711,0.8048780487804879,1.0,1.0,10/27,32.28%,TSC1;ATM;CASTOR2;RNF152;PRKAA1;PRKAA2;SESN2;DDIT4;STK11;UBR1
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.437642367706076,-0.8005607554145271,0.7866666666666666,1.0,1.0,5/21,21.52%,SHLD2;MMS19;FANCB;RIF1;ZCWPW1
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.3084235544029816,0.8004782550018806,0.9,1.0,1.0,20/105,11.15%,SYNDIG1;FIBIN;VCAN;MAP2;TCEAL7;SEMA5B;CDO1;BRINP1;TMEM178A;LDB2;FRZB;THY1;PRDX6;RGS7BP;EDIL3;STOX2;WASF3;DOK5;PABPC5;CSRNP3
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.40024218509686826,-0.8004246175670975,0.8275862068965517,1.0,1.0,5/37,16.37%,CD44;TMCC2;MYO1F;MPP1;RSAD2
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.3583872895210015,-0.8001325908872591,0.8260869565217391,1.0,1.0,18/82,22.40%,MX1;SRF;TIMP3;PLSCR1;LIFR;OSMR;CALCOCO2;STAT3;IRAK2;IL6R;TRIM56;STAT1;HDAC4;RIPK1;ADAM9;NLRP12;IGBP1;ADAR
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.452346553082811,-0.8001267351884895,0.7837837837837838,1.0,1.0,2/21,11.57%,GUK1;GLRX
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.4158074318621307,-0.8001023025073328,0.759493670886076,1.0,1.0,4/26,14.51%,B3GNT5;GCNT1;GALNT15;ST3GAL1
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),-0.5090560290317345,-0.8000244703903686,0.8356164383561644,1.0,1.0,1/8,9.95%,GRAMD1C
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.5398997974773494,-0.7998913131499105,0.8,1.0,1.0,2/6,9.83%,SLC22A4;RIMS1
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.32779330111470123,0.7998354899360904,0.6956521739130435,1.0,1.0,9/42,15.93%,PMEPA1;PPM1A;SMURF2;SMAD3;TGFBR1;SMAD7;FNTA;RHOA;BMP2
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.45407277073045393,-0.7992314281823755,0.7654320987654321,1.0,1.0,3/18,10.42%,PTPRC;SHLD2;GPI
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.2704968487228192,0.7991030169496778,1.0,1.0,1.0,31/262,10.44%,MMP2;SIRT2;CLNK;POLR2J;ACTB;ACTG1;NCSTN;ARPC5;POLR2L;FLRT3;EPHA5;ATP6V0A4;PDGFRA;LYN;NGF;ROR2;EFNA2;ZFYVE27;BCAR1;EPHB3;ATP6V0E1;PDGFD;TNK2;MTSS1;ATP6V1G1;MAPK11;ATP6V1B2;POLR2K;ATP6V0D1;FLRT2;GAB1
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),-0.5016476656579271,-0.7990912170480287,0.7971014492753623,1.0,1.0,2/8,12.41%,VEGFA;AHI1
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.526952879977376,-0.7989173436121829,0.7611940298507462,1.0,1.0,4/7,36.21%,DCTN1;UBA5;SHANK1;PAFAH1B1
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),0.4613923395700582,0.7988353197040846,0.6176470588235294,1.0,1.0,2/5,5.33%,CSAD;CDO1
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.5055581754329739,-0.79856629818431,0.8,1.0,1.0,2/7,21.89%,MCTS1;EIF2D
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.37447425493193864,0.7983728620068159,0.6666666666666666,1.0,1.0,2/24,5.29%,RAB26;GOLGA7
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.41309482620240456,-0.7983671410007497,0.7816091954022989,1.0,1.0,1/27,1.06%,STMN2
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),-0.38478170776952525,-0.7982876807348914,0.8888888888888888,1.0,1.0,14/70,23.59%,SPDYA;PTPRC;MMD2;ALK;EPHA7;NTRK3;TYRO3;DDR2;IGF1R;ROR1;CACUL1;EPHA4;PDGFRB;ZNF622
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),-0.5104500057280986,-0.7982818352308952,0.8309859154929577,1.0,1.0,2/9,8.03%,SYT1;KCNMB4
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),0.29409002110052623,0.7980658331447799,1.0,1.0,1.0,28/234,6.49%,UBB;MARCKS;MARCKSL1;MAP7D3;FBLN5;RND2;NCSTN;RHOBTB1;HSPG2;LAMA3;COL12A1;CCDC88C;CD151;COL8A1;LTBP3;PLOD1;SHROOM2;RHOC;CGNL1;TSPAN14;MYO1D;SNCAIP;P3H2;CLIP3;MAP10;COL4A4;BCAR1;GREM1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3261810432392625,0.7980468645092317,0.8,1.0,1.0,8/61,9.10%,SIRT2;RNF144A;HSPA1A;RNF139;PRICKLE1;ZYG11B;BAG2;PSMD10
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.3861640255509807,-0.7980173766524313,0.8,1.0,1.0,16/40,31.97%,AGT;WDR91;APOE;TSC1;EIF2B4;CNDP1;RBM4B;TGFB1;WNT7A;EIF2A;RBM3;NOLC1;CSF1;APP;NFKBIA;ATXN2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),0.38126248189359596,0.7979513561899263,0.7142857142857143,1.0,1.0,3/11,8.71%,PHB2;NPM1;CDC73
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),-0.5195929670987685,-0.7976397028836356,0.8225806451612904,1.0,1.0,1/5,9.85%,APOE
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.48314863430579835,-0.7976349768614264,0.7391304347826086,1.0,1.0,4/11,25.23%,ENTPD3;ENTPD7;ENTPD1;CMPK2
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.34188223255499334,0.7974803269790721,0.6428571428571429,1.0,1.0,5/31,8.07%,YAP1;TSPAN14;MAML2;RBPJ;ENHO
prerank,MSigDB_Hallmark_2020__UV Response Up,0.30588529779775686,0.7974047551254149,0.8,1.0,1.0,20/117,9.01%,STARD3;E2F5;SIGMAR1;ONECUT1;CNP;CTSV;PPT1;BTG1;LYN;FKBP4;CDO1;PPIF;BTG3;EIF5;PLCL1;TMBIM6;GRPEL1;NXF1;CLTB;PDLIM3
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.3720964927047639,0.7971699702389682,0.84,1.0,1.0,4/17,6.44%,CHRNA7;LYN;LRRTM3;SP1
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),-0.3904633627965629,-0.7971507588650559,0.8352941176470589,1.0,1.0,10/51,22.26%,CDH7;CDH12;CDH9;CDH19;PVR;CTNNA1;TGFB2;CDHR3;CDH8;TGFB1
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.37642317482358245,-0.7969898537579044,0.8333333333333334,1.0,1.0,9/63,13.66%,G6PC2;ITPR1;KCNJ11;EFNA5;CACNA1C;MYRIP;NR1D1;SNAP25;BMP8A
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.3441905867103452,0.7968101571089323,0.7,1.0,1.0,1/37,0.59%,NUP42
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.4314941149459462,0.7967514754846056,0.6785714285714286,1.0,1.0,5/12,22.75%,TNK2;NEU3;UBQLN2;WASL;BMP2K
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),-0.4727838478323557,-0.7967136528777464,0.7941176470588235,1.0,1.0,1/13,9.85%,APOE
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),-0.5446560279831045,-0.7964634568138663,0.8194444444444444,1.0,1.0,2/5,30.41%,CHIT1;GNPDA2
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),-0.48550221232046525,-0.7963928074232169,0.7313432835820896,1.0,1.0,1/6,3.16%,PTPRC
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.3837802555821673,0.7962883388849029,0.7083333333333334,1.0,1.0,3/18,9.89%,ATP6V0A4;ATP6V0E1;ATP6V0D1
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.35023379399204185,0.7961707859339996,0.7857142857142857,1.0,1.0,12/45,15.40%,PLXNA3;MCF2;NGF;THY1;EPHB3;LINGO1;PLXNA2;PLXNC1;CHODL;LRRC4C;RHOA;CDH2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.3731618251744727,-0.7960837727665789,0.8241758241758241,1.0,1.0,13/69,19.41%,ITPR1;BCL2L2;BRCA1;MSH6;BCL2L11;MOAP1;DNAJC10;CYP1B1;IFI6;PDK1;PDK2;ATM;ZNF385B
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.3727264887919871,-0.7960736611584986,0.7471264367816092,1.0,1.0,7/48,17.71%,CDC42EP3;VASP;VIL1;RASA1;ABITRAM;PFN2;BAIAP2
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.5301038896328085,0.7959802762975431,0.7647058823529411,1.0,1.0,2/5,23.85%,CHD7;SKI
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),-0.37880279763887115,-0.7955833484966964,0.8,1.0,1.0,7/32,20.11%,ITPK1;PLCH1;ITPKC;NUDT11;INPP4B;INPP5A;INPP4A
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),-0.4994077246776739,-0.7952940538377833,0.6666666666666666,1.0,1.0,1/7,21.01%,ANKFY1
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),-0.40304247078365735,-0.7951387926163961,0.7682926829268293,1.0,1.0,11/30,34.59%,KIF1C;HAP1;NEFL;KIF1A;MAP1A;BLOC1S2;AP3B2;TRAK1;MAPK8IP3;DTNBP1;AP3D1
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.368298646036851,-0.7948077117730526,0.8235294117647058,1.0,1.0,20/64,29.63%,NLRC5;IRF1;STAT6;POLR1C;IFIH1;POLR3H;TRIM56;TRAF3;UFD1;TRIM25;POLR3A;CGAS;TIRAP;ISG15;POLR3D;POLR3E;NPLOC4;CYLD;DHX36;PQBP1
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.4374742154518043,0.7943055130538277,0.7741935483870968,1.0,1.0,3/9,16.66%,SOX8;ZNF516;PGRMC2
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),-0.5138787705473412,-0.7939769814834832,0.6986301369863014,1.0,1.0,4/7,35.80%,NLRP12;TMED10;FOXP1;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.4461805222994748,-0.7939038972862131,0.7837837837837838,1.0,1.0,7/20,29.62%,THRAP3;CELF4;NCBP1;CELF3;NCBP2;RBM3;DHX36
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.3410828330073283,0.7938060192229958,0.6666666666666666,1.0,1.0,2/18,4.72%,CUL7;CAPRIN1
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.38171580330841354,0.7937580827550463,0.7272727272727273,1.0,1.0,1/19,0.85%,SMDT1
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.4159429930981824,-0.793586402462932,0.7948717948717948,1.0,1.0,4/26,22.21%,SRSF5;CELF4;LUC7L3;CELF3
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.3170949700967615,0.7934332529748414,0.7777777777777778,1.0,1.0,5/21,15.93%,SMPD1;PPIA;CALM3;CALM1;BMP2
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.40519411790488236,0.7934013054730663,0.5862068965517241,1.0,1.0,2/15,5.97%,G0S2;PML
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),0.42136847695096097,0.7932107773928689,0.7142857142857143,1.0,1.0,5/13,10.81%,GPX1;PRDX1;CAT;PRDX5;PRDX3
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),-0.36225178565252897,-0.7928834501355099,0.8901098901098901,1.0,1.0,13/111,13.69%,GSTM5;PAH;ELOVL2;MGST1;GCNT1;PCTP;NMRAL1;RHCE;LPCAT3;APOE;SLC44A3;DEGS2;TYW1
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.3606455949344387,0.7928210780135804,0.84,1.0,1.0,8/18,15.99%,PPP1R35;TIPRL;GPATCH2;CHP1;PPP1R26;HSP90B1;BMP2;ZCCHC9
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.43624389649579154,-0.7927489450030311,0.7721518987341772,1.0,1.0,2/17,7.82%,BRCA1;RNF138
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.5035452409398109,-0.7926426066696239,0.7796610169491526,1.0,1.0,1/6,16.46%,GPR171
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),-0.48261763903151983,-0.7918966033278574,0.8169014084507042,1.0,1.0,2/9,9.69%,NLRC4;LPCAT3
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.39915366434088906,0.7912182387227299,0.6666666666666666,1.0,1.0,4/16,10.08%,PCGF2;RYBP;BMI1;RNF2
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),0.3139703301138553,0.7911144376867268,0.9375,1.0,1.0,3/41,2.06%,POLR2J;H1-10;POLR2L
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.4006201442066374,0.7910261494654429,0.7096774193548387,1.0,1.0,2/13,2.59%,MMP2;ERN1
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.3441134269068309,0.7910000096284914,0.85,1.0,1.0,3/16,6.52%,S100A10;THY1;LIMS1
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.41211013698343096,0.7904482554061774,0.8125,1.0,1.0,2/16,7.74%,ADCY6;PRKAR2B
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.403227078827632,0.7904428035131909,0.7619047619047619,1.0,1.0,3/16,4.90%,CTSV;ZFP36L1;SGPP1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),-0.5303579394045957,-0.7900963682936958,0.796875,1.0,1.0,2/5,41.10%,FOXP1;CD47
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.49428583053308073,-0.7900591347842925,0.8108108108108109,1.0,1.0,1/7,6.36%,PLSCR1
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.34793328272300333,0.7899880599284413,0.75,1.0,1.0,5/24,18.75%,DCX;MAP1S;CHP1;AAAS;PSRC1
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.32623074450547423,0.7897612495001539,0.7894736842105263,1.0,1.0,3/38,6.08%,HSPA1A;ERN1;NUDT16L1
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),-0.45335823161706446,-0.7894468326095221,0.7333333333333333,1.0,1.0,3/10,26.73%,PPP3CC;INPP5A;HRH1
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.36667117541248134,0.7892169777256578,0.7777777777777778,1.0,1.0,9/25,15.92%,ACTB;ACTG1;LEPR;ARL6IP5;MUL1;WWC1;NRP1;DNAJA1;EPB41
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),-0.5359035428169625,-0.7891571362557451,0.8387096774193549,1.0,1.0,1/5,21.13%,DAB2IP
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.38451960667993174,0.7891122029513057,0.8636363636363636,1.0,1.0,1/13,1.54%,MOSPD2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.4683903222920077,-0.7889816510758567,0.7083333333333334,1.0,1.0,4/13,21.13%,PRKD2;GRB10;CNMD;DAB2IP
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),0.4107433748748774,0.7889438435097472,0.7241379310344828,1.0,1.0,1/11,6.07%,RO60
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),-0.5201291232153397,-0.7887761345708394,0.7941176470588235,1.0,1.0,2/5,14.34%,VEGFA;ADGRV1
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),-0.4352378541129014,-0.7887098703431331,0.7906976744186046,1.0,1.0,1/13,4.10%,PYGL
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.4377357146484426,0.7885076013658235,0.65,1.0,1.0,1/11,4.40%,CHST7
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),-0.516531265196734,-0.7877878497583274,0.8285714285714286,1.0,1.0,2/7,6.91%,HEY2;ZFPM1
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.3451298346152538,-0.7877669986690566,0.8,1.0,1.0,11/76,17.31%,NR4A3;SLC39A14;TBC1D4;FOXO1;TSHR;RAB15;AKT2;USF1;SORBS1;ADCY1;ADCY5
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.3770876905904886,0.7877366854580253,0.75,1.0,1.0,4/14,21.44%,EMC6;EMC8;GET3;EMC4
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),-0.3312038269715765,-0.7876529390185445,0.98,1.0,1.0,104/754,22.29%,B3GNT5;NUAK1;CAMK1;STK17A;ART4;USP6;PARP9;PTPRC;FBXL13;MAK;CDK7;TNC;PIGH;PSMB8;FBXO6;PARP14;CP;PTPRB;TSSK3;ASB14;ASB16;RARA;NEK3;GRK4;RAB11A;LIMK1;DAPK1;HIF3A;FLG;MAP3K12;APOE;TLK1;CDK19;RAB3A;ALG10B;DUSP8;DDB2;FUT2;TRIB1;CAMK2B;FBXO31;TAF1;SPP1;PLK2;GLRX;NEK11;PAK1;PSMA4;VRK1;LCMT1;CAMK2A;CDK4;MBTPS1;ST3GAL1;EVA1A;AKT2;ASB18;WWP2;PTPRR;FAM20C;STRADB;SPARCL1;CSNK1D;DAPK3;VRK2;PPP2R3A;FN3KRP;PAK2;MAP2K1;BCR;PDK1;NEK6;SUMF1;PPP3CC;JAK1;COQ8B;SERPIND1;PRKD2;TGFB2;PSMA3;CTBP1;FBXO22;CDC42BPB;PDK2;PTPRJ;ATM;UBXN7;FBXL5;ST3GAL6;FAM20A;ATG7;MKNK1;CHRM3;CSNK1G2;HS3ST5;FBXW12;PRKAR1B;CDKL1;PPP5C;MEN1;DCLK1;KLHL25;TGFB1;TNIK
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.4158378824485446,0.7875093998704146,0.7241379310344828,1.0,1.0,2/14,7.74%,ADCY6;PRKAR2B
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.2818013780034528,0.7874918025188871,1.0,1.0,1.0,26/204,10.21%,TCF7L1;BAD;CAND2;MAGI1;YAP1;ST13;TMED2;TGFA;KLHL12;CXCL12;PEF1;CTSC;PREB;TSPAN4;SEC24D;CDC123;PML;TLE4;DNAJB12;BOK;CDC73;RAB1B;GPAA1;WASF3;TSPAN33;PPP2R1A
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.40973422092259526,0.7874872274137436,0.7142857142857143,1.0,1.0,5/15,13.87%,NPM1;CHMP2A;NAT10;FBXW5;SIRT1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),-0.5301368969259718,-0.7874085226111265,0.8148148148148148,1.0,1.0,1/5,8.23%,CAV3
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.4883062426591977,-0.7873656919261692,0.84375,1.0,1.0,3/10,23.09%,ENTPD3;ENTPD7;ENTPD1
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),0.4702311135279283,0.7872358155814482,0.75,1.0,1.0,1/7,2.16%,HSD17B10
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.5183390200320925,-0.7870595889231128,0.8405797101449275,1.0,1.0,2/7,18.65%,DARS2;GARS1
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),-0.37335251242375506,-0.7870048493743856,0.7386363636363636,1.0,1.0,7/53,18.73%,GALNTL6;MAP3K12;TAF1;CIT;MAP2K1;PRKD2;CDC42BPB
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),-0.49429298983482306,-0.786931952473265,0.7868852459016393,1.0,1.0,3/5,32.81%,SLF1;SMC5;MACROH2A1
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),-0.49429298983482306,-0.786931952473265,0.7868852459016393,1.0,1.0,3/5,32.81%,SLF1;SMC5;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),-0.49429298983482306,-0.786931952473265,0.7868852459016393,1.0,1.0,3/5,32.81%,SLF1;SMC5;MACROH2A1
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.383932008192341,0.7868486672275783,0.8461538461538461,1.0,1.0,1/14,2.10%,YAP1
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.3679460100377349,-0.7868193594591076,0.8888888888888888,1.0,1.0,19/87,24.82%,CAMK1;ZFPM1;B2M;DTX3L;TAF1;ITGB1BP1;IFIT1;LRPAP1;TIAM1;CTSZ;HDAC4;DVL1;PEX14;PSEN1;MEN1;DDX11;PRMT8;MITD1;AKTIP
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.38774293061105636,-0.7867765409871296,0.8313253012048193,1.0,1.0,8/45,21.59%,APOE;B2M;DTX3L;TAF1;BDNF;TIAM1;PSEN1;MEN1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.4118034863212479,-0.7867635561238273,0.7721518987341772,1.0,1.0,5/25,13.58%,MFSD6;B2M;HLA-F;HLA-C;TAPBP
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),-0.4989275810710537,-0.7865461188201102,0.7887323943661971,1.0,1.0,1/7,13.65%,SYT4
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),-0.39826035814494576,-0.7864129042156963,0.75,1.0,1.0,5/25,19.20%,YWHAH;AHCYL1;SNTA1;PER1;NKAIN2
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.34833906146556304,0.786385372317235,0.7333333333333333,1.0,1.0,9/49,12.59%,POLR2J;POLR2L;FLRT3;POLR2K;FLRT2;TRIM71;GRB2;GTF2F1;POLR2E
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),-0.39901021116332813,-0.7862590133865657,0.8421052631578947,1.0,1.0,1/33,1.03%,SYNJ2
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.3401261879895918,-0.7860733425112972,0.9222222222222223,1.0,1.0,19/128,12.78%,CD44;MYLK;CRLF1;GADD45B;TNC;RGS4;GADD45A;TIMP3;COL5A1;LAMA2;GLIPR1;ITGA2;ABI3BP;VEGFA;TPM1;SPP1;GJA1;BDNF;PVR
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.467569630935941,0.7858059494935408,0.7777777777777778,1.0,1.0,2/5,20.84%,GRM5;PRNP
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),0.39910820916434897,0.7856940326996472,0.7,1.0,1.0,1/10,6.31%,MGMT
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),0.39910820916434897,0.7856940326996472,0.7,1.0,1.0,1/10,6.31%,MGMT
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.34209264567906755,-0.7856795506290145,0.9595959595959596,1.0,1.0,29/251,15.34%,TMSB4X;ENPP2;GNA12;VSIR;PLET1;MYLK;FGF1;NEDD9;VCL;FGF9;SST;DUSP22;CEMIP;VEGFA;PLXNA4;CAMK2B;TPM1;SRGAP3;PAK1;VIL1;SEMA4B;SULF1;CAMK2A;TMSB15B;MACF1;IGSF10;AKT2;NTRK3;CYP1B1
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),-0.4966454204128962,-0.7856451700399942,0.7702702702702703,1.0,1.0,5/9,41.46%,CD55;CD46;JAG1;GNL1;MSH2
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.42897216990953446,-0.7855676291531115,0.8108108108108109,1.0,1.0,4/17,26.07%,RMND1;RPUSD3;MALSU1;TRUB2
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),-0.5508174141626905,-0.7853186336165605,0.8656716417910447,1.0,1.0,2/5,17.65%,LOXL3;SUMF1
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.3428445219819253,-0.7850625168231478,0.8829787234042553,1.0,1.0,28/152,24.56%,EMP2;RAB40A;RFTN1;PLEKHF1;CAV3;RAB11A;RAB3A;RAB40B;PDZK1;ITGB1BP1;SH3PXD2B;RAB15;KCNB2;RAB3D;GAK;MRAP;SHANK3;RDX;ATP1B1;DVL1;DLG4;RAB8B;TNIK;RAB40C;MAP7;PACSIN1;ARL5B;ITGA4
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.4010519870126083,-0.785028661159993,0.7931034482758621,1.0,1.0,6/37,21.33%,PARP9;ATG14;TSC1;EIF2B4;PER1;RBM4B
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.37904742977794514,-0.7848917582587872,0.7816091954022989,1.0,1.0,7/44,21.13%,FBXO6;APOE;NR1D1;ADAMTS9;DENND3;RIPK1;DAB2IP
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),-0.37911453956679675,-0.784626233675168,0.7875,1.0,1.0,9/34,24.55%,EFHC1;TTC19;RASA1;USP8;CHMP4B;CIT;RAB35;ECT2;MITD1
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),0.29824079242332696,0.7844206327145113,0.9090909090909091,1.0,1.0,8/64,10.40%,GPNMB;SLC30A10;PPT1;TOX3;NGF;LIG4;MT3;ATF4
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.32224281304915636,0.7843385963083254,0.8181818181818182,1.0,1.0,9/45,14.15%,RBM15B;AARS1;TYW5;JMJD6;NAT10;ANKRD16;PUS7L;HENMT1;DTWD1
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.44015517384759506,0.7843299134929032,0.7333333333333333,1.0,1.0,1/8,0.92%,CHRNA4
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),0.4199911831598664,0.7842758114055923,0.6764705882352942,1.0,1.0,2/7,9.12%,LYN;PLAUR
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.4558073030313742,-0.7842664299626845,0.7397260273972602,1.0,1.0,5/16,28.63%,CACNA1C;ATP1B1;RYR2;CAMK2D;GSTO1
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,0.2864649242298543,0.7842370252140425,1.0,1.0,1.0,19/134,15.72%,MARCKS;ODC1;CCND1;KPNA2;PML;CDKN2C;SQLE;HSPA8;LBR;SS18;SMAD3;JPT1;HIRA;EZH2;KIF15;E2F4;MT2A;TLE3;TMPO
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,-0.35630857560168094,-0.7841301294276856,0.8295454545454546,1.0,1.0,8/86,13.36%,PAPPA;LIFR;EDNRA;AKAP12;TPM1;GJA1;ADGRL2;ADAMTS9
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),-0.40936185044102613,-0.7841167179805582,0.8048780487804879,1.0,1.0,5/24,22.26%,VEGFA;RDX;MAP2K5;SPINT2;TGFB1
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.4310255368580893,-0.7839774241470283,0.8028169014084507,1.0,1.0,1/15,3.44%,TRPC5
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.36815525300219576,-0.7839424039255035,0.875,1.0,1.0,18/81,23.90%,STEAP4;APIP;POLQ;RNF213;NLRC4;B2M;RYR3;SHMT1;IKZF4;ACACB;CLYBL;NINJ1;HCN1;AQP4;CBY1;MPP2;ECT2;PRMT8
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),0.347257684736939,0.7839220313561811,0.8823529411764706,1.0,1.0,10/34,17.36%,TRMT112;CSKMT;PRMT6;RAB6A;VCPKMT;EZH2;SNRPB;BHMT;SETD3;PRMT5
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.4985825301597263,-0.7836195252560021,0.7272727272727273,1.0,1.0,2/6,23.63%,DAB2IP;PIK3CB
prerank,MSigDB_Hallmark_2020__Androgen Response,-0.35184854432991214,-0.7835929491810848,0.8888888888888888,1.0,1.0,8/87,10.87%,STEAP4;MAK;SRF;HERC3;LIFR;B2M;AKAP12;FKBP5
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3386730183762231,0.7835207775139134,1.0,1.0,1.0,6/43,7.74%,ADCY6;VIPR2;LYN;CALCRL;RXFP1;PRKAR2B
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.3822985865105134,0.7833781610064718,0.7714285714285715,1.0,1.0,2/16,7.90%,ANKRD13D;NEU3
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),-0.5097002658572217,-0.7830676250863577,0.7538461538461538,1.0,1.0,3/5,33.17%,CHDH;DMGDH;ALDH7A1
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.2979852670550461,0.7830353105525333,0.8333333333333334,1.0,1.0,10/50,16.56%,PSMD8;PSMB4;PSMB6;PSMD10;PSME3;PSMB2;PSMD12;FBXL7;PSMC1;PSMD4
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.4916140912863922,0.7826773915465249,0.6363636363636364,1.0,1.0,1/5,4.64%,NLGN2
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.3650716044546872,-0.7826143665529399,0.8352941176470589,1.0,1.0,14/56,26.34%,IRF1;STAT6;POLR1C;OAS1;IFIH1;TOMM70;POLR3H;TRIM56;STAT1;POLR3A;CGAS;ISG15;POLR3D;POLR3E
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.3521432729576579,0.7824481501887546,0.8,1.0,1.0,2/30,6.67%,PRR5L;ZFAND1
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.5260253114905458,-0.7824422882912487,0.7941176470588235,1.0,1.0,3/6,27.10%,MYORG;IGFBP5;ZFAND2B
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.4750862038798029,-0.782422987734188,0.7671232876712328,1.0,1.0,2/11,17.57%,IL7;IL6R
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.34069737767823005,0.7823288263827887,0.7368421052631579,1.0,1.0,1/38,0.59%,NUP42
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.3786112617369845,0.7822868237209814,0.7619047619047619,1.0,1.0,3/19,11.59%,CGNL1;TMEFF2;ARAP1
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.40141990096858965,-0.7819837174472468,0.8271604938271605,1.0,1.0,5/30,12.25%,SGCA;LAMA2;EMD;CAV3;MEF2D
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.40824921451968726,0.7817052683050387,0.7,1.0,1.0,6/6,59.19%,MLLT3;SMYD5;NCOA3;CDK2AP2;ESRRB;PRDM15
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.4548086571948964,-0.7815740115918955,0.7761194029850746,1.0,1.0,2/11,21.54%,CACNA1C;HCN2
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.4961219491929054,-0.781204766284525,0.7945205479452054,1.0,1.0,3/8,24.72%,RBM4;AGO1;AGO4
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.4961219491929054,-0.781204766284525,0.7945205479452054,1.0,1.0,3/8,24.72%,RBM4;AGO1;AGO4
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.3393689482371955,0.7811096498410328,0.7692307692307693,1.0,1.0,1/24,3.29%,RNF6
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.33359278633831607,0.7808796404522674,0.8235294117647058,1.0,1.0,13/63,13.20%,GPC4;SOWAHA;STARD13;BCAR1;PCGF2;PRR36;ATN1;CAMSAP3;LINGO1;GLIS2;NOL4;WWC1;DUSP15
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),-0.401885746370887,-0.7805199987293975,0.8082191780821918,1.0,1.0,7/25,27.41%,FBXO6;DONSON;ATM;CDC5L;DOT1L;HINFP;CLOCK
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),-0.34859053776763976,-0.7804335893665871,0.8604651162790697,1.0,1.0,21/108,24.02%,EMP2;RAB40A;PLEKHF1;CAV3;RAB11A;RAB3A;RAB40B;PDZK1;ITGB1BP1;RAB15;KCNB2;RAB3D;GAK;MRAP;RDX;ATP1B1;RAB8B;TNIK;RAB40C;MAP7;PACSIN1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.36627235294978644,-0.7803595996310587,0.875,1.0,1.0,9/74,13.08%,PTPRC;GADD45A;PTPRB;CAV3;UBASH3B;TRIB1;CAMK2N1;SH3BP5;ITGB1BP1
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.4607031473937245,-0.7800428010665574,0.8285714285714286,1.0,1.0,5/14,37.00%,ATG7;RB1CC1;ATG12;ULK1;ULK2
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),-0.5019828940055201,-0.7800391463690958,0.8260869565217391,1.0,1.0,2/9,14.25%,CALCOCO2;CLEC16A
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.3688380468238819,-0.7799526749438647,0.8837209302325582,1.0,1.0,9/69,17.66%,AKAP5;YWHAH;NMT1;CEMIP;PDZK1;ITGB1BP1;AKT2;SORBS1;PPP3CC
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.39573296498943433,-0.7798000080753593,0.8395061728395061,1.0,1.0,7/30,25.74%,CCT6A;CCT8;PARN;PNKP;ATM;HMBOX1;MAP2K7
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),0.31047738190866264,0.7794238959055294,0.7692307692307693,1.0,1.0,10/46,16.56%,PSMD8;PSMB4;PSMB6;PSMD10;PSME3;PSMB2;PSMD12;FBXL7;PSMC1;PSMD4
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.37294191403131166,-0.7793942093534326,0.8390804597701149,1.0,1.0,5/66,5.10%,IGF2BP2;IGF2BP3;PTPRC;LRRC19;AGT
prerank,MSigDB_Hallmark_2020__Angiogenesis,-0.44035714422267647,-0.7793403456222602,0.8481012658227848,1.0,1.0,3/17,14.80%,VEGFA;SPP1;LRPAP1
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.4862254536335402,-0.7793039213823296,0.881578947368421,1.0,1.0,2/10,1.67%,IGF2BP2;IGF2BP3
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),-0.43665256341706576,-0.7792485133731762,0.8026315789473685,1.0,1.0,3/20,12.20%,AHR;KCNQ1;HCN3
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),-0.3954675897790916,-0.7789278507646413,0.75,1.0,1.0,5/21,22.31%,RAB17;CAMK2B;GRIPAP1;MDGA1;EPHA4
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.43413389905596267,-0.7787603441492312,0.821917808219178,1.0,1.0,8/18,25.54%,LRP2;TPM1;TGFB2;RYR2;SMAD4;TGFB1;ZFPM2;TGFBR3
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),-0.47958790240894184,-0.7785735179108713,0.8333333333333334,1.0,1.0,1/8,11.47%,XRCC3
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.48328839768438236,0.776937979832503,0.8,1.0,1.0,4/8,21.17%,ATF4;CREB3L1;HSPA5;TP53
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.39735225153212494,0.7768632336408884,0.7419354838709677,1.0,1.0,2/10,18.67%,EDEM1;SAR1B
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.47540087334657377,0.7763253372154787,0.696969696969697,1.0,1.0,1/6,3.41%,CXCL12
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.46367403152361825,-0.7761802077460411,0.7671232876712328,1.0,1.0,1/13,0.29%,TUFT1
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.3952440806825297,-0.7757757128316772,0.8227848101265823,1.0,1.0,6/22,22.37%,RBM4;PER1;BHLHE40;PDE6B;RBM4B;FBXL17
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.4503045313594882,0.7756123164383099,0.7391304347826086,1.0,1.0,4/10,19.41%,NIPA2;MAGT1;NIPAL3;NIPA1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),-0.5153204848043835,-0.775548034024471,0.7857142857142857,1.0,1.0,2/5,26.01%,SLC8B1;PLN
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.36745230582246646,-0.7755255500495143,0.8505747126436781,1.0,1.0,14/59,23.70%,HTR2C;TPCN2;SLC39A14;CALCB;HTR2B;SLC24A2;ATP2B3;ATP13A5;ATP1B1;RYR2;SLC8B1;SLC30A9;SLC24A5;SLC41A1
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),-0.41304960330946056,-0.7752182714458805,0.7738095238095238,1.0,1.0,6/23,25.25%,SLC9B1;SLC4A4;CA2;SLC4A8;SLC9A8;SLC4A3
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.4217446733761877,-0.77513839866979,0.782051282051282,1.0,1.0,4/17,21.38%,COL5A1;VEGFA;STAT3;TENM3
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.4462155278734682,0.7750925258345357,0.8518518518518519,1.0,1.0,2/10,8.39%,NAA11;METAP1D
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.2823701953828208,0.7747347457016178,1.0,1.0,1.0,13/85,14.34%,SIRT2;NUP42;PLOD1;TRIM28;UBE2I;TRPM4;VCPKMT;SUMO1;SUMO3;SIRT4;HDAC9;SIRT1;AAAS
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.3677291293213568,-0.774596358701106,0.896551724137931,1.0,1.0,10/54,21.59%,CDKN2A;GADD45A;AGT;CAV3;APOE;PKIG;PTPRJ;PRKAR1B;DAB2IP;MEN1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.44146137612425385,-0.774253847525899,0.8,1.0,1.0,4/12,30.12%,DAB2IP;PIK3CB;TSPAN12;MYO1C
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.3098030423382329,0.7737218276144309,1.0,1.0,1.0,8/63,10.29%,MMP16;NCSTN;TSPAN14;NAA11;CIAO2B;TSPAN17;TSPAN33;SDE2
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),0.3938063447673464,0.773480653409396,0.7142857142857143,1.0,1.0,4/11,15.74%,SMPD1;MYOF;MYH9;ANXA6
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.3880020171698158,0.7734498245436694,0.7272727272727273,1.0,1.0,6/16,14.09%,C12ORF57;CALM3;SRI;SMAD7;CALM1;GRK2
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.4220855593057019,0.7732450025483643,0.7647058823529411,1.0,1.0,2/9,5.05%,PYCR1;GPR37L1
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.28804979125177205,0.7729896841801573,1.0,1.0,1.0,36/243,8.99%,SOX4;STOX1;SOX11;BAD;BTC;IL15;NACC1;YAP1;SOX8;GID8;CALR;TGFBR2;COPS9;CNBP;TGFA;TBRG4;CHRNA7;POU3F2;PDGFRA;CAPNS1;NPM1;LYN;CDC123;RBPJ;CLEC11A;GREM1;S100B;ACER2;RPS15A;PDGFD;BMI1;ZNF268;BAMBI;TRPM4;LIG4;RPRD1B
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),-0.4496395429355808,-0.772986647269464,0.7733333333333333,1.0,1.0,5/14,31.01%,PDK1;PDK2;PDK3;GNB3;FOXK2
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),0.4473664480512822,0.7726943425703383,0.6333333333333333,1.0,1.0,1/5,7.92%,GUCY1B1
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),0.455861339098877,0.7725054108678806,0.7878787878787878,1.0,1.0,5/6,32.76%,CHP1;CABP1;APOD;UFM1;RAB23
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),0.455861339098877,0.7725054108678806,0.7878787878787878,1.0,1.0,5/6,32.76%,CHP1;CABP1;APOD;UFM1;RAB23
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.4014299303440497,0.7723891410823012,0.72,1.0,1.0,2/14,3.78%,PDGFRA;ESR1
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),-0.4691775102010708,-0.7723816496985269,0.7866666666666666,1.0,1.0,2/8,21.78%,PARG;UGP2
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.37778790957346997,-0.7723338823100107,0.8539325842696629,1.0,1.0,13/51,24.56%,CAMK1;ZFPM1;B2M;ITGB1BP1;IFIT1;LRPAP1;CTSZ;ARRB2;DVL1;PEX14;DDX11;MITD1;ITGA4
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.3732446195055492,0.7722013252684213,0.6818181818181818,1.0,1.0,5/18,12.51%,SIRT2;PDE3A;SMURF2;LHFPL2;PLCB1
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.45419420186313514,-0.7721767391923315,0.8205128205128205,1.0,1.0,1/14,9.30%,WDR12
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),-0.5027008348583312,-0.7721580360459858,0.75,1.0,1.0,1/6,14.75%,TBXAS1
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.35305803242618156,-0.7720716541117166,0.8604651162790697,1.0,1.0,2/52,3.21%,CMTR1;METTL2B
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.45851619868376764,-0.7720045479425222,0.7971014492753623,1.0,1.0,3/11,21.44%,VEGFA;EIF2B4;NUP107
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),-0.4850567395945842,-0.7718210615863188,0.7903225806451613,1.0,1.0,1/7,4.26%,CDKN2A
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.35076057157559587,0.7718066395383115,0.8,1.0,1.0,5/30,12.86%,UBXN1;ALAD;RYBP;N4BP1;MARCHF7
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),-0.4893524388452368,-0.7716883186712263,0.9154929577464789,1.0,1.0,1/8,10.54%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.4152970294578506,-0.7715692694515576,0.8372093023255814,1.0,1.0,3/19,16.37%,APOE;SYT4;RSAD2
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.302757128934937,0.7715491409235634,0.9333333333333333,1.0,1.0,8/35,16.89%,NR1H2;ARL6IP5;SNX12;MCTP1;ERBB3;PRKD1;RUBCN;NDFIP2
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),-0.46254666425238,-0.7714563100197637,0.7792207792207793,1.0,1.0,1/8,10.54%,VEGFA
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.3917752820764527,-0.7712450158464147,0.8780487804878049,1.0,1.0,5/34,12.48%,BCL2L2;BRCA1;MSH6;BCL2L11;MOAP1
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.34643122583790675,0.7711161194158405,0.8333333333333334,1.0,1.0,3/18,9.23%,CGNL1;FBP1;SPRY1
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.33167274041103983,-0.7709743587738601,0.968421052631579,1.0,1.0,40/198,22.66%,SOX9;PTPRC;IRF1;CDK7;TSPYL2;GADD45B;CDKN2A;GADD45A;BRCA1;RARA;WDR12;CAMK2N1;CRLF3;TSC1;CDK4;PDCD4;AKT2;WDR6;BEX2;DAPK3;KIF20B;SRA1;STAT3;NUDT6;MASTL;MAP2K1;SPATA22;NEK6;TGFB2;CTBP1;ATM;CDKN2B;CCPG1;MED25;DAB2IP;JUNB;MEN1;TGFB1;FBXL17;MAPK12
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.37367467108950775,-0.7707598652989125,0.7857142857142857,1.0,1.0,10/46,22.79%,APIP;KCNC1;B2M;RYR3;SHMT1;ACACB;HCN1;AQP4;CBY1;GRIN1
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),0.35554238854271,0.770704916516442,0.9444444444444444,1.0,1.0,4/17,14.87%,SLC5A6;ABCG2;SLC14A2;GLTP
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.34075389777375464,-0.7704410723044306,0.9583333333333334,1.0,1.0,26/137,20.57%,G6PC2;PTPRC;PTPRB;ITPK1;ACYP1;PLCH1;GPI;DUSP8;ALK;PAK1;ITPKC;PFKP;HTR2B;NUDT11;EPHA7;EPHX2;PPA1;PNKP;STAT3;PAK2;INPP4B;AGK;PIP4P1;INPP5A;INPP4A;PANK2
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),0.4667912623553847,0.7701150335448498,0.7058823529411765,1.0,1.0,1/7,1.48%,CFL1
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.3909971331900578,-0.7700359422462518,0.7432432432432432,1.0,1.0,7/25,21.60%,VEGFA;AHI1;ARRB1;LRPAP1;ARRB2;MKLN1;DLG4
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),0.42830696415589786,0.7699560609240667,0.8076923076923077,1.0,1.0,1/12,0.98%,MALT1
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.38496359834710653,-0.769922434925703,0.8024691358024691,1.0,1.0,2/27,7.29%,AZIN2;MSH6
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.3838018128320295,-0.7698690791702933,0.8311688311688312,1.0,1.0,4/27,17.04%,PRUNE1;RASA1;ABITRAM;PFN2
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.33805131417074086,0.7696366331445835,0.8333333333333334,1.0,1.0,2/22,3.54%,MMP2;CHRNA7
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),-0.4947692054581886,-0.7696305212006621,0.863013698630137,1.0,1.0,2/5,32.12%,RORB;RPGRIP1L
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,-0.3832768660387525,-0.7695846980832198,0.8607594936708861,1.0,1.0,4/31,15.77%,HEY2;VEGFA;RASA1;CRMP1
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,-0.3526431124754515,-0.7694500714790348,0.8817204301075269,1.0,1.0,9/86,9.82%,HEY2;DRAM1;PAMR1;TIMP3;LAMA2;NRGN;TNS1;ARID5A;EDNRA
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.29225857611729655,0.769181229514197,0.9166666666666666,1.0,1.0,2/52,2.25%,YAP1;EVI5L
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.35028074631753664,-0.7691450674135103,0.8095238095238095,1.0,1.0,2/69,4.46%,RFC4;CCT6B
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.44895366717924723,0.7690528209277451,0.7037037037037037,1.0,1.0,8/8,55.13%,IL17D;CREBBP;PTN;MYSM1;PURB;PRKCB;RUNX1;CBFB
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),0.43757312237218526,0.7688845000884261,0.72,1.0,1.0,4/9,21.14%,DNAAF2;SPEF2;DYNC1I1;SPAG17
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.28558496447627124,0.7688711155988763,1.0,1.0,1.0,17/141,9.56%,MALT1;TAB3;GSTP1;IKBKB;TRAF5;ESR1;RHOC;PLEKHG5;UBE2N;TRAF4;PPM1A;S100B;TMEM9B;TSPAN6;PELI1;ATP2C1;RIPK2
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),-0.48783297743739606,-0.7684231830009821,0.7741935483870968,1.0,1.0,2/8,18.87%,ECSIT;HDAC6
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.5010951418638446,-0.7684127663429511,0.8648648648648649,1.0,1.0,1/6,9.49%,UBASH3B
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.46347672125223416,-0.7681647618793154,0.7922077922077922,1.0,1.0,6/15,22.71%,C4BPA;CPB2;C1S;PROS1;CD59;CD55
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.46347672125223416,-0.7681647618793154,0.7922077922077922,1.0,1.0,6/15,22.71%,C4BPA;CPB2;C1S;PROS1;CD59;CD55
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.39074623185000573,0.7679282204141418,0.8,1.0,1.0,2/11,5.96%,ESR1;MYCN
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.46311073613371123,0.7674438733002025,0.717948717948718,1.0,1.0,2/5,18.72%,BMP2;NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.36707771103894576,0.7673367936808068,0.7272727272727273,1.0,1.0,8/15,22.77%,NFKBIL1;LYN;GPR108;MFHAS1;PTPRS;GRAMD4;LRRC14;LGR4
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),0.42665005495785135,0.7672917483414675,0.7857142857142857,1.0,1.0,6/8,18.48%,NEU1;NEU3;GBA3;NEU4;MANBA;MAN2B1
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.4782959000095186,-0.7672502690024462,0.85,1.0,1.0,3/9,21.01%,RBSN;GAK;ANKFY1
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),-0.44881430525516547,-0.7672418403557161,0.828125,1.0,1.0,1/10,5.10%,AGT
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.29801897895649243,0.7666916713713268,0.9,1.0,1.0,12/50,13.89%,CRB2;TGFBR2;MCRIP1;GREM1;BAMBI;SPRY1;SMAD3;TGFBR1;MAD2L2;SMAD7;GLIPR2;EZH2
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.30433217552678604,0.7665434306985942,0.9,1.0,1.0,8/54,9.80%,PSMD8;CALR;PSMB4;IKBKB;PSMB6;ITGB5;PSMD10;PSME3
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),-0.5134441822768283,-0.766414399497306,0.8095238095238095,1.0,1.0,5/6,35.55%,TGFB2;CBY1;KDM6B;AKAP13;NRG1
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),0.2926177995250893,0.7661863924213668,0.8888888888888888,1.0,1.0,9/45,16.49%,SIRT2;PCBP2;ENPP3;MUL1;OTULIN;TRAFD1;FEM1A;MFHAS1;TRAF3IP1
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),-0.4970528122502683,-0.7661276155386465,0.8169014084507042,1.0,1.0,5/8,47.74%,MACROH2A1;RPS6KA5;CDK9;AKAP8L;AKAP8
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),-0.49915442986567027,-0.7660156881925699,0.8064516129032258,1.0,1.0,1/5,1.82%,ALOX12
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.38553563670982643,-0.7660108387818219,0.8604651162790697,1.0,1.0,5/48,12.86%,FGF1;RAB11A;EFHC1;PLK2;HTR2B
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),-0.3545978847686898,-0.7659945710387364,0.8372093023255814,1.0,1.0,7/73,8.77%,HEY2;SOX9;SRF;ZFPM1;MTHFD1;CACNA1C;DVL2
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),0.30275922034700375,0.765606950316215,0.9545454545454546,1.0,1.0,5/33,8.50%,COLEC12;STAB2;GSDMB;RPS19;PPP1R11
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.47597655414990464,-0.7654849330943845,0.8589743589743589,1.0,1.0,1/11,10.59%,DDB2
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.3886098520775281,-0.7654579483681286,0.8533333333333334,1.0,1.0,9/34,27.01%,FABP3;APOE;USF1;ABCA2;XBP1;PRKAA1;PNPLA2;ACOXL;PRKAA2
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3374522478492486,0.765131474957524,0.75,1.0,1.0,6/44,7.74%,ADCY6;VIPR2;LYN;CALCRL;RXFP1;PRKAR2B
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.5252588790089114,-0.7651203404123896,0.85,1.0,1.0,2/6,31.45%,PLAAT3;PLA2G12A
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),-0.42496936201144364,-0.7650876367283337,0.7866666666666666,1.0,1.0,5/14,31.55%,ACTL6B;SRRM4;LGI4;C3;APP
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.3627521569215943,-0.7650866618138434,0.8522727272727273,1.0,1.0,10/50,25.02%,VEGFA;VAV3;SULF1;PAK2;BAIAP2;PRKD2;DAB2IP;PIK3CB;NRP2;SHC2
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.39404344362400057,-0.7649145724699281,0.7951807228915663,1.0,1.0,2/31,8.18%,STMN2;EFNA5
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.4091409469943051,-0.7646591513246588,0.8048780487804879,1.0,1.0,5/26,23.09%,ENTPD3;SIDT2;NCBP1;ENTPD7;ENTPD1
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.3313342772019673,0.7646445011393721,0.8148148148148148,1.0,1.0,2/17,8.66%,NCSTN;HM13
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.3445800051455778,0.7646147789864396,0.8125,1.0,1.0,5/25,12.25%,UBB;GTF2H2;PARP1;UBC;ERCC3
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),-0.35275985903820267,-0.764423908733636,0.9310344827586207,1.0,1.0,19/91,21.68%,STMN2;CAMK1;ROBO2;DVL2;SS18L2;APOE;PLXNA4;CAMK2B;BDNF;CAMK1D;NTRK3;PTK7;AVIL;TIAM1;DVL1;DAB2IP;TENM3;DLG4;ROR1
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.37276515712324226,0.7643829203578493,0.6666666666666666,1.0,1.0,4/13,14.09%,CHRNA7;GNA11;PLCB1;GRK2
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),-0.4941962087886921,-0.7642839781532889,0.8636363636363636,1.0,1.0,2/7,31.55%,C3;APP
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.39688677534321437,-0.7639548353228456,0.7972972972972973,1.0,1.0,5/27,19.12%,B2M;VEGFA;AHI1;ARRB1;ARRB2
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.3900839757171817,-0.7639237723445348,0.8205128205128205,1.0,1.0,1/34,0.68%,SOX9
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.35647831569667376,0.7636352618363915,0.6842105263157895,1.0,1.0,3/25,8.51%,FNBP1L;CANX;CLTB
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),-0.47508788283912673,-0.7634696622910441,0.8169014084507042,1.0,1.0,2/8,22.35%,PLS3;SPIRE1
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),0.4383976655533117,0.7633292766789973,0.7666666666666667,1.0,1.0,1/11,1.48%,CFL1
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),-0.33852762769862116,-0.7633046898418301,0.9021739130434783,1.0,1.0,22/101,28.28%,FHDC1;SPTBN5;ATP8B1;VRK1;GOLGA8B;BAG5;TANGO2;ATP8B2;CSNK1D;GAK;GOLPH3L;GOLGA8M;PLEKHM2;VPS51;FAM174B;ZW10;STX5;BCAS3;RAB29;NPLOC4;RAB1A;COG4
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.4306851421118263,0.7631120869949984,0.7419354838709677,1.0,1.0,2/6,26.01%,PEX13;HACL1
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),-0.4224024227505131,-0.7631095005524131,0.7948717948717948,1.0,1.0,1/16,13.99%,PTRH2
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),-0.5130741732098743,-0.7630300297290942,0.7763157894736842,1.0,1.0,2/6,35.86%,SPPL3;CAMTA1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.5130741732098743,-0.7630300297290942,0.7763157894736842,1.0,1.0,2/6,35.86%,SPPL3;CAMTA1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.477949868565375,-0.7630262876373145,0.8235294117647058,1.0,1.0,2/7,24.00%,HLA-F;STX4
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.4661832269511439,-0.7627847977415838,0.88,1.0,1.0,1/8,4.95%,VCL
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),0.46408646498353767,0.7626996633277178,0.7741935483870968,1.0,1.0,4/7,18.76%,GREM1;SOX6;BMP2;FRS2
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.3949702100737009,0.7624475072062757,0.7727272727272727,1.0,1.0,3/12,10.79%,NR1H2;LDLR;SCARB1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.32676212285880535,-0.7623076901748072,0.9361702127659575,1.0,1.0,28/205,19.93%,HEY2;SOX9;VSIR;TTN;FGF1;OVOL2;BRCA1;FGF9;FAM98B;PLSCR1;HMGN5;RIMS1;VEGFA;DTX3L;CAMK2N1;GJA1;AHI1;ARRB1;EPHX2;NTRK3;OLFM1;STAT3;MAP2K1;ARRB2;ATM;RDX;AGO1;MAP2K5
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.33216723872188825,-0.7619264444051475,0.9574468085106383,1.0,1.0,21/231,13.28%,RFC4;PMS2;PARP9;GADD45A;FBXO6;POLQ;FANCC;BRCA1;MSH6;RFC2;ZRANB3;MMS19;FANCI;DDB2;BACH1;DTX3L;RPA3;XRCC3;FANCB;EME2;NEIL2
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.3938761057109724,-0.7618691127946766,0.8441558441558441,1.0,1.0,5/32,15.34%,ALOX12;ELOVL2;ACSL1;PTGR1;CYP1B1
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.3878292158465808,-0.7617652695804049,0.8333333333333334,1.0,1.0,7/34,25.29%,SPI1;ZFPM1;RPS14;CDKN2B;TIRAP;UBA5;ACIN1
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),-0.3568034853255342,-0.7617057311527132,0.8315789473684211,1.0,1.0,13/59,31.83%,SHTN1;EMD;LPCAT3;TRAM1L1;GAK;DNM1L;MOSPD3;STX5;RAB10;SEC31B;TRAM2;APP;RAB18
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),-0.5080126439193096,-0.7615829605533867,0.8888888888888888,1.0,1.0,5/7,25.87%,ACMSD;TGFB1;ABCA2;AP2A1;CLTC
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),0.5123663197960521,0.761547313343723,0.7096774193548387,1.0,1.0,2/5,2.73%,CHRNA4;INSYN1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.42684220463490036,-0.7614957645982408,0.8433734939759037,1.0,1.0,1/19,1.93%,ITPR1
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.3904619476343009,-0.7614196256329773,0.7894736842105263,1.0,1.0,2/24,5.83%,FBXO6;DONSON
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.3587170720890845,-0.7611244198937095,0.8913043478260869,1.0,1.0,9/77,15.74%,IGF2BP2;IGF2BP3;DAPK1;PUS7;SHMT1;TSC1;ZNF540;RBM4;DAPK3
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.29077800134613413,0.7609518980817267,1.0,1.0,1.0,28/109,19.39%,BICD2;CALR;LAMP5;MICALL1;WASHC2A;COG3;IFT20;TSPAN17;WDR35;TOLLIP;RAB6A;SEC61B;ARL3;LAMP1;AUP1;TRAM1;DNAJA1;SEC61G;RAB33B;UBE2J2;LMNA;DDX1;VPS35;UBAC2;DDX3X;DCP1A;BICD1;SNX10
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),-0.4729724258217796,-0.7605920655846747,0.8666666666666667,1.0,1.0,2/10,23.27%,CTBP1;NNMT
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.35709091882214816,0.7605809275756543,0.75,1.0,1.0,3/22,5.30%,SIRT2;ZFP36L1;PIK3C2G
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),-0.37487971821687166,-0.7605535447801031,0.8837209302325582,1.0,1.0,15/50,27.01%,SREBF1;ATG14;TSC1;FOXO1;CLEC16A;WRN;PDK2;RPTOR;CDKN2B;ATG7;FAM107A;XBP1;PRKAA1;GAS2L1;PRKAA2
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,-0.3419938530234945,-0.7604530823354053,0.8977272727272727,1.0,1.0,10/67,15.77%,NEFM;STMN2;BRCA1;CACNA1B;SULT4A1;ACTL6B;JPH3;SYT4;KCNB2;CRMP1
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.4260650164313472,-0.7603284036400779,0.7971014492753623,1.0,1.0,2/14,11.86%,SLC6A6;GJA1
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.326669363214159,-0.7601607603715721,0.9494949494949495,1.0,1.0,24/265,12.48%,RFC4;SPDYA;GADD45A;FBXO6;POLQ;BCL2L2;FANCC;BRCA1;MSH6;BRAT1;RFC2;ZRANB3;MMS19;VAV3;DDB2;BACH1;BCL2L11;DTX3L;FBXO31;TAF1;XRCC3;PAK1;FOXO1;MOAP1
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.3468288437297896,-0.7600467533965067,0.9010989010989011,1.0,1.0,16/99,22.53%,TUBA4A;CDK7;TPD52L1;BORA;BACH1;CEP135;CCDC57;DNM2;LCMT1;CSNK1D;MASTL;HAUS5;CDKN2B;DCTN1;FBXL17;CEP72
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.43153642750817794,-0.7600449309720834,0.8928571428571429,1.0,1.0,3/15,16.37%,APOE;WWP2;RSAD2
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.41041285285477375,-0.7600320257845818,0.7692307692307693,1.0,1.0,3/22,10.81%,ELOVL2;ACSBG1;ACSL1
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.4128389102102272,-0.7599059543576716,0.8024691358024691,1.0,1.0,4/22,21.28%,RFC1;GAR1;TELO2;TERF2IP
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.4564458881919684,0.7598006871539885,0.7586206896551724,1.0,1.0,3/7,9.37%,PSPH;SRR;PSAT1
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.2948018206024009,0.7597639589086448,0.7916666666666666,1.0,1.0,8/36,21.44%,RPS19;IRAG2;CHMP2A;SUN2;NUP35;SEH1L;LEMD3;WDR73
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.39178936185237256,-0.7597125222206845,0.8780487804878049,1.0,1.0,14/35,34.05%,DARS2;PPA1;YARS1;GATB;GARS1;CARS1;HARS1;DARS1;NARS1;VARS1;QRSL1;PPA2;MARS1;WARS1
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),-0.4651787078520896,-0.7596541950915008,0.8055555555555556,1.0,1.0,2/9,11.87%,VEGFA;THOC5
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.3517174087923755,-0.7596486323826072,0.8275862068965517,1.0,1.0,8/49,15.74%,VCL;DUSP22;EFNA5;VEGFA;TSC1;ITGB1BP1;MACF1;DAPK3
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.3795237915368095,-0.7592782678581032,0.7906976744186046,1.0,1.0,5/42,15.14%,KCNN3;KCNMB4;CAV3;KCNQ1;WWP2
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.3453312047512669,-0.7591472046718788,0.9101123595505618,1.0,1.0,12/75,19.57%,TMSB4X;CARD14;PSMB8;EDARADD;CD27;PSMA4;MAP3K14;STAT1;PSMA3;TRAF3;ST18;RIPK1
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.30541395717439646,0.7589395662905554,0.8421052631578947,1.0,1.0,4/39,9.84%,MAP7D3;MID1IP1;CHMP2A;WASF3
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),-0.3521106673841455,-0.7588854534585464,0.9148936170212766,1.0,1.0,15/82,23.63%,FGF1;FGF9;NRG4;P2RY12;AKR1C2;LRP2;ITGB1BP1;AKT2;MYORG;KITLG;PTPRJ;IGF1R;TGFB1;PDGFRB;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),0.29194667975574695,0.7588195607799672,0.8888888888888888,1.0,1.0,12/67,13.06%,SIRT2;RNF144A;HSPA1A;PRICKLE1;ZYG11B;BAG2;PSMD10;TMTC3;RCHY1;SUMO1;SMAD7;TMEM259
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),-0.4975398660830394,-0.7587598066559949,0.8611111111111112,1.0,1.0,1/6,0.55%,HEY2
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3553737909169087,0.7586801879662498,0.8181818181818182,1.0,1.0,4/23,6.92%,YAP1;ESR1;CNOT9;WBP2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),-0.4744355504717196,-0.7583802560512238,0.7538461538461538,1.0,1.0,1/6,16.37%,RSAD2
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.26756856866981243,0.7581847577458787,1.0,1.0,1.0,16/123,10.54%,UBB;HSPA1A;PCBP4;PSMD8;PSMB4;ZFP36L1;TBRG4;NPM1;PSMB6;FXR2;HSPA8;PSMD10;PSME3;RC3H1;EXOSC8;UBC
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.2815634268733855,0.7581767886897174,1.0,1.0,1.0,9/57,10.40%,SOX11;YAP1;GREM1;BAMBI;TRPM4;CTNNBIP1;LIMD1;LRP3;ATF4
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),-0.5339448474799283,-0.7580579873532599,0.8412698412698413,1.0,1.0,1/5,3.58%,PAH
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.3539262174432354,-0.7578342959261306,0.8901098901098901,1.0,1.0,6/95,6.56%,NLRC5;EMP2;SRPX2;CDKN2A;POM121C;STAT2
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),-0.44631895558597856,-0.7575421726857072,0.8481012658227848,1.0,1.0,2/14,10.42%,PTPRC;GPI
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.3400901279884539,-0.7573494927710502,0.9166666666666666,1.0,1.0,26/141,22.71%,TSPYL2;OVOL2;RGS4;HHIP;PLSCR1;INTU;LFNG;GRK4;CAV3;LIFR;UBASH3B;ITGB1BP1;SULF1;TULP3;TRIM5;GNG7;ZIC1;IRAK2;RGS5;GNG4;NLRP12;BRAP;CASTOR2;TGFB1;FBXL17;CD55
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),-0.42150549363377987,-0.7570139708717701,0.8571428571428571,1.0,1.0,6/15,25.21%,VEGFA;CAMK1D;ADCY1;PRKD2;CRTC3;RELN
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),0.2907390075607854,0.7567075223565978,1.0,1.0,1.0,15/87,13.87%,MALT1;PSMD8;TAB3;PSMB4;IKBKB;PSMB6;LYN;JUN;PSMD10;PSME3;NFATC1;GRB2;PSMB2;PSMD12;CALM1
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.3638264587963611,0.7566282073924666,0.8888888888888888,1.0,1.0,6/19,15.07%,SEMA5A;SEMA5B;SEMA3B;SEMA4F;NRP1;SEMA6C
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.4506343156379104,-0.7565486761813582,0.7837837837837838,1.0,1.0,2/11,8.87%,CCT6A;CCT8
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.3611992990796249,-0.7562266552240186,0.8505747126436781,1.0,1.0,6/55,10.23%,SLC2A3;MCCC1;ALDH1L1;MTHFD1;BTD;SHMT1
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.39778835493394027,-0.7561363924826581,0.9047619047619048,1.0,1.0,7/24,23.51%,CDKN2A;B2M;IFIH1;RSAD2;TGFB2;ARG2;CGAS
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),0.3549432984322801,0.7559756819162203,0.9130434782608695,1.0,1.0,4/17,11.95%,BAD;TIMM13;HSPA4;TIMM22
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.5112104138303225,-0.7558565324363042,0.7916666666666666,1.0,1.0,1/5,10.88%,TPM1
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.27558261492098735,0.7557165415944169,1.0,1.0,1.0,16/122,10.28%,SOX4;TMEM9;PSMD8;GID8;LGR5;GSKIP;PSMB4;SEMA5A;PSMB6;PPM1A;BAMBI;TRPM4;CDC73;PSMD10;PSME3;SMURF2
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.3430185771335732,-0.7556553005365483,0.8969072164948454,1.0,1.0,18/134,18.76%,PMS2;CDKN2A;SLBP;BRCA1;DONSON;ANP32E;RFC1;RFC2;ATAD2;SHMT1;RPA3;TACC3;CDK4;ORC2;CIT;SPC25;XPO1;LUC7L3
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),0.4370614827520943,0.7556047692234076,0.75,1.0,1.0,3/6,18.42%,SRM;SAT1;SAT2
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.3309547298373354,0.7555402569761662,0.9230769230769231,1.0,1.0,6/38,12.20%,CFL1;TWF1;SVIL;MICAL1;WASF3;CFL2
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.4015626161945085,-0.7554771544144409,0.8552631578947368,1.0,1.0,2/18,9.21%,ENPP2;AOAH
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.3976401023318795,-0.7552905826180418,0.7906976744186046,1.0,1.0,6/27,21.24%,NMRAL1;RHCE;DEGS2;ABCA8;AGK;ARG2
prerank,GO_Biological_Process_2021__SA node cell action potential (GO:0086015),-0.5143889230926477,-0.7552430681479578,0.859375,1.0,1.0,3/5,46.62%,CACNA1D;KCNA5;CACNA1G
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.3937534842917684,-0.7552264928193221,0.8681318681318682,1.0,1.0,6/30,19.39%,MYO1H;HAP1;SYT4;MYO1F;CCDC186;KIF1A
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.3961546573691136,0.7550406400651875,0.8461538461538461,1.0,1.0,1/12,1.59%,FGF12
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.29163929185162657,0.7550198966494528,0.9,1.0,1.0,11/82,10.83%,U2AF1;NUP42;RBM15B;CPSF1;CPSF4;NXF1;AGFG1;EIF4A3;EIF4E;RBM8A;POLDIP3
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.43356920908853425,-0.7548148062834926,0.7894736842105263,1.0,1.0,2/14,10.63%,USP13;BCL2L11
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.34438394160161506,-0.7547357620826481,0.8695652173913043,1.0,1.0,5/90,5.07%,CD44;SOX9;PRELP;HHIP;COL10A1
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.39903326992573973,0.7544791826709023,0.7941176470588235,1.0,1.0,1/8,10.56%,CXXC4
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.4047114390219567,0.7541633271634892,0.7714285714285715,1.0,1.0,2/10,12.76%,EMC6;EMC8
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.3527959003244009,0.7538531723618597,0.7619047619047619,1.0,1.0,4/22,11.87%,SMDT1;ADRA1A;SLC35G1;JPH4
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.4364728285821732,-0.7537502344582182,0.8169014084507042,1.0,1.0,3/11,26.18%,MTCH2;ISG15;HK1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),-0.46811131532577954,-0.7537439766173657,0.8333333333333334,1.0,1.0,4/9,35.56%,GALNT2;MGAT5B;POGLUT1;POGLUT3
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),-0.46155292448478236,-0.7537333179730739,0.8,1.0,1.0,1/8,4.04%,RAB17
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.38129971260152473,0.7537219979756529,0.7142857142857143,1.0,1.0,7/21,16.57%,B4GALT6;SMPD1;SPTLC1;SGMS1;ST6GALNAC3;CERS2;SAMD8
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),-0.4832253099904017,-0.7535843432849154,0.8833333333333333,1.0,1.0,1/6,20.09%,ADAM9
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),-0.5033863759182817,-0.7535618342315304,0.835820895522388,1.0,1.0,2/5,18.43%,SPI1;CTBP1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.31519783096781817,-0.7534756259596181,0.9578947368421052,1.0,1.0,33/277,17.33%,CD44;SOX9;ANGPTL4;CARD14;ALOX12;APIP;CRLF1;TMEM14A;BCL2L2;RNF213;CD27;LRP2;HMGN5;APOE;IL7;VEGFA;MAG;PLK2;RNF157;BDNF;AHI1;FOXO1;FANK1;RASA1;HTR2B;PTRH2;AKT2;IFIT3;CRYAB;GCLC;IFI6;TYRO3;PAK2
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.34900024744939134,-0.7528723523349911,0.9090909090909091,1.0,1.0,19/97,22.29%,PTPRC;APIP;CAV3;PAK1;TRAF7;RASGRP1;NBR1;EPHA7;TRIM5;NTRK3;BCAR3;VRK2;PAK2;MAP2K1;PTPRJ;IGF1R;DAB2IP;ROR1;TNIK
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),-0.34899771744515845,-0.7527558325941217,0.8505747126436781,1.0,1.0,12/56,26.39%,EFNA1;SPI1;RILPL1;MICALL2;TBCD;ITGA8;TYRO3;SIPA1L3;LAMB1;ITGA4;RELN;ARL13B
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),-0.35487390574832156,-0.7525697094129332,0.9176470588235294,1.0,1.0,2/49,3.72%,PON1;PIGH
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.34120846463390814,-0.7525121488271109,0.9583333333333334,1.0,1.0,26/119,22.04%,CD44;MMP19;TNC;COL10A1;COL5A1;LAMA2;MMP21;ITGA2;HRNR;ADAMTS13;SPP1;ADAMTS16;ADAMTS9;ITGA9;ECM2;THSD4;ITGA8;COL5A3;ADAMTS10;DDR2;ACAN;COL15A1;MMP24;ADAMTS7;GFOD2;COL4A5
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.31506846635918473,0.7522986344124672,0.8235294117647058,1.0,1.0,5/39,11.16%,G0S2;GSTP1;PML;PSME3;TGFBR1
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),-0.4429753494161872,-0.7521637037739718,0.8076923076923077,1.0,1.0,2/11,27.39%,ATP1B1;NEDD4L
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.3006609569076489,0.7521314350537429,1.0,1.0,1.0,12/58,16.14%,ACTG1;RHOC;CGNL1;S100A10;RAPGEF3;TMEFF2;TGFBR1;ARAP1;PPM1E;NRP1;RHOA;CDC42
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,0.3103049270068031,0.7516957824265087,0.8571428571428571,1.0,1.0,16/94,7.59%,AMOTL2;BGN;ADCY6;HSPG2;YAP1;NR1H2;TNS2;STIM1;CXCL12;CTSA;SEMA5B;ITGB5;DOCK6;CDC42EP1;SLC2A10;BOK
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.3625250529927424,0.751573418167762,0.75,1.0,1.0,3/13,12.36%,INTS9;MTREX;INTS7
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),-0.5013721210847788,-0.751566111500177,0.8285714285714286,1.0,1.0,2/5,19.53%,SHANK3;ANO6
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.30268287117918014,0.7514341022335156,0.8571428571428571,1.0,1.0,20/77,13.87%,UBB;TGFBR2;ZFP36L1;PDE3A;ITGB5;LIMS1;NR3C1;BAMBI;SOX6;JUN;UBC;SMAD9;SMAD3;TGFBR1;TWSG1;ZYX;SMAD7;DUSP15;FNTA;SIRT1
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),0.44413828675388867,0.7511476838229385,0.7142857142857143,1.0,1.0,3/6,15.12%,ABCC11;SLCO3A1;ABCC10
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.344591352057483,-0.751139293470266,0.8850574712643678,1.0,1.0,10/77,10.00%,PTPRC;CDKN2A;IFNGR2;IGSF6;SPI1;BRCA1;GCNT1;STAT4;B2M;IL7
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.3337361922728387,-0.7510759185520932,0.9895833333333334,1.0,1.0,22/174,15.34%,CD44;OPTC;MMP19;TNC;A2M;COL10A1;COL5A1;SCUBE3;LAMA2;MMP21;ITGA2;ADAMTS13;P4HA3;SPP1;ADAMTS16;LOXL3;SH3PXD2B;ADAMTS9;ITGA9;ECM2;THSD4;CYP1B1
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.4494390093984458,-0.7509529822099229,0.8289473684210527,1.0,1.0,6/16,22.71%,C4BPA;CPB2;C1S;PROS1;CD59;CD55
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.3481722726107934,0.7507764853028175,0.7619047619047619,1.0,1.0,4/21,12.47%,HIPK1;SALL2;MEIS3;ZDHHC16
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),0.2936082692262926,0.7507450684530322,1.0,1.0,1.0,15/102,10.06%,MALT1;PSMD8;PSMB4;IKBKB;PSMB6;UBE2N;ERMAP;BCAR1;THY1;PDE4B;PSMD10;RIPK2;PSME3;TNFRSF21;RC3H1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.4380504724960861,-0.7507275961002247,0.8333333333333334,1.0,1.0,4/17,22.54%,P2RY12;ATG14;TGFB1;PDGFRB
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.3950290909867658,-0.7505149311147541,0.7922077922077922,1.0,1.0,8/24,23.31%,OTUD7B;NR1D1;STAT1;PER1;RIPK1;NLRP12;DAB2IP;USP10
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),0.44963843286932703,0.750347643170533,0.78125,1.0,1.0,2/5,23.30%,SLX4;MUS81
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.30806798333345964,0.750321970075545,0.9333333333333333,1.0,1.0,10/49,12.40%,BAD;RAN;ACOT9;THEM4;ACLY;SULT1C4;ACOT8;ACSM5;OXSM;ACOT13
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.36597324929881214,-0.7501590153401064,0.8928571428571429,1.0,1.0,2/49,5.10%,EPN1;AGT
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.3769728339511614,-0.7499625854160082,0.8292682926829268,1.0,1.0,1/28,1.02%,NLRC5
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.4141882400826217,-0.7499481167351273,0.8356164383561644,1.0,1.0,3/20,16.26%,GUK1;REXO2;NMNAT3
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),-0.48104058148657114,-0.7498493366017943,0.8428571428571429,1.0,1.0,1/7,5.29%,PTPRB
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.29609745103651736,0.7497654295492172,1.0,1.0,1.0,12/44,16.27%,BTC;LYN;RPS19;ARHGAP18;ZSWIM6;MEMO1;TGFBR1;ARAP1;ERBB3;RHOA;CADM4;ETS1
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.3800675632170857,-0.7496417441065072,0.8918918918918919,1.0,1.0,8/46,21.90%,AGT;PLSCR1;PDCD4;IFI35;RIPK1;NINJ1;NLRP12;NPAS2
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.32703269637183424,0.7496408936485313,0.9333333333333333,1.0,1.0,3/29,4.27%,HSPA1A;ZFP36L1;LYN
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),0.4589842614026013,0.749515408366421,0.8571428571428571,1.0,1.0,1/5,2.95%,GSTP1
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.39040215637951375,-0.7494157513493,0.9036144578313253,1.0,1.0,4/34,12.64%,SLC39A14;CP;ATP6V1E2;DNM2
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.4355298173203672,-0.7494089402940464,0.8157894736842105,1.0,1.0,2/10,18.04%,APOE;ABCA8
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.28725027467505326,0.7490697514268004,0.8461538461538461,1.0,1.0,6/53,10.41%,GPX1;SPCS2;GSTP1;SEC11C;HM13;SEC11A
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),-0.5019448436960676,-0.7490272653880357,0.7971014492753623,1.0,1.0,2/5,20.25%,DOCK5;CHRM3
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),-0.4330628186347867,-0.7488277570409129,0.8648648648648649,1.0,1.0,2/12,13.20%,PTPRC;RASGRP1
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),-0.3914237474852902,-0.7488097610019763,0.863013698630137,1.0,1.0,6/23,18.40%,SOX9;FGF9;LRP2;ADAM21;KITLG;TGFB2
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.3049697083593707,0.7487841110758086,0.8695652173913043,1.0,1.0,1/27,0.65%,RFWD3
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),0.4585110257511934,0.7486478479523335,0.7741935483870968,1.0,1.0,3/6,15.26%,NTNG2;NTN4;LAMB4
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.3563107067866243,-0.7486104084984253,0.8645833333333334,1.0,1.0,7/51,14.73%,PIGH;ZDHHC9;GLUL;PIGL;PIGC;MPPE1;ZDHHC14
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),-0.3859939311327967,-0.7485835477537242,0.898876404494382,1.0,1.0,2/28,4.66%,PRELP;CHAC2
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),-0.3901478399239298,-0.7480367279171756,0.825,1.0,1.0,3/24,14.05%,SEMA4B;LRTM1;EPHA7
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),-0.48543431271175397,-0.7479580394340174,0.7692307692307693,1.0,1.0,1/6,8.92%,LRP2
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.32825118065474257,0.7479205369043953,0.9444444444444444,1.0,1.0,6/24,15.86%,RNF6;MAP2;MT3;WWC2;WWC1;DCC
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.3589580845708628,-0.7479198787153715,0.8837209302325582,1.0,1.0,3/43,8.55%,EMP2;NEDD9;DOCK5
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.274879673576894,0.7476857808148286,0.9285714285714286,1.0,1.0,13/54,16.17%,GPC1;UBE2D1;GREM1;BMPER;BAMBI;SPRY1;SMURF2;SMAD9;CREB3L1;SMAD7;BMP2;CADM4;SPRY4
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.36235498376969694,-0.7476028138563064,0.9213483146067416,1.0,1.0,7/45,18.37%,OVOL2;AKR1C2;VEGFA;VIL1;AKT2;GSTK1;RHCG
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),-0.41319551856809156,-0.7466378804260955,0.8313253012048193,1.0,1.0,9/18,34.59%,SLC4A4;RHCG;SLC4A8;CAMK2D;SLC4A3;NEDD4L;KLHL3;SLC12A5;AP3D1
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.3093555334107409,0.7464825939041442,0.9545454545454546,1.0,1.0,5/24,13.87%,SMPD1;PPIA;CALM3;DUSP26;CALM1
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.2833949243988972,0.7457475382967904,1.0,1.0,1.0,13/97,11.78%,AMOTL2;ADCY6;MAGI1;SLITRK2;YAP1;TCEAL7;FRZB;THY1;EDIL3;SEMA3B;MEIS3;CSRNP3;INSC
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),-0.4862818189474368,-0.7457324119666114,0.8181818181818182,1.0,1.0,2/5,25.21%,STAT5A;RELN
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),-0.4320524403190841,-0.7456057591220498,0.8253968253968254,1.0,1.0,6/11,33.90%,RPTOR;FAM107A;PRKAA1;PRKAA2;KCNB1;ULK1
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),-0.47610723523541065,-0.7454621712066165,0.7681159420289855,1.0,1.0,1/5,8.92%,LRP2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),0.43403422655223417,0.7452237610722245,0.8055555555555556,1.0,1.0,1/5,4.64%,NLGN2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.36300565515406563,0.7446632944053896,0.9047619047619048,1.0,1.0,3/15,11.49%,MALT1;PDE4B;PNP
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.3360688589742704,-0.744542582335941,0.8823529411764706,1.0,1.0,15/116,12.90%,CD44;CRYM;HES1;FAM13C;GSTM5;PAMR1;TIMP3;AGT;COL5A1;LIFR;GLUL;APOE;VEGFA;GJA1;ADGRL2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.4412353979056003,-0.7443162531345071,0.8695652173913043,1.0,1.0,1/14,3.39%,IRF1
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.30427910109114614,0.7440585411261454,0.9285714285714286,1.0,1.0,5/39,6.52%,CUL7;CALR;CAPRIN1;S100A10;LIMS1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),-0.44423004451470127,-0.7439851838569606,0.75,1.0,1.0,2/10,8.87%,CCT6A;CCT8
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),-0.48856746229356174,-0.7438208833657504,0.8656716417910447,1.0,1.0,1/6,4.26%,CDKN2A
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.3690451016641057,-0.7437037700206923,0.8586956521739131,1.0,1.0,11/58,15.80%,MAGOHB;SLBP;POM121C;RFTN1;SIDT2;SRSF5;THOC5;POM121;CASC3;NCBP1;CDC40
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),-0.45007978733478937,-0.7436401894025589,0.8157894736842105,1.0,1.0,4/10,32.27%,MED1;APP;DMTN;FOXP1
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),-0.47755783733014456,-0.7434997656358846,0.864406779661017,1.0,1.0,1/7,3.06%,STEAP4
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),-0.47755783733014456,-0.7434997656358846,0.864406779661017,1.0,1.0,1/7,3.06%,STEAP4
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.2675517706360161,0.7434004889717474,1.0,1.0,1.0,8/56,13.16%,G0S2;ACHE;FABP5;LEPR;ESRRG;ZNF516;GNAS;PDGFC
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.4108348791424452,-0.7429868686992475,0.8870967741935484,1.0,1.0,1/14,8.23%,CAV3
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.28344159477333464,0.742937245600567,0.9411764705882353,1.0,1.0,9/60,13.87%,RFWD3;AEN;SMPD1;LIG4;CLK2;INTS7;GRB2;RAD1;SIRT1
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.29157011569891095,0.7428486296117273,1.0,1.0,1.0,8/58,10.14%,RFWD3;SFR1;UBE2N;SEM1;RAD51B;PARP1;EXD2;ZFYVE26
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),-0.4705883134979693,-0.7428458238444754,0.8142857142857143,1.0,1.0,1/7,14.09%,DPH6
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),-0.5093504706652856,-0.7427243148650792,0.855072463768116,1.0,1.0,3/5,47.31%,ITCH;OTUD4;TNIP1
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),0.4234561733797098,0.7426019071465716,0.7941176470588235,1.0,1.0,3/6,30.38%,ITM2C;BACE2;ITM2B
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.39240616810879553,-0.7425825037233172,0.868421052631579,1.0,1.0,6/24,14.55%,NR4A3;FGF9;TPM1;GJA1;MEF2D;PDCD4
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.38907931664844997,-0.7425424430285967,0.8205128205128205,1.0,1.0,3/25,13.67%,PTPRC;PLSCR1;CAMK1D
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.34431819296920396,0.7424574013137956,0.8,1.0,1.0,10/58,11.02%,ACTB;ACTG1;CHRNA7;SDK1;NLGN2;RAB39B;LIMS1;GRM5;NLGN3;SMAD3
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.3188075423928133,0.7422457605471257,0.7777777777777778,1.0,1.0,9/69,9.80%,GPNMB;PSMD8;PSMB4;ZFP36L1;PSMB6;CDKN2C;CDC73;PSMD10;PSME3
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),0.4490167803916036,0.7421767459729319,0.7142857142857143,1.0,1.0,4/5,35.20%,TDG;ALKBH1;ALKBH3;ALKBH2
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.30018264249606086,0.7417493917332162,1.0,1.0,1.0,11/78,8.29%,CLNK;EPHA5;PDGFRA;LYN;NGF;ROR2;BCAR1;EPHB3;PTPRF;TNK2;MTSS1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.29060494534629827,0.7412696216964919,0.9047619047619048,1.0,1.0,4/25,11.57%,GSTP1;PPIA;DUSP3;QARS1
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.32446264494095006,0.7410771475868122,0.9375,1.0,1.0,10/43,13.89%,LRRC8D;SLC25A24;ABCG2;SLC2A10;ABCC11;CA3;SLC25A4;SLC35B4;SLC2A8;SLCO3A1
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),-0.516832139873975,-0.7409157917647101,0.890625,1.0,1.0,1/5,10.17%,CFAP69
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.443345143391938,0.7408677249286024,0.75,1.0,1.0,6/6,55.68%,IWS1;TPR;SETD2;NSUN2;SUPT6H;AKAP8L
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.443345143391938,0.7408677249286024,0.75,1.0,1.0,6/6,55.68%,IWS1;TPR;SETD2;NSUN2;SUPT6H;AKAP8L
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.3696092340610434,-0.7408263769093599,0.9024390243902439,1.0,1.0,6/37,17.04%,LIMK1;TPM1;PAK1;VIL1;ITGB1BP1;PFN2
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.39387046213077614,0.7407856790137164,0.7777777777777778,1.0,1.0,4/9,20.05%,WNT3;WNT7B;LATS1;ERBB4
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),0.45768412107283996,0.7406602374623076,0.8108108108108109,1.0,1.0,1/5,3.55%,MSN
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),0.45768412107283996,0.7406602374623076,0.8108108108108109,1.0,1.0,1/5,3.55%,MSN
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.31119917266736186,0.7406003652177641,0.8333333333333334,1.0,1.0,2/26,6.33%,PML;PPP1R10
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),-0.43438245852723706,-0.7404892753457578,0.7794117647058824,1.0,1.0,6/11,35.55%,CBY1;SORT1;MEF2C;KDM6B;AKAP13;NRG1
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.46155720851378007,-0.7398787909279666,0.8450704225352113,1.0,1.0,1/7,14.99%,AKT2
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.34584922042962524,-0.7398265801993208,0.9213483146067416,1.0,1.0,18/106,21.13%,CD160;ANGPTL4;FGF1;EMP2;BRCA1;RHOJ;GLUL;VEGFA;NAXE;SULF1;CYP1B1;PRKD2;STAT1;TGFB2;CNMD;AGO1;NINJ1;DAB2IP
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),0.30991091177837005,0.739699929747294,1.0,1.0,1.0,5/42,8.71%,GSTP1;NFKBIL1;LYN;PDE4B;CDC73
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.3969346800534397,0.7396971551007736,0.7692307692307693,1.0,1.0,2/10,7.59%,ERN1;BOK
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),-0.4732748123811621,-0.7396357252670993,0.7878787878787878,1.0,1.0,2/7,21.76%,ATP2B3;SLC8B1
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.4164837436884226,0.7395545093590343,0.7941176470588235,1.0,1.0,1/6,2.75%,RIT2
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),0.3613612293320036,0.7394162600690467,0.75,1.0,1.0,3/12,16.02%,PDE4B;SRI;CBARP
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.3779143234087749,-0.7386754732183765,0.8255813953488372,1.0,1.0,4/32,12.16%,GRIN2A;NLRC4;DAPK1;USP50
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.40228980994409336,-0.7386373814384399,0.7974683544303798,1.0,1.0,3/19,12.03%,TTN;TPM1;KCNQ1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),-0.5042780748663102,-0.7385045382919714,0.84375,1.0,1.0,5/5,49.60%,MTMR4;MTMR9;MTMR2;MTMR3;MTMR1
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.2886408537114941,0.7384110251241663,1.0,1.0,1.0,16/80,14.75%,CFL1;CALR;MAP2K6;UBE2N;NGF;THEM4;DUSP3;EIF4E;YWHAB;RIT1;GRB2;PLCB1;RALB;ATF1;GRK2;HSP90B1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.2899251976602861,0.7381028896701575,1.0,1.0,1.0,14/57,14.44%,OSTC;UBE2J1;ALG2;ALG10;ALG1;DDOST;ALG8;ALG3;STT3A;MAGT1;FUT8;MOGS;UGGT1;ALG13
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),0.32317916637718375,0.7379596921787784,0.9047619047619048,1.0,1.0,4/33,7.16%,CFL1;MSN;PPIA;AIP
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.3305346535158356,-0.7379117985959808,0.9042553191489362,1.0,1.0,13/119,15.02%,SOX9;HES1;EFNA1;OVOL2;COL5A1;ZFPM1;RANBP3L;FOXO1;NBR1;ADGRV1;PDCD4;SUZ12;MEIS2
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.43165342101142534,-0.7370131899645007,0.8421052631578947,1.0,1.0,4/10,28.02%,TRIM5;GSN;MID2;CIITA
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),-0.49586944000572897,-0.7368569425614613,0.890625,1.0,1.0,1/6,11.17%,TAF1
prerank,MSigDB_Hallmark_2020__Pperoxisome,0.275786017304158,0.736818855020802,1.0,1.0,1.0,13/76,12.25%,IDH1;TSPO;CNBP;PRDX1;ECH1;PEX11A;CAT;PRDX5;ABCD2;ACOT8;NUDT19;SLC25A4;ERCC3
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.3701123089353894,-0.7366740954949125,0.85,1.0,1.0,8/26,25.21%,STX1B;TMEM25;RIMS1;SHANK3;DLG4;GRIN1;WNT7A;RELN
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.3974411548326066,-0.7364780928205096,0.875,1.0,1.0,2/20,9.40%,SOX9;RANBP3L
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),-0.4515713952789515,-0.7364630403130717,0.7534246575342466,1.0,1.0,2/9,8.87%,CCT6A;CCT8
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.40863674475646533,0.73644242177102,0.75,1.0,1.0,3/9,14.17%,TUBB2B;ZSWIM6;NRP1
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),-0.3127908110813351,-0.7358965068280181,0.9795918367346939,1.0,1.0,58/312,27.36%,ABLIM1;FHDC1;FAM161A;TMOD3;MAK;RAB17;VPS37C;INTU;RAB11A;CFAP221;INPP5E;ATG14;CCDC57;RPGR;AHI1;GOLGA8B;RILPL1;SH3PXD2B;CFAP52;CHMP4B;CFAP70;AVIL;CSNK1D;B9D1;PGM5;CENPC;HAUS5;NEK6;ATG16L2;DNAH5;HDAC6;DHX37;ATG7;GOLGA8M;RB1CC1;VPS37A;RAB8B;RUFY4;CC2D2A;EXOC3;TRAPPC14;CFAP43;IFT52;HYLS1;NCOR1;TCTN1;WDR19;DYNC2I1;CHMP6;EIF2A;TUBGCP3;RAB11FIP3;ARL13B;TUBGCP2;GSN;BBS7;WDR11;LMOD1
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.3676398216581388,-0.7357421502833477,0.8947368421052632,1.0,1.0,8/32,22.45%,APIP;B2M;RYR3;SHMT1;ACACB;HCN1;AQP4;CBY1
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.4466614627971546,-0.7354937831695414,0.8,1.0,1.0,1/10,14.04%,BEGAIN
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),0.4057357784908216,0.7353590449772468,0.9130434782608695,1.0,1.0,1/9,6.14%,MAP1LC3A
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),0.4057357784908216,0.7353590449772468,0.9130434782608695,1.0,1.0,1/9,6.14%,MAP1LC3A
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),-0.4294478785415419,-0.7349884177697025,0.821917808219178,1.0,1.0,1/9,21.44%,NUP107
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),-0.3320545709572394,-0.7349724830949921,0.978494623655914,1.0,1.0,18/108,24.26%,FGF1;FGF9;NRG4;P2RY12;AKR1C2;LRP2;ITGB1BP1;AKT2;NTRK3;MYORG;KITLG;PTPRJ;ARRB2;IGF1R;TGFB1;PDGFRB;PIK3CB;TPTE2
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),-0.36213489618833555,-0.7349444490550356,0.8148148148148148,1.0,1.0,6/29,21.13%,AGT;APOE;BAG5;RDX;GFAP;DAB2IP
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),-0.3846153287886704,-0.7349301942795042,0.8441558441558441,1.0,1.0,7/26,20.25%,YWHAH;CAV3;AHCYL1;PDZK1;WWP2;RIPK1;CHRM3
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.42070605194964183,-0.7346537627376355,0.8507462686567164,1.0,1.0,2/12,18.21%,RNF157;MRAP
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.2883023835144839,0.7345077920138023,1.0,1.0,1.0,10/117,6.73%,UBB;ACTB;SLITRK2;FLRT3;BTBD3;MAP2;ARC;NGF;S100B;EPHB3
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),-0.5036492610579166,-0.7344331047127506,0.8360655737704918,1.0,1.0,1/5,28.83%,VPS13C
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),0.4580805302439794,0.7342170815769988,0.7380952380952381,1.0,1.0,1/5,5.33%,CDO1
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.4026490733454169,-0.7340871174081283,0.8875,1.0,1.0,4/22,17.33%,CLDN18;MICALL2;TBCD;PAK2
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),-0.4724663017218336,-0.7340621408167399,0.8,1.0,1.0,1/6,13.73%,TACC3
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),-0.4724663017218336,-0.7340621408167399,0.8,1.0,1.0,1/6,13.73%,TACC3
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.31890165883068156,-0.7340218718631052,0.9787234042553191,1.0,1.0,34/141,29.38%,TMSB4X;ITPR1;OTUD7B;BCL2L2;SPI1;CAV3;RNF157;TSC1;NR1D1;CIT;IFI35;STAT1;PER1;PTPRJ;ARRB2;RIPK1;NLRP12;DAB2IP;RFFL;USP10;PIK3CB;ARHGAP12;DGKG;PDE10A;HDAC7;PRKAA1;DUSP1;PRKAA2;NOP53;PHLPP2;STAMBP;DDIT4;PPP2R5C;CYLD
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.4595954090607345,-0.7338684417336613,0.8311688311688312,1.0,1.0,1/8,9.17%,TRIM41
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),-0.43970314002503863,-0.7335388379263658,0.84,1.0,1.0,1/11,9.95%,GRAMD1C
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),-0.49378861318905937,-0.7335381443148034,0.8571428571428571,1.0,1.0,3/6,40.37%,ZNF445;UHRF1;HELLS
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.39972775471267963,-0.7334071469086566,0.8831168831168831,1.0,1.0,3/26,10.00%,PTPRC;DOCK8;IL7
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.37914845232887673,0.7332413058784312,0.7741935483870968,1.0,1.0,1/8,6.36%,STPG1
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),-0.4661345609239419,-0.7332387218937015,0.8,1.0,1.0,1/8,14.52%,SLC24A2
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),-0.4661345609239419,-0.7332387218937015,0.8,1.0,1.0,1/8,14.52%,SLC24A2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.347378222682079,0.7331881298853676,0.9565217391304348,1.0,1.0,2/23,2.59%,MMP2;ERN1
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.343421564964801,-0.7329598323958884,0.9230769230769231,1.0,1.0,12/58,18.38%,SOX9;VCL;MTHFD1;AKR1C2;VEGFA;VIL1;AHI1;LOXL3;PPP2R3A;GSTK1;RHCG;STAT1
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.3081766788108317,-0.7328530939335479,0.979381443298969,1.0,1.0,19/217,12.86%,CD44;SOX9;ANGPTL4;CARD14;APIP;TMEM14A;BCL2L2;CD27;LRP2;HMGN5;IL7;VEGFA;PLK2;RNF157;AHI1;FOXO1;FANK1;RASA1;HTR2B
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.27423377167675095,0.7326060432903881,1.0,1.0,1.0,14/109,12.13%,ODC1;DHCR7;PSMD8;PSMB4;TM7SF2;PSMB6;SP1;SQLE;LDLR;PSMD10;PSME3;NFYA;HMGCS1;HMGCR
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),-0.42697339676272594,-0.7321941087918495,0.8333333333333334,1.0,1.0,5/10,34.57%,PEX5L;PEX14;PEX1;PEX16;PEX6
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),0.3998575005144117,0.7321141978174303,0.7428571428571429,1.0,1.0,1/5,13.77%,ATP5F1D
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.4234060122768786,-0.7319984578576205,0.8414634146341463,1.0,1.0,3/14,28.93%,TUBD1;EVC;TXNDC15
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.48081277941618583,-0.7319965955171404,0.8181818181818182,1.0,1.0,5/6,46.92%,NUP107;LDB1;PCID2;NUP133;NUP155
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),-0.49878119678059074,-0.7314815428080588,0.8493150684931506,1.0,1.0,2/5,43.06%,RPS6KA5;CDK9
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.2896900862503927,0.7310815408647918,1.0,1.0,1.0,9/64,12.69%,ACTB;SLITRK2;BTBD3;MAP2;S100B;NTNG2;SDC2;MAP1S;TMEM106B
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),-0.4465642395549897,-0.7309479846128522,0.8382352941176471,1.0,1.0,1/9,19.14%,RPTOR
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.33253402672679067,-0.730911368451044,0.9438202247191011,1.0,1.0,12/124,11.47%,CYP2E1;SLC6A6;HSD11B1;TPST1;NMT1;FMO3;MTHFD1;AKR1C2;MAN1A1;APOE;PTGR1;TMEM97
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.3548608754937115,0.7308700858231219,0.8076923076923077,1.0,1.0,4/13,19.14%,RBPJ;CDH13;PTPN12;RHBDF2
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.4752752036076402,-0.7304841287460758,0.8181818181818182,1.0,1.0,3/6,19.57%,RFTN1;OAS1;RIPK1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.4622379953261224,-0.7301730668289134,0.8493150684931506,1.0,1.0,6/12,33.79%,UCK1;TK2;TYMP;PUDP;CAD;UCKL1
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.30451495108126564,0.7298778965408729,1.0,1.0,1.0,6/56,6.82%,SOX11;ASCL1;CALR;NGF;BRINP1;MOSMO
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.43796656827023045,0.7293043592083447,0.78125,1.0,1.0,4/6,25.89%,NBDY;CNOT6;CNOT1;CNOT6L
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.2829586515253126,0.7292286740450667,1.0,1.0,1.0,29/245,11.66%,COPZ1;SYNDIG1;BICD2;FBLN5;ARL4A;EVI5L;AMOT;TMED2;NPM1;ARFIP1;CTSA;RRAGA;VPS26B;TMED5;RAB5B;RAP2A;COG3;SEPTIN3;TBC1D25;STX6;RAB1B;LAMTOR2;EPB41L3;SEPTIN11;RAB6A;AP4M1;SNX17;RABL3;TMED3
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),0.39238797907897144,0.7291984321991651,0.7567567567567568,1.0,1.0,3/9,20.35%,SLC25A33;VCP;PINK1
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),-0.41307360163329276,-0.7291047553796676,0.8181818181818182,1.0,1.0,3/16,20.44%,SLC4A4;KCNQ1;ATP1B1
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),-0.40447346398761663,-0.7289906106304311,0.7866666666666666,1.0,1.0,2/19,5.96%,SLC6A6;MGST1
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),0.32129742281855866,0.7288886716515063,0.95,1.0,1.0,4/35,7.16%,CFL1;MSN;PPIA;AIP
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.4134680216725193,0.728363928281377,0.8148148148148148,1.0,1.0,2/9,7.95%,ZFP36L1;NR3C1
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),0.3022172920805735,0.7282614148502303,0.9615384615384616,1.0,1.0,8/33,12.33%,SIRT2;LDLR;SNX12;EDNRB;PFDN1;VBP1;HMGCR;MAD2L2
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.39595546097748613,-0.7276707360193855,0.8734177215189873,1.0,1.0,4/24,14.91%,PLK2;XRCC3;CENATAC;CHMP4B
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),-0.39802383418505904,-0.7274996696093793,0.868421052631579,1.0,1.0,1/23,0.68%,SOX9
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.4627206574989565,0.7274603406016787,0.7058823529411765,1.0,1.0,2/5,25.30%,DNAJA1;LRRK2
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,0.2641463278050965,0.7271665473821671,0.9473684210526315,1.0,1.0,12/66,16.63%,IDH1;RBP1;PEX11A;CAT;PRDX5;ABCD2;PEX13;ABCA6;PFKM;ABCA3;CROT;FADS1
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.3512105341248957,-0.7270878246208591,0.8795180722891566,1.0,1.0,6/37,19.59%,NEDD9;EFNA5;DOCK5;ITGB1BP1;PDPN;RAC3
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.33054459102708283,-0.7268114557845987,0.8913043478260869,1.0,1.0,15/100,22.53%,TUBA4A;CDK7;TPD52L1;BORA;CEP135;CCDC57;DNM2;LCMT1;CSNK1D;MASTL;HAUS5;CDKN2B;DCTN1;FBXL17;CEP72
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.37200802786119885,-0.7267141224412338,0.8795180722891566,1.0,1.0,2/24,8.67%,ART4;GLUL
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),-0.3786635317432782,-0.7266989387403494,0.8205128205128205,1.0,1.0,4/21,15.74%,VCL;EFNA5;MACF1;DAPK3
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.3584317997415165,-0.726636816357669,0.8554216867469879,1.0,1.0,6/26,18.40%,SOX9;FGF9;LRP2;ADAM21;KITLG;TGFB2
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,0.29616120801977924,0.7264845054931628,1.0,1.0,1.0,42/161,15.50%,DHCR7;IDH1;TUBG1;CALR;DHFR;CTSC;TM7SF2;PRDX1;MCM4;ATP5MC1;PSPH;NFIL3;TCEA1;PPIA;NUFIP1;SQLE;CANX;LDLR;ACLY;TXNRD1;PSAT1;STARD4;MTHFD2L;PSME3;SEC11A;PSMG1;STIP1;HSPA4;PNP;HMGCS1;HMGCR;RIT1;VLDLR;PSMD12;TPI1;HSP90B1;HSPA5;GAPDH;INSIG1;CYB5B;EDEM1;SSR1
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),-0.38197248585735827,-0.7264132533851813,0.8533333333333334,1.0,1.0,5/29,14.32%,CYP2E1;ALOX12;LPCAT3;CYP3A5;EPHX2
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),-0.37859868408630504,-0.7260602210636036,0.9176470588235294,1.0,1.0,4/26,5.10%,NEDD9;EFNA1;PTPRC;AGT
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.4005580928271319,-0.7259076736068664,0.8441558441558441,1.0,1.0,3/11,20.64%,BRCA1;CTBP1;AASS
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),-0.3995477203116823,-0.7258470453414257,0.8533333333333334,1.0,1.0,5/18,17.09%,CDKN2A;BAZ2A;POLE3;EZH1;NRDE2
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.35470461732416325,0.7255348101322802,0.9,1.0,1.0,2/15,6.73%,ARC;EPHB3
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),0.40414788890263387,0.7254306646472669,0.7333333333333333,1.0,1.0,3/8,18.48%,AGA;NGLY1;MAN2B1
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.2955872021307756,0.7254155251793257,0.9166666666666666,1.0,1.0,9/59,10.81%,GSTP1;NFKBIL1;HNRNPA0;PDE4B;SRR;PELI1;CDC73;SCARB1;PRDX3
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),-0.4148920731236557,-0.7252437261345336,0.8289473684210527,1.0,1.0,5/16,29.70%,IL7;TCF7;XBP1;FANCA;SPINK5
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),-0.4959956097962235,-0.7251902038761615,0.8309859154929577,1.0,1.0,1/5,4.67%,PARP14
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),-0.4959956097962235,-0.7251902038761615,0.8309859154929577,1.0,1.0,1/5,4.67%,PARP14
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),-0.3678214758860748,-0.7251625304784052,0.875,1.0,1.0,4/26,17.03%,NUAK1;PTPA;TSC1;MASTL
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.3505457051111578,0.7249016429302955,0.88,1.0,1.0,3/21,13.95%,KDM3B;RIOX2;KDM5C
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.46728634810503633,-0.7244951711203376,0.7962962962962963,1.0,1.0,2/5,39.17%,YTHDC2;NUCKS1
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,-0.3314075061612637,-0.7244057565744684,0.9560439560439561,1.0,1.0,7/87,9.42%,SOX9;HES1;SNCB;KCNC1;MMD2;CACNA1B;SULT4A1
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),-0.5017035911364063,-0.7241979011812715,0.8125,1.0,1.0,1/5,23.18%,RNF20
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),0.38629493996186404,0.724139009404182,0.8333333333333334,1.0,1.0,1/7,3.84%,DYNLT1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.4432707445153554,-0.7240921698332274,0.8513513513513513,1.0,1.0,1/11,7.84%,CEMIP
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),-0.4496004953165566,-0.7238894348026863,0.9166666666666666,1.0,1.0,1/7,20.09%,ADAM9
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.366134419834781,-0.7238643062046461,0.8780487804878049,1.0,1.0,5/29,18.84%,EMP2;TSC1;ECM2;TBCD;PDPN
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.3279309117570749,-0.7238568666410091,0.9583333333333334,1.0,1.0,25/120,22.04%,CD44;MMP19;TNC;COL10A1;COL5A1;LAMA2;MMP21;ITGA2;ADAMTS13;SPP1;ADAMTS16;ADAMTS9;ITGA9;ECM2;THSD4;ITGA8;COL5A3;ADAMTS10;DDR2;ACAN;COL15A1;MMP24;ADAMTS7;GFOD2;COL4A5
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.288734797447994,0.7236611999830924,1.0,1.0,1.0,19/90,15.11%,RND2;CFL1;RHOBTB1;FGD3;RHOC;WTIP;ARC;THY1;MICAL1;EPB41L3;WASF3;LIMD1;SH3D19;PAK5;PALLD;RHOG;CAPZB;RHOA;CSPG5
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),-0.3809313091790154,-0.7234432524432823,0.8714285714285714,1.0,1.0,6/23,18.40%,SOX9;FGF9;LRP2;ADAM21;KITLG;TGFB2
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),-0.42538951995834606,-0.723389474689793,0.8533333333333334,1.0,1.0,2/11,16.49%,PUS7;GAR1
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),0.4641878755969192,0.72332217013432,0.8064516129032258,1.0,1.0,1/5,3.55%,MSN
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.3380812033942408,-0.723316395150951,0.9069767441860465,1.0,1.0,7/53,16.99%,SOX9;RARA;TRIB1;SPP1;FOXO1;STAT3;STAT5B
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),0.4895114115288884,0.7232219253041302,0.8,1.0,1.0,1/5,2.59%,CALR
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",-0.3682871889969998,-0.7231060101504485,0.9166666666666666,1.0,1.0,3/47,9.46%,SOX9;CDKN2A;RUNX2
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),-0.4361899940810412,-0.7230601928153515,0.7910447761194029,1.0,1.0,2/8,10.23%,MTHFD1;SHMT1
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.36232770140483234,-0.7230061563048366,0.8765432098765432,1.0,1.0,7/38,22.61%,MGST1;GLRX;PTPA;PFKP;GCLC;JUNB;ATOX1
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.3623575624615641,-0.7226992771965054,0.872093023255814,1.0,1.0,7/31,25.77%,ZFPM1;VEGFA;RPS14;UBA5;ACIN1;TGFBR3;MED1
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.3412546174360096,-0.7226729016891417,0.9101123595505618,1.0,1.0,9/85,12.80%,SLC38A4;SLC22A4;SLC6A6;SLC6A15;SLC3A1;SLC7A6;LRP2;SLC25A45;SLC1A4
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),0.37354738108062946,0.7225441603986043,0.9090909090909091,1.0,1.0,2/13,3.01%,SIRT2;PPT1
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.3366090069453621,-0.722430557219065,0.898876404494382,1.0,1.0,9/52,19.51%,APOE;VEGFA;FUT2;HTR2B;SULF1;STAT5A;PRKD2;STAT1;CNMD
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.3759610745584227,-0.7223018265239068,0.8987341772151899,1.0,1.0,4/23,22.75%,TSC1;CLEC16A;CHMP4B;USP36
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),0.44434892333898673,0.721639772850466,0.75,1.0,1.0,1/5,9.08%,MT3
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.3448266715560434,0.7213911335592328,0.8076923076923077,1.0,1.0,1/17,1.24%,GPX1
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),-0.3720653384842552,-0.7211947319349379,0.8205128205128205,1.0,1.0,2/24,14.64%,PPIE;IFIT1
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),0.42374728504204934,0.7211748016118198,0.7222222222222222,1.0,1.0,1/6,5.39%,PIH1D1
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.4707778558487973,-0.7210412597026941,0.868421052631579,1.0,1.0,1/7,5.31%,FPR3
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.3225573198523057,0.7208421154980514,0.9444444444444444,1.0,1.0,2/22,4.06%,DYNLT1;KIF25
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),-0.4010383713739176,-0.7205767073559257,0.8714285714285714,1.0,1.0,3/15,15.82%,YWHAH;CAV3;SNTA1
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.48207788243014615,-0.7200896336944104,0.8142857142857143,1.0,1.0,2/5,26.95%,MMP24;PLEKHA7
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),0.3045520535930807,0.7199149134840146,0.9230769230769231,1.0,1.0,7/28,15.20%,MAP2;RNF139;GAS1;LAMP1;WWC1;AAAS;NUP214
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.30663830043339474,0.7196044646797103,0.8709677419354839,1.0,1.0,6/20,17.87%,CXCL12;ARHGAP18;BRK1;COTL1;DBNL;LATS1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),-0.43307334133126063,-0.7195739346079967,0.8607594936708861,1.0,1.0,3/12,24.83%,SAE1;ATG7;UBA5
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.39134491821895734,-0.7192489926433813,0.8481012658227848,1.0,1.0,1/20,1.06%,STMN2
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.36803911414117185,0.7191421908282044,0.8888888888888888,1.0,1.0,2/13,9.27%,CHRNA7;ABCD2
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.28726794815482726,0.719128650188371,1.0,1.0,1.0,11/87,10.83%,U2AF1;NUP42;RBM15B;CPSF1;CPSF4;NXF1;AGFG1;EIF4A3;EIF4E;RBM8A;POLDIP3
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),0.38985090593033367,0.7190501725909977,0.8285714285714286,1.0,1.0,8/8,61.04%,AGRN;PICK1;KCNIP2;MTCH1;CNTNAP2;CNTN2;NRCAM;SPTBN4
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),-0.46265013482664574,-0.7190501096915058,0.8214285714285714,1.0,1.0,1/5,8.67%,GLUL
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.3571264392452561,-0.7190254819468092,0.8658536585365854,1.0,1.0,7/40,21.10%,AGT;OSMR;PDCD4;IFI35;RIPK1;NINJ1;NLRP12
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.37385012084116986,-0.7190072160941016,0.8717948717948718,1.0,1.0,2/26,8.01%,TSPYL2;GRK4
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.29550877524553304,0.7187823520569125,1.0,1.0,1.0,8/35,16.14%,FNBP1L;FXR2;SRGAP2C;ARAP1;CAPZB;NRP1;MYO10;CDC42
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.2942383632690657,0.7186655578837828,1.0,1.0,1.0,16/92,10.79%,CUBN;FNBP1L;HSPG2;CALR;COLEC12;PPT1;STAB2;CALCRL;AP4E1;MICALL1;CANX;LDLR;CLTB;LRP3;NLGN3;SCARB1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.33387581285429235,0.7184741637256844,0.7333333333333333,1.0,1.0,3/23,2.95%,DHRS4;TGFBR2;GSTP1
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),-0.46220981802479044,-0.7184419293684705,0.8591549295774648,1.0,1.0,5/8,29.60%,P4HA3;P4HTM;EGLN3;OGFOD1;CRTAP
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.3067151491419838,0.7183819336245649,0.9565217391304348,1.0,1.0,3/17,19.21%,PML;FIS1;HERPUD1
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,-0.3783007878328944,-0.7179537640535941,0.8860759493670886,1.0,1.0,3/28,13.28%,HEY2;DVL2;TCF7
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.3673416496557109,0.717658185394113,0.8888888888888888,1.0,1.0,5/12,26.10%,ABCG2;SLC1A2;SLC1A3;CXADR;GPLD1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),-0.47873748787162795,-0.7175810624049026,0.8285714285714286,1.0,1.0,2/6,21.08%,TGFB2;SMAD4
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.31091460784591457,0.7174307205229142,1.0,1.0,1.0,8/73,2.47%,AMOTL2;BTC;ADCY6;HSPG2;LAMA3;YAP1;COL12A1;GPC1
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),0.4178063388383513,0.7173604918226016,0.8461538461538461,1.0,1.0,3/5,14.17%,PLEKHG5;NR4A1;NRP1
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),-0.3856402213496729,-0.7173084348496342,0.8947368421052632,1.0,1.0,2/21,13.36%,HHIP;TULP3
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.31599514369970105,0.7169551705670035,0.92,1.0,1.0,2/19,8.86%,YAP1;LIG4
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),0.3935872973682746,0.7169045323903963,0.8787878787878788,1.0,1.0,2/5,12.82%,MGLL;ABHD2
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),-0.37872695139582185,-0.7164414316827857,0.9295774647887324,1.0,1.0,5/21,27.97%,APOE;SORBS1;TGFB1;GRIN1;ADGRB1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),-0.4271850124260463,-0.7164043022533907,0.8088235294117647,1.0,1.0,1/10,0.68%,SOX9
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.38399758822589136,-0.7162149021165882,0.8513513513513513,1.0,1.0,2/17,10.87%,PPIE;FKBP5
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.4291117647517247,-0.7158227090881443,0.8285714285714286,1.0,1.0,4/13,28.63%,CACNA1C;RYR2;CAMK2D;GSTO1
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.318463995717834,0.7155416682861815,0.7647058823529411,1.0,1.0,8/41,10.75%,ARV1;FNBP1L;SMPD1;MICALL1;MYOF;ABCD2;EPB41L3;MYH9
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.3013351679670968,0.7155288471091175,0.9,1.0,1.0,2/32,5.92%,PMEPA1;PPM1A
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),-0.413537311319393,-0.7154922734272847,0.84,1.0,1.0,3/11,25.66%,CHMP4B;MITD1;CHMP6
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),-0.3433859335563637,-0.715064393643449,0.8977272727272727,1.0,1.0,3/50,5.39%,ANGPTL4;FGF1;BRCA1
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.41711329345028636,0.7150609226461404,0.9090909090909091,1.0,1.0,2/7,14.03%,ARC;GRID2
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),-0.38461020155374115,-0.7149498458737317,0.88,1.0,1.0,1/16,5.10%,AGT
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.4998492459020858,-0.7149095760815554,0.8636363636363636,1.0,1.0,2/5,23.03%,DDRGK1;BFAR
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.373475316850518,-0.7148782959978047,0.8777777777777778,1.0,1.0,7/28,18.03%,SLC6A11;NCOA1;SLC51A;ATP8B1;SLC16A3;ABCC3;SLC16A4
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),-0.385531052834414,-0.7143194396358702,0.8648648648648649,1.0,1.0,2/18,9.56%,FOS;BAZ2A
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.409052129126504,-0.7138714028516248,0.9078947368421053,1.0,1.0,2/15,9.30%,LAS1L;WDR12
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),-0.4227912338281699,-0.7137151776862463,0.881578947368421,1.0,1.0,5/11,35.24%,AKT2;NNMT;PPARGC1A;IRS2;PTPN2
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.29808932691627155,0.7135138497039105,0.9444444444444444,1.0,1.0,8/50,10.99%,UBE2D4;RNF6;KBTBD6;UBE2D1;KBTBD7;PELI1;UBE2Q2;UBE2G1
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),-0.3468707309824042,-0.7133153846849789,0.8928571428571429,1.0,1.0,1/44,1.05%,PIP4K2C
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.391825512096901,-0.7132768206608435,0.8552631578947368,1.0,1.0,1/16,4.01%,SRF
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.36936043381360706,0.7131412987301656,0.8125,1.0,1.0,1/9,4.64%,NLGN2
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.3417523527357389,-0.7130946011107849,0.9222222222222223,1.0,1.0,8/57,18.47%,STMN2;CAV3;APOE;TBCD;CRYAB;PFN2;PFDN6;SHANK3
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.34479639027433084,0.7129248885951739,0.875,1.0,1.0,2/16,4.05%,ARV1;ACADVL
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),-0.33614190966737756,-0.7129076806149537,0.9148936170212766,1.0,1.0,5/64,14.51%,B3GNT5;GALNTL6;GCNT1;GALNT15;ST3GAL1
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.38923121620152734,-0.7126263109480214,0.8333333333333334,1.0,1.0,7/20,30.29%,BMP8A;TGFB2;SMAD4;TGFB1;GDF11;RBPMS;ENG
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.34882503809619536,0.7124555205661892,0.88,1.0,1.0,4/23,9.98%,CTSC;RNF139;BAG2;TMTC3
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.32313672835038754,0.7124299016656893,0.88,1.0,1.0,5/19,11.41%,HSD17B10;SLC25A44;DLD;ALDH6A1;ACAD8
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.32313672835038754,0.7124299016656893,0.88,1.0,1.0,5/19,11.41%,HSD17B10;SLC25A44;DLD;ALDH6A1;ACAD8
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.3213091391296609,0.7116274464063793,0.8888888888888888,1.0,1.0,9/26,17.52%,CPSF1;CPSF4;LSM11;CSTF2T;SNRPF;SNRPB;NUDT21;SNRPE;PAPOLA
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),0.42085061384844574,0.7113586481405703,0.9047619047619048,1.0,1.0,1/10,4.44%,UBE2N
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.3151754118012128,0.711341405355785,0.8947368421052632,1.0,1.0,2/21,2.59%,IL15;CALR
prerank,MSigDB_Hallmark_2020__Notch Signaling,-0.37431928102789735,-0.7111570953179642,0.8765432098765432,1.0,1.0,3/24,13.95%,HES1;LFNG;ARRB1
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.39827937857741785,-0.7110031569761313,0.9,1.0,1.0,3/17,26.83%,LCMT1;NEK6;DUSP1
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),0.40320055302024604,0.7109828032866573,0.8076923076923077,1.0,1.0,1/9,3.98%,RHOC
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.3270846428909976,-0.7108457267607765,0.9545454545454546,1.0,1.0,14/92,17.40%,AHR;NR4A3;BRCA1;P2RY12;GABRG2;RYR3;TAF1;SPP1;KCNQ1;HCN3;CYP1B1;ADCY1;ADCY5;CTNNA1
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.37086314100421214,0.7102710989503095,0.8857142857142857,1.0,1.0,8/8,62.93%,ARID1A;SERTAD2;PADI2;ZMIZ1;ARID1B;ELOF1;SMARCD1;ZMIZ2
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),-0.45278952030893593,-0.7102668976769438,0.825,1.0,1.0,1/6,2.65%,ARX
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),0.35607057287726185,0.7100055057828141,0.7647058823529411,1.0,1.0,2/13,8.50%,STAB2;PPP1R11
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.44405080213903736,0.7099534404555929,0.7878787878787878,1.0,1.0,5/5,55.61%,SH3GL2;TMEM108;WASF1;NTRK2;MAPT
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),0.2687438770276576,0.7098970882587303,1.0,1.0,1.0,15/112,10.06%,MALT1;PSMD8;PSMB4;IKBKB;PSMB6;UBE2N;ERMAP;BCAR1;THY1;PDE4B;PSMD10;RIPK2;PSME3;TNFRSF21;RC3H1
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.40454151958978046,-0.709805541174052,0.8589743589743589,1.0,1.0,3/13,21.28%,NEIL2;NTHL1;TERF2IP
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),-0.4037670129778625,-0.7097348025475937,0.8974358974358975,1.0,1.0,6/16,31.71%,MEIOC;CDYL;NECTIN2;SYCP3;YTHDC2;CEP57
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.4188582825542513,-0.7095061281104634,0.8285714285714286,1.0,1.0,3/11,16.42%,TTN;TPM1;MYOM2
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.31427682965575826,-0.7094863105220037,0.9896907216494846,1.0,1.0,29/249,19.97%,RFC4;GTPBP2;IGF2BP3;RPS6KB2;BRCA1;DONSON;RPL12;EEF2K;GCNT1;RFC2;BAZ2A;APOE;MMS19;RPA3;RPS14;CDC7;RPS8;RPL37A;POLE3;ORC2;EEFSEC;RPS27;ING5;WRN;ATM;MRPS18C;RPS6;RPS4X;HELB
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.22819764616960045,0.7093890844729652,1.0,1.0,1.0,46/318,14.15%,CFL1;FNBP1L;FGD3;HSD17B10;CUL7;TTC29;TMED2;PHB2;KIF25;WTIP;MCOLN1;TMED5;SURF4;ARC;THY1;MICAL1;PTCD2;PPIA;NDP;COG3;IRAG2;PEX11A;SNX11;CHMP2A;PARP1;LIG4;VAPB;ABCD2;MTX2;WASF3;LIMD1;GORASP2;PRDX3;LNPK;ESRRA;TMED3;SLC25A33;GOLGA8N;STX7;AUP1;SH3D19;SIRT4;PAK5;GABPA;PALLD;CAPZB
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.4419090160829494,-0.7093227040869311,0.8421052631578947,1.0,1.0,1/8,2.02%,EMP2
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),-0.4225685987824733,-0.7092698878085183,0.8354430379746836,1.0,1.0,5/12,35.74%,COQ6;COQ8B;COQ3;UBIAD1;PDSS1
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),-0.45004500773510236,-0.7091155673120451,0.8333333333333334,1.0,1.0,1/6,9.68%,CDC42EP3
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),-0.45004500773510236,-0.7091155673120451,0.8333333333333334,1.0,1.0,1/6,9.68%,CDC42EP3
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),-0.3852852162614378,-0.709048985332448,0.8860759493670886,1.0,1.0,2/26,4.66%,GSTM5;CHAC2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),-0.416502784388895,-0.7089395664046187,0.9285714285714286,1.0,1.0,1/9,8.23%,CAV3
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.31812255354254043,-0.7089070390586092,0.9666666666666667,1.0,1.0,14/103,19.57%,TMSB4X;CARD14;PSMB8;BRCA1;EDARADD;CD27;PSMA4;NR1D1;MAP3K14;STAT1;PSMA3;TRAF3;ST18;RIPK1
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.34498871316222884,-0.7088684182229466,0.9101123595505618,1.0,1.0,11/52,14.32%,SLC28A2;TREH;TMC4;ASPN;SLC51A;CDH19;DEGS2;PDZK1;VIL1;GULP1;EPHX2
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),-0.45625217356415615,-0.7087101346953318,0.8181818181818182,1.0,1.0,1/6,12.57%,TTLL4
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.42719737574924377,-0.7086832299941628,0.8840579710144928,1.0,1.0,2/11,20.40%,BTBD18;BRD4
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.33265534230813504,-0.7085894921947866,0.9072164948453608,1.0,1.0,9/81,20.71%,SEL1L2;FBXO6;USP13;MAN1A1;FAF2;DNAJC10;RNF175;UFD1;TRIM25
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),-0.3673769047189007,-0.7082033189769732,0.8953488372093024,1.0,1.0,4/31,12.02%,IQSEC2;GRIK5;CACNA1B;BDNF
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.33480321919200523,0.7080380577559313,0.9545454545454546,1.0,1.0,1/17,0.50%,SIRT2
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.43608200895906746,-0.7079199043918667,0.8450704225352113,1.0,1.0,3/8,26.17%,TGFB2;TGFB1;SEMA7A
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.35052717871766426,0.7072489080648962,0.8636363636363636,1.0,1.0,1/15,3.60%,TLR1
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.3094253567867781,-0.70689783714074,0.9887640449438202,1.0,1.0,15/110,17.75%,CD44;EMP2;OVOL2;TPD52L1;FOS;ITPK1;FKBP5;XRCC3;PDZK1;SLC1A4;PDCD4;TIAM1;OLFM1;CA2;JAK1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.35120282476761805,-0.706788686673854,0.9302325581395349,1.0,1.0,1/36,3.51%,AKAP5
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.40294400066277536,-0.7065998343433751,0.8378378378378378,1.0,1.0,1/16,3.16%,PTPRC
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.3271163508695605,0.7063592911622437,0.8461538461538461,1.0,1.0,6/24,17.47%,GREM1;ACER2;BOK;JMY;MYBBP1A;FHIT
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),0.33296858371632454,0.706346060831451,0.8636363636363636,1.0,1.0,5/17,15.38%,SPTLC1;ACER2;ACER3;CYB5R3;CYB5B
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),-0.4282836932216041,-0.7062794204434407,0.8289473684210527,1.0,1.0,2/9,16.68%,SLC29A2;SLC25A19
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),-0.4881039317741837,-0.7062487848975106,0.8787878787878788,1.0,1.0,1/5,9.85%,APOE
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),-0.4881039317741837,-0.7062487848975106,0.8787878787878788,1.0,1.0,1/5,9.85%,APOE
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),-0.4881039317741837,-0.7062487848975106,0.8787878787878788,1.0,1.0,1/5,9.85%,APOE
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.4479236315663375,-0.7060911406278727,0.9090909090909091,1.0,1.0,1/7,15.00%,ZIC1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.41746611718559656,-0.7054741147175916,0.8169014084507042,1.0,1.0,1/8,10.25%,HLA-F
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.35140899317943086,-0.7053602061780874,0.8947368421052632,1.0,1.0,4/26,16.09%,YWHAH;B2M;MAG;HOOK3
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.2822906603451232,0.7050619942526442,0.9230769230769231,1.0,1.0,6/52,8.07%,YAP1;TSPAN14;POFUT1;MAML2;RBPJ;ENHO
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),-0.3293426455317411,-0.7049471871027374,0.872093023255814,1.0,1.0,10/43,21.76%,G6PC2;PYGL;CAV3;OAS1;USF1;STAT3;PDK2;RPS6;IGF1R;SLC8B1
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.361193845745116,0.7049383033936024,0.8181818181818182,1.0,1.0,4/7,22.34%,PNP;NT5C1A;AMPD2;AMPD3
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.28956802219128036,-0.7049129916145371,1.0,1.0,1.0,92/576,22.26%,HEY2;SOX9;NLRC5;PLAG1;AHR;HES1;NR4A3;CAMK1;FGF1;MAFF;IRF1;CDK7;SRF;SPI1;BRCA1;SREBF1;ELK3;PLSCR1;FOS;ZFPM1;MAX;RARA;BCL9;KLF6;DVL2;ATAD2;STAT6;RUNX2;SS18L2;NCOA1;VEGFA;THRAP3;ARNT2;ETV4;CRLF3;MEF2D;AHI1;PTPRN;FOXO1;NR1D1;ITGB1BP1;ARRB1;KLF15;CREBRF;MEIS2;USF1;BTBD18;SSBP4;GABPB1;STAT3;MLIP;DBP;STAT5B;SMARCA1;PAXBP1;PRKD2;STAT1;TGFB2;MAML3;PER1;HDAC4;ZFHX3;ATM;CDKN2B;ST18;LHX4;ASXL2;RFXAP;RIPK1;AGO1;CEBPZ;MAP2K5;CDC5L;LMO2;IRF2;CSRNP2;BRD4;NFIC;DVL1;MED25;SMAD4;DAB2IP;TFDP1;DDRGK1;JUNB;MEN1;SLC30A9;TMF1;NPAS2;KMT2A;SIN3A;TGFB1
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.3381969354379177,-0.7047191363779234,0.9058823529411765,1.0,1.0,7/61,14.11%,RFC4;ATAD5;MSH6;ZGRF1;FANCI;CDC7;ERCC6L
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),-0.47564342688410355,-0.704659853563496,0.8805970149253731,1.0,1.0,1/5,1.60%,HES1
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.3445105352227916,-0.7042538785287235,0.9090909090909091,1.0,1.0,6/33,16.37%,MX1;PLSCR1;OAS1;IFIH1;IFIT1;RSAD2
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.3503705709668673,0.7039935741338543,0.9230769230769231,1.0,1.0,2/15,5.39%,RRAGA;PIH1D1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.38963531516616656,0.7037057932007965,0.8333333333333334,1.0,1.0,2/9,8.21%,GSKIP;ARL6IP5
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.4714051414067475,-0.7035283395964435,0.9253731343283582,1.0,1.0,3/6,27.22%,SEC14L1;UFD1;NPLOC4
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),-0.4577728179092161,-0.7033612839160649,0.8636363636363636,1.0,1.0,1/6,16.12%,GALM
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.3118272063587199,-0.7032787849934653,0.9438202247191011,1.0,1.0,15/96,15.34%,HEY2;ENPP4;SRPX;PROCR;SRPX2;TIMP3;COL5A1;FKBP9;SVEP1;EDNRA;NR1D1;SULF1;ITGA9;EPHX2;CYP1B1
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.43923811870358,0.702573955727134,0.8108108108108109,1.0,1.0,2/5,12.81%,RPS19;PTPRO
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),-0.4605814495070263,-0.7024596997302615,0.8387096774193549,1.0,1.0,1/6,10.26%,KLC1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),0.3604517491851963,0.7022647814445082,0.8235294117647058,1.0,1.0,2/16,5.39%,DNMT3B;PIH1D1
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),-0.39066927463053464,-0.7022235451719973,0.875,1.0,1.0,4/15,25.25%,SLC4A4;CA2;SLC4A8;SLC4A3
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.3827950272357592,-0.7020387760371466,0.8441558441558441,1.0,1.0,3/18,11.19%,CCT6A;CCT8;PARN
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.4068235974201426,-0.7015943150923619,0.8529411764705882,1.0,1.0,2/12,10.03%,CIAO2A;MMS19
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.33274968498353114,0.7014135167577391,0.7931034482758621,1.0,1.0,1/11,4.74%,MRPL44
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),-0.3372048693968592,-0.7013435114739319,0.8717948717948718,1.0,1.0,2/31,7.59%,SOX9;RARA
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.4166086108192719,0.7010872674236804,0.7027027027027027,1.0,1.0,4/6,22.31%,CPNE3;HDHD5;FAR1;CPNE1
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.44111424480786543,0.7010105288194984,0.8333333333333334,1.0,1.0,2/5,17.03%,SETMAR;SETD3
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.39070718669208093,-0.7008796536040567,0.8513513513513513,1.0,1.0,3/14,14.64%,RFTN1;IFIH1;IFIT1
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.38506425843141184,-0.7006819489445038,0.7945205479452054,1.0,1.0,1/15,2.83%,EFNA1
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.4320027297072032,-0.7006155048411166,0.9066666666666666,1.0,1.0,1/8,5.83%,DONSON
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.41343078268326094,-0.700525647111772,0.8666666666666667,1.0,1.0,2/16,10.90%,DDB2;DTX3L
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),-0.4250203945334605,-0.7004342105358478,0.88,1.0,1.0,1/10,14.99%,AKT2
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.3280507354922964,0.7004175405204857,0.9230769230769231,1.0,1.0,5/16,24.79%,LIG4;PIF1;SETMAR;CENPV;TERF2
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.3520274100549466,-0.7003425039582498,0.9285714285714286,1.0,1.0,8/42,21.13%,CD160;NAXE;SULF1;STAT1;TGFB2;CNMD;AGO1;DAB2IP
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.44156618857530494,-0.7003296595020427,0.8732394366197183,1.0,1.0,4/8,22.15%,ZFPM1;THOC5;KITLG;KMT2A
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),-0.2982684310448905,-0.7001502994462543,1.0,1.0,1.0,33/326,12.68%,HEY2;SOX9;AHR;HES1;PARP9;IRF1;YWHAH;AGT;BRCA1;FOS;MYRF;RARA;SEC14L2;KLF6;ATAD2;RUNX2;HMGN5;MAP3K12;APOE;MMS19;NCOA1;THRAP3;DNAJC2;DTX3L;SPP1;ARNT2;ESR2;CRLF3;TRIM44;FOXO1;NR1D1;DNM2;FANK1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.416563679806683,-0.7001449065083211,0.9538461538461539,1.0,1.0,2/10,17.57%,VEGFA;IL6R
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),-0.4423890231448913,-0.6989474039153265,0.859375,1.0,1.0,4/7,30.12%,VEGFA;PRKD2;PIK3CD;MYO1C
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.3386438142092055,-0.6988369879418167,0.9615384615384616,1.0,1.0,7/47,16.37%,MX1;PPIE;PLSCR1;OAS1;IFIH1;IFIT1;RSAD2
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.36583228161758524,-0.6988083682638818,0.9358974358974359,1.0,1.0,3/26,12.03%,KCNN3;KCNMB4;KCNQ1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),-0.36037897145922093,-0.6987240051009909,0.9620253164556962,1.0,1.0,4/28,10.52%,PTPRB;DUSP22;UBASH3B;DUSP8
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.3349668322421231,-0.698574220891068,0.9560439560439561,1.0,1.0,7/68,15.80%,SOX9;IHO1;RAB11A;BORA;PLK2;DAPK3;KIF20B
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.3164019105732081,-0.6983079700649362,0.9565217391304348,1.0,1.0,11/100,14.12%,CDH7;CLDN18;CDH12;PCDHB5;CDH9;CLDN12;ROBO2;CDH19;MAG;PVR;UNC5D
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.42174250451985085,-0.6980276862197933,0.8181818181818182,1.0,1.0,1/7,18.87%,HDAC6
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.26975259337093144,0.6980204857382775,1.0,1.0,1.0,12/54,16.10%,U2AF1;CPSF1;CPSF4;RPRD1B;EIF4A3;RBM8A;POLDIP3;CSTF2T;SRSF3;MAGOH;NUDT21;SRSF9
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.4121226551308159,0.6977621223051368,0.8214285714285714,1.0,1.0,2/7,8.73%,PDE3A;FGFBP3
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.3143281551722155,-0.6976234987900578,0.989010989010989,1.0,1.0,6/121,11.17%,RFC4;NUAK1;BRCA1;RFC2;RPA3;TAF1
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,-0.30784475235903164,-0.6975318675964524,0.956989247311828,1.0,1.0,16/114,15.40%,SOX9;ANGPTL4;HSD11B1;PSMB8;FGF9;ITGA2;TRIB1;AKAP12;SPP1;ETV4;GLRX;SNAP25;RBM4;AKT2;PTPRR;SPARCL1
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.3864941589487485,0.6975285421057841,0.84375,1.0,1.0,2/8,12.20%,SEMA5A;CFL2
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),-0.445978215774016,-0.6972980972868931,0.8787878787878788,1.0,1.0,5/8,43.06%,RNF20;ZC3H14;NELFE;CTR9;CDK9
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.36273736265111584,-0.6971367540255614,0.9024390243902439,1.0,1.0,9/24,18.38%,STAT2;CACNA1B;STAT4;STAT6;EIF2B4;STAT5A;STAT3;STAT5B;STAT1
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.3995815267344765,0.6971272712200807,0.8055555555555556,1.0,1.0,1/7,8.12%,SLC12A8
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.3995815267344765,0.6971272712200807,0.8055555555555556,1.0,1.0,1/7,8.12%,SLC12A8
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.4051482141060027,-0.6970933034592522,0.8571428571428571,1.0,1.0,2/12,10.88%,TTN;TPM1
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.4051482141060027,-0.6970933034592522,0.8571428571428571,1.0,1.0,2/12,10.88%,TTN;TPM1
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.2838769988257487,0.696920107374816,1.0,1.0,1.0,4/38,6.37%,SLC30A10;NR1H2;LYN;THY1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),-0.30624867075241186,-0.6966907348893754,0.967741935483871,1.0,1.0,24/181,19.16%,DEPP1;PIP4K2C;ITPR1;TPCN2;DRAM1;USP13;SREBF1;PLEKHF1;CISD2;ATP6V1E2;DAPK1;PLK2;FOXO1;HTR2B;WDR41;TRIM5;WDR6;DAPK3;STAT3;TPCN1;HDAC6;DNM1L;RPTOR;ATM
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.44881138688647404,-0.6966015405459515,0.8309859154929577,1.0,1.0,1/6,20.44%,ATP1B1
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),-0.47225209063922613,-0.6965022772163889,0.8235294117647058,1.0,1.0,1/5,8.97%,DAPK1
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.4753522038655319,-0.6963846160097451,0.90625,1.0,1.0,1/6,1.50%,AZIN2
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",0.3676334794743773,0.6959979606466015,0.84375,1.0,1.0,1/11,5.69%,CHAMP1
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.4137992847246851,-0.6957165066865185,0.85,1.0,1.0,3/11,16.32%,PAH;SLC9B2;SLC39A11
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.3159235914452366,0.6957093545193264,0.8888888888888888,1.0,1.0,7/41,11.37%,CCDC88C;LYN;PML;PPP1R16A;MT3;GRM5;RABL3
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.3881732884174415,-0.6953488300982912,0.8461538461538461,1.0,1.0,1/15,1.85%,MYLK
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),0.3949322951509662,0.6951068915943507,0.8421052631578947,1.0,1.0,1/8,5.69%,CHAMP1
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.2985575923293767,0.6950848309664367,0.9310344827586207,1.0,1.0,5/16,16.14%,RHOBTB1;MYH9;RHOG;ELMO1;CDC42
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.28275100463806313,0.6949845770117291,1.0,1.0,1.0,6/56,5.35%,PSMD8;CALR;PSMB4;IKBKB;PSMB6;ITGB5
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.3659137741279787,0.6944997211213838,0.896551724137931,1.0,1.0,3/10,12.60%,ALDH6A1;DPYSL4;DPYSL5
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.40056455118230144,-0.6944986987810481,0.835820895522388,1.0,1.0,1/9,8.23%,CAV3
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),-0.34095370500183836,-0.6944233258497559,0.9135802469135802,1.0,1.0,5/51,12.69%,IGF2BP2;IGF2BP3;MBNL3;OAS1;RASA1
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),0.4241997107108041,0.6940943450023956,0.75,1.0,1.0,1/5,2.16%,HSD17B10
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.41564142798024084,0.6940746449156273,0.8108108108108109,1.0,1.0,5/7,24.72%,ERCC4;PIF1;POT1;TP53;TERF1
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.3379779094088978,-0.6933676535103821,0.9036144578313253,1.0,1.0,5/40,14.00%,SLC29A2;LAS1L;TMEM97;RABEPK;CDK4
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,-0.3146866594368731,-0.6928909651650673,0.9655172413793104,1.0,1.0,12/99,13.65%,STMN2;FAM13C;ARX;AGT;SST;LIFR;PLCXD3;SHISA6;APOBEC2;SNAP25;ADGRL2;SYT4
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.35276030847003254,0.692780503371298,0.8461538461538461,1.0,1.0,1/10,3.57%,KCNN2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),-0.3428603954624803,-0.6926861020970673,0.9397590361445783,1.0,1.0,1/35,3.51%,AKAP5
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.25239340711674846,0.6925872554714971,1.0,1.0,1.0,24/189,10.28%,SOX4;TMEM9;PSMD8;GID8;CCDC88C;LGR5;GSKIP;PSMB4;KLHL12;SEMA5A;PSMB6;PRICKLE1;PPM1A;RUVBL2;FRZB;TLE4;GREM1;BAMBI;TRPM4;PSMD10;AMER2;PSME3;LIMD1;SMURF2
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.32162048829459167,0.69251276589014,0.8518518518518519,1.0,1.0,5/23,13.87%,DSCC1;NAA11;NAT10;NAT9;SIRT1
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.3684587999718373,0.69212851789372,0.8260869565217391,1.0,1.0,2/9,7.83%,PML;AFF2
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.2723970962519216,0.6919935445254846,0.8888888888888888,1.0,1.0,12/38,15.91%,NEU1;CTSA;SMPD1;SMPD3;NEU3;GBA3;ST6GALNAC3;ESYT2;UGT8;GM2A;GLTP;NEU4
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.25454564187442413,0.691914540337362,1.0,1.0,1.0,9/79,8.44%,ADCY6;GSTP1;VIPR2;LYN;CALCRL;RXFP1;RPS19;PRKAR2B;ENPP3
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.2845867924776293,0.6915618749203907,0.8636363636363636,1.0,1.0,10/23,22.01%,ERN1;GAS1;GAB1;NR4A1;NRP1;PRKD1;NOTCH1;HSPB1;NUS1;VEGFB
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),-0.33853859491850957,-0.6915583968610648,0.9156626506024096,1.0,1.0,7/36,18.40%,AGT;ROBO2;VEGFA;SULF1;IFT27;ITGA8;TGFB2
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.3495949716052512,-0.6915012697136746,0.8961038961038961,1.0,1.0,6/34,14.00%,SPI1;RARA;VEGFA;THOC5;SRP54;CDK4
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.3163589190647078,-0.6914140392629595,0.9764705882352941,1.0,1.0,7/55,20.77%,POLQ;BRCA1;RIF1;LIG3;XRCC4;ATM;POLM
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),0.4172546630738841,0.6911495820425888,0.8709677419354839,1.0,1.0,1/6,1.92%,IL15
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.3572240802857798,-0.6905772754878567,0.8928571428571429,1.0,1.0,2/26,4.92%,TRPC5;CP
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.29769451720630014,0.6899442858097262,0.9333333333333333,1.0,1.0,1/21,1.24%,GPX1
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.4017022184669873,-0.689939543826989,0.8625,1.0,1.0,1/15,2.02%,EMP2
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.34358395747318027,-0.6898643502089553,0.9166666666666666,1.0,1.0,13/40,24.00%,P2RY12;VEGFA;TPM1;ECM2;PRKD2;TGFB2;PTPRJ;ZFHX3;ATM;RAC3;ADAM9;EPHA4;STX4
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.2538965296591812,0.6897296645267947,1.0,1.0,1.0,8/71,9.80%,YAP1;PSMD8;PSMB4;PDGFRA;PSMB6;TCF12;PSMD10;PSME3
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),0.39268990386679814,0.6896665376098042,0.8076923076923077,1.0,1.0,2/8,20.03%,EXOSC8;XRN1
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.4014387370445527,-0.6896383172596957,0.855072463768116,1.0,1.0,2/9,21.16%,SVIP;USP14
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.3159430223779609,0.6896082710282995,0.9629629629629629,1.0,1.0,2/15,5.41%,TWF1;SVIL
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.3159430223779609,0.6896082710282995,0.9629629629629629,1.0,1.0,2/15,5.41%,TWF1;SVIL
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),-0.42263053941160855,-0.6895286648995848,0.8309859154929577,1.0,1.0,2/7,31.55%,GRIN1;APP
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.4413794484891616,-0.6890598570741454,0.84375,1.0,1.0,3/7,39.33%,KDM6B;JAG1;PROX1
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.3123163726109848,-0.6890332676356618,0.9782608695652174,1.0,1.0,17/104,19.59%,TTN;EMP2;NEDD9;TMOD3;MYO1H;RHOBTB2;TPM1;VIL1;MYO1F;PLS3;AVIL;RFLNA;ERMN;RND3;BAIAP2;MPRIP;RAC3
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.42032583955170333,0.6888661389273062,0.84,1.0,1.0,4/8,22.61%,NLGN2;NLGN1;NRXN1;LRRC4
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.3441506821681104,-0.6886354490691162,0.9285714285714286,1.0,1.0,5/33,17.04%,LIMK1;TPM1;PAK1;ITGB1BP1;PFN2
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),-0.4354029826689718,-0.6883117928851192,0.8301886792452831,1.0,1.0,2/5,19.03%,MGME1;LIG3
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.3314595148442986,-0.6879183390594681,0.9285714285714286,1.0,1.0,6/55,13.08%,PTPRC;CAV3;UBASH3B;TRIB1;CAMK2N1;ITGB1BP1
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,-0.3216015378561183,-0.6879087366993535,0.9560439560439561,1.0,1.0,4/61,5.97%,CALB1;TMEM213;ALDH1L1;SLC3A1
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),-0.39165724681757025,-0.6875036334545153,0.935064935064935,1.0,1.0,1/17,1.08%,FABP3
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.30173070112857525,0.6868952571758741,1.0,1.0,1.0,1/17,2.50%,DACH1
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.30693469561183817,0.6868376063494663,0.9259259259259259,1.0,1.0,3/23,8.71%,GPNMB;CDKN2C;CDC73
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),0.4204158031954008,0.6865840650215225,0.8484848484848485,1.0,1.0,6/6,57.98%,NDUFA12;NDUFV3;NDUFV1;NDUFB6;COA6;NDUFS2
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),0.30490785785577734,0.6865314097839715,0.8947368421052632,1.0,1.0,8/26,12.40%,ACOT9;THEM4;ACOT8;ACSM5;SUCLA2;OXSM;HMGCS1;ACOT13
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),-0.3571555226975107,-0.6861560596269828,0.9125,1.0,1.0,3/27,18.43%,BRCA1;ARRB1;CTBP1
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.2391843468509579,0.6861458672625821,1.0,1.0,1.0,17/143,11.31%,FGF12;TMEM9;CNPPD1;GPC1;CLSTN2;MAP2;TTC9;TMEM178A;PTPRF;LRRC49;TOLLIP;MEIS3;RNF128;PRR36;ARL3;LINGO1;KCTD1
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),-0.37644455245749064,-0.6860526426513484,0.8607594936708861,1.0,1.0,7/17,28.64%,MIGA2;USP30;STX4;AFG3L2;SPG7;EEA1;CHCHD3
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),-0.3644316579933765,-0.6858119182556848,0.8873239436619719,1.0,1.0,4/18,15.20%,VEGFA;ZNF568;ARNT2;PTPRR
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),-0.4474788028062117,-0.6856090288455797,0.8767123287671232,1.0,1.0,2/5,26.21%,WNT7A;WNT5B
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),-0.457785696144237,-0.6855946014379092,0.8923076923076924,1.0,1.0,1/5,16.12%,GALM
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.31568964551984335,0.68555315014016,0.9473684210526315,1.0,1.0,2/22,8.71%,CPSF1;CDC73
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.31568964551984335,0.68555315014016,0.9473684210526315,1.0,1.0,2/22,8.71%,CPSF1;CDC73
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.3706375604141337,-0.685456997870259,0.95,1.0,1.0,4/26,11.42%,OVOL2;CEBPD;TMC4;SLC44A3
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.2832164917315718,0.685363274549854,0.9230769230769231,1.0,1.0,9/54,14.15%,TRMT112;TRMT10A;AARS1;METTL2A;TYW5;TRMT5;ANKRD16;TRMO;DTWD1
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.35787854467629754,0.6852894372389694,0.875,1.0,1.0,13/13,64.24%,CHP1;PRNP;DYRK2;ATP2B4;LMCD1;AKAP6;EFHB;SLC9A1;PTBP1;GSK3B;HOMER2;CAMTA1;SPPL3
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),-0.3935768092614967,-0.6851097667655163,0.8734177215189873,1.0,1.0,5/13,30.24%,CLEC16A;HDAC6;IGF1R;OGFOD1;ETF1
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.29425798247750246,0.6850130802224048,1.0,1.0,1.0,13/88,6.27%,HSPA1A;PPT1;RNF6;CGRRF1;BTG1;MAP2;NDUFS3;EI24;PML;IP6K2;CDKN2C;FRZB;FBP1
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.3016388639723027,-0.6848996201469906,0.9770114942528736,1.0,1.0,19/78,24.42%,AGT;C4BPA;APOE;FZR1;PLK2;FOXO1;WWP1;RASGRP1;WWP2;SLC6A9;ATG7;MAP2K5;OAZ2;DAB2IP;PSEN1;TGFB1;ABCA2;STX5;WNT7A
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.3097597312155761,-0.684853296972306,1.0,1.0,1.0,14/100,21.13%,SOX9;AHR;MGST1;TRIM41;SPP1;NR1D1;PDCD4;PTK7;ADCY1;ADCY5;PDCD1LG2;ATM;ADAM9;DAB2IP
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),-0.3172135251524524,-0.6843652813355606,0.927710843373494,1.0,1.0,7/68,12.02%,CDH7;CDH12;PCDHB5;CDH9;VASP;CDH19;BDNF
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),0.34126271677438036,0.6840144796411927,0.7692307692307693,1.0,1.0,1/16,0.98%,MALT1
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),0.3941844919786096,0.6837656552128984,0.8292682926829268,1.0,1.0,5/5,60.59%,PRPF39;SFSWAP;SRSF12;SNRPC;PSIP1
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.42528436183278057,-0.6835661375426931,0.8648648648648649,1.0,1.0,1/7,4.95%,VCL
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.2556906203158653,0.6834417876540171,1.0,1.0,1.0,4/49,8.91%,ATG16L1;MAP1LC3A;EMC6;RAB1B
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),0.30558486987271377,0.6831938850574687,0.8666666666666667,1.0,1.0,8/40,12.28%,HSD17B10;SRR;ACLY;ACOT8;ACSM5;OXSM;ELOVL4;ALDH1A2
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.43708397855415093,-0.6831915351125202,0.8405797101449275,1.0,1.0,2/10,23.18%,DTX3L;RNF20
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.3904529607118724,-0.682997021236333,0.859375,1.0,1.0,4/11,30.72%,TGFB2;MMP24;RELN;CDK6
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),-0.3363075447713696,-0.6828062760354495,0.9240506329113924,1.0,1.0,7/38,25.54%,RUNX2;BMP8A;PDCD4;TGFB2;SMAD4;TGFB1;TGFBR3
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.34109740756822043,-0.6826849513738558,0.9204545454545454,1.0,1.0,8/49,21.57%,CD44;DAPK1;VEGFA;EPHA7;IFI6;MAP2K5;NLRP12;IGBP1
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.374334482883505,-0.6825916479760054,0.9125,1.0,1.0,2/17,5.03%,YWHAH;NMT1
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.374334482883505,-0.6825916479760054,0.9125,1.0,1.0,2/17,5.03%,YWHAH;NMT1
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.3654111989161662,-0.6825719083552333,0.925,1.0,1.0,5/24,17.33%,CLDN18;CLDN12;MICALL2;TBCD;PAK2
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.3173824314828896,-0.6822992178186033,0.945054945054945,1.0,1.0,10/63,20.67%,OPTC;COL10A1;COL5A1;P4HA3;LOXL3;CYP1B1;COL5A3;TGFB2;DDR2;COL15A1
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),0.41538514958524947,0.6821625778964157,0.7741935483870968,1.0,1.0,1/6,9.48%,ABHD5
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),0.41665348260385543,0.6817554747338123,0.84375,1.0,1.0,1/5,2.16%,HSD17B10
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.4018205383594187,0.68122460504657,0.8333333333333334,1.0,1.0,1/8,3.51%,PDE3A
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),-0.45015455551969563,-0.6810336562585608,0.8703703703703703,1.0,1.0,2/5,18.84%,JAK1;PDPN
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.25867026123079956,0.6807551012395745,1.0,1.0,1.0,4/47,8.91%,ATG16L1;MAP1LC3A;EMC6;RAB1B
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),-0.3638296247868347,-0.6805008470318935,0.9012345679012346,1.0,1.0,7/23,28.18%,DVL2;PAK1;PDCD4;DAB2IP;DVL3;MAP3K10;SASH1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.3578990108373396,-0.6804989030611461,0.8888888888888888,1.0,1.0,6/21,22.26%,GADD45A;APOE;ITGB1BP1;ANGPT2;MAP2K5;TGFB1
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),0.43692955112384985,0.6804787399790551,0.9428571428571428,1.0,1.0,2/6,9.62%,PDE4B;SRI
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.33421566514072243,-0.6803094981994292,0.9529411764705882,1.0,1.0,6/42,12.86%,BRCA1;DONSON;FZR1;FBXO31;NEK11;EME2
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.2846021335686295,0.6802565846556918,1.0,1.0,1.0,16/85,11.17%,HSPA1A;PPT1;CGRRF1;BTG1;NDUFS3;EI24;PML;IP6K2;CDKN2C;FRZB;FBP1;MT1E;MT3;PPP2R1A;SMAD3;MUL1
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.3000454845679543,0.6802157676230935,0.8823529411764706,1.0,1.0,6/23,15.07%,SEMA5A;SEMA5B;DUSP3;SEMA3B;SEMA4F;SEMA6C
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.2812042727540789,0.6801737703590146,0.9545454545454546,1.0,1.0,6/47,9.14%,PRR5L;ACHE;VPS28;ZFAND1;PPIA;ATP2C1
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.2808123590233504,0.6801418642588738,1.0,1.0,1.0,3/49,3.72%,SOX11;ACHE;RAB27B
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.32612981485511494,0.6801139614448372,1.0,1.0,1.0,3/14,12.51%,MAPK11;RIPK2;PLCB1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3091963418919706,0.680050067699055,0.9230769230769231,1.0,1.0,3/22,8.71%,GPNMB;CDKN2C;CDC73
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.3534115890940843,0.6799159701078545,0.9333333333333333,1.0,1.0,6/14,24.79%,PARP1;ERCC4;SLX4;POT1;TERF1;TERF2
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),-0.46458278385447505,-0.6797739800819196,0.9264705882352942,1.0,1.0,1/6,1.60%,HES1
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),-0.34724186676768487,-0.6796227804687824,0.9375,1.0,1.0,2/25,8.78%,MREG;ATP6V1E2
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.403242707677418,-0.6788464700089885,0.92,1.0,1.0,1/12,10.54%,VEGFA
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),-0.39059281852838057,-0.678576217729784,0.8421052631578947,1.0,1.0,2/11,19.83%,EME2;SHOC1
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.3886368818096575,-0.6785244811655469,0.8767123287671232,1.0,1.0,2/13,21.44%,RYR2;DDRGK1
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.3379688162897,-0.6783947161916482,0.9125,1.0,1.0,7/35,23.03%,ARIH2;TRIM5;WWP2;TRIM56;TRAF3;RNF152;BFAR
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.43524487939838935,-0.678366728936723,0.8873239436619719,1.0,1.0,2/5,26.71%,VIL1;GSN
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.3214418377512129,-0.678020270484061,0.9545454545454546,1.0,1.0,10/53,28.33%,PARP9;DTX3L;PDZK1;DDRGK1;TGFB1;STX4;MAP1A;PRKAA1;PRKAA2;SESN2
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.40618832923928466,-0.6779178476531987,0.9583333333333334,1.0,1.0,4/14,33.53%,EIF2B4;PFKL;IRS2;EIF2B5
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),-0.41648807241840846,-0.6776987080180067,0.8235294117647058,1.0,1.0,2/7,18.08%,DNAH17;DNAH5
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),0.37473608767995553,0.6775975226072775,0.8571428571428571,1.0,1.0,1/7,6.60%,DNAJB12
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.3382124835049263,-0.6775440497942007,0.9259259259259259,1.0,1.0,2/26,8.55%,NEDD9;DOCK5
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.329437373003676,-0.67745296602421,0.9411764705882353,1.0,1.0,6/49,13.81%,POM121C;SAE1;RNF212B;POM121;IFIH1;BCL11A
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),-0.35968690095915173,-0.6771011699078998,0.9390243902439024,1.0,1.0,1/25,4.65%,GLRA1
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.3280977652066277,-0.6770473939593101,0.9540229885057471,1.0,1.0,9/75,14.51%,NAAA;MCCC1;ALDH1L1;MTHFD1;BTD;DNPEP;SHMT1;ACSM6;ST3GAL1
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.29832331368981346,-0.6766279734665445,0.9791666666666666,1.0,1.0,30/207,21.61%,RFC4;GADD45A;FBXO6;POLQ;FANCC;BRCA1;MSH6;RFC1;RFC2;ZRANB3;MMS19;DDB2;BACH1;RPA3;XRCC3;CDC7;THAP9;POLE3;ORC2;PNKP;NTHL1;RIF1;WRN;LIG3;ATM;PARG;HELB;TERF2IP;MEN1;RECQL
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),-0.4373387521151388,-0.6763782604114558,0.8333333333333334,1.0,1.0,2/6,12.52%,APOE;NR1D1
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),-0.3912811640687705,-0.6761050213469306,0.9014084507042254,1.0,1.0,2/11,22.64%,CHMP4B;PPP2R2D
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.43592392830433907,-0.6759237901176199,0.8857142857142857,1.0,1.0,3/8,20.90%,TPM1;KCNQ1;RYR2
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.4031346058928412,-0.6756842440882714,0.8787878787878788,1.0,1.0,2/10,11.86%,VEGFA;GJA1
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),-0.410390578113853,-0.6756424699145732,0.8769230769230769,1.0,1.0,6/10,26.21%,RILPL1;SIPA1L3;TMEM79;ACTA2;WNT7A;WNT5B
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.2982443251676824,0.6755689508849042,0.88,1.0,1.0,8/21,25.34%,ARL6IP5;SLC7A2;SLC1A2;SLC7A1;SLC1A3;CTNS;SFXN1;SLC7A8
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),-0.40254967686387466,-0.6751465210202023,0.8857142857142857,1.0,1.0,4/13,26.13%,DOCK7;HOOK3;DCTN1;TMEM201
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,-0.3046763156628506,-0.6751204603638773,0.9583333333333334,1.0,1.0,20/92,25.18%,HTR2C;SOX9;AGT;APOE;SLC2A12;SLC44A3;KIAA1217;ADGRL2;ADCY5;SMARCA1;PCDHB4;CDC42BPB;ATP1B1;DAB2IP;CADPS2;ARHGEF17;BACE1;IGFBP5;SHC2;PDZRN3
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),-0.37410811304238367,-0.6749074301561135,0.9285714285714286,1.0,1.0,3/19,13.65%,SYT1;SYT2;SYT4
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),-0.3306872720767414,-0.6748441793968156,0.9204545454545454,1.0,1.0,5/51,14.99%,PON1;CALY;APOE;CAMK1D;AKT2
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.36767611144098344,-0.6747300264315939,0.8875,1.0,1.0,7/22,30.99%,APOE;SULF1;STAT1;CNMD;SCG2;MEF2C;ATP5IF1
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),-0.335546153447701,-0.6743235697292462,0.9518072289156626,1.0,1.0,4/35,7.97%,PTPRC;LFNG;LMBR1L;KLF6
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),-0.37012912809032283,-0.6739556958165409,0.9342105263157895,1.0,1.0,4/19,7.93%,PTPRC;SPI1;LFNG;LMBR1L
prerank,PanglaoDB_Augmented_2021__Satellite Cells,-0.31171866993013564,-0.6739074174357671,0.9560439560439561,1.0,1.0,10/92,13.13%,SOX9;NUAK1;SRPX;SRPX2;TIMP3;FKBP9;LIFR;EDNRA;KIAA1217;SH3PXD2B
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.3906036462963556,-0.6738601526989509,0.95,1.0,1.0,2/18,7.65%,GUK1;MTHFD1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.4141970176497556,-0.6735616607024396,0.8857142857142857,1.0,1.0,5/9,37.75%,KLF15;BASP1;PODXL;JAG1;IQGAP1
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.38316668082593397,-0.6732469058861166,0.85,1.0,1.0,3/11,15.80%,BORA;DAPK3;KIF20B
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.4028453423842556,-0.673066737750316,0.9324324324324325,1.0,1.0,3/12,11.58%,DPAGT1;ALG6;ALG14
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.34311026572145553,0.6728728641243017,0.9130434782608695,1.0,1.0,2/12,13.87%,MT3;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.39998139009224604,-0.672868967664831,0.8987341772151899,1.0,1.0,3/11,22.26%,SHLD2;RIF1;TGFB1
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.2973158880635429,-0.6725133575206986,0.9782608695652174,1.0,1.0,11/118,15.46%,RASGRF1;ARHGAP15;ZC3H15;EFNA5;DOCK8;VAV3;PLXNA4;ITGB1BP1;RASGRP1;TBC1D10B;BCAR3
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.4701538030516046,-0.6724667168668763,0.8787878787878788,1.0,1.0,3/5,32.82%,NOP53;MACROH2A1;FLNA
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.31132383790841944,0.6720710731809421,1.0,1.0,1.0,4/24,8.75%,TSR1;RPS19;WDR46;NGDN
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.32973516174768247,-0.671955244377601,0.9285714285714286,1.0,1.0,5/32,20.44%,KCNN3;KCNMB4;KCNQ1;ANO6;ATP1B1
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),-0.42415632297027966,-0.6719389132114544,0.8888888888888888,1.0,1.0,4/6,35.54%,PEX1;PEX16;PEX6;LONP2
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),-0.42415632297027966,-0.6719389132114544,0.8888888888888888,1.0,1.0,4/6,35.54%,PEX1;PEX16;PEX6;LONP2
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.3368114734460732,0.6719071697144942,0.8823529411764706,1.0,1.0,2/11,11.49%,CMPK1;PNP
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),-0.3204763054420635,-0.6712689259787545,0.9518072289156626,1.0,1.0,7/51,15.34%,PTPRC;ARHGDIG;PLXNA4;RASA1;ITGB1BP1;TBCD;CYP1B1
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.4147954961914675,0.6712383616261373,0.9032258064516129,1.0,1.0,1/5,10.71%,MKKS
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.30090627059970987,-0.670885025912198,1.0,1.0,1.0,9/116,12.01%,SOX9;PSMB8;LMBR1L;EMD;DVL2;APOE;SHISA6;NPHP4;PSMA4
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),-0.35797939909786963,-0.6708129204471591,0.8985507246376812,1.0,1.0,3/19,14.52%,TMEM25;PLK2;SLC24A2
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),-0.4210092469327179,-0.6707558059472364,0.8484848484848485,1.0,1.0,4/6,46.70%,PARP10;UBR5;PLAA;GPS2
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,-0.29461465221465233,-0.6702404030853882,0.9891304347826086,1.0,1.0,16/119,16.11%,GRIN2A;OPALIN;A2M;ALDH1L1;MMD2;ACSBG1;PSD2;SHISA6;SLC4A4;GJA1;GRM3;BAALC;CAMK2A;NTRK3;SPARCL1;PLP1
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.34813884907386067,-0.6702313752901468,0.8795180722891566,1.0,1.0,8/26,24.10%,TPD52L1;BCL2L14;BDNF;TRAF7;ING5;DAB2IP;MADD;MAPK8IP2
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.2701014571625589,0.6699709855489837,0.9230769230769231,1.0,1.0,4/58,4.22%,MALT1;PSMD8;PSMB4;PSMB6
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.36310506367109313,0.6698141970656142,0.8387096774193549,1.0,1.0,4/12,12.48%,NGF;ZFYVE27;BCAR1;GRB2
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.3927461313836134,0.6694489687276288,0.8780487804878049,1.0,1.0,2/7,11.16%,RBPJ;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),-0.4326648758308774,-0.6693983156403158,0.9375,1.0,1.0,3/9,18.46%,APOE;CRYAB;PFDN6
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),-0.4377500117405178,-0.66936938768345,0.8961038961038961,1.0,1.0,2/6,23.50%,SHMT1;GLDC
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.35904146611646276,-0.6693166131091443,0.925,1.0,1.0,4/19,24.87%,PARN;CNOT11;SAMD4A;SAMD4B
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),0.40517650924613,0.669301856993503,0.8,1.0,1.0,2/5,18.92%,MUL1;DDX3X
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.34734267665891594,0.669175761983092,0.95,1.0,1.0,3/11,18.48%,FARSA;NUDT21;KRT10
prerank,PanglaoDB_Augmented_2021__Merkel Cells,-0.37573923167973694,-0.668856500905611,0.9466666666666667,1.0,1.0,3/17,12.04%,OVOL2;SLC44A3;VIL1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.29344920578829886,-0.6687919625034803,0.9680851063829787,1.0,1.0,22/151,19.57%,PTPRC;IRF1;AGT;BRCA1;RFTN1;ZFPM1;RARA;BTN3A1;STAT6;IL7;POLR1C;HTR2B;RASGRP1;SULF1;IFIH1;CYP1B1;STAT3;IL6R;POLR3H;PRKD2;C1QTNF4;RIPK1
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.38216219830179865,0.6686966392247747,0.8461538461538461,1.0,1.0,8/8,61.80%,RAB11B;EHD1;EIPR1;SORL1;ARHGAP1;INPP5F;ATP9A;ACTN2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.3072415501761618,-0.6686433759348912,0.9529411764705882,1.0,1.0,18/66,27.16%,MFSD6;HLA-F;KLC1;DNM2;ACTR1B;DCTN6;HLA-DMA;AP2A2;DCTN1;OSBPL1A;CLTA;HLA-A;AP2M1;AP2A1;SEC24A;CLTC;KIF3C;ACTR1A
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.23933624625762798,0.6685175069934152,1.0,1.0,1.0,14/106,11.10%,SLITRK2;STON2;RIT2;SNCAIP;RAB5B;METTL4;BCAR1;SSRP1;SLC2A10;SNX12;HSPA8;LAMTOR2;SNX17;CAMSAP3
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),-0.3212320887420122,-0.6684881948887598,0.9759036144578314,1.0,1.0,3/43,11.84%,B3GNT5;ELOVL2;DEGS2
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),0.4199922283994754,0.668173522279891,0.9615384615384616,1.0,1.0,2/7,10.06%,SNX12;GAS1
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.3625089075016762,0.6676531680536376,0.9032258064516129,1.0,1.0,2/12,6.39%,METTL4;SSRP1
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.35035548362152436,0.667318183114976,0.7777777777777778,1.0,1.0,4/11,16.58%,SEC61B;HSPA5;SEC61G;GET3
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),-0.35647460102583317,-0.6672061527795187,0.875,1.0,1.0,10/23,28.17%,SHISA6;SHISA9;CACNG8;SHANK3;CACNG2;CACNG7;MAPK8IP2;RELN;CNIH2;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.2892255433010691,-0.6671439403081361,1.0,1.0,1.0,27/151,21.68%,CARD14;SRF;TRIM52;AGT;NLRC4;DVL2;TRIM41;VEGFA;ALK;TAF1;ESR2;FANK1;CAMK1D;CAMK2A;TRIM5;ADCY1;STAT3;IRAK2;PRKD2;HDAC4;DDR2;RIPK1;TRIM25;TERF2IP;TFDP1;DDRGK1;ROR1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.2978105764613688,-0.6670086246328295,0.9782608695652174,1.0,1.0,13/103,18.62%,RFC4;PSMB8;RFC1;RFC2;RPA3;PSMA4;CDC7;POLE3;ORC2;PNKP;PSMA3;MGME1;WRN
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),-0.44936985077374547,-0.6668428907114199,0.9104477611940298,1.0,1.0,5/6,42.69%,C3;VSTM2A;LPL;PLIN5;NFKB1
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),-0.3132159369709875,-0.6664631916371275,0.9090909090909091,1.0,1.0,7/47,18.73%,MAP3K12;TAF1;CAMK2A;CIT;MAP2K1;PRKD2;CDC42BPB
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),-0.31526888315368695,-0.666216715492618,1.0,1.0,1.0,3/59,5.39%,ANGPTL4;FGF1;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),0.3919849686139854,0.6661966655529086,0.7916666666666666,1.0,1.0,1/5,7.02%,NOC2L
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.37751692857717845,-0.6661439905823832,0.8888888888888888,1.0,1.0,4/16,21.38%,CACNA1C;VEGFA;CYP1B1;TENM3
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.44033911154180166,-0.6659776751694347,0.9253731343283582,1.0,1.0,1/7,8.89%,MCEE
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.40435790251429654,-0.6658891489024102,0.8441558441558441,1.0,1.0,3/13,20.90%,HAP1;ATP1B1;RYR2
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),-0.45054151680398263,-0.6656949489144212,0.9384615384615385,1.0,1.0,3/5,29.78%,KCNK10;KCNK12;KCNK1
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.29842595425243135,0.6656656839196606,0.95,1.0,1.0,2/17,9.86%,WTIP;LIMD1
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.27780671474098273,0.6655735134790822,1.0,1.0,1.0,4/23,15.16%,GSTP1;DUSP3;MAPK8IP1;DNAJA1
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.37770168653684627,-0.6651550529000798,0.8947368421052632,1.0,1.0,2/12,14.58%,RBSN;STX10
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.33372040152023064,-0.6645676777926711,0.9397590361445783,1.0,1.0,7/37,15.60%,ATP10A;PCTP;APOE;ATP8B1;PITPNA;ATP8B2;PITPNC1
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.2956926338668389,-0.6645608024203707,0.9895833333333334,1.0,1.0,35/174,25.82%,SOX9;SYCE2;HES1;NEDD9;SKAP2;FANCC;STAG3;RHOJ;RIMS1;VASP;VIL1;TAPBP;PLS3;BAIAP2;NDUFAF1;DNM1L;RAC3;SYCP2;DVL1;FBLIM1;PEX14;DLG4;KMT2A;TGFB1;RHOU;ZW10;FAM107A;WNT7A;LRGUK;AFG3L2;DARS1;WDR19;SPG7;PCLO;FANCA
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.3677447417371413,-0.6645554852899679,0.9142857142857143,1.0,1.0,3/16,17.16%,RARA;RHOBTB2;TYRO3
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),0.45274064171122996,0.6645255970049322,0.8620689655172413,1.0,1.0,5/5,54.74%,HSP90AB1;HSP90AA1;RB1;CLU;SORL1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.3897110478531093,-0.6642015403857391,0.9166666666666666,1.0,1.0,5/11,24.04%,NR1D1;IFI35;NINJ1;DAB2IP;TIRAP
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.30444461157180325,0.6640438529520543,0.9230769230769231,1.0,1.0,5/22,10.14%,FKBP4;P3H2;PPIF;PPIA;PPWD1
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.3018256435077661,0.6639673634392235,0.8846153846153846,1.0,1.0,4/22,10.08%,ATXN7L3;RYBP;CDC73;RNF2
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.3380457929492558,-0.6638122278805934,0.9166666666666666,1.0,1.0,9/26,31.97%,TSC1;EIF2B4;RBM4B;EIF2A;RBM3;TMED10;NOLC1;APP;ATXN2
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.30871543498006065,-0.6635025389378867,0.9770114942528736,1.0,1.0,9/52,21.19%,RAB17;ATP8B1;ABITRAM;TBC1D10B;TBC1D8;TBC1D2B;TBC1D13;RDX;CDKL1
prerank,GO_Biological_Process_2021__translation (GO:0006412),0.24240414534860263,0.663392459882727,1.0,1.0,1.0,29/186,12.76%,TRMT112;MRPL10;MRPL11;MRPS33;MRPL28;EEF2;RPL8;EEF1A1;AARS1;MRPS12;RPL15;MRPL47;RPS19;RPS15A;RPL29;MRPL36;RPS2;MRPS16;TUFM;MRPS18A;MRPL13;MRPL52;MRPL27;QARS1;FARSA;RPSA;TMA7;EIF4EBP2;RPL23A
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),-0.3513453079753952,-0.6631412162839745,0.9315068493150684,1.0,1.0,8/18,28.07%,STX1B;RIMS1;SHANK3;DLG4;GRIN1;WNT7A;RELN;PRKCZ
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.28356295051802255,-0.6630967168576987,1.0,1.0,1.0,45/383,19.00%,HEY2;SOX9;IGF2BP2;AHR;HES1;IGF2BP3;IRF1;TSPYL2;CDKN2A;NKX6-2;SPI1;BRCA1;ELK3;MAEL;RARA;ARID5A;DAPK1;RUNX2;PUS7;SHMT1;ZNF568;ATP8B1;TSC1;FOXO1;NR1D1;LOXL3;WWP1;ZNF540;ZNF224;IKZF4;PDCD4;RBM15;RBM4;WWP2;DAPK3;CRYAB;GCLC;L3MBTL4;L3MBTL3;PBXIP1;CTBP1;PER1;BHLHE40;HDAC6;HDAC4
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.4391309920895662,-0.6629429156104714,0.855072463768116,1.0,1.0,2/7,21.13%,CNMD;DAB2IP
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.3842396510293203,-0.6629145583249345,0.8875,1.0,1.0,4/14,23.06%,WDR91;RDX;DAB2IP;RGP1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),-0.4335667353980003,-0.6626943882667071,0.8148148148148148,1.0,1.0,1/5,10.54%,VEGFA
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.30411501084132286,0.6626111121400475,1.0,1.0,1.0,1/47,0.59%,NUP42
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.32383833257841754,0.6625574023603511,0.84,1.0,1.0,1/12,5.39%,PIH1D1
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.3972100655758226,0.6624064307893145,0.9375,1.0,1.0,1/7,2.69%,TGFBR2
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),-0.3547712495151567,-0.6623972166976332,0.922077922077922,1.0,1.0,3/23,12.78%,LIMK1;DTX3L;BAG5
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),0.2757306761010197,0.6621248687457495,1.0,1.0,1.0,3/28,10.75%,NCSTN;HM13;MYH9
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),-0.3851416574479354,-0.6619706482031122,0.9210526315789473,1.0,1.0,1/12,12.18%,CECR2
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.35853711191426585,0.6613886061297873,0.8947368421052632,1.0,1.0,3/10,18.18%,AUP1;UGGT1;VCP
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.3813171695733503,-0.661130640545801,0.9493670886075949,1.0,1.0,6/18,37.31%,WDR12;ERI2;EXOSC10;ERI3;PES1;RPS21
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.31154575436665916,-0.6609910951213027,0.989010989010989,1.0,1.0,20/101,25.74%,RFC4;RFC2;ALK;DTX3L;PARN;EPHA7;PNKP;NTRK3;TYRO3;PARM1;DDR2;IGF1R;ROR1;TGFB1;EPHA4;PDGFRB;ZNF622;SERINC1;HMBOX1;MAP2K7
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.30927432596526633,0.6605540358330553,0.9375,1.0,1.0,6/23,17.11%,BTC;CPNE3;GAB1;GRB2;ERBB3;PTPN12
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),-0.3966547907860568,-0.6604916743982029,0.9178082191780822,1.0,1.0,2/9,21.24%,CYP1B1;ARG2
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),-0.3966547907860568,-0.6604916743982029,0.9178082191780822,1.0,1.0,2/9,21.24%,CYP1B1;ARG2
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),-0.4114631993551393,-0.6600907803032805,0.8985507246376812,1.0,1.0,2/8,22.75%,GAR1;RPUSD3
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.35546584240587137,-0.6599165726260574,0.8717948717948718,1.0,1.0,4/27,21.61%,XRCC3;THAP9;WRN;RECQL
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),0.28132578118909357,0.6598754037040496,1.0,1.0,1.0,4/25,14.97%,ATP5MC1;ATP5F1A;ATP5F1D;ATP5PD
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.2537196899881223,0.6596634645925765,0.9473684210526315,1.0,1.0,7/40,14.33%,RAB26;GOLGA7;EXOC5;COMMD1;ARL3;STXBP6;EXOC6
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.3385987012538108,-0.6596194522968104,0.9404761904761905,1.0,1.0,10/38,28.86%,DARS2;TARS3;PPA1;YARS1;GARS1;CARS1;HARS1;DARS1;NARS1;VARS1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),0.3993130851405545,0.6593701648078528,0.8181818181818182,1.0,1.0,2/5,13.79%,BDP1;CRCP
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.3348374443965121,-0.6591916383440108,0.9078947368421053,1.0,1.0,6/31,24.16%,RPA3;RIF1;WRN;ATM;TERF2IP;DOT1L
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.3086575249234072,0.6590021092659565,0.8888888888888888,1.0,1.0,5/18,14.91%,RBPJ;MT3;ATF4;CREB3L1;HSPA5
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.271341810898696,0.6588724508247963,1.0,1.0,1.0,7/32,17.47%,UBXN1;PML;RYBP;N4BP1;QRICH2;CSNK2A2;FHIT
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),0.38458889896253706,0.6588119426959009,0.8787878787878788,1.0,1.0,2/9,3.67%,PIWIL2;PIWIL4
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.3582026136742634,-0.658664997325114,0.9176470588235294,1.0,1.0,2/18,10.93%,DDB2;RPA3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.3582026136742634,-0.658664997325114,0.9176470588235294,1.0,1.0,2/18,10.93%,DDB2;RPA3
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),-0.3629902950516148,-0.6583277801711287,0.9871794871794872,1.0,1.0,5/22,15.30%,P2RY12;EDNRA;BDNF;HTR2B;NTRK3
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.3010170154675572,-0.6580420805453364,1.0,1.0,1.0,11/105,16.30%,GNA12;CDKN2A;ARHGDIG;SHTN1;LIMK1;CDC42EP3;PLK2;USP50;RASGRP1;USP8;TIAM1
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.3019358962449015,-0.6580309043548962,1.0,1.0,1.0,3/87,9.14%,RASGRF1;ZC3H15;DOCK8
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),-0.45892092930440287,-0.6579871577099011,0.9090909090909091,1.0,1.0,1/5,20.90%,RYR2
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.27801323170439335,0.6576991679343118,0.9,1.0,1.0,2/25,10.84%,RNF128;AP4M1
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.3610864666762269,0.6574869141986732,0.8,1.0,1.0,5/12,19.08%,SLC25A33;TEFM;TFB1M;FASTKD1;TFB2M
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.38190404136583145,-0.6572763296697086,0.9210526315789473,1.0,1.0,2/12,18.58%,SHLD2;RIF1
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),-0.3589048308878547,-0.6569282410936339,0.927710843373494,1.0,1.0,4/19,19.51%,HS3ST4;SULF1;CHST9;CNMD
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.35529760280286865,-0.6555269988427754,0.9,1.0,1.0,4/13,26.01%,CAV3;PLPP4;PDGFRB;PLN
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),0.3139545864479909,0.6554138287905198,0.9411764705882353,1.0,1.0,1/11,3.41%,CXCL12
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.3594271995292348,-0.6549113357720318,0.8831168831168831,1.0,1.0,1/16,6.47%,FOS
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.3688327316486162,0.6544713710881068,0.8571428571428571,1.0,1.0,7/7,63.13%,ERC2;RIMBP2;FCHSD2;TSPOAP1;KIF1B;ERC1;DTNA
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.35242429435158573,-0.6542973252426013,0.922077922077922,1.0,1.0,1/17,6.47%,FOS
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),0.38579382250878586,0.6541993505204644,0.825,1.0,1.0,1/6,5.32%,UBXN1
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.3713673776537283,0.6538046098641397,0.8918918918918919,1.0,1.0,3/10,12.91%,MALT1;TRPM4;SMAD7
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.3843664217708214,0.6534799920835711,0.9,1.0,1.0,1/7,5.60%,EIF4E2
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.3843664217708214,0.6534799920835711,0.9,1.0,1.0,1/7,5.60%,EIF4E2
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.30396695894586884,0.6533531935786844,0.95,1.0,1.0,4/30,14.99%,WRAP73;MAP10;AAAS;RHOA
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.3404057306080988,-0.6531729901732497,0.8888888888888888,1.0,1.0,3/25,10.54%,PTPRC;IL7;VAV3
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.3025238560392866,-0.6531487101937635,0.989247311827957,1.0,1.0,16/77,22.26%,CAMK1;CALY;ATP10A;APOE;VEGFA;BCL2L11;CAMK2B;TGFB2;SHANK3;DCTN1;IGF1R;FRMPD4;PLEKHM2;DAB2IP;SLF1;TGFB1
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.3802913794785845,0.6525244243512971,0.8857142857142857,1.0,1.0,1/5,9.09%,VAPB
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.2831511975217935,0.6525078160370759,1.0,1.0,1.0,14/48,18.30%,ACHE;FLRT3;SDK1;NLGN2;LRRTM3;SHANK2;NLGN3;NLGN4X;SDK2;GRID2;CDH2;DBNL;NLGN1;WNT5A
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.34222758362468575,-0.6524855399922116,0.9113924050632911,1.0,1.0,4/32,21.86%,CISD2;ATG7;USP30;RB1CC1
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),-0.3994824651353913,-0.6519207860372775,0.9384615384615385,1.0,1.0,3/8,17.33%,VCL;TBCD;PAK2
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.4032427993061334,-0.6517089215784062,0.9154929577464789,1.0,1.0,2/9,21.78%,NR1D1;UGP2
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.4032427993061334,-0.6517089215784062,0.9154929577464789,1.0,1.0,2/9,21.78%,NR1D1;UGP2
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),-0.3113631742623237,-0.6511341205143935,0.9647058823529412,1.0,1.0,13/58,27.01%,POM121C;PRXL2C;SLC4A4;GAPDHS;POM121;HDAC4;NUP188;PSEN1;NUP107;NCOR1;PFKFB2;PRKAA1;PRKAA2
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.29366867700665633,-0.6510897347520259,0.989247311827957,1.0,1.0,23/101,27.01%,PLEKHF1;PRXL2C;DAPK1;APOE;DTX3L;SLC4A4;PLK2;GAPDHS;FOXO1;TRIM5;AKT2;TPCN1;RDX;ADAM9;SVIP;PSEN1;RNF152;PIK3CB;PFKFB2;PRKAA1;PNPLA2;MID2;PRKAA2
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.33338638608747156,0.6507734427578749,0.9230769230769231,1.0,1.0,2/12,12.25%,TOP1MT;ERCC3
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.2598003562954883,0.6506577563843065,1.0,1.0,1.0,15/75,14.33%,GOLGA7;AP1M1;SCAMP3;AP4E1;ACBD3;EXOC5;CHMP2A;COMMD1;HSPA8;BLOC1S4;AP4M1;ARL3;SH3D19;STXBP6;EXOC6
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),0.25136974928155986,0.6504471997102302,1.0,1.0,1.0,7/41,14.97%,ATP5MC1;ATP5F1A;MTX2;TIMM13;TIMM22;ATP5F1D;ATP5PD
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.3116754235440314,-0.6498806003225526,0.945054945054945,1.0,1.0,8/69,20.71%,SEL1L2;FBXO6;MAN1A1;FAF2;DNAJC10;RNF175;UFD1;TRIM25
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.29376844610312536,-0.649732175814335,1.0,1.0,1.0,10/133,12.01%,SOX9;PSMB8;RNF213;LMBR1L;EMD;DVL2;APOE;SHISA6;NPHP4;PSMA4
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.3079351447591122,0.6497123634556471,0.9090909090909091,1.0,1.0,6/17,20.23%,ABCD2;FIS1;PEX13;ACBD5;PEX5;PEX2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.35507010574990183,0.6493858154160451,0.9615384615384616,1.0,1.0,4/12,20.05%,RBPJ;TGFBR1;NOTCH1;ERBB4
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,-0.29328442047356784,-0.6493287406375653,0.9782608695652174,1.0,1.0,21/82,26.55%,STMN2;SNCB;KCNC1;MMD2;SULT4A1;ACTL6B;PSD2;JPH3;SLC6A9;KIF1A;CACNG7;TMEM151A;CELF3;GRIN1;MPP2;CAMK2N2;PHYHIP;INA;LRRC4B;CNIH2;BRSK1
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.37780372119297423,0.6489749058462224,0.90625,1.0,1.0,1/6,3.78%,ESR1
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),0.386075725980216,0.6489048880593496,0.8,1.0,1.0,3/9,14.91%,CALR;HSP90B1;HSPA5
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.3290819122217941,0.6487149908941299,0.9047619047619048,1.0,1.0,2/15,6.93%,ARV1;SPTLC1
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),-0.29146628632804883,-0.6486162413378642,0.9887640449438202,1.0,1.0,11/117,14.29%,IGF2BP2;AHR;IGF2BP3;PTPRC;STX1B;APOE;TRIM44;RASA1;TAPBP;CDK4;TRIM5
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),-0.44299875767613467,-0.6485403205394992,0.9384615384615385,1.0,1.0,2/5,34.60%,ADGRB1;FLOT1
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.2730741815368533,0.6485090659831011,1.0,1.0,1.0,8/62,10.40%,SLC30A10;SIGMAR1;PPT1;TOX3;NGF;LIG4;MT3;ATF4
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.3614797932082784,0.6484668060062972,0.7916666666666666,1.0,1.0,4/9,19.08%,SLC25A33;TEFM;TFB1M;TFB2M
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.40109928626931723,-0.6482351683344751,0.8923076923076924,1.0,1.0,1/6,3.58%,PAH
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.4013212247938831,-0.6478651258720772,0.8918918918918919,1.0,1.0,2/9,28.46%,ADSS2;PAICS
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.2910563356604501,-0.6478534640425279,0.9894736842105263,1.0,1.0,21/114,24.10%,TESPA1;CCDC39;VAMP1;CALY;OTUD6B;SRP54;CHMP4B;TBCD;TIAM1;CENPC;NDUFAF1;PFDN6;HIGD1C;SMAD4;NUP107;TGFB1;CLTA;SAMM50;AP2M1;FCHO1;MAPK8IP2
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.4035034588891995,-0.6470089055477694,0.9154929577464789,1.0,1.0,5/6,30.32%,TGFB2;TGFB1;MEF2C;DHX36;EFNB2
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.32190284326677,0.6469485119474242,0.9523809523809523,1.0,1.0,4/14,15.18%,AADAT;OAT;FPGS;GLS
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.26836302254880395,-0.6469117889709497,1.0,1.0,1.0,115/755,22.26%,HEY2;SOX9;NLRC5;PLAG1;AHR;HES1;NR4A3;CAMK1;FGF1;MAFF;PARP9;IRF1;CDK7;SRF;YWHAH;AGT;SPI1;BRCA1;SREBF1;ELK3;PLSCR1;FOS;MYRF;ZFPM1;MAX;RARA;BCL9;SEC14L2;KLF6;DVL2;ATAD2;STAT6;RUNX2;HMGN5;MAP3K12;SS18L2;APOE;MMS19;NCOA1;VEGFA;THRAP3;DNAJC2;DTX3L;SPP1;ARNT2;ETV4;ESR2;THOC5;CRLF3;MEF2D;TRIM44;AHI1;PTPRN;FOXO1;NR1D1;DNM2;FANK1;ITGB1BP1;ARRB1;KLF15;CREBRF;ZIC1;MEIS2;USF1;SSBP4;GABPB1;STAT3;MLIP;DBP;STAT5B;SMARCA1;MAP2K1;ZBTB48;ING5;TRIM56;PAXBP1;PRKD2;STAT1;MAML3;PER1;HDAC4;ZFHX3;RPTOR;ATM;CDKN2B;ST18;LHX4;ASXL2;RFXAP;RIPK1;AGO1;TFAM;CEBPZ;MAP2K5;CDC5L;LMO2;IRF2;CSRNP2;BRD4;NFIC;DVL1;MED25;SMAD4;DAB2IP;TFDP1;PSEN1;DDRGK1;JUNB;MEN1;SLC30A9;TMF1;NPAS2;KMT2A;SIN3A;TGFB1
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.36938289523177265,-0.6468501978853153,0.9411764705882353,1.0,1.0,3/15,19.06%,PGM5;MYL6B;IGSF8
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),-0.284190429035208,-0.6465416430864497,1.0,1.0,1.0,13/96,20.26%,SLC39A14;ATP6V1E2;TBC1D4;FOXO1;RAB15;AKT2;USF1;BCAR3;SORBS1;BAIAP2;GRB10;PDK2;IGF1R
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),-0.34450267804477563,-0.646470301842339,0.9069767441860465,1.0,1.0,1/35,0.68%,SOX9
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.2966206900583604,-0.6452717205159909,1.0,1.0,1.0,27/94,23.27%,HSD11B1;STEAP4;SRPX2;TIMP3;AGT;LAMA2;APOL6;TNS1;SVEP1;ASPN;STAT6;ACSL1;GULP1;ECM2;CYP1B1;CRYAB;ABCA8;COL5A3;C1S;BCAT2;COL15A1;ACADSB;EPAS1;PDGFRB;ACTA2;OLFML1;NNMT
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),-0.42947360670434254,-0.6451913924212181,0.9545454545454546,1.0,1.0,2/6,26.09%,ING5;BRD1
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.2774672212710725,-0.6448603822116722,1.0,1.0,1.0,24/236,15.74%,HEY2;IGF2BP2;IGF2BP3;PARP9;OVOL2;PHF19;PARP14;SPI1;AEBP2;LSM5;DAPK1;NUDT12;APOE;PUS7;SHMT1;VEGFA;TAF1;TSC1;ZNF540;PTRH2;SUZ12;RBM4;WWP2;DAPK3
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.3501671677669625,-0.6447582794655731,0.948051948051948,1.0,1.0,2/30,5.01%,AZIN2;TIMP3
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.33787169271640316,-0.6442895523591861,0.9625,1.0,1.0,5/30,21.13%,ARHGAP24;TGFB2;STMN3;SYNGAP1;DAB2IP
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.40040988566103425,-0.6438967413875597,0.9178082191780822,1.0,1.0,7/10,32.50%,TRIB1;TRIM5;CD55;SCIMP;SASH1;PRKCA;CARD8
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),-0.3200377308903758,-0.6438390772579142,0.9666666666666667,1.0,1.0,2/50,5.49%,SOX9;NRG4
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.21448379301509868,0.6437300081696695,1.0,1.0,1.0,25/266,11.33%,UBB;RNF144A;UBE2J1;PSMD8;PSMB4;UBE2D4;TRAF5;RNF6;KBTBD6;PSMB6;UBE2D1;UBE2N;KBTBD7;KLHL42;PELI1;UBE2Q2;PSMD10;AREL1;PSME3;RC3H1;SMURF2;UBC;UBE2G1;MUL1;TRIM71
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),-0.40184365520802756,-0.6435907921576913,0.9193548387096774,1.0,1.0,1/7,15.69%,KDM7A
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.3446745924370984,-0.6431933506838026,0.9655172413793104,1.0,1.0,2/23,13.37%,EMD;TRAM1L1
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.3201468414889172,0.64287887239869,0.88,1.0,1.0,1/11,6.71%,PTCD2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.3209833445408372,-0.6428564685685274,0.9878048780487805,1.0,1.0,8/48,20.14%,SPDYA;RARA;CCDC57;CDK4;MEIS2;EIF4EBP1;TGFB2;CCPG1
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.3492775224907603,0.642720444173551,0.9090909090909091,1.0,1.0,3/17,6.35%,NGF;ZFYVE27;BCAR1
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.2830826818895932,0.6425076210443108,1.0,1.0,1.0,4/24,14.74%,SURF4;LIG4;LNPK;PFDN2
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.3790659179094211,0.6424322815917854,0.92,1.0,1.0,1/6,5.43%,PPIF
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),-0.31709980185624365,-0.6423411325832514,0.9438202247191011,1.0,1.0,1/52,0.94%,GNA12
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),-0.389634020066472,-0.6422796025172299,0.9295774647887324,1.0,1.0,2/10,14.34%,VEGFA;ADGRV1
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.25177725444468246,0.6420488508545712,1.0,1.0,1.0,14/72,16.56%,PSMD8;PSMB4;PSMB6;UBE2D1;MN1;PSMD10;PSME3;ERCC3;PSMB2;PSMD12;ANAPC11;ANAPC7;PSMC1;PSMD4
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.3150394921775899,0.6419302079898095,0.9090909090909091,1.0,1.0,7/13,25.85%,INTS9;INTS7;INTS6L;INTS11;INTS8;INTS1;INTS14
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.3427682293272616,-0.6417584220917125,0.9375,1.0,1.0,4/27,9.49%,DSC2;VCL;P2RY12;UBASH3B
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.3039487012984232,-0.6414761127399052,0.9655172413793104,1.0,1.0,6/78,10.68%,CAMK1;CDK7;GADD45A;MTCP1;CCNI2;TRIB1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.3599552185193829,-0.6412499890903037,0.8933333333333333,1.0,1.0,3/12,22.15%,BRCA1;SMAD4;KMT2A
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.2923329080738507,-0.640968881255549,0.989010989010989,1.0,1.0,14/102,24.08%,MAGOHB;RPL12;RPS14;RPS8;RPL37A;CASC3;NCBP1;RPS27;UPF2;RPS6;RPS4X;RPS25;RPL27A;NCBP2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.3669381493825806,-0.6409653261359824,0.9473684210526315,1.0,1.0,1/14,7.84%,CEMIP
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.3803157553457575,-0.64055441668797,0.9178082191780822,1.0,1.0,1/12,5.39%,BRCA1
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.30471541274167546,-0.6404464646460878,0.9659090909090909,1.0,1.0,13/56,32.82%,RAB11A;GOLGA8B;CSNK1D;HAUS5;NEK6;GOLGA8M;NCOR1;TUBGCP3;TUBGCP2;MAPRE3;KIF11;ABRAXAS1;FLNA
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.32056781531757356,-0.6401945519904042,0.975609756097561,1.0,1.0,10/42,24.02%,CNTNAP1;SHTN1;PAK1;BDNF;DNM2;KIF20B;DAB2IP;DCLK1;TNIK;PACSIN1
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.4313730400966743,0.640103603649935,0.84375,1.0,1.0,2/5,18.70%,DCC;PTPRS
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.29972882926449895,0.6398223517831412,0.9459459459459459,1.0,1.0,2/11,11.16%,RBPJ;TGFBR1
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),-0.4399616221403035,-0.6398039228442639,0.90625,1.0,1.0,2/5,33.42%,DPY19L1;DPY19L4
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),-0.4399616221403035,-0.6398039228442639,0.90625,1.0,1.0,2/5,33.42%,DPY19L1;DPY19L4
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),-0.31545593615649586,-0.6397710158930482,0.9397590361445783,1.0,1.0,4/38,17.16%,EFNA1;MICALL2;ITGA8;TYRO3
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.2768918966136053,0.6397624155348972,1.0,1.0,1.0,4/20,20.02%,CRPPA;TMTC3;DPM2;DPM3
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.2539259561589875,0.6396744176436499,1.0,1.0,1.0,7/60,9.80%,YAP1;PSMD8;PSMB4;PSMB6;TCF12;PSMD10;PSME3
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),-0.4052221576870835,-0.6396279908856763,0.9342105263157895,1.0,1.0,1/6,19.16%,ATM
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.3392472935415781,-0.639605755214973,0.9764705882352941,1.0,1.0,4/21,17.71%,NEDD9;PLS3;RFLNA;BAIAP2
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",0.3730614973262033,0.639428402384702,0.8518518518518519,1.0,1.0,5/5,62.71%,NOP14;ABT1;KRI1;UTP20;RPS21
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),0.39423330966824965,0.6394141253564303,0.8571428571428571,1.0,1.0,1/7,2.16%,HSD17B10
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),0.404102132266629,0.6392482657021499,0.7948717948717948,1.0,1.0,1/5,3.67%,PIWIL4
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.3520651672530553,-0.6389785765133434,0.9230769230769231,1.0,1.0,3/21,8.89%,BRCA1;RARA;ARID5A
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.30634528510594466,0.638369314611509,0.9047619047619048,1.0,1.0,3/22,11.59%,CGNL1;TMEFF2;ARAP1
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.3011726587402623,-0.6375405070864996,0.9772727272727273,1.0,1.0,18/70,27.01%,TTN;SYT1;KCNMB4;RYR3;AHCYL1;SYT2;SYT4;ADGRV1;ADCY1;KCNH1;ADAM9;RYR2;ECT2;CAMK2D;CPNE4;PRKAA1;ITPKB;PRKAA2
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),0.39922935897061124,0.6374818941907076,0.8,1.0,1.0,2/5,13.32%,NPM1;MRPL18
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.3306559011385038,0.6370731305275635,0.9285714285714286,1.0,1.0,2/7,17.77%,COMMD1;WNK2
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),0.3289730413794849,0.6370513228750692,0.8571428571428571,1.0,1.0,2/12,7.02%,PDE4B;PPIA
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),0.37188481939693263,0.6366009091905602,0.8518518518518519,1.0,1.0,2/5,15.12%,ABCC11;ABCC10
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),0.3128771874967389,0.6365784344542926,0.9333333333333333,1.0,1.0,5/12,14.74%,CHRNA7;LDLR;PFDN1;VBP1;PFDN2
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),0.3749582191322951,0.6364497341168603,0.8695652173913043,1.0,1.0,6/6,62.52%,NOS1AP;SIRPA;SELENOS;RAC1;CD47;JAK2
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),0.3335302557344489,0.6363497121199103,0.92,1.0,1.0,4/12,11.22%,SFR1;LOC400499;WBP2;TRIM24
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),-0.3411514905841192,-0.6363008754732218,0.9620253164556962,1.0,1.0,6/25,30.19%,ADGRV1;ANO6;TGFB1;ISG15;MEF2C;NELL1
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),-0.3411514905841192,-0.6363008754732218,0.9620253164556962,1.0,1.0,6/25,30.19%,ADGRV1;ANO6;TGFB1;ISG15;MEF2C;NELL1
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.3306299409254682,-0.6360387694700282,0.9102564102564102,1.0,1.0,8/24,36.45%,CSNK1D;DCTN1;ARL13B;IFT122;RPGRIP1L;BBS10;CEP250;TMEM216
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),-0.3064540231709303,-0.6359684441996475,0.9302325581395349,1.0,1.0,7/47,23.15%,FOS;TPM1;CYP1B1;HDAC6;PDK2;RIPK1;ECT2
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),0.2634453436008346,0.6359572693439303,1.0,1.0,1.0,8/24,18.52%,NPM1;CENPQ;HIRA;RUVBL1;RBBP4;UBN1;CENPX;H3-3A
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.3220277353287979,0.6356173298186263,0.9,1.0,1.0,2/19,10.84%,HSPA8;AP4M1
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.243154246071108,0.6352105779206115,1.0,1.0,1.0,9/65,13.16%,G0S2;ACHE;FABP5;LEPR;ACLY;ESRRG;ZNF516;GNAS;PDGFC
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),0.3410250555122175,0.6351314764270815,0.8518518518518519,1.0,1.0,1/9,3.41%,CXCL12
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.2807431692114528,0.6349635419904511,0.896551724137931,1.0,1.0,4/29,7.68%,CFL1;CAPRIN1;ARC;LZTS3
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),-0.2945375661374357,-0.6342381067957817,0.9888888888888889,1.0,1.0,15/108,18.80%,RASGRF1;STMN2;SRF;DOCK7;RAB11A;ACTL6B;APOE;ALK;MICALL2;TBCD;SRRM4;PLP1;MAP4;TGFB2;STMN3
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.3522922513683084,-0.6339949812136445,0.9879518072289156,1.0,1.0,6/22,24.00%,P2RY12;ZSWIM4;USP14;TGFB1;PDGFRB;STX4
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),0.314561978738338,0.6339176646746544,0.8888888888888888,1.0,1.0,2/23,6.75%,MALT1;PDE4B
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.3858241072070485,-0.6338721495377933,0.9104477611940298,1.0,1.0,5/8,39.21%,PTPRJ;NDRG4;HGS;PTPN2;SNCA
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),-0.37363703096053424,-0.6338544141096817,0.9436619718309859,1.0,1.0,3/10,32.28%,RPTOR;SESN2;UBR1
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),-0.37363703096053424,-0.6338544141096817,0.9436619718309859,1.0,1.0,3/10,32.28%,RPTOR;SESN2;UBR1
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.30886290232279257,-0.6338091100677402,0.9529411764705882,1.0,1.0,6/48,12.27%,SREBF1;LIPI;ACSL1;GPAM;LIPH;ACSM6
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),-0.40667849465804906,-0.6336756431000854,0.8923076923076924,1.0,1.0,3/6,17.60%,AHCYL1;CAMK2A;CA2
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),-0.4129273226216569,-0.633209630193078,0.8947368421052632,1.0,1.0,2/5,32.27%,MED1;FOXP1
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),-0.4007244183614021,-0.6329783329281089,0.9295774647887324,1.0,1.0,2/6,28.49%,ASXL2;ASXL1
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),-0.42215996339500567,-0.6325588631724183,0.864406779661017,1.0,1.0,3/5,45.23%,PNPT1;NFKB1;HRAS
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.36165323208221195,0.6322965079810338,0.8571428571428571,1.0,1.0,1/9,2.69%,TGFBR2
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.2996786187863335,-0.6320112357917538,0.9885057471264368,1.0,1.0,12/54,22.31%,ARHGAP15;EFNA5;VAV3;PLXNA4;ITGB1BP1;CAMK2A;TBC1D10B;WRN;STMN3;RDX;DAB2IP;EPHA4
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.3202252660212189,-0.6319072004408847,0.9078947368421053,1.0,1.0,7/31,21.13%,AGT;EMD;CDK4;DDR2;MED25;FTH1;DAB2IP
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),-0.2909149110540587,-0.6319014511547907,0.9895833333333334,1.0,1.0,7/99,11.19%,B3GNT5;TMEM258;DPAGT1;ALG6;ALG10B;FUT2;MGAT4C
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),-0.43314216111495774,-0.6306841898923623,0.9577464788732394,1.0,1.0,1/5,16.76%,MYORG
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),-0.43314216111495774,-0.6306841898923623,0.9577464788732394,1.0,1.0,1/5,16.76%,MYORG
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.23808690477109762,0.6306783177985772,1.0,1.0,1.0,20/130,13.51%,RFWD3;SFR1;UBE2N;UBXN1;KPNA2;SEM1;PAXX;RAD51B;SMARCAD1;PARP1;EXD2;LIG4;ACTR8;ZFYVE26;POLB;SUMO1;MAD2L2;BAZ1B;REV3L;ERCC4
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.37736895806536636,-0.6298951668540085,0.8918918918918919,1.0,1.0,4/15,22.79%,USP50;EPHA7;NLRP12;GRIN1
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),0.3100187368288408,0.6294483172581543,0.95,1.0,1.0,4/13,16.02%,CALM3;SRI;CALM1;CBARP
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),-0.41889948181430015,-0.6294352343956886,0.8840579710144928,1.0,1.0,1/5,22.54%,PDGFRB
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.29506222400642323,0.629331548329578,0.8928571428571429,1.0,1.0,19/19,70.53%,DDX3X;BICD1;YTHDF1;PRRC2C;YTHDF2;CSDE1;YTHDF3;EIF2S1;G3BP1;LSM14A;DDX6;RPS23;CIRBP;DYNC1H1;MAPT;C9ORF72;UBAP2L;ATXN2;OGFOD1
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.32372945947909615,-0.6291966776167583,0.9382716049382716,1.0,1.0,3/37,10.00%,NUBP1;CP;B2M
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.3664217128731714,0.6291316692569541,0.8421052631578947,1.0,1.0,3/6,27.52%,PLA2G4C;PLA2G7;LPCAT2
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.40282675323090694,-0.6290312803281343,0.9122807017543859,1.0,1.0,2/5,19.12%,ARRB1;ARRB2
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.3920477307891004,-0.6289527695475559,0.9076923076923077,1.0,1.0,1/9,4.87%,CNTNAP1
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),0.3547459893048128,0.628933387723326,0.8571428571428571,1.0,1.0,5/5,64.54%,MGST2;GGT7;ALOX5;MGST3;LTA4H
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),-0.3278779672029438,-0.6285071835166148,0.9560439560439561,1.0,1.0,7/28,22.26%,EFNA5;EPHA7;PTPRR;MDGA1;SPINT2;TENM3;TGFB1
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),0.36149054014053494,0.6282362891359549,0.8421052631578947,1.0,1.0,2/9,20.03%,EXOSC8;XRN1
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.2930312017932234,-0.6281874286062168,1.0,1.0,1.0,15/83,18.60%,EFHC1;PLK2;PTPA;SGO2;TACC3;ERCC6L;CENPC;NUF2;RPS27;DCTN6;NEK6;MAP4;ITGB3BP;SPC25;XPO1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.3612113918973126,0.6281712555216468,0.9411764705882353,1.0,1.0,7/7,63.90%,WNT5A;ADAM17;ADAM10;WNK1;PTK2B;OXSR1;STK39
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.337801276824948,-0.6280236864015426,0.926829268292683,1.0,1.0,2/23,5.03%,YWHAH;NMT1
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),0.33045225661857874,0.6280193500873608,0.9428571428571428,1.0,1.0,1/7,5.10%,MCM4
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.2893403340901838,0.6274281404368364,0.9375,1.0,1.0,4/21,10.12%,PAWR;SHROOM2;MICAL1;LIMA1
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.3711869009059731,0.6271920789232341,0.88,1.0,1.0,1/5,7.02%,NOC2L
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.367153619776812,0.6261563257655685,0.9090909090909091,1.0,1.0,2/6,13.50%,PTAR1;FNTA
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.311680411333668,-0.6260124325314433,0.9759036144578314,1.0,1.0,1/40,0.56%,ENPP2
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.33980391222606876,-0.6256039500399327,0.9358974358974359,1.0,1.0,3/28,13.00%,CEMIP;UBASH3B;JPH3
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.2740768440250251,-0.6254847771786243,1.0,1.0,1.0,18/135,20.33%,DRAM1;TSPYL2;PROCR;TPD52L1;CDKN2A;GADD45A;FOS;DDB2;PLK2;POM121;WWP1;PITPNC1;STOM;BAIAP2;CDKN2B;PVT1;NINJ1;CSRNP2
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),-0.3978127524897356,-0.6254373697445865,0.9420289855072463,1.0,1.0,2/8,32.09%,RAB20;SYT7
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),0.3562404659931653,0.6251850148790643,0.8823529411764706,1.0,1.0,1/6,5.02%,CMPK1
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.2877124415348188,-0.6250891129061872,0.989010989010989,1.0,1.0,5/76,12.01%,FBXL13;PSMB8;FBXO6;FBXO31;PSMA4
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.2850913298560898,0.6249534998037477,0.9,1.0,1.0,7/17,19.56%,HM13;SEC61B;AUP1;HSP90B1;VCP;HERPUD1;DERL2
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),-0.4008661232417054,-0.6248226215665248,0.9142857142857143,1.0,1.0,2/8,19.22%,TOMM70;AGK
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),0.3922294135610142,0.6244724638731702,0.896551724137931,1.0,1.0,1/5,16.63%,FADS1
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.34611879122220146,-0.6230930544171328,0.9393939393939394,1.0,1.0,4/14,20.85%,TRIM5;TYRO3;TRIM25;HS3ST5
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),0.35189426413594227,0.6228179655971906,0.9069767441860465,1.0,1.0,1/9,4.44%,UBE2N
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),-0.4344846563682785,-0.622662426093147,0.9206349206349206,1.0,1.0,1/5,3.58%,PAH
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.3008617615475017,-0.6224136837734948,0.9736842105263158,1.0,1.0,5/45,12.69%,CRLF1;APOE;MAG;BDNF;RASA1
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),-0.29422065122491303,-0.622350897462131,0.9888888888888889,1.0,1.0,14/46,28.17%,SYT1;RYR3;SYT2;SYT4;ADGRV1;ADCY1;KCNH1;ECT2;CAMK2D;CPNE4;PRKAA1;ITPKB;PRKAA2;MEF2C
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),-0.3927594656686757,-0.6217047359603596,0.9264705882352942,1.0,1.0,2/8,16.07%,ST3GAL1;ST6GALNAC5
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.38203990779363883,-0.6215334484031025,0.9154929577464789,1.0,1.0,2/8,24.09%,CACNB1;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.2882453125992122,-0.6206377766726741,0.9882352941176471,1.0,1.0,12/60,21.13%,C4BPA;APOE;FZR1;PLK2;FOXO1;WWP1;WWP2;RDX;ATG7;OAZ2;ADAM9;DAB2IP
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),-0.28317583557642184,-0.6204386770967053,0.9893617021276596,1.0,1.0,21/150,21.08%,NUBP1;TSPYL2;CDKN2A;AGT;BRAT1;TP53TG5;NME6;OSGIN2;TMEM97;ESR2;GJA1;CRLF3;TCHP;NCBP1;PAPPA2;TGFB2;PTPRJ;RPTOR;GNG4;ENO1;SMAD4
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),0.23808940611316312,0.6203153297027606,0.8,1.0,1.0,8/61,12.67%,SNF8;RHOC;PIH1D1;SMPD3;CHMP2A;SMAD3;SUMO1;BRK1
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),-0.2619363715878726,-0.6200142548931318,1.0,1.0,1.0,54/661,14.32%,HEY2;SOX9;IGF2BP2;MSL3;VSIR;PLAG1;AHR;IGF2BP3;TTN;FGF1;PARP9;PTPRC;LRRC19;OVOL2;PPIE;PHF19;NKX6-2;USP13;PARP14;SPI1;BRCA1;FGF9;ZNF90;STX1B;FAM98B;PLSCR1;PTP4A3;MBNL3;TCFL5;DVL2;BTN3A1;ATXN1L;BAZ2A;HMGN5;ATG14;RIMS1;APOE;VEGFA;BACH1;CAMK2N1;TAF1;ARNT2;ESR2;GJA1;TRIM44;DNM2;SPIN2A;TCF7;TULP3;TAPBP;PTRH2;CDK4;TRIM5;EPHX2
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.3897739563520839,0.6199741422703972,0.9411764705882353,1.0,1.0,1/5,3.41%,CXCL12
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),-0.2873923213199817,-0.6197291753836606,0.9770114942528736,1.0,1.0,9/82,19.00%,SOX9;BAZ2A;ACTL6B;PAK1;CECR2;POLE3;EZH1;SMARCA1;HDAC4
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),-0.3673173049190904,-0.6193101773322393,0.8918918918918919,1.0,1.0,2/12,17.33%,HVCN1;RAB11FIP5
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.3442093635576431,-0.6184940586985982,0.9493670886075949,1.0,1.0,5/20,25.68%,EFNA5;NR1D1;ADCY5;STX4;CDK16
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.3017841574180439,0.6178673373628901,0.8846153846153846,1.0,1.0,3/19,11.28%,CHMP2A;VTA1;LAPTM4B
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),-0.347433254156957,-0.6168124312940202,0.948051948051948,1.0,1.0,1/13,3.80%,SLC39A14
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),0.28374478640880163,0.616756085527077,1.0,1.0,1.0,25/136,14.90%,MRPL10;MRPL11;MRPS33;MRPL28;RPL8;EEF1A1;MRPS12;RPL15;RPS19;RPS15A;RPL29;MRPL36;RPS2;MRPS16;MRPS18A;MRPL13;MRPL52;MRPL27;RPSA;EIF4EBP2;RPL23A;MRPL18;RPL27;GSPT2;RPL7A
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.33820958785856875,-0.6167120036866256,0.8783783783783784,1.0,1.0,3/12,29.80%,DDRGK1;BFAR;ATF6B
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),-0.2549698430770848,-0.6166180153088654,1.0,1.0,1.0,203/1384,21.90%,HEY2;SOX9;ZIC4;NLRC5;PLAG1;AHR;CRYM;ZNF233;HES1;NR4A3;CAMK1;FGF1;ZNF235;ARX;MAFF;EFNA1;ZNF850;PARP9;IRF1;CDK7;OVOL2;CBX7;MNT;ZFP69;SRF;OTUD7B;CDKN2A;GADD45A;PROX2;NKX6-2;EBF1;ZFP92;ZNF184;ZSCAN1;ZNF550;ZNF552;SPI1;BRCA1;ZNF555;ZNF829;NFE2L3;SREBF1;SP140;ELK3;PLSCR1;FOS;STAT2;ZNF546;ZFPM1;AEBP2;MAX;DUSP22;RARA;ZNF136;BCL9;KLF6;CEBPD;ZNF394;TCFL5;DUXB;IFRD1;DVL2;ZNF749;ARID5A;HIF3A;STAT4;ATAD2;STAT6;RUNX2;ZFP28;BRD9;ZNF211;SS18L2;ACTL6B;APOE;ZNF133;ZNF790;NCOA1;VEGFA;BACH1;THRAP3;ZNF568;TAF1;ARNT2;RPS14;ZNF785;ETV4;ESR2;ZNF814;ZNF232;CRLF3;MEF2D;KLF9;AHI1;PTPRN;ZNF449;FOXO1;NR1D1;ZNF160;ZNF415;ZNF169;ITGB1BP1;ZNF540;ZNF226;ZNF224;FOXO6;TCF7;ZNF154;ZSCAN2;CCNQ;BCL11A;ZNF765;ZNF599;ARRB1;CDK4;IKZF4;STAT5A;KLF15;TCF25;ZNF81;ORC2;DDX20;CREBRF;ZIC1;MEIS2;ZNF197;WWP2;USF1;KDM7A;ZNF517;ZNF565;SSBP4;EZH1;GABPB1;SRA1;STAT3;MLIP;DBP;STAT5B;ZNF586;SMARCA1;ZBTB48;PAXBP1;PRKD2;MRGBP;ZNF461;STAT1;CTBP1;MAML3;PER1;RIF1;BHLHE40;ZNF234;ZNF44;ZNF613;HDAC4;ZFHX3;ATM;CDKN2B;ST18;LHX4;ASXL2;ZNF490;RFXAP;RIPK1;AGO1;CEBPZ;ZNF589;MAP2K5;ZNF7;CDC5L;ZNF316;LMO2;IRF2;ENO1;CSRNP2;ZNF652;ZSCAN18;ZNF432;BRD4;NFIC;ZNF610;ZNF275;AASS;ZSCAN32;DVL1;MED25;SMAD4;DAB2IP;TSHZ2;RFX1;TFDP1;ZNF566;PSEN1;DDRGK1;JUNB;IGBP1;MEN1;ZBTB8A;UXT;SLC30A9;TMF1;NPAS2
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),-0.3253940956389597,-0.6160799141225656,0.9620253164556962,1.0,1.0,3/22,15.72%,APOE;AVIL;SORBS1
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),0.31867446894677354,0.6158711262148964,0.92,1.0,1.0,1/12,5.10%,MCM4
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.25747838214648294,-0.6155075946602515,1.0,1.0,1.0,97/640,22.74%,HEY2;SOX9;AHR;CRYM;HES1;NR4A3;EFNA1;PARP9;IRF1;CBX7;MNT;ZFP69;OTUD7B;CDKN2A;GADD45A;NKX6-2;ZNF550;SPI1;BRCA1;ZNF555;ELK3;MAEL;ZFPM1;MAX;DUSP22;RARA;ZNF136;TCFL5;ZNF749;ARID5A;RUNX2;ZNF133;VEGFA;BACH1;ZNF568;ATP8B1;TAF1;RPS14;ZNF785;ESR2;FOXO1;NR1D1;LOXL3;WWP1;ZNF169;ZNF540;ZNF224;BCL11A;ZNF599;IKZF4;TCF25;PDCD4;ORC2;RBM15;DDX20;MEIS2;WWP2;CRYAB;EZH1;GCLC;L3MBTL4;STAT3;MLIP;L3MBTL3;PBXIP1;STAT1;CTBP1;PER1;RIF1;BHLHE40;HDAC6;HDAC4;ZFHX3;ZNF589;MAP2K5;IRF2;ENO1;NFIC;AASS;MED25;SMAD4;PEX14;DAB2IP;ZNF566;PSEN1;IGBP1;MEN1;SCMH1;UXT;ZNF141;SIN3A;TGFB1;CBY1;FOXP2;BCL7A;ZBTB2;ETV6
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.28202909554946715,-0.6150349427469249,0.989010989010989,1.0,1.0,6/94,12.01%,SOX9;CDK7;PSMB8;DDB2;RPA3;PSMA4
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.28363297341782506,-0.6150092193348692,0.9772727272727273,1.0,1.0,14/65,26.35%,GADD45A;AGT;APOE;VEGFA;AHI1;ARRB1;ACACB;ARRB2;RIPK1;TGFB1;PDGFRB;WNT7A;SFRP4;RAB29
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),-0.3631647267144188,-0.6149074747146022,0.9344262295081968,1.0,1.0,2/12,16.74%,VEGFA;OXTR
prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.2669382267545716,-0.6148294563457019,1.0,1.0,1.0,22/152,20.07%,SLC22A4;GYPE;ALDH1L1;SIDT2;TNS1;RHCE;TMCC2;BACH1;MPP1;SEC14L1;CAST;SLC6A9;KDM7A;NARF;EZH1;GCLC;MBOAT2;CA2;CPOX;FBXO34;FECH;LMO2
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.3499826742890116,-0.6147841151367636,1.0,1.0,1.0,3/15,19.44%,AGT;CDK4;DDR2
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),0.3830213903743317,0.6147757833270164,0.8888888888888888,1.0,1.0,5/5,61.71%,EPHB2;ANAPC2;DBN1;CPLX2;ADCY8
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",-0.40336188843635007,-0.6145680891719864,0.8923076923076924,1.0,1.0,2/5,27.10%,SRP54;ZFAND2B
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),0.3305399330748648,0.6145607913749653,0.8928571428571429,1.0,1.0,1/10,3.05%,PORCN
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.3620775738295311,-0.6143626378354455,0.9487179487179487,1.0,1.0,2/16,13.01%,CEMIP;HAP1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),0.2487456567082259,0.6143108201196795,1.0,1.0,1.0,26/111,18.96%,LSM4;EIF4H;EIF5;RPS19;GEMIN8;CDC73;PUF60;DENR;RPSA;RPL23A;SF3A2;SNRPF;SNRPB;NUDT21;STRAP;SRSF9;SNRPD2;PRPF19;DDX1;SNRPE;PRMT5;RPS5;BRIX1;MRPS7;COIL;CELF5
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.3509294940143558,-0.6136691871704718,0.9358974358974359,1.0,1.0,2/12,18.58%,SHLD2;RIF1
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.3120016114605261,0.6134645128122586,0.9333333333333333,1.0,1.0,2/13,7.95%,ZFP36L1;NR3C1
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.28405784949740576,-0.6130456985324596,1.0,1.0,1.0,16/92,23.18%,VCL;DUSP22;TRIB1;TPM1;SRGAP3;GJA1;ITGB1BP1;SULF1;PTPRR;CYP1B1;PFN2;PTPRJ;DAB2IP;EPHA4;ZMYND8;RNF20
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.3610341429710955,0.6130319460906183,0.9393939393939394,1.0,1.0,2/6,12.60%,DPYSL4;DPYSL5
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.2889115620028982,-0.6127177557627871,0.9764705882352941,1.0,1.0,13/81,22.26%,STX1B;APOE;VEGFA;BCL2L11;LCMT1;CRYAB;HDAC6;SVIP;FBLIM1;GFAP;DAB2IP;SLF1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),-0.3098225412518838,-0.6122882739072244,0.9764705882352941,1.0,1.0,5/46,19.14%,RFTN1;BRAT1;NCBP1;TGFB2;RPTOR
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),0.35562265194723647,0.6121673531634467,0.972972972972973,1.0,1.0,1/6,3.41%,CXCL12
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.3513170209921112,0.61189490262924,0.8666666666666667,1.0,1.0,7/7,64.88%,MORC2;RESF1;MPHOSPH8;TASOR;TOP2B;INPP5K;SETDB1
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.3283255160962902,0.6118627785666011,1.0,1.0,1.0,5/14,18.27%,TGFBR2;TGFBR1;GRAMD1B;OSBPL7;LRP6
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),-0.32917125725991436,-0.6115694234781515,0.9866666666666667,1.0,1.0,8/18,30.14%,RAB11A;ADCY1;ADCY5;PRKAR1B;AQP4;PRKAR2A;ADCY3;RAB11FIP2
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.3223886585528957,0.6111638937415081,0.9166666666666666,1.0,1.0,11/11,67.78%,CEPT1;PCYT2;ETNK1;CHKA;LPIN2;SELENOI;SLC27A1;PISD;LPIN1;ETNK2;CHKB
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.2818367086729913,0.6109358671791792,0.9166666666666666,1.0,1.0,3/13,13.44%,GUCY1B1;MT3;DDI2
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.28585351445121354,-0.6103466650172285,1.0,1.0,1.0,13/62,28.60%,CAMK1;ZFPM1;ITGB1BP1;IFIT1;LRPAP1;CTSZ;DVL1;PEX14;DDX11;MITD1;PLN;HABP4;WAPL
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.39518520268264473,0.6095927106031771,0.9310344827586207,1.0,1.0,1/5,6.75%,PDE4B
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.3373651128656896,-0.6095542377156263,0.9418604651162791,1.0,1.0,5/19,23.90%,FAM98B;LCMT1;ETFBKMT;METTL21A;PRMT8
prerank,GO_Biological_Process_2021__eye development (GO:0001654),-0.3030065389901596,-0.6092235496150519,0.9878048780487805,1.0,1.0,6/32,20.45%,COL5A1;CACNA1C;SH3PXD2B;MEIS2;TGFB2;SIPA1L3
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.3312086417918277,-0.6089047537505256,0.95,1.0,1.0,4/18,18.84%,DUOX1;VEGFA;AKT2;PDPN
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),0.33716290278896366,0.6085929352033801,0.9642857142857143,1.0,1.0,1/10,4.68%,BCO1
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.23505037865935952,0.6085148385951019,1.0,1.0,1.0,13/38,21.62%,RBP1;ABHD5;ABHD4;USF2;SLC4A10;WNK2;ZBTB20;ACOX1;DDX3X;FBXW7;SLC4A7;NR1H3;VGF
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.377072192513369,0.6084207236356312,0.8064516129032258,1.0,1.0,5/5,62.31%,PHLDB2;CLASP2;CLASP1;PHLDB1;DAG1
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.377072192513369,0.6084207236356312,0.8064516129032258,1.0,1.0,5/5,62.31%,PHLDB2;CLASP2;CLASP1;PHLDB1;DAG1
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.3611872451367071,0.6077143672921627,0.9375,1.0,1.0,6/6,63.90%,WNT5A;ADAM17;ADAM10;WNK1;OXSR1;STK39
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.3611872451367071,0.6077143672921627,0.9375,1.0,1.0,6/6,63.90%,WNT5A;ADAM17;ADAM10;WNK1;OXSR1;STK39
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.2928906835314573,-0.6075158616136671,1.0,1.0,1.0,5/46,16.89%,TSPYL2;CDKN2A;CAMK2N1;PDCD4;NUDT6
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),0.27680743394998697,0.6074980058232848,0.9166666666666666,1.0,1.0,4/16,15.73%,SPCS2;SRP14;EDEM1;SEC61G
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.3954990649336214,-0.607021011927294,0.9354838709677419,1.0,1.0,2/6,19.31%,DTX3L;RDX
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.3954990649336214,-0.607021011927294,0.9354838709677419,1.0,1.0,2/6,19.31%,DTX3L;RDX
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.3954990649336214,-0.607021011927294,0.9354838709677419,1.0,1.0,2/6,19.31%,DTX3L;RDX
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.4064231840257355,-0.6068631534538359,0.9538461538461539,1.0,1.0,2/7,23.76%,ALG10B;ABCA2
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.2921458393365628,-0.6066092614904333,0.989247311827957,1.0,1.0,8/63,15.80%,MAGOHB;SLBP;SRSF5;AHCYL1;THOC5;CASC3;NCBP1;CDC40
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),0.3501181752434187,0.6065331778153237,1.0,1.0,1.0,5/8,33.01%,SETMAR;MUS81;DFFB;ISG20;XRN2
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),0.31964691721278593,0.6063188036570559,1.0,1.0,1.0,11/11,68.06%,NIFK;SPIN1;BRF1;POLR1G;RPAP2;SNAPC3;GTF3C1;SIRT7;USPL1;MARS1;GTF3A
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),-0.4104616833953189,-0.6060076590729863,0.9090909090909091,1.0,1.0,1/5,18.43%,CTBP1
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.2803004517888391,-0.6054683587956128,0.9891304347826086,1.0,1.0,7/70,12.68%,POLQ;BRCA1;RNF138;RPA3;XRCC3;CDC7;FANCB
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.3137707329857789,-0.6041084116398213,0.975609756097561,1.0,1.0,5/35,21.86%,CISD2;ATG14;ATG7;USP30;RB1CC1
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.26186210673805665,-0.6035129160745087,1.0,1.0,1.0,40/256,25.07%,FBXL13;TNC;PSMB8;FBXO6;CP;ASB14;ASB16;RAB11A;HIF3A;APOE;RAB3A;DDB2;FBXO31;SPP1;PSMA4;MBTPS1;EVA1A;ASB18;FAM20C;SPARCL1;FN3KRP;ESCO1;SUMF1;SERPIND1;PSMA3;FBXO22;UBXN7;FBXL5;FBXW12;MEN1;KLHL25;EPAS1;LAMB1;FBXL18;DCAF10;RABGGTB;IGFBP5;CALU;SCG2;KNG1
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),-0.2590803011517409,-0.6034734570109201,1.0,1.0,1.0,47/321,22.59%,HEY2;SOX9;AHR;HES1;IRF1;CDKN2A;NKX6-2;SPI1;BRCA1;ELK3;MAEL;RARA;ARID5A;RUNX2;ZNF568;ATP8B1;FOXO1;NR1D1;LOXL3;WWP1;ZNF540;ZNF224;IKZF4;PDCD4;RBM15;WWP2;CRYAB;GCLC;L3MBTL4;L3MBTL3;PBXIP1;CTBP1;PER1;BHLHE40;HDAC6;HDAC4;ENO1;SMAD4;PEX14;DAB2IP;MEN1;SCMH1;SIN3A;TGFB1;CBY1;FOXP2;BCL7A
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),0.3164686072085905,0.6033212754971294,0.9545454545454546,1.0,1.0,2/8,13.56%,CLK2;MST1
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.3244483307644915,-0.6030107726912457,0.9873417721518988,1.0,1.0,1/19,4.01%,SRF
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),0.3305917223906333,0.602686642885683,0.9642857142857143,1.0,1.0,1/9,8.53%,ACLY
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),-0.31160454934533555,-0.6025816776720847,0.9875,1.0,1.0,6/29,24.96%,RAB3A;RAB15;TANGO2;RAB3D;RAB8B;SCG2
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),-0.3916412967946403,-0.6025216685753992,0.9253731343283582,1.0,1.0,1/6,14.70%,GTF3C2
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.3086977896203319,-0.6022352281281781,0.9767441860465116,1.0,1.0,8/35,24.08%,CAMK1;EMD;ZIC1;NRDE2;PSEN1;TGFB1;ECT2;NCBP2
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),0.3207131464917302,0.6020303360063557,0.96875,1.0,1.0,1/9,1.92%,IL15
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.3571198465606091,-0.6020161567124387,0.9411764705882353,1.0,1.0,1/10,14.55%,PDCD4
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),-0.3730371633193059,-0.6020125320403176,0.9682539682539683,1.0,1.0,1/9,10.54%,VEGFA
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),0.24739430568705795,0.6019585085792957,1.0,1.0,1.0,1/24,3.78%,ESR1
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.27032529369343755,0.6019491422695347,1.0,1.0,1.0,9/39,12.93%,GSTP1;RAP2A;KLHDC10;GREM1;PPIA;ARL6IP5;INAVA;QARS1;MAPK8IP1
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.3351615277916681,-0.6019072663220327,0.9452054794520548,1.0,1.0,1/14,10.87%,CELF4
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),-0.4126459799146798,-0.6019001574406496,0.9344262295081968,1.0,1.0,2/6,23.70%,RYR3;SLC41A1
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),-0.2579904033689722,-0.6017689449103338,1.0,1.0,1.0,54/316,23.63%,SOX9;FGF1;PTPRC;LRRC19;TRIM52;AGT;FGF9;NRG4;P2RY12;PTP4A3;AKR1C2;CD27;LRP2;TNFRSF19;VEGFA;BCL2L11;PLK2;GJA1;TRIM44;TRAF7;HTR2B;ITGB1BP1;TRIM5;ADGRV1;PDCD4;AKT2;NTRK3;BCAR3;MYORG;KITLG;NEK6;PRKD2;MAP3K14;IFI35;TGFB2;C1QTNF4;DNM1L;PTPRJ;RPTOR;RIPK1;IGF1R;BRD4;TRIM25;NLRP12;DAB2IP;TERF2IP;PPP5C;ROR1;TGFB1;PDGFRB;ECT2;CGAS;ZNF622;PIK3CB
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.32837771037620067,0.6014821568535694,0.9090909090909091,1.0,1.0,3/7,18.90%,CDC42;PDCD10;YWHAZ
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.3653491012943871,-0.6012424059867632,0.9285714285714286,1.0,1.0,7/10,33.57%,YME1L1;MIPEP;AFG3L2;SPG7;PMPCB;PMPCA;ATP23
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.3850004094995458,0.6011633216236776,0.9428571428571428,1.0,1.0,1/5,3.52%,SEMA5A
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.3912408130362425,-0.6011576703165165,0.9552238805970149,1.0,1.0,3/9,20.90%,KCNQ1;TGFB2;RYR2
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.32607210070011333,0.6011477598559279,0.9629629629629629,1.0,1.0,1/13,3.41%,CXCL12
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.2787075287521189,-0.600999467383048,0.989247311827957,1.0,1.0,6/82,12.78%,GNA12;ARIH2;ZER1;TRIB1;TAF1;BAG5
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),-0.39661253468635893,-0.600972190836314,0.927536231884058,1.0,1.0,1/7,12.02%,BDNF
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.31748896911351776,0.6007243959956171,0.896551724137931,1.0,1.0,7/7,68.27%,MAP3K7;AKT1;MTOR;PIK3CA;DAPK2;TSC2;STK11
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),-0.3147534568565574,-0.6001150522011381,0.9736842105263158,1.0,1.0,3/23,23.88%,MEN1;KMT2A;CXXC1
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.4033746375294592,-0.5999355032762275,0.953125,1.0,1.0,2/5,25.13%,TRIM44;PARP10
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.31036380813221315,-0.5998913363067446,0.958904109589041,1.0,1.0,5/25,23.64%,RAP1GAP2;VAV3;RPTOR;RDX;AP2M1
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),-0.35048621167959093,-0.5997716870611393,0.9565217391304348,1.0,1.0,2/12,19.16%,XRCC4;ATM
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.38401448716157405,0.5996880700093974,0.875,1.0,1.0,2/6,8.86%,MGMT;LIG4
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.35698211333810204,-0.5995416240773966,0.9545454545454546,1.0,1.0,2/10,18.40%,ZFPM1;TGFB2
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),-0.3296339848620586,-0.5990755366727046,0.9736842105263158,1.0,1.0,3/13,25.66%,CHMP4B;MITD1;CHMP6
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),-0.4116775838232527,-0.5987170147656008,1.0,1.0,1.0,2/5,26.71%,ST18;GSN
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),-0.40352940043719326,-0.5978218273363528,0.9365079365079365,1.0,1.0,2/6,34.60%,ADGRB1;FLOT1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),-0.33778366019811557,-0.597805566675992,0.9565217391304348,1.0,1.0,3/23,10.81%,ELOVL2;ACSBG1;ACSL1
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),-0.360226145589534,-0.5977913727548628,0.9253731343283582,1.0,1.0,2/8,15.30%,VEGFA;NTRK3
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),0.35270731347157325,0.5977072946621833,0.9714285714285714,1.0,1.0,2/7,11.17%,GSTP1;MUL1
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.33725516411524836,0.5976070210927167,0.8823529411764706,1.0,1.0,6/6,66.29%,SENP7;SENP5;SENP2;SENP1;SENP6;USPL1
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.3875799941853334,-0.5975470012777364,0.9487179487179487,1.0,1.0,3/8,22.26%,MAP2K1;RIPK1;TGFB1
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.28056060891615725,-0.5972586980777994,1.0,1.0,1.0,4/48,13.08%,NEDD9;ITGA2;ADAMTS13;ITGB1BP1
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),-0.39082813769449387,-0.596667417838213,0.9298245614035088,1.0,1.0,1/6,22.40%,ADAR
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),-0.36840846606092276,-0.5960971114624273,0.9,1.0,1.0,2/7,19.03%,MGME1;LIG3
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.2796676220524144,-0.5956829799212775,0.9888888888888889,1.0,1.0,5/44,19.16%,CCT6A;CCT8;PARN;PNKP;ATM
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.3156522731422713,0.5956812197698674,1.0,1.0,1.0,3/10,16.89%,SNX12;DNAJA1;NDFIP2
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.359384194970371,0.594790925992701,0.9655172413793104,1.0,1.0,4/8,13.22%,SLC2A10;CHP1;PLCB1;SOAT1
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.3700617498901888,-0.5946378527689301,0.9420289855072463,1.0,1.0,1/7,20.44%,ATP1B1
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.3331957997389149,0.5946337739748607,0.9285714285714286,1.0,1.0,3/14,8.76%,CPSF1;CPSF4;TSEN34
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.29496645016621714,-0.5945718947438047,1.0,1.0,1.0,6/27,22.34%,CLEC16A;TELO2;ATM;PIP4P1;CASTOR2;RNF152
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),-0.3768864414773766,-0.5942147007632189,0.9523809523809523,1.0,1.0,2/6,28.18%,PARP10;SASH1
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),0.3146186344353167,0.593956363889126,0.9428571428571428,1.0,1.0,1/9,8.44%,ENPP3
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),0.23008373380935845,0.5938100574162819,1.0,1.0,1.0,22/137,14.00%,TSPO;HSD17B10;PHB2;MFF;PTCD2;AIP;IMMP2L;PARP1;MTX2;TIMM13;PRDX3;MUL1;ESRRA;SLC25A33;TIMM22;SLC25A4;AIFM2;SIRT4;FIS1;ATP5F1D;GABPA;DNAJC19
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),-0.2654140774066047,-0.5928378831473253,0.989247311827957,1.0,1.0,6/106,11.88%,SOX9;PHF19;SPI1;BAZ2A;ACTL6B;PAK1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.31873727828835846,0.5926333591427283,0.92,1.0,1.0,1/10,6.44%,SP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.3208789582638397,-0.5925482879602961,1.0,1.0,1.0,7/26,25.83%,IFIH1;STAT3;IL6R;C1QTNF4;TIRAP;XBP1;SCIMP
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.32862894753431454,-0.5921886282590921,0.9583333333333334,1.0,1.0,2/15,17.13%,RPS14;RPS27
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.2624980163555717,-0.5921252603497604,1.0,1.0,1.0,27/129,26.32%,HEY2;PARP9;OVOL2;PARP14;SPI1;APOE;VEGFA;TAF1;PTRH2;LRPAP1;WWP2;OLFM1;MAP2K1;RBL2;TGFB2;AGO1;PSEN1;DDRGK1;DLG4;TGFB1;CCDC3;TCEAL1;AGO4;PARP10;SFMBT2;HINFP;PRKAA1
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.3198288541248828,0.5921027157999904,0.9333333333333333,1.0,1.0,7/7,68.03%,PNKD;SYT11;RAP1A;FMR1;PRKN;RAP1B;SLC30A1
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),0.337804887042211,0.5920828323207356,0.9666666666666667,1.0,1.0,1/6,13.77%,ATP5F1D
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),-0.3200029898956181,-0.5915601439280407,0.9487179487179487,1.0,1.0,4/20,29.06%,AVIL;MED1;PRKAA2;C3
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.37422538694406615,-0.5912863294251074,0.9538461538461539,1.0,1.0,1/9,5.39%,BRCA1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.26767493377973234,0.5902651033930303,0.92,1.0,1.0,2/21,6.81%,PDGFRA;RAPGEF3
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),-0.3576130322951153,-0.5894396735798256,0.9113924050632911,1.0,1.0,5/10,32.47%,NCBP1;NCBP2;CPEB1;DHX36;CPEB3
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.3703954687488,-0.5894145369203876,0.9565217391304348,1.0,1.0,5/7,35.64%,DCTN1;PSEN1;MAP1A;APP;INSR
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.3085321571961047,-0.5891294147522796,1.0,1.0,1.0,4/23,24.08%,SLBP;NCBP1;ATM;NCBP2
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.33148428096978394,-0.5889318004788935,0.948051948051948,1.0,1.0,1/19,1.94%,ARHGAP24
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.30494977600834794,0.5888071649824168,1.0,1.0,1.0,6/10,21.16%,RPIA;PGM2;DERA;RPE;TALDO1;H6PD
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.34487565207842974,-0.5887406104172839,0.9305555555555556,1.0,1.0,2/9,19.05%,VEGFA;PTPRJ
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.3802881275294844,0.5887140075968171,0.8918918918918919,1.0,1.0,2/5,12.85%,IMMP2L;IMMP1L
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),-0.3654422753304285,-0.5881166100047438,0.9411764705882353,1.0,1.0,3/9,28.61%,LIG3;XRCC4;LIG1
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),-0.33035888940271163,-0.5880262764569932,0.9714285714285714,1.0,1.0,3/13,26.83%,PPP5C;PPP2R2D;DUSP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.37792436018108666,-0.587837660831313,0.9402985074626866,1.0,1.0,4/8,33.87%,STAT3;ISG15;PRKCZ;CD46
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.29259238591409925,0.5874971230371949,0.9642857142857143,1.0,1.0,5/11,24.44%,CERS2;PTPRS;CRK;CASK;AJAP1
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),0.31730962091328485,0.5871239161147507,0.8611111111111112,1.0,1.0,8/8,68.29%,TP53;TMCO1;DDIT3;SELENOS;EIF2AK3;GSK3B;WFS1;ATG10
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.33590319274417807,0.5868166564203279,0.9629629629629629,1.0,1.0,1/11,3.41%,CXCL12
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.2854509982984799,0.5863016386938539,0.9565217391304348,1.0,1.0,3/17,6.60%,BAG3;NGF;ZDHHC3
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.39170170624879913,-0.5861805116616217,0.9393939393939394,1.0,1.0,1/5,22.26%,TGFB1
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),-0.34449636019408747,-0.5851232857126808,0.9066666666666666,1.0,1.0,2/11,19.02%,SLIRP;DNM1L
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),0.3126044801069877,0.5850820797617317,0.9393939393939394,1.0,1.0,10/10,68.76%,CCNK;PPIB;EIF2AK4;VAPA;TBC1D20;FMR1;FBXL2;PRKN;NUCKS1;YTHDC2
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),0.38510297856975206,0.5848960285336733,0.8461538461538461,1.0,1.0,2/5,19.33%,KIT;EFEMP2
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.35063729449360176,0.5833966291834711,0.9655172413793104,1.0,1.0,3/5,22.19%,TBC1D23;FAM91A1;TRIP11
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),-0.31809778746679385,-0.5833957089661068,0.961038961038961,1.0,1.0,4/23,24.56%,ITGB1BP1;DVL1;DLG4;ITGA4
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),-0.3766412470032121,-0.582836608442879,0.9206349206349206,1.0,1.0,3/5,34.05%,MAP2K5;NFE2L2;ABCA1
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),-0.28868557770056164,-0.5827271135517046,1.0,1.0,1.0,10/43,27.78%,NEDD9;PAK1;MICALL2;PTK7;CDC42BPB;MKLN1;TNIK;GSN;THSD7B;PHACTR1
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.32845860366765284,-0.5820608707728906,0.9733333333333334,1.0,1.0,7/16,27.90%,BACH1;BRD4;TFDP1;CDK16;HINFP;CDK17;NPAT
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),-0.2886846024646607,-0.5820281311439677,0.9876543209876543,1.0,1.0,5/39,16.34%,RAB3A;PTPRN;RAB15;TANGO2;RAB3D
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),-0.3745069651422135,-0.5817531849052298,0.9117647058823529,1.0,1.0,1/6,8.92%,LRP2
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.36595125462292666,-0.5815526448536668,0.9852941176470589,1.0,1.0,3/9,25.88%,SLC2A12;SLC5A9;SLC2A9
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),-0.4107382993677655,-0.5814636199914511,0.9841269841269841,1.0,1.0,3/5,38.72%,PRKCA;PRKCI;PRKCH
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.35999083911455554,0.5812126783188362,0.9166666666666666,1.0,1.0,2/7,12.23%,PELI1;SLC25A4
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),0.35999083911455554,0.5812126783188362,0.9166666666666666,1.0,1.0,2/7,12.23%,PELI1;SLC25A4
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),0.3512700534759358,0.5808793757815542,0.8823529411764706,1.0,1.0,5/5,64.88%,SUV39H2;SETDB2;BEND3;PRDM5;SETDB1
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.38143681711794464,-0.5802435681076913,0.9365079365079365,1.0,1.0,1/5,21.44%,DDRGK1
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),0.26075364695426184,0.5798932317750225,0.9444444444444444,1.0,1.0,1/24,2.33%,HIPK1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.2509593630094038,0.5798022774643266,1.0,1.0,1.0,4/21,18.99%,DYNLT1;INSC;NSFL1C;SPDL1
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),-0.3556674808136022,-0.5797372295710376,0.9130434782608695,1.0,1.0,4/9,24.36%,BCL2L11;KLF9;ZFP36L2;FAM107A
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),-0.32820447586361745,-0.5796815415928994,1.0,1.0,1.0,5/15,28.64%,MIGA2;USP30;AFG3L2;SPG7;CHCHD3
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.28243287388100574,0.5795875638236637,0.9565217391304348,1.0,1.0,7/17,22.81%,CALM3;SRI;JPH4;CALM1;JPH1;PDE4D;GSTM2
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.3069702239473688,0.5788398426948639,0.8888888888888888,1.0,1.0,1/11,3.28%,HP1BP3
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.31153637769670534,0.578707851570077,0.9090909090909091,1.0,1.0,3/13,12.54%,PPIA;SQLE;AUP1
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),0.35129353566414867,0.5784403258570003,0.8846153846153846,1.0,1.0,6/6,64.88%,MORC2;RESF1;MPHOSPH8;TASOR;INPP5K;SETDB1
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.3738327491329776,0.5775749715288198,0.95,1.0,1.0,2/5,23.05%,RHOA;SLIT2
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.35869739603058337,-0.5770345560784671,0.9230769230769231,1.0,1.0,1/6,15.34%,CYP1B1
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.2630336036990919,-0.5765162601114547,0.9887640449438202,1.0,1.0,15/105,18.60%,RAB11A;EFHC1;PLK2;PTPA;SGO2;ERCC6L;CENPC;NUF2;RPS27;DCTN6;NEK6;MAP4;ITGB3BP;SPC25;XPO1
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),-0.3826097137894423,-0.5757245434268816,0.9692307692307692,1.0,1.0,1/6,18.62%,WRN
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.2907303370786517,0.5751491573679898,0.9642857142857143,1.0,1.0,13/13,70.95%,SIRT1;FBXW7;ITGAV;ALKBH7;NFKB1;FTO;PLIN5;LPL;PTPN2;VSTM2A;NFKBIA;MEST;C3
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),-0.3652021778657575,-0.5750281800933283,0.9583333333333334,1.0,1.0,1/8,23.27%,NNMT
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.3101229564942347,-0.5749147368153631,0.9512195121951219,1.0,1.0,1/25,9.78%,ATG14
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.3752951119567322,-0.5746554401759444,1.0,1.0,1.0,3/6,21.57%,HAP1;HDAC6;IGBP1
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.26050684209690556,-0.5745745085355151,1.0,1.0,1.0,10/84,23.75%,ZC3H15;RPL12;RPS14;RPS8;RPL37A;RPS27;RPS6;RPS4X;RPS25;RPL27A
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),0.31632935095850484,0.5743262530466343,0.9259259259259259,1.0,1.0,3/10,20.09%,ERH;NT5C1A;MACROD2
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.32368749118371243,-0.5743254951810952,0.9054054054054054,1.0,1.0,5/15,25.13%,EMD;MED25;FTH1;DAB2IP;PARP10
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.35741978609625685,0.5742136632158573,1.0,1.0,1.0,5/5,64.27%,BICD1;APC;MARK4;GSK3B;CEP250
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),-0.25313136523225443,-0.573915520540381,1.0,1.0,1.0,20/154,19.44%,SOX9;CAMK1;SLC6A6;SRF;AGT;MMD2;AAMDC;RANBP3L;RUNX2;GJA1;RBM4;TIAM1;OLFM1;KITLG;CTNNA1;IL6R;TGFB2;PDPN;ASXL2;DDR2
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),0.30378780586294496,0.5738116495726886,1.0,1.0,1.0,3/12,13.00%,COLEC12;MUL1;RALB
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),-0.26359374000708496,-0.5736277436846128,1.0,1.0,1.0,13/72,25.77%,ZFP69;SREBF1;NCOA1;GPAM;NR1D1;ACACB;PANK2;SIN3A;LACTB;CCDC3;NCOR1;MVK;MED1
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),0.2929601632962989,0.5735024002922199,0.9117647058823529,1.0,1.0,2/13,7.02%,PDE4B;PPIA
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.34515683989833623,0.5726737069708538,0.918918918918919,1.0,1.0,2/6,9.08%,GUCY1B1;MT3
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),-0.3634926875146893,-0.5725399874356562,0.9166666666666666,1.0,1.0,3/6,35.24%,NNMT;PPARGC1A;PTPN2
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),-0.3333617017844193,-0.5723155470980952,0.974025974025974,1.0,1.0,4/15,26.71%,GULP1;SPIRE1;ARHGAP12;GSN
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.35275344004823217,-0.571753955698267,0.9558823529411765,1.0,1.0,3/8,25.42%,CD27;ZFP36L2;XBP1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.32911057660957865,-0.5714689851220223,0.9342105263157895,1.0,1.0,4/16,28.63%,CACNA1C;RYR2;CAMK2D;GSTO1
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.3520741316318232,0.5712163143062563,0.9047619047619048,1.0,1.0,2/5,9.08%,GUCY1B1;MT3
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.3520741316318232,0.5712163143062563,0.9047619047619048,1.0,1.0,2/5,9.08%,GUCY1B1;MT3
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.29245791503230356,0.5708613441249726,0.9583333333333334,1.0,1.0,1/13,8.32%,PPP1R16A
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.31550444607875905,0.5705900137099191,0.9428571428571428,1.0,1.0,8/8,68.47%,CX3CL1;IFNGR1;GRN;CLU;MAPT;SNCA;JAK2;APP
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),-0.34856242694154915,-0.5701916887799409,0.971830985915493,1.0,1.0,3/10,21.76%,CAMK1D;IL6R;SLC8B1
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.31340988965095284,-0.5698493738575623,0.9705882352941176,1.0,1.0,1/16,9.88%,FZR1
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.33876277651308556,0.5698486689225581,0.9393939393939394,1.0,1.0,3/6,20.05%,ZSWIM6;SALL1;ERBB4
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.30737006213298057,-0.5698275908741816,0.9459459459459459,1.0,1.0,1/18,12.49%,TRAF7
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.30511550948679905,-0.569755882617396,0.9864864864864865,1.0,1.0,5/21,25.25%,CACNA1C;KCNQ1;ATP1B1;HCN2;SLC4A3
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),-0.36074263738247947,-0.5696268374604946,0.9436619718309859,1.0,1.0,1/7,17.66%,PPP3CC
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),-0.36074263738247947,-0.5696268374604946,0.9436619718309859,1.0,1.0,1/7,17.66%,PPP3CC
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.36290708764194723,-0.5695701479777664,0.9242424242424242,1.0,1.0,4/7,17.75%,STAT5A;STAT3;STAT5B;JAK1
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.36290708764194723,-0.5695701479777664,0.9242424242424242,1.0,1.0,4/7,17.75%,STAT5A;STAT3;STAT5B;JAK1
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.2963879598662206,0.5690254765604962,0.875,1.0,1.0,15/15,70.39%,RAB14;TDG;KAT2A;PTN;MYSM1;TRIP12;NIPBL;BAG6;DUSP9;CCSAP;RACGAP1;DUSP6;INSR;EHMT1;DHX36
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),-0.38788662803608087,-0.5683731067401673,0.9420289855072463,1.0,1.0,2/6,22.02%,HDAC6;ETFBKMT
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.3217792758394852,-0.5678984006423214,0.972972972972973,1.0,1.0,4/14,28.83%,AP2A1;EPS15;SORT1;VPS13C
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),0.30618927140283747,0.5672768486033263,1.0,1.0,1.0,4/10,17.81%,PTPN14;AAAS;NUP214;KHDRBS1
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),0.30954505981791236,0.5672231228764159,0.9459459459459459,1.0,1.0,3/9,21.08%,RC3H1;PRNP;HMGB1
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),0.3028745081916968,0.5669992875502464,0.9259259259259259,1.0,1.0,1/9,4.52%,ARFIP1
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),-0.37412384708160645,-0.5665976759253808,0.9411764705882353,1.0,1.0,2/5,36.07%,APPL2;APPL1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),-0.26193272029035863,-0.5662010877362942,1.0,1.0,1.0,18/100,24.12%,SOX9;NUAK1;LIFR;TNFRSF19;CAMK2N1;ARNT2;SH3PXD2B;TYRO3;CDC42BPB;KIAA1549L;GFAP;DAB2IP;HSPA12A;ZNRF3;ARHGEF17;PHYHIP;BACE1;CHST3
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),0.29777095626886546,0.5658270511632083,1.0,1.0,1.0,2/13,7.02%,PDE4B;PPIA
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.3576283834077214,0.5642430386788774,0.9629629629629629,1.0,1.0,1/5,9.88%,JMJD6
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),-0.34211807354159024,-0.5641079643312095,0.9736842105263158,1.0,1.0,2/10,22.71%,IGF1R;GIGYF2
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.29206816845405653,-0.5635784067749169,0.9871794871794872,1.0,1.0,7/24,28.47%,ANP32E;MIS18BP1;CENPC;ITGB3BP;CENPP;MIS18A;CENPH
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.27304057938467385,0.5628011759102464,1.0,1.0,1.0,3/12,13.87%,PRKAR2B;MST1;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.3025805588982483,0.561887891760074,0.9642857142857143,1.0,1.0,7/7,69.76%,VHL;ADIPOR1;CAV1;NF2;SH2B3;HGS;PTPRT
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),-0.32545318042104193,-0.5618738907530781,0.9855072463768116,1.0,1.0,2/10,21.67%,SHANK3;VPS51
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.3628342245989305,0.561841116558283,0.9347826086956522,1.0,1.0,5/5,63.73%,DDX3X;EIF2AK4;NCK1;EIF4G1;IMPACT
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.28977033912847955,-0.5617458811813618,0.96,1.0,1.0,2/19,11.88%,VEGFA;PAK1
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),-0.3631940008922196,-0.5613263186725038,0.9850746268656716,1.0,1.0,2/6,22.57%,PAK2;RFFL
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.3244200815562538,0.5611473872314655,0.9629629629629629,1.0,1.0,6/6,67.57%,KDM1B;MECP2;DNMT3A;PRMT7;PCGF5;PCGF3
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.354405622931005,-0.560468979007753,0.9701492537313433,1.0,1.0,1/6,22.15%,KMT2A
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.29147400165556914,0.5601634568618491,0.9285714285714286,1.0,1.0,2/12,12.13%,IP6K2;ACER3
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.2971896101622441,-0.5599946699469677,1.0,1.0,1.0,5/25,24.72%,CAMK2A;AGO1;PDE6B;FZD6;AGO4
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.29405312207980855,-0.5594014468078768,0.987012987012987,1.0,1.0,2/20,10.54%,RUNX2;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),-0.3527056885504874,-0.5592891333372841,0.9315068493150684,1.0,1.0,3/8,25.35%,PKIG;PRKAR1B;PRKAR2A
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.31236052841430606,-0.5592780987591874,0.9759036144578314,1.0,1.0,3/17,18.42%,PSMB8;PSMA4;PSMA3
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.28565969713165956,-0.5579870437083663,0.9864864864864865,1.0,1.0,5/27,19.22%,DPAGT1;DHDDS;GPAM;ABCA8;AGK
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.26025863446821845,-0.557491717180873,1.0,1.0,1.0,6/80,12.16%,IL5;VEGFA;DDB2;BCL2L11;RPA3;USP50
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),-0.31259162768262205,-0.5570206982516968,0.9315068493150684,1.0,1.0,4/11,29.88%,APOE;ABCA2;TMED10;RANBP9
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),-0.32191096358370774,-0.5567016376887863,0.9736842105263158,1.0,1.0,1/16,8.29%,MAN1A1
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.2814921883462594,0.5561968161968085,1.0,1.0,1.0,3/16,14.37%,PPP1R3D;PPP1R3B;PPP1R3F
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.27962021930997605,0.5557243344418774,0.9629629629629629,1.0,1.0,9/9,72.05%,ADAT2;URM1;ALKBH1;ELP4;MTO1;ELP3;ALKBH8;TRMT9B;GTPBP3
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.26515403468426807,0.5552988970290504,0.9642857142857143,1.0,1.0,6/15,26.35%,CNOT3;WDR43;ZC3H13;KAT2A;CNOT1;ZNF706
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),-0.3001980304871632,-0.5550050861503454,0.9875,1.0,1.0,3/21,22.35%,STAT2;DNM1L;SPIRE1
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.33083762283575113,0.5546462322883619,0.8947368421052632,1.0,1.0,6/6,66.93%,SLIT2;ROBO1;PADI2;HIF1A;SH2B3;SLIT3
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),-0.29478626945506425,-0.5546011242675958,0.9868421052631579,1.0,1.0,2/19,13.95%,BRCA1;ARRB1
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),-0.2412580525167517,-0.5542572849209982,1.0,1.0,1.0,13/146,14.12%,EFNA1;LAMA2;ROBO2;EFNA5;SPTBN5;VEGFA;PLXNA4;VASP;BDNF;SEMA4B;LRTM1;EPHA7;UNC5D
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),0.2767729489944848,0.5540178853593445,0.9615384615384616,1.0,1.0,1/8,5.69%,CHAMP1
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.25878283715369804,-0.5539859900359536,1.0,1.0,1.0,8/82,17.05%,TUBA4A;RAB11A;CEP135;NPHP4;AHI1;CSNK1D;B9D1;HAUS5
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.2659269644106704,-0.5539441233900242,0.9883720930232558,1.0,1.0,5/52,17.23%,ANKRD53;RAB11A;PLK2;KIF20B;CIT
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),-0.3331453234068026,-0.5539363054888146,0.9428571428571428,1.0,1.0,3/11,25.42%,BDNF;HDAC4;XBP1
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),-0.3561518982200379,-0.5538408028596609,0.96,1.0,1.0,2/6,22.26%,SMAD4;TGFB1
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),-0.3482114208420875,-0.5534192768844609,0.9726027397260274,1.0,1.0,1/9,17.00%,ESCO1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.3163731713166491,-0.5528384795835842,1.0,1.0,1.0,5/14,25.21%,CACNG8;SHANK3;CACNG2;CACNG7;RELN
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.3208366606701647,-0.5524097727665598,0.9571428571428572,1.0,1.0,5/9,42.59%,NOP53;PNPT1;PRDM16;NOA1;PRELID1
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.3207240665189234,-0.5514709265571166,0.9620253164556962,1.0,1.0,2/11,12.86%,APOE;HTR2B
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.2724928955169274,-0.5508333559704901,1.0,1.0,1.0,7/32,23.63%,AGT;CAV3;APOE;PDCD4;PTPRJ;DAB2IP;PIK3CB
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),-0.34412054402270575,-0.5508205886182919,0.9130434782608695,1.0,1.0,2/8,15.75%,WWP2;CABYR
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),0.2137290110981527,0.5506181743931817,1.0,1.0,1.0,15/86,15.50%,RPL8;RPL15;RPS19;RPS15A;RPL29;RPS2;SRP14;SSR2;RPSA;SRP72;RPL23A;TRAM1;RPL27;RPL7A;SSR1
prerank,MSigDB_Hallmark_2020__UV Response Dn,-0.2409324200094741,-0.5506158929237442,1.0,1.0,1.0,16/120,22.54%,SYNJ2;RGS4;GCNT1;SCN8A;GJA1;BDNF;ADGRL2;DBP;RND3;BHLHE40;INPP4B;MAP2K5;IGF1R;PEX14;DMAC2L;PDGFRB
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.3501997671048306,-0.5500499532172184,0.9859154929577465,1.0,1.0,4/8,33.17%,CHDH;DMGDH;SMOX;ALDH7A1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.2855780527176145,-0.5499263981386203,1.0,1.0,1.0,6/29,22.89%,DONSON;ZRANB3;EME2;WRN;DDX11;MMS22L
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.27045682720115516,0.5492599833200347,1.0,1.0,1.0,6/21,13.87%,ADRA1A;PDE4B;CALM3;SRI;SMAD7;CALM1
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),-0.2953503185690023,-0.549189463646058,1.0,1.0,1.0,2/20,15.67%,SLC1A4;SLC6A9
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.24442194276654694,-0.548719924193126,1.0,1.0,1.0,21/156,21.54%,PIP4K2C;PTPRC;HHIP;AGT;TMEM25;UBASH3B;TRIB1;RNF157;BDNF;SULF1;TULP3;ARRB1;LRPAP1;WWP2;TYRO3;GRB10;PTPRJ;CNMD;NLRP12;DAB2IP;BRAP
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.31459240067800104,-0.5484364967260129,1.0,1.0,1.0,3/16,19.06%,MYORG;MYL6B;IGSF8
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.2533586917013729,0.547964182135144,1.0,1.0,1.0,4/18,18.99%,DYNLT1;INSC;NSFL1C;SPDL1
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.2949588269102508,0.5476953740948354,0.9090909090909091,1.0,1.0,1/8,8.29%,MTSS1
prerank,GO_Biological_Process_2021__gas homeostasis (GO:0033483),0.347859405291285,0.5471960429337969,0.96875,1.0,1.0,2/5,27.57%,WNT7B;CAV1
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),-0.31200847535242143,-0.5470928485645101,0.9705882352941176,1.0,1.0,5/17,25.35%,PEX5L;RNF157;PRKAR1B;CGAS;PRKAR2A
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),0.22933674708835008,0.5459241389086654,1.0,1.0,1.0,2/17,12.23%,PELI1;SLC25A4
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.2785251213049477,-0.5456321423749252,1.0,1.0,1.0,8/35,30.19%,NBR1;ADGRV1;DDR2;ANO6;TGFB1;ISG15;MEF2C;NELL1
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.27484093643986607,0.5454965015957071,1.0,1.0,1.0,2/10,9.48%,ABCD2;ABHD5
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.28997163723330577,-0.5450132877904321,1.0,1.0,1.0,7/25,29.95%,WDR83;DBR1;TXNL4A;PRPF3;SRRM1;DDX23;PRPF4
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),-0.2928330397448494,-0.5443086272030996,1.0,1.0,1.0,6/24,20.57%,APOE;FMO5;EPHX2;PDK1;PDK2;PANK2
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.31740089578180364,0.5441780834372268,1.0,1.0,1.0,6/6,68.27%,USP7;ATXN3;USP15;BAP1;USP47;USP1
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.28533208481038075,0.5441394007268837,0.9333333333333333,1.0,1.0,14/14,71.49%,TOB1;CNOT1;TENT4A;POLR2G;TNRC6C;TNRC6B;AGO2;CNOT7;TNRC6A;PABPC1;CPEB3;TENT4B;EIF4ENIF1;BTG2
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),-0.33773813632246685,-0.5440882813254342,0.9605263157894737,1.0,1.0,3/8,30.88%,KCNQ1;GSN;KLHL3
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),-0.3251991559735575,-0.543709269361081,0.9594594594594594,1.0,1.0,2/8,19.89%,FOXO1;ATG7
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.22881802636631887,0.5434084709190902,1.0,1.0,1.0,12/44,18.30%,SEMA5A;SP1;TGFBR1;NRAS;NR4A1;SIRT1;NRP1;BMP2;PRKD1;CDH13;THBS4;WNT5A
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),0.312855137375493,0.5433219894602532,0.9642857142857143,1.0,1.0,6/6,68.73%,LRP6;FBN1;ALDH1A3;RARG;FBN2;KDM2B
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.2332154934674819,-0.5429997501521413,1.0,1.0,1.0,50/302,25.08%,PAPPA;IGF2BP3;USP6;RPS6KB2;TNC;PIGH;CP;RPL12;APOE;SPP1;RPS14;RPS8;LCMT1;RPL37A;DENND3;MBTPS1;ST3GAL1;EVA1A;AKT2;WWP2;FAM20C;SPARCL1;PAPPA2;RPS27;SERPIND1;FBXO22;MRPS18C;RIPK1;ST3GAL6;YME1L1;RPS6;RPS4X;CHRM3;DAB2IP;APH1B;PSEN1;MEN1;LAMB1;RPS25;RPL27A;DUSP12;RABGGTB;HARS1;MRPL23;IGFBP5;CALU;SCG2;AFG3L2;KNG1;DARS1
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.2739740292064116,-0.5428821853548526,1.0,1.0,1.0,10/38,25.83%,IFIH1;ARRB1;STAT3;IL6R;C1QTNF4;NLRP12;HLA-B;TIRAP;XBP1;SCIMP
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),0.3190508021390374,0.5427390532409705,0.9777777777777777,1.0,1.0,5/5,68.11%,VPS35;LRRK2;CAV2;DTNBP1;PALM
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),-0.36608596731950566,-0.5425352952318064,0.9666666666666667,1.0,1.0,4/6,32.60%,WDR19;RAB29;ARL13B;RABEP1
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),0.29609573472389356,0.5424143293243859,0.9375,1.0,1.0,7/7,70.40%,CYP7B1;CX3CL1;GAS6;SLC12A2;CXCL16;GPR183;PIK3CD
prerank,GO_Biological_Process_2021__regulation of entry of bacterium into host cell (GO:2000535),0.32730870710619375,0.5420067566254637,0.918918918918919,1.0,1.0,1/5,15.01%,EXOC7
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),0.3271861154466111,0.5414339372290804,0.9375,1.0,1.0,2/5,20.33%,PITHD1;FAXDC2
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.3682553245176196,-0.5413376803523824,0.9701492537313433,1.0,1.0,2/5,23.05%,CD55;HLA-A
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.2921914125035926,-0.5413174090651051,1.0,1.0,1.0,6/17,28.47%,MIS18BP1;CENPC;ITGB3BP;CENPP;MIS18A;CENPH
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.2921914125035926,-0.5413174090651051,1.0,1.0,1.0,6/17,28.47%,MIS18BP1;CENPC;ITGB3BP;CENPP;MIS18A;CENPH
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),-0.33113129957615306,-0.5409855969533599,0.9852941176470589,1.0,1.0,1/7,22.15%,KMT2A
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),-0.339995504078019,-0.5409140229292774,0.9384615384615385,1.0,1.0,1/5,14.55%,PDCD4
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),-0.27547113975118265,-0.5405416838028485,1.0,1.0,1.0,5/33,25.21%,TPST1;DDR2;EPHA4;PDGFRB;RELN
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),-0.3712989681271259,-0.540289202618793,0.9722222222222222,1.0,1.0,2/6,19.38%,SLC25A19;SLC25A36
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.2396930193674072,-0.5392362165318363,1.0,1.0,1.0,21/154,24.87%,MAGOHB;RPL12;THRAP3;PARN;RPS14;RPS8;RPL37A;CASC3;CNOT11;NCBP1;RPS27;UPF2;ATM;AGO1;RPS6;RPS4X;SAMD4A;RPS25;RPL27A;NCBP2;SAMD4B
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.29918679471030973,-0.5392226936144642,0.9876543209876543,1.0,1.0,2/15,12.86%,APOE;HTR2B
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.31096256684491985,0.5387578708524282,0.9333333333333333,1.0,1.0,5/5,68.91%,ELAVL4;TENT4A;LARP4B;METTL16;TENT4B
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.2508947774240597,-0.5383810287085549,1.0,1.0,1.0,16/66,28.33%,PLEKHF1;DAPK1;PLK2;FOXO1;TRIM5;TPCN1;SVIP;BNIP3L;RUFY4;RNF152;PIK3CB;PRKAA1;MID2;PRKAA2;PAFAH1B2;SESN2
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.3002215525359827,0.537798956579197,0.9333333333333333,1.0,1.0,1/9,8.70%,TRPM4
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.3526428913786238,-0.5374972084260813,0.971830985915493,1.0,1.0,3/7,24.84%,CENPC;NUF2;RMDN1
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),-0.3303238444967431,-0.537400904500239,0.9552238805970149,1.0,1.0,5/9,43.06%,RNF20;ZC3H14;NELFE;CTR9;CDK9
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.28331661651621537,0.5355432870704102,0.9666666666666667,1.0,1.0,10/10,71.69%,SESN3;SESN1;EIF2AK4;MTOR;RRAGD;RRAGB;LARS1;IMPACT;GCN1;SESN2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.3168682705016907,0.5350971645888357,1.0,1.0,1.0,1/8,8.57%,COMMD1
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.34665896040157124,-0.534517063959027,0.9452054794520548,1.0,1.0,2/7,30.24%,OGFOD1;ETF1
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.32360479740547116,0.5343484739252385,0.967741935483871,1.0,1.0,1/6,6.27%,FBP1
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.32360479740547116,0.5343484739252385,0.967741935483871,1.0,1.0,1/6,6.27%,FBP1
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.3271939561191229,0.5341469529913495,0.9166666666666666,1.0,1.0,1/7,4.80%,ANTXR2
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.2852939209523173,0.5341353173352076,0.9375,1.0,1.0,12/12,71.49%,TOB1;CNOT1;POLR2G;TNRC6C;TNRC6B;AGO2;CNOT7;TNRC6A;PABPC1;CPEB3;EIF4ENIF1;BTG2
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.2732781190512132,-0.5325697786473034,1.0,1.0,1.0,3/30,17.54%,EMD;TRAM1L1;EMC3
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.28812658222246584,-0.5313168791458112,0.9875,1.0,1.0,1/14,8.23%,CAV3
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),-0.22714167312130268,-0.5309792584576938,1.0,1.0,1.0,20/182,19.35%,EFNA1;LAMA2;SHTN1;ROBO2;EFNA5;DOCK7;SPTBN5;RAB3A;VASP;BDNF;SEMA4B;LRTM1;EPHA7;UNC5D;BAIAP2;SHANK3;CCK;GRB10;DOK1;DAB1
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.290004897970102,-0.5305798471696384,1.0,1.0,1.0,1/17,12.18%,CECR2
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.33081550802139037,0.5301782743789702,0.9767441860465116,1.0,1.0,5/5,66.93%,SLIT2;ROBO1;PADI2;SH2B3;SLIT3
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.2372995166029696,0.5296458810520347,0.9473684210526315,1.0,1.0,1/18,4.30%,ZC3H3
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.3040434879907101,-0.5283381669573872,0.9733333333333334,1.0,1.0,2/13,19.02%,SLIRP;DNM1L
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),-0.25611967909119715,-0.5278186767439695,1.0,1.0,1.0,9/43,28.99%,KIAA0319;VEGFA;CCK;MDGA1;RELN;TUBGCP2;SEMA3A;MEF2C;DDIT4
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),0.28318181532644904,0.5270371695016457,0.9411764705882353,1.0,1.0,2/12,13.56%,C5;MST1
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),-0.31932988202657125,-0.5267166465153882,0.9868421052631579,1.0,1.0,1/9,11.19%,PARN
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.235756825929037,-0.5266756096153691,1.0,1.0,1.0,10/94,19.88%,RPL12;MAN1A1;RPS14;RPS8;RPL37A;SRP54;CHMP4B;RPS27;RPS6;RPS4X
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.3241310160427808,0.5266022341211185,0.9375,1.0,1.0,5/5,67.60%,PTPN12;LRP1;HIP1;PTPN2;HIP1R
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.28088103107507784,0.5266021294805071,0.9642857142857143,1.0,1.0,4/16,20.35%,PPIA;SIRT1;HSPB1;PINK1
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),-0.35806567934026495,-0.525993768834144,0.9827586206896551,1.0,1.0,2/5,32.07%,ISG15;HERC5
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),0.28047484887515306,0.5254209989977048,1.0,1.0,1.0,1/7,5.69%,CHAMP1
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),-0.3448068786442415,-0.5248965502607374,1.0,1.0,1.0,1/6,22.35%,SPIRE1
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),-0.2608350383872551,-0.5247172770865042,1.0,1.0,1.0,12/45,29.94%,RAB17;MICALL2;ARL4C;CCDC93;VPS52;RAB35;VPS51;EPS15;RAB11FIP3;VPS53;WASHC1;SNX4
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),-0.32081465228307693,-0.5231033066778619,0.9722222222222222,1.0,1.0,1/9,27.96%,GTPBP3
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),0.247968938174983,0.5230196251582648,1.0,1.0,1.0,3/15,17.90%,GTF3C6;NIFK;SPIN1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.2814594884851863,0.5220061610732385,0.9117647058823529,1.0,1.0,1/10,6.18%,RBPJ
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.2971135505826643,0.5210226021380144,0.96,1.0,1.0,3/8,18.51%,SLC25A30;SLC25A11;SLC25A14
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.2600809715829873,-0.5203690715867104,1.0,1.0,1.0,8/52,25.87%,AKAP5;PPFIA1;SORBS1;MRAP;TGFB1;AP2M1;STX4;CLTC
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.27379700050021816,-0.5198450658367039,0.9861111111111112,1.0,1.0,6/19,28.47%,MIS18BP1;CENPC;ITGB3BP;CENPP;MIS18A;CENPH
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),0.3239614814552828,0.5194465530783487,0.9615384615384616,1.0,1.0,1/5,9.01%,DHODH
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),0.27146555959668167,0.519445591071389,0.9583333333333334,1.0,1.0,5/12,24.79%,PARP1;ERCC4;SLX4;TERF1;TERF2
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),-0.2436911279796618,-0.5190348886697193,1.0,1.0,1.0,7/59,21.19%,PLK2;TBC1D10B;TBC1D8;TBC1D2B;TBC1D13;RDX;CDKL1
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.29389790807681326,-0.5189507170157905,0.972972972972973,1.0,1.0,3/12,28.17%,PTPA;PDGFRB;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),0.30982620320855614,0.5188948807372085,0.9767441860465116,1.0,1.0,5/5,69.03%,PINK1;TOMM7;PRKN;HUWE1;ATP5IF1
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.24740999931606886,-0.5187861147531401,1.0,1.0,1.0,11/68,23.99%,CDKN2A;ATG14;DNAJC10;NTRK3;HDAC4;CDKN2B;DAB2IP;TERF2IP;MEN1;TGFB1;NCOR1
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),-0.22616249830200943,-0.5186828090080664,1.0,1.0,1.0,13/115,24.26%,PTPRC;PTPRB;DUSP22;UBASH3B;DUSP8;PTPRR;PPP2R3A;PPP3CC;PTPRJ;PPP5C;PPP2R2D;DUSP12;TPTE2
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),0.33094919786096266,0.5167045646663571,0.9166666666666666,1.0,1.0,5/5,66.92%,TCF4;SETD2;RPL23;SUPT6H;MCM3AP
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),-0.31935705863754815,-0.5165429819236234,0.9855072463768116,1.0,1.0,3/8,36.28%,RAB11FIP5;TRPV1;IMPACT
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),-0.3099034767259358,-0.5163526796402069,0.958904109589041,1.0,1.0,1/10,9.40%,RANBP3L
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),-0.3538329105319188,-0.5160467431210642,0.9857142857142858,1.0,1.0,3/5,30.29%,CAMK2A;CAMK2D;ENG
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.292632265752345,-0.5155923657798763,1.0,1.0,1.0,3/17,21.59%,CDKN2B;SMAD4;MEN1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.292632265752345,-0.5155923657798763,1.0,1.0,1.0,3/17,21.59%,CDKN2B;SMAD4;MEN1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),-0.30166334956884666,-0.5155222123865204,0.9868421052631579,1.0,1.0,2/10,30.16%,MAP2K1;DENND10
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.27309435866882664,-0.5152783092153368,1.0,1.0,1.0,4/24,23.63%,B2M;LRPAP1;MKLN1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.2816661826137182,0.5145958869982986,0.972972972972973,1.0,1.0,1/9,6.18%,RBPJ
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),-0.320114935348325,-0.5122526660233659,0.9861111111111112,1.0,1.0,3/7,36.28%,RAB11FIP5;TRPV1;IMPACT
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.23836729843993557,-0.5105423961936066,1.0,1.0,1.0,14/75,26.35%,RBSN;STX10;CLTCL1;TBC1D10B;RAB6B;TMEM87B;VPS52;DCTN1;ANKFY1;VPS51;RGP1;STX5;CLTC;RAB29
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),-0.33438747975885164,-0.5090844770571754,1.0,1.0,1.0,2/7,27.01%,PRKAA1;PRKAA2
prerank,GO_Biological_Process_2021__limb development (GO:0060173),-0.282712623736924,-0.5082837096355887,0.9871794871794872,1.0,1.0,6/20,31.55%,INTU;ZNF141;ZNRF3;RSPO2;IFT122;IQCE
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),0.28288351712018256,0.5080410776917962,1.0,1.0,1.0,2/8,12.54%,CHP1;ERRFI1
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.27837950766695185,-0.5061538066336264,0.9746835443037974,1.0,1.0,3/17,21.28%,NEIL2;NTHL1;TERF2IP
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),-0.3006777672610691,-0.5060115282553124,1.0,1.0,1.0,5/15,35.34%,FAM20A;GRIN1;TMTC2;SELENON;CNNM2
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.343077103463449,-0.5056945947820913,0.9736842105263158,1.0,1.0,2/6,20.13%,CBLN2;DCTN1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.21366434689507485,0.5054484486871961,1.0,1.0,1.0,21/21,78.66%,NTNG2;VPS35;IL1RAPL1;HOMER1;AKT1;PTEN;CTNNA2;ZNF804A;CCDC88A;NDEL1;NCS1;BRSK2;CAMK2G;MARK1;NTNG1;GSK3B;ULK4;DISC1;FBXO7;BRSK1;PSEN1
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),-0.3146091101778903,-0.50540743036236,0.9848484848484849,1.0,1.0,2/6,31.77%,GRB10;APPL2
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),-0.31727497493823087,-0.5054074225022576,0.9701492537313433,1.0,1.0,2/8,24.42%,SHANK3;WNT7A
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),-0.30622516199649175,-0.5053390334906797,0.9850746268656716,1.0,1.0,1/9,12.61%,ITPKC
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),-0.3372428508468133,-0.5040920670540309,0.9682539682539683,1.0,1.0,4/6,37.49%,XBP1;CIITA;TAF7;JAK2
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.2787134619338273,-0.5030213249486293,0.9746835443037974,1.0,1.0,1/15,12.18%,CECR2
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.29184816811402264,-0.5020617854599622,0.9873417721518988,1.0,1.0,2/12,28.46%,ADSS2;PAICS
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.26937289951032917,0.5016801047335607,0.9705882352941176,1.0,1.0,1/9,7.86%,IFT20
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.23308662908387484,0.5015125848604738,1.0,1.0,1.0,7/24,20.23%,ABCD2;FIS1;PEX13;ACBD5;PEX5;ZFAND6;PEX2
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),0.3242303127041466,0.5013030182704841,0.9411764705882353,1.0,1.0,1/5,8.55%,ALDH6A1
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.2521966928274561,0.4999183569757187,1.0,1.0,1.0,2/13,13.73%,MRPL44;HENMT1
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),-0.2785387655424525,-0.49985897798910306,0.972972972972973,1.0,1.0,3/16,21.60%,APOE;SHANK3;DLG4
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.26355915200963004,0.4987622399452181,0.9705882352941176,1.0,1.0,12/12,73.67%,LAMTOR1;OPTN;ECE1;NSF;AP1AR;KIF16B;TBC1D16;SCRIB;INPP5F;SNCA;VAMP3;RAB29
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),-0.2917545052955025,-0.4986138401238049,0.9861111111111112,1.0,1.0,2/11,14.64%,TSC1;IFIT1
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),0.2451055966679963,0.497543795045897,0.967741935483871,1.0,1.0,1/11,6.99%,RPS19
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.23041493702581706,-0.4973462534879335,1.0,1.0,1.0,15/63,27.16%,KLC1;DNM2;ACTR1B;DCTN6;HLA-DMA;AP2A2;DCTN1;OSBPL1A;CLTA;AP2M1;AP2A1;SEC24A;CLTC;KIF3C;ACTR1A
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.2426498812334126,-0.49693323389904975,1.0,1.0,1.0,10/47,26.15%,BRCA1;NR1D1;RIPK1;ADAM9;DAB2IP;IGBP1;ADAMTS7;ZFP36L2;MAP2K7;YBX3
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.27925417290076393,-0.49692476712279027,1.0,1.0,1.0,4/27,19.00%,AZIN2;ALK;AZIN1;HDAC4
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.25819001884282067,-0.4967856770984719,1.0,1.0,1.0,6/21,28.47%,MIS18BP1;CENPC;ITGB3BP;CENPP;MIS18A;CENPH
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),-0.3288157180296371,-0.49639688352558214,0.9857142857142858,1.0,1.0,2/5,29.62%,LZTFL1;CCDC66
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),-0.3115438674470353,-0.49576337841466717,0.9824561403508771,1.0,1.0,1/7,18.48%,MGME1
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),-0.2990609884497317,-0.4955084284356036,1.0,1.0,1.0,2/8,31.77%,GRB10;APPL2
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.21357859531772572,0.49509805795746237,1.0,1.0,1.0,15/15,78.66%,NRP1;DSCAM;BCL10;BTBD10;AR;GLMN;EGFR;KCTD20;SRC;PTGES3;ILK;SDCBP;SNCA;APP;PSEN1
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.26021770269611766,-0.4941467873140104,1.0,1.0,1.0,4/24,21.08%,CAV3;PFN2;SHANK3;SMAD4
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),0.25844199264460066,0.49328441967782527,1.0,1.0,1.0,10/10,74.17%,BLOC1S4;AP3M1;AP3S1;AP3B1;SNAPIN;AP3M2;AP3D1;DTNBP1;AP3B2;BLOC1S2
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),0.25844199264460066,0.49328441967782527,1.0,1.0,1.0,10/10,74.17%,BLOC1S4;AP3M1;AP3S1;AP3B1;SNAPIN;AP3M2;AP3D1;DTNBP1;AP3B2;BLOC1S2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),0.2935828877005348,0.492849386425181,1.0,1.0,1.0,5/5,70.65%,WNT5A;KARS1;HSPD1;CD226;NECTIN2
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.2519208141959917,0.49272794286688953,1.0,1.0,1.0,1/8,11.02%,SMAD3
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),-0.3414702736334947,-0.4917304065850138,1.0,1.0,1.0,2/5,19.15%,LIG3;XRCC4
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.2633196540189375,0.4914420308339152,1.0,1.0,1.0,1/14,5.41%,SVIL
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.21944706671334197,0.4913293056334167,1.0,1.0,1.0,3/18,16.14%,BRK1;ARPC2;CDC42
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.22392033000999614,-0.49033705296238844,1.0,1.0,1.0,15/83,29.99%,RPL12;RPS14;RPS8;RPL37A;SRP54;RPS27;RPS6;RPS4X;RPS25;RPL27A;RPLP2;ZFAND2B;RPL32;RPL14;RPL30
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),0.2949197860962567,0.4899170561225947,0.9722222222222222,1.0,1.0,5/5,70.52%,LTN1;MTRES1;RACK1;NEMF;ZNF598
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),-0.32834077768763414,-0.4898290629502282,0.9827586206896551,1.0,1.0,1/7,20.26%,IGF1R
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),-0.32886143973345794,-0.48982680873322676,0.9857142857142858,1.0,1.0,2/5,31.97%,SLC36A4;SLC25A29
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),-0.2994277188340668,-0.48913330248373865,0.9714285714285714,1.0,1.0,1/7,14.99%,AKT2
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.2802492019329975,-0.48881948151325755,0.9873417721518988,1.0,1.0,3/15,27.22%,FAF2;UFD1;NPLOC4
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.22506408655811252,0.4888112300984908,1.0,1.0,1.0,10/35,18.11%,DNAJC15;GRPEL1;SEC61B;DNAJC19;HSPA5;SEC61G;TIMM21;TIMM50;PEX5;TIMM23
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.22692502493742717,-0.48877855098695555,1.0,1.0,1.0,15/65,27.16%,KLC1;DNM2;ACTR1B;DCTN6;HLA-DMA;AP2A2;DCTN1;OSBPL1A;CLTA;AP2M1;AP2A1;SEC24A;CLTC;KIF3C;ACTR1A
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.29005269869023265,-0.488739106406221,0.9726027397260274,1.0,1.0,2/10,21.08%,TGFB2;SMAD4
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.2918487678935958,-0.4874575680503031,0.9864864864864865,1.0,1.0,3/12,20.04%,MGME1;SLC25A36;TYMP
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),-0.32190075699834075,-0.4861855485378534,0.9824561403508771,1.0,1.0,1/5,18.64%,PDCD1LG2
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.22206069092754183,-0.4842459141249323,1.0,1.0,1.0,15/66,29.60%,ATG14;PTPA;DNAJC10;PNKP;NTRK3;SNTA1;DAB2IP;TERF2IP;MEN1;TGFB1;ENSA;PRKAA1;PRKAA2;CDYL;CRTAP
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),0.2541794837501672,0.48421264260694896,0.967741935483871,1.0,1.0,11/11,74.60%,WDR35;CILK1;IFT140;IFT43;TTC21B;DYNC2H1;TTC21A;DYNC2LI1;IFT122;DYNC2I1;WDR19
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.25722575394033975,0.4821072525951555,1.0,1.0,1.0,2/13,11.75%,ACLY;HMGCS1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),-0.28513658754262267,-0.4820291853534658,0.9764705882352941,1.0,1.0,3/13,22.26%,PDPN;DDR2;TGFB1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.2566766946420387,0.4806686061357483,0.9333333333333333,1.0,1.0,1/14,6.44%,SP1
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),-0.23530691625803113,-0.48061439073255097,1.0,1.0,1.0,8/39,29.85%,GADD45A;CRYAB;WRN;ATM;ECT2;CLOCK;KDM4D;RAD9A
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),0.285099856763381,0.4805633805686472,1.0,1.0,1.0,1/6,8.97%,HSPA8
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),-0.2890138021574246,-0.4801666881541711,0.9852941176470589,1.0,1.0,4/9,38.26%,TGFB1;CIITA;TGFB3;RGCC
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.22327021186637264,0.4801433194007075,1.0,1.0,1.0,1/14,8.12%,SLC12A8
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),-0.28282838893859275,-0.47796641225876474,0.9866666666666667,1.0,1.0,7/10,45.30%,METRNL;FNDC5;VSTM2A;SOX13;FTO;BMP7;HNRNPU
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),0.29286717026539205,0.4767792351831331,0.9310344827586207,1.0,1.0,6/6,70.73%,TPI1;GK;PGP;GK5;COQ3;GOT1
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),-0.2605220843842698,-0.47663980725022015,0.9873417721518988,1.0,1.0,3/14,28.88%,SLC6A9;CHMP6;SOCS4
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.2736804129386752,-0.47417849468290707,0.9861111111111112,1.0,1.0,2/9,28.88%,CHMP6;SOCS4
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.2784086353999774,-0.47239617960069136,0.9861111111111112,1.0,1.0,1/14,12.78%,BAG5
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.2749875935860098,-0.4712275423460372,1.0,1.0,1.0,3/12,28.39%,SULF1;SFRP4;PCSK6
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.228330658105939,0.47045532294359327,1.0,1.0,1.0,13/13,77.19%,DDI2;HSF1;ATP2B4;RIOK3;PDE12;RTF2;ROCK2;FMR1;EPG5;BLM;SPIDR;ATRX;DDX11
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.3069575273452258,-0.46998474949101426,0.9861111111111112,1.0,1.0,1/6,28.63%,GSTO1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.2444085334373835,-0.4691714250209973,1.0,1.0,1.0,6/26,27.30%,BAG5;SVIP;USP14;DDRGK1;MAP1A;NOP53
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),0.27639245729674616,0.46814467188389614,1.0,1.0,1.0,2/5,18.66%,RABL3;DBI
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.27743020100151383,-0.46732342187285364,1.0,1.0,1.0,4/14,24.04%,RSAD2;IFI35;NINJ1;TIRAP
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),0.2601283594063375,0.46730678792334696,0.9696969696969697,1.0,1.0,7/7,74.00%,CBARP;YWHAE;BIN1;ATP1A2;SESTD1;VDAC1;PLN
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),-0.30460536312203024,-0.4662687934881628,1.0,1.0,1.0,1/8,12.02%,BDNF
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.27910993735949663,-0.4660803569070458,0.984375,1.0,1.0,2/11,20.04%,SLC25A19;TYMP
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),0.2226290328705766,0.46559677086870405,1.0,1.0,1.0,6/22,20.23%,ABCD2;FIS1;PEX13;ACBD5;PEX5;PEX2
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),-0.24526589939818322,-0.46541085342332217,1.0,1.0,1.0,6/26,29.08%,PTPRJ;ARRB2;PIK3CB;NOP53;PHLPP2;PPP2R5C
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.21755683492554823,-0.46257826561409965,1.0,1.0,1.0,4/66,15.58%,P2RY12;CDC42EP3;PLEKHM1;AVIL
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),0.21453623899633636,0.4597345772499027,1.0,1.0,1.0,4/12,24.79%,CTC1;POT1;TERF1;TERF2
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),-0.2996723806224326,-0.4585933378187949,0.9868421052631579,1.0,1.0,2/8,28.07%,SORBS1;PRKCZ
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),-0.2996723806224326,-0.4585933378187949,0.9868421052631579,1.0,1.0,2/8,28.07%,SORBS1;PRKCZ
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),-0.29489585768007354,-0.45836476335776705,1.0,1.0,1.0,3/7,30.24%,PFKP;HK1;PFKL
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.24006954660960278,0.4574515306181378,0.96,1.0,1.0,11/11,76.01%,COX6B1;COX6C;COX5A;COX7C;COX5B;COX10;COX7A2L;COX4I1;COX7B;CYCS;AFG1L
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.22912249173821936,-0.45672716165099014,1.0,1.0,1.0,7/47,24.04%,LAS1L;WDR12;TRAF7;HEATR3;MALSU1;ZNF622;PAK1IP1
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),-0.2792555260465085,-0.45558325581134484,1.0,1.0,1.0,3/11,32.53%,HCN2;SLC6A1;SLC9C1
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.25670292082552665,-0.4554223929506612,1.0,1.0,1.0,3/13,27.28%,DDX20;PRPF3;USP4
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.2823529411764705,0.45371073994197963,0.9714285714285714,1.0,1.0,5/5,71.77%,NAA30;NAA20;NAA25;NAA16;NAA15
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),0.2554366185126781,0.4529399129333984,1.0,1.0,1.0,1/7,9.01%,DHODH
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),0.24630389115824713,0.452360933552464,1.0,1.0,1.0,5/14,19.42%,COX19;TIMM21;COA5;COX17;SMIM20
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),-0.2825040150037377,-0.45135368383692354,0.9852941176470589,1.0,1.0,1/7,14.34%,ADGRV1
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),0.23926173021019406,0.45073439104808405,1.0,1.0,1.0,5/16,19.42%,COX19;TIMM21;COA5;COX17;SMIM20
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.23061415558996695,0.44956744545616817,1.0,1.0,1.0,5/11,26.88%,LNPK;PRNP;PICK1;FYN;ITGA3
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.2973331464039153,-0.4483747324821045,1.0,1.0,1.0,2/5,28.17%,STAT1;MEF2C
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),-0.26436441510931186,-0.4475399849202516,1.0,1.0,1.0,3/10,30.27%,KCNH1;ADAM12;ERVW-1
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),0.2549465240641712,0.44704680794001667,1.0,1.0,1.0,5/5,74.51%,SLCO3A1;SLCO5A1;SLC16A2;SLCO2B1;SLCO1A2
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),0.24969100611689665,0.4463731741774363,1.0,1.0,1.0,2/6,16.40%,ATF4;WNT7B
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.27301290193194727,0.44439136570916693,1.0,1.0,1.0,6/6,72.71%,VCP;TANK;WDR48;TNIP1;SART3;NOP53
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.2275003868059739,-0.4441504121353435,1.0,1.0,1.0,4/36,29.21%,DVL2;DVL1;DVL3;MAP1LC3B
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),-0.26463175415572715,-0.44391748443936996,0.9864864864864865,1.0,1.0,1/10,14.99%,AKT2
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.2745147869175364,0.4433996142282097,0.967741935483871,1.0,1.0,1/6,12.13%,HMGCR
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),-0.25033944149478116,-0.44147139140902775,1.0,1.0,1.0,7/11,39.33%,TGFB1;PIEZO1;MEF2C;EFNB2;NRG1;ATP11A;PROX1
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.21448635634028906,0.43771038578319,1.0,1.0,1.0,13/13,78.57%,NUP35;SEH1L;NUP98;TPR;NUP54;AHCTF1;RTN4;NDC1;NUP153;NUP133;NUP205;NUP93;NUP107
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),-0.24790242990902067,-0.4376958859315923,0.9875,1.0,1.0,3/15,27.09%,TMEM120B;GRIN1;KCNC2
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.27760695187165774,0.4371167617386389,1.0,1.0,1.0,5/5,72.25%,DDX21;SRPK2;SIRT7;PRIMPOL;DDX23
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),-0.26318353945594564,-0.43612937975888527,1.0,1.0,1.0,4/9,40.56%,NCOR1;FOXP1;PIAS2;NCOR2
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),0.24809304427910506,0.43490191850071447,1.0,0.9995460321333772,1.0,1/8,10.16%,EXOSC8
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",0.24809304427910506,0.43490191850071447,1.0,0.9995460321333772,1.0,1/8,10.16%,EXOSC8
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.21392979278967433,-0.4337129585607958,1.0,1.0,1.0,4/38,21.46%,ROBO2;PVR;TENM3;FAT2
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),-0.2797258023102292,-0.4318026735570573,1.0,1.0,1.0,3/6,33.53%,STAT3;CDK6;EIF2B5
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.2661215047753893,-0.43093532689931546,0.9701492537313433,1.0,1.0,2/8,26.96%,EPHA4;SEMA3A
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),-0.28330276750137656,-0.4303369113425382,1.0,1.0,1.0,1/6,18.47%,SHANK3
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.26288228156621896,-0.4293568093250936,1.0,1.0,1.0,1/14,9.49%,UBASH3B
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.22490470139771307,0.42731811188213537,1.0,0.9999011139497436,1.0,12/12,77.53%,AGPS;FAR1;PLA2G7;DHRS7B;GNPAT;PLA2G6;AGMO;PEX7;LIPE;PAFAH1B1;PLAAT3;NCEH1
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),0.19986613119143246,0.42336445123018546,1.0,0.9996853021080991,1.0,25/25,80.05%,PRIM1;TAF12;PRMT5;NAT14;TAF6;TCEA2;RSF1;SETX;TBP;SMARCA5;POLR2A;TAF13;TTF2;BRF1;TTF1;NCOA6;POLA1;TBPL1;PRIM2;TAF7;TAF4;TAF5;GTF2B;MTERF1;HELB
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),-0.23322791996782366,-0.42267657241697054,1.0,1.0,1.0,1/15,22.71%,GIGYF2
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),-0.22270576085402966,-0.4219375772023199,1.0,1.0,1.0,7/28,31.01%,AKT2;PDK1;PDK2;PDK3;GNB3;IRS2;FOXK2
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),-0.26724151337554986,-0.4215563877327325,1.0,1.0,1.0,2/6,28.60%,TERF2IP;WAPL
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),-0.2633664542848369,-0.42040840656536943,1.0,1.0,1.0,1/8,25.45%,SFRP4
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),-0.2424221211470275,-0.4194347775919721,1.0,1.0,1.0,1/18,13.08%,ITGB1BP1
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.22498165226811642,0.41764910582566583,1.0,0.999631418259299,1.0,1/8,11.65%,CREB3L1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.22973070362610404,-0.4134823763426183,1.0,1.0,1.0,1/22,11.87%,THOC5
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),-0.2548703315107349,-0.4095224329914035,1.0,1.0,1.0,1/9,10.83%,CAMK2B
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.22933009160261814,-0.4090942577212386,1.0,1.0,1.0,4/11,40.90%,KMT2A;OGT;TET3;CTR9
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.2522100369106994,-0.40798180891863983,1.0,1.0,1.0,1/9,21.28%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.22531256267968197,0.4070852795952105,1.0,0.9996286313735767,1.0,8/8,77.48%,NSFL1C;BICD1;APC;UBXN2B;MARK4;GSK3B;CEP250;CEP72
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.268769127687407,-0.4049163865923932,0.9841269841269841,1.0,1.0,1/6,21.28%,TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),-0.25694899796552817,-0.4013182207638191,0.984375,1.0,1.0,1/5,22.31%,EPHA4
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.25859209971763797,-0.39787160737900307,1.0,1.0,1.0,1/7,22.83%,DDX11
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),0.19577285800280916,0.39674171644968514,1.0,0.9995408124218743,1.0,14/14,80.44%,PELI1;STUB1;BIRC2;ASAH1;HSP90AA1;PDCD6IP;FLOT2;CFLAR;SDCBP;CDC37;OGT;FLOT1;CYLD;RIPK1
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),-0.24834928521479616,-0.3963317301630676,1.0,1.0,1.0,3/7,33.08%,NRP2;SEMA3A;SLIT3
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),-0.24834928521479616,-0.3963317301630676,1.0,1.0,1.0,3/7,33.08%,NRP2;SEMA3A;SLIT3
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.23967760656943338,-0.3913341051711763,1.0,1.0,1.0,1/8,22.31%,EPHA4
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.22032663915023876,-0.38501895757851406,1.0,1.0,1.0,3/16,34.19%,ADSS2;PAICS;AK4
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.2454810357197717,-0.3754017869794159,1.0,1.0,1.0,1/6,21.28%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.2454810357197717,-0.3754017869794159,1.0,1.0,1.0,1/6,21.28%,TERF2IP
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.23005737459579606,-0.3663248162287038,1.0,1.0,1.0,1/8,22.83%,DDX11
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.24275990162702912,-0.3628003502959132,1.0,1.0,1.0,4/9,37.31%,ERI2;EXOSC10;ERI3;RPS21
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.2017327952320021,-0.36223682195457557,1.0,0.9998521766981202,1.0,3/18,29.62%,RPTOR;ZNF345;DHX36
